Clustering O 0 0.0104062519967556
of O 0 8.444023842457682e-05
missense O 0 0.025552792474627495
mutations O 0 0.0021692693699151278
in O 0 0.00021188049868214875
the O 0 0.0017834878526628017
ataxia B-Disease 1 1.0
- I-Disease 1 0.9993316531181335
telangiectasia I-Disease 1 0.9999396800994873
gene O 0 0.0029681436717510223
in O 0 9.282989776693285e-05
a O 0 0.0010056046303361654
sporadic B-Disease 0 0.0921546220779419
T I-Disease 1 0.9999874830245972
- I-Disease 1 0.6444382071495056
cell I-Disease 1 0.6434869170188904
leukaemia I-Disease 1 0.9999998807907104
. O 0 0.0010095485486090183

Ataxia B-Disease 1 0.9999992847442627
- I-Disease 1 0.9980164766311646
telangiectasia I-Disease 1 0.999995231628418
( O 0 0.005302546080201864
A B-Disease 1 0.999627947807312
- I-Disease 1 0.9990019202232361
T I-Disease 1 0.9999860525131226
) O 0 0.00029465972329489887
is O 0 0.00016777250857558101
a O 0 0.001012946479022503
recessive B-Disease 1 0.9969096779823303
multi I-Disease 1 0.9990021586418152
- I-Disease 1 0.9989120960235596
system I-Disease 1 0.9824777245521545
disorder I-Disease 1 0.9999998807907104
caused O 0 0.062443312257528305
by O 0 0.00015781892579980195
mutations O 0 0.0021726388949900866
in O 0 0.0001498622732469812
the O 0 0.00026174774393439293
ATM O 0 0.028526755049824715
gene O 0 0.0029370610136538744
at O 0 0.0020255299750715494
11q22 O 0 0.2067415714263916
- O 0 0.019795779138803482
q23 O 0 0.11537856608629227
( O 0 0.0026207829359918833
ref O 1 0.6963440775871277
. O 0 0.0003437305276747793
3 O 0 0.001719230436719954
) O 0 0.00046414975076913834
. O 0 0.0004406753578223288

The O 0 0.0010867365635931492
risk O 0 0.25551658868789673
of O 0 0.0004264897434040904
cancer B-Disease 1 1.0
, O 0 0.0005601136363111436
especially O 0 0.003799484111368656
lymphoid B-Disease 1 0.9997169375419617
neoplasias I-Disease 1 0.9937126040458679
, O 0 0.00033629362587817013
is O 0 0.00043435610132291913
substantially O 0 0.01726885698735714
elevated O 1 0.9886839985847473
in O 0 0.00036014444776810706
A B-Disease 1 0.9997280240058899
- I-Disease 1 0.9999737739562988
T I-Disease 1 0.9999998807907104
patients O 1 0.9999988079071045
and O 0 0.0003385537420399487
has O 0 0.0010735512478277087
long O 0 0.0033893967047333717
been O 0 0.0004253808583598584
associated O 0 0.0004757951246574521
with O 0 0.00032553914934396744
chromosomal O 1 0.9986976385116577
instability O 1 0.9908203482627869
. O 0 0.001586536760441959

By O 0 0.0003018380084540695
analysing O 0 0.10166985541582108
tumour B-Disease 1 0.9999998807907104
DNA O 0 0.00386240566149354
from O 0 0.000399032753193751
patients O 1 0.9999892711639404
with O 0 0.00017312861746177077
sporadic B-Disease 0 0.08560881018638611
T I-Disease 1 0.9999610185623169
- I-Disease 0 0.019857998937368393
cell I-Disease 0 0.012527849525213242
prolymphocytic I-Disease 1 0.9994766116142273
leukaemia I-Disease 1 0.9999998807907104
( O 0 0.008438605815172195
T B-Disease 1 0.9999827146530151
- I-Disease 1 0.7901060581207275
PLL I-Disease 1 0.9996833801269531
) O 0 0.0004981032107025385
, O 0 0.00015172440907917917
a O 0 0.0009219108615070581
rare O 0 0.03043193928897381
clonal B-Disease 1 0.9826388359069824
malignancy I-Disease 1 0.9999771118164062
with O 0 0.00015190885460469872
similarities O 0 0.0010657395469024777
to O 0 9.352542838314548e-05
a O 0 0.0013836754951626062
mature B-Disease 1 0.9975926280021667
T I-Disease 1 0.9999953508377075
- I-Disease 0 0.10716050118207932
cell I-Disease 0 0.0591297373175621
leukaemia I-Disease 1 0.9999994039535522
seen O 0 0.002424010308459401
in O 0 0.0004208068421576172
A B-Disease 1 0.9990012049674988
- I-Disease 1 0.9989053010940552
T I-Disease 1 0.9999951124191284
, O 0 0.0004544588446151465
we O 0 0.00021805048163514584
demonstrate O 0 0.0018143273191526532
a O 0 0.0003607574908528477
high O 0 0.0008951190975494683
frequency O 0 8.17503678263165e-05
of O 0 2.4810602553770877e-05
ATM O 0 0.03757921978831291
mutations O 0 0.004235885571688414
in O 0 0.0015366215957328677
T B-Disease 1 0.9999614953994751
- I-Disease 1 0.6184213757514954
PLL I-Disease 1 0.9994346499443054
. O 0 0.0011641846504062414

In O 0 0.0010904246009886265
marked O 0 0.0024589733220636845
contrast O 0 0.0016372723039239645
to O 0 7.148701115511358e-05
the O 0 0.00018636661116033792
ATM O 0 0.023641390725970268
mutation O 0 0.002279887907207012
pattern O 0 0.0035044222604483366
in O 0 0.0008143638842739165
A B-Disease 1 0.9996635913848877
- I-Disease 1 0.9994339346885681
T I-Disease 1 0.9999964237213135
, O 0 0.0003214153693988919
the O 0 0.00011957987589994445
most O 0 0.00017501380352769047
frequent O 0 0.002836038824170828
nucleotide O 0 0.00030339541262947023
changes O 0 0.0003117642772849649
in O 0 0.00018423776782583445
this O 0 0.0006562324124388397
leukaemia B-Disease 1 0.9999991655349731
were O 0 0.00032761896727606654
missense O 0 0.03100891038775444
mutations O 0 0.0060458118095994
. O 0 0.0005740298074670136

These O 0 0.0002426292485324666
clustered O 0 0.004295274615287781
in O 0 0.000300776882795617
the O 0 0.00028655093046836555
region O 0 0.001605502562597394
corresponding O 0 0.0002666794171091169
to O 0 5.733693978982046e-05
the O 0 0.00024906767066568136
kinase O 0 0.02102392539381981
domain O 0 0.0013537772465497255
, O 0 0.0002598856808617711
which O 0 6.651996955042705e-05
is O 0 0.00016974077152553946
highly O 0 0.0010082052322104573
conserved O 0 0.0003249754081480205
in O 0 0.00030772783793509007
ATM O 0 0.05710168182849884
- O 0 0.008487827144563198
related O 0 0.0008652621181681752
proteins O 0 0.00017551144992467016
in O 0 0.0005116050015203655
mouse O 0 0.015428906306624413
, O 0 0.0002976855612359941
yeast O 0 0.004469725303351879
and O 0 0.00027095069526694715
Drosophila O 0 0.008757134899497032
. O 0 0.0005298073519952595

The O 0 0.00042730665882118046
resulting O 0 0.001319096889346838
amino O 0 0.0011603179154917598
- O 0 0.00866602547466755
acid O 0 0.007207838818430901
substitutions O 0 0.0010774357942864299
are O 0 3.383097646292299e-05
predicted O 0 0.0018933372339233756
to O 0 0.00012421778228599578
interfere O 0 0.009435184299945831
with O 0 0.0003976846346631646
ATP O 1 0.9921002984046936
binding O 0 0.0014846418052911758
or O 0 0.0005395087064243853
substrate O 0 0.011825134046375751
recognition O 0 0.004633419681340456
. O 0 0.0008567132754251361

Two O 0 6.18751801084727e-05
of O 0 2.5150666260742582e-05
seventeen O 0 0.008637119084596634
mutated O 0 0.30723515152931213
T B-Disease 1 0.9998810291290283
- I-Disease 0 0.09993275254964828
PLL I-Disease 1 0.9973600506782532
samples O 0 0.0008481292170472443
had O 0 0.0003241115191485733
a O 0 0.00035843972000293434
previously O 0 0.0019539794884622097
reported O 0 0.006351590156555176
A B-Disease 1 0.9899700284004211
- I-Disease 1 0.9964717626571655
T I-Disease 1 0.9999630451202393
allele O 0 0.01606825180351734
. O 0 0.0007377085858024657

In O 0 0.0010611314792186022
contrast O 0 0.0040064286440610886
, O 0 0.0004554528568405658
no O 0 0.0004603688430506736
mutations O 0 0.0019036777084693313
were O 0 6.59962315694429e-05
detected O 0 0.005441212560981512
in O 0 7.048196130199358e-05
the O 0 0.0002234615240013227
p53 O 0 0.017719974741339684
gene O 0 0.002543885027989745
, O 0 0.00016450513794552535
suggesting O 0 0.002176557434722781
that O 0 7.471039134543389e-05
this O 0 0.000407892424846068
tumour B-Disease 1 1.0
suppressor O 0 0.142217755317688
is O 0 0.0005766389076597989
not O 0 0.00018219175399281085
frequently O 0 0.0012340983375906944
altered O 0 0.002337453421205282
in O 0 0.00018854525114875287
this O 0 0.0007118046632967889
leukaemia B-Disease 1 0.9999998807907104
. O 0 0.0016711249481886625

Occasional O 0 0.024351786822080612
missense O 0 0.04667488858103752
mutations O 0 0.004086130298674107
in O 0 0.00035845203092321754
ATM O 0 0.016395894810557365
were O 0 4.904927845927887e-05
also O 0 0.00014809622371103615
found O 0 0.0002667912922333926
in O 0 0.0006198055343702435
tumour B-Disease 1 0.9999998807907104
DNA O 0 0.0027917472179979086
from O 0 0.00037190536386333406
patients O 1 0.9999914169311523
with O 0 0.00024992282851599157
B B-Disease 1 0.9986211061477661
- I-Disease 0 0.008873905055224895
cell I-Disease 0 0.0037243596743792295
non I-Disease 0 0.01454129721969366
- I-Disease 1 0.9992190599441528
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999942779541016
( O 0 0.0034888642840087414
B B-Disease 1 0.9968371391296387
- I-Disease 0 0.021293839439749718
NHL I-Disease 0 0.11880811303853989
) O 0 0.0001517087803222239
and O 0 0.00010743333405116573
a O 0 0.0022494925651699305
B B-Disease 1 0.9954975843429565
- I-Disease 0 0.025203395634889603
NHL I-Disease 0 0.36119523644447327
cell O 0 0.008787203580141068
line O 0 0.003135517006739974
. O 0 0.0005036076181568205

The O 0 0.0006230731960386038
evidence O 0 0.0002516319218557328
of O 0 1.1665891179291066e-05
a O 0 0.00026602347497828305
significant O 0 0.00028422405011951923
proportion O 0 0.00027374541969038546
of O 0 6.09526177868247e-05
loss O 1 0.5381116271018982
- O 0 0.004735346417874098
of O 0 5.115627573104575e-05
- O 0 0.00843121949583292
function O 0 0.0017152968794107437
mutations O 0 0.0019475178560242057
and O 0 0.00012454038369469345
a O 0 0.0007505824323743582
complete O 0 0.002058729762211442
absence O 0 0.0031476346775889397
of O 0 1.9707083993125707e-05
the O 0 0.0003603635705076158
normal O 0 0.005373544059693813
copy O 0 0.0012227316619828343
of O 0 3.874717731378041e-05
ATM O 0 0.027074577286839485
in O 0 0.0001172232223325409
the O 0 8.594646351411939e-05
majority O 0 0.00014344426745083183
of O 0 9.020508878165856e-05
mutated O 1 0.9742217063903809
tumours B-Disease 1 0.9999994039535522
establishes O 1 0.612761914730072
somatic O 0 0.046981729567050934
inactivation O 0 0.3278355002403259
of O 0 2.817845052049961e-05
this O 0 0.00011704584176186472
gene O 0 0.0017499510431662202
in O 0 0.00012870179489254951
the O 0 0.00044994012569077313
pathogenesis O 1 0.9992311000823975
of O 0 0.0001687001931713894
sporadic B-Disease 1 0.7606599926948547
T I-Disease 1 0.9999829530715942
- I-Disease 1 0.948050320148468
PLL I-Disease 1 0.999674916267395
and O 0 0.00045373334432952106
suggests O 0 0.002016944345086813
that O 0 8.88000286067836e-05
ATM O 0 0.009743645787239075
acts O 0 0.00039196034776978195
as O 0 0.0003568891261238605
a O 0 0.0050597465597093105
tumour B-Disease 1 0.9999998807907104
suppressor O 0 0.20080576837062836
. O 0 0.0007823850028216839

As O 0 0.0009473820100538433
constitutional O 0 0.0011461544781923294
DNA O 0 0.002810858655720949
was O 0 0.0010668453760445118
not O 0 0.00011092497879872099
available O 0 0.00014905305579304695
, O 0 9.450180368730798e-05
a O 0 0.0007997585344128311
putative O 0 0.2983318269252777
hereditary O 1 0.9994561076164246
predisposition O 1 0.9999542236328125
to O 0 0.002928798785433173
T B-Disease 1 0.9999741315841675
- I-Disease 1 0.6324315071105957
PLL I-Disease 1 0.9993023872375488
will O 0 0.00023096651420928538
require O 0 0.0006242766394279897
further O 0 0.0004606926522683352
investigation O 0 0.00817146897315979
. O 0 0.00024220396880991757
. O 0 0.0004052850999869406

Myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999998807907104
protein O 0 0.011138561181724072
kinase O 0 0.05667635798454285
is O 0 0.0006278501241467893
involved O 0 0.0008943031425587833
in O 0 7.519419159507379e-05
the O 0 6.862569716759026e-05
modulation O 0 0.001055561937391758
of O 0 1.7724210920277983e-05
the O 0 0.0005661654286086559
Ca2 O 1 0.9589712619781494
+ O 0 0.10211797058582306
homeostasis O 1 0.9959776997566223
in O 0 0.0019849268719553947
skeletal O 1 0.9999947547912598
muscle O 1 0.9999213218688965
cells O 0 0.014371071942150593
. O 0 0.0006538423476740718

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.8398613929748535
DM B-Disease 1 1.0
) O 0 0.0012099238811060786
, O 0 0.00010958776692859828
the O 0 8.737567986827344e-05
most O 0 0.0005678060697391629
prevalent O 1 0.9993072748184204
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 0.002113068476319313
adults O 1 0.7643947005271912
, O 0 0.00037579788477160037
is O 0 0.0006210549618117511
caused O 0 0.007377493195235729
by O 0 0.00017111259512603283
( O 0 0.003168201306834817
CTG O 1 0.9989136457443237
) O 0 0.0015092676039785147
n O 0 0.011436443775892258
- O 0 0.013829829171299934
repeat O 0 0.010067474097013474
expansion O 0 0.0014854365726932883
in O 0 8.907481242204085e-05
a O 0 0.00027963772299699485
gene O 0 0.0003461034211795777
encoding O 0 9.029192733578384e-05
a O 0 0.00015339732635766268
protein O 0 0.0014768271939828992
kinase O 0 0.04041946306824684
( O 0 0.0027770453598350286
DM B-Disease 1 0.9999990463256836
protein O 0 0.0039701214991509914
kinase O 0 0.04772438481450081
; O 0 0.001044608885422349
DMPK O 1 0.9997339844703674
) O 0 0.00046876445412635803
and O 0 0.00015032912779133767
involves O 0 0.0031804312020540237
changes O 0 0.0006016334518790245
in O 0 0.00033053880906663835
cytoarchitecture O 1 0.9563964605331421
and O 0 0.0002410463202977553
ion O 0 0.022586263716220856
homeostasis O 1 0.9983729124069214
. O 0 0.001318698632530868

To O 0 0.0004562785034067929
obtain O 0 0.0012450903886929154
clues O 0 0.002991695189848542
to O 0 5.188255454413593e-05
the O 0 0.00015893705131020397
normal O 0 0.0037548679392784834
biological O 0 0.002212691353634
role O 0 0.001559522352181375
of O 0 6.633923476329073e-05
DMPK O 1 0.9988831877708435
in O 0 0.00029302650364115834
cellular O 0 0.009620307944715023
ion O 0 0.027165628969669342
homeostasis O 1 0.999245285987854
, O 0 0.0005773756420239806
we O 0 0.0001567425933899358
have O 0 4.190554318483919e-05
compared O 0 0.0003959747264161706
the O 0 0.000302417844068259
resting O 1 0.9946510195732117
[ O 0 0.04870005324482918
Ca2 O 1 0.9609638452529907
+ O 1 0.779044508934021
] O 0 0.05340701714158058
i O 0 0.004365172702819109
, O 0 0.00011895187344634905
the O 0 7.239635306177661e-05
amplitude O 0 0.0004701593134086579
and O 0 0.00012546223297249526
shape O 0 0.0040952106937766075
of O 0 5.8288209402235225e-05
depolarization O 1 0.9305914044380188
- O 0 0.05459950119256973
induced O 1 0.9914146065711975
Ca2 O 1 0.9661689400672913
+ O 1 0.7043955326080322
transients O 1 0.5791399478912354
, O 0 0.0003526427608449012
and O 0 6.197503535076976e-05
the O 0 5.6068711273837835e-05
content O 0 0.0001496808836236596
of O 0 7.333221583394334e-05
ATP O 1 0.9996044039726257
- O 0 0.0055814944207668304
driven O 0 0.0009437798289582133
ion O 0 0.005187906790524721
pumps O 0 0.015953844413161278
in O 0 0.0004430435656104237
cultured O 0 0.19865967333316803
skeletal O 1 0.9999414682388306
muscle O 1 0.9978939890861511
cells O 0 0.0016314571257680655
of O 0 1.9639055608422495e-05
wild O 0 0.0011089820181950927
- O 0 0.008522110059857368
type O 0 0.004392797127366066
and O 0 0.0004379781021270901
DMPK O 1 0.9999381303787231
[ O 0 0.06373598426580429
- O 0 0.11361411213874817
/ O 1 0.5680803060531616
- O 0 0.020957263186573982
] O 0 0.02103930152952671
knockout O 0 0.07294254750013351
mice O 0 0.02065300941467285
. O 0 0.0006079428712837398

In O 0 0.0005410959129221737
vitro O 0 0.006937987636774778
- O 0 0.01166375819593668
differentiated O 0 0.27419689297676086
DMPK O 1 0.9995946288108826
[ O 0 0.0677766278386116
- O 0 0.15896673500537872
/ O 1 0.7747491002082825
- O 0 0.022888273000717163
] O 0 0.0208954606205225
myotubes O 0 0.09257962554693222
exhibit O 0 0.0014465026324614882
a O 0 0.00031046484946273267
higher O 0 0.0014436920173466206
resting O 1 0.9959931373596191
[ O 0 0.03660076856613159
Ca2 O 1 0.9530214071273804
+ O 0 0.2778341770172119
] O 0 0.021633563563227654
i O 0 0.0016922904178500175
than O 0 9.651513391872868e-05
do O 0 0.00040790156344883144
wild O 0 0.0011553983204066753
- O 0 0.018601655960083008
type O 0 0.022933850064873695
myotubes O 1 0.9871627688407898
because O 0 0.00045473207137547433
of O 0 1.7095328075811267e-05
an O 0 0.0005759806954301894
altered O 0 0.0061673871241509914
open O 0 0.000807330128736794
probability O 0 4.925894972984679e-05
of O 0 1.3228360330685973e-05
voltage O 0 0.004064744804054499
- O 0 0.007020944729447365
dependent O 0 0.005186995025724173
l O 0 0.44124144315719604
- O 0 0.011592388153076172
type O 0 0.017927920445799828
Ca2 O 1 0.5871495008468628
+ O 0 0.048857759684324265
and O 0 0.000878400111105293
Na O 1 0.9360334277153015
+ O 0 0.03122781589627266
channels O 0 0.0013100029900670052
. O 0 0.0005542133003473282

The O 0 0.001336310408078134
mutant O 0 0.022810032591223717
myotubes O 1 0.698441743850708
exhibit O 0 0.00293850339949131
smaller O 0 0.00019015550788026303
and O 0 0.00012833414075430483
slower O 0 0.00628029415383935
Ca2 O 1 0.7033592462539673
+ O 0 0.03977380692958832
responses O 0 0.0012320762034505606
upon O 0 0.0006394058582372963
triggering O 0 0.00619181664660573
by O 0 0.00019728094048332423
acetylcholine O 1 0.8978666067123413
or O 0 0.000840775144752115
high O 0 0.004563266411423683
external O 0 0.008979656733572483
K O 1 0.9801367521286011
+ O 0 0.09828434139490128
. O 0 0.0007347906357608736

In O 0 0.0010194198694080114
addition O 0 0.000896788842510432
, O 0 0.00022740625718142837
we O 0 0.0001238950644619763
observed O 0 0.00021150305110495538
that O 0 2.4625205696793273e-05
these O 0 7.582279067719355e-05
Ca2 O 1 0.9614536166191101
+ O 1 0.5131751894950867
transients O 1 0.9446151852607727
partially O 0 0.05024700611829758
result O 0 0.0007117537315934896
from O 0 4.6670167648699135e-05
an O 0 8.11124627944082e-05
influx O 0 0.0003779591352213174
of O 0 2.1909776478423737e-05
extracellular O 0 0.018613597378134727
Ca2 O 1 0.5843673348426819
+ O 0 0.021701347082853317
through O 0 0.00021914011449553072
the O 0 0.0005440727109089494
l O 1 0.6889942288398743
- O 0 0.014950139448046684
type O 0 0.018557937815785408
Ca2 O 1 0.686473548412323
+ O 0 0.04877382144331932
channel O 0 0.004229470621794462
. O 0 0.0006578278844244778

Neither O 0 0.011675521731376648
the O 0 0.00020353792933747172
content O 0 0.0005159955471754074
nor O 0 0.001813305076211691
the O 0 4.6466684580082074e-05
activity O 0 0.00017852558812592179
of O 0 7.987101707840338e-05
Na O 1 0.9986152648925781
+ O 1 0.8342407941818237
/ O 1 0.7144374251365662
K O 0 0.18710438907146454
+ O 0 0.0482456274330616
ATPase O 0 0.17339515686035156
and O 0 0.0011679704766720533
sarcoplasmic O 1 0.999491810798645
reticulum O 1 0.995559573173523
Ca2 O 1 0.935027539730072
+ O 0 0.14287447929382324
- O 0 0.021396994590759277
ATPase O 0 0.07430461049079895
are O 0 6.369926268234849e-05
affected O 0 0.004200310911983252
by O 0 0.00025725329760462046
DMPK O 1 0.9995532631874084
absence O 0 0.020323891192674637
. O 0 0.0006916927522979677

In O 0 0.0009490543161518872
conclusion O 0 0.0021934895776212215
, O 0 0.00017134934023488313
our O 0 0.00025731418281793594
data O 0 0.00021250364079605788
suggest O 0 0.001277643023058772
that O 0 0.00030783022521063685
DMPK O 1 0.9985873699188232
is O 0 0.0006875722319819033
involved O 0 0.001116140279918909
in O 0 0.0003243609971832484
modulating O 0 0.14055250585079193
the O 0 0.0003031860978808254
initial O 0 0.0011527714086696506
events O 0 8.091692143352702e-05
of O 0 2.8711579943774268e-05
excitation O 0 0.031721994280815125
- O 0 0.011473496444523335
contraction O 0 0.018818160519003868
coupling O 0 0.00458037992939353
in O 0 0.001329201040789485
skeletal O 1 0.9999974966049194
muscle O 1 0.9999802112579346
. O 0 0.0007851274567656219
. O 0 0.0006597891333512962

Constitutional O 0 0.02434125728905201
RB1 O 1 0.9999762773513794
- O 0 0.05546565353870392
gene O 0 0.005152755416929722
mutations O 0 0.0032127818558365107
in O 0 0.0008037560619413853
patients O 1 0.9999780654907227
with O 0 0.00028617336647585034
isolated O 0 0.07084127515554428
unilateral B-Disease 1 0.942366898059845
retinoblastoma I-Disease 1 0.9999669790267944
. O 0 0.0014352956786751747

In O 0 0.0009073926485143602
most O 0 0.0013435371220111847
patients O 1 0.9999830722808838
with O 0 0.0001821730111259967
isolated O 0 0.08354286849498749
unilateral B-Disease 1 0.967938244342804
retinoblastoma I-Disease 1 0.9999988079071045
, O 0 0.002774470020085573
tumor B-Disease 1 0.9999933242797852
development O 0 0.0029575428925454617
is O 0 0.0005548160988837481
initiated O 0 0.006491189822554588
by O 0 0.00010278025001753122
somatic O 0 0.025694021955132484
inactivation O 0 0.13256174325942993
of O 0 2.45593510044273e-05
both O 0 0.00015839512343518436
alleles O 0 0.0009447797201573849
of O 0 2.8417654903023504e-05
the O 0 0.0019288751063868403
RB1 O 1 0.9999924898147583
gene O 0 0.009928897023200989
. O 0 0.0007014530710875988

However O 0 0.0019081932259723544
, O 0 0.00012544967466965318
some O 0 1.8148864910472184e-05
of O 0 1.8007700418820605e-05
these O 0 0.0003001609875354916
patients O 1 0.9999974966049194
can O 0 0.0005318796029314399
transmit O 0 0.058966197073459625
retinoblastoma B-Disease 1 0.9999978542327881
predisposition O 1 0.9994075298309326
to O 0 0.00011917553638340905
their O 0 8.189987420337275e-05
offspring O 0 0.0030637735035270452
. O 0 0.0005481457919813693

To O 0 0.0004481807991396636
determine O 0 0.00048680356121622026
the O 0 0.0001124225091189146
frequency O 0 0.0003138757892884314
and O 0 0.00012996872828807682
nature O 0 0.001254585455171764
of O 0 5.241126200417057e-05
constitutional O 0 0.009944729506969452
RB1 O 1 0.9999982118606567
- O 0 0.05193738266825676
gene O 0 0.003978684078902006
mutations O 0 0.002454698085784912
in O 0 0.0007508497219532728
patients O 1 0.9999939203262329
with O 0 0.00028281871345825493
isolated O 0 0.3416931927204132
unilateral B-Disease 1 0.989330530166626
retinoblastoma I-Disease 1 0.9999943971633911
, O 0 0.0003297460207249969
we O 0 0.00012048006465192884
analyzed O 0 0.0011483189882710576
DNA O 0 0.0006556769367307425
from O 0 0.00013551303709391505
peripheral O 1 0.9999765157699585
blood O 1 0.997538685798645
and O 0 0.00023180263815447688
from O 0 0.0009312348556704819
tumor B-Disease 1 0.9999995231628418
tissue O 1 0.9993414282798767
. O 0 0.000962749938480556

The O 0 0.00031282362760975957
analysis O 0 0.00035385735100135207
of O 0 0.00018699103384278715
tumors B-Disease 1 0.9999997615814209
from O 0 0.0005886403960175812
54 O 0 0.016694938763976097
( O 0 0.0017118318937718868
71 O 0 0.015356374904513359
% O 0 9.375223453389481e-05
) O 0 0.00011390124564059079
of O 0 3.435271355556324e-05
76 O 0 0.1096024140715599
informative O 1 0.9264145493507385
patients O 1 0.9999967813491821
showed O 0 0.002834353828802705
loss O 0 0.0027010180056095123
of O 0 2.1169918909436092e-05
constitutional O 0 0.0026913953479379416
heterozygosity O 1 0.9994708895683289
( O 0 0.011623912490904331
LOH O 1 0.9999995231628418
) O 0 0.00085976452101022
at O 0 0.0023544421419501305
intragenic O 1 0.9531525373458862
loci O 0 0.027341200038790703
. O 0 0.0007353180553764105

Three O 0 0.00012882775627076626
of O 0 4.301966691855341e-05
13 O 0 0.008026988245546818
uninformative O 1 0.9999738931655884
patients O 1 0.9999985694885254
had O 0 0.0008740760968066752
constitutional O 0 0.0006896223640069366
deletions O 0 0.004413064103573561
. O 0 0.0005668221856467426

For O 0 0.0007712855003774166
39 O 0 0.0027695177122950554
randomly O 0 0.0006245782715268433
selected O 0 0.002650234615430236
tumors B-Disease 1 0.999998927116394
, O 0 0.0014101555570960045
SSCP O 1 0.9997826218605042
, O 0 0.001734056044369936
hetero O 1 0.9970333576202393
- O 0 0.03188027814030647
duplex O 0 0.06950843334197998
analysis O 0 0.0004641431150957942
, O 0 0.00020692437828984112
sequencing O 0 0.0010063181398436427
, O 0 0.0003189529525116086
and O 0 0.0003266319108661264
Southern O 0 0.00943754706531763
blot O 1 0.9875990152359009
analysis O 0 0.0004173181368969381
were O 0 2.6737237931229174e-05
used O 0 0.00013976368063595146
to O 0 0.00010575600754236802
identify O 0 0.0031497646123170853
mutations O 0 0.004071703180670738
. O 0 0.0005455792415887117

Mutations O 0 0.00602994579821825
were O 0 7.555033516837284e-05
detected O 0 0.006399129051715136
in O 0 0.00032990009640343487
21 O 0 0.0037739842664450407
( O 0 0.0012788840103894472
91 O 0 0.01926490291953087
% O 0 9.937231516232714e-05
) O 0 0.00012680981308221817
of O 0 5.070323823019862e-05
23 O 0 0.044027600437402725
tumors B-Disease 1 1.0
with O 0 0.0038976354990154505
LOH O 1 0.9999998807907104
. O 0 0.0012835822999477386

In O 0 0.0016499040648341179
6 O 0 0.004897379782050848
( O 0 0.0009000744321383536
38 O 0 0.002894227160140872
% O 0 7.176479994086549e-05
) O 0 9.499213774688542e-05
of O 0 3.468737122602761e-05
16 O 0 0.013104794546961784
tumors B-Disease 1 1.0
without O 0 0.007451260928064585
LOH O 1 0.9999998807907104
, O 0 0.0002752665022853762
one O 0 0.00018495078256819397
mutation O 0 0.0022426226641982794
was O 0 0.0019295187667012215
detected O 0 0.013209711760282516
, O 0 0.0002222906332463026
and O 0 0.00016019685426726937
in O 0 0.00046685984125360847
9 O 0 0.005757865495979786
( O 0 0.001061393995769322
56 O 0 0.0048879096284508705
% O 0 8.118287951219827e-05
) O 0 8.201874879887328e-05
of O 0 1.959325891220942e-05
the O 0 0.0027549562510102987
tumors B-Disease 1 1.0
without O 0 0.01981957256793976
LOH O 1 0.9999998807907104
, O 0 0.0004957164637744427
both O 0 0.00023354007862508297
mutations O 0 0.0020242214668542147
were O 0 6.593572470592335e-05
found O 0 0.0006373487995006144
. O 0 0.0004921936197206378

Thus O 0 0.00210781954228878
, O 0 0.00017368253611493856
a O 0 0.00017249850498046726
total O 0 4.169543171883561e-05
of O 0 1.674245322647039e-05
45 O 0 0.0010822415351867676
mutations O 0 0.0019608261063694954
were O 0 4.841946793021634e-05
identified O 0 0.0013524485984817147
in O 0 0.0006088712834753096
tumors B-Disease 1 0.9999994039535522
of O 0 0.00011407559941289946
36 O 0 0.016588011756539345
patients O 1 0.9999920129776001
. O 0 0.0008491647313348949

Thirty O 0 0.016907772049307823
- O 0 0.004332472570240498
nine O 0 0.00010648947500158101
of O 0 1.0675362318579573e-05
the O 0 0.0003644573444034904
mutations O 0 0.007216196972876787
- O 0 0.0055765449069440365
including O 0 0.00011644602636806667
34 O 0 0.0017212351085618138
small O 0 0.00039664533687755466
mutations O 0 0.0033487204927951097
, O 0 0.00026244643959216774
2 O 0 0.0007285004248842597
large O 0 0.00036930202622897923
structural O 1 0.9979161620140076
alterations O 0 0.25119608640670776
, O 0 0.00035834164009429514
and O 0 0.00041247846093028784
hypermethylation O 1 0.9971243739128113
in O 0 0.0007500465144403279
3 O 0 0.012447560206055641
tumors O 1 0.9999998807907104
- O 0 0.009358302690088749
were O 0 3.970221951021813e-05
not O 0 0.00012929739023093134
detected O 0 0.0034813620150089264
in O 0 3.6883506254525855e-05
the O 0 7.49471437302418e-05
corresponding O 0 0.0013557985657826066
peripheral O 1 0.9999823570251465
blood O 1 0.9984632730484009
DNA O 0 0.005325610749423504
. O 0 0.00041048406274057925

In O 0 0.0017883911496028304
6 O 0 0.0077805169858038425
( O 0 0.0015743313124403358
17 O 0 0.003232486080378294
% O 0 8.757854084251449e-05
) O 0 9.330719331046566e-05
of O 0 1.2392336429911666e-05
the O 0 0.0006126801599748433
36 O 0 0.016794070601463318
patients O 1 0.9999945163726807
, O 0 0.00023496462381444871
a O 0 0.0008397923083975911
mutation O 0 0.0036546860355883837
was O 0 0.0017276558792218566
detected O 0 0.006786099635064602
in O 0 0.00013766158372163773
constitutional O 0 0.001077815773896873
DNA O 0 0.0038628496695309877
, O 0 0.0003453970712143928
and O 0 0.00023600031272508204
1 O 0 0.0006932218093425035
of O 0 1.1816988262580708e-05
these O 0 5.667882214765996e-05
mutations O 0 0.0035632336512207985
is O 0 0.0005462121916934848
known O 0 0.0008486530277878046
to O 0 9.599827899364755e-05
be O 0 0.00010880504123633727
associated O 0 0.0003003625606652349
with O 0 0.00011181546142324805
reduced O 0 0.01694696955382824
expressivity O 1 0.9984731078147888
. O 0 0.0014473500195890665

The O 0 0.0005416740896180272
presence O 0 0.0003983087372034788
of O 0 1.437097216694383e-05
a O 0 0.0006369389593601227
constitutional O 0 0.0014399406500160694
mutation O 0 0.005611450877040625
was O 0 0.0019773091189563274
not O 0 0.0002138166018994525
associated O 0 0.00024301311350427568
with O 0 3.304019264760427e-05
an O 0 0.00030615227296948433
early O 0 0.001636344357393682
age O 0 0.0024780507665127516
at O 0 0.00664648087695241
treatment O 1 0.999990701675415
. O 0 0.0009449436329305172

In O 0 0.0011062809498980641
1 O 0 0.006392919924110174
patient O 1 0.9998633861541748
, O 0 0.0007316964911296964
somatic O 0 0.10709799081087112
mosaicism O 1 0.9993441700935364
was O 0 0.003249501343816519
demonstrated O 0 0.0029514518100768328
by O 0 5.307776154950261e-05
molecular O 0 0.001565700164064765
analysis O 0 0.00015631900168955326
of O 0 2.109629895130638e-05
DNA O 0 0.001372000202536583
and O 0 8.810508734313771e-05
RNA O 0 0.002089104149490595
from O 0 0.00042223831405863166
peripheral O 1 0.9999483823776245
blood O 1 0.9958699345588684
. O 0 0.0009754276252351701

In O 0 0.0016677530948072672
2 O 0 0.0067076170817017555
patients O 1 0.999946117401123
without O 0 0.00011741428897948936
a O 0 0.00041912298183888197
detectable O 0 0.018700093030929565
mutation O 0 0.0022341159638017416
in O 0 0.0004440458142198622
peripheral O 1 0.9999861717224121
blood O 1 0.9994285702705383
, O 0 0.002083027036860585
mosaicism O 1 0.9996829032897949
was O 0 0.00393613800406456
suggested O 0 0.0023833003360778093
because O 0 0.0004181093827355653
1 O 0 0.00024320778902620077
of O 0 9.910905646393076e-06
the O 0 0.0009814013028517365
patients O 1 0.9999997615814209
showed O 1 0.5332241654396057
multifocal O 1 0.9999998807907104
tumors B-Disease 1 1.0
and O 0 0.00033363449620082974
the O 0 0.0001711193035589531
other O 0 7.133278268156573e-05
later O 0 0.0007163300178945065
developed O 0 0.006754727102816105
bilateral B-Disease 0 0.21697577834129333
retinoblastoma I-Disease 1 0.999970555305481
. O 0 0.0012593528954312205

In O 0 0.0010918674524873495
conclusion O 0 0.0027873138897120953
, O 0 0.00022467007511295378
our O 0 0.0006144789513200521
results O 0 0.0008916486985981464
emphasize O 0 0.005104382988065481
that O 0 5.756798054790124e-05
the O 0 0.0002453863271512091
manifestation O 1 0.9663682579994202
and O 0 0.0005736707244068384
transmissibility O 1 0.7936465740203857
of O 0 0.00030353429610840976
retinoblastoma B-Disease 1 0.9999507665634155
depend O 0 0.002813013968989253
on O 0 0.00027443713042885065
the O 0 0.00017697919975034893
nature O 0 0.001215276075527072
of O 0 1.651026468607597e-05
the O 0 0.00020072034385520965
first O 0 0.000505581614561379
mutation O 0 0.003002205630764365
, O 0 0.000152186315972358
its O 0 0.00016950590361375362
time O 0 0.00020501119433902204
in O 0 0.0003288146108388901
development O 0 0.005418757442384958
, O 0 0.0004766130878124386
and O 0 0.00014407427806872874
the O 0 0.000157315909746103
number O 0 4.172255648882128e-05
and O 0 0.0001487238478148356
types O 0 0.0005953513900749385
of O 0 4.677996184909716e-05
cells O 0 0.006772900465875864
that O 0 6.519314047181979e-05
are O 0 4.090241782250814e-05
affected O 0 0.007472630124539137
. O 0 0.0002459942188579589
. O 0 0.0004724960308521986

Hereditary B-Disease 1 0.9999806880950928
deficiency I-Disease 1 0.9999998807907104
of I-Disease 0 8.454650378553197e-05
the I-Disease 0 0.0003792597563005984
fifth I-Disease 0 0.0033935466781258583
component I-Disease 0 0.0030978377908468246
of I-Disease 0 2.1205200027907267e-05
complement I-Disease 0 0.0033441875129938126
in O 0 0.0006204983219504356
man O 0 0.013348276726901531
. O 0 0.0006258958019316196

I O 0 0.10578471422195435
. O 0 0.0008020251989364624

Clinical O 1 0.9999874830245972
, O 0 0.0019631111063063145
immunochemical O 1 0.9947145581245422
, O 0 0.0005558562115766108
and O 0 0.0002885553112719208
family O 0 0.0012191464193165302
studies O 0 0.0025694037321954966
. O 0 0.0006540786125697196

The O 0 0.0004356820718385279
first O 0 0.00029842325602658093
recognized O 0 0.0033077048137784004
human O 0 0.005043123848736286
kindred O 1 0.9993638396263123
with O 0 0.001747086993418634
hereditary B-Disease 1 0.9999877214431763
deficiency I-Disease 1 0.9999998807907104
of I-Disease 0 6.908400973770767e-05
the I-Disease 0 0.00036334889591671526
fifth I-Disease 0 0.002929678885266185
component I-Disease 0 0.0027645044028759003
of I-Disease 0 3.35125696437899e-05
complement I-Disease 0 0.009739235043525696
( O 0 0.0027508120983839035
C5 O 1 0.9995380640029907
) O 0 0.0008227107464335859
is O 0 0.000649561348836869
described O 0 0.006186478305608034
. O 0 0.0006377638201229274

The O 0 0.0015322872204706073
proband O 0 0.206765815615654
, O 0 0.0002456611837260425
a O 0 0.0005646608187817037
20 O 0 0.0014672832330688834
- O 0 0.005289175547659397
year O 0 0.0016245858278125525
- O 0 0.009018847718834877
old O 0 0.004460453987121582
black O 0 0.009236611425876617
female O 0 0.004485480021685362
with O 0 0.03317762538790703
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 0.026438184082508087
age O 0 0.0022374519612640142
11 O 0 0.0018528449581936002
, O 0 0.0003671393496915698
lacked O 1 0.5909772515296936
serum O 1 0.9998458623886108
hemolytic O 1 0.9999984502792358
complement O 0 0.0067262183874845505
activity O 0 0.0009784095454961061
, O 0 0.00022596355120185763
even O 0 0.0005359779461286962
during O 0 0.004886741284281015
remission O 1 0.9996473789215088
. O 0 0.0007165464339777827

C5 O 1 0.9980995059013367
was O 0 0.008713707327842712
undetectable O 1 0.9968435764312744
in O 0 0.00041388641693629324
her O 0 0.002556951716542244
serum O 1 0.9774636626243591
by O 0 6.810402555856854e-05
both O 0 0.0003902727912645787
immunodiffusion O 1 0.9917355179786682
and O 0 0.0019469887483865023
hemolytic O 1 0.9999986886978149
assays O 0 0.009258520789444447
. O 0 0.0009269737056456506

Other O 0 0.0001634991349419579
complement O 0 0.0019446115475147963
components O 0 0.0013138646027073264
were O 0 5.6883116485551e-05
normal O 0 0.003080830443650484
during O 0 0.0031609446741640568
remission O 1 0.9996263980865479
of O 0 0.0006041575106792152
lupus O 1 1.0
, O 0 0.0013591288588941097
but O 0 0.0016886048251762986
C1 O 1 0.9999954700469971
, O 0 0.001390482415445149
C4 O 1 0.9988794922828674
, O 0 0.002372062997892499
C2 O 1 0.9999961853027344
, O 0 0.0006310961325652897
and O 0 0.0007229183102026582
C3 O 1 0.9999291896820068
levels O 0 0.01559174619615078
fell O 0 0.03357233852148056
during O 0 0.00619090348482132
exacerbations O 1 0.999954104423523
. O 0 0.001311071333475411

A O 0 0.010320093482732773
younger O 0 0.005073413718491793
half O 0 0.0012865436729043722
- O 0 0.02604971081018448
sister O 0 0.006741674151271582
, O 0 0.0004447619430720806
who O 0 0.0006577817839570343
had O 0 0.0006829319754615426
no O 0 0.0006324514397419989
underlying O 1 0.999975323677063
disease O 1 1.0
, O 0 0.0007282578153535724
was O 0 0.0019915010780096054
also O 0 0.0002119500277331099
found O 0 0.0001681623252807185
to O 0 7.1313937951345e-05
lack O 0 0.00620616041123867
immunochemically O 1 0.9940416216850281
detectable O 1 0.6287965178489685
C5 O 1 0.9983217120170593
. O 0 0.0011039538076147437

By O 0 0.001981555949896574
hemolytic O 1 0.9999972581863403
assay O 0 0.0359666682779789
, O 0 0.0012528187362477183
she O 0 0.0026440208312124014
exhibited O 0 0.018994281068444252
1 O 0 0.006642270367592573
- O 0 0.006813795771449804
2 O 0 0.0004718917771242559
% O 0 1.0807061698869802e-05
of O 0 5.4572042245126795e-06
the O 0 0.00023521026014350355
normal O 0 0.017171775922179222
serum O 1 0.9996452331542969
C5 O 1 0.999427318572998
level O 0 0.005831326358020306
and O 0 0.00019131123553961515
normal O 0 0.004269703757017851
concentrations O 0 0.0033342023380100727
of O 0 1.2071516721334774e-05
other O 0 4.434386210050434e-05
complement O 0 0.003446906106546521
components O 0 0.004398329183459282
. O 0 0.0007612250046804547

C5 O 1 0.9962748289108276
levels O 0 0.005567033775150776
of O 0 4.037008693558164e-05
other O 0 0.00013553514145314693
family O 0 0.0010084194364026189
members O 0 0.00015464566240552813
were O 0 5.931552004767582e-05
either O 0 0.0005041994154453278
normal O 0 0.0031862962059676647
or O 0 0.0003066944773308933
approximately O 0 0.0006582910427823663
half O 0 0.0007193097844719887
- O 0 0.007845422253012657
normal O 0 0.0039510661736130714
, O 0 0.00024109275545924902
consistent O 0 0.007480754517018795
with O 0 0.0006490913219749928
autosomal O 1 0.9995930790901184
codominant O 1 0.9968637228012085
inheritance O 0 0.0014621063601225615
of O 0 1.3034944458922837e-05
the O 0 0.00022952290601097047
gene O 0 0.004559462424367666
determining O 0 0.026851242408156395
C5 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
. O 0 0.001704430440440774

Normal O 1 0.720940887928009
hemolytic O 1 0.9999990463256836
titers O 1 0.9937574863433838
were O 0 0.0001659264089539647
restored O 0 0.0020999787375330925
to O 0 3.2151008781511337e-05
both O 0 0.0001421664492227137
homozygous O 0 0.02447045035660267
C5 B-Disease 1 0.999992847442627
- I-Disease 1 0.9973741769790649
deficient I-Disease 1 0.9999997615814209
( O 0 0.009491343051195145
C5D B-Disease 1 0.9999970197677612
) O 0 0.0017634545220062137
sera O 0 0.03388817980885506
by O 0 2.7164829589310102e-05
addition O 0 0.00010324300092179328
of O 0 1.2889621757494751e-05
highly O 0 0.005986838135868311
purified O 0 0.07432743161916733
human O 0 0.008009394630789757
C5 O 1 0.9994359612464905
. O 0 0.0012189523549750447

In O 0 0.0007536619086749852
specific O 0 0.001806274289265275
C5 O 1 0.9998008608818054
titrations O 1 0.9961647987365723
, O 0 0.0008759661577641964
however O 0 0.0005642421310767531
, O 0 0.0002798049245029688
it O 0 0.00027981962193734944
was O 0 0.001886312966234982
noted O 0 0.0009618047042749822
that O 0 6.090131137170829e-05
when O 0 0.00021187645324971527
limited O 0 0.00047859048936516047
amounts O 0 0.00024019335978664458
of O 0 0.00011321256897645071
C5 O 1 0.9992146492004395
were O 0 0.00013505687820725143
assayed O 0 0.00887223519384861
in O 0 0.00011770395940402523
the O 0 9.508393122814596e-05
presence O 0 0.00030707483529113233
of O 0 3.2504151022294536e-05
low O 0 0.008066832087934017
dilutions O 1 0.6594357490539551
of O 0 7.16337381163612e-05
either O 0 0.003946675453335047
C5D B-Disease 1 0.9999971389770508
serum O 1 0.9979566335678101
, O 0 0.0005483093555085361
curving O 0 0.014886979945003986
rather O 0 0.00019488355610519648
than O 0 0.0001171096955658868
linear O 0 0.007088772486895323
dose O 1 0.9863927960395813
- O 0 0.015427086502313614
response O 0 0.002394738607108593
plots O 0 0.001018886687234044
were O 0 9.147646051133052e-05
consistently O 0 0.007799192797392607
obtained O 0 0.0007843236089684069
, O 0 0.0002170728548662737
suggesting O 0 0.001974621554836631
some O 0 4.8722293286118656e-05
inhibitory O 0 0.004275503568351269
effect O 0 0.0026167400646954775
. O 0 0.0006148233660496771

Further O 0 0.0013805682538077235
studies O 0 0.000993874971754849
suggested O 0 0.0009536879369989038
that O 0 5.189294461160898e-05
low O 0 0.004322540946304798
dilutions O 1 0.5155746936798096
of O 0 0.00022136846382636577
C5D B-Disease 1 0.9999587535858154
serum O 1 0.7852177619934082
contain O 0 0.0003788668545894325
a O 0 0.000627986853942275
factor O 0 0.004685988184064627
( O 0 0.000998752424493432
or O 0 0.0006535978172905743
factors O 0 0.0014207465574145317
) O 0 0.0006293536280281842
interfering O 0 0.015354091301560402
at O 0 0.0007808637456037104
some O 0 5.423425682238303e-05
step O 0 0.0021346064750105143
in O 0 0.00014577900583390146
the O 0 0.0009757403749972582
hemolytic O 1 0.9999979734420776
assay O 0 0.013537579216063023
of O 0 0.0002124286984326318
C5 O 1 0.9996805191040039
, O 0 0.00034678663359954953
rather O 0 0.00017739956092555076
than O 0 6.844884774181992e-05
a O 0 0.0005940562696196139
true O 0 0.00521419383585453
C5 O 1 0.9997147917747498
inhibitor O 1 0.9601357579231262
or O 0 0.0018286190461367369
inactivator O 1 0.9521285891532898
. O 0 0.0007907362305559218

Of O 0 0.0004232730425428599
clinical O 1 0.9998722076416016
interest O 0 0.00031932926503941417
are O 0 6.294433842413127e-05
( O 0 0.0006551416590809822
a O 0 0.0010073564480990171
) O 0 0.00015744406846351922
the O 0 7.169599120970815e-05
documentation O 0 0.0010920183267444372
of O 0 0.0001277406554436311
membranous O 1 0.9999974966049194
glomerulonephritis B-Disease 1 1.0
, O 0 0.059027161449193954
vasculitis B-Disease 1 1.0
, O 0 0.0031600717920809984
and O 0 0.014266951940953732
arthritis B-Disease 1 1.0
in O 0 0.0002582101442385465
an O 0 0.0002192473184550181
individual O 0 0.0009016605326905847
lacking O 1 0.9988464117050171
C5 O 1 0.9998941421508789
( O 0 0.001217246288433671
and O 0 0.00016767111083026975
its O 0 0.0006026374758221209
biologic O 0 0.43596088886260986
functions O 0 0.0012336563086137176
) O 0 0.0005638459697365761
, O 0 0.00038774771383032203
and O 0 0.00039320223731920123
( O 0 0.0020694357808679342
b O 0 0.03312002494931221
) O 0 0.00013369509542826563
a O 0 0.00028346956241875887
remarkable O 0 0.004654579795897007
propensity O 0 0.39615246653556824
to O 0 0.0012021836591884494
bacterial B-Disease 1 0.9999998807907104
infections I-Disease 1 1.0
in O 0 0.0005614383844658732
the O 0 0.0009956273715943098
proband O 1 0.9876547455787659
, O 0 0.0004983942490071058
even O 0 0.0002846386923920363
during O 0 0.0005834235926158726
periods O 0 0.00038627046160399914
of O 0 2.5204402845702134e-05
low O 0 0.009105239994823933
- O 0 0.01107658352702856
dose O 0 0.050914980471134186
or O 0 0.0003802912833634764
alternate O 0 0.0015107659855857491
- O 0 0.009522791020572186
day O 0 0.005887441802769899
corticosteroid O 1 0.9999986886978149
therapy O 1 0.9999392032623291
. O 0 0.0008473731577396393

Other O 0 0.0002175713743781671
observations O 0 0.0014129308983683586
indicate O 0 0.001005377620458603
that O 0 0.00010154584015253931
the O 0 0.0008951511117629707
C5D B-Disease 1 0.9999445676803589
state O 0 0.00043094795546494424
is O 0 0.00024770217714831233
compatible O 0 0.0014044175622984767
with O 0 0.00012379526742734015
normal O 0 0.011461500078439713
coagulation O 1 0.9160606265068054
function O 0 0.0017376720206812024
and O 0 0.0001390755787724629
the O 0 0.0001349447702523321
capacity O 0 0.0019084621453657746
to O 0 0.00022848532535135746
mount O 1 0.7775490283966064
a O 0 0.003643233794718981
neutrophilic O 1 0.9999845027923584
leukocytosis O 1 0.999880313873291
during O 0 0.02869979292154312
pyogenic B-Disease 1 0.999984622001648
infection I-Disease 1 0.9999985694885254
. O 0 0.0005396675551310182
. O 0 0.0005322242504917085

Susceptibility O 1 0.9953511953353882
to O 0 0.006005787290632725
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.009673204272985458
twins O 0 0.4447079598903656
: O 0 0.0002709378313738853
the O 0 0.00010235156514681876
role O 0 0.0010798806324601173
of O 0 2.8302494683885016e-05
genes O 0 0.0013161308597773314
, O 0 0.0020146153401583433
HLA O 1 0.9999165534973145
, O 0 0.0005460552638396621
and O 0 0.00013656739611178637
the O 0 0.0003388753393664956
environment O 0 0.008892742916941643
. O 0 0.0008648334769532084

OBJECTIVE O 0 0.06716383993625641
To O 0 0.0002946266031358391
determine O 0 0.00047507407725788653
the O 0 8.26301402412355e-05
relative O 0 0.0005952887004241347
effects O 0 0.0037095905281603336
of O 0 4.484298551687971e-05
genetic O 0 0.003761812811717391
and O 0 0.00016321644943673164
environmental O 0 0.005336328875273466
factors O 0 0.0002803734678309411
in O 0 0.0002601822488941252
susceptibility O 1 0.9934254884719849
to O 0 0.004261552356183529
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 0.020586324855685234
AS B-Disease 1 0.9861672520637512
) O 0 0.0008557632099837065
. O 0 0.0005409105215221643

METHODS O 0 0.021540291607379913
Twins O 0 0.04439704865217209
with O 0 0.0003101045440416783
AS B-Disease 0 0.03192371502518654
were O 0 8.040672400966287e-05
identified O 0 0.0006655596080236137
from O 0 4.0196719055529684e-05
the O 0 0.0002067744790110737
Royal O 0 0.014568784274160862
National O 1 0.861583948135376
Hospital O 1 0.9999998807907104
for O 0 0.03635202720761299
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 0.009363963268697262
. O 0 0.0008526433957740664

Clinical O 1 0.9999579191207886
and O 0 0.0014682909240946174
radiographic O 1 0.9997952580451965
examinations O 0 0.26533061265945435
were O 0 5.697432061424479e-05
performed O 0 0.0009259784128516912
to O 0 0.00012975487334188074
establish O 0 0.007941802963614464
diagnoses O 1 0.9999923706054688
, O 0 0.0009359415853396058
and O 0 0.0033790715970098972
disease O 1 1.0
severity O 1 0.9999632835388184
was O 0 0.00345343304798007
assessed O 0 0.009611004963517189
using O 0 8.203009201679379e-05
a O 0 0.00044274251558817923
combination O 0 0.002050975803285837
of O 0 2.254823994007893e-05
validated O 0 0.007297365926206112
scoring O 0 0.00048593292012810707
systems O 0 0.021013809368014336
. O 0 0.0007743749883957207

HLA O 1 0.9982942938804626
typing O 0 0.02233816683292389
for O 0 0.001878568553365767
HLA O 1 0.999893069267273
- O 0 0.020559480413794518
B27 O 0 0.07331427931785583
, O 0 0.0015752902254462242
HLA O 1 0.9998384714126587
- O 0 0.015930863097310066
B60 O 0 0.04380547255277634
, O 0 0.00039085643948055804
and O 0 0.001014992012642324
HLA O 1 0.9999890327453613
- O 1 0.8175116181373596
DR1 O 1 0.9998478889465332
was O 0 0.0030525359325110912
performed O 0 0.0008484820718877017
by O 0 4.916611942462623e-05
polymerase O 0 0.006414713338017464
chain O 0 0.005842843558639288
reaction O 0 0.0008530469494871795
with O 0 7.457663014065474e-05
sequence O 0 0.00021801081311423331
- O 0 0.0038277367129921913
specific O 0 0.00039314417517744005
primers O 0 0.03531378135085106
, O 0 0.0005034382920712233
and O 0 0.00041244173189625144
zygosity O 1 0.9932934045791626
was O 0 0.002266734139993787
assessed O 0 0.00792642217129469
using O 0 0.00029723922489210963
microsatellite O 0 0.07072819024324417
markers O 0 0.015035945922136307
. O 0 0.0005752553697675467

Genetic O 0 0.011825154535472393
and O 0 0.0002705369552131742
environmental O 0 0.006114236079156399
variance O 0 0.0004866170638706535
components O 0 0.0017109864857047796
were O 0 8.532045467291027e-05
assessed O 0 0.007563319988548756
with O 0 5.7313380239065737e-05
the O 0 0.0006055877893231809
program O 0 0.03241557255387306
Mx O 1 0.998383641242981
, O 0 0.00018183821521233767
using O 0 9.018521086545661e-05
data O 0 0.00014198708231560886
from O 0 7.636483496753499e-05
this O 0 6.787088932469487e-05
and O 0 0.00012988287198822945
previous O 0 0.0006356753874570131
studies O 0 0.0005380540969781578
of O 0 5.242730912868865e-05
twins O 0 0.03911418840289116
with O 0 0.00032017641933634877
AS B-Disease 1 0.5927810072898865
. O 0 0.0009833599906414747

RESULTS O 0 0.006192884873598814
Six O 0 0.00022193611948750913
of O 0 3.1303661671699956e-05
8 O 0 0.004346576984971762
monozygotic O 1 0.9839591383934021
( O 0 0.008150428533554077
MZ O 1 0.9999710321426392
) O 0 0.0020269618835300207
twin O 0 0.02086552046239376
pairs O 0 0.0013616241049021482
were O 0 0.0008364740060642362
disease O 1 0.9999998807907104
concordant O 1 0.9473097920417786
, O 0 0.0005716108717024326
compared O 0 0.0012493559624999762
with O 0 8.92973766895011e-05
4 O 0 0.000700778909958899
of O 0 2.416864299448207e-05
15 O 0 0.0018702701199799776
B27 O 0 0.09027613699436188
- O 0 0.009633992798626423
positive O 0 0.004797754809260368
dizygotic O 1 0.9694030284881592
( O 0 0.0050884452648460865
DZ O 1 0.9996211528778076
) O 0 0.00197598640806973
twin O 0 0.023388143628835678
pairs O 0 0.002503438154235482
( O 0 0.0023924410343170166
27 O 0 0.00686358567327261
% O 0 0.00021309570001903921
) O 0 0.00039794534677639604
and O 0 0.0001948370918398723
4 O 0 0.0008778796764090657
of O 0 5.802167652291246e-05
32 O 0 0.011307232081890106
DZ O 1 0.9995126724243164
twin O 0 0.03756740689277649
pairs O 0 0.0013850168325006962
overall O 0 0.008416908793151379
( O 0 0.0016528134001418948
12 O 0 0.0022214550990611315
. O 0 0.00018532607646193355
5 O 0 0.0011512136552482843
% O 0 0.0001685251045273617
) O 0 0.0005730395205318928
. O 0 0.0005986230680719018

Nonsignificant O 1 0.9562172293663025
increases O 0 0.0038569385651499033
in O 0 0.00015864103625062853
similarity O 0 0.0007695209933444858
with O 0 9.63620186666958e-05
regard O 0 0.0016755865653976798
to O 0 0.0002277644962305203
age O 0 0.0034224402625113726
at O 0 0.25046998262405396
disease O 1 1.0
onset O 1 0.9999830722808838
and O 0 0.00012624950613826513
all O 0 1.410322238371009e-05
of O 0 3.426124021643773e-05
the O 0 0.003330470062792301
disease O 1 1.0
severity O 1 0.9997624754905701
scores O 0 0.001773620257154107
assessed O 0 0.009060999378561974
were O 0 3.9372687751892954e-05
noted O 0 0.0008839701185934246
in O 0 0.0012900008587166667
disease O 1 1.0
- O 1 0.7064197659492493
concordant O 1 0.9963418841362
MZ O 1 0.9999667406082153
twins O 0 0.02938680164515972
compared O 0 0.0010670383926481009
with O 0 0.0002962989965453744
concordant O 1 0.9915952086448669
DZ O 1 0.9999581575393677
twins O 0 0.19788189232349396
. O 0 0.0007076602196320891

HLA O 1 0.999858021736145
- O 0 0.04759266972541809
B27 O 0 0.06426764279603958
and O 0 0.0004814853600692004
B60 O 0 0.04607347398996353
were O 0 7.533529424108565e-05
associated O 0 0.0003257213975302875
with O 0 0.00011186282063135877
the O 0 0.0026343599893152714
disease O 1 0.9999998807907104
in O 0 0.0013037924654781818
probands O 1 0.9977745413780212
, O 0 0.0003316388465464115
and O 0 7.28019731468521e-05
the O 0 9.87669627647847e-05
rate O 0 0.0002223932242486626
of O 0 0.00016153747856151313
disease O 1 1.0
concordance O 0 0.0158575177192688
was O 0 0.0019629192538559437
significantly O 0 0.005434513092041016
increased O 0 0.0007661196868866682
among O 0 0.0010243423748761415
DZ O 1 0.9998370409011841
twin O 0 0.03501094877719879
pairs O 0 0.000675369577948004
in O 0 0.0002016020443988964
which O 0 8.689880633028224e-05
the O 0 0.0008217307040467858
co O 1 0.879860520362854
- O 0 0.02762739546597004
twin O 0 0.015374780632555485
was O 0 0.001203202293254435
positive O 0 0.0007675231900066137
for O 0 0.00015012671065051109
both O 0 0.00034492783015593886
B27 O 0 0.26414281129837036
and O 0 0.0013863021740689874
DR1 O 1 0.9999239444732666
. O 0 0.0015747621655464172

Additive O 0 0.020031334832310677
genetic O 0 0.005900743883103132
effects O 0 0.00564012723043561
were O 0 5.5379652621923015e-05
estimated O 0 0.0005495527293533087
to O 0 0.00016573129687458277
contribute O 0 0.010524253360927105
97 O 0 0.010431059636175632
% O 0 3.296692011645064e-05
of O 0 1.0668667528079823e-05
the O 0 0.00014482122787740082
population O 0 7.746796472929418e-05
variance O 0 0.0007832510164007545
. O 0 0.0008081370615400374

CONCLUSION O 0 0.0388096459209919
Susceptibility O 1 0.8136005997657776
to O 0 0.0004527116543613374
AS B-Disease 0 0.015297465957701206
is O 0 0.00037447595968842506
largely O 0 0.000805080693680793
genetically O 0 0.0018169129034504294
determined O 0 0.003029927145689726
, O 0 0.0002197282447014004
and O 0 8.702866762178019e-05
the O 0 0.00023584264272358268
environmental O 0 0.009432622231543064
trigger O 0 0.005948922596871853
for O 0 0.000333826377755031
the O 0 0.002007625997066498
disease O 1 1.0
is O 0 0.0011153127998113632
probably O 0 0.0031816894188523293
ubiquitous O 0 0.019770102575421333
. O 0 0.0006910655065439641

HLA O 1 0.9998996257781982
- O 0 0.03925519064068794
B27 O 0 0.043297190219163895
accounts O 0 0.0002536990796215832
for O 0 0.0001631604100111872
a O 0 0.0005012988112866879
minority O 0 0.00047184451250359416
of O 0 1.2328964658081532e-05
the O 0 0.00018177634046878666
overall O 0 0.00527615612372756
genetic O 0 0.007140050176531076
susceptibility O 1 0.9450173377990723
to O 0 0.0004280011053197086
AS B-Disease 0 0.08693666011095047
. O 0 0.0006779690738767385

Cell O 0 0.016551485285162926
cycle O 0 0.005413212347775698
- O 0 0.007175601087510586
dependent O 0 0.0032941612880676985
colocalization O 0 0.0682239755988121
of O 0 0.00014564146113116294
BARD1 O 1 0.9998424053192139
and O 0 0.0010096697369590402
BRCA1 O 1 0.9973706007003784
proteins O 0 0.0001096412815968506
in O 0 0.00010360119631513953
discrete O 0 0.0019752955995500088
nuclear O 0 0.006460385862737894
domains O 0 0.003355729393661022
. O 0 0.0006402006838470697

Germ O 1 0.9999165534973145
- O 0 0.022041471675038338
line O 0 0.0020538822282105684
mutations O 0 0.0004912794101983309
of O 0 1.0298515917384066e-05
the O 0 0.0009230433497577906
BRCA1 O 1 0.99997878074646
gene O 0 0.01273099984973669
predispose O 1 0.9517078399658203
women O 0 0.0007417846936732531
to O 0 9.050381777342409e-05
early O 0 0.0014949612086638808
- O 1 0.9960412979125977
onset O 1 0.9999997615814209
breast B-Disease 1 1.0
and I-Disease 1 0.9664450883865356
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.0002144464524462819
compromising O 0 0.08702985942363739
the O 0 0.000322408857755363
genes O 0 0.0009168088436126709
presumptive O 1 0.6230441927909851
function O 0 0.0006152524729259312
as O 0 0.0002521811693441123
a O 0 0.002752795582637191
tumor B-Disease 1 0.9999958276748657
suppressor O 0 0.1832909882068634
. O 0 0.0005934688379056752

Although O 0 0.0010239322436973453
the O 0 0.00021647510584443808
biochemical O 0 0.011887769214808941
properties O 0 0.0019360154401510954
of O 0 0.0002153946115868166
BRCA1 O 1 0.9999009370803833
polypeptides O 0 0.011876650154590607
are O 0 6.020343425916508e-05
not O 0 0.00030908032204024494
understood O 0 0.006426436360925436
, O 0 0.00013177884102333337
their O 0 4.870264092460275e-05
expression O 0 0.0013861245242878795
pattern O 0 0.0051378365606069565
and O 0 0.00021468089835252613
subcellular O 0 0.017328670248389244
localization O 0 0.013576969504356384
suggest O 0 0.0009506416972726583
a O 0 0.00040900387102738023
role O 0 0.002489818725734949
in O 0 0.0004037272010464221
cell O 0 0.010210924781858921
- O 0 0.005311495158821344
cycle O 0 0.0018821876728907228
regulation O 0 0.0019387697102501988
. O 0 0.0006212015869095922

When O 0 0.004389653913676739
resting O 1 0.845736026763916
cells O 0 0.00410285871475935
are O 0 6.204198143677786e-05
induced O 0 0.14269086718559265
to O 0 0.0004214860964566469
proliferate O 0 0.03744049742817879
, O 0 0.00013813271652907133
the O 0 0.00023836300533730537
steady O 0 0.01695679873228073
- O 0 0.004478419665247202
state O 0 0.00011749358236556873
levels O 0 0.0015872734365984797
of O 0 7.175501377787441e-05
BRCA1 O 1 0.9996764659881592
increase O 0 0.0008029829477891326
in O 0 0.00046234941692091525
late O 0 0.00739344721660018
G1 O 1 0.9964509010314941
and O 0 0.0001550481392769143
reach O 0 0.0003863062011078
a O 0 0.00020743186178151518
maximum O 0 0.0007399405003525317
during O 0 0.004155207425355911
S O 1 0.9825009703636169
phase O 0 0.019156569615006447
. O 0 0.0006074760458432138

Moreover O 0 0.012769930996000767
, O 0 0.00038911207229830325
in O 0 0.0006896351696923375
S O 1 0.9877287149429321
phase O 0 0.024403009563684464
cells O 0 0.006012397818267345
, O 0 0.0008853450417518616
BRCA1 O 1 0.9987536668777466
polypeptides O 0 0.010731243528425694
are O 0 0.00015851085481699556
hyperphosphorylated O 1 0.7524194121360779
and O 0 0.0002470144536346197
accumulate O 0 0.008557679131627083
into O 0 8.365064422832802e-05
discrete O 0 0.0029586395248770714
subnuclear O 1 0.8080674409866333
foci O 0 0.12239530682563782
termed O 1 0.5642724633216858
" O 0 0.004961887374520302
BRCA1 O 1 0.9995238780975342
nuclear O 0 0.01793379709124565
dots O 0 0.05190838873386383
. O 0 0.0007903387886472046

" O 0 0.015572217293083668
BRCA1 O 1 0.9999401569366455
associates O 1 0.982883870601654
in O 0 0.0004728373314719647
vivo O 0 0.008711092174053192
with O 0 6.221474177436903e-05
a O 0 0.0009869716595858335
structurally O 0 0.34666457772254944
related O 0 0.00171516218688339
protein O 0 0.003115247003734112
termed O 1 0.9423578977584839
BARD1 O 1 0.9994334578514099
. O 0 0.0010639183456078172

Here O 0 0.0017268056981265545
we O 0 0.0002361342340009287
show O 0 0.00023908338334877044
that O 0 2.9198965421528555e-05
the O 0 0.0001301377487834543
steady O 0 0.012451370246708393
- O 0 0.003982414025813341
state O 0 0.00015708447608631104
levels O 0 0.0020795282907783985
of O 0 0.00010403043415863067
BARD1 O 1 0.9999114274978638
, O 0 0.0005408143624663353
unlike O 0 0.0008476610528305173
those O 0 5.525157757801935e-05
of O 0 0.0001687518524704501
BRCA1 O 1 0.9999929666519165
, O 0 0.0005490064504556358
remain O 0 0.001002872595563531
relatively O 0 0.0006019133725203574
constant O 0 0.0007265823660418391
during O 0 0.0020462381653487682
cell O 0 0.008508527651429176
cycle O 0 0.007380510680377483
progression O 1 0.9958588480949402
. O 0 0.0007559449877589941

However O 0 0.0016645826399326324
, O 0 0.0008077890961430967
immunostaining O 1 0.9944078922271729
revealed O 0 0.013103061355650425
that O 0 0.00023413938470184803
BARD1 O 1 0.9981446266174316
resides O 0 0.014269090257585049
within O 0 0.0006467091152444482
BRCA1 O 1 0.99979168176651
nuclear O 0 0.020428981631994247
dots O 0 0.0827019140124321
during O 0 0.0051842606626451015
S O 1 0.5452683568000793
phase O 0 0.0027533299289643764
of O 0 1.1536954843904823e-05
the O 0 0.0003203853266313672
cell O 0 0.006850700359791517
cycle O 0 0.002767927246168256
, O 0 0.00026528415037319064
but O 0 0.0001627163728699088
not O 0 0.00010154236224479973
during O 0 0.0007369525264948606
the O 0 0.0008595375111326575
G1 O 1 0.9970217347145081
phase O 0 0.023623522371053696
. O 0 0.0007532576564699411

Nevertheless O 0 0.02904682792723179
, O 0 0.0017826308030635118
BARD1 O 1 0.9971861243247986
polypeptides O 0 0.009774069301784039
are O 0 5.684591451426968e-05
found O 0 0.0002735356683842838
exclusively O 0 0.00046299948007799685
in O 0 0.00012200030323583633
the O 0 0.00013456595479510725
nuclear O 0 0.0010974674951285124
fractions O 0 0.00015652558067813516
of O 0 1.6874904758878984e-05
both O 0 0.0009275789489038289
G1 O 1 0.9997698664665222
- O 0 0.012962477281689644
and O 0 0.0007537534693256021
S O 1 0.9962134957313538
- O 0 0.011072243563830853
phase O 0 0.014526375569403172
cells O 0 0.005003022961318493
. O 0 0.0003903209581039846

Therefore O 0 0.002517606131732464
, O 0 0.0006779616815038025
progression O 1 0.9818040132522583
to O 0 0.0006813067593611777
S O 1 0.9887352585792542
phase O 0 0.016790488734841347
is O 0 0.0004941637744195759
accompanied O 0 0.0009505461202934384
by O 0 2.8681419280474074e-05
the O 0 0.00011116333189420402
aggregation O 0 0.0017893031472340226
of O 0 5.1706319936783984e-05
nuclear O 0 0.016433604061603546
BARD1 O 1 0.9878376722335815
polypeptides O 0 0.006648796144872904
into O 0 0.0009899861179292202
BRCA1 O 1 0.9996598958969116
nuclear O 0 0.02034713327884674
dots O 0 0.0631457194685936
. O 0 0.0006939528393559158

This O 0 0.00031605613185092807
cell O 0 0.004138503223657608
cycle O 0 0.004185326863080263
- O 0 0.005538042169064283
dependent O 0 0.0036970239598304033
colocalization O 0 0.10134833306074142
of O 0 0.0001602442207513377
BARD1 O 1 0.9995821118354797
and O 0 0.0012173663126304746
BRCA1 O 1 0.9998542070388794
indicates O 0 0.0028076660819351673
a O 0 0.00040583289228379726
role O 0 0.00190098793245852
for O 0 0.0006775708752684295
BARD1 O 1 0.9972735047340393
in O 0 0.001233163638971746
BRCA1 O 1 0.999968409538269
- O 0 0.31836315989494324
mediated O 1 0.9900998473167419
tumor B-Disease 1 0.9999963045120239
suppression O 0 0.06187905743718147
. O 0 0.0009026926127262414

Ethnic O 0 0.00043407068005762994
differences O 0 0.0012410134077072144
in O 0 0.00017987203318625689
the O 0 0.0007532784948125482
HFE O 1 0.9984537363052368
codon O 0 0.01975896954536438
282 O 0 0.09395232051610947
( O 0 0.006763358134776354
Cys O 1 0.9999934434890747
/ O 1 0.9963560104370117
Tyr O 1 0.9997894167900085
) O 0 0.0005511209019459784
polymorphism O 0 0.0035882077645510435
. O 0 0.0004851592530030757

Recent O 0 0.0031558102928102016
studies O 0 0.0006055846461094916
have O 0 4.658403486246243e-05
shown O 0 0.0006680411170236766
that O 0 0.0005830249865539372
hereditary B-Disease 1 0.9999997615814209
hemochromatosis I-Disease 1 1.0
( O 1 0.8743481636047363
HH B-Disease 1 1.0
) O 0 0.0015420143026858568
is O 0 0.0006954060518182814
likely O 0 0.0009051226079463959
to O 0 6.376137025654316e-05
be O 0 0.00013625729479826987
caused O 0 0.003854949725791812
by O 0 0.00011974965309491381
homozygosity O 1 0.6244768500328064
for O 0 0.00022997018822934479
a O 0 0.0014944893773645163
Cys282Tyr O 1 0.9307039976119995
mutation O 0 0.0018793877679854631
in O 0 0.0001424036017851904
the O 0 0.0007864445797167718
HFE O 1 0.9997830986976624
gene O 0 0.006801283452659845
located O 0 0.003174683079123497
4 O 0 0.0023703158367425203
. O 0 0.0004896013415418565

5 O 0 0.0058883908204734325
Mb O 1 0.9042795300483704
telomeric O 1 0.6120660901069641
to O 0 0.0016755363903939724
HLA O 1 0.9999070167541504
- O 0 0.014319978654384613
A O 0 0.005951566155999899
. O 0 0.0005960688577033579

Population O 0 0.00031009389203973114
studies O 0 0.0004471578577067703
of O 0 1.429598341928795e-05
this O 0 8.214289118768647e-05
polymorphism O 0 0.0029253587126731873
are O 0 5.508879985427484e-05
facilitated O 0 0.008905944414436817
by O 0 4.4828404497820884e-05
the O 0 0.00016738455451559275
fact O 0 0.0004409915709402412
that O 0 5.115363819641061e-05
the O 0 0.0002731999848037958
Cys282Tyr O 1 0.9694852828979492
mutation O 0 0.0023693586699664593
creates O 0 0.0022370771039277315
a O 0 0.0013343329774215817
Rsal O 0 0.4718845784664154
restriction O 0 0.0021035652607679367
site O 0 0.003984311129897833
. O 0 0.0003977033484261483

We O 0 0.0007838207529857755
have O 0 5.562110527534969e-05
studied O 0 0.0003728944284375757
the O 0 0.0001290067593799904
codon O 0 0.009323897771537304
282 O 0 0.08751269429922104
( O 0 0.007193668745458126
Cys O 1 0.9999816417694092
/ O 1 0.9963879585266113
Tyr O 1 0.9998099207878113
) O 0 0.0008437244687229395
polymorphism O 0 0.0021941824816167355
in O 0 7.827088847989216e-05
different O 0 9.781970220501535e-06
ethnic O 0 7.471279968740419e-05
groups O 0 0.00012173409049864858
. O 0 0.0006197311449795961

In O 0 0.0011192199308425188
agreement O 0 0.001674541155807674
with O 0 7.358650327660143e-05
previous O 0 0.00048196615534834564
observations O 0 0.0013699985574930906
the O 0 0.0011450665770098567
Tyr O 1 0.999646782875061
allele O 0 0.020328467711806297
appeared O 0 0.002792846178635955
to O 0 8.248268568422645e-05
be O 0 0.00018466268375050277
rare O 0 0.005593226291239262
or O 0 0.0011034396011382341
absent O 0 0.017054323107004166
in O 0 0.0009683900862000883
Asiatic O 1 0.9934201836585999
( O 0 0.001677954918704927
Indian O 0 0.0022503361105918884
, O 0 0.0004025111556984484
Chinese O 0 0.0006971120019443333
) O 0 0.0003361546841915697
populations O 0 0.0007283668965101242
. O 0 0.0004244864685460925

The O 0 0.0008097791578620672
highest O 0 0.005672034807503223
allele O 0 0.005822435021400452
frequency O 0 0.0013810390373691916
( O 0 0.0012417430989444256
7 O 0 0.002657126635313034
. O 0 0.00017260215827263892
5 O 0 0.000905964698176831
% O 0 0.00011033674672944471
) O 0 0.00041683827294036746
was O 0 0.0015193586004897952
found O 0 0.0003589740372262895
in O 0 0.00024920832947827876
Swedes O 0 0.009356451220810413
. O 0 0.0005958458641543984

Saamis O 1 0.9660248160362244
( O 0 0.0019459381001070142
2 O 0 0.001557268318720162
% O 0 0.00012888823403045535
) O 0 0.00038043319364078343
and O 0 0.0006067996728233993
Mordvinians O 1 0.9983668923377991
( O 0 0.001723466906696558
1 O 0 0.002783693838864565
. O 0 0.00023810405400581658
8 O 0 0.0013529069256037474
% O 0 0.00015684215759392828
) O 0 0.0005219276645220816
had O 0 0.0014294267166405916
significantly O 0 0.008544621989130974
lower O 0 0.00147236546035856
frequencies O 0 6.508114893222228e-05
of O 0 1.805814099498093e-05
the O 0 0.0010557268979027867
Tyr O 1 0.9993316531181335
allele O 0 0.0208357535302639
. O 0 0.000938322045840323

Comparisons O 0 0.002103948500007391
with O 0 0.0001506791595602408
allele O 0 0.003974344115704298
frequencies O 0 0.0002735150628723204
based O 0 0.00020879626390524209
on O 0 0.000654974952340126
prevalence O 1 0.9762204885482788
estimates O 0 0.0013706092722713947
of O 0 0.0003661738883238286
HH B-Disease 1 0.9999998807907104
showed O 0 0.004127155989408493
some O 0 8.398914360441267e-05
disagreements O 0 0.007669060491025448
with O 0 8.727241220185533e-05
the O 0 0.0006778366514481604
RFLP O 1 0.9895706176757812
data O 0 0.0003539541794452816
, O 0 0.00030881998827680945
particularly O 0 0.001974573591724038
in O 0 0.0005142284790053964
Finns O 0 0.04021725058555603
. O 0 0.0008463749545626342

The O 0 0.001125361886806786
newly O 0 0.012095911428332329
described O 0 0.023252058774232864
HFE O 1 0.999852180480957
marker O 0 0.0387248620390892
provides O 0 0.0035821469500660896
a O 0 0.0006543771596625447
new O 0 0.0003665502299554646
approach O 0 0.0019946498796343803
to O 0 5.165595575817861e-05
the O 0 0.00018582685152068734
screening O 0 0.007349616847932339
of O 0 0.00031281946576200426
HH B-Disease 1 0.9999990463256836
as O 0 0.0008211616077460349
well O 0 0.00039507323526777327
as O 0 0.0003126572410110384
studies O 0 0.0003690155572257936
of O 0 1.2503424841270316e-05
the O 0 0.00027987619978375733
relationship O 0 0.005006981547921896
between O 0 0.00039668503450229764
the O 0 0.0020032033789902925
HFE O 1 0.999984860420227
Tyr O 1 0.999946117401123
allele O 0 0.011187995783984661
and O 0 0.0001878685288829729
different O 0 0.0002790060534607619
disorders O 1 1.0
including O 0 0.011921416968107224
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9995125532150269
dominant I-Disease 1 0.9919447302818298
neurohypophyseal I-Disease 1 0.9999938011169434
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999992847442627
associated O 0 0.0016098469495773315
with O 0 5.085407246951945e-05
a O 0 0.0005898007075302303
missense O 0 0.009418927133083344
mutation O 0 0.0011909640161320567
encoding O 0 0.0019209828460589051
Gly23 O 1 0.9940232634544373
- O 0 0.030438514426350594
- O 0 0.018187256529927254
> O 0 0.03653709590435028
Val O 1 0.9895415306091309
in O 0 0.0009615113958716393
neurophysin O 1 0.9973168969154358
II O 1 0.9992393255233765
. O 0 0.0006745124701410532

Autosomal B-Disease 1 0.9969622492790222
dominant I-Disease 1 0.9765351414680481
neurohypophyseal I-Disease 1 0.9999904632568359
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
( O 0 0.00858134962618351
ADNDI B-Disease 1 0.9998387098312378
) O 0 0.0003881082811858505
is O 0 0.00037589878775179386
an O 0 0.0031284659635275602
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.7633264660835266
by O 0 0.00033715314930304885
progressive O 1 0.9982171654701233
degeneration O 1 0.9999996423721313
of O 0 6.481828313553706e-05
the O 0 0.0006630619172938168
magnocellular O 1 0.9962148070335388
neurons O 0 0.007375073619186878
of O 0 1.7286118236370385e-05
the O 0 0.0006807330064475536
hypothalamus O 1 0.9912419319152832
leading O 0 0.003622922580689192
to O 0 0.00021580819156952202
decreased O 0 0.015233191661536694
ability O 0 0.0013190944446250796
to O 0 3.217959601897746e-05
produce O 0 7.21940741641447e-05
the O 0 0.000221350317588076
hormone O 1 0.9528364539146423
arginine O 0 0.20876656472682953
vasopressin O 1 0.9871594905853271
( O 0 0.006362129468470812
AVP O 1 0.999991774559021
) O 0 0.0014914745697751641
. O 0 0.0005550583591684699

Affected O 0 0.02193405106663704
individuals O 0 0.0003201587242074311
are O 0 4.9531776312505826e-05
not O 0 0.0005894635105505586
symptomatic O 1 0.9999958276748657
at O 0 0.0027386967558413744
birth O 0 0.0028372902888804674
, O 0 0.00020386483811307698
but O 0 0.00021248498524073511
usually O 0 0.0009860843420028687
develop O 1 0.9997172951698303
diabetes B-Disease 1 1.0
insipidus I-Disease 1 0.9999991655349731
at O 0 0.00523629505187273
1 O 0 0.005237363278865814
- O 0 0.011508668772876263
6 O 0 0.00392514793202281
yr O 1 0.78935307264328
of O 0 6.60156219964847e-05
age O 0 0.00263233482837677
. O 0 0.000871110416483134

The O 0 0.0006638022605329752
genetic O 0 0.0018794744974002242
locus O 0 0.005694313440471888
of O 0 3.7966074160067365e-05
the O 0 0.0018604418728500605
disease O 1 0.9999998807907104
is O 0 0.0005301913479343057
the O 0 0.0011051063193008304
AVP O 1 0.9999946355819702
- O 0 0.13745780289173126
neurophysin O 1 0.9966990351676941
II O 1 0.9992092251777649
( O 0 0.003423315705731511
NPII O 1 0.9994383454322815
) O 0 0.0007976389024406672
gene O 0 0.002898378996178508
, O 0 0.0001907936966745183
and O 0 0.0001717137492960319
mutations O 0 0.0028699301183223724
that O 0 0.0002252128761028871
cause O 1 0.9902029037475586
ADNDI B-Disease 1 0.9998263716697693
have O 0 0.0003324935969430953
been O 0 0.00053726154146716
found O 0 0.00029242286109365523
in O 0 8.519914990756661e-05
both O 0 7.35948487999849e-05
the O 0 9.989353566197678e-05
signal O 0 0.0012924880720674992
peptide O 0 0.0009421306313015521
of O 0 1.0862228918995243e-05
the O 0 0.0005018916563130915
prepro O 1 0.9942465424537659
- O 1 0.5238877534866333
AVP O 1 0.9999704360961914
- O 0 0.056434664875268936
NPII O 1 0.9934647679328918
precursor O 0 0.016554800793528557
and O 0 0.0001519030483905226
within O 0 0.0004914395394735038
NPII O 1 0.9980536699295044
itself O 0 0.009259456768631935
. O 0 0.0005668781814165413

An O 0 0.0024346564896404743
affected O 0 0.034549932926893234
girl O 0 0.12182732671499252
who O 0 0.0016433006385341287
presented O 0 0.0021685657557100058
at O 0 0.0023910505697131157
9 O 0 0.003040976356714964
months O 0 0.0011906808940693736
of O 0 3.385521631571464e-05
age O 0 0.001890716957859695
and O 0 0.0004130218585487455
her O 0 0.003388460958376527
similarly O 0 0.018272865563631058
affected O 0 0.051803287118673325
younger O 0 0.020069865509867668
brother O 0 0.011672791093587875
and O 0 0.0006512862164527178
father O 0 0.005405858624726534
were O 0 5.513210271601565e-05
all O 0 4.117496428079903e-05
found O 0 0.00030855718068778515
to O 0 5.0091868615709245e-05
have O 0 4.0497445297660306e-05
a O 0 0.00035335723077878356
novel O 0 0.0019913988653570414
missense O 0 0.023772794753313065
mutation O 0 0.00479692779481411
( O 0 0.0012556236470118165
G1758 O 1 0.5994056463241577
- O 0 0.0477779395878315
- O 0 0.041781820356845856
> O 0 0.08608117699623108
T O 1 0.993044912815094
) O 0 0.00011667543731164187
encoding O 0 9.267670247936621e-05
the O 0 4.11806940974202e-05
amino O 0 0.0002054581418633461
acid O 0 0.004234465770423412
substitution O 0 0.002383208367973566
Gly23 O 1 0.9897961020469666
- O 0 0.02898198552429676
- O 0 0.020960208028554916
> O 0 0.04403213411569595
Val O 1 0.9732711911201477
within O 0 0.0012458468554541469
NPII O 1 0.9984207153320312
. O 0 0.0011462976690381765

The O 0 0.001251943875104189
mutation O 0 0.006120550446212292
was O 0 0.0027482935693114996
confirmed O 0 0.0020285339560359716
by O 0 3.250601002946496e-05
restriction O 0 0.0010218711104243994
endonuclease O 0 0.057945333421230316
analysis O 0 0.0012772316113114357
. O 0 0.0007064173696562648

A O 0 0.042143743485212326
T1 O 1 0.9998857975006104
- O 0 0.008244055323302746
weighted O 0 0.0009493038523942232
magnetic O 0 0.0015950545202940702
resonance O 0 0.010809185914695263
imaging O 0 0.2845290005207062
of O 0 2.506915552658029e-05
the O 0 0.00046560587361454964
fathers O 0 0.01210011262446642
pituitary O 1 0.9999052286148071
gland O 1 0.9996461868286133
demonstrates O 0 0.01479813177138567
an O 0 0.0006192352157086134
attenuated O 1 0.9929441809654236
posterior O 1 0.9993013143539429
pituitary O 1 0.9999661445617676
bright O 1 0.9882538318634033
spot O 0 0.021629808470606804
. O 0 0.0006694094627164304

This O 0 0.0005710995756089687
mutation O 0 0.005721201654523611
may O 0 0.0014117794344201684
be O 0 8.328371040988714e-05
valuable O 0 0.0018742388347163796
for O 0 0.00019187480211257935
developing O 0 0.004211102146655321
models O 0 0.0004172379558440298
of O 0 8.571891521569341e-05
dominantly B-Disease 1 0.999893307685852
inherited I-Disease 1 0.9999958276748657
neurodegeneration I-Disease 1 1.0
, O 0 0.0009147461969405413
as O 0 0.0002646183129400015
the O 0 0.0001793703850125894
early O 0 0.0006240080110728741
age O 0 0.0003780588158406317
of O 0 6.382160063367337e-05
onset O 1 0.9999929666519165
of O 0 0.0005690830294042826
symptoms O 1 0.9999998807907104
suggests O 0 0.0038298354484140873
that O 0 4.7974281187634915e-05
this O 0 0.00010491168359294534
mutation O 0 0.005171934142708778
may O 0 0.001428260700777173
be O 0 9.874172246782109e-05
particularly O 0 0.0014576729154214263
deleterious O 0 0.023092765361070633
to O 0 0.00011954248475376517
the O 0 0.0005809565773233771
magnocellular O 1 0.9985124468803406
neuron O 1 0.9945819973945618
. O 0 0.00042870856123045087
. O 0 0.00044948828872293234

Frequent O 0 0.022868668660521507
inactivation O 0 0.3016740679740906
of O 0 0.00047917108167894185
PTEN O 1 0.9999996423721313
/ O 1 0.9986675977706909
MMAC1 O 1 0.999325156211853
in O 0 0.0009460245491936803
primary O 1 0.9999030828475952
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0013249447802081704

Sporadic B-Disease 1 0.999254047870636
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.0008999774581752717
the O 0 0.00014372082659974694
most O 0 0.00033570887171663344
common O 0 0.01206521037966013
male B-Disease 0 0.43521633744239807
cancer I-Disease 1 1.0
in O 0 0.0003349337785039097
the O 0 0.000452465086709708
Western O 0 0.004089299123734236
world O 0 0.002659408375620842
, O 0 0.0005808065179735422
yet O 0 0.0006595909944735467
many O 0 2.1683124941773713e-05
of O 0 1.2949970368936192e-05
the O 0 0.0003175520687364042
major O 0 0.004915119148790836
genetic O 0 0.002076670527458191
events O 0 0.0003602948854677379
involved O 0 0.0011465521529316902
in O 0 0.0001660753769101575
the O 0 0.0003346423909533769
progression O 1 0.8318220973014832
of O 0 1.8897861082223244e-05
this O 0 0.00020223432511556894
often O 0 0.008183334954082966
fatal O 1 1.0
cancer B-Disease 1 1.0
remain O 0 0.0021560355089604855
to O 0 7.924724195618182e-05
be O 0 0.00019723955483641475
elucidated O 0 0.2537045180797577
. O 0 0.0005249101668596268

Numerous O 0 0.005728478077799082
cytogenetic O 1 0.994178056716919
and O 0 0.0015290973242372274
allelotype O 1 0.9946631193161011
studies O 0 0.0014703625347465277
have O 0 0.00020616635447368026
reported O 0 0.0037436112761497498
frequent O 0 0.005605335347354412
loss O 0 0.004849676974117756
of O 0 6.484808545792475e-05
heterozygosity O 1 0.9837921857833862
on O 0 0.0006910651572979987
chromosomal O 0 0.1185087189078331
arm O 1 0.9958471655845642
10q O 0 0.12457811832427979
in O 0 0.000890204741153866
sporadic B-Disease 1 0.9998339414596558
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0012754063354805112

Deletion O 0 0.03244604915380478
mapping O 0 0.010817223228514194
studies O 0 0.0015156117733567953
have O 0 0.00020871286687906832
unambiguously O 0 0.03647080436348915
identified O 0 0.0011910826433449984
a O 0 0.00039842797559686005
region O 0 0.0010487785330042243
of O 0 4.6749588364036754e-05
chromosome O 0 0.009099377319216728
10q23 O 0 0.06371212005615234
to O 0 0.00011392471787985414
be O 0 5.9194535424467176e-05
the O 0 9.802161366678774e-05
minimal O 0 0.004200241062790155
area O 0 0.001164820627309382
of O 0 4.726172483060509e-05
loss O 0 0.10328933596611023
. O 0 0.000806070223916322

A O 0 0.005517447367310524
new O 0 0.001957281492650509
tumor B-Disease 1 0.9999903440475464
suppressor O 0 0.07423592358827591
gene O 0 0.0047961752861738205
, O 0 0.0019392614485695958
PTEN O 1 0.9999969005584717
/ O 1 0.9973255395889282
MMAC1 O 1 0.9996291399002075
, O 0 0.0006684159161522985
was O 0 0.0032174522057175636
isolated O 0 0.03250329568982124
recently O 0 0.009374749846756458
at O 0 0.0005917783128097653
this O 0 4.744370380649343e-05
region O 0 0.0008307164534926414
of O 0 4.594708661898039e-05
chromosome O 0 0.011395142413675785
10q23 O 0 0.10891791433095932
and O 0 0.0002750285784713924
found O 0 0.00034692499320954084
to O 0 5.7176519476342946e-05
be O 0 0.00014775348245166242
inactivated O 0 0.028583500534296036
by O 0 2.9957840524730273e-05
mutation O 0 0.0008706672815605998
in O 0 0.0002337610931135714
three O 0 0.005197695456445217
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.019914381206035614
lines O 0 0.0020440658554434776
. O 0 0.0005550840869545937

We O 0 0.0009675835026428103
screened O 0 0.010441889055073261
80 O 0 0.036343738436698914
prostate B-Disease 1 1.0
tumors I-Disease 1 0.9999997615814209
by O 0 0.0001993368350667879
microsatellite O 0 0.044434528797864914
analysis O 0 0.0005897501250728965
and O 0 0.00022144487593322992
found O 0 0.0009611276909708977
chromosome O 0 0.004478609189391136
10q23 O 0 0.034006889909505844
to O 0 9.618850890547037e-05
be O 0 0.00010975341137964278
deleted O 0 0.0023737833835184574
in O 0 0.000229300232604146
23 O 0 0.004569723270833492
cases O 0 0.003414321457967162
. O 0 0.0006771651678718626

We O 0 0.0017014641780406237
then O 0 0.0005105138407088816
proceeded O 0 0.001187504967674613
with O 0 2.2603569959755987e-05
sequence O 0 2.628154106787406e-05
analysis O 0 4.9393576773582026e-05
of O 0 6.833549377915915e-06
the O 0 0.0003363997384440154
entire O 0 0.0522150881588459
PTEN O 1 0.9999921321868896
/ O 1 0.9899069666862488
MMAC1 O 1 0.9968926310539246
coding O 0 0.02044500596821308
region O 0 0.0034252943005412817
and O 0 0.00040607090340927243
tested O 0 0.015802230685949326
for O 0 0.0002973083464894444
homozygous O 0 0.007849416695535183
deletion O 0 0.006944725755602121
with O 0 0.00016577490896452218
new O 0 0.001702896784991026
intragenic O 1 0.9596987962722778
markers O 0 0.009536798112094402
in O 0 0.000161085874424316
these O 0 5.539201447390951e-05
23 O 0 0.003218467580154538
cases O 0 0.001366834039799869
with O 0 0.00019008117669727653
10q23 O 1 0.719150960445404
loss O 0 0.007703050039708614
of O 0 9.785723523236811e-05
heterozygosity O 1 0.9974212646484375
. O 0 0.0009796067606657743

The O 0 0.0004881068889517337
identification O 0 0.00022837142751086503
of O 0 1.074746160156792e-05
the O 0 0.00021421369456220418
second O 0 0.0012444021413102746
mutational O 1 0.7979770302772522
event O 0 0.002058375161141157
in O 0 0.0003386318567208946
10 O 0 0.0009515699930489063
( O 0 0.0005984975723549724
43 O 0 0.0027423095889389515
% O 0 0.00021555730199906975
) O 0 0.0025391853414475918
tumors B-Disease 1 1.0
establishes O 1 0.9998288154602051
PTEN O 1 0.9999984502792358
/ O 1 0.9977414608001709
MMAC1 O 1 0.9984898567199707
as O 0 0.0003262665122747421
a O 0 0.0005792914307676256
main O 0 0.002184536773711443
inactivation O 0 0.07005707919597626
target O 0 0.000327587709762156
of O 0 2.20414931391133e-05
10q O 0 0.1896684318780899
loss O 0 0.00786552857607603
in O 0 0.0008474077912978828
sporadic B-Disease 1 0.9998624324798584
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0006682494422420859
. O 0 0.0004204940050840378

Risk O 1 0.8760678172111511
reversals O 0 0.0248881708830595
in O 0 0.0002676317817531526
predictive O 0 0.04057880491018295
testing O 0 0.03178510442376137
for O 0 0.009387675672769547
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.001457196893170476

The O 0 0.000267964496742934
first O 0 0.00017973109788727015
predictive O 0 0.01690956950187683
testing O 0 0.014782054349780083
for O 0 0.004931693896651268
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.006875726860016584
HD B-Disease 1 0.9995290040969849
) O 0 0.0007410307880491018
was O 0 0.0012621484929695725
based O 0 0.00010599204688332975
on O 0 7.519849896198139e-05
analysis O 0 0.00013467056851368397
of O 0 4.5617282012244686e-05
linked O 0 0.06190444529056549
polymorphic O 0 0.10842855274677277
DNA O 0 0.005427452735602856
markers O 0 0.004977933596819639
to O 0 0.00010544766701059416
estimate O 0 0.0006522129406221211
the O 0 0.00011486127914395183
likelihood O 0 0.002889417577534914
of O 0 3.4765456803143024e-05
inheriting O 0 0.3972615599632263
the O 0 0.0002809835714288056
mutation O 0 0.003375470172613859
for O 0 0.001116706058382988
HD B-Disease 1 0.9967309236526489
. O 0 0.001052275882102549

Limits O 0 0.0011860737577080727
to O 0 7.727983029326424e-05
accuracy O 0 0.0009309735614806414
included O 0 0.00011351936700521037
recombination O 0 0.0013744907919317484
between O 0 0.00011208255455130711
the O 0 0.00025754189118742943
DNA O 0 0.0037590335123240948
markers O 0 0.0052874041721224785
and O 0 8.19469933048822e-05
the O 0 0.0002706878585740924
mutation O 0 0.004286743700504303
, O 0 0.0005624662153422832
pedigree O 0 0.05639700964093208
structure O 0 0.007814876735210419
, O 0 0.00035906030097976327
and O 0 0.00019857556617353112
whether O 0 0.0008537763496860862
DNA O 0 0.0013122113887220621
samples O 0 0.0003104441275354475
were O 0 3.5979854146717116e-05
available O 0 0.00020080493413843215
from O 0 0.00013794424012303352
family O 0 0.0008677741861902177
members O 0 0.0002859676897060126
. O 0 0.00065468909451738

With O 0 0.00018942767928820103
direct O 0 0.0005211186944507062
tests O 0 0.0018441877327859402
for O 0 0.00015274371253326535
the O 0 0.0007330385269597173
HD B-Disease 1 0.9987336993217468
mutation O 0 0.00506387185305357
, O 0 0.00030711290310136974
we O 0 0.0002596935082692653
have O 0 0.00010523421224206686
assessed O 0 0.006113604176789522
the O 0 9.310695168096572e-05
accuracy O 0 0.0009234598255716264
of O 0 3.5146782465744764e-05
results O 0 0.0010178092634305358
obtained O 0 0.00034722479176707566
by O 0 8.392726158490404e-05
linkage O 0 0.04639574885368347
approaches O 0 0.01244292501360178
when O 0 0.0009726096759550273
requested O 0 0.0022544071543961763
to O 0 0.00014944715076126158
do O 0 0.00033555302070453763
so O 0 9.696863708086312e-05
by O 0 2.0653771571232937e-05
the O 0 0.000250552489887923
test O 0 0.0037012447137385607
individuals O 0 0.00041391164995729923
. O 0 0.0005371719016693532

For O 0 0.0008615448023192585
six O 0 0.00028409319929778576
such O 0 4.561788955470547e-05
individuals O 0 0.00036911340430378914
, O 0 0.0002909631293732673
there O 0 0.0001693682570476085
was O 0 0.001269122469238937
significant O 0 0.0012022833107039332
disparity O 0 0.03280187398195267
between O 0 0.0002373071911279112
the O 0 0.0004679810954257846
tests O 0 0.007755493279546499
. O 0 0.0005710091791115701

Three O 0 0.00045778349158354104
went O 0 0.0011311043053865433
from O 0 0.00010545732220634818
a O 0 0.0015322384424507618
decreased O 0 0.4222833514213562
risk O 0 0.06445580720901489
to O 0 8.826259727356955e-05
an O 0 0.00027188699459657073
increased O 0 0.002628086833283305
risk O 1 0.9774986505508423
, O 0 0.0003837111289612949
while O 0 0.00022015794820617884
in O 0 0.00013663903519045562
another O 0 0.0003078850859310478
three O 0 5.2977633458795026e-05
the O 0 0.000313903292408213
risk O 1 0.9870299696922302
was O 0 0.003428656840696931
decreased O 0 0.04992189258337021
. O 0 0.0006599343032576144

Knowledge O 0 0.003673444502055645
of O 0 3.526344880810939e-05
the O 0 0.0003552456619217992
potential O 0 0.003279305761680007
reasons O 0 0.0014737099409103394
for O 0 0.00017317452875431627
these O 0 4.58359245385509e-05
changes O 0 0.0006685315165668726
in O 0 0.00037686253199353814
results O 0 0.001289203530177474
and O 0 0.00011948378960369155
impact O 0 0.001184171182103455
of O 0 1.605891520739533e-05
these O 0 9.807854803511873e-05
risk O 1 0.9585313200950623
reversals O 0 0.05498939007520676
on O 0 0.0005275480798445642
both O 0 0.0012362211709842086
patients O 1 0.9999969005584717
and O 0 0.00022233431809581816
the O 0 0.0008555740932933986
counseling O 1 0.9986152648925781
team O 0 0.0033175237476825714
can O 0 0.00017697701696306467
assist O 0 0.002929511945694685
in O 0 0.00013737427070736885
the O 0 0.0001373503328068182
development O 0 0.0010293556842952967
of O 0 3.288879452156834e-05
strategies O 0 0.009740541689097881
for O 0 0.000358161807525903
the O 0 0.0011915040668100119
prevention O 1 0.9998754262924194
and O 0 0.0004451051354408264
, O 0 0.0004826391814276576
where O 0 0.00038071986637078226
necessary O 0 0.0018259941134601831
, O 0 0.0005128739285282791
management O 0 0.04865770414471626
of O 0 4.55256704299245e-05
a O 0 0.00296019297093153
risk O 1 0.900644063949585
reversal O 0 0.014808847568929195
in O 0 0.0001301660668104887
any O 0 0.00015449737838935107
predictive O 0 0.0431523323059082
testing O 0 0.027310455217957497
program O 0 0.007367415353655815
. O 0 0.00022846090723760426
. O 0 0.0003930036327801645

A O 0 0.009568776935338974
novel O 0 0.0035818303003907204
common O 0 0.003857398172840476
missense O 0 0.04129822179675102
mutation O 0 0.006112071685492992
G301C O 0 0.03479691967368126
in O 0 0.0001640242844587192
the O 0 0.00044015745515935123
N O 0 0.04183029755949974
- O 0 0.01669515110552311
acetylgalactosamine O 1 0.8054815530776978
- O 0 0.008729202672839165
6 O 0 0.00368671421892941
- O 0 0.015939986333251
sulfate O 1 0.9969682097434998
sulfatase O 1 0.9983211159706116
gene O 0 0.0054047489538788795
in O 0 0.0008659957675263286
mucopolysaccharidosis B-Disease 1 0.9982537627220154
IVA I-Disease 1 0.9998325109481812
. O 0 0.001031119260005653

Mucopolysaccharidosis B-Disease 1 0.9986273050308228
IVA I-Disease 1 0.9999120235443115
( O 0 0.0068620131351053715
MPS B-Disease 1 0.9983184337615967
IVA I-Disease 1 0.9999984502792358
) O 0 0.0006518506561405957
is O 0 0.00023709282686468214
an O 0 0.0005416198400780559
autosomal B-Disease 1 0.9999773502349854
recessive I-Disease 1 0.9999864101409912
lysosomal I-Disease 1 0.9999994039535522
storage I-Disease 1 0.9999628067016602
disorder I-Disease 1 1.0
caused O 0 0.2396032065153122
by O 0 8.216780406655744e-05
a O 0 0.0020907442085444927
genetic B-Disease 1 0.9969082474708557
defect I-Disease 1 0.9999665021896362
in O 0 0.0008865626296028495
N O 0 0.04928825423121452
- O 0 0.015199465677142143
acetylgalactosamine O 1 0.6995552778244019
- O 0 0.006725782062858343
6 O 0 0.0029557673260569572
- O 0 0.018808934837579727
sulfate O 1 0.9998140931129456
sulfatase O 1 0.9999270439147949
( O 0 0.005932879634201527
GALNS O 1 0.9995916485786438
) O 0 0.0011207995703443885
. O 0 0.0004850934201385826

In O 0 0.0009662336087785661
previous O 0 0.0015408898470923305
studies O 0 0.002366903005167842
, O 0 0.00030389244784601033
we O 0 0.00020676205167546868
have O 0 5.832028909935616e-05
found O 0 0.00013788399519398808
two O 0 3.618728442233987e-05
common O 0 0.002104266081005335
mutations O 0 0.004432098474353552
in O 0 0.0008557791006751359
Caucasians O 1 0.9918990135192871
and O 0 0.0004188489983789623
Japanese O 0 0.0033391513861715794
, O 0 0.0006316014914773405
respectively O 0 0.001741131185553968
. O 0 0.0006642591906711459

To O 0 0.0006769828614778817
characterize O 0 0.0453014075756073
the O 0 0.0009012973168864846
mutational O 1 0.9548469185829163
spectrum O 0 0.011381618678569794
in O 0 0.00016524954116903245
various O 0 3.7392172089312226e-05
ethnic O 0 9.890955698210746e-05
groups O 0 9.939118172042072e-05
, O 0 0.00037727769813500345
mutations O 0 0.002179657109081745
in O 0 0.00016699907428119332
the O 0 0.000692695495672524
GALNS O 1 0.9970589876174927
gene O 0 0.002326826099306345
in O 0 0.00031867329380474985
Colombian O 0 0.040823642164468765
MPS B-Disease 1 0.9994540810585022
IVA I-Disease 1 0.9999998807907104
patients O 1 0.999998927116394
were O 0 0.0002697156451176852
investigated O 0 0.19949230551719666
, O 0 0.0003974716237280518
and O 0 0.0003597100148908794
genetic O 0 0.004072968848049641
backgrounds O 0 0.0020514384377747774
were O 0 9.977597073884681e-05
extensively O 0 0.00669082161039114
analyzed O 0 0.002346053719520569
to O 0 0.00012733459880109876
identify O 0 0.0018105970229953527
racial O 0 0.0017657409189268947
origin O 0 0.0001242549769813195
, O 0 0.00016739188868086785
based O 0 0.00012470829824451357
on O 0 0.00022165781410876662
mitochondrial O 0 0.004561346024274826
DNA O 0 0.0034865587949752808
( O 0 0.0008115962846204638
mtDNA O 0 0.002492201281711459
) O 0 0.0005050772451795638
lineages O 0 0.0027190386317670345
. O 0 0.0005850685993209481

Three O 0 0.0004992139874957502
novel O 0 0.004432464484125376
missense O 0 0.04594683647155762
mutations O 0 0.008829176425933838
never O 0 0.0053028529509902
identified O 0 0.002565596252679825
previously O 0 0.0012646802933886647
in O 0 0.00012400817649904639
other O 0 7.279690180439502e-05
populations O 0 0.0005969685153104365
and O 0 0.00023985328152775764
found O 0 0.000661162834148854
in O 0 0.0002107108011841774
16 O 0 0.0007105389377102256
out O 0 4.8090216296259314e-05
of O 0 2.7807283913716674e-05
19 O 0 0.005433329846709967
Colombian O 0 0.03618789464235306
MPS B-Disease 1 0.988286554813385
IVA I-Disease 1 0.9999912977218628
unrelated O 0 0.02250632457435131
alleles O 0 0.0032295624259859324
account O 0 0.00029605647432617843
for O 0 0.0006122756167314947
84 O 0 0.024656526744365692
. O 0 0.000726583763025701

2 O 0 0.0022067376412451267
% O 0 3.6462952266447246e-05
of O 0 1.610078106750734e-05
the O 0 0.00038187357131391764
alleles O 0 0.0044081141240894794
in O 0 0.0002138015115633607
this O 0 0.00010799960000440478
study O 0 0.0023208227939903736
. O 0 0.00041539239464327693

The O 0 0.0017275736900046468
G301C O 0 0.07704108208417892
and O 0 0.00047848623944446445
S162F O 0 0.06028611212968826
mutations O 0 0.0011108076432719827
account O 0 0.00017216855485457927
for O 0 0.0004030427662655711
68 O 0 0.013389548286795616
. O 0 0.0005339871859177947

4 O 0 0.0034904396161437035
% O 0 0.00013563585525844246
and O 0 0.00026004781830124557
10 O 0 0.0012165611842647195
. O 0 0.0005438202060759068

5 O 0 0.001554603106342256
% O 0 4.4023599912179634e-05
of O 0 3.705897688632831e-05
mutations O 0 0.007922234944999218
, O 0 0.00060343521181494
respectively O 0 0.001867517945356667
, O 0 0.00036747075500898063
whereas O 0 0.0017475103959441185
the O 0 0.0002740726340562105
remaining O 0 0.001188881229609251
F69V O 1 0.9966481328010559
is O 0 0.0006284939590841532
limited O 0 0.0007735452381893992
to O 0 4.506169352680445e-05
a O 0 0.00031969512929208577
single O 0 0.0005772155127488077
allele O 0 0.012387740425765514
. O 0 0.0008690270478837192

The O 0 0.0011644779006019235
skewed O 0 0.019891824573278427
prevalence O 0 0.34470894932746887
of O 0 8.138851262629032e-05
G301C O 0 0.06507567316293716
in O 0 0.00021052826195955276
only O 0 0.000316882214974612
Colombian O 0 0.06444951146841049
patients O 1 0.9999818801879883
and O 0 0.00046882565948180854
haplotype O 0 0.05997886136174202
analysis O 0 0.0002882346452679485
by O 0 3.561668927432038e-05
restriction O 0 0.0006814139196649194
fragment O 0 0.003364886622875929
length O 0 0.0006346009322442114
polymorphisms O 0 0.002826132345944643
in O 0 0.00017576332902535796
the O 0 0.000835187267512083
GALNS O 1 0.999875545501709
gene O 0 0.004443405661731958
suggest O 0 0.000958993739914149
that O 0 0.0001447992690373212
G301C O 0 0.0515633225440979
originated O 0 0.0009419458801858127
from O 0 7.584976992802694e-05
a O 0 0.0007287095068022609
common O 0 0.0026296621654182673
ancestor O 0 0.0036734899040311575
. O 0 0.0007244966691359878

Investigation O 0 0.0101874228566885
of O 0 2.5997065677074715e-05
the O 0 0.0003613664011936635
genetic O 0 0.0037823026068508625
background O 0 0.0011965984012931585
by O 0 5.2437259000726044e-05
means O 0 0.0004575561615638435
of O 0 3.6625744542106986e-05
mtDNA O 0 0.0023868887219578028
lineages O 0 0.002217681612819433
indicate O 0 0.0009311797912232578
that O 0 4.2327865230618045e-05
all O 0 5.1811108278343454e-05
our O 0 0.004248918034136295
patients O 1 0.9999915361404419
are O 0 5.713498831028119e-05
probably O 0 0.0006724089616909623
of O 0 1.4978179933677893e-05
native O 0 0.0005380143411457539
American O 0 0.0018950313096866012
descent O 0 0.009218023158609867

Low O 0 0.003649447811767459
frequency O 0 0.00029046228155493736
of O 0 0.00015000208804849535
BRCA1 O 1 0.9998600482940674
germline O 1 0.8709235191345215
mutations O 0 0.0014633405953645706
in O 0 0.00012007303303107619
45 O 0 0.0013083538506180048
German O 1 0.9988516569137573
breast B-Disease 1 1.0
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0016080207424238324
. O 0 0.000632101611699909

In O 0 0.00039226424996741116
this O 0 5.7535540690878406e-05
study O 0 0.0006189198466017842
we O 0 0.00014738101162947714
investigated O 0 0.005831053480505943
45 O 0 0.0008992772200144827
German O 1 0.9960545301437378
breast B-Disease 1 1.0
/ I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0009143013157881796
for O 0 0.0006311078905127943
germline O 1 0.9831874966621399
mutations O 0 0.0017582621658220887
in O 0 0.00013553668395616114
the O 0 0.0008548524929210544
BRCA1 O 1 0.9999653100967407
gene O 0 0.007958478294312954
. O 0 0.0006649470888078213

We O 0 0.0010667345486581326
identified O 0 0.000892577285412699
four O 0 0.00018288989667780697
germline O 0 0.15819552540779114
mutations O 0 0.001364357303828001
in O 0 0.00017593789380043745
three O 0 0.001752527547068894
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.00027752379537560046
and O 0 4.728182466351427e-05
in O 0 0.00012484894250519574
one O 0 0.001597642432898283
breast B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.003554734168574214
. O 0 0.00014670718519482762
among O 0 4.908783012069762e-05
these O 0 1.4072656995267607e-05
were O 0 3.440149157540873e-05
one O 0 0.0004760128795169294
frameshift O 1 0.9790326356887817
mutation O 0 0.00453058211132884
, O 0 0.00026743768830783665
one O 0 0.00032345435465686023
nonsense O 0 0.025355570018291473
mutation O 0 0.004222673363983631
, O 0 0.0002295855083502829
one O 0 0.00024208900867961347
novel O 0 0.002925888868048787
splice O 0 0.05949363484978676
site O 0 0.007695523556321859
mutation O 0 0.003348846919834614
, O 0 0.00017769717669580132
and O 0 0.0001001877462840639
one O 0 0.00034049860551021993
missense O 0 0.02917720563709736
mutation O 0 0.006662452127784491
. O 0 0.0007135752821341157

The O 0 0.0011180848814547062
missense O 0 0.026527713984251022
mutation O 0 0.00458352267742157
was O 0 0.0020450172014534473
also O 0 0.0002835750055965036
found O 0 0.000313482218189165
in O 0 0.0002428072039037943
2 O 0 0.002107717329636216
. O 0 0.0005171963130123913

8 O 0 0.0027091067750006914
% O 0 4.362402614788152e-05
of O 0 1.679232627793681e-05
the O 0 0.0003548545646481216
general O 0 0.0023362203501164913
population O 0 0.00014536091475747526
, O 0 0.00036666798405349255
suggesting O 0 0.003277859650552273
that O 0 5.427710129879415e-05
it O 0 0.00010132685565622523
is O 0 0.0006168478284962475
not O 0 0.0017069788882508874
disease O 1 1.0
associated O 0 0.0019802888855338097
. O 0 0.0006413238006643951

The O 0 0.0005394330946728587
average O 0 0.002043567830696702
age O 0 0.0012735624331980944
of O 0 0.0005478019011206925
disease O 1 1.0
onset O 1 0.9999948740005493
in O 0 0.0003845673054456711
those O 0 0.00018769250891637057
families O 0 0.001217413111589849
harbouring O 1 0.9987916350364685
causative O 1 0.9864612221717834
mutations O 0 0.006283411290496588
was O 0 0.001424487680196762
between O 0 0.0003125687362626195
32 O 0 0.002856289502233267
. O 0 0.0006329338066279888

3 O 0 0.0032895489130169153
and O 0 0.0003603764344006777
37 O 0 0.005394035018980503
. O 0 0.0005949179758317769

4 O 0 0.005700348410755396
years O 0 0.001580814248882234
, O 0 0.0003111944242846221
whereas O 0 0.0017354937735944986
the O 0 0.00044164492283016443
family O 0 0.002754796529188752
harbouring O 1 0.9724060893058777
the O 0 0.0007379617309197783
missense O 0 0.033466219902038574
mutation O 0 0.004230843856930733
had O 0 0.0005889810854569077
an O 0 0.0002068501926260069
average O 0 0.0022358086425811052
age O 0 0.0006925499183125794
of O 0 7.491862925235182e-05
onset O 1 0.999687910079956
of O 0 0.0001446696842322126
51 O 0 0.017888972535729408
. O 0 0.0009068525396287441

2 O 0 0.0045945611782372
years O 0 0.0012574944412335753
. O 0 0.0004939245991408825

These O 0 0.0001983747788472101
findings O 0 0.00324652181006968
show O 0 0.0007656828965991735
that O 0 0.0005173326353542507
BRCA1 O 1 0.9999127388000488
is O 0 0.002517048269510269
implicated O 1 0.6081935167312622
in O 0 9.816078818403184e-05
a O 0 0.00012716568016912788
small O 0 6.776960071874782e-05
fraction O 0 0.0007530201110057533
of O 0 0.00046690943418070674
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0013435307191684842
suggesting O 0 0.0029927550349384546
the O 0 0.00017846297123469412
involvement O 0 0.004811576101928949
of O 0 1.7947470041690394e-05
another O 0 0.0013387352228164673
susceptibility O 1 0.9805128574371338
gene O 0 0.010370809584856033
( O 0 0.0023750553373247385
s O 0 0.2955529987812042
) O 0 0.0014347633114084601

Paternal O 0 0.037149060517549515
transmission O 0 0.04282010346651077
of O 0 0.0017725283978506923
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.005866534076631069

We O 0 0.0010850239777937531
report O 0 0.0007928594131954014
a O 0 0.0005231144023127854
rare O 0 0.0036079082638025284
case O 0 0.0006615640595555305
of O 0 4.3528078094823286e-05
paternally O 1 0.999347984790802
transmitted O 1 0.9999227523803711
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9909691214561462
DM B-Disease 1 1.0
) O 0 0.002258561784401536
. O 0 0.0006231889710761607

The O 0 0.0016371507663279772
proband O 0 0.15229591727256775
is O 0 0.0003922885225620121
a O 0 0.000656740739941597
23 O 0 0.002601948566734791
year O 0 0.0012360129039734602
old O 0 0.005237107630819082
, O 0 0.0018595230067148805
mentally B-Disease 1 1.0
retarded I-Disease 1 0.9999992847442627
male O 0 0.010491803288459778
who O 0 0.049235280603170395
suffers O 1 1.0
severe O 1 0.9999998807907104
muscular B-Disease 1 1.0
weakness I-Disease 1 0.9999915361404419
. O 0 0.001735901227220893

He O 0 0.0045549869537353516
presented O 0 0.00181971350684762
with O 0 0.0013476856984198093
respiratory O 1 1.0
and O 0 0.0010967343114316463
feeding O 0 0.420124351978302
difficulties O 1 0.7010070085525513
at O 0 0.003625366138294339
birth O 0 0.005112375598400831
. O 0 0.0006265084375627339

His O 0 0.002526091178879142
two O 0 0.0005815285257995129
sibs O 1 0.9998559951782227
suffer O 1 0.9999321699142456
from O 0 0.0008064830908551812
childhood O 1 0.9999412298202515
onset O 1 0.9999997615814209
DM B-Disease 1 1.0
. O 0 0.003300931304693222

Their O 0 0.0005888739251531661
late O 0 0.004748146515339613
father O 0 0.003481915220618248
had O 0 0.00048355423496104777
the O 0 0.00012851662177126855
adult O 0 0.003061337862163782
type O 0 0.010255035944283009
of O 0 0.0006454705144278705
DM B-Disease 1 1.0
, O 0 0.0009273663745261729
with O 0 0.0005132608348503709
onset O 1 0.9998923540115356
around O 0 0.0007685796590521932
30 O 0 0.0020700343884527683
years O 0 0.001019932678900659
. O 0 0.00041483048698864877

Only O 0 0.0004006702802143991
six O 0 0.00024125189520418644
other O 0 4.646375964512117e-05
cases O 0 0.0005924063734710217
of O 0 2.6140935005969368e-05
paternal O 0 0.02710196003317833
transmission O 0 0.08789026737213135
of O 0 0.001359492656774819
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.0009638549527153373
been O 0 0.0012585571967065334
reported O 0 0.006482170894742012
recently O 0 0.0071876258589327335
. O 0 0.0005133513477630913

We O 0 0.0009237855556420982
review O 0 0.001123456982895732
the O 0 0.000263447203906253
sex O 0 0.001962680136784911
related O 0 0.0021942034363746643
effects O 0 0.005036837421357632
on O 0 0.00041045821853913367
transmission O 0 0.015131935477256775
of O 0 0.0009557892335578799
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.002892492339015007

Decreased O 1 0.7328820824623108
fertility O 0 0.19623412191867828
of O 0 3.785032095038332e-05
males O 0 0.0008998570847325027
with O 0 0.0002334530436201021
adult O 1 0.6374419331550598
onset O 1 0.9999997615814209
DM B-Disease 1 1.0
and O 0 0.0010094887111335993
contraction O 0 0.023190554231405258
of O 0 2.9457085474859923e-05
the O 0 0.0004520278889685869
repeat O 0 0.02179751545190811
upon O 0 0.0014975357335060835
male O 0 0.00380021333694458
transmission O 0 0.019078480079770088
contribute O 0 0.005751810967922211
to O 0 7.638421084266156e-05
the O 0 0.00014816276961937547
almost O 0 0.0008875186322256923
absent O 0 0.01004291046410799
occurrence O 0 0.004214635118842125
of O 0 3.444798130658455e-05
paternal O 0 0.017610015347599983
transmission O 0 0.07978400588035583
of O 0 0.0019460631301626563
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.004159404896199703

Also O 0 0.0008940392290242016
the O 0 0.00014920993999112397
fathers O 0 0.0007693626102991402
of O 0 1.749464718159288e-05
the O 0 0.0007650398765690625
reported O 0 0.030058907344937325
congenitally O 1 0.9994080066680908
affected O 0 0.032445188611745834
children O 0 0.002910652896389365
showed O 0 0.0027070024516433477
, O 0 0.00016373081598430872
on O 0 0.00024038166156969965
average O 0 0.001790369744412601
, O 0 0.0006192142027430236
shorter O 0 0.034887611865997314
CTG O 1 0.9980813264846802
repeat O 0 0.027207965031266212
lengths O 0 0.003666996257379651
and O 0 0.00013518186460714787
hence O 0 0.0013434591237455606
less O 0 0.003990401513874531
severe O 1 0.9999995231628418
clinical O 1 1.0
symptoms O 1 0.9999994039535522
than O 0 0.00018146861111745238
the O 0 0.00024978347937576473
mothers O 0 0.006524993106722832
of O 0 2.7986163331661373e-05
children O 0 0.0027093617245554924
with O 0 0.0052836062386631966
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.003946774639189243

We O 0 0.0007878419710323215
conclude O 0 0.004316210281103849
that O 0 5.1512415666365996e-05
paternal O 0 0.005434180144220591
transmission O 0 0.022514665499329567
of O 0 0.0009819892002269626
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 0.0036726698745042086
rare O 0 0.006374702788889408
and O 0 0.00018872962391469628
preferentially O 0 0.009281008504331112
occurs O 0 0.0008812583982944489
with O 0 0.00020765606313943863
onset O 1 0.9997566342353821
of O 0 0.0008096594829112291
DM B-Disease 1 1.0
past O 0 0.003256790107116103
30 O 0 0.0018185221124440432
years O 0 0.0005139868590049446
in O 0 0.00017164123710244894
the O 0 0.0006262173992581666
father O 0 0.008171816356480122
. O 0 0.0003653377352748066
. O 0 0.0006202215445227921

The O 0 0.005356028210371733
RB1 O 1 0.9998722076416016
gene O 0 0.00545132951810956
mutation O 0 0.0015465411124750972
in O 0 0.00010340281733078882
a O 0 0.0009395643137395382
child O 0 0.007941870018839836
with O 0 0.0010497646871954203
ectopic B-Disease 1 0.9999958276748657
intracranial I-Disease 1 0.9999998807907104
retinoblastoma I-Disease 1 0.9999979734420776
. O 0 0.002590910065919161

The O 0 0.00532629806548357
RB1 O 1 0.9999384880065918
gene O 0 0.008592980913817883
mutation O 0 0.004623973276466131
was O 0 0.0025330958887934685
investigated O 0 0.011624420993030071
in O 0 0.00013431406114250422
a O 0 0.0009617917821742594
child O 0 0.006291726604104042
with O 0 0.000841001863591373
ectopic B-Disease 1 0.9999970197677612
intracranial I-Disease 1 0.9999998807907104
retinoblastoma I-Disease 1 0.9999816417694092
using O 0 0.0006786640733480453
DNA O 0 0.0017610840732231736
obtained O 0 0.00023430195869877934
from O 0 4.259081106283702e-05
both O 0 8.930955664254725e-05
the O 0 0.000618774734903127
pineal B-Disease 1 0.9996892213821411
and I-Disease 0 0.002558352192863822
retinal I-Disease 1 0.9999998807907104
tumours I-Disease 1 0.9999985694885254
of O 0 5.9529214922804385e-05
the O 0 0.0012606699019670486
patient O 1 0.9999897480010986
. O 0 0.0008055883808992803

A O 0 0.009642158634960651
nonsense O 0 0.02312278188765049
mutation O 0 0.002829331438988447
in O 0 0.0003682287351693958
exon O 0 0.05539088696241379
17 O 0 0.0048743002116680145
( O 0 0.0007644737488590181
codon O 0 0.009763754904270172
556 O 0 0.06739907711744308
) O 0 0.0001526892592664808
of O 0 1.9158456780132838e-05
the O 0 0.0019040737533941865
RB1 O 1 0.9999955892562866
gene O 0 0.00919464509934187
was O 0 0.002100664423778653
found O 0 0.0003000997530762106
to O 0 7.472463039448485e-05
be O 0 9.884121391223744e-05
present O 0 0.0003531243419274688
homozygously O 1 0.6160278916358948
in O 0 0.000135142428916879
both O 0 0.0001467061956645921
the O 0 0.0008838471840135753
retinal B-Disease 1 0.9999433755874634
and I-Disease 0 0.0003291310276836157
the I-Disease 0 0.0020919223316013813
pineal I-Disease 1 0.9999895095825195
tumours I-Disease 1 0.9999995231628418
. O 0 0.0013194436905905604

The O 0 0.000502140901517123
same O 0 0.00025839044246822596
mutation O 0 0.004234451800584793
was O 0 0.0017535497900098562
present O 0 0.0005991356447339058
heterozygously O 1 0.981533944606781
in O 0 0.00019815338600892574
the O 0 0.00023830006830394268
DNA O 0 0.0014768257969990373
from O 0 5.650838647852652e-05
the O 0 0.00012189902918180451
constitutional O 0 0.0006385825108736753
cells O 0 0.0011167465709149837
of O 0 1.3563629181589931e-05
the O 0 0.0010001661721616983
patient O 1 0.9999973773956299
, O 0 0.0008884125272743404
proving O 1 0.858898937702179
it O 0 0.00012954123667441308
to O 0 4.486903708311729e-05
be O 0 3.5208613553550094e-05
of O 0 3.1111823773244396e-05
germline O 1 0.9300315976142883
origin O 0 0.00019590675947256386
. O 0 0.0005506782326847315

The O 0 0.0006439837743528187
initial O 0 0.003620271570980549
mutation O 0 0.004527941811829805
was O 0 0.002061237348243594
shown O 0 0.000779994239564985
to O 0 0.00010591899626888335
have O 0 0.00010852476407308131
occurred O 0 0.0010960397776216269
in O 0 8.383911335840821e-05
the O 0 0.0002941102138720453
paternally O 0 0.10863006860017776
derived O 0 0.005455340724438429
RB1 O 1 0.9998875856399536
allele O 0 0.025536753237247467
. O 0 0.0011319778859615326

The O 0 0.001234562718309462
mutation O 0 0.004816262051463127
is O 0 0.0005137199186719954
in O 0 0.0001694912207312882
an O 0 0.0003262332174926996
area O 0 0.0010711178183555603
of O 0 1.6894664440769702e-05
the O 0 0.0002795540203806013
gene O 0 0.0013853188138455153
that O 0 2.726857019297313e-05
encodes O 0 0.00044103991240262985
the O 0 0.00011506475129863247
protein O 0 0.0016972350422292948
- O 0 0.004938181955367327
binding O 0 0.0008938197861425579
region O 0 0.00267629511654377
known O 0 0.0010586900170892477
as O 0 0.00031036423752084374
the O 0 0.0006478930008597672
pocket O 1 0.8494046330451965
region O 0 0.0038368734531104565
and O 0 0.00031615825719200075
has O 0 0.0010031864512711763
been O 0 0.000771520019043237
detected O 0 0.0058114067651331425
in O 0 8.61047810758464e-05
other O 0 3.920741073670797e-05
cases O 0 0.0012462812010198832
of O 0 0.0001608274324098602
retinoblastoma B-Disease 1 0.9999963045120239
. O 0 0.0007561563979834318
. O 0 0.0005592131055891514

Low O 0 0.007504275068640709
levels O 0 0.0015932454261928797
of O 0 3.130025652353652e-05
beta O 0 0.027561211958527565
hexosaminidase O 1 0.9302272796630859
A O 0 0.0034952894784510136
in O 0 0.00039120399742387235
healthy O 0 0.08541873097419739
individuals O 0 0.0002936985983978957
with O 0 0.00035919228685088456
apparent O 1 0.9967259168624878
deficiency O 1 0.9999997615814209
of O 0 2.9834847737220116e-05
this O 0 0.00010871742415474728
enzyme O 0 0.00684200506657362
. O 0 0.0006161720375530422

Appreciable O 0 0.05009664222598076
beta O 0 0.02411949448287487
hexosaminidase O 1 0.5506215691566467
A O 0 0.007170805707573891
( O 0 0.0010211198823526502
hex O 0 0.026384329423308372
A O 0 0.005898064933717251
) O 0 0.00025744567392393947
activity O 0 0.00045480855624191463
has O 0 0.00036769939470104873
been O 0 0.00026380360941402614
detected O 0 0.003902311436831951
in O 0 0.00024142145412042737
cultured O 1 0.9877620935440063
skin O 1 1.0
fibroblasts O 1 0.9995094537734985
and O 0 0.007147196214646101
melanoma B-Disease 1 1.0
tissue O 1 0.9998817443847656
from O 0 0.00037955024163238704
healthy O 0 0.16695347428321838
individuals O 0 0.00033689948031678796
previously O 0 0.002555055543780327
reported O 0 0.003669329918920994
as O 0 0.0005927226739004254
having O 0 0.017622319981455803
deficiency B-Disease 1 0.9999994039535522
of I-Disease 0 8.824878750601783e-05
hex I-Disease 0 0.0330851785838604
A I-Disease 0 0.0033286355901509523
activity O 0 0.0008402728708460927
indistinguishable O 0 0.009360168129205704
from O 0 4.577293657348491e-05
that O 0 2.5856234060483985e-05
of O 0 5.396649430622347e-05
patients O 1 0.9999992847442627
with O 0 0.002590084681287408
Tay B-Disease 1 1.0
- I-Disease 1 0.9999762773513794
Sachs I-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
( O 0 0.007290336769074202
TSD B-Disease 1 0.9999958276748657
) O 0 0.0015609634574502707
. O 0 0.0005893905181437731

Identification O 0 0.003201796906068921
and O 0 0.00028463598573580384
quantitation O 0 0.04401827231049538
of O 0 7.942298543639481e-05
hex O 0 0.032006893306970596
A O 0 0.005341894458979368
, O 0 0.0004399484023451805
amounting O 0 0.009989694692194462
to O 0 0.00024682917864993215
3 O 0 0.0018122385954484344
. O 0 0.0005244143540039659

5 O 0 0.0029087078291922808
% O 0 0.00029306364012882113
- O 0 0.010625641793012619
6 O 0 0.0026071772444993258
. O 0 0.000462624040665105

9 O 0 0.0027932662051171064
% O 0 1.766090645105578e-05
of O 0 5.860757028131047e-06
total O 0 0.00021011574426665902
beta O 0 0.023903409019112587
hexosaminidase O 1 0.5625966787338257
activity O 0 0.0013105814578011632
, O 0 0.0003149819385726005
has O 0 0.00039124395698308945
been O 0 0.00011973093933193013
obtained O 0 8.511875057592988e-05
by O 0 3.4790034987963736e-05
cellulose O 0 0.085211381316185
acetate O 0 0.17474724352359772
gel O 1 0.9924529194831848
electrophoresis O 0 0.07379545271396637
, O 0 0.0011258004233241081
DEAE O 1 0.9966488480567932
- O 0 0.009076135233044624
cellulose O 0 0.03368697315454483
ion O 0 0.009795310907065868
- O 0 0.006610637065023184
exchange O 0 0.0020058946684002876
chromatography O 0 0.2592024803161621
, O 0 0.0013506049290299416
radial O 1 0.9991803765296936
immunodiffusion O 1 0.9931254386901855
, O 0 0.0006233571912162006
and O 0 0.0005363773670978844
radioimmunoassay O 1 0.9949743747711182
. O 0 0.0007493485463783145

Previous O 0 0.0046953316777944565
family O 0 0.001752600073814392
studies O 0 0.0022572793532162905
suggested O 0 0.0018220673082396388
that O 0 4.24955906055402e-05
these O 0 2.2846812498755753e-05
individuals O 0 0.00041758737643249333
may O 0 0.002042078645899892
be O 0 0.00029786615050397813
compound O 0 0.022412428632378578
heterozygotes O 0 0.09330043196678162
for O 0 0.00014256963913794607
the O 0 0.00018859612464439124
common O 0 0.00579032301902771
mutant O 0 0.08002575486898422
TSD B-Disease 1 0.9999294281005859
gene O 0 0.004389703273773193
and O 0 0.00012660092033911496
a O 0 0.0010641393018886447
rare O 0 0.016163500025868416
( O 0 0.0018556489376351237
allelic O 0 0.10753683745861053
) O 0 0.0008456449722871184
mutant O 0 0.01137329451739788
gene O 0 0.005226641893386841
. O 0 0.0006659774226136506

Thus O 0 0.0017043062252923846
, O 0 0.00015000623534433544
the O 0 0.00016626754950266331
postulated O 0 0.011212875135242939
rate O 0 0.0005011024186387658
mutant O 0 0.00898518692702055
gene O 0 0.00512583926320076
appears O 0 0.0055315569043159485
to O 0 0.00010465529339853674
code O 0 0.00028596114134415984
for O 0 0.00014731076953466982
the O 0 0.00010141365783056244
expression O 0 0.00031636119820177555
of O 0 2.0937222870998085e-05
low O 0 0.001990013523027301
amounts O 0 0.00021702378580812365
of O 0 4.7988003643695265e-05
hex O 0 0.03507619351148605
A O 0 0.0068594301119446754
. O 0 0.0007358900620602071

Heterozygotes O 1 0.8955200910568237
for O 0 0.0003260569355916232
the O 0 0.00046178451157175004
rare O 0 0.015487266704440117
mutant O 0 0.020687170326709747
may O 0 0.0021935123950242996
be O 0 0.00013352463429328054
indistinguishable O 0 0.009989896789193153
from O 0 0.00026025366969406605
heterozygotes O 0 0.10377199202775955
for O 0 0.00020396341278683394
the O 0 0.0005074326181784272
common O 0 0.020822560414671898
TSD B-Disease 1 0.9999818801879883
mutant O 0 0.028823701664805412
. O 0 0.0009219446801580489

However O 0 0.0014578873524442315
, O 0 0.00014490701141767204
direct O 0 0.0004507014527916908
visualization O 0 0.055914413183927536
and O 0 0.0004557420907076448
quantitation O 0 0.05685952305793762
of O 0 8.252060069935396e-05
hex O 0 0.0361483134329319
A O 0 0.0022365173790603876
by O 0 2.8670207029790618e-05
the O 0 0.00012384960427880287
methods O 0 0.0013137771748006344
described O 0 0.007530044764280319
may O 0 0.0018399768741801381
prevent O 0 0.007267874199897051
false O 0 0.0023509860038757324
- O 0 0.045786626636981964
positive O 0 0.01294657588005066
prenatal O 1 0.9999957084655762
diagnosis O 1 0.9999994039535522
of O 0 0.0003748038434423506
TSD B-Disease 1 0.9999916553497314
in O 0 0.001071095815859735
fetuses O 0 0.10180339217185974
having O 0 0.0007530068978667259
the O 0 0.00015551720571238548
incomplete O 0 0.009321251884102821
hex B-Disease 0 0.07351946830749512
A I-Disease 0 0.09211110323667526
deficiency I-Disease 1 0.9999996423721313
of O 0 3.928739533876069e-05
the O 0 0.0006433427915908396
type O 0 0.04164930433034897
described O 0 0.00386471813544631
in O 0 0.000118004456453491
the O 0 0.00015984180208761245
four O 0 0.0002550971694290638
healthy O 0 0.15050320327281952
individuals O 0 0.0012943253386765718

The O 0 0.002070365473628044
tumor B-Disease 1 0.9999723434448242
suppressor O 0 0.2899239659309387
gene O 0 0.018690872937440872
Smad4 O 1 0.9995367527008057
/ O 1 0.9815846681594849
Dpc4 O 1 0.9502139091491699
is O 0 0.00030471145873889327
required O 0 0.00045281610800884664
for O 0 0.0006063674227334559
gastrulation O 1 0.9982920289039612
and O 0 0.0003688008582685143
later O 0 0.0007776194252073765
for O 0 0.0008181756711564958
anterior O 1 0.9998291730880737
development O 0 0.0017372494330629706
of O 0 2.3226073608384468e-05
the O 0 0.0004749918880406767
mouse O 0 0.018572984263300896
embryo O 0 0.00947465468198061
. O 0 0.0006036610575392842

Mutations O 0 0.0036422209814190865
in O 0 0.00014435412595048547
the O 0 0.0008443244732916355
SMAD4 O 1 0.9999949932098389
/ O 1 0.9992666840553284
DPC4 O 1 0.999950647354126
tumor B-Disease 1 0.9999873638153076
suppressor O 0 0.0949125587940216
gene O 0 0.0029033746104687452
, O 0 0.00011984746379312128
a O 0 0.00027925780159421265
key O 0 0.0016492160502821207
signal O 0 0.003012363100424409
transducer O 0 0.03281897306442261
in O 0 0.00024823457351885736
most O 0 0.00080071174306795
TGFbeta O 1 0.9987877011299133
- O 0 0.04582782834768295
related O 0 0.006798760965466499
pathways O 0 0.05068677291274071
, O 0 0.0002952665963675827
are O 0 3.552703492459841e-05
involved O 0 0.0009031356312334538
in O 0 0.00012438335397746414
50 O 0 0.0003079523448832333
% O 0 4.2958217818522826e-05
of O 0 0.00022659223759546876
pancreatic B-Disease 1 1.0
cancers I-Disease 1 0.9999997615814209
. O 0 0.0011590674985200167

Homozygous O 0 0.04764597862958908
Smad4 O 1 0.9197736382484436
mutant O 0 0.03243788704276085
mice O 0 0.11733788996934891
die O 1 0.9280540347099304
before O 0 0.000949396169744432
day O 0 0.0014870654558762908
7 O 0 0.0019291129428893328
. O 0 0.0004661837301682681

5 O 0 0.0012314814375713468
of O 0 5.9370300732553005e-05
embryogenesis O 1 0.9811175465583801
. O 0 0.0010112248128280044

Mutant O 0 0.0158329326659441
embryos O 0 0.0011761978967115283
have O 0 8.785039244685322e-05
reduced O 0 0.0018523435574024916
size O 0 0.000663834041915834
, O 0 0.0006816483801230788
fail O 0 0.08387800306081772
to O 0 0.0003701726964209229
gastrulate O 1 0.8826426863670349
or O 0 0.0005854498012922704
express O 0 0.0024384937714785337
a O 0 0.0013351707020774484
mesodermal O 1 0.9699576497077942
marker O 0 0.04346505552530289
, O 0 0.00026426961994729936
and O 0 0.00012967409566044807
show O 0 0.0016412733821198344
abnormal O 1 0.9209368824958801
visceral O 1 0.9969658255577087
endoderm O 1 0.9995778203010559
development O 0 0.006792363710701466
. O 0 0.0007559147197753191

Growth B-Disease 1 0.9842858910560608
retardation I-Disease 1 0.9999972581863403
of O 0 5.0051039579557255e-05
the O 0 0.0009954475099220872
Smad4 O 1 0.9998347759246826
- O 1 0.8020158410072327
deficient O 1 0.9997556805610657
embryos O 0 0.0015497648855671287
results O 0 0.00047086275299079716
from O 0 9.914809197653085e-05
reduced O 0 0.005250170826911926
cell O 0 0.006619018968194723
proliferation O 0 0.011941109783947468
rather O 0 0.00015078061551321298
than O 0 6.283135735429823e-05
increased O 0 0.0008637336432002485
apoptosis O 0 0.009145363233983517
. O 0 0.00035709142684936523

Aggregation O 0 0.004224675241857767
of O 0 7.805242785252631e-05
mutant O 0 0.029975857585668564
Smad4 O 1 0.9891223311424255
ES O 1 0.7922937870025635
cells O 0 0.0018724629189819098
with O 0 6.312057666946203e-05
wild O 0 0.0012704856926575303
- O 0 0.01038388442248106
type O 0 0.010028377175331116
tetraploid O 0 0.19586534798145294
morulae O 1 0.9902092218399048
rescues O 0 0.10207336395978928
the O 0 0.0011998747941106558
gastrulation B-Disease 1 0.9996035695075989
defect I-Disease 1 0.9994489550590515
. O 0 0.0011962810531258583

These O 0 0.00017494171333964914
results O 0 0.0008846029522828758
indicate O 0 0.0011469878954812884
that O 0 0.00024163727357517928
Smad4 O 1 0.9920252561569214
is O 0 0.0006694291951134801
initially O 0 0.0016800247831270099
required O 0 0.0003626206307671964
for O 0 8.797286136541516e-05
the O 0 0.00010102081432705745
differentiation O 0 0.0010588301811367273
of O 0 1.5582247215206735e-05
the O 0 0.0005410332232713699
visceral O 1 0.9983593821525574
endoderm O 1 0.9992305040359497
and O 0 0.0002061740233330056
that O 0 7.196861406555399e-05
the O 0 0.000567612936720252
gastrulation B-Disease 1 0.9996542930603027
defect I-Disease 1 0.9946570992469788
in O 0 0.00025187170831486583
the O 0 0.0009098679875023663
epiblast O 1 0.9999525547027588
is O 0 0.0020755701698362827
secondary O 0 0.018875114619731903
and O 0 0.0002980377175845206
non O 0 0.008419993333518505
- O 0 0.011703119613230228
cell O 0 0.003019578056409955
autonomous O 0 0.0015345345018431544
. O 0 0.000465784571133554

Rescued O 0 0.0604274719953537
embryos O 0 0.0028838985599577427
show O 0 0.004083035513758659
severe O 1 0.9999767541885376
anterior O 1 0.9999959468841553
truncations O 1 0.9705197811126709
, O 0 0.0007020108751021326
indicating O 0 0.0026033276226371527
a O 0 0.00036762107629328966
second O 0 0.0002347764966543764
important O 0 0.00029922096291556954
role O 0 0.0023406927939504385
for O 0 0.0006080411258153617
Smad4 O 1 0.9924969673156738
in O 0 0.0011975389206781983
anterior O 1 0.9999594688415527
patterning O 1 0.9937841892242432
during O 0 0.007356967777013779
embryogenesis O 1 0.8268828988075256
. O 0 0.0009103140910156071

Prevalence O 1 0.9900522828102112
of O 0 9.83009158517234e-05
p16 O 1 0.9152448177337646
and O 0 0.0008585900068283081
CDK4 O 1 0.9995899796485901
germline O 1 0.9563482999801636
mutations O 0 0.0019950182177126408
in O 0 0.0004292348457966
48 O 0 0.07086897641420364
melanoma B-Disease 1 1.0
- O 1 0.9324720501899719
prone O 1 0.9551105499267578
families O 0 0.0006927357753738761
in O 0 0.00047024982632137835
France O 0 0.00718642259016633
. O 0 0.0009287772700190544

The O 0 0.0011350784916430712
French O 0 0.03060333803296089
Familial B-Disease 1 0.9999998807907104
Melanoma I-Disease 1 1.0
Study O 0 0.019759301096200943
Group O 0 0.0016046208329498768
. O 0 0.0005131994257681072

Germline O 1 0.9250056743621826
mutations O 0 0.0029199072159826756
in O 0 0.00016049743862822652
the O 0 0.0005381082301028073
p16 O 1 0.9496710896492004
and O 0 0.000961919198743999
CDK4 O 1 0.9962791800498962
genes O 0 0.0005058376118540764
have O 0 0.00010623144771670923
been O 0 0.0004936567274853587
reported O 0 0.0014598093694075942
in O 0 4.509513746597804e-05
a O 0 0.00024552439572289586
subset O 0 0.002637008670717478
of O 0 0.00038633972872048616
melanoma B-Disease 1 1.0
pedigrees O 0 0.21901847422122955
, O 0 0.0004468487168196589
but O 0 0.00015115662245079875
their O 0 0.00011265173088759184
prevalence O 1 0.9975689053535461
is O 0 0.0004948340356349945
not O 0 0.000127321487525478
well O 0 0.0002844838018063456
known O 0 0.001935281208716333
. O 0 0.0005716424784623086

We O 0 0.001314843539148569
searched O 0 0.005332258064299822
for O 0 0.0001203371211886406
such O 0 0.00013029880938120186
germline O 1 0.8470112681388855
mutations O 0 0.0018226937390863895
in O 0 0.00026135423104278743
48 O 0 0.008002410642802715
French O 0 0.32097381353378296
melanoma B-Disease 1 1.0
- O 1 0.9950852990150452
prone O 1 0.9954167604446411
families O 0 0.0008604278555139899
selected O 0 0.0006964699132367969
according O 0 0.00022265082225203514
to O 0 7.523407111875713e-05
two O 0 7.840378384571522e-05
major O 0 0.0046316650696098804
criteria O 0 0.004274649545550346
families O 0 0.00026022735983133316
with O 0 9.179969492834061e-05
at O 0 0.0013459095498546958
least O 0 0.0003066944773308933
three O 0 0.0001231728820130229
affected O 0 0.005174999590963125
members O 0 0.00038907796260900795
( O 0 0.001265350729227066
n O 0 0.012160955928266048
= O 0 0.016788983717560768
20 O 0 0.0024957077112048864
) O 0 0.0005088154575787485
or O 0 0.0005186168127693236
families O 0 0.00024225453671533614
with O 0 0.0001063676827470772
two O 0 0.0002118475822499022
affected O 0 0.012268160469830036
members O 0 0.00030129350489005446
, O 0 0.00022898083261679858
one O 0 7.463746442226693e-05
of O 0 1.7981015844270587e-05
them O 0 0.00011850117152789608
affected O 0 0.008700404316186905
before O 0 0.0006578928441740572
the O 0 0.00016564376710448414
age O 0 0.0004492462903726846
of O 0 3.214466414647177e-05
50 O 0 0.0017674291739240289
( O 0 0.001288649276830256
n O 0 0.012054294347763062
= O 0 0.017990779131650925
28 O 0 0.006972727365791798
) O 0 0.00047595499199815094
, O 0 0.00022143263777252287
and O 0 9.501224121777341e-05
one O 0 0.0001446063834009692
additional O 0 0.0007502913940697908
minor O 0 0.17501068115234375
criterion O 0 0.05783788487315178
. O 0 0.0008100599516183138

Sixteen O 0 0.003564083483070135
different O 0 0.00015168939717113972
p16 O 1 0.9394429922103882
germline O 1 0.9838601350784302
mutations O 0 0.0031681677792221308
were O 0 7.063058001222089e-05
found O 0 0.00033243780490010977
in O 0 0.00028087213286198676
21 O 0 0.002559301443397999
families O 0 0.0003467015048954636
, O 0 0.00018376634398009628
while O 0 0.0002412090980214998
one O 0 0.0005998181877657771
germline O 1 0.9567790031433105
mutation O 0 0.005568660330027342
, O 0 0.000790162943303585
Arg24His O 1 0.9977992177009583
, O 0 0.00045463821152225137
was O 0 0.00196566223166883
detected O 0 0.00597429508343339
in O 0 0.00010451167327119038
the O 0 0.0006724357372149825
CDK4 O 1 0.9992753863334656
gene O 0 0.006420235149562359
. O 0 0.0004980948870070279

The O 0 0.00022924429504200816
frequency O 0 0.0001493467134423554
of O 0 5.817997225676663e-05
p16 O 0 0.2611064910888672
gene O 0 0.00398215651512146
mutation O 0 0.0012757082004100084
in O 0 8.415960473939776e-05
our O 0 0.00026969454484060407
sample O 0 0.0004024206136818975
( O 0 0.000764903670642525
44 O 0 0.001765096327289939
% O 0 0.00015439724666066468
) O 0 0.000379452743800357
is O 0 0.00029617559630423784
among O 0 8.137081749737263e-05
the O 0 0.00022974182502366602
highest O 0 0.008206991478800774
rates O 0 0.0018269027350470424
yet O 0 0.0020638499408960342
reported O 0 0.0039015067741274834
and O 0 0.00011269288370385766
the O 0 0.0006855445681139827
CDK4 O 1 0.9986695051193237
mutation O 0 0.003229298396036029
is O 0 0.0001852087734732777
the O 0 0.00010335056140320376
second O 0 0.0006371167837642133
mutation O 0 0.004330395720899105
detected O 0 0.008154057897627354
in O 0 9.829575719777495e-05
this O 0 8.021747635211796e-05
gene O 0 0.0032693352550268173
worldwide O 0 0.001892031286843121
. O 0 0.0006900730077177286

In O 0 0.0010341594461351633
summary O 0 0.003925039898604155
, O 0 0.00033058138797059655
our O 0 0.0007202969281934202
results O 0 0.001269470783881843
show O 0 0.0008919851388782263
frequent O 0 0.005823155865073204
involvement O 0 0.005695350468158722
of O 0 1.3453868632495869e-05
the O 0 0.0003951745748054236
p16 O 1 0.8525816798210144
gene O 0 0.00443265400826931
in O 0 0.0011683517368510365
familial B-Disease 1 0.9999996423721313
melanoma I-Disease 1 1.0
and O 0 0.0008245269418694079
confirm O 0 0.0033691974822431803
the O 0 9.56352669163607e-05
role O 0 0.00098895444534719
of O 0 1.8728369468590245e-05
the O 0 0.0005950838676653802
CDK4 O 1 0.9974921941757202
gene O 0 0.001893595908768475
as O 0 0.00035430744173936546
a O 0 0.008047681301832199
melanoma B-Disease 1 1.0
- O 1 0.6908777952194214
predisposing O 1 0.940269410610199
gene O 0 0.005726813338696957
. O 0 0.0002954812371172011
. O 0 0.0004479608323890716

Progression O 1 0.782683253288269
of O 0 0.00013631992624141276
somatic O 0 0.2660130262374878
CTG O 1 0.9982637763023376
repeat O 0 0.01675425097346306
length O 0 0.0008308217511512339
heterogeneity O 0 0.007850048132240772
in O 0 0.00010552723688306287
the O 0 0.0002571101067587733
blood O 1 0.9808661937713623
cells O 0 0.0028493485879153013
of O 0 0.0002989563508890569
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
. O 0 0.001336109358817339

The O 0 0.0003340673865750432
genetic O 0 0.0005621312302537262
basis O 0 9.593622962711379e-05
of O 0 0.0002783953968901187
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9298893213272095
DM B-Disease 1 1.0
) O 0 0.0014963626163080335
is O 0 0.0002283925423398614
the O 0 7.386223296634853e-05
expansion O 0 0.0006473124376498163
of O 0 1.905223325593397e-05
an O 0 0.0016431910917162895
unstable O 1 0.9998754262924194
CTG O 1 0.9997740387916565
repeat O 0 0.027400368824601173
in O 0 0.00021145203209016472
the O 0 0.0002416275819996372
34 O 0 0.00263551389798522
UTR O 0 0.03826203942298889
of O 0 3.0170978789101355e-05
the O 0 0.001246619620360434
DM B-Disease 1 0.9999984502792358
protein O 0 0.002307857619598508
kinase O 0 0.019915588200092316
gene O 0 0.001688475371338427
on O 0 0.0003274203627370298
chromosome O 0 0.004099109675735235
19 O 0 0.0033031036145985126
. O 0 0.0004317111161071807

One O 0 0.00030545724439434707
of O 0 1.9655280993902124e-05
the O 0 0.0003276549105066806
principal O 0 0.004798376467078924
features O 0 0.00017736066365614533
of O 0 3.811836722888984e-05
the O 0 0.002997753908857703
DM B-Disease 1 1.0
mutation O 0 0.005067626014351845
is O 0 0.00027888716431334615
an O 0 0.00035573015338741243
extraordinarily O 1 0.9703803062438965
high O 0 0.005067125428467989
level O 0 0.0020334231667220592
of O 0 7.371890387730673e-05
somatic O 1 0.7848749160766602
mosaicism O 1 0.9996161460876465
, O 0 0.0007656613597646356
due O 0 0.0013578538782894611
to O 0 8.199489820981398e-05
an O 0 0.00038701892481185496
extremely O 0 0.033869776874780655
high O 0 0.006840077228844166
degree O 0 0.0026729158125817776
of O 0 6.488520739367232e-05
somatic O 0 0.07177931070327759
instability O 0 0.016723914071917534
both O 0 0.0002182607859140262
within O 0 0.00018156104488298297
and O 0 0.00011824539978988469
between O 0 0.00014570758503396064
different O 0 8.338488260051236e-05
tissues O 1 0.9645230174064636
. O 0 0.0009222596418112516

This O 0 0.0006840771529823542
instability O 0 0.03176601976156235
appears O 0 0.008642428554594517
to O 0 0.00014369313430506736
be O 0 0.00017161719733849168
biased O 0 0.00685511389747262
towards O 0 0.0007810791139490902
further O 0 0.00044338448788039386
expansion O 0 0.002267450327053666
and O 0 0.00010153441689908504
continuous O 0 0.00245868181809783
throughout O 0 0.0003499366284813732
the O 0 0.00020815106108784676
life O 0 0.0006719838129356503
of O 0 1.4686731447000057e-05
an O 0 0.0003348510945215821
individual O 0 0.0006884000613354146
, O 0 0.0005656715366058052
features O 0 0.000619257043581456
that O 0 0.00014883422409184277
could O 0 0.0003338871174491942
be O 0 0.00010685729648685083
associated O 0 0.0001940127112902701
with O 0 4.504308890318498e-05
the O 0 0.00029175172676332295
progressive O 0 0.04429873451590538
nature O 0 0.0021009263582527637
of O 0 5.334482193575241e-05
the O 0 0.004207285586744547
disease O 1 1.0
. O 0 0.0011562290601432323

Although O 0 0.0007333875400945544
increasing O 0 0.0004062875232193619
measured O 0 0.0013105295365676284
allele O 0 0.005217840429395437
size O 0 0.001017891801893711
between O 0 0.0028232140466570854
patients O 1 0.9999986886978149
clearly O 0 0.0037078727036714554
correlates O 0 0.0053921290673315525
with O 0 3.903996548615396e-05
an O 0 0.00021308941359166056
increased O 0 0.0018499564612284303
severity O 1 0.9996762275695801
of O 0 0.00038000152562744915
symptoms O 1 0.9999998807907104
and O 0 0.0002826834097504616
an O 0 0.0004825135983992368
earlier O 0 0.0015220331260934472
age O 0 0.0007963970419950783
of O 0 0.00014573786756955087
onset O 1 0.99998939037323
, O 0 0.0004058065824210644
this O 0 9.965567733161151e-05
correlation O 0 0.0030299960635602474
is O 0 0.00044750343658961356
not O 0 9.977768058888614e-05
precise O 0 0.0008565427851863205
and O 0 0.00012534874258562922
measured O 0 0.0022321988362818956
allele O 0 0.008321301080286503
length O 0 0.0019622505642473698
cannot O 0 0.0020198412239551544
be O 0 8.268333476735279e-05
used O 0 8.605274342698976e-05
as O 0 8.176253322744742e-05
an O 0 0.00013191663310863078
accurate O 0 0.0024351428728550673
predictor O 0 0.031030278652906418
of O 0 3.905247649527155e-05
age O 0 0.0009647176484577358
of O 0 0.0001522121747257188
onset O 1 0.9999668598175049
. O 0 0.0018474814714863896

In O 0 0.0005105576128698885
order O 0 0.00010028801625594497
to O 0 5.808246351080015e-05
further O 0 0.000273742014542222
characterize O 0 0.0259737316519022
the O 0 0.0003257285279687494
dynamics O 0 0.03054153360426426
of O 0 0.000925970496609807
DM B-Disease 1 1.0
CTG O 1 0.9998039603233337
repeat O 0 0.05559359863400459
somatic O 0 0.032437875866889954
instability O 0 0.0232594832777977
, O 0 0.0004192112828604877
we O 0 0.0002316532627446577
have O 0 0.0001160993124358356
studied O 0 0.0016694598598405719
repeat O 0 0.008265404962003231
length O 0 0.0005241305334493518
changes O 0 0.00017494303756393492
over O 0 7.875447772676125e-05
time O 0 0.00011563340376596898
in O 0 0.0005467236624099314
111 O 1 0.9975199103355408
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999990463256836
with O 0 0.0002084479492623359
varying O 0 0.003063463605940342
clinical O 1 0.9999994039535522
severity O 1 0.9998854398727417
and O 0 0.001420819666236639
CTG O 1 0.9992270469665527
repeat O 0 0.020637409761548042
size O 0 0.00039368608850054443
over O 0 0.00011769588309107348
time O 0 7.547832501586527e-05
intervals O 0 0.0003238585777580738
of O 0 3.334835491841659e-05
1 O 0 0.00595300504937768
- O 0 0.011404675431549549
7 O 0 0.0019367277855053544
years O 0 0.001147245871834457
. O 0 0.00047011475544422865

We O 0 0.0010893500875681639
have O 0 0.00010152589675271884
found O 0 0.0001672795624472201
a O 0 0.0002747023245319724
direct O 0 0.0006860115681774914
progression O 0 0.39634841680526733
of O 0 2.2198521037353203e-05
the O 0 0.00022895942674949765
size O 0 0.0009670172585174441
heterogeneity O 0 0.017237333580851555
over O 0 0.00029409953276626766
time O 0 0.00023289702949114144
related O 0 0.0012895389227196574
to O 0 0.00018542133329901844
initial O 0 0.007621869444847107
CTG O 1 0.9987102746963501
repeat O 0 0.02641499601304531
size O 0 0.0006923054461367428
and O 0 0.00014160566206555814
the O 0 0.00018211029237136245
time O 0 0.00022005049686413258
interval O 0 0.0027765780687332153
and O 0 0.00020889879669994116
always O 0 0.0012290943413972855
biased O 0 0.007945988327264786
towards O 0 0.0007137731881812215
further O 0 0.00037879677256569266
expansion O 0 0.004016617313027382
. O 0 0.0005702719208784401

Attempts O 0 0.0026658992283046246
to O 0 0.00015160322072915733
mathematically O 0 0.004322011489421129
model O 0 0.000906608474906534
the O 0 0.00037480294122360647
dynamics O 0 0.03186294436454773
have O 0 0.00022120136418379843
proved O 0 0.009050117805600166
only O 0 0.00022781275038141757
partially O 0 0.02645927667617798
successful O 0 0.004013969097286463
suggesting O 0 0.0025866995565593243
that O 0 2.473856511642225e-05
individual O 0 0.00010344028851250187
specific O 0 0.0005668816738761961
genetic O 0 0.009441621601581573
and O 0 0.0018260942306369543
/ O 1 0.9971702694892883
or O 0 0.0009648922714404762
environmental O 0 0.007364451419562101
factors O 0 0.0005831139860674739
also O 0 0.00016330921789631248
play O 0 9.205347305396572e-05
a O 0 0.00032865945831872523
role O 0 0.0022984629031270742
in O 0 0.0005238847807049751
somatic O 0 0.46657824516296387
mosaicism O 1 0.999672532081604
. O 0 0.0004333026008680463
. O 0 0.00045046460581943393

Aspartylglucosaminuria B-Disease 1 0.9983024597167969
among O 0 0.001030454528518021
Palestinian O 0 0.016381744295358658
Arabs O 0 0.007085788995027542
. O 0 0.0006341786356642842

Aspartylglucosaminuria B-Disease 1 0.9999637603759766
( O 0 0.01905505731701851
AGU B-Disease 1 0.9999996423721313
) O 0 0.0008033793419599533
is O 0 0.0003149714320898056
a O 0 0.0010361142922192812
rare O 0 0.3452024459838867
disorder B-Disease 1 0.9999984502792358
of I-Disease 0 0.00014924378774594516
glycoprotein I-Disease 1 0.9995797276496887
metabolism I-Disease 1 0.9990752935409546
caused O 0 0.018442373722791672
by O 0 8.446205174550414e-05
the O 0 0.0011367276310920715
deficiency B-Disease 1 0.9999984502792358
of I-Disease 0 1.8407679817755707e-05
the I-Disease 0 0.0004101328377146274
lysosomal I-Disease 1 0.9998106360435486
enzyme I-Disease 0 0.021892497316002846
aspartylglucosaminidase I-Disease 1 0.9936177730560303
( O 0 0.003985566087067127
AGA O 1 0.9997856020927429
) O 0 0.0007351134554482996
. O 0 0.0004230620397720486

AGU B-Disease 1 0.9999991655349731
is O 0 0.00522948382422328
inherited O 1 0.9948423504829407
as O 0 0.0005121405120007694
an O 0 0.0013486703392118216
autosomal O 1 0.9999253749847412
recessive O 1 0.9999136924743652
trait O 1 0.9948209524154663
and O 0 0.0010159768862649798
occurs O 0 0.001854883972555399
with O 0 9.113358100876212e-05
a O 0 0.0009809409966692328
high O 0 0.002797036897391081
frequency O 0 0.00036823173286393285
in O 0 0.00020259387383703142
Finland O 0 0.002957988530397415
because O 0 0.0002707198727875948
of O 0 1.6934975064941682e-05
a O 0 0.0018247744301334023
founder O 0 0.029746685177087784
effect O 0 0.0031421517487615347
. O 0 0.000625459011644125

While O 0 0.0008911254117265344
very O 0 0.00132566608954221
few O 0 0.002160310512408614
patients O 1 0.9999973773956299
with O 0 0.0013823905028402805
AGU B-Disease 1 0.9999998807907104
have O 0 0.0004328241047915071
been O 0 0.0005929893814027309
reported O 0 0.002120749093592167
from O 0 0.00011829683353425935
non O 0 0.004558910615742207
- O 0 0.0071555753238499165
Finnish O 0 0.006907663773745298
origin O 0 0.00012584660726133734
, O 0 0.0004644427390303463
we O 0 0.0035460146609693766
diagnosed O 1 1.0
the O 0 0.001995665952563286
disorder O 1 0.9999997615814209
in O 0 0.0012820435222238302
8 O 0 0.010433687828481197
patients O 1 0.999995231628418
originating O 0 0.0024781792890280485
from O 0 0.000370638445019722
3 O 0 0.0032636935357004404
unrelated O 0 0.015346956439316273
families O 0 0.0007405627984553576
, O 0 0.00026517544756643474
all O 0 0.0001099912406061776
Palestinian O 0 0.013377797789871693
Arabs O 0 0.003490414936095476
from O 0 0.00012106797657907009
the O 0 0.00019773139501921833
region O 0 0.0014907262520864606
of O 0 6.606941315112635e-05
Jerusalem O 0 0.0468691922724247
. O 0 0.0007083325181156397

The O 0 0.003788492176681757
clinical O 1 0.9999994039535522
diagnosis O 1 0.9999997615814209
of O 0 0.0008549208869226277
AGU B-Disease 1 1.0
is O 0 0.0021751709282398224
often O 0 0.0007773493998683989
difficult O 0 0.008738916367292404
, O 0 0.0003195951576344669
in O 0 0.00017942786507774144
particular O 0 0.0004371216637082398
early O 0 0.000676209107041359
in O 0 0.00014006334822624922
the O 0 0.0002454511704854667
course O 0 0.005826212000101805
of O 0 4.5978729758644477e-05
the O 0 0.004994624760001898
disease O 1 1.0
, O 0 0.00044581425026990473
and O 0 8.379235077882186e-05
most O 0 6.295910861808807e-05
of O 0 1.769325535860844e-05
the O 0 0.0017528245225548744
patients O 1 0.9999996423721313
are O 0 0.0007934792665764689
diagnosed O 1 1.0
after O 0 0.0021037093829363585
the O 0 0.00019129317661281675
age O 0 0.0004677042015828192
of O 0 3.32914169121068e-05
5 O 0 0.002025692956522107
years O 0 0.0014690748648718
. O 0 0.0004912426229566336

However O 0 0.002128531225025654
, O 0 0.0004912655567750335
since O 0 0.0014295412693172693
these O 0 0.00026323276688344777
patients O 1 0.9999945163726807
excrete O 1 0.9216826558113098
early O 0 0.00041325442725792527
large O 0 6.382811261573806e-05
amounts O 0 0.00016827782383188605
of O 0 4.7036857722559944e-05
aspartylglucosamine O 1 0.9869532585144043
in O 0 0.0005943157011643052
urine O 0 0.02648133412003517
, O 0 0.0004564844712149352
biochemical O 0 0.030245119705796242
screening O 0 0.009029785171151161
is O 0 0.0002748815168160945
easy O 0 0.0007608616724610329
by O 0 8.903268462745473e-05
urine O 0 0.04741215333342552
chromatography O 1 0.9790025949478149
. O 0 0.0006180530181154609
. O 0 0.0005464670248329639

Detection O 0 0.013041616417467594
of O 0 4.6745983127038926e-05
heterozygous O 0 0.004256094340234995
carriers O 0 0.00370403123088181
of O 0 3.1314706575358286e-05
the O 0 0.0021026507019996643
ataxia B-Disease 1 1.0
- I-Disease 1 0.9995811581611633
telangiectasia I-Disease 1 0.999996542930603
( O 0 0.0036219777539372444
ATM O 0 0.04436960443854332
) O 0 0.0004889963893219829
gene O 0 0.0017842674860730767
by O 0 0.00022530010028276592
G2 O 1 0.9998548030853271
phase O 0 0.02953219972550869
chromosomal O 0 0.03256751596927643
radiosensitivity O 0 0.11318494379520416
of O 0 0.00013990288425702602
peripheral O 1 0.9999974966049194
blood O 1 0.9999449253082275
lymphocytes O 1 0.9997846484184265
. O 0 0.0010282481089234352

In O 0 0.0040380521677434444
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9988678693771362
telangiectasia I-Disease 1 0.9999934434890747
( O 0 0.004089718218892813
A B-Disease 1 0.9998437166213989
- I-Disease 1 0.9998493194580078
T I-Disease 1 0.9999990463256836
) O 0 0.00394352525472641
patients O 1 0.9999978542327881
, O 0 0.00033273969893343747
mutations O 0 0.0012879614951089025
in O 0 8.4572377090808e-05
a O 0 0.0003496010322123766
single O 0 0.0007482838700525463
gene O 0 0.004191229585558176
, O 0 0.00047218307736329734
ATM O 0 0.033558592200279236
, O 0 0.00027063884772360325
result O 0 0.0005024178535677493
in O 0 0.00019138878269586712
an O 0 0.003976771607995033
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.000922058941796422
embraces O 0 0.024027956649661064
a O 0 0.0005508640897460282
variety O 0 0.00044031362631358206
of O 0 0.00010066694812849164
clinical O 1 0.9999911785125732
features O 0 0.0009696438210085034
and O 0 0.000554246362298727
manifests O 1 0.9204536080360413
extreme O 0 0.048557426780462265
radiosensitivity O 1 0.9810186624526978
and O 0 0.0001298434945056215
a O 0 0.00040679462836124003
strong O 0 0.0007873436552472413
pre O 0 0.03508222848176956
- O 0 0.013949025422334671
disposition O 0 0.052149973809719086
to O 0 0.0010600301902741194
malignancy B-Disease 1 0.9999929666519165
. O 0 0.000864499481394887

Heterozygotes O 1 0.7314584851264954
for O 0 0.00040323566645383835
the O 0 0.0005015212227590382
ATM O 0 0.04888182133436203
gene O 0 0.0030856099911034107
have O 0 8.590269862907007e-05
no O 0 0.00024995405692607164
clinical O 1 0.9976503252983093
expression O 0 0.00023792638967279345
of O 0 5.06933247379493e-05
A B-Disease 1 0.999772846698761
- I-Disease 1 0.9995871186256409
T I-Disease 1 0.9999983310699463
but O 0 0.0005805901600979269
may O 0 0.002248130738735199
be O 0 0.0016687335446476936
cancer B-Disease 1 1.0
prone O 1 0.9496871829032898
with O 0 0.00010439284960739315
a O 0 0.0007842069608159363
moderate O 0 0.008502522483468056
increase O 0 0.0005204480839893222
in O 0 0.00015239411732181907
in O 0 0.00027646770467981696
vitro O 0 0.01810992695391178
radiosensitivity O 1 0.972518265247345
. O 0 0.0009822380961850286

We O 0 0.0007983954856172204
performed O 0 0.0018169776303693652
a O 0 0.001296732109040022
blind O 1 0.9801488518714905
chromosomal O 0 0.013553832657635212
analysis O 0 0.000595188292209059
on O 0 0.001431607874110341
G2 O 1 0.9999767541885376
- O 0 0.02322508580982685
phase O 0 0.026261724531650543
lymphocytes O 1 0.9851377010345459
from O 0 0.00012768368469551206
7 O 0 0.0014454933116212487
unrelated O 0 0.00924721360206604
A B-Disease 1 0.998950719833374
- I-Disease 1 0.9998791217803955
T I-Disease 1 0.9999996423721313
patients O 1 0.9999927282333374
, O 0 0.000327060668496415
13 O 0 0.0020608098711818457
obligate O 1 0.5859429240226746
A B-Disease 1 0.9978263974189758
- I-Disease 1 0.9992462396621704
T I-Disease 1 0.9999970197677612
heterozygotes O 1 0.9932802319526672
( O 0 0.0009885719045996666
parents O 0 0.00031579346978105605
of O 0 3.088361336267553e-05
the O 0 0.0023095139767974615
patients O 1 0.9999995231628418
) O 0 0.000678157084621489
, O 0 0.00027405458968132734
and O 0 0.00019927564426325262
14 O 0 0.0010737081756815314
normal O 0 0.0021513761021196842
controls O 0 0.0020276999566704035
following O 0 0.002520589390769601
X O 0 0.13465294241905212
- O 0 0.010414734482765198
irradiation O 0 0.01888887770473957
with O 0 0.00020271597895771265
1 O 0 0.00609419122338295
Gy O 1 0.9675512909889221
in O 0 0.00015126043581403792
order O 0 9.414121450390667e-05
to O 0 0.00011251420073676854
evaluate O 0 0.014136362820863724
this O 0 0.000110051259980537
cytogenetic O 0 0.13509684801101685
method O 0 0.0005999390850774944
as O 0 0.0002444084675516933
a O 0 0.0005772394360974431
tool O 0 0.007106750272214413
for O 0 0.00033550860825926065
detection O 0 0.006348767783492804
of O 0 7.446931704180315e-05
ATM O 0 0.1015385165810585
carriers O 0 0.030589429661631584
. O 0 0.0007563895778730512

Both O 0 0.0014434382319450378
A B-Disease 1 0.9968714118003845
- I-Disease 1 0.9991143345832825
T I-Disease 1 0.999997615814209
homozygotes O 1 0.9965245127677917
and O 0 0.0008137658587656915
heterozygotes O 1 0.9236114025115967
showed O 0 0.002419888973236084
significantly O 0 0.0029658558778464794
increased O 0 0.00022670376347377896
levels O 0 0.001073487219400704
of O 0 6.753412890248e-05
radiation O 1 0.9999878406524658
- O 1 0.862208902835846
induced O 1 0.9994620680809021
chromatid O 1 0.9996559619903564
damage O 1 0.9816892147064209
relative O 0 0.000655330833978951
to O 0 7.312314846785739e-05
that O 0 2.442081313347444e-05
of O 0 1.8867789549403824e-05
normal O 0 0.005408561788499355
controls O 0 0.0036474040243774652
. O 0 0.0007660211995244026

These O 0 0.00014872172323521227
results O 0 0.0006401250720955431
show O 0 0.00026335931033827364
that O 0 5.1696461014216766e-05
the O 0 0.0007109728176146746
G2 O 1 0.9999707937240601
- O 0 0.01820394955575466
phase O 0 0.01851089484989643
chromosomal O 0 0.06134749948978424
radiosensitivity O 1 0.9317373037338257
assay O 0 0.011558248661458492
can O 0 0.00021181951160542667
be O 0 5.14204402861651e-05
used O 0 6.645403482252732e-05
for O 0 6.312207551673055e-05
the O 0 9.851488721324131e-05
detection O 0 0.0036923966836184263
of O 0 6.898355059092864e-05
A B-Disease 1 0.999701201915741
- I-Disease 1 0.999321460723877
T I-Disease 1 0.9999935626983643
heterozygotes O 1 0.981304407119751
. O 0 0.0010284862946718931

In O 0 0.0010341894812881947
combination O 0 0.006988559849560261
with O 0 0.00021675432799383998
molecular O 0 0.00942277628928423
genetic O 0 0.003104414092376828
analyses O 0 0.0022999877110123634
, O 0 0.00028023208142258227
this O 0 0.0001891493593575433
test O 0 0.008202075958251953
may O 0 0.00129358796402812
be O 0 3.0521376174874604e-05
of O 0 5.676877663063351e-06
value O 0 0.00012936325219925493
in O 0 0.00011966519377892837
studies O 0 0.0005331452703103423
of O 0 5.501897248905152e-05
familial B-Disease 1 0.9999052286148071
and I-Disease 0 0.0012558265589177608
sporadic I-Disease 1 0.5206798315048218
cancers I-Disease 1 0.9999935626983643
aimed O 0 0.004799137823283672
at O 0 0.0014526898739859462
determination O 0 0.0035326704382896423
of O 0 1.9228560631745495e-05
the O 0 0.0001875434973044321
potential O 0 0.001758066238835454
involvement O 0 0.006434309296309948
of O 0 3.974222272518091e-05
ATM O 0 0.06893594563007355
mutations O 0 0.005277251824736595
in O 0 0.0014118036488071084
tumor B-Disease 1 0.9999998807907104
risk O 1 0.9968456625938416
or O 0 0.0006906214402988553
development O 0 0.003600101685151458
. O 0 0.0002502869756426662
. O 0 0.0004231923376210034

Ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999055862426758
telangiectasia I-Disease 1 0.9999982118606567
: O 0 0.0014291723491623998
identification O 0 0.0005424690316431224
and O 0 0.00010617027874104679
detection O 0 0.004462215583771467
of O 0 7.169244054239243e-05
founder O 1 0.6635512113571167
- O 0 0.00933713000267744
effect O 0 0.001549678621813655
mutations O 0 0.0014676625141873956
in O 0 0.00013082491932436824
the O 0 0.00041108555160462856
ATM O 0 0.058246392756700516
gene O 0 0.002997493604198098
in O 0 0.00014816049952059984
ethnic O 0 0.00014327885583043098
populations O 0 0.0012036808766424656
. O 0 0.0007135817431844771

To O 0 0.000281239248579368
facilitate O 0 0.0015445213066413999
the O 0 0.0001718570856610313
evaluation O 0 0.01577717810869217
of O 0 8.547730976715684e-05
ATM O 0 0.20808497071266174
heterozygotes O 1 0.8411799073219299
for O 0 0.0005659279995597899
susceptibility O 1 0.863810122013092
to O 0 0.00022580740915145725
other O 0 0.0005319133633747697
diseases O 1 0.9999998807907104
, O 0 0.00015850858471821994
such O 0 8.736958989175037e-05
as O 0 0.07030817866325378
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0006157593452371657
we O 0 0.00028327666223049164
have O 0 8.097296085907146e-05
attempted O 0 0.0012741964310407639
to O 0 7.844925858080387e-05
define O 0 0.0020059894304722548
the O 0 0.0002079465048154816
most O 0 0.00046483607729896903
common O 0 0.0037086638621985912
mutations O 0 0.0027717482298612595
and O 0 5.766561298514716e-05
their O 0 1.630262704566121e-05
frequencies O 0 0.00020333388238213956
in O 0 0.000994399655610323
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9990887641906738
telangiectasia I-Disease 1 0.9999922513961792
( O 0 0.004618674051016569
A B-Disease 1 0.9993643164634705
- I-Disease 1 0.9991950392723083
T I-Disease 1 0.9999939203262329
) O 0 0.0016743019223213196
homozygotes O 1 0.9309535026550293
from O 0 0.00023987660824786872
10 O 0 0.0003422000736463815
ethnic O 0 0.00011796328180935234
populations O 0 0.0013245252193883061
. O 0 0.0007684632437303662

Both O 0 0.0008023075642995536
genomic O 0 0.007059104274958372
mutations O 0 0.0027236207388341427
and O 0 8.856391650624573e-05
their O 0 6.402128929039463e-05
effects O 0 0.004769451450556517
on O 0 0.00032595498487353325
cDNA O 0 0.0028823220636695623
were O 0 0.00012357212835922837
characterized O 0 0.04066859185695648
. O 0 0.0009252962772734463

Protein O 0 0.006538025569170713
- O 0 0.013778455555438995
truncation O 0 0.03045632876455784
testing O 0 0.002789844060316682
of O 0 1.1405156328692101e-05
the O 0 0.0001368924422422424
entire O 0 0.0034931141417473555
ATM O 0 0.018165886402130127
cDNA O 0 0.008018354885280132
detected O 0 0.020415931940078735
92 O 0 0.030398055911064148
( O 0 0.0015428763581439853
66 O 0 0.012864322401583195
% O 0 0.00019166198035236448
) O 0 0.0006723550031892955
truncating O 0 0.4807368218898773
mutations O 0 0.0026359837502241135
in O 0 0.00018805776198860258
140 O 0 0.004030685406178236
mutant O 0 0.011289515532553196
alleles O 0 0.007721766829490662
screened O 0 0.011556277051568031
. O 0 0.0006573462742380798

The O 0 0.0016232792986556888
haplotyping O 1 0.6599229574203491
of O 0 0.00030271155992522836
patients O 1 0.9999967813491821
with O 0 0.00017261203902307898
identical O 0 0.0017491623293608427
mutations O 0 0.0060806479305028915
indicates O 0 0.002654131967574358
that O 0 6.067448339308612e-05
almost O 0 0.0002295469748787582
all O 0 1.5313180483644828e-05
of O 0 1.1962850294366945e-05
these O 0 3.433987149037421e-05
represent O 0 0.0007476577302441001
common O 0 0.004045451991260052
ancestry O 0 0.0010668742470443249
and O 0 0.0001678246771916747
that O 0 0.0001089075012714602
very O 0 0.0008059438550844789
few O 0 0.0006724847480654716
spontaneously O 0 0.04176134243607521
recurring O 1 0.9671293497085571
ATM O 0 0.07829675078392029
mutations O 0 0.006005451083183289
exist O 0 0.0009847100591287017
. O 0 0.00048386817798018456

Assays O 0 0.008637242019176483
requiring O 0 0.003000509226694703
minimal O 0 0.0023514311760663986
amounts O 0 0.0002156479749828577
of O 0 2.946562563010957e-05
genomic O 0 0.006627304013818502
DNA O 0 0.0019757843110710382
were O 0 4.6159209887264296e-05
designed O 0 0.0008323315414600074
to O 0 5.997108019073494e-05
allow O 0 0.0003252782626077533
rapid O 0 0.014082588255405426
screening O 0 0.00876519363373518
for O 0 0.00028162135276943445
common O 0 0.0013980583753436804
ethnic O 0 0.0003657644847407937
mutations O 0 0.007189630530774593
. O 0 0.0007139364606700838

These O 0 0.00010718855628510937
rapid O 0 0.00854491163045168
assays O 0 0.004112442024052143
detected O 0 0.01259460486471653
mutations O 0 0.0019502800423651934
in O 0 0.0003036468697246164
76 O 0 0.01027747429907322
% O 0 3.0453953513642773e-05
of O 0 2.8843196560046636e-05
Costa O 0 0.027536511421203613
Rican O 0 0.024259692057967186
patients O 1 0.9999974966049194
( O 0 0.0015966242644935846
3 O 0 0.0033508753404021263
) O 0 0.00038298641447909176
, O 0 0.00020602918812073767
50 O 0 0.0002889866882469505
% O 0 1.9530187273630872e-05
of O 0 3.281348108430393e-05
Norwegian O 0 0.18905171751976013
patients O 1 0.999998927116394
( O 0 0.0018556037684902549
1 O 0 0.004619458690285683
) O 0 0.00040797796100378036
, O 0 0.00019893751596100628
25 O 0 0.0003147175011690706
% O 0 2.5172214009216987e-05
of O 0 6.553246203111485e-05
Polish O 1 0.9994584918022156
patients O 1 0.9999997615814209
( O 0 0.0018944686744362116
4 O 0 0.004677953198552132
) O 0 0.000521439709700644
, O 0 0.0003365288721397519
and O 0 0.00023143825819715858
14 O 0 0.0008902385598048568
% O 0 2.5918174287653528e-05
of O 0 5.301988494466059e-05
Italian O 0 0.23546193540096283
patients O 1 0.9999984502792358
( O 0 0.0024619284085929394
1 O 0 0.005403506103903055
) O 0 0.000395183393266052
, O 0 0.00020886815036647022
as O 0 0.00021710884175263345
well O 0 0.00017315916193183511
as O 0 0.0003286538121756166
in O 0 0.0006925123161636293
patients O 1 0.999957799911499
of O 0 0.00011563186126295477
Amish O 1 0.872856855392456
/ O 1 0.885884702205658
Mennonite O 0 0.061009012162685394
and O 0 0.0005280443583615124
Irish O 0 0.004964336287230253
English O 0 0.0013864677166566253
backgrounds O 0 0.004697517957538366
. O 0 0.0008667851216159761

Additional O 0 0.0017139780102297664
mutations O 0 0.001684658695012331
were O 0 4.3132633436471224e-05
observed O 0 0.000449291430413723
in O 0 0.00016847753431648016
Japanese O 0 0.00174710713326931
, O 0 0.0005174719262868166
Utah O 0 0.014110090211033821
Mormon O 0 0.004358537960797548
, O 0 0.00023012769815977663
and O 0 0.0002574469253886491
African O 0 0.003835595678538084
American O 0 0.006355353631079197
patients O 1 0.9999946355819702
. O 0 0.0010415149154141545

These O 0 9.732955368235707e-05
assays O 0 0.001400721026584506
should O 0 0.0001852969144238159
facilitate O 0 0.0014113258803263307
screening O 0 0.003611974883824587
for O 0 0.0005209061200730503
A B-Disease 1 0.9981334805488586
- I-Disease 1 0.998450756072998
T I-Disease 1 0.9999914169311523
heterozygotes O 0 0.47607484459877014
in O 0 0.00022014220303390175
the O 0 0.00022035786241758615
populations O 0 0.0007660244591534138
studied O 0 0.0025849395897239447
. O 0 0.0002635821292642504
. O 0 0.00047512815217487514

The O 0 0.001666453666985035
von B-Disease 1 0.9854342937469482
Hippel I-Disease 1 0.9999765157699585
- I-Disease 1 0.9985495209693909
Lindau I-Disease 1 0.9999903440475464
tumor I-Disease 1 0.9999924898147583
suppressor O 0 0.1383325159549713
gene O 0 0.002278192201629281
is O 0 0.0001763300533639267
required O 0 0.00030877196695655584
for O 0 0.00022464564244728535
cell O 0 0.0039639961905777454
cycle O 0 0.0019965653773397207
exit O 0 0.007251516915857792
upon O 0 0.0011091179912909865
serum O 1 0.9944813251495361
withdrawal O 0 0.02162919193506241
. O 0 0.0005729994736611843

The O 0 0.0008871766040101647
inactivation O 0 0.0283065065741539
of O 0 2.013097946473863e-05
the O 0 0.0005635080160573125
von B-Disease 1 0.9935658574104309
Hippel I-Disease 1 0.9999852180480957
- I-Disease 1 0.9916031956672668
Lindau I-Disease 1 0.9999871253967285
( I-Disease 0 0.003804078558459878
VHL I-Disease 1 0.9999935626983643
) I-Disease 0 0.0043027205392718315
tumor I-Disease 1 0.9999972581863403
suppressor O 1 0.8538857698440552
gene O 0 0.016956163570284843
predisposes O 1 0.9995823502540588
affected O 0 0.0060529992915689945
individuals O 0 9.68588501564227e-05
to O 0 4.739210635307245e-05
the O 0 0.00029727633227594197
human O 1 0.9954307079315186
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.000348457891959697
is O 0 0.0004060935170855373
associated O 0 0.00026062014512717724
with O 0 0.00015597653691656888
sporadic B-Disease 1 0.9947745203971863
renal I-Disease 1 1.0
cell I-Disease 1 0.9994992017745972
carcinomas I-Disease 1 0.9999998807907104
( O 0 0.01226786058396101
RCC B-Disease 1 0.9999998807907104
) O 0 0.0013568887952715158
and O 0 0.0011360240168869495
brain B-Disease 1 0.9999977350234985
hemangioblastomas I-Disease 1 0.9958773851394653
. O 0 0.0009975756984204054

VHL O 1 0.9997159838676453
- O 0 0.024574290961027145
negative O 0 0.0051410305313766
786 O 1 0.9785900712013245
- O 0 0.027020366862416267
0 O 0 0.010668795555830002
RCC B-Disease 1 0.9999963045120239
cells O 0 0.004434141796082258
are O 0 6.79403092362918e-05
tumorigenic O 0 0.46697700023651123
in O 0 0.0007149274460971355
nude O 1 0.8319782614707947
mice O 0 0.018856309354305267
which O 0 0.00011282565537840128
is O 0 0.00043070586980320513
suppressed O 0 0.003554094582796097
by O 0 2.8193770049256273e-05
the O 0 0.0001788332883734256
reintroduction O 0 0.02231287956237793
of O 0 0.00020592549117282033
VHL B-Disease 1 0.999963641166687
. O 0 0.0016392362304031849

Remarkably O 1 0.7521170973777771
, O 0 0.0005303217330947518
this O 0 9.953619883162901e-05
occurs O 0 0.0012688591377809644
without O 0 0.0003352750209160149
affecting O 0 0.009393526241183281
the O 0 0.00024287388077937067
growth O 0 0.001836824812926352
rate O 0 0.00036147990613244474
and O 0 0.00023700283782090992
cell O 0 0.006882186513394117
cycle O 0 0.002670213347300887
profile O 0 0.0028752333018928766
of O 0 1.575176793267019e-05
these O 0 5.1913531933678314e-05
cells O 0 0.0029669729992747307
in O 0 0.00019873675773851573
culture O 0 0.0015720040537416935
. O 0 0.0007412723498418927

The O 0 0.002392941853031516
786 O 1 0.9574469327926636
- O 0 0.014296973124146461
0 O 0 0.002321036998182535
cell O 0 0.004088472109287977
line O 0 0.0018031552899628878
, O 0 0.0001952563034137711
like O 0 0.000559542968403548
many O 0 0.0009526172652840614
cancer B-Disease 1 1.0
cells O 0 0.013246217742562294
, O 0 0.000686073035467416
fails O 0 0.044545650482177734
to O 0 0.0001548185828141868
exit O 0 0.005783253349363804
the O 0 0.00016077744658105075
cell O 0 0.002801129361614585
cycle O 0 0.0013712540967389941
upon O 0 0.0010528664570301771
serum O 1 0.9948417544364929
withdrawal O 0 0.02169216237962246
. O 0 0.0006045805639587343

Here O 0 0.002134001348167658
, O 0 0.00036237025051377714
it O 0 0.00019745218742173165
is O 0 0.0003281572135165334
shown O 0 0.000665835861582309
that O 0 6.187677354319021e-05
reintroduction O 0 0.00534678203985095
of O 0 7.649769031559117e-06
the O 0 0.00019790777878370136
wild O 0 0.0017183730378746986
- O 0 0.028754035010933876
type O 0 0.15503962337970734
VHL B-Disease 1 0.9999725818634033
gene O 0 0.00895705446600914
restores O 0 0.018775440752506256
the O 0 8.737192547414452e-05
ability O 0 0.001340084127150476
of O 0 0.000141689000884071
VHL O 1 0.9999990463256836
- O 1 0.9191116690635681
negative O 0 0.07782735675573349
RCC B-Disease 1 1.0
cancer I-Disease 1 1.0
cells O 0 0.004070590250194073
to O 0 0.00011356862523825839
exit O 0 0.0052561527118086815
the O 0 0.00018837022071238607
cell O 0 0.0034960035700351
cycle O 0 0.0017224737675860524
and O 0 0.00024628383107483387
enter O 0 0.010687691159546375
G0 O 1 0.9999619722366333
/ O 1 0.6753979921340942
quiescence O 0 0.08913081884384155
in O 0 0.00036807364085689187
low O 0 0.009469883516430855
serum O 1 0.9957677125930786
. O 0 0.0006982350605539978

Both O 0 0.0037825850304216146
VHL O 1 0.9999297857284546
- O 0 0.013270551338791847
positive O 0 0.001802313607186079
and O 0 0.0009287050343118608
VHL O 1 0.9999934434890747
- O 0 0.06705989688634872
negative O 0 0.014237294904887676
RCC B-Disease 1 0.9999972581863403
cells O 0 0.012760737910866737
exit O 0 0.007958561182022095
the O 0 0.00023215652618091553
cell O 0 0.0035004164092242718
cycle O 0 0.0010531202424317598
by O 0 5.975518070044927e-05
contact O 0 0.00521879643201828
inhibition O 0 0.01078594010323286
. O 0 0.0006624088273383677

The O 0 0.0016062044305726886
cyclin O 1 0.8706817030906677
- O 0 0.0060594771057367325
dependent O 0 0.0029604886658489704
kinase O 0 0.030674610286951065
inhibitor O 0 0.0780855268239975
, O 0 0.0007048423867672682
p27 O 1 0.9777323007583618
, O 0 0.0005233520641922951
accumulates O 0 0.0433654747903347
upon O 0 0.0017415388720110059
serum O 1 0.9951039552688599
withdrawal O 0 0.022573130205273628
, O 0 0.0001838131429394707
only O 0 5.0114897021558136e-05
in O 0 5.320689160726033e-05
the O 0 0.00010369795927545056
presence O 0 0.0008257388835772872
of O 0 0.00021648190158884972
VHL B-Disease 1 0.9999947547912598
, O 0 0.0008594809914939106
as O 0 0.00038432489964179695
a O 0 0.000503170071169734
result O 0 0.00039627330261282623
of O 0 1.7854310499387793e-05
the O 0 0.0002627410867717117
stabilization O 0 0.03602827340364456
of O 0 1.7236567146028392e-05
the O 0 0.00017363352526444942
protein O 0 0.0017715226858854294
. O 0 0.0004959303187206388

We O 0 0.0011325565865263343
propose O 0 0.003684381954371929
that O 0 4.074754178873263e-05
the O 0 0.00011624766193563119
loss O 0 0.0028467741794884205
of O 0 2.2738695406587794e-05
wild O 0 0.0018570589600130916
- O 0 0.05161789432168007
type O 0 0.11534782499074936
VHL B-Disease 1 0.9999452829360962
gene O 0 0.0061783515848219395
results O 0 0.000574904028326273
in O 0 6.198484334163368e-05
a O 0 0.0002651380200404674
specific O 0 0.0005223974003456533
cellular O 0 0.03079347126185894
defect O 1 0.9988579750061035
in O 0 0.0007866844534873962
serum O 1 0.9981105327606201
- O 0 0.007836216129362583
dependent O 0 0.002279087668284774
growth O 0 0.0016848343657329679
control O 0 0.0019013379933312535
, O 0 0.00020655694243032485
which O 0 0.00011445237760199234
may O 0 0.0017496878281235695
initiate O 0 0.16414709389209747
tumor B-Disease 1 0.9999958276748657
formation O 0 0.03066316992044449
. O 0 0.0005992099177092314

This O 0 0.0005207855137996376
is O 0 0.001264216611161828
corrected O 0 0.03465956449508667
by O 0 3.546467996784486e-05
the O 0 0.00013078788470011204
reintroduction O 0 0.007656361907720566
of O 0 2.2262905986281112e-05
wild O 0 0.001382712391205132
- O 0 0.0397360660135746
type O 0 0.45128387212753296
VHL B-Disease 1 0.9999873638153076
, O 0 0.0029772764537483454
implicating O 1 0.9986166954040527
VHL B-Disease 1 0.9999277591705322
as O 0 0.000404599733883515
the O 0 0.00021302318782545626
first O 0 0.0015774830244481564
tumor B-Disease 1 0.9999898672103882
suppressor O 0 0.047742199152708054
involved O 0 0.0012486046180129051
in O 0 9.175287414109334e-05
the O 0 0.00012076013081241399
regulation O 0 0.0006646970869041979
of O 0 4.417499076225795e-05
cell O 0 0.009460987523198128
cycle O 0 0.005634300410747528
exit O 0 0.0201970674097538
, O 0 0.00027474816306494176
which O 0 6.711541209369898e-05
is O 0 0.0002738448674790561
consistent O 0 0.0021776347421109676
with O 0 7.721764268353581e-05
its O 0 0.0005954143707640469
gatekeeper O 1 0.9934647679328918
function O 0 0.001186614972539246
in O 0 0.0002958877303171903
the O 0 0.0023876111954450607
kidney O 1 1.0
. O 0 0.0007607043371535838
. O 0 0.0006154832663014531

Piebaldism B-Disease 1 0.9999692440032959
with O 0 0.004462262615561485
deafness B-Disease 1 1.0
: O 0 0.0013575067277997732
molecular O 0 0.0022959625348448753
evidence O 0 0.00020666370983235538
for O 0 0.0001011136409942992
an O 0 0.0005160706350579858
expanded O 1 0.5887347459793091
syndrome O 1 1.0
. O 0 0.0013149199075996876

In O 0 0.0008384147076867521
a O 0 0.0017296553123742342
South O 0 0.005079434718936682
African O 0 0.004577334970235825
girl O 0 0.015423399396240711
of O 0 0.00012806740414816886
Xhosa O 1 0.997314989566803
stock O 0 0.018056999891996384
with O 0 0.0006490470841526985
severe O 1 0.9999951124191284
piebaldism B-Disease 1 0.9991421699523926
and O 0 0.0008802433731034398
profound O 1 0.9999752044677734
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.001872626948170364
identified O 0 0.0011257259175181389
a O 0 0.0004940182552672923
novel O 0 0.002414375776425004
missense O 0 0.013036112301051617
substitution O 0 0.0011489585740491748
at O 0 0.00075911806197837
a O 0 0.0004118366923648864
highly O 0 0.0017618151614442468
conserved O 0 0.0004698676348198205
residue O 0 0.007775715086609125
in O 0 9.275168122258037e-05
the O 0 0.00012908797361887991
intracellular O 0 0.01582379639148712
kinase O 0 0.0071326508186757565
domain O 0 0.00016132614109665155
of O 0 1.3257989849080332e-05
the O 0 0.0008073201170191169
KIT O 1 0.999164342880249
proto O 1 0.994899570941925
- O 0 0.06396686285734177
oncogene O 1 0.9758898019790649
, O 0 0.0010598950320854783
R796G O 0 0.07000823318958282
. O 0 0.0006664615357294679

Though O 0 0.0058248392306268215
auditory B-Disease 1 0.9903655052185059
anomalies I-Disease 1 0.978367269039154
have O 0 0.00019128696294501424
been O 0 0.000245073955738917
observed O 0 0.00035505203413777053
in O 0 0.00021670557907782495
mice O 0 0.007416814099997282
with O 0 0.000142934441100806
dominant O 0 0.028511660173535347
white O 1 0.7850306034088135
spotting O 1 0.9993525147438049
( O 0 0.012328062206506729
W O 1 0.9998393058776855
) O 0 0.0006436334224417806
due O 0 0.0014873924665153027
to O 0 0.00039644629578106105
KIT O 1 0.9998214840888977
mutations O 0 0.010798515751957893
, O 0 0.0023307232186198235
deafness B-Disease 1 1.0
is O 0 0.001174628152512014
not O 0 0.00017749126709531993
typical O 0 0.0018227502005174756
in O 0 0.0003141359193250537
human O 0 0.005395897198468447
piebaldism B-Disease 1 0.996206521987915
. O 0 0.0008183841709978878

Thus O 0 0.0012193588772788644
, O 0 0.00011665307101793587
the O 0 0.00013777543790638447
occurrence O 0 0.01074159611016512
of O 0 0.00034229017910547554
sensorineural B-Disease 1 0.9999998807907104
deafness I-Disease 1 1.0
in O 0 0.0010519741335883737
this O 0 0.00045390057493932545
patient O 1 0.9998512268066406
extends O 0 0.02396422065794468
considerably O 0 0.007271054200828075
the O 0 0.00020404373935889453
phenotypic O 0 0.010308610275387764
range O 0 0.0007894239388406277
of O 0 7.642661512363702e-05
piebaldism B-Disease 1 0.9970985651016235
due O 0 0.0023341786582022905
to O 0 0.00042479689000174403
KIT O 1 0.9938064813613892
gene O 0 0.004402601160109043
mutation O 0 0.002163836732506752
in O 0 0.00024358119117096066
humans O 0 0.0034020033199340105
and O 0 0.0007056960021145642
tightens O 1 0.6664066314697266
the O 0 0.0013089427957311273
clinical O 1 0.9997561573982239
similarity O 0 0.0028933419380337
between O 0 0.0009078899747692049
piebaldism B-Disease 1 0.9882432818412781
and O 0 0.00013071231660433114
the O 0 5.006426363252103e-05
various O 0 2.4713266611797735e-05
forms O 0 0.0008046860457397997
of O 0 0.0007093759486451745
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0009001335129141808
. O 0 0.0006958565209060907

Cycloheximide O 1 0.9029334783554077
facilitates O 0 0.01775227300822735
the O 0 0.00016860869072843343
identification O 0 0.0003295853966847062
of O 0 5.3292860684450716e-05
aberrant O 0 0.36922645568847656
transcripts O 0 0.0032896148040890694
resulting O 0 0.0009211589931510389
from O 0 6.794509681640193e-05
a O 0 0.0005924317520111799
novel O 0 0.0034181023947894573
splice O 0 0.08093287795782089
- O 0 0.014004903845489025
site O 0 0.002660077763721347
mutation O 0 0.001887451740913093
in O 0 0.0005053494242019951
COL17A1 O 1 0.9980687499046326
in O 0 0.0003232428862247616
a O 0 0.0018773932242766023
patient O 1 0.9997977614402771
with O 0 0.0003799331025220454
generalized O 1 0.9994122982025146
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 0.9999997615814209
bullosa I-Disease 1 0.9999963045120239
. O 0 0.0034598754718899727

Patients O 1 0.999994158744812
with O 0 0.00046273256884887815
generalized O 1 0.9989765882492065
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999969005584717
often O 0 0.0023317181039601564
show O 0 0.0010498465271666646
decreased O 0 0.005928749684244394
expression O 0 0.0002511518250685185
of O 0 5.4272855777526274e-05
type O 1 0.9989767074584961
XVII O 1 0.9999996423721313
collagen O 1 0.9999418258666992
, O 0 0.000291308417217806
a O 0 0.0004999341908842325
transmembrane O 0 0.013278934173285961
hemidesmosomal O 0 0.04634321108460426
protein O 0 0.00027120995218865573
encoded O 0 6.974396092118695e-05
by O 0 0.00019800591690000147
COL17A1 O 1 0.9993367791175842
. O 0 0.000870233925525099

This O 0 0.0004413641872815788
report O 0 0.000929208763409406
documents O 0 0.00028980447677895427
a O 0 0.0006783546414226294
novel O 0 0.003550821216776967
splice O 0 0.08678083121776581
- O 0 0.0157536119222641
site O 0 0.0029466080013662577
mutation O 0 0.0019091269932687283
in O 0 0.00041045586112886667
COL17A1 O 1 0.9968311190605164
in O 0 0.00024617885355837643
a O 0 0.001618009526282549
patient O 1 0.9998189806938171
with O 0 0.00042159538134001195
generalized O 1 0.9997479319572449
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 0.9999997615814209
bullosa I-Disease 1 0.9999990463256836
, O 0 0.0022928668186068535
and O 0 0.0003379402623977512
applies O 0 0.0021342674735933542
a O 0 0.0006398853147402406
new O 0 0.0004841046466026455
methodology O 0 0.006542387884110212
to O 0 0.0001889673003461212
define O 0 0.0047471956349909306
and O 0 0.0002874127821996808
characterize O 0 0.03875873237848282
the O 0 0.00016781922022346407
resulting O 0 0.0008653964614495635
mRNA O 0 0.0008113461663015187
splice O 0 0.02948525734245777
variants O 0 0.0029257594142109156
. O 0 0.0006047459319233894

Mutational O 0 0.16416692733764648
analysis O 0 0.00042852244223468006
of O 0 9.976749424822628e-05
COL17A1 O 1 0.9992986917495728
identified O 0 0.001430183183401823
a O 0 0.000731858192011714
maternally O 0 0.09272599965333939
inherited O 1 0.9989895224571228
G O 1 0.9650126695632935
- O 0 0.010755395516753197
to O 0 0.0006222308147698641
- O 0 0.18160592019557953
T O 1 0.9988667964935303
transversion O 0 0.41104230284690857
at O 0 0.001226301770657301
the O 0 0.000535867060534656
- O 0 0.006328622344881296
1 O 0 0.0007572997128590941
position O 0 0.0005503338179551065
of O 0 3.387760079931468e-05
exon O 0 0.06153737008571625
32 O 0 0.0036910846829414368
. O 0 0.000547999341506511

This O 0 0.0005041653057560325
acceptor O 0 0.3652566075325012
splice O 0 0.2937481105327606
- O 0 0.027367398142814636
site O 0 0.0044420273043215275
mutation O 0 0.002024953719228506
led O 0 0.00041569321183487773
to O 0 6.878268322907388e-05
the O 0 0.00017909043526742607
formation O 0 0.00689861923456192
of O 0 6.330575706670061e-05
aberrant O 1 0.6757400631904602
transcripts O 0 0.003762710141018033
present O 0 0.0003151877026539296
at O 0 0.001079839887097478
extremely O 0 0.011870352551341057
low O 0 0.007893566973507404
levels O 0 0.01029906515032053
. O 0 0.0005257576704025269

Based O 0 0.0008260146714746952
on O 0 0.00019375387637410313
our O 0 0.0003231190494261682
recent O 0 0.0005540767451748252
finding O 0 0.001070500584319234
that O 0 0.00019301302381791174
cycloheximide O 1 0.9899599552154541
stabilized O 1 0.9976772665977478
mutant O 0 0.025895651429891586
COL17A1 O 1 0.9837250113487244
transcripts O 0 0.00269059045240283
in O 0 0.00037019187584519386
keratinocytes O 1 0.9376943707466125
homozygous O 0 0.004664856940507889
for O 0 0.0002099139237543568
a O 0 0.002443333389237523
frameshift O 1 0.9745703935623169
mutation O 0 0.007400841452181339
, O 0 0.00022857073054183275
the O 0 0.00017906518769450486
effects O 0 0.0027165981009602547
of O 0 2.3081864128471352e-05
the O 0 0.000613631505984813
splice O 0 0.12891820073127747
- O 0 0.014921431429684162
site O 0 0.0023708606604486704
mutation O 0 0.000911204784642905
on O 0 0.00012201951176393777
splicing O 0 0.001076186541467905
of O 0 0.00010593060869723558
COL17A1 O 1 0.9995424747467041
transcripts O 0 0.002908948343247175
were O 0 3.386435491847806e-05
determined O 0 0.0004470280837267637
using O 0 9.9546457931865e-05
reverse O 0 0.007324771489948034
transcriptase O 0 0.03168528154492378
polymerase O 0 0.00782071240246296
chain O 0 0.0037831778172403574
reaction O 0 0.00034560440690256655
of O 0 8.269403224403504e-06
total O 0 0.0001259780692635104
RNA O 0 0.0018791068578138947
from O 0 0.00023190189676824957
keratinocytes O 0 0.4366624653339386
incubated O 0 0.007725337520241737
for O 0 0.00039799409569241107
2 O 0 0.0019908701069653034
. O 0 0.0005267529049888253

5 O 0 0.006378178019076586
h O 0 0.028782006353139877
in O 0 0.00017700958414934576
the O 0 0.0002563525049481541
presence O 0 0.001544546103104949
or O 0 0.0005891579785384238
absence O 0 0.0023978608660399914
of O 0 2.9431113944156095e-05
10 O 0 0.001539421733468771
microg O 1 0.690704882144928
cycloheximide O 0 0.16926154494285583
per O 0 0.0009408053592778742
ml O 0 0.1389426738023758
. O 0 0.0008915874641388655

Using O 0 0.0003725872084032744
this O 0 7.561081292806193e-05
approach O 0 0.003166382433846593
, O 0 0.00020505147404037416
an O 0 0.0004981383099220693
abnormally O 1 0.9835665822029114
spliced O 0 0.01964019052684307
transcript O 0 0.021026557311415672
was O 0 0.0017662534955888987
identified O 0 0.0006516705616377294
that O 0 2.1944530089967884e-05
contains O 0 5.6323155149584636e-05
an O 0 0.00011239870946155861
extra O 0 0.0009648941340856254
264 O 0 0.01593935489654541
bases O 0 0.0010227116290479898
upstream O 0 0.0045913937501609325
from O 0 0.00022369407815858722
exon O 0 0.03707611560821533
32 O 0 0.0023538139648735523
, O 0 0.00020467799913603812
resulting O 0 0.0009734760969877243
in O 0 0.00021631416166201234
a O 0 0.0023844821844249964
premature O 1 0.9938987493515015
termination O 0 0.4855930805206299
codon O 0 0.014500703662633896
27 O 0 0.007623312994837761
bp O 0 0.07728012651205063
downstream O 0 0.0045064520090818405
from O 0 7.010671106399968e-05
the O 0 0.0003052994143217802
cryptic O 0 0.09253246337175369
splice O 0 0.0706230029463768
site O 0 0.007327212952077389
. O 0 0.0005093705840408802

Three O 0 0.0003747516602743417
other O 0 0.00011271006223978475
splice O 0 0.04621434584259987
variants O 0 0.0031896058935672045
, O 0 0.000272607256192714
including O 0 7.919224299257621e-05
one O 0 0.00014318735338747501
derived O 0 0.00017882921383716166
from O 0 7.81437338446267e-05
the O 0 0.00024542916798964143
skipping O 0 0.01891627535223961
of O 0 8.629415970062837e-05
exon O 0 0.06099904328584671
32 O 0 0.003354092361405492
, O 0 0.00027033197693526745
were O 0 7.040872878860682e-05
also O 0 0.0004672079812735319
identified O 0 0.0026087325531989336
. O 0 0.00047733145765960217

These O 0 0.00016155412595253438
results O 0 0.000850267824716866
indicate O 0 0.0006952185649424791
the O 0 0.00016211086767725646
usefulness O 0 0.0340583436191082
of O 0 0.00016678075189702213
cycloheximide O 1 0.9998279809951782
treatment O 1 0.9999396800994873
in O 0 0.00028776732506230474
evaluating O 0 0.01711837202310562
the O 0 0.00040350831113755703
abnormal O 0 0.03604637831449509
processing O 0 0.00039340381044894457
of O 0 1.0891106285271235e-05
mRNA O 0 0.0005282333586364985
due O 0 0.00078247778583318
to O 0 0.00015200534835457802
splice O 0 0.048865269869565964
- O 0 0.011435030959546566
site O 0 0.0030884924344718456
mutations O 0 0.002414301037788391
, O 0 0.00041430958663113415
because O 0 0.0022996661718934774
( O 0 0.0014321970520541072
i O 0 0.006466776132583618
) O 0 0.0004430887056514621
aberrant O 0 0.026396000757813454
splicing O 0 0.002052673837170005
often O 0 0.00025046433438546956
generates O 0 0.0011306066298857331
a O 0 0.0018592177657410502
premature O 1 0.9919724464416504
termination O 1 0.530780553817749
codon O 0 0.013177267275750637
, O 0 0.0008660362800583243
( O 0 0.002027529990300536
ii O 1 0.8235768675804138
) O 0 0.0004077425692230463
transcripts O 0 0.0017710633110255003
with O 0 0.0002588942588772625
premature O 1 0.998892605304718
termination O 1 0.9850780963897705
codons O 0 0.010469351895153522
can O 0 0.0002163756435038522
occur O 0 0.000613301177509129
at O 0 0.000794692081399262
low O 0 0.005331891588866711
or O 0 0.001823936472646892
undetectable O 1 0.9995063543319702
levels O 0 0.008947014808654785
due O 0 0.0016316327964887023
to O 0 0.00020970783953089267
nonsense O 0 0.021290749311447144
- O 0 0.005033137276768684
mediated O 0 0.008306290954351425
mRNA O 0 0.000559249660000205
decay O 0 0.004884256049990654
, O 0 0.0004228161124046892
and O 0 0.0005404711700975895
( O 0 0.003425631206482649
iii O 1 0.9193263053894043
) O 0 0.0003791609196923673
the O 0 0.0001868379331426695
levels O 0 0.0020839544013142586
of O 0 1.3943956219009124e-05
these O 0 4.085403634235263e-05
transcripts O 0 0.001945933443494141
can O 0 6.621063221246004e-05
be O 0 3.755466241273098e-05
increased O 0 0.0002255814615637064
by O 0 0.00011133636871818453
cycloheximide O 1 0.9838674068450928
. O 0 0.0008084525470621884

A O 0 0.008586402982473373
deletion O 0 0.01545718777924776
mutation O 0 0.003789267735555768
in O 0 0.0007337284623645246
COL17A1 O 1 0.9991890788078308
in O 0 0.0002757553302217275
five O 0 0.0002648090885486454
Austrian O 0 0.0065870629623532295
families O 0 0.000298246624879539
with O 0 0.00034353864612057805
generalized O 1 0.999681830406189
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 0.9999994039535522
bullosa I-Disease 1 0.9999958276748657
represents O 0 0.005929989740252495
propagation O 0 0.000867885013576597
of O 0 1.714230893412605e-05
an O 0 0.00039157416904345155
ancestral O 0 0.013741287402808666
allele O 0 0.01684056967496872
. O 0 0.0009134491556324065

Patients O 1 0.999980092048645
with O 0 0.0005933693028055131
generalized O 1 0.999634861946106
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 0.9999997615814209
bullosa I-Disease 1 0.9999933242797852
, O 0 0.001110572600737214
a O 0 0.0007935290923342109
usually O 0 0.0003920238232240081
nonlethal O 0 0.04513102024793625
form O 0 0.0004099385696463287
of O 0 0.00019006922957487404
junctional B-Disease 1 0.9999942779541016
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999951124191284
, O 0 0.0007108569843694568
have O 0 0.00011671661195578054
generalized O 0 0.01903279311954975
blistering B-Disease 1 0.9925565719604492
, O 0 0.0032801195047795773
nail B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
, O 0 0.005823541432619095
patchy B-Disease 1 0.9999967813491821
alopecia I-Disease 1 1.0
, O 0 0.002452756045386195
and O 0 0.0032586511224508286
dental B-Disease 1 1.0
abnormalities I-Disease 1 0.9999756813049316
. O 0 0.0008981373975984752

Skin B-Disease 1 0.9999998807907104
fragility I-Disease 1 0.9997029900550842
in O 0 0.0007837355951778591
most O 0 0.0006784034194424748
cases O 0 0.004098176024854183
is O 0 0.0007522483938373625
due O 0 0.0016609508311375976
to O 0 0.00013061014760751277
mutations O 0 0.0010895789600908756
in O 0 5.5410509958164766e-05
the O 0 8.302868809551e-05
gene O 0 0.0010331269586458802
encoding O 0 0.0010874407598748803
type O 0 0.3766877055168152
XVII O 1 0.9999970197677612
collagen O 1 0.999987006187439
( O 0 0.00710361497476697
COL17A1 O 1 0.9999233484268188
) O 0 0.0009131830302067101
. O 0 0.0004575646889861673

Recently O 0 0.02950090356171131
, O 0 0.0004903341177850962
we O 0 0.00040482328040525317
reported O 0 0.003093623323366046
five O 0 0.0001862282515503466
Austrian O 0 0.005358844064176083
families O 0 0.0002608966315165162
with O 0 0.0003913267282769084
generalized O 1 0.9991067051887512
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 0.9999997615814209
bullosa I-Disease 1 0.9999979734420776
who O 0 0.0031921931076794863
share O 0 0.0002830814628396183
the O 0 0.0001348471560049802
same O 0 0.0005067535093985498
COL17A1 O 1 0.9994851350784302
mutation O 0 0.006490188185125589
. O 0 0.0005202918546274304

Affected O 0 0.029622074216604233
individuals O 0 0.0004839253961108625
in O 0 0.00023022953246254474
three O 0 0.00011271102994214743
families O 0 0.00018232504953630269
are O 0 5.4962551075732335e-05
homozygous O 0 0.005448850803077221
for O 0 0.0007799753220751882
4003delTC O 1 0.9866597652435303
, O 0 0.0007449888507835567
whereas O 0 0.002123243873938918
those O 0 8.291167614515871e-05
in O 0 0.00014740013284608722
two O 0 6.559267785632983e-05
others O 0 0.0003662093367893249
are O 0 7.226227171486244e-05
compound O 0 0.04397747293114662
heterozygotes O 1 0.921005368232727
. O 0 0.0010561443632468581

To O 0 0.0004895569873042405
determine O 0 0.001069317338988185
if O 0 0.0002824274415615946
the O 0 0.00017122863209806383
occurrence O 0 0.008811729960143566
of O 0 0.00010842855408554897
4003delTC O 1 0.983620285987854
in O 0 0.0002712650166358799
these O 0 8.436014468315989e-05
unrelated O 0 0.010919365100562572
families O 0 0.0005481051048263907
signifies O 0 0.011959587223827839
propagation O 0 0.0008327151299454272
of O 0 2.1355293938540854e-05
an O 0 0.00039598342846147716
ancestral O 0 0.009109878912568092
allele O 0 0.009895783849060535
or O 0 0.0005965155432932079
a O 0 0.002167866099625826
mutational O 1 0.9685876965522766
hot O 0 0.08455026894807816
spot O 0 0.019622955471277237
, O 0 0.0006959973834455013
haplotypes O 0 0.013981811702251434
were O 0 6.747477891622111e-05
determined O 0 0.0012401301646605134
for O 0 0.00021448139159474522
polymorphisms O 0 0.0026834679301828146
both O 0 0.00010099366772919893
within O 0 0.00014590166392736137
and O 0 0.00043925948557443917
flanking O 1 0.9872050285339355
COL17A1 O 1 0.9998292922973633
. O 0 0.001145503600127995

Five O 0 0.0026372091379016638
intragenic O 0 0.16182447969913483
polymorphisms O 0 0.006744896527379751
were O 0 8.020852692425251e-05
chosen O 0 0.00037637248169630766
based O 0 0.0001567094004712999
on O 0 0.00018530027591623366
their O 0 0.00016900691844057292
informativeness O 1 0.9745792150497437
. O 0 0.0007344335899688303

One O 0 0.00024778698571026325
of O 0 1.3626627151097637e-05
these O 0 4.394239658722654e-05
, O 0 0.0003032892709597945
not O 0 0.0002520609996281564
previously O 0 0.0021962004248052835
reported O 0 0.004249366465955973
, O 0 0.00028639225638471544
was O 0 0.0033818718511611223
2988 O 0 0.3402971625328064
A O 0 0.008365622721612453
or O 0 0.0018166812369599938
C O 0 0.10269499570131302
that O 0 9.431770740775391e-05
introduces O 0 0.0023724273778498173
a O 0 0.00032043966348282993
new O 0 0.00019084410450886935
restriction O 0 0.0007366615463979542
site O 0 0.001956685446202755
for O 0 0.0005612179520539939
Eco0109 O 1 0.9105493426322937
I O 0 0.055064283311367035
. O 0 0.0005117596010677516

All O 0 0.00014040834503248334
the O 0 0.000555426231585443
4003delTC O 1 0.7436110377311707
alleles O 0 0.006623451132327318
showed O 0 0.0017878037178888917
the O 0 0.00016991757729556412
same O 0 0.00040840543806552887
haplotype O 0 0.06167007237672806
for O 0 0.00012762926053255796
these O 0 1.99454661924392e-05
five O 0 0.00020863843383267522
polymorphic O 0 0.06933930516242981
markers O 0 0.01824282296001911
. O 0 0.0005548563203774393

Fourteen O 0 0.009319311007857323
microsatellite O 0 0.07016776502132416
polymorphisms O 0 0.005764316767454147
were O 0 7.346639904426411e-05
selected O 0 0.0003285513666924089
based O 0 0.0001330619998043403
on O 0 0.00015022995648905635
their O 0 0.00010312395170331001
high O 0 0.011604716069996357
heterozygosity O 1 0.9479247331619263
and O 0 0.00010865853255381808
their O 0 3.748089147848077e-05
location O 0 0.0004946388653479517
within O 0 0.00031962504726834595
10q23 O 0 0.330986350774765
- O 0 0.019826317206025124
q25 O 0 0.09643396735191345
near O 0 0.014370226301252842
COL17A1 O 1 0.9960514903068542
. O 0 0.0009038522839546204

Three O 0 0.0003895409172400832
families O 0 0.00024002256395760924
shared O 0 0.0014707189984619617
microsatellite O 0 0.10481865704059601
polymorphisms O 0 0.014182722195982933
covering O 0 0.0239558182656765
at O 0 0.0021262418013066053
most O 0 0.000813410384580493
19 O 0 0.007022580597549677
cM O 0 0.02410055510699749
, O 0 0.0007113353931345046
whereas O 0 0.002807551296427846
the O 0 0.00042918388498947024
others O 0 0.0005564806633628905
shared O 0 0.0004678793775383383
smaller O 0 0.00024129051598720253
regions O 0 0.0006592808640561998
consistent O 0 0.00660952553153038
with O 0 0.00043487540096975863
cross O 0 0.030142534524202347
- O 0 0.007922827266156673
over O 0 0.00021111543173901737
events O 0 0.00031344007584266365
during O 0 0.0010232925415039062
passage O 0 0.0004824299248866737
of O 0 1.0174139788432512e-05
this O 0 8.61029839143157e-05
mutation O 0 0.001854671398177743
through O 0 0.00019189274462405592
several O 0 9.266300912713632e-05
generations O 0 0.0015373043715953827
. O 0 0.0006638418999500573

These O 0 0.00019506237003952265
results O 0 0.001069915946573019
indicate O 0 0.0011972556822001934
that O 0 0.00020573298388626426
4003delTC O 1 0.8408412933349609
occurs O 0 0.0011789347045123577
on O 0 0.0001409543037880212
a O 0 0.0004093586467206478
single O 0 0.0005402417737059295
ancestral O 0 0.011563151143491268
allele O 0 0.016378162428736687
. O 0 0.00047727549099363387
. O 0 0.0005903428536839783

The O 0 0.002529190620407462
haptoglobin O 1 0.9922897219657898
- O 0 0.021050557494163513
gene O 0 0.00342898303642869
deletion O 0 0.007642343640327454
responsible O 0 0.00526046846061945
for O 0 0.0009416846442036331
anhaptoglobinemia B-Disease 1 0.975352942943573
. O 0 0.0009313364280387759

We O 0 0.0009397048852406442
have O 0 9.258122008759528e-05
found O 0 0.00016855179273989052
an O 0 0.00023206225887406617
allelic O 0 0.04812835901975632
deletion O 0 0.004172980319708586
of O 0 2.020680040004663e-05
the O 0 0.0009786223527044058
haptoglobin O 1 0.9975659847259521
( O 0 0.005125513765960932
Hp O 1 0.9721285700798035
) O 0 0.0007850803667679429
gene O 0 0.0017363306833431125
from O 0 5.2435858378885314e-05
an O 0 0.00013209084863774478
individual O 0 0.00029140146216377616
with O 0 0.00046032347017899156
anhaptoglobinemia B-Disease 1 0.9992056488990784
. O 0 0.0009251433075405657

The O 0 0.0029277813155204058
Hp O 1 0.9105835556983948
gene O 0 0.007874775677919388
cluster O 0 0.011189093813300133
consists O 0 0.0002984773018397391
of O 0 3.97753574361559e-05
coding O 0 0.014891219325363636
regions O 0 0.000327418529195711
of O 0 1.6188354493351653e-05
the O 0 0.00035693999961949885
alpha O 0 0.006080835126340389
chain O 0 0.005194325931370258
and O 0 0.0002597371058072895
beta O 0 0.009644481353461742
chain O 0 0.0011485733557492495
of O 0 1.2818718460039236e-05
the O 0 0.0005056587397120893
haptoglobin O 1 0.9925903081893921
gene O 0 0.011737766675651073
( O 0 0.002692684531211853
Hp O 1 0.9532884955406189
) O 0 0.00039343565003946424
and O 0 5.543555744225159e-05
of O 0 1.2763618542521726e-05
the O 0 0.00023998183314688504
alpha O 0 0.0051410202868282795
chain O 0 0.003700889414176345
and O 0 0.00018914429529104382
beta O 0 0.008049608208239079
chain O 0 0.0011535705998539925
of O 0 1.4114835721557029e-05
the O 0 0.0005553402006626129
haptoglobin O 1 0.9988921284675598
- O 0 0.0170652624219656
related O 0 0.003769895527511835
gene O 0 0.007730667479336262
( O 0 0.002969017717987299
Hpr O 1 0.9988975524902344
) O 0 0.001140449894592166
, O 0 0.0003522513434290886
in O 0 0.00036849812022410333
tandem O 0 0.01324542611837387
from O 0 0.00012443994637578726
the O 0 0.0003804792941082269
5 O 0 0.0026302351616322994
side O 0 0.00962122157216072
. O 0 0.0006945093045942485

Southern O 0 0.017882464453577995
blot O 1 0.9822419881820679
and O 0 0.000631889037322253
PCR O 0 0.020359758287668228
analyses O 0 0.002550029195845127
have O 0 0.00025051471311599016
indicated O 0 0.0034073940478265285
that O 0 3.4656026400625706e-05
the O 0 7.673069194424897e-05
individual O 0 0.0001650501653784886
with O 0 0.000336260738549754
anhaptoglobinemia B-Disease 1 0.998683750629425
was O 0 0.002382569247856736
homozygous O 0 0.0029471053276211023
for O 0 0.0001082253729691729
the O 0 0.0002580398868303746
gene O 0 0.005860930308699608
deletion O 0 0.009437412954866886
and O 0 0.00012624745431821793
that O 0 4.739857104141265e-05
the O 0 0.00024173702695406973
gene O 0 0.004520105198025703
deletion O 0 0.01120139192789793
was O 0 0.0017524732975289226
included O 0 0.00017177255358546972
at O 0 0.0009372351923957467
least O 0 0.0002955265517812222
from O 0 7.74295549490489e-05
the O 0 0.0004894054145552218
promoter O 0 0.05014484003186226
region O 0 0.002055804943665862
of O 0 8.85420449776575e-05
Hp O 1 0.9178661108016968
to O 0 0.0007534666219726205
Hpr O 1 0.9906241297721863
alpha O 0 0.004818481858819723
but O 0 0.00015185886877588928
not O 0 7.270560308825225e-05
to O 0 0.00016284910088870674
Hpr O 1 0.9927024841308594
beta O 0 0.03539607301354408
( O 0 0.0020064169075340033
Hpdel O 1 0.9899897575378418
) O 0 0.000828385294880718
. O 0 0.000497010420076549

In O 0 0.000955271243583411
addition O 0 0.0009502177708782256
, O 0 0.00038482254603877664
we O 0 0.00028665203717537224
found O 0 0.00027345531270839274
seven O 0 0.00019597065693233162
individuals O 0 0.00021403850405476987
with O 0 0.00034334236988797784
hypohaptoglobinemia B-Disease 1 0.9836175441741943
in O 0 0.000376218551537022
three O 0 0.0001827429368859157
families O 0 0.000507100485265255
, O 0 0.0003624922246672213
and O 0 0.0001940822839969769
the O 0 0.0005499531398527324
genotypes O 0 0.04046836867928505
of O 0 2.5776145776035264e-05
six O 0 0.00020729682000819594
of O 0 1.685544521023985e-05
the O 0 0.00027941568987444043
seven O 0 0.0003606459067668766
individuals O 0 0.00014297042798716575
were O 0 4.2854731873376295e-05
found O 0 0.00019488169346004725
to O 0 7.480826025130227e-05
be O 0 0.00048651781980879605
Hp2 O 1 0.9994263648986816
/ O 1 0.9838972687721252
Hpdel O 1 0.982901930809021
. O 0 0.0009430130594410002

The O 0 0.0022320018615573645
phenotypes O 0 0.043944668024778366
and O 0 0.0009823046857491136
genotypes O 0 0.19476202130317688
in O 0 0.0002162362216040492
one O 0 7.748525240458548e-05
of O 0 1.137128310801927e-05
these O 0 3.078408553847112e-05
three O 0 0.00011192191595910117
families O 0 0.00033386770519427955
showed O 0 0.0018569915555417538
the O 0 0.0003263187827542424
father O 0 0.0022585962433367968
to O 0 0.00010219318937743083
be O 0 0.00030164013151079416
hypohaptoglobinemic B-Disease 1 0.9788411259651184
( O 0 0.0018614038126543164
Hp2 O 1 0.9928389191627502
) O 0 0.0005023963167332113
and O 0 0.0006198551272973418
Hp2 O 1 0.99967360496521
/ O 1 0.9816882014274597
Hpdel O 1 0.976524829864502
, O 0 0.0004192108754068613
the O 0 0.00033475534291937947
mother O 0 0.0032516380306333303
to O 0 0.00011773336154874414
be O 0 0.00032379990443587303
Hp2 O 1 0.8996264338493347
- O 0 0.007108701858669519
1 O 0 0.001504158484749496
and O 0 0.0007166888099163771
Hp1 O 1 0.9993788003921509
/ O 1 0.9877745509147644
Hp2 O 1 0.9807963371276855
, O 0 0.0003321007825434208
one O 0 5.907245213165879e-05
of O 0 1.09354623418767e-05
the O 0 0.000190340171684511
two O 0 0.00010104240936925635
children O 0 0.000801808899268508
to O 0 0.00010263019794365391
be O 0 0.0003313945489935577
hypohaptoglobinemic B-Disease 1 0.8887826800346375
( O 0 0.0017918121302500367
Hp2 O 1 0.9895368814468384
) O 0 0.0006040869047865272
and O 0 0.0007148177828639746
Hp2 O 1 0.9997839331626892
/ O 1 0.9928044676780701
Hpdel O 1 0.9949842691421509
, O 0 0.0004661443817894906
and O 0 0.00012176274321973324
the O 0 0.00023359397891908884
other O 0 0.00013117931666783988
child O 0 0.004172203131020069
to O 0 0.00011408713180571795
be O 0 0.0002843801921699196
Hp1 O 1 0.958730161190033
and O 0 0.0009490216616541147
Hp1 O 1 0.999776303768158
/ O 1 0.9939966201782227
Hpdel O 1 0.9967214465141296
, O 0 0.0003168084949720651
showing O 0 0.0012710248120129108
an O 0 0.0004410306573845446
anomalous O 1 0.721165120601654
inheritance O 0 0.003931933548301458
of O 0 0.00016896113811526448
Hp O 1 0.994600772857666
phenotypes O 0 0.02721739374101162
in O 0 0.00029454572359099984
the O 0 0.00048064207658171654
child O 0 0.008801057934761047
with O 0 0.00046623076195828617
Hp1 O 1 0.9967821836471558
. O 0 0.0010086268885061145

The O 0 0.004894749727100134
Hp2 O 1 0.9993001222610474
/ O 1 0.9928410053253174
Hpdel O 1 0.983359158039093
individuals O 0 0.0004163479898124933
had O 0 0.00045800916268490255
an O 0 0.00017351798305753618
extremely O 0 0.007810461334884167
low O 0 0.0029006702825427055
level O 0 0.001543070306070149
of O 0 6.77856951369904e-05
Hp O 1 0.9757670760154724
( O 0 0.0011210307711735368
mean O 0 0.009182901121675968
+ O 0 0.3763897120952606
/ O 0 0.2389000654220581
- O 0 0.022153353318572044
SD O 1 0.9170680642127991
= O 0 0.0067778900265693665
0 O 0 0.0016332321101799607
. O 0 0.000553253514226526
049 O 1 0.9918506741523743
+ O 0 0.44674670696258545
/ O 0 0.09114059060811996
- O 0 0.005852931644767523
0 O 0 0.0013106344267725945
. O 0 0.00034616264747455716
043 O 1 0.9665566682815552
mg O 1 0.9979212880134583
/ O 1 0.8262919187545776
ml O 0 0.3471416234970093
; O 0 0.000554954691324383
n O 0 0.00851526204496622
= O 0 0.01360836811363697
6 O 0 0.0047255042009055614
) O 0 0.00040856681880541146
, O 0 0.00020382927323225886
compared O 0 0.0008384666871279478
with O 0 6.405059684766456e-05
the O 0 0.0003680639492813498
level O 0 0.00900891050696373
( O 0 0.0008579198620282114
1 O 0 0.0019542500376701355
. O 0 0.00018039844871964306
64 O 0 0.004626539070159197
+ O 0 0.19764983654022217
/ O 0 0.0686001405119896
- O 0 0.006031266413629055
1 O 0 0.0014643092872574925
. O 0 0.0005284380749799311
07 O 1 0.995050847530365
mg O 1 0.9992658495903015
/ O 1 0.919726550579071
ml O 0 0.3539212644100189
) O 0 0.0002817470522131771
obtained O 0 0.0002746674872469157
from O 0 0.00015684409299865365
52 O 0 0.008554564788937569
healthy O 1 0.7645808458328247
volunteers O 0 0.011797639541327953
having O 0 0.004833057522773743
phenotype O 1 0.8205234408378601
Hp2 O 1 0.9862581491470337
, O 0 0.00038293638499453664
whereas O 0 0.0014319111360237002
the O 0 0.0006525579956360161
serum O 1 0.9971574544906616
Hp O 0 0.29415765404701233
level O 0 0.0011852990137413144
of O 0 8.69342329679057e-06
an O 0 0.00012008585326839238
individual O 0 0.00020897452486678958
with O 0 0.0006206331308931112
Hp1 O 1 0.9997825026512146
/ O 1 0.984683096408844
Hpdel O 1 0.9719321131706238
was O 0 0.002806629054248333
0 O 0 0.0023792393039911985
. O 0 0.00036477899993769825

50 O 0 0.008949612267315388
mg O 1 0.9973325729370117
/ O 1 0.8788034915924072
ml O 1 0.5745805501937866
, O 0 0.0004956592456437647
which O 0 0.00011435092892497778
was O 0 0.000982023891992867
approximately O 0 0.0003464943147264421
half O 0 0.00011723908392013982
the O 0 0.00011344360973453149
level O 0 0.0020203900057822466
of O 0 7.140123489079997e-05
Hp O 1 0.913617730140686
in O 0 0.0004873769939877093
control O 0 0.005285018123686314
sera O 0 0.07982543110847473
from O 0 0.00011620310397120193
the O 0 0.00047435209853574634
Hp1 O 1 0.9885220527648926
phenotype O 0 0.1346442550420761
( O 0 0.0008625410846434534
1 O 0 0.0017204963369295
. O 0 0.00019608091679401696
26 O 0 0.005114767700433731
+ O 0 0.19971878826618195
/ O 0 0.08584246784448624
- O 0 0.00473208911716938
0 O 0 0.0008563300361856818
. O 0 0.0001246312604052946
33 O 0 0.0071762939915061
mg O 1 0.998058021068573
/ O 1 0.6980012655258179
ml O 0 0.2516835331916809
; O 0 0.0005909689352847636
n O 0 0.008989030495285988
= O 0 0.013658813200891018
9 O 0 0.003639521077275276
) O 0 0.00021902626031078398
, O 0 0.00011730394908227026
showing O 0 0.0009971358813345432
a O 0 0.001131727360188961
gene O 0 0.007748769596219063
- O 0 0.017692450433969498
dosage O 1 0.9902652502059937
effect O 0 0.002755453111603856
. O 0 0.0006121229962445796

The O 0 0.0004982584505341947
other O 0 0.0001485464017605409
allele O 0 0.024123016744852066
( O 0 0.0038555904757231474
Hp2 O 1 0.9790129661560059
) O 0 0.00016892248822841793
of O 0 1.0900374945777003e-05
individuals O 0 0.00022875300783198327
with O 0 0.0006653785239905119
Hp2 O 1 0.9999204874038696
/ O 1 0.9949108958244324
Hpdel O 1 0.9961295127868652
was O 0 0.0028579127974808216
found O 0 0.00037006608908995986
to O 0 8.246026845881715e-05
have O 0 9.475058323005214e-05
, O 0 0.00013185727584641427
in O 0 0.00010178277443628758
all O 0 5.5201075156219304e-05
exons O 0 0.011722460389137268
, O 0 0.0003495117125567049
no O 0 0.000394083937862888
mutation O 0 0.0020387268159538507
, O 0 0.00010241200652671978
by O 0 4.558106229524128e-05
DNA O 0 0.0012682024389505386
sequencing O 0 0.0013923250371590257
. O 0 0.0005738709005527198

On O 0 0.0008640465675853193
the O 0 9.990725084207952e-05
basis O 0 6.426344043575227e-05
of O 0 1.4175510841596406e-05
the O 0 0.00027649433468468487
present O 0 0.0006780069670639932
study O 0 0.002296822378411889
, O 0 0.00012596053420566022
the O 0 0.00011437697685323656
mechanism O 0 0.0014068009331822395
of O 0 7.991841266630217e-05
anhaptoglobinemia B-Disease 1 0.9924387335777283
and O 0 0.0001449799892725423
the O 0 0.00012220838107168674
mechanism O 0 0.001045656274072826
of O 0 6.132389535196126e-05
anomalous O 1 0.9478275179862976
inheritance O 0 0.004622700624167919
of O 0 0.00016612080798950046
Hp O 1 0.9969179630279541
phenotypes O 0 0.03412064164876938
were O 0 0.00010448158718645573
well O 0 0.0004950690199621022
explained O 0 0.005952104460448027
. O 0 0.0004851019475609064

However O 0 0.0017579657724127173
, O 0 0.00015694793546572328
the O 0 0.00010551908053457737
mechanism O 0 0.001132202916778624
of O 0 0.00010457109601702541
hypohaptoglobinemia B-Disease 1 0.994159460067749
remains O 0 0.011303741484880447
unknown O 0 0.0036851693876087666

ATM O 0 0.05380349978804588
mutations O 0 0.004538488108664751
and O 0 0.0003257151984144002
phenotypes O 0 0.05128961801528931
in O 0 0.002343379892408848
ataxia B-Disease 1 1.0
- I-Disease 1 0.9996370077133179
telangiectasia I-Disease 1 0.9999843835830688
families O 0 0.0010055633028969169
in O 0 0.00022365803306456655
the O 0 0.000576587044633925
British O 0 0.010404474101960659
Isles O 0 0.07145696133375168
: O 0 0.00033118578721769154
expression O 0 0.0002812620659824461
of O 0 4.1082315874518827e-05
mutant O 0 0.011071288958191872
ATM O 0 0.01975616067647934
and O 0 0.00013707556354347616
the O 0 0.0003054321859963238
risk O 1 0.5968071818351746
of O 0 0.0003753240453079343
leukemia B-Disease 1 1.0
, O 0 0.3662787079811096
lymphoma B-Disease 1 1.0
, O 0 0.0015775123611092567
and O 0 0.007686479948461056
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0009645098471082747

We O 0 0.0015443682204931974
report O 0 0.0008257656008936465
the O 0 0.00012550828978419304
spectrum O 0 0.0022674351930618286
of O 0 6.270470476010814e-05
59 O 0 0.016523588448762894
ATM O 0 0.02233421616256237
mutations O 0 0.0018698569620028138
observed O 0 0.0005657561705447733
in O 0 0.0008458262891508639
ataxia B-Disease 1 0.9999996423721313
- I-Disease 1 0.9985653758049011
telangiectasia I-Disease 1 0.9999887943267822
( O 0 0.004419437609612942
A B-Disease 1 0.9997650980949402
- I-Disease 1 0.9997848868370056
T I-Disease 1 0.9999986886978149
) O 0 0.0031200379598885775
patients O 1 0.9999563694000244
in O 0 0.00016569985018577427
the O 0 0.0004299578722566366
British O 0 0.008092666044831276
Isles O 0 0.049665823578834534
. O 0 0.0008730498375371099

Of O 0 0.00020204061002004892
51 O 0 0.01613737642765045
ATM O 0 0.060470737516880035
mutations O 0 0.007435875944793224
identified O 0 0.0019304169109091163
in O 0 0.0002554938546381891
families O 0 0.0003508859081193805
native O 0 0.00028036729781888425
to O 0 0.00012277041969355196
the O 0 0.00048427240108139813
British O 0 0.00997565034776926
Isles O 0 0.053068339824676514
, O 0 0.0008164058672264218
11 O 0 0.0020370008423924446
were O 0 0.00012487107596825808
founder O 0 0.033093106001615524
mutations O 0 0.00507458858191967
, O 0 0.00035173739888705313
and O 0 0.00024610423133708537
2 O 0 0.0006199355120770633
of O 0 1.2832515494665131e-05
these O 0 5.3850311815040186e-05
11 O 0 0.0033632817212492228
conferred O 0 0.12369171530008316
a O 0 0.0031384483445435762
milder O 1 0.9986818432807922
clinical O 1 0.9999828338623047
phenotype O 0 0.43633314967155457
with O 0 7.35696594347246e-05
respect O 0 0.0003355603839736432
to O 0 8.989733032649383e-05
both O 0 0.0007670160266570747
cerebellar B-Disease 1 0.9999995231628418
degeneration I-Disease 1 1.0
and O 0 0.0009670680155977607
cellular O 0 0.012273130007088184
features O 0 0.0009206794202327728
. O 0 0.0007031142013147473

We O 0 0.001618946553207934
report O 0 0.0011393000604584813
, O 0 0.00011017221549991518
in O 0 9.348906314698979e-05
two O 0 0.00013057381147518754
A B-Disease 1 0.9977602958679199
- I-Disease 1 0.9989331364631653
T I-Disease 1 0.9999879598617554
families O 0 0.0005165472393855453
, O 0 0.0001264016464119777
an O 0 0.00023067732399795204
ATM O 0 0.026863370090723038
mutation O 0 0.005067955236881971
( O 0 0.0012536083813756704
7271T O 0 0.3872625231742859
- O 0 0.022837096825242043
- O 0 0.018531085923314095
> O 0 0.038692228496074677
G O 0 0.3022649586200714
) O 0 0.0004977979697287083
that O 0 0.00020217087876517326
may O 0 0.0017590196803212166
be O 0 0.00012812310887966305
associated O 0 0.00021618920436594635
with O 0 2.7265294193057343e-05
an O 0 0.00015938779688440263
increased O 0 0.0011251620016992092
risk O 1 0.8754106163978577
of O 0 0.0005098524852655828
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0003194029850419611
both O 0 0.0005460323300212622
homozygotes O 1 0.9969837069511414
and O 0 0.0009604594088159502
heterozygotes O 1 0.954588770866394
( O 0 0.0009436534601263702
relative O 0 0.0016909594414755702
risk O 0 0.2503584921360016
12 O 0 0.0018219096818938851
. O 0 0.00022920756600797176
7 O 0 0.002529936609789729
; O 0 0.0006574240396730602
P O 1 0.944757342338562
= O 0 0.018252242356538773
. O 0 0.001095639425329864
0025 O 1 0.9962319731712341
) O 0 0.0010403502965345979
, O 0 0.00026281076134182513
although O 0 0.0002387749555055052
there O 0 4.2439784010639414e-05
is O 0 0.00012252085434738547
a O 0 0.00032977270893752575
less O 0 0.0017586145550012589
severe O 1 0.9999940395355225
A B-Disease 1 0.9999198913574219
- I-Disease 1 0.9998716115951538
T I-Disease 1 0.9999979734420776
phenotype O 0 0.2994309961795807
in O 0 0.00015548015653621405
terms O 0 0.00014451416791416705
of O 0 9.80259028438013e-06
the O 0 0.00016724049055483192
degree O 0 0.0025639785453677177
of O 0 0.00021755417401436716
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 0 0.0020429727155715227

This O 0 0.0002936602395493537
mutation O 0 0.0034804758615791798
( O 0 0.0012123343767598271
7271T O 0 0.25728973746299744
- O 0 0.032994937151670456
- O 0 0.026267603039741516
> O 0 0.04677601903676987
G O 0 0.15228641033172607
) O 0 0.0003606633981689811
also O 0 0.00011804205132648349
allows O 0 0.00011049563181586564
expression O 0 0.00023485776910092682
of O 0 2.6367850296082906e-05
full O 0 0.0019238292006775737
- O 0 0.005314820911735296
length O 0 0.0008150323410518467
ATM O 0 0.012449431233108044
protein O 0 0.0009496688726358116
at O 0 0.0008229405502788723
a O 0 0.0006804696749895811
level O 0 0.0043172468431293964
comparable O 0 0.0033480930142104626
with O 0 9.770318865776062e-05
that O 0 0.00012926090857945383
in O 0 0.00048615114064887166
unaffected O 1 0.9110417366027832
individuals O 0 0.0008353536832146347
. O 0 0.0007662132265977561

In O 0 0.0008288922836072743
addition O 0 0.0008144260500557721
, O 0 0.00025108022964559495
we O 0 0.00012210100248921663
have O 0 4.4237425754545256e-05
studied O 0 0.0007185516878962517
18 O 0 0.001076216110959649
A B-Disease 1 0.9991459846496582
- I-Disease 1 0.9998992681503296
T I-Disease 1 0.9999998807907104
patients O 1 0.9999983310699463
, O 0 0.00034109369153156877
in O 0 0.0002019019448198378
15 O 0 0.0007647732272744179
families O 0 0.00018888909835368395
, O 0 0.00026812395663000643
who O 0 0.0019004631321877241
developed O 1 0.998809814453125
leukemia B-Disease 1 1.0
, O 0 0.07332102209329605
lymphoma B-Disease 1 1.0
, O 0 0.003005225444212556
preleukemic O 1 0.9998102784156799
T O 1 0.9999384880065918
- O 0 0.022576190531253815
cell O 0 0.006137259770184755
proliferation O 0 0.404308557510376
, O 0 0.0005802679224871099
or O 0 0.19770802557468414
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.0011793699814006686
mostly O 0 0.0002804916293825954
in O 0 0.0007909664418548346
childhood O 1 0.9995445609092712
. O 0 0.001092436141334474

A O 0 0.007666316814720631
wide O 0 0.0013078723568469286
variety O 0 0.0003625938843470067
of O 0 6.049953299225308e-05
ATM O 0 0.08492672443389893
mutation O 0 0.004694132599979639
types O 0 0.0012209417764097452
, O 0 0.0002267197414766997
including O 0 0.00019669379980769008
missense O 0 0.02771906740963459
mutations O 0 0.0025837658904492855
and O 0 0.00015213643200695515
in O 0 0.0005923872231505811
- O 0 0.015131977386772633
frame O 0 0.009119340218603611
deletions O 0 0.005854249466210604
, O 0 0.0002989728527609259
were O 0 5.6366461649304256e-05
seen O 0 0.0012581066694110632
in O 0 0.0001863090437836945
these O 0 0.0002845654380507767
patients O 1 0.999997615814209
. O 0 0.0007087417179718614

We O 0 0.0012036269763484597
also O 0 0.0002909603645093739
show O 0 0.00043440889567136765
that O 0 6.006190596963279e-05
25 O 0 0.00017158346599899232
% O 0 9.112215593631845e-06
of O 0 5.59775344299851e-06
all O 0 0.0001297646522289142
A B-Disease 1 0.999734103679657
- I-Disease 1 0.9998633861541748
T I-Disease 1 0.9999994039535522
patients O 1 0.9999593496322632
carried O 0 0.0006293182377703488
in O 0 0.0003927952202502638
- O 0 0.009560761973261833
frame O 0 0.007309722248464823
deletions O 0 0.0063339825719594955
or O 0 0.0016147653805091977
missense O 0 0.06601885706186295
mutations O 0 0.0065985796973109245
, O 0 0.00023947695444803685
many O 0 4.3176176404813305e-05
of O 0 2.6280134989065118e-05
which O 0 0.00013156137720216066
were O 0 7.079734496073797e-05
also O 0 0.0003336033259984106
associated O 0 0.00029224363970570266
with O 0 3.1888983357930556e-05
expression O 0 0.00030102042364887893
of O 0 3.253268005209975e-05
mutant O 0 0.007892272435128689
ATM O 0 0.01643519103527069
protein O 0 0.0016800008015707135
. O 0 0.0004963226965628564

The O 0 0.0015121231554076076
DMPK O 1 0.9975104331970215
gene O 0 0.001588473911397159
of O 0 8.924782741814852e-05
severely O 1 0.9999792575836182
affected O 1 0.9985193610191345
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999998807907104
is O 0 0.0032942083198577166
hypermethylated O 1 0.9944685697555542
proximal O 1 0.998871386051178
to O 0 0.0001297583366977051
the O 0 0.00010383559128968045
largely O 0 0.0008451092871837318
expanded O 0 0.00627489248290658
CTG O 1 0.9969252943992615
repeat O 0 0.03943797945976257
. O 0 0.0007367745856754482

Using O 0 0.0007371542160399258
methylation O 0 0.003261356381699443
- O 0 0.0070531838573515415
sensitive O 0 0.005825916305184364
restriction O 0 0.000947479042224586
enzymes O 0 0.000837079540360719
, O 0 0.00034449962549842894
we O 0 0.0004026292881462723
characterized O 0 0.010524595156311989
the O 0 0.00026906453422270715
methylation O 0 0.001433825003914535
pattern O 0 0.003925570752471685
on O 0 0.0003721101675182581
the O 0 0.00037211156450212
5 O 0 0.0013840054161846638
side O 0 0.001645613112486899
of O 0 2.1503024981939234e-05
the O 0 0.001204987522214651
CTG O 1 0.9991044402122498
repeat O 0 0.018013345077633858
in O 0 0.0002426433638902381
the O 0 0.0008054160280153155
DMPK O 1 0.9979301691055298
gene O 0 0.0016267101746052504
of O 0 2.9528831873903982e-05
normal O 0 0.0036792815662920475
individuals O 0 0.00015290488954633474
and O 0 0.0001083814277080819
of O 0 0.0001597371301613748
patients O 1 0.9999997615814209
affected O 0 0.022743146866559982
with O 0 0.0024256641045212746
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.0020986003801226616
showing O 0 0.003473135642707348
expansions O 0 0.00378027674742043
of O 0 1.2871872058894951e-05
the O 0 0.00033739881473593414
repetitive O 0 0.25108224153518677
sequence O 0 0.0005154990358278155
. O 0 0.0005272165290080011

The O 0 0.0012504348997026682
gene O 0 0.0038382806815207005
segment O 0 0.005338379647582769
analyzed O 0 0.001769974478520453
corresponds O 0 0.0003842016158159822
to O 0 4.589098898577504e-05
the O 0 0.00016981587396003306
genomic O 0 0.013127570040524006
SacI O 1 0.9491281509399414
- O 0 0.01707887463271618
HindIII O 0 0.08799690753221512
fragment O 0 0.0027986583299934864
carrying O 0 0.0006490208324976265
exons O 0 0.009677817113697529
11 O 0 0.005309051834046841
- O 0 0.010149598121643066
15 O 0 0.0013601150130853057
. O 0 0.0003929278173018247

There O 0 0.0004115135525353253
is O 0 0.0004343099135439843
constitutive O 0 0.03290834277868271
methylation O 0 0.0015347105218097568
in O 0 0.0004553936014417559
intron O 1 0.9423704147338867
12 O 0 0.002124364487826824
at O 0 0.000543599424418062
restriction O 0 0.00042436423245817423
sites O 0 0.0001759474544087425
of O 0 6.603564543183893e-05
SacII O 1 0.9907009601593018
and O 0 0.0006818186375312507
HhaI O 1 0.9749577641487122
, O 0 0.0004950760630890727
localized O 0 0.018904294818639755
1 O 0 0.0023878158535808325
, O 0 0.0005479648243635893
159 O 0 0.040577828884124756
- O 0 0.009308988228440285
1 O 0 0.0016701561398804188
, O 0 0.00040966624510474503
232 O 0 0.033147845417261124
bp O 0 0.06382691115140915
upstream O 0 0.002409854903817177
of O 0 2.642373146954924e-05
the O 0 0.001280086231417954
CTG O 1 0.9996597766876221
repeat O 0 0.047692518681287766
, O 0 0.000529050943441689
whereas O 0 0.0027462870348244905
most O 0 0.0005640083109028637
, O 0 0.0005422161775641143
if O 0 0.0007552900933660567
not O 0 0.00015366873412858695
all O 0 3.413554804865271e-05
, O 0 0.00010237596870865673
of O 0 1.143853114626836e-05
the O 0 0.00012338127999100834
other O 0 3.2269021176034585e-05
sites O 0 0.00017416577611584216
of O 0 5.553614755626768e-05
SacII O 1 0.9967485666275024
, O 0 0.0014018286019563675
HhaI O 1 0.9948095083236694
, O 0 0.000693767738994211
and O 0 0.0005349502898752689
HpaII O 1 0.9861917495727539
in O 0 0.00017766242672223598
this O 0 7.581744284834713e-05
region O 0 0.0022019490133970976
are O 0 0.000134861926198937
unmethylated O 1 0.8982135653495789
, O 0 0.0004003961512353271
in O 0 0.0003215036413166672
normal O 0 0.0050801164470613
individuals O 0 0.0002374142495682463
and O 0 9.336130460724235e-05
most O 0 8.739625627640635e-05
of O 0 2.3237482309923507e-05
the O 0 0.002120426157489419
patients O 1 0.9999994039535522
. O 0 0.0007472941069863737

In O 0 0.000362618564395234
a O 0 0.0002068001194857061
number O 0 1.692862861091271e-05
of O 0 3.2057381758932024e-05
young O 0 0.01350285392254591
and O 0 0.0016297820257022977
severely O 1 0.9999942779541016
affected O 1 0.9956467747688293
patients O 1 0.9999995231628418
, O 0 0.0005492775817401707
however O 0 0.0004031097632832825
, O 0 0.00017266898066736758
complete O 0 0.0008548610494472086
methylation O 0 0.00024179603497032076
of O 0 6.2298699958773796e-06
these O 0 2.1297471903380938e-05
restriction O 0 0.0006297009531408548
sites O 0 0.000556074024643749
was O 0 0.0016481963684782386
found O 0 0.00029408495174720883
in O 0 8.461231482215226e-05
the O 0 0.00031549707637168467
mutated O 0 0.020399589091539383
allele O 0 0.015545793808996677
. O 0 0.0009806802263483405

In O 0 0.0003907468926627189
most O 0 8.33561789477244e-05
of O 0 2.4265042156912386e-05
these O 0 0.0003808597684837878
patients O 1 0.9999991655349731
, O 0 0.00022660392278339714
the O 0 0.0003286534920334816
onset O 1 0.9996790885925293
of O 0 4.576368519337848e-05
the O 0 0.003744929563254118
disease O 1 1.0
was O 1 0.9963066577911377
congenital O 1 1.0
. O 0 0.0017677507130429149

Preliminary O 0 0.002517788205295801
in O 0 0.0007317612762562931
vivo O 0 0.04844752699136734
footprinting O 1 0.9863678812980652
data O 0 0.0001604025746928528
gave O 0 0.00035929979640059173
evidence O 0 0.00010968499555019662
for O 0 0.00010261707939207554
protein O 0 0.0024984050542116165
- O 0 0.0095104044303298
DNA O 0 0.002143613062798977
contact O 0 0.0019467506790533662
in O 0 0.00021360385289881378
normal O 0 0.0034003558102995157
genes O 0 0.0004345886700320989
at O 0 0.0008687537047080696
an O 0 0.0008519762777723372
Sp1 O 1 0.9895385503768921
consensus O 0 0.0012573524145409465
binding O 0 0.0009496657294221222
site O 0 0.0017650810768827796
upstream O 0 0.0017772507853806019
of O 0 2.0924027921864763e-05
the O 0 0.0013879038160666823
CTG O 1 0.9995648264884949
repeat O 0 0.03367575258016586
and O 0 0.000156321533722803
for O 0 0.00018207207904197276
a O 0 0.00047164419083856046
significant O 0 0.0008545739692635834
reduction O 0 0.0031274042557924986
of O 0 1.1939314390474465e-05
this O 0 4.009461554232985e-05
interaction O 0 0.0004320664156693965
in O 0 0.00020299451716709882
cells O 0 0.0017616188852116466
with O 0 5.804918328067288e-05
a O 0 0.00225828867405653
hypermethylated O 1 0.9968871474266052
DMPK O 1 0.9993645548820496
gene O 0 0.006106839515268803
. O 0 0.00022601915406994522
. O 0 0.0004126566636841744

The O 0 0.007273037452250719
hemochromatosis B-Disease 1 0.9999997615814209
gene O 0 0.009002432227134705
product O 0 0.00300876353867352
complexes O 0 0.0063035315833985806
with O 0 6.072357064113021e-05
the O 0 0.00044860198977403343
transferrin O 1 0.957194447517395
receptor O 0 0.011921018362045288
and O 0 0.00036417096271179616
lowers O 0 0.17880237102508545
its O 0 0.0001658311957726255
affinity O 0 0.00230780360288918
for O 0 0.0002505261800251901
ligand O 0 0.01047695241868496
binding O 0 0.0017291877884417772
. O 0 0.000592377909924835

We O 0 0.0029600646812468767
recently O 0 0.012165206484496593
reported O 0 0.002280471147969365
the O 0 0.00012392448843456805
positional O 0 0.008459130302071571
cloning O 0 0.0025493016000837088
of O 0 1.4658073268947192e-05
a O 0 0.0005707645905204117
candidate O 0 0.002002355409786105
gene O 0 0.0027264172676950693
for O 0 0.001869737752713263
hereditary B-Disease 1 0.9999996423721313
hemochromatosis I-Disease 1 1.0
called O 1 0.6764543652534485
HFE O 1 0.9999765157699585
. O 0 0.001704627531580627

The O 0 0.001101748668588698
gene O 0 0.0031191352754831314
product O 0 0.0019512918079271913
, O 0 0.00020357406174298376
a O 0 0.00044126491411589086
member O 0 0.00023977782984729856
of O 0 1.0281431968905963e-05
the O 0 0.0002824667899403721
major O 0 0.019092587754130363
histocompatibility O 1 0.9999983310699463
complex O 0 0.04119892045855522
class O 0 0.021516283974051476
I O 1 0.9210863709449768
- O 0 0.009819112718105316
like O 0 0.0005120958085171878
family O 0 0.0011636861599981785
, O 0 0.0005021478864364326
was O 0 0.0023389614652842283
found O 0 0.0002687043452169746
to O 0 4.106856795260683e-05
have O 0 2.9828188417013735e-05
a O 0 0.00033071788493543863
mutation O 0 0.0027006766758859158
, O 0 0.000953979673795402
Cys O 1 0.9997790455818176
- O 0 0.018232466652989388
282 O 0 0.06535063683986664
- O 0 0.017642933875322342
- O 0 0.015163456089794636
> O 0 0.04066342115402222
Tyr O 1 0.9995700716972351
( O 0 0.0028438789304345846
C282Y O 0 0.1311998814344406
) O 0 0.0005270590190775692
, O 0 0.0001953465980477631
in O 0 0.00025842495961114764
85 O 0 0.003393973922356963
% O 0 4.1819312173174694e-05
of O 0 7.855728472350165e-05
patient O 1 0.9998672008514404
chromosomes O 0 0.0019613406620919704
. O 0 0.0007488966803066432

This O 0 0.0003443100431468338
mutation O 0 0.0029830329585820436
eliminates O 0 0.013396945782005787
the O 0 0.00018633498984854668
ability O 0 0.003026046324521303
of O 0 0.0001788298977771774
HFE O 1 0.9998639822006226
to O 0 0.00037341078859753907
associate O 0 0.010864860378205776
with O 0 0.00024753808975219727
beta2 O 1 0.9946209192276001
- O 0 0.03229670226573944
microglobulin O 1 0.9785307049751282
( O 0 0.0016912491992115974
beta2m O 1 0.9632248878479004
) O 0 0.00034032046096399426
and O 0 0.0002470657927915454
prevents O 0 0.06137493997812271
cell O 0 0.009672053158283234
- O 0 0.007320175413042307
surface O 0 0.0053914999589324
expression O 0 0.001993025653064251
. O 0 0.000622401072178036

A O 0 0.005600398872047663
second O 0 0.0007748082280158997
mutation O 0 0.0021441997960209846
that O 0 8.129203342832625e-05
has O 0 0.00039361760718747973
no O 0 0.00012394080113153905
effect O 0 0.0007884454680606723
on O 0 0.000713308050762862
beta2m O 1 0.9967723488807678
association O 0 0.043155040591955185
, O 0 0.0017361901700496674
H63D O 1 0.999640703201294
, O 0 0.0009698318899609149
was O 0 0.0022835927084088326
found O 0 0.00033981516025960445
in O 0 0.00011061201803386211
eight O 0 0.00016708140901755542
out O 0 5.3948795539326966e-05
of O 0 2.979151759063825e-05
nine O 0 0.0025668921880424023
patients O 1 0.9999475479125977
heterozygous O 0 0.004071964882314205
for O 0 0.00015006489411462098
the O 0 0.0004603511479217559
C282Y O 0 0.14182481169700623
mutant O 0 0.01129376981407404
. O 0 0.0005534595693461597

In O 0 0.0006476339767687023
this O 0 0.00018336938228458166
report O 0 0.0018158331513404846
, O 0 0.00022606138372793794
we O 0 0.00015965868078637868
demonstrate O 0 0.001600778428837657
in O 0 0.00016894907457754016
cultured O 0 0.028326667845249176
293 O 0 0.11408793181180954
cells O 0 0.010958211496472359
overexpressing O 1 0.9774025082588196
wild O 0 0.002420076634734869
- O 0 0.014312631450593472
type O 0 0.007271301932632923
or O 0 0.0010510919382795691
mutant O 0 0.019743481650948524
HFE O 1 0.9926919341087341
proteins O 0 0.0001572919136378914
that O 0 4.3951571569778025e-05
both O 0 6.508102524094284e-05
the O 0 0.00022751100186724216
wild O 0 0.0018163706408813596
- O 0 0.013076870702207088
type O 0 0.010216535069048405
and O 0 0.0010185402352362871
H63D O 1 0.9997730851173401
HFE O 1 0.9976182579994202
proteins O 0 0.0003722440742421895
form O 0 0.001288133324123919
stable O 0 0.04019518569111824
complexes O 0 0.006089573726058006
with O 0 4.339238512329757e-05
the O 0 0.0003403355658520013
transferrin O 1 0.980326771736145
receptor O 0 0.023453373461961746
( O 0 0.0029460822697728872
TfR O 1 0.999214768409729
) O 0 0.0010096576297655702
. O 0 0.0005412260652519763

The O 0 0.0015626410022377968
C282Y O 0 0.0686175674200058
mutation O 0 0.004294350743293762
nearly O 0 0.0023191827349364758
completely O 0 0.011743133887648582
prevents O 0 0.01924571767449379
the O 0 0.00032087622093968093
association O 0 0.004237488843500614
of O 0 1.767499270499684e-05
the O 0 0.00039495292003266513
mutant O 0 0.019733527675271034
HFE O 1 0.9927172660827637
protein O 0 0.0007451358833350241
with O 0 0.00010809284140123054
the O 0 0.0009591956622898579
TfR O 1 0.9992571473121643
. O 0 0.0012604149524122477

Studies O 0 0.0020522421691566706
on O 0 0.00037480919854715466
cell O 0 0.008374780416488647
- O 0 0.007265022955834866
associated O 0 0.001000448246486485
transferrin O 1 0.9671674370765686
at O 0 0.001968165161088109
37 O 0 0.004282254260033369
degrees O 0 0.007047496270388365
C O 0 0.08755990862846375
suggest O 0 0.0006587799871340394
that O 0 3.864868267555721e-05
the O 0 0.0003200226346962154
overexpressed O 1 0.9521317481994629
wild O 0 0.00208504730835557
- O 0 0.015895871445536613
type O 0 0.02068311721086502
HFE O 1 0.9984602928161621
protein O 0 0.001702604116871953
decreases O 0 0.003331954823806882
the O 0 0.00010874520376091823
affinity O 0 0.001104041002690792
of O 0 1.9997192794107832e-05
the O 0 0.0008169778739102185
TfR O 1 0.9983997941017151
for O 0 0.0011462168768048286
transferrin O 1 0.9958553910255432
. O 0 0.001025472767651081

The O 0 0.0026816129684448242
overexpressed O 1 0.9674023389816284
H63D O 1 0.9901055693626404
protein O 0 0.0028680709656327963
does O 0 0.0012637819163501263
not O 0 0.00012229557614773512
have O 0 4.498655835050158e-05
this O 0 3.7232268368825316e-05
effect O 0 0.001501542399637401
, O 0 0.00023663908359594643
providing O 0 0.0034203885588794947
the O 0 0.00014866598939988762
first O 0 0.00013939714699517936
direct O 0 0.0002307910763192922
evidence O 0 0.00029606325551867485
for O 0 0.00012495719420257956
a O 0 0.0006094385171309114
functional O 0 0.007703352253884077
consequence O 0 0.004097938071936369
of O 0 2.3094655261957087e-05
the O 0 0.0011378542985767126
H63D O 1 0.9995237588882446
mutation O 0 0.007346536032855511
. O 0 0.0005382949020713568

Addition O 0 0.0004767380596604198
of O 0 3.485273555270396e-05
soluble O 1 0.6879653930664062
wild O 0 0.002605611691251397
- O 0 0.03560422360897064
type O 1 0.6883087754249573
HFE O 1 0.9999935626983643
/ O 1 0.9922727346420288
beta2m O 1 0.8561456799507141
heterodimers O 0 0.26673299074172974
to O 0 0.0002732445136643946
cultured O 0 0.0315617173910141
cells O 0 0.0053835283033549786
also O 0 0.0004343803448136896
decreased O 0 0.012424392625689507
the O 0 0.00029484101105481386
apparent O 0 0.0072894468903541565
affinity O 0 0.002107334090396762
of O 0 3.325165744172409e-05
the O 0 0.0010544996475800872
TfR O 1 0.9923978447914124
for O 0 0.0002150908694602549
its O 0 0.000282693887129426
ligand O 0 0.012804717756807804
under O 0 0.0009489764925092459
steady O 0 0.018281297758221626
- O 0 0.009177710860967636
state O 0 0.0005220877355895936
conditions O 0 0.006863180082291365
, O 0 0.00022834420087747276
both O 0 0.000128703992231749
in O 0 0.00044503467506729066
293 O 0 0.10769542306661606
cells O 0 0.0038155231159180403
and O 0 0.00012596618034876883
in O 0 0.0006833779043518007
HeLa O 1 0.9975245594978333
cells O 0 0.00807560421526432
. O 0 0.00042939133709296584

Furthermore O 0 0.012434800155460835
, O 0 0.00044295552652329206
at O 0 0.0016458106692880392
4 O 0 0.002719663316383958
degrees O 0 0.009371919557452202
C O 0 0.10553935915231705
, O 0 0.00016364871407859027
the O 0 0.00014184985775500536
added O 0 0.0015908894129097462
soluble O 0 0.0629618912935257
complex O 0 0.004030103795230389
of O 0 0.00035332675906829536
HFE O 1 0.9999978542327881
/ O 1 0.991503119468689
beta2m O 1 0.9401947259902954
inhibited O 0 0.018383804708719254
binding O 0 0.000283570698229596
of O 0 3.750377436517738e-05
transferrin O 1 0.9490317106246948
to O 0 0.0004902243381366134
HeLa O 1 0.9929623007774353
cell O 0 0.01325480081140995
TfR O 1 0.9928733110427856
in O 0 0.00016881365445442498
a O 0 0.0007626077276654541
concentration O 0 0.019704477861523628
- O 0 0.006893404293805361
dependent O 0 0.0023815594613552094
manner O 0 0.0030468686018139124
. O 0 0.0009006066247820854

Scatchard O 0 0.06683164834976196
plots O 0 0.0010287329787388444
of O 0 1.3210421457188204e-05
these O 0 2.064522595901508e-05
data O 0 0.00017495172505732626
indicate O 0 0.0007179873646236956
that O 0 4.626506051863544e-05
the O 0 0.00015560917381662875
added O 0 0.003446906106546521
heterodimer O 0 0.19523638486862183
substantially O 0 0.019488757476210594
reduced O 0 0.0013138195499777794
the O 0 7.876018207753077e-05
affinity O 0 0.0019706636667251587
of O 0 0.00011054422793677077
TfR O 1 0.9993791580200195
for O 0 0.0014060590183362365
transferrin O 1 0.9862151741981506
. O 0 0.0011986420722678304

These O 0 0.00015731682651676238
results O 0 0.0005522723076865077
establish O 0 0.0010540992952883244
a O 0 0.0007801722967997193
molecular O 0 0.007186973001807928
link O 0 0.018377916887402534
between O 0 0.0017239804146811366
HFE O 1 0.9999203681945801
and O 0 0.0002453793422318995
a O 0 0.00041494041215628386
key O 0 0.0011171236401423812
protein O 0 0.0007961606606841087
involved O 0 0.0010999285150319338
in O 0 0.0005150042125023901
iron O 1 0.985637366771698
transport O 0 0.020188728347420692
, O 0 0.000547799572814256
the O 0 0.0015750426100566983
TfR O 1 0.9996500015258789
, O 0 0.000725594989489764
and O 0 0.00021730602020397782
raise O 0 0.001489096786826849
the O 0 0.00020392354053910822
possibility O 0 0.0027354531921446323
that O 0 0.00014417542843148112
alterations O 0 0.006388363428413868
in O 0 0.00010505764657864347
this O 0 6.347792805172503e-05
regulatory O 0 0.00962942186743021
mechanism O 0 0.006390003953129053
may O 0 0.001709859468974173
play O 0 0.00013329717330634594
a O 0 0.0004045241221319884
role O 0 0.001925067394040525
in O 0 0.00019628593872766942
the O 0 0.000687831430695951
pathogenesis O 1 0.9999709129333496
of O 0 0.0009131194092333317
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.0024936941917985678
. O 0 0.0007477307808585465

Genomic O 0 0.005962973926216364
organization O 0 0.000883552129380405
of O 0 2.417507494101301e-05
the O 0 0.0015553671400994062
UBE3A O 1 0.9999891519546509
/ O 1 0.9968018531799316
E6 O 1 0.9988093376159668
- O 0 0.1889689862728119
AP O 0 0.02707989141345024
gene O 0 0.0024752977769821882
and O 0 0.00025289534823969007
related O 0 0.005449026357382536
pseudogenes O 0 0.07328452914953232
. O 0 0.0008797114132903516

The O 0 0.002015381585806608
UBE3A O 1 0.9841910600662231
gene O 0 0.001731265103444457
encodes O 0 0.0008815057226456702
the O 0 0.0006140679470263422
E6 O 1 0.9959938526153564
- O 0 0.0273272767663002
AP O 0 0.016357427462935448
ubiquitin O 0 0.015898600220680237
- O 0 0.002713690511882305
protein O 0 0.0007447279640473425
ligase O 0 0.010128810070455074
and O 0 0.0003484469198156148
has O 0 0.0016920431517064571
recently O 0 0.006898452527821064
been O 0 0.0002528401091694832
shown O 0 0.00020571492495946586
to O 0 3.4347667678957805e-05
be O 0 0.00010321818990632892
mutated O 0 0.014666080474853516
in O 0 0.006317818071693182
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
who O 0 0.0021075839176774025
lack O 0 0.011280540376901627
15q11 O 1 0.9878484010696411
- O 0 0.026853187009692192
q13 O 0 0.05396367609500885
deletions O 0 0.003962555900216103
or O 0 0.000470074824988842
chromosome O 0 0.004040289204567671
15 O 0 0.0019001332111656666
paternal O 0 0.250998854637146
uniparental B-Disease 1 0.9999961853027344
disomy I-Disease 1 0.9986560344696045
. O 0 0.0013546227710321546

Previous O 0 0.007115524262189865
UBE3A O 1 0.9909220337867737
cDNA O 0 0.006980543024837971
analysis O 0 0.0006460844306275249
has O 0 0.0006990256370045245
shown O 0 0.0006894984981045127
a O 0 0.000585742003750056
coding O 0 0.009549377486109734
region O 0 0.0009988676756620407
of O 0 3.336912777740508e-05
approximately O 0 0.001203429768793285
2 O 0 0.002745242789387703
. O 0 0.0005759462947025895

6 O 0 0.007630383130162954
kb O 0 0.021866517141461372
and O 0 0.00019133987370878458
a O 0 0.0013568460708484054
3 O 0 0.0034556181635707617
- O 0 0.011664394289255142
untranslated O 0 0.09788230061531067
region O 0 0.005766126327216625
( O 0 0.0015115025453269482
UTR O 1 0.6284037232398987
) O 0 0.0001888228434836492
of O 0 5.0180318794446066e-05
< O 0 0.08705871552228928
50 O 0 0.002806486329063773
bp O 0 0.190695658326149
, O 0 0.0006119859754107893
whereas O 0 0.0028029789682477713
Northern O 0 0.002355931093916297
analysis O 0 0.0006145413499325514
has O 0 0.0006167104584164917
indicated O 0 0.0015022308798506856
mRNA O 0 0.00015670896391384304
sizes O 0 0.00011460669338703156
of O 0 2.679415774764493e-05
5 O 0 0.0031112628057599068
- O 0 0.00951797142624855
8 O 0 0.002356629353016615
kb O 0 0.041596926748752594
. O 0 0.0007346200873143971

We O 0 0.0007248717010952532
have O 0 5.51949160580989e-05
analyzed O 0 0.0007933416054584086
additional O 0 0.00023846824478823692
cDNA O 0 0.005254971329122782
clones O 0 0.008839928545057774
and O 0 0.00013513675366993994
provide O 0 0.0007498972117900848
evidence O 0 0.0002537924447096884
for O 0 8.772247383603826e-05
an O 0 0.00015786798030603677
additional O 0 0.0006512865074910223
0 O 0 0.002791003789752722
. O 0 0.000518949527759105

5 O 0 0.002585019450634718
kb O 0 0.010477971285581589
of O 0 6.086711437092163e-05
5 O 0 0.003304265206679702
- O 0 0.014203866012394428
UTR O 0 0.1524849385023117
and O 0 0.00041831305134110153
> O 0 0.01594666577875614
2 O 0 0.0010953075252473354
kb O 0 0.0075484090484678745
of O 0 4.461486605578102e-05
3 O 0 0.003699184861034155
- O 0 0.015876784920692444
UTR O 0 0.39862290024757385
. O 0 0.0007777101709507406

We O 0 0.000999118434265256
have O 0 9.462633897783235e-05
established O 0 0.00035494405892677605
the O 0 0.00011428724974393845
genomic O 0 0.00404528109356761
organization O 0 0.0027685300447046757
of O 0 0.00018336658831685781
UBE3A O 1 0.9992928504943848
and O 0 0.00015909959620330483
the O 0 5.3706920880358666e-05
sequence O 0 3.6336463381303474e-05
of O 0 4.31223088526167e-05
intron O 1 0.9961192607879639
- O 0 0.028309574350714684
exon O 0 0.048198070377111435
borders O 0 0.00506141223013401
. O 0 0.0007073237211443484

We O 0 0.0011595909018069506
have O 0 0.00013355494593270123
also O 0 0.00016935582971200347
mapped O 0 0.0020012238528579473
two O 0 2.997153023898136e-05
highly O 0 0.0020632557570934296
homologous O 0 0.003953239414840937
processed O 0 0.0013633474009111524
pseudogenes O 0 0.03721312806010246
, O 0 0.001243522041477263
UBE3AP1 O 1 0.9994494318962097
and O 0 0.0013535685138776898
UBE3AP2 O 1 0.9997857213020325
, O 0 0.00030868573230691254
to O 0 9.265021071769297e-05
chromosomes O 0 0.00039551337249577045
2 O 0 0.0011393179884180427
and O 0 0.0002437140792608261
21 O 0 0.003774224780499935
, O 0 0.0004841777263209224
respectively O 0 0.0016657336382195354
, O 0 0.0003342967538628727
and O 0 0.00017913740884978324
determined O 0 0.0010283479932695627
their O 0 4.2321084038121626e-05
genomic O 0 0.004365989472717047
organization O 0 0.0060909101739525795
. O 0 0.000783152470830828

These O 0 0.0002876658400055021
results O 0 0.001183703658170998
will O 0 0.0001713090023258701
form O 0 0.000247173011302948
the O 0 9.212987060891464e-05
basis O 0 0.0001013903456623666
for O 0 0.00016557697381358594
studies O 0 0.00041782850166782737
of O 0 2.0794350348296575e-05
mutation O 0 0.002728452207520604
and O 0 0.00018213513249065727
imprinting O 0 0.05340394377708435
of O 0 0.00028888421365991235
UBE3A O 1 0.999828577041626
. O 0 0.0018075970001518726

Mutation O 0 0.009859347715973854
spectrum O 0 0.0065033636055886745
and O 0 0.000686976476572454
genotype O 1 0.9557093381881714
- O 0 0.03429953753948212
phenotype O 0 0.043233174830675125
analyses O 0 0.0021583952475339174
in O 0 0.0015423621516674757
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.0009388967300765216
Bannayan B-Disease 1 0.9999649524688721
- I-Disease 1 0.9998836517333984
Zonana I-Disease 1 0.9999991655349731
syndrome I-Disease 1 1.0
, O 0 0.0006235321052372456
two O 0 0.0005627383943647146
hamartoma B-Disease 1 0.9999945163726807
syndromes I-Disease 1 0.999983549118042
with O 0 0.0013604821870103478
germline O 1 0.999582827091217
PTEN O 1 0.9999510049819946
mutation O 0 0.011422618292272091
. O 0 0.0006509579252451658

The O 0 0.00520009221509099
tumour B-Disease 1 0.9999998807907104
suppressor O 1 0.9493444561958313
gene O 0 0.024099143221974373
PTEN O 1 0.9996998310089111
, O 0 0.0004080857033841312
which O 0 4.279474524082616e-05
maps O 0 0.0003568710817489773
to O 0 0.00017903769912663847
10q23 O 0 0.1372263878583908
. O 0 0.0005278143798932433

3 O 0 0.0020834861788898706
and O 0 0.00012422051804605871
encodes O 0 0.0011740464251488447
a O 0 0.0006359432591125369
403 O 0 0.014915679581463337
amino O 0 0.0004009815165773034
acid O 0 0.0054893032647669315
dual O 0 0.0030972533859312534
specificity O 0 0.004173130728304386
phosphatase O 1 0.7472516894340515
( O 0 0.00039831100730225444
protein O 0 0.0013278205879032612
tyrosine O 0 0.028225600719451904
phosphatase O 1 0.9812895655632019
; O 0 0.0010794294066727161
PTPase O 1 0.992408037185669
) O 0 0.0006376340752467513
, O 0 0.00033790001180022955
was O 0 0.0021759276278316975
shown O 0 0.001777224475517869
recently O 0 0.003097063396126032
to O 0 5.004392733098939e-05
play O 0 9.826980385696515e-05
a O 0 0.0004987478605471551
broad O 0 0.00947476550936699
role O 0 0.0038471112493425608
in O 0 0.0007050714921206236
human O 0 0.05611855909228325
malignancy B-Disease 1 0.9999971389770508
. O 0 0.0011748418910428882

Somatic O 1 0.9731506109237671
PTEN O 1 0.9998761415481567
deletions O 0 0.011576199904084206
and O 0 0.0002906248555518687
mutations O 0 0.001385589363053441
were O 0 1.9186029021511786e-05
observed O 0 0.00026940618408843875
in O 0 0.00019879359751939774
sporadic B-Disease 0 0.3862761855125427
breast I-Disease 1 1.0
, I-Disease 0 0.0021166158840060234
brain I-Disease 1 0.9999998807907104
, I-Disease 0 0.015562630258500576
prostate I-Disease 1 1.0
and I-Disease 0 0.17410293221473694
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.014664770103991032
lines O 0 0.001239278120920062
and O 0 9.85092410701327e-05
in O 0 0.00010819925955729559
several O 0 0.0001642484130570665
primary O 0 0.14651232957839966
tumours B-Disease 1 0.9999997615814209
such O 0 7.114141044439748e-05
as O 0 0.0026167635805904865
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.9886460304260254
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.8388104438781738
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.0020158630795776844

In O 0 0.0008890111930668354
addition O 0 0.001233287388458848
, O 0 0.0018966952338814735
PTEN O 1 0.999970555305481
was O 0 0.00486789783462882
identified O 0 0.0011940189870074391
as O 0 0.00011491441546240821
the O 0 0.00020215527911204845
susceptibility O 0 0.17074337601661682
gene O 0 0.0011645350605249405
for O 0 0.00014550612831953913
two O 0 0.0005996550316922367
hamartoma B-Disease 1 0.9999992847442627
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.0021469909697771072
CD B-Disease 0 0.02160404995083809
; O 0 0.0015851015923544765
MIM O 1 0.9999650716781616
158350 O 1 0.9377474784851074
) O 0 0.00041597429662942886
and O 0 0.00039604041376151145
Bannayan B-Disease 1 0.9974068999290466
- I-Disease 0 0.20575390756130219
Zonana I-Disease 1 0.9994261264801025
( I-Disease 0 0.002847564872354269
BZS I-Disease 1 0.9715518355369568
) I-Disease 0 0.0005161475273780525
or I-Disease 0 0.001137860817834735
Ruvalcaba I-Disease 1 0.9998862743377686
- I-Disease 0 0.42079484462738037
Riley I-Disease 1 0.9976639747619629
- I-Disease 1 0.9802775979042053
Smith I-Disease 1 0.9990984201431274
syndrome I-Disease 1 1.0
( O 0 0.010008910670876503
MIM O 1 0.9999953508377075
153480 O 1 0.9903897643089294
) O 0 0.0009160902118310332
. O 0 0.0004588468582369387

Constitutive O 0 0.23900580406188965
DNA O 0 0.0036607019137591124
from O 0 0.0002002531400648877
37 O 0 0.004051105119287968
CD B-Disease 0 0.005597064737230539
families O 0 0.000318172387778759
and O 0 0.00022663069830741733
seven O 0 0.001296854461543262
BZS B-Disease 1 0.9737542867660522
families O 0 0.000805883901193738
was O 0 0.001569766434840858
screened O 0 0.004292905330657959
for O 0 0.000785206735599786
germline O 1 0.9986805319786072
PTEN O 1 0.9998247027397156
mutations O 0 0.009574024006724358
. O 0 0.0006142845377326012

PTEN O 1 0.9996111989021301
mutations O 0 0.006964095402508974
were O 0 0.00013124987890478224
identified O 0 0.001010111765936017
in O 0 0.000152685766806826
30 O 0 0.0004817815206479281
of O 0 3.752133852685802e-05
37 O 0 0.007457423955202103
( O 0 0.001668485696427524
81 O 0 0.019135702401399612
% O 0 0.00021546485368162394
) O 0 0.0006463005556724966
CD B-Disease 0 0.007748590782284737
families O 0 0.0005071906489320099
, O 0 0.0002609140647109598
including O 0 0.0002700640179682523
missense O 0 0.028432277962565422
and O 0 0.0003741480177268386
nonsense O 0 0.02378443442285061
point O 0 0.0019384815823286772
mutations O 0 0.003494156524538994
, O 0 0.0003662028757389635
deletions O 0 0.004394392482936382
, O 0 0.00031880458118394017
insertions O 0 0.00847693532705307
, O 0 0.000244348804699257
a O 0 0.0018312206957489252
deletion O 0 0.08011674880981445
/ O 0 0.4100390076637268
insertion O 0 0.018015634268522263
and O 0 0.0003445176698733121
splice O 0 0.04491668939590454
site O 0 0.00590110756456852
mutations O 0 0.003942514304071665
. O 0 0.0004544432449620217

These O 0 0.0003333327767904848
mutations O 0 0.0022433737758547068
were O 0 5.936605157330632e-05
scattered O 0 0.00038043232052586973
over O 0 0.00012132823758292943
the O 0 0.0001522181264590472
entire O 0 0.0031786179170012474
length O 0 0.0010862682247534394
of O 0 0.00029554430511780083
PTEN O 1 0.9999837875366211
, O 0 0.0006214804598130286
with O 0 9.363197750644758e-05
the O 0 0.0003113884886261076
exception O 0 0.0013394162524491549
of O 0 1.729927862470504e-05
the O 0 0.00022588256979361176
first O 0 0.00046228570863604546
, O 0 0.000367925560567528
fourth O 0 0.002108830725774169
and O 0 0.000265930691966787
last O 0 0.0021459474228322506
exons O 0 0.01061645895242691
. O 0 0.0005924947909079492

A O 0 0.00883981492370367
hot O 0 0.01872876286506653
spot O 0 0.007292742840945721
for O 0 0.0016106057446449995
PTEN O 1 0.9996594190597534
mutation O 0 0.004063976462930441
in O 0 0.00029081114917062223
CD B-Disease 0 0.00680546136572957
was O 0 0.002216905355453491
identified O 0 0.0009701068047434092
in O 0 0.00023326059454120696
exon O 0 0.034940119832754135
5 O 0 0.0007080922368913889
that O 0 3.0478793632937595e-05
contains O 0 8.510414772899821e-05
the O 0 0.00037455576239153743
PTPase O 1 0.9084122180938721
core O 0 0.011322163045406342
motif O 0 0.007759405300021172
, O 0 0.00024612582637928426
with O 0 0.00010547683632466942
13 O 0 0.0011338277254253626
of O 0 4.2813153413590044e-05
30 O 0 0.002939942991361022
( O 0 0.0009431564249098301
43 O 0 0.0034246076829731464
% O 0 0.00017768616089597344
) O 0 0.0005385486874729395
CD B-Disease 0 0.008525059558451176
mutations O 0 0.0038178223185241222
identified O 0 0.0008828397840261459
in O 0 8.433826587861404e-05
this O 0 0.00010625475988490507
exon O 0 0.05484088882803917
. O 0 0.0006479172734543681

Seven O 0 0.0007329694926738739
of O 0 5.910113759455271e-05
30 O 0 0.0042289202101528645
( O 0 0.001562371733598411
23 O 0 0.005416675936430693
% O 0 0.00015598889149259776
) O 0 0.00023205848992802203
were O 0 2.5781382646528073e-05
within O 0 5.402983515523374e-05
the O 0 0.0002292661229148507
core O 0 0.012879123911261559
motif O 0 0.00922373030334711
, O 0 0.0003461497835814953
the O 0 0.0003783901920542121
majority O 0 0.0008837216882966459
( O 0 0.0007480750209651887
five O 0 0.00011502064444357529
of O 0 2.8120786737417802e-05
seven O 0 0.0007993204053491354
) O 0 0.00015388047904707491
of O 0 1.578481897013262e-05
which O 0 9.396830864716321e-05
were O 0 0.00011986870231339708
missense O 0 0.0368611104786396
mutations O 0 0.00644645607098937
, O 0 0.0006002931040711701
possibly O 0 0.00528502743691206
pointing O 0 0.004448322579264641
to O 0 8.311702549690381e-05
the O 0 0.00012115702702431008
functional O 0 0.003936386667191982
significance O 0 0.0007740207947790623
of O 0 2.1710977307520807e-05
this O 0 0.00012888798664789647
region O 0 0.004808308556675911
. O 0 0.0006056801648810506

Germline O 1 0.9991462230682373
PTEN O 1 0.9997606873512268
mutations O 0 0.006783714983612299
were O 0 0.00012439095007721335
identified O 0 0.0008719877805560827
in O 0 6.890609802212566e-05
four O 0 3.9187190850498155e-05
of O 0 1.752647767716553e-05
seven O 0 0.0006809721235185862
( O 0 0.0013305118773132563
57 O 0 0.011412348598241806
% O 0 0.00027565809432417154
) O 0 0.0014048804296180606
BZS B-Disease 1 0.9851900935173035
families O 0 0.0011240622261539102
studied O 0 0.003989561926573515
. O 0 0.0006745776627212763

Interestingly O 0 0.12661148607730865
, O 0 0.0005670480895787477
none O 0 0.00044139951933175325
of O 0 1.1529816219990607e-05
these O 0 5.9174621128477156e-05
mutations O 0 0.003769122064113617
was O 0 0.0012298333458602428
observed O 0 0.0003982962516602129
in O 0 0.00010154410847462714
the O 0 0.0004742440360132605
PTPase O 1 0.9756893515586853
core O 0 0.012409377843141556
motif O 0 0.014576584100723267
. O 0 0.0008228966034948826

It O 0 0.0009769017342478037
is O 0 0.0005600433796644211
also O 0 0.00029082942637614906
worthy O 0 0.0053398157469928265
of O 0 2.6546633307589218e-05
note O 0 0.0008318352047353983
that O 0 3.5502511309459805e-05
a O 0 0.0002656760043464601
single O 0 0.0004214615619275719
nonsense O 0 0.011348925530910492
point O 0 0.00146928196772933
mutation O 0 0.003714675083756447
, O 0 0.0005913807544857264
R233X O 0 0.13136164844036102
, O 0 0.0004613720520865172
was O 0 0.0010269867489114404
observed O 0 0.00036596451536752284
in O 0 9.504396439297125e-05
the O 0 0.00048199971206486225
germline O 1 0.9511858820915222
DNA O 0 0.0017003159737214446
from O 0 7.306947372853756e-05
two O 0 8.319640619447455e-05
unrelated O 0 0.01245351042598486
CD B-Disease 0 0.00726363668218255
families O 0 0.00032520073000341654
and O 0 0.00023878358479123563
one O 0 0.0012430062051862478
BZS B-Disease 1 0.9953250885009766
family O 0 0.002778685884550214
. O 0 0.0006900299922563136

Genotype O 1 0.9850233793258667
- O 0 0.0672801211476326
phenotype O 0 0.07066003978252411
studies O 0 0.001350159989669919
were O 0 5.1699815230676904e-05
not O 0 0.00017618315177969635
performed O 0 0.0012287783902138472
on O 0 0.0001355363056063652
this O 0 3.843139347736724e-05
small O 0 0.00015353412891272455
group O 0 0.00037645408883690834
of O 0 0.00012964331835974008
BZS B-Disease 1 0.9966754913330078
families O 0 0.0012663576053455472
. O 0 0.0007013448048382998

However O 0 0.0014565199380740523
, O 0 0.0008046419825404882
genotype O 1 0.9332093000411987
- O 0 0.03342807665467262
phenotype O 0 0.04033532366156578
analysis O 0 0.001396672916598618
inthe O 0 0.12770146131515503
group O 0 0.0005577008705586195
of O 0 4.689788329415023e-05
CD B-Disease 0 0.011562061496078968
families O 0 0.0008524098666384816
revealed O 0 0.008684441447257996
two O 0 4.575613638735376e-05
possible O 0 0.00045464103459380567
associations O 0 0.0008064915891736746
worthy O 0 0.007660022471100092
of O 0 5.129407873027958e-05
follow O 0 0.0019258774118497968
- O 0 0.005012450739741325
up O 0 0.00013904614024795592
in O 0 0.0001010152482194826
independent O 0 0.00027572119142860174
analyses O 0 0.002605597022920847
. O 0 0.000626965134870261

The O 0 0.0007094262982718647
first O 0 0.0005385715048760176
was O 0 0.001959389541298151
an O 0 0.0007053726585581899
association O 0 0.047914475202560425
noted O 0 0.002177824266254902
in O 0 0.00021275097969919443
the O 0 0.0001599250390427187
group O 0 0.00018586016085464507
of O 0 2.1056945115560666e-05
CD B-Disease 0 0.004782336298376322
families O 0 0.0003738064842764288
with O 0 0.002052461728453636
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.0012284447439014912

A O 0 0.006131661590188742
correlation O 0 0.003945493139326572
was O 0 0.0013292396906763315
observed O 0 0.000410841079428792
between O 0 0.00013325143663678318
the O 0 0.00037986933602951467
presence O 0 0.00720862066373229
/ O 1 0.615077793598175
absence O 0 0.0026574525982141495
of O 0 2.9032062229816802e-05
a O 0 0.00465324567630887
PTEN O 1 0.9999649524688721
mutation O 0 0.003667044686153531
and O 0 7.690914208069444e-05
the O 0 0.00013450246478896588
type O 0 0.004799840971827507
of O 0 0.0002208296355092898
breast O 1 1.0
involvement O 1 0.9905208349227905
( O 0 0.0020825774408876896
unaffected O 1 0.9817855954170227
versus O 1 0.9031208157539368
benign O 1 0.9999914169311523
versus O 1 0.9994283318519592
malignant O 1 1.0
) O 0 0.0016134107718244195
. O 0 0.0006031184457242489

Specifically O 0 0.0033934274688363075
and O 0 0.00012777587107848376
more O 0 8.10199198895134e-05
directly O 0 0.0006786542944610119
, O 0 0.0002529990451876074
an O 0 0.0007435050792992115
association O 0 0.472481906414032
was O 0 0.0038825804367661476
also O 0 0.0003777138772420585
observed O 0 0.00037828771746717393
between O 0 6.79711447446607e-05
the O 0 8.698502642801031e-05
presence O 0 0.0002246218646178022
of O 0 1.7952024791156873e-05
a O 0 0.0030093842651695013
PTEN O 1 0.9999620914459229
mutation O 0 0.01277802512049675
and O 0 0.008626457303762436
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.0015128981322050095

Secondly O 0 0.10843536257743835
, O 0 0.0005492985364980996
there O 0 0.00020588409097399563
appeared O 0 0.0016819589072838426
to O 0 5.506821253220551e-05
be O 0 6.895185651956126e-05
an O 0 0.0003518775920383632
interdependent O 1 0.9772621393203735
association O 0 0.025666866451501846
between O 0 0.000700968608725816
mutations O 0 0.0041099428199231625
upstream O 0 0.006433425005525351
and O 0 8.513759530615062e-05
within O 0 0.00012064711336279288
the O 0 0.0005650080274790525
PTPase O 1 0.9853109121322632
core O 0 0.01191712636500597
motif O 0 0.008318444713950157
, O 0 0.00021987620857544243
the O 0 0.00021854105580132455
core O 0 0.006876821164041758
motif O 0 0.003991459496319294
containing O 0 0.0001877972244983539
the O 0 9.813149517867714e-05
majority O 0 0.0001539118675282225
of O 0 5.519660044228658e-05
missense O 0 0.05835677683353424
mutations O 0 0.006352053489536047
, O 0 0.00040257754153572023
and O 0 0.00018566459766589105
the O 0 0.0002883019915316254
involvement O 0 0.008052768185734749
of O 0 1.565130878589116e-05
all O 0 6.083253174438141e-05
major O 0 0.007711496204137802
organ O 1 0.9885045886039734
systems O 0 0.28044214844703674
( O 0 0.001076088985428214
central O 0 0.0024193008430302143
nervous O 1 0.9981160163879395
system O 0 0.00825102161616087
, O 0 0.0022550809662789106
thyroid O 1 1.0
, O 0 0.010579902678728104
breast O 1 1.0
, O 0 0.00553342467173934
skin O 1 1.0
and O 0 0.009735483676195145
gastrointestinal O 1 1.0
tract O 1 0.9999996423721313
) O 0 0.0015247981064021587
. O 0 0.0006910951342433691

However O 0 0.001914054504595697
, O 0 0.00016395265993196517
these O 0 2.100764322676696e-05
observations O 0 0.0011907059233635664
would O 0 0.00026881811209023
need O 0 0.000738631933927536
to O 0 0.00012498161231633276
be O 0 0.0002546840114519
confirmed O 0 0.002326462883502245
by O 0 3.549371103872545e-05
studying O 0 0.001011835876852274
a O 0 0.0002842438407242298
larger O 0 0.00014985540474299341
number O 0 1.758379949023947e-05
of O 0 2.7045254682889208e-05
CD B-Disease 0 0.010931371711194515
families O 0 0.0006076822173781693
. O 0 0.0005760875064879656

Molecular O 1 0.8069618344306946
defects O 1 0.9999520778656006
leading O 0 0.002116349758580327
to O 0 6.88940126565285e-05
human O 0 0.0006619837367907166
complement B-Disease 0 0.00760275311768055
component I-Disease 1 0.9951403141021729
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.00043570902198553085
an O 0 0.0006153672002255917
African O 0 0.007698582485318184
- O 0 0.017934763804078102
American O 0 0.0015095967100933194
family O 0 0.0015515676932409406
. O 0 0.0006736352224834263

Complement B-Disease 0 0.014764264225959778
component I-Disease 1 0.9932078719139099
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 0.008967376314103603
C6D B-Disease 1 0.9999411106109619
) O 0 0.0016948888078331947
was O 0 0.014088832773268223
diagnosed O 1 0.9999995231628418
in O 0 0.00022143052774481475
a O 0 0.0007860969635657966
16 O 0 0.002367130247876048
- O 0 0.0067670997232198715
year O 0 0.0019134560134261847
- O 0 0.00614379346370697
old O 0 0.0032301959581673145
African O 0 0.0031138949561864138
- O 0 0.006179132033139467
American O 0 0.0008490360924042761
male O 0 0.0028169748838990927
with O 0 0.003741193562746048
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.0020910375751554966

The O 0 0.006343355868011713
patients O 1 0.9999982118606567
father O 0 0.005340063478797674
and O 0 0.00015747365250717849
two O 0 0.00012761222023982555
brothers O 0 0.0026307629887014627
also O 0 0.0006906592170707881
had O 0 0.004138112533837557
C6D B-Disease 1 0.999873161315918
, O 0 0.00038529225275851786
but O 0 0.00016338055138476193
gave O 0 0.0004438964242581278
no O 0 0.00011258385347900912
history O 0 0.000437069742474705
of O 0 0.00030154266278259456
meningitis B-Disease 1 1.0
or O 0 0.0008194317924790084
other O 0 0.00035921556991524994
neisserial B-Disease 1 0.9999659061431885
infection I-Disease 1 0.999998927116394
. O 0 0.0007617053342983127

By O 0 0.00015579775208607316
using O 0 0.0003501767641864717
exon O 0 0.03429863601922989
- O 0 0.0023160534910857677
specific O 0 0.0001499587669968605
polymerase O 0 0.004389805253595114
chain O 0 0.005561687983572483
reaction O 0 0.0027036922983825207
( O 0 0.001357467146590352
PCR O 0 0.050945498049259186
) O 0 0.0018354423809796572
/ O 0 0.036785513162612915
single O 0 0.0011997973779216409
- O 0 0.008531325496733189
strand O 0 0.005114044528454542
conformation O 0 0.004281892441213131
polymorphism O 0 0.002236747182905674
as O 0 0.0003434908576309681
a O 0 0.0013234899379312992
screening O 0 0.01225647609680891
step O 0 0.0026066540740430355
and O 0 5.250116009847261e-05
nucleotide O 0 0.0001208362664328888
sequencing O 0 0.0002275665319757536
of O 0 1.8302353055332787e-05
target O 0 0.0017536109080538154
exons O 0 0.011832311749458313
, O 0 0.00037881877506151795
we O 0 0.0002815027255564928
determined O 0 0.0008806901751086116
that O 0 4.200829425826669e-05
the O 0 0.00024080697039607912
proband O 1 0.7867578268051147
was O 0 0.0012086274800822139
a O 0 0.0006737258518114686
compound O 0 0.014830917119979858
heterozygote O 0 0.0420914962887764
for O 0 0.00020324783690739423
two O 0 0.0003377302782610059
C6 O 1 0.9999840259552002
gene O 0 0.008947492577135563
mutations O 0 0.00461732130497694
. O 0 0.0005826678243465722

The O 0 0.000751083716750145
first O 0 0.0004940950311720371
, O 0 0.0005984987365081906
1195delC O 0 0.12686575949192047
located O 0 0.0027075770776718855
in O 0 0.0003704259288497269
exon O 0 0.047699473798274994
7 O 0 0.0023816197644919157
, O 0 0.00021255349565763026
is O 0 0.0002746826794464141
a O 0 0.0007697956752963364
novel O 0 0.003504139604046941
mutation O 0 0.004681004676967859
, O 0 0.00026052797329612076
while O 0 0.0001782945910235867
the O 0 0.00018061893933918327
second O 0 0.0007341676391661167
, O 0 0.000556022918317467
1936delG O 0 0.15340320765972137
in O 0 0.0005090240738354623
exon O 0 0.04737884923815727
12 O 0 0.002219623187556863
, O 0 0.0003774885553866625
has O 0 0.0008964792359620333
been O 0 0.0005875726928934455
described O 0 0.0027870899066329002
before O 0 0.0005714161670766771
to O 0 0.0002110610657837242
cause O 0 0.26009219884872437
C6D B-Disease 1 0.9993984699249268
in O 0 0.00031454229610972106
an O 0 0.000549714604858309
unrelated O 0 0.019153164699673653
African O 0 0.009065289981663227
- O 0 0.010935712605714798
American O 0 0.0007659416878595948
individual O 0 0.0005810213624499738
. O 0 0.0008054167265072465

Both O 0 0.0007791573880240321
mutations O 0 0.002699580043554306
result O 0 0.0008741127676330507
in O 0 0.0006804635049775243
premature O 1 0.9990712404251099
termination O 1 0.9684255719184875
codons O 0 0.01425611786544323
and O 0 0.0011940734693780541
C6 O 1 0.9999384880065918
null O 0 0.050674933940172195
alleles O 0 0.009907690808176994
. O 0 0.0008210278465412557

Allele O 0 0.043146632611751556
- O 0 0.007870780304074287
specific O 0 0.0005633914843201637
PCR O 0 0.026043212041258812
indicated O 0 0.005075893364846706
that O 0 6.203937664395198e-05
the O 0 0.000289188144961372
probands O 0 0.2864324450492859
two O 0 0.0001883147342596203
brothers O 0 0.003537494223564863
also O 0 0.0010447959648445249
inherited O 1 0.9976073503494263
the O 0 0.0008658691076561809
1195delC O 1 0.916682779788971
mutation O 0 0.0024865143932402134
from O 0 7.285899482667446e-05
their O 0 0.00011284427455393597
heterozygous O 0 0.013079904951155186
mother O 0 0.007059398107230663
and O 0 0.0001991472381632775
the O 0 0.000626696040853858
1936delG O 1 0.9555574059486389
mutation O 0 0.0020496665965765715
from O 0 6.626918184338138e-05
their O 0 0.00011921600525965914
homozygous O 0 0.01576543040573597
father O 0 0.005872176494449377
. O 0 0.0003467825008556247
. O 0 0.0005672654369845986

PAX6 O 1 0.9991866946220398
mutations O 0 0.013152265921235085
reviewed O 0 0.008509235456585884
. O 0 0.0005922059644944966

Mutations O 0 0.01415923424065113
in O 0 0.0010914384620264173
PAX6 O 1 0.9998223185539246
are O 0 8.666262874612585e-05
responsible O 0 0.004248708486557007
for O 0 0.0005707164527848363
human O 0 0.009072721004486084
aniridia B-Disease 1 0.9999336004257202
and O 0 0.0002515107917133719
have O 0 0.00010221989214187488
also O 0 0.0001451470743631944
been O 0 0.0002217472210759297
found O 0 0.0002415483322693035
in O 0 0.0004575542116072029
patients O 1 0.9999978542327881
with O 0 0.0005791130824945867
Peters B-Disease 1 0.9999961853027344
anomaly I-Disease 1 0.999901294708252
, O 0 0.000879514089319855
with O 0 0.01457112468779087
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 0.0008688236703164876
with O 0 0.0005163901951164007
autosomal B-Disease 1 0.9999006986618042
dominant I-Disease 1 0.9990562796592712
keratitis I-Disease 1 0.9999996423721313
, O 0 0.0008525828598067164
and O 0 0.00015754559717606753
with O 0 0.0003239280777052045
isolated B-Disease 1 0.9935863614082336
foveal I-Disease 1 0.999987006187439
hypoplasia I-Disease 1 0.9999990463256836
. O 0 0.0026067097205668688

No O 0 0.001338912989012897
locus O 0 0.00912261102348566
other O 0 5.948329999228008e-05
than O 0 0.00018381576228421181
chromosome O 0 0.006080938503146172
11p13 O 0 0.05538668856024742
has O 0 0.001151818665675819
been O 0 0.0010602979455143213
implicated O 1 0.9621762037277222
in O 0 0.0009362400160171092
aniridia B-Disease 1 0.9998760223388672
, O 0 0.0008412888855673373
and O 0 0.0011076786322519183
PAX6 O 1 0.9999847412109375
is O 0 0.0010445630177855492
clearly O 0 0.002057010307908058
the O 0 0.00025720184203237295
major O 0 0.005049091763794422
, O 0 0.0004109299916308373
if O 0 0.0005022682598792017
not O 0 7.485150854336098e-05
only O 0 6.0540220147231594e-05
, O 0 0.0002744554658420384
gene O 0 0.004065489862114191
responsible O 0 0.011013315990567207
. O 0 0.0008692643605172634

Twenty O 0 0.014113313518464565
- O 0 0.00547016179189086
eight O 0 0.00020165453315712512
percent O 0 0.0002500165137462318
of O 0 2.9033448299742304e-05
identified O 0 0.007281673606485128
PAX6 O 1 0.999742329120636
mutations O 0 0.003345735836774111
are O 0 0.00016273096844088286
C O 1 0.9942147135734558
- O 1 0.5315080285072327
T O 1 0.9977422952651978
changes O 0 0.0007457446190528572
at O 0 0.0021271805744618177
CpG O 0 0.10263251513242722
dinucleotides O 1 0.9730386734008789
, O 0 0.0005375783075578511
20 O 0 0.0005771018913947046
% O 0 2.5607772840885445e-05
are O 0 3.0613227863796055e-05
splicing O 0 0.004880860447883606
errors O 0 0.013980082236230373
, O 0 0.00033073333906941116
and O 0 0.0001288895873585716
more O 0 8.39683270896785e-05
than O 0 0.0002181068412028253
30 O 0 0.0009192537399940193
% O 0 4.146647188463248e-05
are O 0 5.2819945267401636e-05
deletion O 0 0.011469936929643154
or O 0 0.000703236204572022
insertion O 0 0.021487394347786903
events O 0 0.0008884996641427279
. O 0 0.0007000449695624411

There O 0 0.0004610983596649021
is O 0 0.0003444489266257733
a O 0 0.0012615661835297942
noticeably O 0 0.29458320140838623
elevated O 1 0.9949012994766235
level O 0 0.0018753418698906898
of O 0 4.307508788770065e-05
mutation O 0 0.002989360596984625
in O 0 0.00020715930440928787
the O 0 0.0004549907171167433
paired O 0 0.008463847450911999
domain O 0 0.00116067158523947
compared O 0 0.0012559383176267147
with O 0 8.639429142931476e-05
the O 0 0.00024232939176727086
rest O 0 0.0009128567762672901
of O 0 1.2225917089381255e-05
the O 0 0.00042587320785969496
gene O 0 0.0061573125422000885
. O 0 0.0006732046604156494

Increased O 0 0.0024955335538834333
mutation O 0 0.0018082570750266314
in O 0 0.0001638073445064947
the O 0 0.0003623605880420655
homeodomain O 0 0.4031631648540497
is O 0 0.0007467370014637709
accounted O 0 0.0013759983703494072
for O 0 0.00010164814011659473
by O 0 4.6292381739476696e-05
the O 0 0.0005346940597519279
hypermutable O 1 0.8847131729125977
CpG O 0 0.06950213760137558
dinucleotide O 0 0.0715026706457138
in O 0 0.00043869431829079986
codon O 0 0.009440398775041103
240 O 0 0.01235834788531065
. O 0 0.0007527449633926153

Very O 0 0.002331828698515892
nearly O 0 0.0009999406756833196
all O 0 9.436214168090373e-05
mutations O 0 0.0045441677793860435
appear O 0 0.001690062927082181
to O 0 0.0003038157010450959
cause O 0 0.12160107493400574
loss O 0 0.005551159381866455
of O 0 1.2869846614194103e-05
function O 0 0.00045790852163918316
of O 0 1.8421884306007996e-05
the O 0 0.0004837990563828498
mutant O 0 0.014334374107420444
allele O 0 0.013287658803164959
, O 0 0.00047704557073302567
and O 0 0.00013316796685103327
more O 0 6.938169826753438e-05
than O 0 0.00015137442096602172
80 O 0 0.0012071557575836778
% O 0 2.9616683605127037e-05
of O 0 3.573127105482854e-05
exonic O 1 0.6860259771347046
substitutions O 0 0.002428440609946847
result O 0 0.0007231539348140359
in O 0 0.00030180811882019043
nonsense O 0 0.03283185139298439
codons O 0 0.01956143043935299
. O 0 0.0007748038042336702

In O 0 0.000763404299505055
a O 0 0.0009360705153085291
gene O 0 0.001642664079554379
with O 0 4.308790812501684e-05
such O 0 0.00011590850772336125
extraordinarily O 1 0.9886699914932251
high O 0 0.004497470334172249
sequence O 0 0.00019082498329225928
conservation O 0 0.005718833766877651
throughout O 0 0.00034260310349054635
evolution O 0 0.0007934811292216182
, O 0 0.00019854884885717183
there O 0 8.296593296108767e-05
are O 0 6.422368460334837e-05
presumed O 0 0.019651083275675774
undiscovered O 0 0.4786260724067688
missense O 0 0.05998648330569267
mutations O 0 0.0053975945338606834
, O 0 0.00018489488866180182
these O 0 2.6414683816256e-05
are O 0 5.272588168736547e-05
hypothesized O 0 0.01431462075561285
to O 0 9.6485237008892e-05
exist O 0 0.00020039353694301099
in O 0 0.00015403181896544993
as O 0 0.0010087902192026377
- O 0 0.015744680538773537
yet O 0 0.0027458209078758955
unidentified O 0 0.05367082357406616
phenotypes O 0 0.044737886637449265
. O 0 0.00039695590385235846
. O 0 0.0006510404055006802

Genetic O 0 0.013842178508639336
heterogeneity O 0 0.031063731759786606
and O 0 0.0006452318630181253
penetrance O 1 0.8076547980308533
analysis O 0 0.00022786702902521938
of O 0 2.064317959593609e-05
the O 0 0.0010613822378218174
BRCA1 O 1 0.9998846054077148
and O 0 0.0009898031130433083
BRCA2 O 1 0.9998548030853271
genes O 0 0.0008071382180787623
in O 0 0.002825702540576458
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0010579972295090556
. O 0 0.0006094459677115083

The O 0 0.0691511332988739
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9856017231941223
Consortium O 0 0.02200762741267681
. O 0 0.0006931622629053891

The O 0 0.00029026682022958994
contribution O 0 0.0015246265102177858
of O 0 0.00013331345689948648
BRCA1 O 1 0.9999827146530151
and O 0 0.0014611870283260942
BRCA2 O 1 0.9999899864196777
to O 0 0.002388026099652052
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 0.0053551956079900265
assessed O 0 0.013036873191595078
by O 0 7.917480979813263e-05
linkage O 0 0.021384278312325478
and O 0 0.00020737509476020932
mutation O 0 0.0016720463754609227
analysis O 0 0.00041170616168528795
in O 0 0.0004664644075091928
237 O 0 0.06943266838788986
families O 0 0.0007713994709774852
, O 0 0.00015528633957728744
each O 0 2.9058708605589345e-05
with O 0 6.0941343690501526e-05
at O 0 0.0007411211263388395
least O 0 0.0001941170630743727
four O 0 7.362608448602259e-05
cases O 0 0.0012733392650261521
of O 0 0.0004414262075442821
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.00011144311429234222
collected O 0 3.2375271985074505e-05
by O 0 3.8006390241207555e-05
the O 0 0.008023462258279324
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9871945977210999
Consortium O 0 0.023083990439772606
. O 0 0.000679824675898999

Families O 0 0.0013738920679315925
were O 0 6.223420496098697e-05
included O 0 0.0001108595315599814
without O 0 0.0002199187729274854
regard O 0 0.0008064124849624932
to O 0 5.1270119001856074e-05
the O 0 0.00010363657202105969
occurrence O 0 0.009136416018009186
of O 0 0.00036170933162793517
ovarian B-Disease 1 1.0
or I-Disease 0 0.0019100086065009236
other I-Disease 0 0.0007893652655184269
cancers I-Disease 1 0.9999986886978149
. O 0 0.0009699639631435275

Overall O 0 0.026890359818935394
, O 0 0.004214899148792028
disease O 1 0.9999998807907104
was O 0 0.004644955508410931
linked O 0 0.015061808750033379
to O 0 0.0005335112218745053
BRCA1 O 1 0.9991016387939453
in O 0 0.00024176535953301936
an O 0 0.00029305749922059476
estimated O 0 0.0018065356416627765
52 O 0 0.004128326196223497
% O 0 4.0553561120759696e-05
of O 0 2.351166222069878e-05
families O 0 0.0006083336193114519
, O 0 0.00048010292812250555
to O 0 0.001004622201435268
BRCA2 O 1 0.9993818998336792
in O 0 0.0007233945070765913
32 O 0 0.001420323271304369
% O 0 4.374037598608993e-05
of O 0 3.281754834461026e-05
families O 0 0.0007083271630108356
, O 0 0.00041682456503622234
and O 0 0.00018295248446520418
to O 0 0.00023425482504535466
neither O 0 0.005926027894020081
gene O 0 0.0023726678919047117
in O 0 0.00032032420858740807
16 O 0 0.001553425332531333
% O 0 0.0001393432030454278
( O 0 0.0007829772075638175
95 O 0 0.0029751372057944536
% O 0 7.955032924655825e-05
confidence O 0 0.004224881995469332
interval O 0 0.013504359871149063
[ O 0 0.16505300998687744
CI O 1 0.9999635219573975
] O 0 0.03645547479391098
6 O 0 0.0028967256657779217
% O 0 0.00025738897966220975
- O 0 0.01013598870486021
28 O 0 0.003272575093433261
% O 0 0.00014211902453098446
) O 0 0.0003928316873498261
, O 0 0.000363401195500046
suggesting O 0 0.004842860158532858
other O 0 0.00021751974418293685
predisposition O 1 0.9985166192054749
genes O 0 0.0012831661151722074
. O 0 0.0005265102372504771

The O 0 0.0008371589938178658
majority O 0 0.001281360280700028
( O 0 0.0014747418463230133
81 O 0 0.013890832662582397
% O 0 5.639011942548677e-05
) O 0 4.152401379542425e-05
of O 0 9.774455065780785e-06
the O 0 0.003378602908924222
breast B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0006932350806891918
were O 0 5.838673314428888e-05
due O 0 0.001636349712498486
to O 0 0.0007705177995376289
BRCA1 O 1 0.9999587535858154
, O 0 0.00032820890191942453
with O 0 9.83860736596398e-05
most O 0 0.0005317034665495157
others O 0 0.001721917069517076
( O 0 0.0011784137459471822
14 O 0 0.0021741054952144623
% O 0 0.00014567327161785215
) O 0 0.00048545977915637195
due O 0 0.0028355494141578674
to O 0 0.0012222252553328872
BRCA2 O 1 0.9998239874839783
. O 0 0.001327074016444385

Conversely O 0 0.07539740949869156
, O 0 0.00043763421126641333
the O 0 0.00018549493688624352
majority O 0 0.00016923766816034913
of O 0 2.684651371964719e-05
families O 0 0.00026173650985583663
with O 0 0.00014832023589406163
male B-Disease 0 0.002447511302307248
and I-Disease 0 0.0008189463405869901
female I-Disease 1 0.9969481825828552
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.0001028056358336471
due O 0 0.0016266658203676343
to O 0 0.0007912283181212842
BRCA2 O 1 0.9999270439147949
( O 0 0.002257111482322216
76 O 0 0.025473657995462418
% O 0 0.0002549152704887092
) O 0 0.0005622172029688954
. O 0 0.0005575414397753775

The O 0 0.0006809922633692622
largest O 0 0.0019867774099111557
proportion O 0 0.0027030007913708687
( O 0 0.0020411519799381495
67 O 0 0.01312957238405943
% O 0 0.00019802950555458665
) O 0 0.00019947977853007615
of O 0 3.2667296181898564e-05
families O 0 0.0006578100728802383
due O 0 0.002147648949176073
to O 0 0.00010097325866809115
other O 0 5.772668737336062e-05
genes O 0 0.0006198722985573113
was O 0 0.0024228361435234547
found O 0 0.0004989110166206956
in O 0 0.00017755541193764657
families O 0 0.0002226537762908265
with O 0 8.477303344989195e-05
four O 0 0.00018248488777317107
or O 0 0.0002893701894208789
five O 0 0.00012686241825576872
cases O 0 0.0006298063090071082
of O 0 5.451135439216159e-05
female O 1 0.9933218359947205
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
only O 0 0.00023186675389297307
. O 0 0.0003807328757829964

These O 0 0.0002017784136114642
estimates O 0 0.0011220863088965416
were O 0 6.121194746810943e-05
not O 0 0.0002935488591901958
substantially O 0 0.026833046227693558
affected O 0 0.005639410577714443
either O 0 0.0003560881013981998
by O 0 4.664253719965927e-05
changing O 0 0.0016059399349614978
the O 0 0.00039898883551359177
assumed O 0 0.032152410596609116
penetrance O 1 0.9791179895401001
model O 0 0.0028676260262727737
for O 0 0.0017419852083548903
BRCA1 O 1 0.9998856782913208
or O 0 0.0007312907837331295
by O 0 5.202867032494396e-05
including O 0 0.00014012532483320683
or O 0 0.0008828107384033501
excluding O 0 0.01098564825952053
BRCA1 O 1 0.9998608827590942
mutation O 0 0.0036668849643319845
data O 0 0.00034822343150153756
. O 0 0.0005602535675279796

Among O 0 0.0004833217244595289
those O 0 0.00010188123997068033
families O 0 0.0003996780142188072
with O 0 0.001430288190022111
disease O 1 1.0
due O 0 0.005066926125437021
to O 0 0.0009251538431271911
BRCA1 O 1 0.9999220371246338
that O 0 0.0001890561543405056
were O 0 0.00010401406325399876
tested O 0 0.010041243396699429
by O 0 2.5230421670130454e-05
one O 0 5.674631393048912e-05
of O 0 1.1370253560016863e-05
the O 0 0.00028274510987102985
standard O 0 0.006254673935472965
screening O 0 0.00976157933473587
methods O 0 0.0014026418793946505
, O 0 0.0005748519324697554
mutations O 0 0.002544226124882698
were O 0 8.70891017257236e-05
detected O 0 0.006969825364649296
in O 0 9.994271385949105e-05
the O 0 0.00021320606174413115
coding O 0 0.01146012358367443
sequence O 0 0.0002764692762866616
or O 0 0.0005764952511526644
splice O 0 0.020512999966740608
sites O 0 0.00035219560959376395
in O 0 9.671155567048118e-05
an O 0 0.0002398093929514289
estimated O 0 0.002140310127288103
63 O 0 0.011175954714417458
% O 0 0.0001820115139707923
( O 0 0.0008907986921258271
95 O 0 0.007740466855466366
% O 0 0.0006305832066573203
CI O 1 0.9998534917831421
51 O 0 0.015504229813814163
% O 0 0.0004124194965697825
- O 0 0.013595265336334705
77 O 0 0.013922605663537979
% O 0 0.000234007733524777
) O 0 0.0005860304227098823
. O 0 0.0006247751298360527

The O 0 0.0007653415086679161
estimated O 0 0.002055551391094923
sensitivity O 0 0.019773362204432487
was O 0 0.0018230859423056245
identical O 0 0.00035173504147678614
for O 0 0.00011935750080738217
direct O 0 0.00023663546016905457
sequencing O 0 0.0008249006350524724
and O 0 9.817165118874982e-05
other O 0 5.364826211007312e-05
techniques O 0 0.00336940074339509
. O 0 0.0008036680519580841

The O 0 0.001664291019551456
penetrance O 1 0.7368242740631104
of O 0 0.000489604368340224
BRCA2 O 1 0.9999699592590332
was O 0 0.00254412111826241
estimated O 0 0.0003626536636147648
by O 0 3.159843254252337e-05
maximizing O 0 0.013352693058550358
the O 0 0.0006792308413423598
LOD O 1 0.9990461468696594
score O 0 0.00036238928441889584
in O 0 0.0014206288615241647
BRCA2 O 1 0.9999696016311646
- O 0 0.042381372302770615
mutation O 0 0.0041022878140211105
families O 0 0.0004324984329286963
, O 0 0.0001691413635853678
over O 0 0.00011672707478282973
all O 0 4.8953297664411366e-05
possible O 0 0.0016271013300865889
penetrance O 1 0.7579444050788879
functions O 0 0.0013002834748476744
. O 0 0.0009720654925331473

The O 0 0.00035467094858177006
estimated O 0 0.000570931879337877
cumulative O 0 0.0052345916628837585
risk O 0 0.14812013506889343
of O 0 0.0005262861377559602
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
reached O 0 0.00460351537913084
28 O 0 0.0031117598991841078
% O 0 0.00011713102867361158
( O 0 0.0006827132892794907
95 O 0 0.006703962106257677
% O 0 0.0007819228922016919
CI O 1 0.9999487400054932
9 O 0 0.005539276171475649
% O 0 0.00021142199693713337
- O 0 0.007476825267076492
44 O 0 0.001447188900783658
% O 0 0.00012516111019067466
) O 0 0.00021127770014572889
by O 0 7.959341746754944e-05
age O 0 0.001993000041693449
50 O 0 0.0014038686640560627
years O 0 0.0010048911208286881
and O 0 0.0003248970315326005
84 O 0 0.019645145162940025
% O 0 0.00019069838162977248
( O 0 0.0009460845030844212
95 O 0 0.007507499773055315
% O 0 0.0006465624319389462
CI O 1 0.9995567202568054
43 O 0 0.008276958018541336
% O 0 0.0002992460795212537
- O 0 0.008511471562087536
95 O 0 0.004847077187150717
% O 0 0.00011650311353150755
) O 0 0.00019345578039065003
by O 0 8.239778253482655e-05
age O 0 0.002194181317463517
70 O 0 0.0035037898924201727
years O 0 0.0017420804360881448
. O 0 0.0005730906850658357

The O 0 0.0014476217329502106
corresponding O 0 0.17338179051876068
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9934296011924744
were O 0 0.0001263464509975165
0 O 0 0.0021863668225705624
. O 0 0.00034848545328713953

4 O 0 0.0031905625946819782
% O 0 0.00020312558626756072
( O 0 0.0009057782590389252
95 O 0 0.007063310127705336
% O 0 0.0006856098771095276
CI O 1 0.9997041821479797
0 O 0 0.004886912647634745
% O 0 0.00026709240046329796
- O 0 0.007475583348423243
1 O 0 0.0016527654370293021
% O 0 0.00012075853010173887
) O 0 0.00024979631416499615
by O 0 0.00011187091149622574
age O 0 0.001947818323969841
50 O 0 0.00151258974801749
years O 0 0.0011581502621993423
and O 0 0.00032364713842980564
27 O 0 0.0038598014507442713
% O 0 0.00015617806639056653
( O 0 0.0008630607044324279
95 O 0 0.007585227023810148
% O 0 0.000707258703187108
CI O 1 0.9996240139007568
0 O 0 0.0037770657800137997
% O 0 0.0002075733063975349
- O 0 0.00736806308850646
47 O 0 0.004155488219112158
% O 0 0.00013072951696813107
) O 0 0.00020540429977700114
by O 0 6.870971992611885e-05
age O 0 0.0022044857032597065
70 O 0 0.00373592390678823
years O 0 0.001532228197902441
. O 0 0.0006021480076014996

The O 0 0.001002203905954957
lifetime O 1 0.6711133122444153
risk O 1 0.7717585563659668
of O 0 0.0007217287784442306
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 0 0.008533495478332043
similar O 0 0.00015599514881614596
to O 0 7.050494605209678e-05
the O 0 0.00031891948310658336
risk O 1 0.8664753437042236
in O 0 0.001479877158999443
BRCA1 O 1 0.9999873638153076
carriers O 0 0.06133728101849556
, O 0 0.0005473658093251288
but O 0 0.00025827789795584977
there O 0 9.693934407550842e-05
was O 0 0.0006049690418876708
some O 0 3.581710916478187e-05
suggestion O 0 0.001928306999616325
of O 0 1.5060037185321562e-05
a O 0 0.001382749993354082
lower O 0 0.017835067585110664
risk O 1 0.9055613875389099
in O 0 0.0018108685035258532
BRCA2 O 1 0.9999016523361206
carriers O 0 0.05982179939746857
< O 0 0.06168237328529358
50 O 0 0.00107018300332129
years O 0 0.00032262594322673976
of O 0 3.1808376661501825e-05
age O 0 0.0027633323334157467
. O 0 0.0007256519165821373

Eye B-Disease 1 0.9999655485153198
movement I-Disease 0 0.010746774263679981
abnormalities I-Disease 1 0.9992762207984924
correlate O 0 0.015141675248742104
with O 0 0.00027883079019375145
genotype O 0 0.29518964886665344
in O 0 0.0007074271561577916
autosomal O 1 0.9992544054985046
dominant O 1 0.9973300695419312
cerebellar B-Disease 1 0.9999998807907104
ataxia I-Disease 1 0.9999998807907104
type I-Disease 1 0.9999388456344604
I I-Disease 1 0.9973702430725098
. O 0 0.000779480382334441

We O 0 0.0009126380318775773
compared O 0 0.0020443336106836796
horizontal O 0 0.027213025838136673
eye O 1 0.9995940327644348
movements O 0 0.0018860256532207131
( O 0 0.0017072992632165551
visually O 0 0.15327979624271393
guided O 0 0.06092533469200134
saccades O 1 0.9989081621170044
, O 0 0.0021160347387194633
antisaccades O 1 0.9818556904792786
, O 0 0.0004015218000859022
and O 0 0.00025416657445020974
smooth O 0 0.03774220123887062
pursuit O 0 0.0583772249519825
) O 0 0.00041176678496412933
in O 0 0.00020412643789313734
control O 0 0.002679229248315096
subjects O 0 0.0072905258275568485
( O 0 0.0016268796753138304
n O 0 0.010983006097376347
= O 0 0.013841604813933372
14 O 0 0.0033845454454421997
) O 0 0.0005937590030953288
and O 0 0.001124030095525086
patients O 1 0.9999973773956299
with O 0 7.760326843708754e-05
three O 0 7.3003931902349e-05
forms O 0 0.00034756356035359204
of O 0 7.593777263537049e-05
autosomal O 1 0.9997685551643372
dominant O 1 0.9858250617980957
cerebellar B-Disease 1 0.9999990463256836
ataxias I-Disease 1 0.999879002571106
type I-Disease 1 0.9929322004318237
I I-Disease 1 0.9970378875732422
spinocerebellar B-Disease 1 0.9999939203262329
ataxias I-Disease 1 0.9744666218757629
1 I-Disease 0 0.0022489072289317846
and I-Disease 0 0.00021499471040442586
2 I-Disease 0 0.00232237228192389
( O 0 0.0016334177926182747
SCA1 B-Disease 1 0.9967367053031921
, O 0 0.0008177380077540874
n O 0 0.008148113265633583
= O 0 0.009991449303925037
11 O 0 0.0034841822925955057
; O 0 0.0005194325931370258
SCA2 B-Disease 1 0.9949554800987244
, O 0 0.000586657493840903
n O 0 0.006970198359340429
= O 0 0.007060274016112089
10 O 0 0.0006309493910521269
) O 0 0.00027576007414609194
and O 0 0.0007274581003002822
SCA3 B-Disease 1 0.9999979734420776
/ O 1 0.9907547831535339
Machado B-Disease 1 0.9900341629981995
- I-Disease 1 0.8460047245025635
Joseph I-Disease 1 0.9757417440414429
disease I-Disease 1 0.9999998807907104
( O 0 0.005164280533790588
MJD B-Disease 1 0.999990701675415
) O 0 0.001224246807396412
( O 0 0.001158911851234734
n O 0 0.009362924844026566
= O 0 0.012375470250844955
16 O 0 0.002620710525661707
) O 0 0.0005008144653402269
. O 0 0.0004945685504935682

In O 0 0.0024143389891833067
SCA1 B-Disease 1 0.9977766871452332
, O 0 0.0005691316328011453
saccade O 0 0.13784301280975342
amplitude O 0 0.0013229706091806293
was O 0 0.0023797149769961834
significantly O 0 0.006964755244553089
increased O 0 0.0006184758385643363
, O 0 0.00018620640912558883
resulting O 0 0.001710668671876192
in O 0 0.0006566575029864907
hypermetria B-Disease 1 0.9925453066825867
. O 0 0.0010544066317379475

The O 0 0.0008841078961268067
smooth O 0 0.02475224994122982
pursuit O 0 0.028201131150126457
gain O 0 0.004573785699903965
was O 0 0.004398560617119074
decreased O 0 0.05070335417985916
. O 0 0.0008035260252654552

In O 0 0.002874090801924467
SCA2 B-Disease 1 0.9945554733276367
, O 0 0.0007773367105983198
saccade O 0 0.13981373608112335
velocity O 0 0.003176008351147175
was O 0 0.0032666546758264303
markedly O 0 0.16235841810703278
decreased O 0 0.0313299261033535
. O 0 0.0007534127798862755

The O 0 0.0003756211663130671
percentage O 0 0.0003606728569138795
of O 0 2.349263559153769e-05
errors O 0 0.008221721276640892
in O 0 0.0007009138353168964
antisaccades O 1 0.9976907968521118
was O 0 0.0026035055052489042
greatly O 0 0.005979530513286591
increased O 0 0.0005788722191937268
and O 0 0.00016535152099095285
was O 0 0.00159763777628541
significantly O 0 0.005804493557661772
correlated O 0 0.003812861628830433
with O 0 0.00012792510096915066
age O 0 0.0036897140089422464
at O 0 0.03908086195588112
disease O 1 1.0
onset O 1 0.9999686479568481
. O 0 0.0013957568444311619

In O 0 0.0008464128477498889
addition O 0 0.0006750001921318471
, O 0 0.00019272632198408246
a O 0 0.0004717909323517233
correlation O 0 0.002437266055494547
between O 0 0.00043847275082953274
smooth O 0 0.08492853492498398
pursuit O 0 0.0776272788643837
gain O 0 0.0033466548193246126
and O 0 8.835514017846435e-05
the O 0 7.992008613655344e-05
number O 0 2.2395868654712103e-05
of O 0 8.326226816279814e-05
trinucleotide O 1 0.9965437054634094
repeats O 0 0.01610378921031952
was O 0 0.0023383053485304117
found O 0 0.0007332160603255033
. O 0 0.00042783308890648186

In O 0 0.0046828496269881725
SCA3 B-Disease 1 0.9999676942825317
, O 0 0.0020470269955694675
gaze B-Disease 1 0.7077234983444214
- I-Disease 0 0.040925830602645874
evoked I-Disease 0 0.11516659706830978
nystagmus I-Disease 1 0.9997041821479797
was O 0 0.003009733511134982
often O 0 0.00023320452601183206
present O 0 0.0001701364672044292
as O 0 0.00036935083335265517
was O 0 0.0033730422146618366
saccade O 1 0.9613889455795288
hypometria O 1 0.5416499376296997
and O 0 0.00035695123369805515
smooth O 0 0.018680119886994362
pursuit O 0 0.02181641384959221
gain O 0 0.003475729376077652
was O 0 0.0036623808555305004
markedly O 1 0.6932348012924194
decreased O 0 0.03547380119562149
. O 0 0.0007230333285406232

Three O 0 0.0006238908972591162
major O 0 0.003865799168124795
criteria O 0 0.0031247357837855816
, O 0 0.0004515148466452956
saccade O 0 0.12314062565565109
amplitude O 0 0.0012082895264029503
, O 0 0.0006283328984864056
saccade O 1 0.562575101852417
velocity O 0 0.003318783827126026
, O 0 0.00027990792295895517
and O 0 8.643557521281764e-05
presence O 0 0.00037953758146613836
of O 0 7.510618888773024e-05
gaze B-Disease 1 0.9947124719619751
- I-Disease 0 0.09396754205226898
evoked I-Disease 0 0.10854463279247284
nystagmus I-Disease 1 0.9994282126426697
, O 0 0.0005068453028798103
permitted O 0 0.0004951553419232368
the O 0 0.00027994875563308597
correct O 0 0.025442294776439667
assignment O 0 0.023300407454371452
of O 0 3.6324614484328777e-05
90 O 0 0.0012403528671711683
% O 0 2.9993658245075494e-05
of O 0 2.1495439796126448e-05
the O 0 0.0014692364493384957
SCA1 B-Disease 1 0.9995939135551453
, O 0 0.000662172504235059
90 O 0 0.0009552271221764386
% O 0 2.7858563043992035e-05
of O 0 2.0602346921805292e-05
the O 0 0.0014343487564474344
SCA2 B-Disease 1 0.9997915625572205
, O 0 0.0008741190540604293
and O 0 0.00045534694800153375
93 O 0 0.012328574433922768
% O 0 3.276932693552226e-05
of O 0 2.561502878961619e-05
the O 0 0.0019615578930824995
patients O 1 0.9999982118606567
with O 0 0.000982860685326159
SCA3 B-Disease 1 0.9999923706054688
to O 0 8.283912757178769e-05
their O 0 4.745863770949654e-05
genetically O 0 0.0035261146258562803
confirmed O 0 0.017219118773937225
patient O 1 0.9999672174453735
group O 0 0.000835713988635689
and O 0 0.00023517933732364327
, O 0 0.00034637690987437963
therefore O 0 0.0009562392369844019
, O 0 0.0004747241619043052
may O 0 0.002013196237385273
help O 0 0.0032014911994338036
orient O 0 0.20526529848575592
diagnoses O 1 0.999403715133667
of O 0 0.0001719869178486988
SCA1 B-Disease 1 0.9999819993972778
, O 0 0.0016685343580320477
SCA2 B-Disease 1 0.9996706247329712
, O 0 0.0007895536837168038
and O 0 0.0008217773283831775
SCA3 B-Disease 1 0.9999967813491821
at O 0 0.002300184452906251
early O 0 0.0021110374946147203
clinical O 1 0.9996201992034912
stages O 0 0.0019744234159588814
of O 0 3.795915836235508e-05
the O 0 0.0026780012995004654
diseases O 1 1.0
. O 0 0.000521364388987422
. O 0 0.0005215522833168507

Genetic O 0 0.0034314850345253944
basis O 0 0.0001226522435899824
and O 0 8.760435594012961e-05
molecular O 0 0.0023652955424040556
mechanism O 0 0.0028636669740080833
for O 0 0.005089618731290102
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 0.0032461087685078382

Ventricular B-Disease 1 0.999998927116394
fibrillation I-Disease 1 0.9999986886978149
causes O 0 0.16521696746349335
more O 0 0.00012773493654094636
than O 0 0.00019354598771315068
300 O 0 0.0019921238999813795
, O 0 0.0005023405537940562
000 O 0 0.01542400848120451
sudden O 0 0.1824597865343094
deaths O 0 0.0124298594892025
each O 0 7.786561036482453e-05
year O 0 0.0007017964962869883
in O 0 0.00014018118963576853
the O 0 0.0007294935639947653
USA O 0 0.09082668274641037
alone O 0 0.005699110217392445
. O 0 0.00048091821372509

In O 0 0.000800930371042341
approximately O 0 0.0012818321119993925
5 O 0 0.003779764985665679
- O 0 0.007175746373832226
12 O 0 0.0006083854241296649
% O 0 2.1328691218513995e-05
of O 0 1.5001752217358444e-05
these O 0 0.00010946808470180258
cases O 0 0.004862335976213217
, O 0 0.0002548678603488952
there O 0 6.413347728084773e-05
are O 0 2.3631633666809648e-05
no O 0 0.0005233851261436939
demonstrable O 1 0.9998533725738525
cardiac O 1 0.9999994039535522
or O 0 0.0016702222637832165
non O 0 0.33279043436050415
- O 1 0.9998202919960022
cardiac O 1 0.9999998807907104
causes O 0 0.27215924859046936
to O 0 0.00011841036757687107
account O 0 0.00016201120160985738
for O 0 0.00019055043230764568
the O 0 0.0004523577226791531
episode O 0 0.00874272733926773
, O 0 0.00025696749798953533
which O 0 4.9794718506745994e-05
is O 0 0.0001852713176049292
therefore O 0 0.0004218383983243257
classified O 0 0.026633376255631447
as O 0 0.004979429300874472
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 0.027626948431134224
IVF B-Disease 1 0.9999841451644897
) O 0 0.0010245722951367497
. O 0 0.000562395784072578

A O 0 0.004400333855301142
distinct O 0 0.000664137362036854
group O 0 0.0005656616413034499
of O 0 0.0003580159100238234
IVF B-Disease 1 0.9999995231628418
patients O 1 0.999998927116394
has O 0 0.001754544209688902
been O 0 0.000541826942935586
found O 0 0.0002439656382193789
to O 0 5.1531478675315157e-05
present O 0 7.735133840469643e-05
with O 0 4.7661003918619826e-05
a O 0 0.0009236891055479646
characteristic O 0 0.02865268476307392
electrocardiographic O 1 0.9997346997261047
pattern O 0 0.02186024934053421
. O 0 0.0009246049448847771

Because O 0 0.0017775333253666759
of O 0 1.821150362957269e-05
the O 0 0.00014502670092042536
small O 0 0.00015691247244831175
size O 0 0.0001895833993330598
of O 0 2.2711086785420775e-05
most O 0 0.0005333726876415312
pedigrees O 0 0.01311641838401556
and O 0 0.00015270062431227416
the O 0 0.00040429335786029696
high O 0 0.014788880944252014
incidence O 1 0.9992772936820984
of O 0 0.00015668997366447002
sudden B-Disease 1 0.9989848732948303
death I-Disease 0 0.022520460188388824
, O 0 0.0004143552214372903
however O 0 0.0003769279283005744
, O 0 0.0002197305584559217
molecular O 0 0.00476367911323905
genetic O 0 0.0018045952310785651
studies O 0 0.0007757021812722087
of O 0 0.00014485367864836007
IVF B-Disease 1 0.9999885559082031
have O 0 0.00018492326489649713
not O 0 0.00013236167433205992
yet O 0 0.0006708509754389524
been O 0 0.0004267882031854242
done O 0 0.002028719987720251
. O 0 0.0003890139632858336

Because O 0 0.015476908534765244
IVF B-Disease 1 0.9999788999557495
causes O 1 0.9997203946113586
cardiac O 1 0.9999998807907104
rhythm O 1 0.8148300051689148
disturbance O 1 0.9986169338226318
, O 0 0.0004925670218653977
we O 0 0.0005746886599808931
investigated O 0 0.01874280907213688
whether O 0 0.0014418666251003742
malfunction O 1 0.9321568608283997
of O 0 2.4541794118704274e-05
ion O 0 0.006154297851026058
channels O 0 0.0009382210555486381
could O 0 0.000634667172562331
cause O 0 0.026032594963908195
the O 0 0.0014462878461927176
disorder O 1 0.9999994039535522
by O 0 0.000121812685392797
studying O 0 0.0017151932697743177
mutations O 0 0.0011983378790318966
in O 0 9.306459833169356e-05
the O 0 0.0005660369643010199
cardiac O 1 0.9999959468841553
sodium O 0 0.020296042785048485
channel O 0 0.0043713608756661415
gene O 0 0.008496925234794617
SCN5A O 1 0.9950230121612549
. O 0 0.0008362599764950573

We O 0 0.0012694122269749641
have O 0 0.00018732616445049644
now O 0 0.0007199043757282197
identified O 0 0.000582789711188525
a O 0 0.0005370212020352483
missense O 0 0.0179095771163702
mutation O 0 0.0026073583867400885
, O 0 0.0001643646537559107
a O 0 0.001042726682499051
splice O 0 0.18889594078063965
- O 0 0.023973513394594193
donor O 0 0.015050103887915611
mutation O 0 0.004269829485565424
, O 0 0.00021070959337521344
and O 0 0.00018007520702667534
a O 0 0.002395250368863344
frameshift O 1 0.9686747193336487
mutation O 0 0.003290437161922455
in O 0 0.0001411234843544662
the O 0 0.00022087070101406425
coding O 0 0.016828671097755432
region O 0 0.0016663775313645601
of O 0 0.00010296191612724215
SCN5A O 1 0.9997455477714539
in O 0 0.0004551080637611449
three O 0 0.0007771719247102737
IVF B-Disease 1 0.9997809529304504
families O 0 0.0010117915226146579
. O 0 0.0005490509793162346

We O 0 0.0008604483446106315
show O 0 0.00036046525929123163
that O 0 5.118746048538014e-05
sodium O 0 0.0038284023758023977
channels O 0 0.00023764456273056567
with O 0 4.8938261898001656e-05
the O 0 0.00043811657815240324
missense O 0 0.04363159090280533
mutation O 0 0.012170704081654549
recover O 1 0.9909257888793945
from O 0 0.0003378753608558327
inactivation O 1 0.5701485872268677
more O 0 0.0001955685584107414
rapidly O 0 0.0067962766624987125
than O 0 0.0001678323606029153
normal O 0 0.003026301972568035
and O 0 8.092849748209119e-05
that O 0 5.570928260567598e-05
the O 0 0.0004643511201720685
frameshift O 1 0.9852120876312256
mutation O 0 0.006402616389095783
causes O 0 0.01580914482474327
the O 0 0.00033905860618688166
sodium O 0 0.011793741956353188
channel O 0 0.0012800758704543114
to O 0 7.888465188443661e-05
be O 0 0.00013327682972885668
non O 0 0.0036532122176140547
- O 0 0.008989956229925156
functional O 0 0.010321302339434624
. O 0 0.0006398255354724824

Our O 0 0.0016353194369003177
results O 0 0.0007731309742666781
indicate O 0 0.000561892578843981
that O 0 6.243542156880721e-05
mutations O 0 0.0016237584641203284
in O 0 0.0005931278574280441
cardiac O 1 0.9999985694885254
ion O 0 0.029128937050700188
- O 0 0.01123849768191576
channel O 0 0.0013091814471408725
genes O 0 0.0002563534944783896
contribute O 0 0.0023860535584390163
to O 0 6.946061330381781e-05
the O 0 0.00022447908122558147
risk O 0 0.02200905606150627
of O 0 8.018421067390591e-05
developing O 1 0.935828447341919
IVF B-Disease 1 0.9999654293060303
. O 0 0.000557728810235858
. O 0 0.0005802693194709718

Molecular O 0 0.01346235815435648
heterogeneity O 0 0.025850452482700348
in O 0 0.0012237867340445518
mucopolysaccharidosis B-Disease 1 0.9958752989768982
IVA I-Disease 1 0.9995779395103455
in O 0 0.0006288609583862126
Australia O 0 0.0014218767173588276
and O 0 0.00031812023371458054
Northern O 0 0.005779585801064968
Ireland O 0 0.0027647782117128372
: O 0 0.0003983563801739365
nine O 0 0.000420159223722294
novel O 0 0.0022265680599957705
mutations O 0 0.002754796529188752
including O 0 0.0003270319721195847
T312S O 1 0.6001786589622498
, O 0 0.0003445243928581476
a O 0 0.0006390290800482035
common O 0 0.002553303726017475
allele O 0 0.006611442193388939
that O 0 0.00016717048129066825
confers O 0 0.19514743983745575
a O 0 0.0035263008903712034
mild O 1 0.9999085664749146
phenotype O 1 0.9769065976142883
. O 0 0.001125733950175345

Mucopolysaccharidosis B-Disease 1 0.9987404942512512
IVA I-Disease 1 0.9999207258224487
( O 0 0.00852329470217228
MPS B-Disease 1 0.9977152347564697
IVA I-Disease 1 0.9999970197677612
) O 0 0.0005275156581774354
is O 0 0.00023773792781867087
an O 0 0.0007341931923292577
autosomal B-Disease 1 0.9999827146530151
recessive I-Disease 1 0.9999929666519165
lysosomal I-Disease 1 0.9999990463256836
storage I-Disease 1 0.9999617338180542
disorder I-Disease 1 1.0
caused O 0 0.2995067536830902
by O 0 7.934992027003318e-05
a O 0 0.0016315161483362317
genetic B-Disease 1 0.9852741956710815
defect I-Disease 1 0.9999644756317139
in O 0 0.0007173970807343721
N O 0 0.043404921889305115
- O 0 0.016075458377599716
acetylgalactosamine O 1 0.6090438365936279
- O 0 0.00818375963717699
6 O 0 0.003719188505783677
- O 0 0.018333010375499725
sulfate O 1 0.999298095703125
sulfatase O 1 0.999579131603241
( O 0 0.0062059867195785046
GALNS O 1 0.9994196891784668
) O 0 0.000943017948884517
. O 0 0.0005349548882804811

Previous O 0 0.0017681176541373134
studies O 0 0.0007686613826081157
of O 0 9.259217040380463e-05
patients O 1 0.9999911785125732
from O 0 0.00013357886928133667
a O 0 0.0014739071484655142
British O 0 0.009277072735130787
- O 0 0.017076920717954636
Irish O 0 0.0023927504662424326
population O 0 9.354612848255783e-05
showed O 0 0.001307389815337956
that O 0 6.808655598433688e-05
the O 0 0.00038112583570182323
I113F O 0 0.2587566077709198
mutation O 0 0.003065591910853982
is O 0 0.00020382110960781574
the O 0 9.319523815065622e-05
most O 0 0.00014924208517186344
common O 0 0.000882596243172884
single O 0 0.0004972919123247266
mutation O 0 0.0033961846493184566
among O 0 0.0010778331197798252
MPS B-Disease 1 0.9996341466903687
IVA I-Disease 1 0.9999998807907104
patients O 1 0.9999988079071045
and O 0 0.00023369601694867015
produces O 0 0.0027514412067830563
a O 0 0.0033553391695022583
severe O 1 0.9999982118606567
clinical O 1 0.9999983310699463
phenotype O 1 0.9915148019790649
. O 0 0.0008145362953655422

We O 0 0.0010298952693119645
studied O 0 0.0014581131981685758
mutations O 0 0.001265408587642014
in O 0 0.00015320903912652284
the O 0 0.0007164767594076693
GALNS O 1 0.9984820485115051
gene O 0 0.002156411064788699
from O 0 0.00011331592395436019
23 O 0 0.0017353605944663286
additional O 0 0.0012436244869604707
MPS B-Disease 1 0.9979363679885864
IVA I-Disease 1 0.9999998807907104
patients O 1 0.9999992847442627
( O 0 0.0014586421893909574
15 O 0 0.0012713898904621601
from O 0 0.00015386271115858108
Australia O 0 0.0013463718350976706
, O 0 0.000437617942225188
8 O 0 0.0011755599407479167
from O 0 0.00019524978415574878
Northern O 0 0.0056527662090957165
Ireland O 0 0.005129631608724594
) O 0 0.0004186426231171936
, O 0 0.00011024241393897682
with O 0 6.328993913484737e-05
various O 0 0.0002717504103202373
clinical O 1 0.9999990463256836
phenotypes O 1 0.9876020550727844
( O 0 0.004703358747065067
severe O 1 0.9999960660934448
, O 0 0.0009423349983990192
16 O 0 0.0027550230734050274
cases O 0 0.0035071924794465303
; O 0 0.00039146834751591086
intermediate O 0 0.08356904983520508
, O 0 0.000530295423232019
4 O 0 0.002885126043111086
cases O 0 0.0038312547840178013
; O 0 0.0007769324001856148
mild O 1 0.9998574256896973
, O 0 0.0008598631247878075
3 O 0 0.003008943982422352
cases O 0 0.005417048465460539
) O 0 0.0006532841944135725
. O 0 0.0005225606728345156

We O 0 0.0011326676467433572
found O 0 0.0002910785551648587
two O 0 6.154006405267864e-05
common O 0 0.0025503807701170444
mutations O 0 0.002613563323393464
that O 0 5.576652620220557e-05
together O 0 6.452941306633875e-05
accounted O 0 0.001864762743934989
for O 0 0.00030661674099974334
32 O 0 0.001093075843527913
% O 0 2.4352926629944704e-05
of O 0 1.2302831237320788e-05
the O 0 0.00041941352537833154
44 O 0 0.0030513533856719732
unrelated O 0 0.014201328158378601
alleles O 0 0.005105046555399895
in O 0 0.0003153698635287583
these O 0 0.00036085379542782903
patients O 1 0.9999990463256836
. O 0 0.0009248577407561243

One O 0 0.0007751882076263428
is O 0 0.00032412976725026965
the O 0 0.00037220242666080594
T312S O 0 0.10783717781305313
mutation O 0 0.003891799133270979
, O 0 0.00020859191135969013
a O 0 0.0006487406208179891
novel O 0 0.0029053185135126114
mutation O 0 0.0022403139155358076
found O 0 0.00017751021368894726
exclusively O 0 0.0005195316625759006
in O 0 0.0007294744136743248
milder O 1 0.9997413754463196
patients O 1 0.9999992847442627
. O 0 0.0009109001257456839

The O 0 0.0006229547434486449
other O 0 9.962174954125658e-05
is O 0 0.0003318611707072705
the O 0 0.00028361607110127807
previously O 0 0.003177723614498973
described O 0 0.006515896413475275
I113F O 0 0.042776308953762054
that O 0 6.915268750162795e-05
produces O 0 0.001923800795339048
a O 0 0.0030163470655679703
severe O 1 0.9999592304229736
phenotype O 1 0.9730254411697388
. O 0 0.0011095961090177298

The O 0 0.0015992250991985202
I113F O 0 0.0669466182589531
and O 0 0.000404948164941743
T312S O 0 0.05400967597961426
mutations O 0 0.001733032870106399
accounted O 0 0.001370548503473401
for O 0 0.00043360586278140545
8 O 0 0.0028239309322088957
( O 0 0.0010340189328417182
18 O 0 0.0013274273369461298
% O 0 0.00015147867088671774
) O 0 0.0005151191144250333
and O 0 0.0004957031924277544
6 O 0 0.009274461306631565
( O 0 0.0016613818006590009
14 O 0 0.0024791317991912365
% O 0 0.00011104752775281668
) O 0 0.00014202497550286353
of O 0 3.404679227969609e-05
44 O 0 0.0030916694086045027
unrelated O 0 0.015018547885119915
alleles O 0 0.010100007988512516
, O 0 0.0007123138639144599
respectively O 0 0.002259298926219344
. O 0 0.0007392638945020735

The O 0 0.0006589454715140164
relatively O 0 0.0024370388127863407
high O 0 0.007254722528159618
residual O 0 0.11080446094274521
GALNS O 1 0.9967901110649109
activity O 0 0.0022578947246074677
seen O 0 0.0023296955041587353
when O 0 0.0002489978796802461
the O 0 0.00021041087165940553
T312S O 0 0.04747750982642174
mutant O 0 0.0056690345518291
cDNA O 0 0.004930259194225073
is O 0 0.0010369650553911924
overexpressed O 0 0.12045774608850479
in O 0 0.0003420996363274753
mutant O 0 0.0089177954941988
cells O 0 0.0030637141317129135
provides O 0 0.0015274172183126211
an O 0 0.00014121663116384298
explanation O 0 0.0015058761928230524
for O 0 0.00016455563309136778
the O 0 0.0007722324226051569
mild O 1 0.9999744892120361
phenotype O 1 0.9971242547035217
in O 0 0.002066142624244094
patients O 1 0.999994158744812
with O 0 8.131450886139646e-05
this O 0 0.00011392318992875516
mutation O 0 0.00427491869777441
. O 0 0.0005567470216192305

The O 0 0.0006519586895592511
distribution O 0 0.0003262341197114438
and O 0 0.0001305232581216842
relative O 0 0.0002868727024178952
frequencies O 0 0.00010766531340777874
of O 0 1.918010093504563e-05
the O 0 0.0006124687497504056
I113F O 0 0.14154888689517975
and O 0 0.000562331872060895
T312S O 0 0.16778410971164703
mutations O 0 0.003237649332731962
in O 0 0.0002868081210181117
Australia O 0 0.001466285204514861
corresponded O 0 0.004994416609406471
to O 0 9.978938760468736e-05
those O 0 7.431396807078272e-05
observed O 0 0.0008492525084875524
in O 0 0.00043361724237911403
Northern O 0 0.0072523606941103935
Ireland O 0 0.003919444978237152
and O 0 0.00021916601690463722
are O 0 3.7584261008305475e-05
unique O 0 0.0005494351498782635
to O 0 8.278684254037216e-05
these O 0 1.7928587112692185e-05
two O 0 5.849200169905089e-05
populations O 0 0.0007291905349120498
, O 0 0.0003914491389878094
suggesting O 0 0.004574976395815611
that O 0 6.698381912428886e-05
both O 0 0.00018753706535790116
mutations O 0 0.002186837140470743
were O 0 8.1636942923069e-05
probably O 0 0.0019876493606716394
introduced O 0 0.00031191177549771965
to O 0 0.00012225685350131243
Australia O 0 0.0006438120035454631
by O 0 8.2039950939361e-05
Irish O 0 0.0034646610729396343
migrants O 0 0.0006876427214592695
during O 0 0.0008352923905476928
the O 0 0.00017642826423980296
19th O 0 0.0010719523997977376
century O 0 0.0007199108949862421
. O 0 0.0005822828388772905

Haplotype O 0 0.10599710047245026
analysis O 0 0.0006304329144768417
using O 0 0.0004316263657528907
6 O 0 0.005683869123458862
RFLPs O 1 0.6431307792663574
provides O 0 0.0019390999805182219
additional O 0 0.0001194530341308564
data O 0 6.357006350299343e-05
that O 0 3.9724527596263215e-05
the O 0 0.0002684498322196305
I113F O 0 0.19621926546096802
mutation O 0 0.0030749489087611437
originated O 0 0.0008349318522959948
from O 0 8.322068606503308e-05
a O 0 0.0007344608311541378
common O 0 0.0027918291743844748
ancestor O 0 0.003910889383405447
. O 0 0.0009236953337676823

The O 0 0.0007105941767804325
other O 0 0.00013091166329104453
9 O 0 0.003447836497798562
novel O 0 0.003369225887581706
mutations O 0 0.0038184404838830233
identified O 0 0.0012223380617797375
in O 0 0.00012596487067639828
these O 0 0.0001473887386964634
23 O 0 0.022764189168810844
patients O 1 0.9999794960021973
were O 0 2.99494422506541e-05
each O 0 2.8502334316726774e-05
limited O 0 0.0006813817308284342
to O 0 6.387730536516756e-05
a O 0 0.00038955669151619077
single O 0 0.0005579103599302471
family O 0 0.001716023776680231
. O 0 0.0007352556567639112

These O 0 5.757561302743852e-05
data O 0 0.00012722537212539464
provide O 0 0.0005541876889765263
further O 0 0.00021470749925356358
evidence O 0 0.00021526504133362323
for O 0 0.00020136671082582325
extensive O 0 0.00967396143823862
allelic O 0 0.0672043040394783
heterogeneity O 0 0.027819199487566948
in O 0 0.001256231451407075
MPS B-Disease 1 0.989875078201294
IVA I-Disease 1 0.9999890327453613
in O 0 0.0008493937202729285
British O 0 0.012841791845858097
- O 1 0.7362859845161438
Irish O 0 0.03202536329627037
patients O 1 0.9999903440475464
and O 0 0.00017635121184866875
provide O 0 0.001267009531147778
evidence O 0 0.0003235478070564568
for O 0 0.00010885777010116726
their O 0 7.410252146655694e-05
transmission O 0 0.00784852635115385
to O 0 0.00016403805057052523
Australia O 0 0.0006852634251117706
by O 0 0.00013110654253978282
British O 0 0.010346241295337677
- O 0 0.020906155928969383
Irish O 0 0.00407166313380003
migrants O 0 0.0008269869722425938
. O 0 0.00023968044843059033
. O 0 0.0005506024463102221

Identification O 0 0.0008517071837559342
of O 0 3.637009285739623e-05
constitutional O 0 0.005156417842954397
WT1 O 1 0.999967098236084
mutations O 0 0.007702758070081472
, O 0 0.0003220662474632263
in O 0 0.0007268267800100148
patients O 1 0.9999943971633911
with O 0 0.00028251580079086125
isolated O 1 0.9976615905761719
diffuse B-Disease 1 0.9999994039535522
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.0013979211216792464
and O 0 9.753862104844302e-05
analysis O 0 0.000289484451059252
of O 0 0.00012582189810927957
genotype O 1 0.9974197149276733
/ O 1 0.990432858467102
phenotype O 0 0.4081520140171051
correlations O 0 0.003802842926234007
by O 0 3.353619831614196e-05
use O 0 5.770203279098496e-05
of O 0 1.2581073860928882e-05
a O 0 0.0012998662423342466
computerized O 0 0.05531967803835869
mutation O 0 0.003908528946340084
database O 0 0.0023865948896855116
. O 0 0.0005465801223181188

Constitutional O 0 0.0023485904093831778
mutations O 0 0.0007865794468671083
of O 0 2.1835978259332478e-05
the O 0 0.0012567867524921894
WT1 O 1 0.9998955726623535
gene O 0 0.003156110644340515
, O 0 8.191268716473132e-05
encoding O 0 0.00041872361907735467
a O 0 0.0012304133269935846
zinc O 1 0.9958468079566956
- O 0 0.011544635519385338
finger O 0 0.02961161732673645
transcription O 0 0.001712766126729548
factor O 0 0.0024066483601927757
involved O 0 0.0024351151660084724
in O 0 0.0027216502930969
renal O 1 1.0
and O 0 0.0034934559371322393
gonadal O 1 0.9999487400054932
development O 0 0.008458958938717842
, O 0 0.00033359156805090606
are O 0 2.9528044251492247e-05
found O 0 0.00017579317500349134
in O 0 9.718025103211403e-05
most O 0 0.0005872011533938348
patients O 1 0.9999911785125732
with O 0 0.0004969504661858082
Denys B-Disease 1 0.9999927282333374
- I-Disease 1 0.9994699358940125
Drash I-Disease 1 0.9999942779541016
syndrome I-Disease 1 1.0
( O 0 0.017873765900731087
DDS B-Disease 1 1.0
) O 0 0.0009704395197331905
, O 0 0.0003256869094911963
or O 0 0.0023288854863494635
diffuse B-Disease 1 0.9999966621398926
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 0.17703156173229218
DMS B-Disease 1 0.9999995231628418
) O 0 0.000873990764375776
associated O 0 0.0005811054725199938
with O 0 0.0002596435078885406
pseudohermaphroditism B-Disease 1 0.9999598264694214
and O 0 0.001247272128239274
/ O 1 0.9958401918411255
or O 0 0.007782937027513981
Wilms B-Disease 1 1.0
tumor I-Disease 1 0.9999995231628418
( O 0 0.0064180511981248856
WT B-Disease 1 0.9998384714126587
) O 0 0.0010699660051614046
. O 0 0.0005410118610598147

Most O 0 0.0009213599259965122
mutations O 0 0.005352366715669632
in O 0 0.002908851718530059
DDS B-Disease 1 1.0
patients O 1 0.9999974966049194
lie O 0 0.01099761575460434
in O 0 0.0003687734133563936
exon O 0 0.04271305352449417
8 O 0 0.0018617210444062948
or O 0 0.000610077811870724
exon O 0 0.036297354847192764
9 O 0 0.0016736055258661509
, O 0 0.00010529906285228208
encoding O 0 0.0012036230182275176
zinc O 1 0.9440118074417114
finger O 1 0.8984275460243225
2 O 0 0.0026418764609843493
or O 0 0.0011527049355208874
zinc O 1 0.9940056800842285
finger O 1 0.9889013767242432
3 O 0 0.0037022188771516085
, O 0 0.0005025088903494179
respectively O 0 0.0009602169739082456
, O 0 0.0001336673303740099
with O 0 5.80507330596447e-05
a O 0 0.0012281989911571145
hot O 0 0.028888370841741562
spot O 0 0.01964576169848442
( O 0 0.0014458505902439356
R394W O 0 0.09097649902105331
) O 0 0.0002897611411754042
in O 0 0.00029686110792681575
exon O 0 0.054413050413131714
9 O 0 0.004498427268117666
. O 0 0.0004964271211065352

We O 0 0.0006550457328557968
analyzed O 0 0.0011050475295633078
a O 0 0.00023258323199115694
series O 0 0.00016476605378556997
of O 0 4.0401704609394073e-05
24 O 0 0.005612923298031092
patients O 1 0.9999852180480957
, O 0 0.0002642975596245378
10 O 0 0.000353100971551612
with O 0 0.00022892186825629324
isolated B-Disease 1 0.9919527173042297
DMS I-Disease 1 0.9999984502792358
( O 0 0.010365176945924759
IDMS B-Disease 1 0.9999957084655762
) O 0 0.001329499762505293
, O 0 0.0003234664036426693
10 O 0 0.0008954518125392497
with O 0 0.0012254397151991725
DDS B-Disease 1 1.0
, O 0 0.000736285001039505
and O 0 0.00020700290042441338
4 O 0 0.0012807137100026011
with O 0 0.0005525333690457046
urogenital B-Disease 1 0.999998927116394
abnormalities I-Disease 1 0.9999934434890747
and O 0 0.002874537603929639
/ O 1 0.9988777041435242
or O 0 0.0054865991696715355
WT B-Disease 1 0.9997958540916443
. O 0 0.001291296910494566

We O 0 0.001673937658779323
report O 0 0.004022756591439247
WT1 O 1 0.9979952573776245
heterozygous O 0 0.011162787675857544
mutations O 0 0.0024099466390907764
in O 0 0.0004848238895647228
16 O 0 0.008567078039050102
patients O 1 0.9999942779541016
, O 0 0.0004306473711039871
4 O 0 0.0009033516398631036
of O 0 3.9597936847712845e-05
whom O 0 0.003045630408450961
presented O 0 0.0021216776221990585
with O 0 0.0011214606929570436
IDMS B-Disease 1 0.9999966621398926
. O 0 0.002162863966077566

One O 0 0.0011868338333442807
male O 0 0.00144072191324085
and O 0 0.00014826819824520499
two O 0 0.00019416093709878623
female O 0 0.03748776763677597
IDMS B-Disease 1 0.9999997615814209
patients O 1 0.9999988079071045
with O 0 0.0011716120643541217
WT1 O 1 0.9999908208847046
mutations O 0 0.04918467998504639
underwent O 1 0.9999960660934448
normal O 0 0.023603854700922966
puberty O 1 0.9933298230171204
. O 0 0.0008149088243953884

Two O 0 0.0004157211515121162
mutations O 0 0.00420427368953824
associated O 0 0.001349734840914607
with O 0 0.0010204882128164172
IDMS B-Disease 1 0.9999969005584717
are O 0 4.4843625801149756e-05
different O 0 1.2999637874600012e-05
from O 0 6.389150075847283e-05
those O 0 9.570157999405637e-05
described O 0 0.00895108375698328
in O 0 0.005481881555169821
DDS B-Disease 1 1.0
patients O 1 0.9999992847442627
. O 0 0.0011199602158740163

No O 0 0.007317788433283567
WT1 O 1 0.9988975524902344
mutations O 0 0.0051774135790765285
were O 0 9.073202818399295e-05
detected O 0 0.005133114755153656
in O 0 7.39091556170024e-05
the O 0 0.00011344966333126649
six O 0 0.0005177020793780684
other O 0 0.0010891632409766316
IDMS B-Disease 1 1.0
patients O 1 0.9999998807907104
, O 0 0.0006187440012581646
suggesting O 0 0.005158824846148491
genetic O 0 0.0018321936950087547
heterogeneity O 0 0.006809697486460209
of O 0 5.1234041166026145e-05
this O 0 0.0012559436727315187
disease O 1 1.0
. O 0 0.0007602742989547551

We O 0 0.0011748927645385265
analyzed O 0 0.008252434432506561
genotype O 1 0.9200464487075806
/ O 1 0.9268417954444885
phenotype O 0 0.18489740788936615
correlations O 0 0.010067259892821312
, O 0 0.0003850748762488365
on O 0 0.00019334955140948296
the O 0 8.20430796011351e-05
basis O 0 5.8777673984877765e-05
of O 0 1.2681733096542303e-05
the O 0 0.00021413566719274968
constitution O 0 0.0002341193176107481
of O 0 1.9968740161857568e-05
a O 0 0.0040926868095994
WT1 O 1 0.999627947807312
mutation O 0 0.0019356866832822561
database O 0 0.0003369905170984566
of O 0 4.154627094976604e-05
84 O 0 0.1575748473405838
germ O 1 0.9999450445175171
- O 0 0.02467992715537548
line O 0 0.004297706298530102
mutations O 0 0.0032865158282220364
, O 0 0.0002284256333950907
to O 0 0.00014270619431044906
compare O 0 0.0029029245488345623
the O 0 0.0001007091996143572
distribution O 0 0.0002442451659590006
and O 0 0.00026843397063203156
type O 0 0.005046517588198185
of O 0 7.252619252540171e-05
mutations O 0 0.0074417912401258945
, O 0 0.0002925338048953563
according O 0 0.0001594142522662878
to O 0 5.176873673917726e-05
the O 0 0.00015787324809934944
different O 0 0.00030524065368808806
symptoms O 1 0.9999979734420776
. O 0 0.0009807280730456114

This O 0 0.000447677361080423
demonstrated O 0 0.01308591291308403
( O 0 0.0014158907579258084
1 O 0 0.003254302078858018
) O 0 0.0002824732509907335
the O 0 0.0003576798480935395
association O 0 0.01315984409302473
between O 0 0.00040456303395330906
mutations O 0 0.0019345004111528397
in O 0 0.0002426211431156844
exons O 0 0.011494975537061691
8 O 0 0.0017036329954862595
and O 0 0.00027520168805494905
9 O 0 0.004199956078082323
and O 0 0.001603724085725844
DMS B-Disease 1 0.9999948740005493
; O 0 0.0010942479129880667
( O 0 0.001167205860838294
2 O 0 0.0022522802464663982
) O 0 0.0003742823319043964
among O 0 0.0007835003780201077
patients O 1 0.9999983310699463
with O 0 0.0016761841252446175
DMS B-Disease 1 0.9999967813491821
, O 0 0.0004587204603012651
a O 0 0.0003985523944720626
higher O 0 0.0003460618609096855
frequency O 0 0.0001243268052348867
of O 0 4.5757660700473934e-05
exon O 0 0.06259553879499435
8 O 0 0.0019056450109928846
mutations O 0 0.0013690926134586334
among O 0 0.00017307944654021412
46 O 0 0.006372117903083563
, O 0 0.0029876967892050743
XY O 1 0.9999865293502808
patients O 1 0.9999955892562866
with O 0 0.00024099853180814534
female O 0 0.004727581515908241
phenotype O 0 0.0974973738193512
than O 0 0.0001164159330073744
among O 0 0.00022298263502307236
46 O 0 0.0070313578471541405
, O 0 0.002508720848709345
XY O 1 0.9999866485595703
patients O 1 0.9999973773956299
with O 0 0.00021872659272048622
sexual O 0 0.005282278172671795
ambiguity O 0 0.007625896483659744
or O 0 0.0017618653364479542
male O 0 0.008904463611543179
phenotype O 1 0.9715652465820312
; O 0 0.0006620761705562472
and O 0 0.0005805408582091331
( O 0 0.0015023370506241918
3 O 0 0.002174179768189788
) O 0 0.00016936115571297705
statistically O 0 0.0011150429490953684
significant O 0 0.0006290840683504939
evidence O 0 0.0004000388435088098
that O 0 0.00010127961286343634
mutations O 0 0.001744067412801087
in O 0 0.0002993453817907721
exons O 0 0.014721550978720188
8 O 0 0.0024846852757036686
and O 0 0.00028814453980885446
9 O 0 0.0026900824159383774
preferentially O 0 0.007282779086381197
affect O 0 0.0014600680442526937
amino O 0 0.0002078129182336852
acids O 0 0.00033419032115489244
with O 0 2.8352578738122247e-05
different O 0 1.6952782971202396e-05
functions O 0 0.00048827071441337466
. O 0 0.00032320283935405314
. O 0 0.0005464774440042675

The O 0 0.0030999889131635427
185delAG O 1 0.9771115183830261
BRCA1 O 1 0.9992920160293579
mutation O 0 0.00675627589225769
originated O 0 0.0013909194385632873
before O 0 0.00046096055302768946
the O 0 0.00014344780356623232
dispersion O 0 0.006258178036659956
of O 0 4.970144800608978e-05
Jews O 0 0.000937645963858813
in O 0 0.00021028811170253903
the O 0 0.00027818503440357745
diaspora O 0 0.0012011530343443155
and O 0 0.00030568649526685476
is O 0 0.00042372738244012
not O 0 0.00015606597298756242
limited O 0 0.001077347667887807
to O 0 0.00043192351586185396
Ashkenazim O 1 0.9699801802635193
. O 0 0.0009540724568068981

The O 0 0.0011652624234557152
185delAG O 0 0.13286133110523224
mutation O 0 0.004279750864952803
in O 0 0.0009099169401451945
BRCA1 O 1 0.9998748302459717
is O 0 0.0016574724577367306
detected O 0 0.009774222038686275
in O 0 0.0003688968427013606
Ashkenazi O 1 0.9463614821434021
Jews O 0 0.0004623725835699588
both O 0 9.771521581569687e-05
in O 0 0.0005943856085650623
familial B-Disease 1 0.9999997615814209
breast I-Disease 1 1.0
and I-Disease 1 0.9910793900489807
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.00032267021015286446
in O 0 0.00017140753334388137
the O 0 0.00020261800091248006
general O 0 0.001348254387266934
population O 0 0.00013732137449551374
. O 0 0.000474025058792904

All O 0 0.0005921450792811811
tested O 0 0.12835898995399475
Ashkenazi O 1 0.9586560130119324
mutation O 0 0.007743986789137125
carriers O 0 0.008048078045248985
share O 0 0.0003530198591761291
the O 0 0.00011844276014016941
same O 0 0.0002916758239734918
allelic O 0 0.06539509445428848
pattern O 0 0.007799620274454355
at O 0 0.0013986269477754831
the O 0 0.0011303394567221403
BRCA1 O 1 0.9999175071716309
locus O 0 0.054276805371046066
. O 0 0.0011022052494809031

Our O 0 0.0020335353910923004
previous O 0 0.0010194794740527868
study O 0 0.0014484139392152429
showed O 0 0.0008466874714940786
that O 0 3.483940599835478e-05
this O 0 0.00010747226770035923
Ashkenazi O 1 0.9833498001098633
mutation O 0 0.005298435688018799
also O 0 0.0005112727521918714
occurs O 0 0.0015445444732904434
in O 0 0.00035299916635267437
Iraqi O 0 0.005358716938644648
Jews O 0 0.0005577338743023574
with O 0 6.618051702389494e-05
a O 0 0.0006186423706822097
similar O 0 0.000818177592009306
allelic O 0 0.14868375658988953
pattern O 0 0.018181413412094116
. O 0 0.0011773849837481976

We O 0 0.0008603748865425587
extended O 0 0.0008649736410006881
our O 0 0.00028078060131520033
analysis O 0 0.0002124116726918146
to O 0 6.437218689825386e-05
other O 0 8.45690883579664e-05
non O 0 0.008770274929702282
- O 0 0.02350357361137867
Ashkenazi O 0 0.13160236179828644
subsets O 0 0.0038018454797565937
354 O 0 0.02018718235194683
of O 0 3.506372377160005e-05
Moroccan O 0 0.0030923972371965647
origin O 0 0.0001354959822492674
, O 0 0.0003252546885050833
200 O 0 0.0023372711148113012
Yemenites O 1 0.9608374834060669
and O 0 0.0003608254191931337
150 O 0 0.0014701670734211802
Iranian O 0 0.001250815694220364
Jews O 0 0.00108532072044909
. O 0 0.0004818490124307573

Heteroduplex O 0 0.4693521559238434
analysis O 0 0.0008346097311004996
complemented O 0 0.005922893527895212
by O 0 3.577638199203648e-05
direct O 0 0.00021532928803935647
DNA O 0 0.0004721522273030132
sequencing O 0 0.0003124200738966465
of O 0 5.381571827456355e-05
abnormally O 1 0.9887487888336182
migrating O 0 0.006349833216518164
bands O 0 0.0009066460770554841
were O 0 9.574585419613868e-05
employed O 0 0.005457698367536068
. O 0 0.0007486480171792209

Four O 0 0.00028631961322389543
of O 0 3.0241149943321943e-05
Moroccan O 0 0.003976179286837578
origin O 0 0.00025652075419202447
( O 0 0.0012659999774768949
1 O 0 0.003256975905969739
. O 0 0.0002634095726534724
1 O 0 0.0021212222054600716
% O 0 0.00016778433928266168
) O 0 0.00044909940334036946
and O 0 0.0002391333255218342
none O 0 0.0006155428127385676
of O 0 2.5231529434677213e-05
the O 0 0.0010087029077112675
Yemenites O 1 0.9986158609390259
or O 0 0.0013730581849813461
Iranians O 0 0.0035494668409228325
was O 0 0.0011232777033001184
a O 0 0.0005774592864327133
carrier O 0 0.009717182256281376
of O 0 1.7618613128433935e-05
the O 0 0.000597719510551542
185delAG O 1 0.979532778263092
mutation O 0 0.005788138136267662
. O 0 0.0005499657127074897

BRCA1 O 1 0.9997541308403015
allelic O 0 0.1778373271226883
patterns O 0 0.0020966739393770695
were O 0 0.00012139351019868627
determined O 0 0.0019736294634640217
for O 0 0.00017047926667146385
four O 0 6.286875577643514e-05
of O 0 1.3797575775242876e-05
these O 0 3.8210848288144916e-05
individuals O 0 0.00023547951423097402
and O 0 0.0001673336373642087
for O 0 0.0003030982334166765
12 O 0 0.0007775508565828204
additional O 0 0.0003920649760402739
non O 0 0.007581121753901243
- O 0 0.05117397382855415
Ashkenazi O 1 0.9833078384399414
185delAG O 1 0.7781341075897217
mutation O 0 0.0035344366915524006
carriers O 0 0.00676055159419775
who O 0 0.0011230433592572808
had O 0 0.029565414413809776
breast B-Disease 1 1.0
/ I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0010857757879421115

Six O 0 0.0028287419117987156
non O 0 0.012900630943477154
- O 0 0.06595568358898163
Ashkenazi O 1 0.9809958338737488
individuals O 0 0.0003366259334143251
shared O 0 0.0005378840141929686
the O 0 0.0003696865460369736
common O 0 0.0126738790422678
Ashkenazi O 1 0.9981149435043335
haplotype O 1 0.8819990158081055
, O 0 0.000535239523742348
four O 0 0.0002179999864893034
had O 0 0.0006462765741162002
a O 0 0.0005167237250134349
closely O 0 0.0009828231995925307
related O 0 0.0030878919642418623
pattern O 0 0.007606751285493374
, O 0 0.0003615255409386009
and O 0 0.0001458966580685228
the O 0 0.00037692757905460894
rest O 0 0.005258060526102781
( O 0 0.0011822246015071869
n O 0 0.010037119500339031
= O 0 0.013684643432497978
6 O 0 0.002554904669523239
) O 0 0.00015995721332728863
displayed O 0 0.0007613403722643852
a O 0 0.0005571303190663457
distinct O 0 0.004466055892407894
BRCA1 O 1 0.9999523162841797
allelic O 1 0.6792519688606262
pattern O 0 0.021217167377471924
. O 0 0.0011012497125193477

We O 0 0.0011361732613295317
conclude O 0 0.004524777177721262
that O 0 4.728132989839651e-05
the O 0 0.00045850034803152084
185delAG O 1 0.9942387342453003
BRCA1 O 1 0.9997336268424988
mutation O 0 0.005830657668411732
occurs O 0 0.0010105603141710162
in O 0 0.00010370477684773505
some O 0 0.00011032696056645364
non O 0 0.01303680520504713
- O 0 0.0564044751226902
Ashkenazi O 1 0.8711357712745667
populations O 0 0.0013519271742552519
at O 0 0.0013531541917473078
rates O 0 0.0010625517461448908
comparable O 0 0.002473503816872835
with O 0 5.6911168940132484e-05
that O 0 6.326750008156523e-05
of O 0 7.397232548100874e-05
Ashkenazim O 1 0.9910365343093872
. O 0 0.0014485359424725175

The O 0 0.0003898366412613541
majority O 0 0.0001586732832947746
of O 0 3.665334588731639e-05
Jewish O 0 0.006815299391746521
185delAG O 1 0.9673447012901306
mutation O 0 0.008627942763268948
carriers O 0 0.00822696927934885
have O 0 8.454561611870304e-05
a O 0 0.0005422978429123759
common O 0 0.004158665891736746
allelic O 1 0.5455323457717896
pattern O 0 0.01771233230829239
, O 0 0.0005770925199612975
supporting O 0 0.0033657376188784838
the O 0 0.0006507309153676033
founder O 0 0.02217281609773636
effect O 0 0.0016104200622066855
notion O 0 0.0030124606564641
, O 0 0.00047241762513294816
but O 0 0.00046426214976236224
dating O 0 0.0016184010310098529
the O 0 0.00025611629826016724
mutations O 0 0.0016642260598018765
origin O 0 5.480103936861269e-05
to O 0 8.346603135578334e-05
an O 0 0.00027518701972439885
earlier O 0 0.0010210516629740596
date O 0 0.0002518193796277046
than O 0 7.960177026689053e-05
currently O 0 0.0006119839381426573
estimated O 0 0.0012884432217106223
. O 0 0.0005829580477438867

However O 0 0.001924282405525446
, O 0 0.00017014391778502613
the O 0 8.574426465202123e-05
different O 0 5.465490175993182e-05
allelic O 0 0.0615469254553318
pattern O 0 0.008607536554336548
at O 0 0.0021178084425628185
the O 0 0.001627075602300465
BRCA1 O 1 0.9999358654022217
locus O 0 0.030853331089019775
even O 0 0.000554871978238225
in O 0 8.694190910318866e-05
some O 0 5.713144855690189e-05
Jewish O 0 0.0028479518368840218
mutation O 0 0.010530924424529076
carriers O 0 0.02971150167286396
, O 0 0.0006856204126961529
might O 0 0.0016220408724620938
suggest O 0 0.0006816275999881327
that O 0 4.166792132309638e-05
the O 0 0.00020205293549224734
mutation O 0 0.002814363921061158
arose O 0 0.0023542954586446285
independently O 0 0.0004972757888026536
. O 0 0.00021411810303106904
. O 0 0.0005132554797455668

Crystal O 0 0.0912134200334549
structure O 0 0.0012024948373436928
of O 0 3.245484549552202e-05
the O 0 0.001679647364653647
hemochromatosis B-Disease 1 0.9999998807907104
protein O 0 0.022670716047286987
HFE O 1 0.9999542236328125
and O 0 0.0006125289364717901
characterization O 0 0.010563155636191368
of O 0 1.8031467334367335e-05
its O 0 9.891597437672317e-05
interaction O 0 0.0003198804915882647
with O 0 0.00019362922466825694
transferrin O 1 0.9889835715293884
receptor O 0 0.016131628304719925
. O 0 0.0005319837364368141

HFE O 1 0.9995676875114441
is O 0 0.0015711078885942698
an O 0 0.0012261943193152547
MHC O 1 0.999313473701477
- O 0 0.012751572765409946
related O 0 0.001057271845638752
protein O 0 0.0005118949920870364
that O 0 5.330144631443545e-05
is O 0 0.0002334425807930529
mutated O 0 0.002507271943613887
in O 0 5.769597919424996e-05
the O 0 0.00036097937845624983
iron B-Disease 1 0.9999661445617676
- I-Disease 1 0.9999275207519531
overload I-Disease 1 0.9999994039535522
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.004747916478663683

HFE O 1 0.9948845505714417
binds O 0 0.009307457134127617
to O 0 0.00030653842259198427
transferrin O 1 0.9040327668190002
receptor O 0 0.02284257672727108
( O 0 0.002803427865728736
TfR O 1 0.998435914516449
) O 0 0.0006340912077575922
and O 0 0.00018967690994031727
reduces O 0 0.013828366063535213
its O 0 0.00013974129979033023
affinity O 0 0.0026509605813771486
for O 0 0.000560348853468895
iron O 1 0.9905153512954712
- O 0 0.0064730169251561165
loaded O 0 0.0022160469088703394
transferrin O 1 0.9211248755455017
, O 0 0.0009571498376317322
implicating O 1 0.9939848780632019
HFE O 1 0.9998137354850769
in O 0 0.0013722169678658247
iron O 1 0.999077558517456
metabolism O 1 0.9885148406028748
. O 0 0.0009231783915311098

The O 0 0.001270816195756197
2 O 0 0.0028970367275178432
. O 0 0.0005319294868968427

6 O 0 0.0056388117372989655
A O 0 0.007160927169024944
crystal O 0 0.23714666068553925
structure O 0 0.0033509363420307636
of O 0 0.00027036183746531606
HFE O 1 0.999994158744812
reveals O 0 0.025902463123202324
the O 0 0.00012232812878210098
locations O 0 0.000288505747448653
of O 0 0.00023655290715396404
hemochromatosis B-Disease 1 1.0
mutations O 0 0.008148321881890297
and O 0 0.00026521843392401934
a O 0 0.0028874301351606846
patch O 1 0.999945878982544
of O 0 0.000139861018396914
histidines O 1 0.9933254718780518
that O 0 0.00011857543722726405
could O 0 0.0001785031199688092
be O 0 5.509426409844309e-05
involved O 0 0.0005563796730712056
in O 0 0.0004767469363287091
pH O 1 0.9821896553039551
- O 0 0.00791018083691597
dependent O 0 0.0023063889238983393
interactions O 0 0.0012374271173030138
. O 0 0.0006473988760262728

We O 0 0.0007032596622593701
also O 0 0.00014431709132622927
demonstrate O 0 0.0013562672538682818
that O 0 0.00016447942471131682
soluble O 1 0.9915052056312561
TfR O 1 0.9993239641189575
and O 0 0.0017084521241486073
HFE O 1 0.9996683597564697
bind O 0 0.012826599180698395
tightly O 0 0.0024169315584003925
at O 0 0.000935795484110713
the O 0 0.00022170008742250502
basic O 0 0.005247788038104773
pH O 0 0.04392852261662483
of O 0 3.074286360060796e-05
the O 0 0.000506531388964504
cell O 0 0.012517082504928112
surface O 0 0.019994521513581276
, O 0 0.000501259055454284
but O 0 0.00030152598628774285
not O 0 0.000135337162646465
at O 0 0.0004957584314979613
the O 0 0.0003504152118694037
acidic O 1 0.9739020466804504
pH O 0 0.07698611170053482
of O 0 4.7695153625681996e-05
intracellular O 0 0.040193866938352585
vesicles O 0 0.08348457515239716
. O 0 0.0010452010901644826

TfR O 1 0.9987276196479797
HFE O 1 0.9991971850395203
stoichiometry O 0 0.09322468191385269
( O 0 0.002119294134899974
2 O 0 0.002663403982296586
1 O 0 0.002013456542044878
) O 0 0.00021225051023066044
differs O 0 0.002568592317402363
from O 0 0.0003252125170547515
TfR O 1 0.9956900477409363
transferrin O 1 0.963089644908905
stoichiometry O 0 0.05352627485990524
( O 0 0.001671035890467465
2 O 0 0.003513115691021085
2 O 0 0.0034145258832722902
) O 0 0.0004861608613282442
, O 0 0.00037908487138338387
implying O 0 0.011190228164196014
a O 0 0.00026972053456120193
different O 0 1.4060008652450051e-05
mode O 0 0.0005024343845434487
of O 0 1.2947093637194484e-05
binding O 0 0.0010242238640785217
for O 0 0.0012597325257956982
HFE O 1 0.9998410940170288
and O 0 0.0008941979613155127
transferrin O 1 0.9841460585594177
to O 0 0.0009898933349177241
TfR O 1 0.9994052648544312
, O 0 0.00037859982694499195
consistent O 0 0.002663373714312911
with O 0 4.166149301454425e-05
our O 0 0.0003930114908143878
demonstration O 0 0.002124871825799346
that O 0 0.000321836065268144
HFE O 1 0.9999394416809082
, O 0 0.0010767515050247312
transferrin O 1 0.9865319132804871
, O 0 0.0005818328354507685
and O 0 0.00058742705732584
TfR O 1 0.9965153932571411
form O 0 0.0007534468895755708
a O 0 0.0009171037818305194
ternary O 0 0.036652375012636185
complex O 0 0.018201354891061783
. O 0 0.0012606539530679584

Identification O 0 0.001004751306027174
of O 0 2.5446302970522083e-05
three O 0 0.00021497829584404826
novel O 0 0.0037074838764965534
mutations O 0 0.003319681389257312
and O 0 0.00017896463396027684
a O 0 0.0010110919829457998
high O 0 0.002165383892133832
frequency O 0 0.00011770585842896253
of O 0 1.3203064554545563e-05
the O 0 0.0005004011909477413
Arg778Leu O 1 0.9902984499931335
mutation O 0 0.002295098500326276
in O 0 0.0003712376346811652
Korean O 1 0.5414408445358276
patients O 1 0.9999986886978149
with O 0 0.001087552634999156
Wilson B-Disease 1 0.999988317489624
disease I-Disease 1 1.0
. O 0 0.0011904706479981542

Four O 0 0.0008626960916444659
mutations O 0 0.0074222506955266
- O 0 0.023083483800292015
- O 0 0.01513668429106474
R778L O 0 0.06152239069342613
, O 0 0.0007117303321138024
A874V O 0 0.12030729651451111
, O 0 0.0007353040273301303
L1083F O 0 0.06261992454528809
, O 0 0.0003972155973315239
and O 0 0.00044733911636285484
2304delC O 1 0.9489498734474182
- O 0 0.01141755748540163
- O 0 0.002229278441518545
in O 0 8.462409459752962e-05
the O 0 0.00022552964219357818
copper O 0 0.041423212736845016
- O 0 0.0031554382294416428
transporting O 0 0.005453305318951607
enzyme O 0 0.005000820383429527
, O 0 0.0009935384150594473
P O 1 0.959709644317627
- O 0 0.0136297307908535
type O 0 0.017778359353542328
ATPase O 1 0.978039562702179
( O 0 0.005749398842453957
ATP7B O 1 0.9995564818382263
) O 0 0.000750578532461077
, O 0 0.00019027304369956255
were O 0 4.897098915535025e-05
identified O 0 0.0009389324113726616
in O 0 0.00028447917429730296
Korean O 1 0.826589822769165
Patients O 1 0.9999996423721313
with O 0 0.0008863329421728849
Wilson B-Disease 1 0.9999901056289673
disease I-Disease 1 0.9999998807907104
. O 0 0.000910229398868978

Arg778Leu O 1 0.9707140326499939
, O 0 0.0005205217166803777
the O 0 0.00020454885088838637
most O 0 0.00038491227314807475
frequently O 0 0.0030118366703391075
reported O 0 0.003456005360931158
mutation O 0 0.00048149985377676785
of O 0 9.821061212278437e-06
this O 0 9.576430602464825e-05
enzyme O 0 0.007006086874753237
, O 0 0.0005567061598412693
was O 0 0.002635905286297202
found O 0 0.0003217394696548581
in O 0 8.127699402393773e-05
six O 0 0.0001172632328234613
of O 0 2.136114017048385e-05
eight O 0 0.0014385886024683714
unrelated O 1 0.9528425931930542
patients O 1 0.9999974966049194
studied O 0 0.0034332042559981346
, O 0 0.00015731291205156595
an O 0 0.0002024938294198364
allele O 0 0.00262054824270308
frequency O 0 0.0001837202871683985
of O 0 4.500822615227662e-05
37 O 0 0.0063802204094827175
. O 0 0.0006174212321639061

5 O 0 0.0032930278684943914
% O 0 0.00014715212455485016
, O 0 0.0002422951947664842
which O 0 0.00010037152969744056
is O 0 0.0005410051671788096
considerably O 0 0.010038238018751144
higher O 0 0.0007795770070515573
than O 0 0.00012130301911383867
those O 0 8.605651964899153e-05
in O 0 0.00016999327635858208
other O 0 9.354353824164718e-05
Asian O 0 0.004626160021871328
populations O 0 0.0018481144215911627
. O 0 0.0006807498866692185

The O 0 0.0005349604762159288
novel O 0 0.0009988709352910519
single O 0 0.00020138938270974904
nucleotide O 0 0.0008123446023091674
deletion O 0 0.01384825725108385
, O 0 0.0009046161430887878
2304delC O 1 0.9433402419090271
, O 0 0.0005927963647991419
was O 0 0.0017912074690684676
found O 0 0.00030960736330598593
in O 0 0.00014130285126157105
one O 0 0.0008083528373390436
patient O 1 0.9999678134918213
. O 0 0.0009226850816048682

Since O 0 0.0020622536540031433
a O 0 0.0004820019821636379
mutation O 0 0.0014111350756138563
at O 0 0.0005995135870762169
cDNA O 0 0.0031841585878282785
nucleotide O 0 0.0027195545844733715
2302 O 1 0.9840346574783325
( O 0 0.0029644574970006943
2302insC O 1 0.9434083700180054
) O 0 0.0008035348728299141
had O 0 0.001268816296942532
been O 0 0.0007666152087040246
previously O 0 0.0020390062127262354
described O 0 0.004049567971378565
, O 0 0.0002459208481013775
this O 0 4.966852065990679e-05
region O 0 0.0005998616106808186
of O 0 1.924338357639499e-05
the O 0 0.0009679934591986239
ATP7B O 1 0.9999550580978394
gene O 0 0.008813631720840931
may O 0 0.0013491850113496184
be O 0 0.00018118921434506774
susceptible O 1 0.7176658511161804
to O 0 0.00012891327787656337
gene O 0 0.003971317317336798
rearrangements O 0 0.10742892324924469
causing O 1 0.9996323585510254
Wilson B-Disease 1 0.9999685287475586
disease I-Disease 1 0.9999998807907104
. O 0 0.0012351631885394454

Disruption O 0 0.01775570772588253
of O 0 3.0678726034238935e-05
splicing O 0 0.0016341794980689883
regulated O 0 0.0013311494840309024
by O 0 7.133073813747615e-05
a O 0 0.0021562252659350634
CUG O 1 0.9956761002540588
- O 0 0.0027665942907333374
binding O 0 0.0003004421596415341
protein O 0 0.0010159221710637212
in O 0 0.0020925626158714294
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.004077086690813303

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9301619529724121
DM B-Disease 1 1.0
) O 0 0.0017285081557929516
is O 0 0.0007872863207012415
caused O 0 0.004557052161544561
by O 0 7.833712879801169e-05
a O 0 0.003273298032581806
CTG O 1 0.9953225255012512
expansion O 0 0.004869787488132715
in O 0 0.000194151682080701
the O 0 0.0003410543140489608
3 O 0 0.001913810265250504
untranslated O 0 0.04369034618139267
region O 0 0.0009006938780657947
of O 0 2.959663834189996e-05
the O 0 0.0035724590998142958
DM B-Disease 1 1.0
gene O 0 0.013091943226754665
. O 0 0.0006653042510151863

One O 0 0.0004907319671474397
model O 0 0.001147221657447517
of O 0 0.0006102255429141223
DM B-Disease 1 1.0
pathogenesis O 1 0.9999967813491821
suggests O 0 0.00680076377466321
that O 0 0.00017152361397165805
RNAs O 0 0.025912370532751083
from O 0 6.695859337924048e-05
the O 0 0.00010810685489559546
expanded O 0 0.0013569650473073125
allele O 0 0.0020855749025940895
create O 0 0.0002846820862032473
a O 0 0.0006350245093926787
gain O 0 0.0033791647292673588
- O 0 0.003558184951543808
of O 0 5.595867696683854e-05
- O 0 0.00848578941076994
function O 0 0.0014764644438400865
mutation O 0 0.0017481883987784386
by O 0 4.560545494314283e-05
the O 0 0.0002901688567362726
inappropriate O 0 0.018198588863015175
binding O 0 0.0003257713688071817
of O 0 9.108453923545312e-06
proteins O 0 9.657073678681627e-05
to O 0 0.0001020299969241023
the O 0 0.0006864647730253637
CUG O 1 0.9989895224571228
repeats O 0 0.02198588289320469
. O 0 0.0006625073729082942

Data O 0 0.0009448940982110798
presented O 0 0.0020861586090177298
here O 0 0.0004230602062307298
indicate O 0 0.0005714853177778423
that O 0 1.4523338904837146e-05
the O 0 3.868083513225429e-05
conserved O 0 0.0003634285822045058
heterogeneous O 0 0.023065492510795593
nuclear O 0 0.023303620517253876
ribonucleoprotein O 1 0.998948872089386
, O 0 0.0011181627633050084
CUG O 1 0.9864961504936218
- O 0 0.001791702932678163
binding O 0 0.0002799183421302587
protein O 0 0.001220636535435915
( O 0 0.0015502608148381114
CUG O 1 0.9997394680976868
- O 0 0.11707336455583572
BP O 1 0.9923378825187683
) O 0 0.000652372429613024
, O 0 0.0005096316454000771
may O 0 0.002416298259049654
mediate O 0 0.01754024624824524
the O 0 0.0007667957688681781
trans O 0 0.21255441009998322
- O 0 0.00882832519710064
dominant O 0 0.003855330403894186
effect O 0 0.0004359982267487794
of O 0 1.1202091627637856e-05
the O 0 0.0002845098206307739
RNA O 0 0.00517701543867588
. O 0 0.000640323618426919

CUG O 1 0.9990977048873901
- O 0 0.2844656705856323
BP O 1 0.9921773076057434
was O 0 0.0023323982022702694
found O 0 0.0001933735329657793
to O 0 4.79091759189032e-05
bind O 0 0.0013121264055371284
to O 0 3.004201062140055e-05
the O 0 0.00019134700414724648
human O 0 0.03173913434147835
cardiac O 1 1.0
troponin O 1 0.9999997615814209
T O 1 0.999907374382019
( O 0 0.0020484458655118942
cTNT O 1 0.6695134043693542
) O 0 0.000556760816834867
pre O 0 0.01427205465734005
- O 0 0.00888354703783989
messenger O 0 0.015810346230864525
RNA O 0 0.0015315638156607747
and O 0 0.00010111287701874971
regulate O 0 0.002224966650828719
its O 0 0.00016985392721835524
alternative O 0 0.001505729160271585
splicing O 0 0.004285732749849558
. O 0 0.000691079709213227

Splicing O 0 0.0021295768674463034
of O 0 6.812922947574407e-05
cTNT O 1 0.542069137096405
was O 0 0.0024982921313494444
disrupted O 0 0.04637980833649635
in O 0 0.0029125686269253492
DM B-Disease 1 1.0
striated O 1 0.9999935626983643
muscle O 1 0.9999264478683472
and O 0 0.0004061456711497158
in O 0 0.0002893233031500131
normal O 0 0.0054386090487241745
cells O 0 0.0034239955712109804
expressing O 0 0.0022688922472298145
transcripts O 0 0.0014309972757473588
that O 0 6.0811889852629974e-05
contain O 0 0.0014314346481114626
CUG O 1 0.9981294274330139
repeats O 0 0.017642291262745857
. O 0 0.0006857082480564713

Altered O 0 0.008623689413070679
expression O 0 0.00031368821510113776
of O 0 1.6062789654824883e-05
genes O 0 0.0003474279656074941
regulated O 0 0.003716542385518551
posttranscriptionally O 0 0.1936071515083313
by O 0 0.0004991198075003922
CUG O 1 0.9996570348739624
- O 0 0.04287298396229744
BP O 1 0.950626015663147
therefore O 0 0.0006570011610165238
may O 0 0.0007442210917361081
contribute O 0 0.005501861684024334
to O 0 0.001912020379677415
DM B-Disease 1 1.0
pathogenesis O 1 0.9999959468841553
. O 0 0.0006814875523559749
. O 0 0.0005159424617886543

Identification O 0 0.0007834466523490846
of O 0 2.506958662706893e-05
a O 0 0.0013769729994237423
novel O 0 0.004941812716424465
nonsense O 0 0.03598548471927643
mutation O 0 0.0036172831896692514
and O 0 0.00013944499369245023
a O 0 0.0007233041687868536
missense O 0 0.007371579762548208
substitution O 0 0.0004375166317913681
in O 0 0.00010665898298611864
the O 0 0.0005390456062741578
vasopressin O 1 0.9956564903259277
- O 0 0.15043635666370392
neurophysin O 1 0.9961228966712952
II O 1 0.9975095987319946
gene O 0 0.001511059352196753
in O 0 7.69689359003678e-05
two O 0 3.6127185012446716e-05
Spanish O 0 0.000504304189234972
kindreds O 0 0.065948486328125
with O 0 0.000512533588334918
familial B-Disease 1 0.9999970197677612
neurohypophyseal I-Disease 1 0.9999992847442627
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999996423721313
. O 0 0.0028221469838172197

Familial B-Disease 1 0.9999936819076538
neurohypophyseal I-Disease 1 0.9999973773956299
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 0.02251560240983963
FNDI B-Disease 1 0.9999961853027344
) O 0 0.00044484256068244576
is O 0 0.0002045742148766294
an O 0 0.0005781843210570514
autosomal B-Disease 1 0.9999712705612183
dominant I-Disease 1 0.999923586845398
disease I-Disease 1 1.0
caused O 1 0.9650765061378479
by O 0 0.0008162728627212346
deficiency O 1 0.9999998807907104
in O 0 0.0002884507703129202
the O 0 0.000539333326742053
antidiuretic O 1 0.9954807758331299
hormone O 1 0.97865229845047
arginine O 0 0.3076154887676239
vasopressin O 1 0.9775872826576233
( O 0 0.0052696531638503075
AVP O 1 0.9998181462287903
) O 0 0.00015778522356413305
encoded O 0 3.2251395168714225e-05
by O 0 2.283864341734443e-05
the O 0 0.0010247724130749702
AVP O 1 0.9999921321868896
- O 0 0.05550596863031387
neurophysin O 1 0.9942536950111389
II O 1 0.9990108013153076
( O 0 0.004447876941412687
AVP O 1 0.999996542930603
- O 0 0.2966872453689575
NPII O 1 0.9979166388511658
) O 0 0.0004430361732374877
gene O 0 0.0013569309376180172
on O 0 0.00032108588493429124
chromosome O 0 0.005870640277862549
20p13 O 0 0.07982504367828369
. O 0 0.0006734177004545927

In O 0 0.0007059377967379987
this O 0 0.00015474966494366527
study O 0 0.0023908368311822414
, O 0 0.00023136413074098527
we O 0 0.00021868760813958943
analyzed O 0 0.0014411844313144684
two O 0 5.299930853652768e-05
families O 0 0.00026007930864579976
with O 0 0.00044489046558737755
FNDI B-Disease 1 0.9995880722999573
using O 0 0.00013002636842429638
direct O 0 0.00028196306084282696
automated O 0 0.0075142537243664265
fluorescent O 0 0.02577020786702633
, O 0 0.00040079312748275697
solid O 0 0.012875777669250965
phase O 0 0.012006429024040699
, O 0 0.00026739994063973427
single O 0 0.0007878773030824959
- O 0 0.00761898560449481
stranded O 0 0.005784695502370596
DNA O 0 0.0002485266013536602
sequencing O 0 0.00012073641119059175
of O 0 1.6868581951712258e-05
PCR O 0 0.026313146576285362
- O 0 0.012055277824401855
amplified O 0 0.019211195409297943
AVP O 1 0.9999681711196899
- O 0 0.05726585537195206
NPII O 1 0.9943139553070068
DNA O 0 0.003411207813769579
. O 0 0.0003345355507917702

In O 0 0.0005741294589824975
one O 0 9.357236558571458e-05
of O 0 1.993968544411473e-05
the O 0 0.00046462079626508057
families O 0 0.0008470304892398417
, O 0 0.0006457009585574269
affected O 0 0.010693595744669437
individuals O 0 0.00034283261629752815
presented O 0 0.0015935798874124885
a O 0 0.0011436521308496594
novel O 0 0.0035018171183764935
nonsense O 0 0.023997601121664047
mutation O 0 0.0032739921007305384
in O 0 0.00041771892574615777
exon O 0 0.04144647344946861
3 O 0 0.000562262546736747
of O 0 1.512701237516012e-05
the O 0 0.0004018139443360269
gene O 0 0.0031880747992545366
, O 0 0.00012723896361421794
consisting O 0 0.0001636921224417165
in O 0 0.0002106250321958214
a O 0 0.0019147861748933792
G O 1 0.5209507942199707
to O 0 0.0011944255093112588
T O 1 0.9988675117492676
transition O 0 0.006364047527313232
at O 0 0.0011684736236929893
nucleotide O 0 0.0024225953966379166
2101 O 1 0.9868764877319336
, O 0 0.0005001556128263474
which O 0 7.747003110125661e-05
produces O 0 0.0015637869946658611
a O 0 0.0007338214199990034
stop O 0 0.0021470433566719294
signal O 0 0.0013367017963901162
in O 0 0.00015869189519435167
codon O 0 0.009062644094228745
82 O 0 0.022283444181084633
( O 0 0.003369478974491358
Glu O 1 0.9996079802513123
) O 0 0.00038930479786358774
of O 0 9.656410838942975e-05
NPII O 1 0.9989244341850281
. O 0 0.0011966399615630507

The O 0 0.0031844053883105516
premature O 1 0.9971383810043335
termination O 1 0.9689833521842957
eliminates O 0 0.025231942534446716
part O 0 0.0005559889832511544
of O 0 2.4578472221037373e-05
the O 0 0.0011392338201403618
C O 1 0.9886954426765442
- O 0 0.026870064437389374
terminal O 0 0.11304984986782074
domain O 0 0.0006297475192695856
of O 0 0.00010459781333338469
NPII O 1 0.9995896220207214
, O 0 0.0002460366813465953
including O 0 4.9824549932964146e-05
a O 0 0.0004980630474165082
cysteine O 0 0.004602713976055384
residue O 0 0.013191046193242073
in O 0 0.00027033378137275577
position O 0 0.005525173153728247
85 O 0 0.011126444675028324
, O 0 0.0003269808366894722
which O 0 8.720527694094926e-05
could O 0 0.0002993390953633934
be O 0 9.054766269400716e-05
involved O 0 0.0005484118009917438
in O 0 0.00011878298391820863
the O 0 0.0003493822878226638
correct O 0 0.016069818288087845
folding O 0 0.011089330539107323
of O 0 3.0491670258925296e-05
the O 0 0.0008534306543879211
prohormone O 1 0.9992181062698364
. O 0 0.0015500024892389774

In O 0 0.000711161526851356
the O 0 0.00029530772008001804
second O 0 0.0009131978149525821
family O 0 0.000975244038272649
, O 0 0.0002483593416400254
a O 0 0.0009944647317752242
G279A O 0 0.03792344778776169
substitution O 0 0.0012592340353876352
at O 0 0.00175070995464921
position O 0 0.006681929342448711
- O 0 0.0054060532711446285
1 O 0 0.00038260361179709435
of O 0 7.485665264539421e-06
the O 0 0.00013599744124803692
signal O 0 0.003545428393408656
peptide O 0 0.009275401942431927
was O 0 0.0013977406779304147
observed O 0 0.0005246030632406473
in O 0 0.00010547522106207907
all O 0 5.809193680761382e-05
affected O 0 0.0074030556716024876
individuals O 0 0.0005248349043540657
. O 0 0.000733420078177005

This O 0 0.00037166522815823555
missense O 0 0.02025151252746582
mutation O 0 0.0026651553343981504
, O 0 0.00028200881206430495
which O 0 0.00025543253286741674
replaces O 1 0.9934768080711365
Ala O 1 0.9999531507492065
with O 0 0.0015754236374050379
Thr O 1 0.9999861717224121
, O 0 0.000650205765850842
is O 0 0.00047147064469754696
frequent O 0 0.007592798210680485
among O 0 0.00245454884134233
FNDI B-Disease 1 0.9999996423721313
patients O 1 0.9999980926513672
and O 0 0.00041106907883659005
is O 0 0.0006281891837716103
thought O 0 0.0012867359910160303
to O 0 7.448395626852289e-05
reduce O 0 0.002648069988936186
the O 0 8.437881479039788e-05
efficiency O 0 0.0015132229309529066
of O 0 4.0631755837239325e-05
cleavage O 0 0.1318974643945694
by O 0 0.00011797486513387412
signal O 0 0.008167813532054424
peptidases O 0 0.4574001729488373
. O 0 0.0004930567229166627
. O 0 0.0005402532988227904

Genetic O 0 0.004207876976579428
heterogeneity O 0 0.00803622417151928
of O 0 0.00011180331057403237
Saethre B-Disease 1 0.9999488592147827
- I-Disease 1 0.9992720484733582
Chotzen I-Disease 1 0.9999809265136719
syndrome I-Disease 1 1.0
, O 0 0.0008173184469342232
due O 0 0.0021014779340475798
to O 0 0.00027597471489571035
TWIST O 0 0.05825543776154518
and O 0 0.0011428053257986903
FGFR O 1 0.9992695450782776
mutations O 0 0.007134880404919386
. O 0 0.0005471477634273469

Thirty O 0 0.017982587218284607
- O 0 0.008691181428730488
two O 0 0.00020974004291929305
unrelated O 0 0.08669015020132065
patients O 1 0.9999855756759644
with O 0 5.043362034484744e-05
features O 0 0.00013972252781968564
of O 0 7.880285556893796e-05
Saethre B-Disease 1 0.9999778270721436
- I-Disease 1 0.9996390342712402
Chotzen I-Disease 1 0.9999890327453613
syndrome I-Disease 1 1.0
, O 0 0.0004972518654540181
a O 0 0.0011569269699975848
common O 0 0.009172921068966389
autosomal B-Disease 1 0.9997730851173401
dominant I-Disease 1 0.9838486909866333
condition I-Disease 1 0.9998798370361328
of O 0 0.00034812718513421714
craniosynostosis B-Disease 1 0.9999998807907104
and O 0 0.006108075845986605
limb B-Disease 1 0.9999994039535522
anomalies I-Disease 1 0.9969577789306641
, O 0 0.0003546007792465389
were O 0 6.232186569832265e-05
screened O 0 0.0024117680732160807
for O 0 0.00015004586020950228
mutations O 0 0.0015871661016717553
in O 0 0.0003424750466365367
TWIST O 0 0.40460205078125
, O 0 0.0018553431145846844
FGFR2 O 1 0.9995427131652832
, O 0 0.000776236760430038
and O 0 0.0007992259925231338
FGFR3 O 1 0.9995666146278381
. O 0 0.0008723805076442659

Nine O 0 0.0020669635850936174
novel O 0 0.002050135750323534
and O 0 0.0002087268076138571
three O 0 0.00045214532292447984
recurrent O 1 0.9999160766601562
TWIST O 1 0.7085016965866089
mutations O 0 0.0041331639513373375
were O 0 7.074914901750162e-05
found O 0 0.00033601128961890936
in O 0 0.00023527172743342817
12 O 0 0.0014809240819886327
families O 0 0.0005409162258729339
. O 0 0.0005798256024718285

Seven O 0 0.002070886781439185
families O 0 0.0003785899025388062
were O 0 6.0537855461006984e-05
found O 0 0.00023422871890943497
to O 0 5.777955811936408e-05
have O 0 5.917744056205265e-05
the O 0 0.0004549213335849345
FGFR3 O 1 0.9992874264717102
P250R O 0 0.3798961639404297
mutation O 0 0.005352450534701347
, O 0 0.0002668767992872745
and O 0 0.00011785377137130126
one O 0 0.00016962396330200136
individual O 0 0.0004582491237670183
was O 0 0.002228461904451251
found O 0 0.000287735543679446
to O 0 5.373607200453989e-05
have O 0 4.8277637688443065e-05
an O 0 0.0006425265455618501
FGFR2 O 1 0.9995112419128418
VV269 O 1 0.5204256176948547
- O 0 0.01279655285179615
270 O 0 0.018463008105754852
deletion O 0 0.01674143224954605
. O 0 0.0005577163537964225

To O 0 0.0006419848650693893
date O 0 0.00043342384742572904
, O 0 0.00010512447624932975
our O 0 0.00033839643583633006
detection O 0 0.0057840594090521336
rate O 0 0.00021935814584139735
for O 0 0.0003588166437111795
TWIST O 0 0.10778258740901947
or O 0 0.0029804769437760115
FGFR O 1 0.997199296951294
mutations O 0 0.004899616353213787
is O 0 0.0006429296336136758
68 O 0 0.00331983738578856
% O 0 3.260402081650682e-05
in O 0 9.366806625621393e-05
our O 0 0.0017700021853670478
Saethre B-Disease 1 0.9999244213104248
- I-Disease 1 0.999649167060852
Chotzen I-Disease 1 0.9999985694885254
syndrome I-Disease 1 1.0
patients O 1 0.9999996423721313
, O 0 0.00022571723093278706
including O 0 5.493728895089589e-05
our O 0 0.000811909616459161
five O 0 0.0015111112734302878
patients O 1 0.9999977350234985
elsewhere O 0 0.002120046876370907
reported O 0 0.0031586827244609594
with O 0 0.0001772845716914162
TWIST O 0 0.13411344587802887
mutations O 0 0.005762202199548483
. O 0 0.0005847031134180725

More O 0 0.00021196356101427227
than O 0 0.000166625453857705
35 O 0 0.0010375006822869182
different O 0 7.099543290678412e-05
TWIST O 0 0.06260434538125992
mutations O 0 0.004457498900592327
are O 0 9.344636782770976e-05
now O 0 0.0015615320298820734
known O 0 0.0007266613538376987
in O 0 0.00011378465569578111
the O 0 0.00019008190429303795
literature O 0 0.0007036129245534539
. O 0 0.0005541773862205446

The O 0 0.0006495025590993464
most O 0 0.000436932488810271
common O 0 0.004480303730815649
phenotypic O 0 0.050991930067539215
features O 0 0.0017960636178031564
, O 0 0.0004708796041086316
present O 0 0.00029394958983175457
in O 0 0.00011977593385381624
more O 0 5.563033482758328e-05
than O 0 8.563509618397802e-05
a O 0 0.00032229971839115024
third O 0 0.00025830301456153393
of O 0 2.9776407245662995e-05
our O 0 0.005329173523932695
patients O 1 0.9999939203262329
with O 0 0.00032371783163398504
TWIST O 0 0.3827739953994751
mutations O 0 0.004274740349501371
, O 0 0.00019347385386936367
are O 0 8.038219675654545e-05
coronal B-Disease 1 0.9765231013298035
synostosis I-Disease 1 0.9737185835838318
, O 0 0.0006214686436578631
brachycephaly B-Disease 0 0.483247309923172
, O 0 0.0003972700797021389
low B-Disease 0 0.0359247662127018
frontal I-Disease 1 0.9999997615814209
hairline I-Disease 1 1.0
, O 0 0.003952912986278534
facial B-Disease 1 0.9999988079071045
asymmetry I-Disease 1 0.9972071051597595
, O 0 0.004210296552628279
ptosis B-Disease 1 0.9999997615814209
, O 0 0.0033087756019085646
hypertelorism B-Disease 1 0.9998307228088379
, O 0 0.0009692577295936644
broad B-Disease 0 0.025758380070328712
great I-Disease 0 0.008051032200455666
toes I-Disease 1 0.9995110034942627
, O 0 0.0007384521304629743
and O 0 0.0005640133749693632
clinodactyly B-Disease 1 0.9933789968490601
. O 0 0.0007850168040022254

Significant O 0 0.00423839595168829
intra O 0 0.16868054866790771
- O 0 0.017657775431871414
and O 0 0.0005338159971870482
interfamilial O 1 0.8867314457893372
phenotypic O 0 0.023593910038471222
variability O 0 0.007131999358534813
is O 0 0.0003203263331670314
present O 0 0.00013813955592922866
for O 0 0.00026084811543114483
either O 0 0.0009989357786253095
TWIST O 0 0.07755003869533539
mutations O 0 0.006383506581187248
or O 0 0.0019102267688140273
FGFR O 1 0.9993852376937866
mutations O 0 0.007969214580953121
. O 0 0.0006389343761838973

The O 0 0.0010253016371279955
overlap O 0 0.005315728485584259
in O 0 0.0011644823243841529
clinical O 1 0.9999356269836426
features O 0 0.0006806071614846587
and O 0 0.00015621722559444606
the O 0 0.0002870970347430557
presence O 0 0.0018732394091784954
, O 0 0.0002912261988967657
in O 0 0.00015863242151681334
the O 0 0.0001409162941854447
same O 0 0.00020192467491142452
genes O 0 0.0004595741629600525
, O 0 0.00010688449401641265
of O 0 2.7670095732901245e-05
mutations O 0 0.0016377642750740051
for O 0 9.142779890680686e-05
more O 0 4.0750692278379574e-05
than O 0 0.0001031368228723295
one O 0 0.0007204836583696306
craniosynostotic B-Disease 1 0.9993914365768433
condition I-Disease 1 0.9998346567153931
- O 0 0.003085818374529481
such O 0 3.341886986163445e-05
as O 0 0.0008571428479626775
Saethre B-Disease 1 0.9979884624481201
- I-Disease 0 0.02850470133125782
Chotzen I-Disease 1 0.9799600839614868
, I-Disease 0 0.0009874268434941769
Crouzon I-Disease 1 0.9922298789024353
, I-Disease 0 0.0007707447512075305
and I-Disease 0 0.002314063487574458
Pfeiffer I-Disease 1 0.9999997615814209
syndromes I-Disease 1 0.999997615814209
- O 0 0.008989604189991951
support O 0 0.00034711899934336543
the O 0 0.00019959393830504268
hypothesis O 0 0.004026162903755903
that O 0 0.0002270152181154117
TWIST O 0 0.06417195498943329
and O 0 0.0008366740657947958
FGFRs O 1 0.9616535902023315
are O 0 3.409279452171177e-05
components O 0 0.0005717318854294717
of O 0 1.3495361599780153e-05
the O 0 0.00015826875460334122
same O 0 0.00025439809542149305
molecular O 0 0.007535131648182869
pathway O 0 0.010617369785904884
involved O 0 0.0009550292161293328
in O 0 9.398740075994283e-05
the O 0 0.00011203980830032378
modulation O 0 0.004013223573565483
of O 0 0.00026223910390399396
craniofacial O 1 1.0
and O 0 0.002991076558828354
limb O 1 0.9999964237213135
development O 0 0.0035689433570951223
in O 0 0.0003250652807764709
humans O 0 0.0030760394874960184
. O 0 0.000241224275669083
. O 0 0.0004456406459212303

Mutation O 0 0.0029397960752248764
analysis O 0 0.00020966667216271162
of O 0 0.000105798571894411
UBE3A O 1 0.999992847442627
in O 0 0.25113019347190857
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999998807907104
. O 0 0.0014222600730136037

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.010291214101016521
AS B-Disease 1 0.9779025912284851
) O 0 0.0006403697771020234
is O 0 0.0005076087545603514
caused O 0 0.004263245966285467
by O 0 0.00011695502325892448
chromosome O 0 0.010532429441809654
15q11 O 1 0.8888163566589355
- O 0 0.023426150903105736
q13 O 0 0.04387567937374115
deletions O 0 0.0017459930386394262
of O 0 3.355612716404721e-05
maternal O 0 0.02268056385219097
origin O 0 0.00012117584992665797
, O 0 0.0001733823592076078
by O 0 0.00011950930638704449
paternal O 0 0.08705384284257889
uniparental B-Disease 1 0.9999560117721558
disomy I-Disease 1 0.9986404776573181
( O 0 0.01010311208665371
UPD B-Disease 1 0.9999897480010986
) O 0 0.0012523869518190622
15 O 0 0.0008727204403840005
, O 0 0.0001435764424968511
by O 0 0.00020066752040293068
imprinting O 1 0.999319314956665
defects O 1 0.9999978542327881
, O 0 0.0005628826911561191
and O 0 0.00012844358570873737
by O 0 8.917807281250134e-05
mutations O 0 0.002300397027283907
in O 0 0.00019007863011211157
the O 0 0.0011435000924393535
UBE3A O 1 0.9998570680618286
gene O 0 0.010363958775997162
. O 0 0.0006457470590248704

UBE3A O 1 0.9330914616584778
encodes O 0 0.0021185525692999363
a O 0 0.0007709676865488291
ubiquitin O 0 0.017837565392255783
- O 0 0.0027935514226555824
protein O 0 0.0007071714499033988
ligase O 0 0.007458634674549103
and O 0 0.00020832435984630138
shows O 0 0.0020149957854300737
brain O 1 0.9999886751174927
- O 0 0.006038632243871689
specific O 0 0.00040968754910863936
imprinting O 0 0.09347587823867798
. O 0 0.0007707340992055833

Here O 0 0.0010709429625421762
we O 0 0.0003637644404079765
describe O 0 0.007699186448007822
UBE3A O 1 0.9986977577209473
coding O 0 0.06545788794755936
- O 0 0.019808810204267502
region O 0 0.00366340228356421
mutations O 0 0.003561766119673848
detected O 0 0.008404615335166454
by O 0 0.00012950185919180512
SSCP O 1 0.9832456111907959
analysis O 0 0.0005413790931925178
in O 0 0.00035174915683455765
13 O 0 0.0038532381877303123
AS B-Disease 0 0.030020684003829956
individuals O 0 0.0004947088309563696
or O 0 0.0007669553742744029
families O 0 0.000648763554636389
. O 0 0.000671581132337451

Two O 0 0.00020836788462474942
identical O 0 0.001072746585123241
de O 0 0.006683357525616884
novo O 0 0.03264358639717102
5 O 0 0.0031037635635584593
- O 0 0.012783368118107319
bp O 0 0.08739204704761505
duplications O 0 0.014643034897744656
in O 0 0.00045517442049458623
exon O 0 0.04153301566839218
16 O 0 0.0013556152116507292
were O 0 6.869904609629884e-05
found O 0 0.0006423731683753431
. O 0 0.0004451447748579085

Among O 0 0.000381582067348063
the O 0 0.00015056970005389303
other O 0 7.376867870334536e-05
11 O 0 0.001404580194503069
unique O 0 0.001192706055007875
mutations O 0 0.004797222558408976
, O 0 0.0004014651640318334
8 O 0 0.0009423676528967917
were O 0 3.1886858778307214e-05
small O 0 0.00026576590607874095
deletions O 0 0.005059016402810812
or O 0 0.0006975237047299743
insertions O 0 0.010148285888135433
predicted O 0 0.003804615465924144
to O 0 0.0001965683768503368
cause O 0 0.0585772842168808
frameshifts O 1 0.9931963682174683
, O 0 0.000569112366065383
1 O 0 0.0017766740638762712
was O 0 0.0008207614882849157
a O 0 0.00044018603512085974
mutation O 0 0.0009942315518856049
to O 0 6.52861490380019e-05
a O 0 0.0005825093248859048
stop O 0 0.003653911640867591
codon O 0 0.005894962698221207
, O 0 0.00030276086181402206
1 O 0 0.001510964473709464
was O 0 0.0008671881514601409
a O 0 0.0007376489229500294
missense O 0 0.023714443668723106
mutation O 0 0.0038431663997471333
, O 0 0.00035012353328056633
and O 0 0.00025361342704854906
1 O 0 0.0029307573568075895
was O 0 0.001570141757838428
predicted O 0 0.0025774005334824324
to O 0 0.00012048408098053187
cause O 0 0.007182898465543985
insertion O 0 0.0065267616882920265
of O 0 3.46121632901486e-05
an O 0 0.0011623998871073127
isoleucine O 1 0.9906699657440186
in O 0 0.0003955346764996648
the O 0 0.0004571785975713283
hect O 0 0.0880001038312912
domain O 0 0.00031726399902254343
of O 0 1.8804072169587016e-05
the O 0 0.0008456792565993965
UBE3A O 1 0.9989610910415649
protein O 0 0.00225384091027081
, O 0 0.00020332437998149544
which O 0 3.2667481718817726e-05
functions O 0 0.00022600450029131025
in O 0 0.0004182791744824499
E2 O 1 0.751861572265625
binding O 0 0.0009914000984281301
and O 0 0.0002270593831781298
ubiquitin O 0 0.016150211915373802
transfer O 0 0.0015277824131771922
. O 0 0.0005331752472557127

Eight O 0 0.00044398297904990613
of O 0 1.679388151387684e-05
the O 0 0.0004718145646620542
cases O 0 0.0038687295746058226
were O 0 0.0003244188555981964
familial O 1 0.9998576641082764
, O 0 0.0008181955199688673
and O 0 0.00020730907272081822
five O 0 0.00019447406521067023
were O 0 8.112444629659876e-05
sporadic O 0 0.010044323280453682
. O 0 0.0006093966658227146

In O 0 0.0006548275705426931
two O 0 0.00035244430182501674
familial O 1 0.9998689889907837
cases O 0 0.0076749264262616634
and O 0 0.00020219401631038636
one O 0 0.0003541375626809895
sporadic O 0 0.011326156556606293
case O 0 0.0041992198675870895
, O 0 0.0008117158431559801
mosaicism O 1 0.9983140230178833
for O 0 0.0018980614840984344
UBE3A O 1 0.9998879432678223
mutations O 0 0.0074439640156924725
was O 0 0.002261565998196602
detected O 0 0.008038463070988655
in O 0 0.00014436969649977982
the O 0 0.00028664630372077227
mother O 0 0.002481495263054967
of O 0 3.126896626781672e-05
three O 0 0.0005591886583715677
AS B-Disease 1 0.9694552421569824
sons O 0 0.017884131520986557
, O 0 0.0002791050064843148
in O 0 0.0001797938602976501
the O 0 0.0004735404800157994
maternal O 0 0.22324159741401672
grandfather O 0 0.010048572905361652
of O 0 2.9579961847048253e-05
two O 0 0.00018101029854733497
AS B-Disease 0 0.035635773092508316
first O 0 0.0009786433074623346
cousins O 0 0.010149895213544369
, O 0 0.0004065502143930644
and O 0 0.0002069634647341445
in O 0 0.00022910136613063514
the O 0 0.0004094546602573246
mother O 0 0.0030083688907325268
of O 0 2.99787334370194e-05
an O 0 0.001301828189752996
AS B-Disease 1 0.9961484670639038
daughter O 0 0.06004440784454346
. O 0 0.0008171608205884695

The O 0 0.000353464885847643
frequencies O 0 0.00016746309120208025
with O 0 6.093006959417835e-05
which O 0 6.828168261563405e-05
we O 0 0.00029112905031070113
detected O 0 0.007675915025174618
mutations O 0 0.0012620527995750308
were O 0 8.79935032571666e-05
5 O 0 0.0016997091006487608
( O 0 0.0009876432595774531
14 O 0 0.002089409390464425
% O 0 8.587273623561487e-05
) O 0 0.00012743334809783846
of O 0 2.282897366967518e-05
35 O 0 0.0019598763901740313
in O 0 0.0003974341379944235
sporadic O 0 0.021407002583146095
cases O 0 0.0042582545429468155
and O 0 0.0005442332476377487
8 O 0 0.004248603247106075
( O 0 0.001027969061397016
80 O 0 0.002697749761864543
% O 0 0.00010061206558020785
) O 0 0.00010031277633970603
of O 0 1.6295258319587447e-05
10 O 0 0.0006629576673731208
in O 0 0.0007109396392479539
familial O 1 0.9999572038650513
cases O 0 0.018627287819981575
. O 0 0.0004097814962733537
. O 0 0.0005107299075461924

The O 0 0.006908154580742121
hemochromatosis B-Disease 1 0.9999997615814209
845 O 1 0.995908260345459
G O 1 0.9715397953987122
- O 0 0.023485850542783737
- O 0 0.009665978141129017
> O 0 0.007887699641287327
A O 0 0.001528052962385118
and O 0 0.00017509859753772616
187 O 0 0.016367251053452492
C O 0 0.37943291664123535
- O 0 0.017680585384368896
- O 0 0.01559672225266695
> O 0 0.027275405824184418
G O 0 0.12237605452537537
mutations O 0 0.004827242810279131
: O 0 0.0010091622825711966
prevalence O 1 0.9762770533561707
in O 0 0.0005475145298987627
non O 0 0.013448864221572876
- O 0 0.04694340378046036
Caucasian O 1 0.7457835674285889
populations O 0 0.0016768097411841154
. O 0 0.0005831851158291101

Hemochromatosis B-Disease 1 0.9999996423721313
, O 0 0.001395434490405023
the O 0 0.0022988782729953527
inherited B-Disease 1 0.9999997615814209
disorder I-Disease 1 1.0
of I-Disease 0 0.00019283403526060283
iron I-Disease 1 0.9999676942825317
metabolism I-Disease 1 0.9990788698196411
, O 0 0.0006205739919096231
leads O 0 0.0043359603732824326
, O 0 0.0004772154497914016
if O 0 0.002872674260288477
untreated O 1 0.9999943971633911
, O 0 0.00017533733625896275
to O 0 0.00017309628310613334
progressive O 1 0.9669050574302673
iron B-Disease 1 0.9999186992645264
overload I-Disease 1 0.999840259552002
and O 0 0.0017391424626111984
premature B-Disease 1 0.9998593330383301
death I-Disease 0 0.010373726487159729
. O 0 0.000633377640042454

The O 0 0.005660181865096092
hemochromatosis B-Disease 1 0.9999998807907104
gene O 0 0.0173138827085495
, O 0 0.0018154813442379236
HFE O 1 0.9999794960021973
, O 0 0.0018456884426996112
recently O 0 0.012019393965601921
has O 0 0.0009697852656245232
been O 0 0.0006464786129072309
identified O 0 0.0019375575939193368
, O 0 0.000230951962294057
and O 0 0.00017852916789706796
characterization O 0 0.014097651466727257
of O 0 2.2849033484817483e-05
this O 0 0.00013950139691587538
gene O 0 0.004616149235516787
has O 0 0.0007636494701728225
shown O 0 0.0006607606774196029
that O 0 4.132419780944474e-05
it O 0 5.6436438171658665e-05
contains O 0 8.66701448103413e-05
two O 0 6.490377563750371e-05
mutations O 0 0.0017377472249791026
that O 0 5.349321509129368e-05
result O 0 0.00026863417588174343
in O 0 5.485002475325018e-05
amino O 0 0.00034276218502782285
acid O 0 0.0064557017758488655
substitutions O 0 0.0017945425352081656
- O 0 0.0026287841610610485
cDNA O 0 0.0028607368003576994
nucleotides O 0 0.0038857832551002502
845 O 0 0.2088848203420639
G O 0 0.4996403455734253
- O 0 0.019431602209806442
- O 0 0.010894796811044216
> O 0 0.012914842925965786
A O 0 0.006810933351516724
( O 0 0.0013006717199459672
C282Y O 0 0.07345204800367355
) O 0 0.00026155688101425767
and O 0 0.00016503207734785974
187 O 0 0.018874358385801315
C O 1 0.6305170655250549
- O 0 0.021136930212378502
- O 0 0.01451750285923481
> O 0 0.031174980103969574
G O 0 0.2019963264465332
( O 0 0.0032659696880728006
H63D O 1 0.9983127117156982
) O 0 0.0011152075603604317
. O 0 0.0005002000252716243

Although O 0 0.016438575461506844
hemochromatosis B-Disease 1 1.0
is O 0 0.0018448435002937913
common O 0 0.0021973762195557356
in O 0 0.0007196580991148949
Caucasians O 1 0.98997962474823
, O 0 0.0006023765308782458
affecting O 0 0.044208038598299026
> O 0 0.07207755744457245
= O 0 0.020641189068555832
1 O 0 0.011098423041403294
/ O 0 0.06498126685619354
300 O 0 0.0015791812911629677
individuals O 0 0.00010660367843229324
of O 0 3.3550881198607385e-05
northern O 0 0.002566417446359992
European O 0 0.0010452615097165108
origin O 0 0.00021885699243284762
, O 0 0.0004178304807282984
it O 0 0.0003632633888628334
has O 0 0.0010163335828110576
not O 0 0.00021776086941827089
been O 0 0.00040528972749598324
recognized O 0 0.0019209554884582758
in O 0 0.00013824141933582723
other O 0 7.47296871850267e-05
populations O 0 0.0011638397118076682
. O 0 0.000661172962281853

The O 0 0.0007807746878825128
present O 0 0.00040260879904963076
study O 0 0.000806796015240252
used O 0 0.00022709317272529006
PCR O 0 0.008108608424663544
and O 0 0.00011514970537973568
restriction O 0 0.0016110276337713003
- O 0 0.008668328635394573
enzyme O 0 0.005423258524388075
digestion O 0 0.027399618178606033
to O 0 0.00014046246360521764
analyze O 0 0.0019713465590029955
the O 0 4.9556107114767656e-05
frequency O 0 6.119735917309299e-05
of O 0 9.399628652317915e-06
the O 0 0.0006524404743686318
845 O 1 0.982797384262085
G O 1 0.87091064453125
- O 0 0.020229119807481766
- O 0 0.009941973723471165
> O 0 0.008095004595816135
A O 0 0.0018052016384899616
and O 0 0.0002640879829414189
187 O 0 0.021434767171740532
C O 1 0.7195720076560974
- O 0 0.020780406892299652
- O 0 0.014338417910039425
> O 0 0.021939482539892197
G O 0 0.047636110335588455
mutations O 0 0.0027473149821162224
in O 0 0.0009272868628613651
HLA O 1 0.9998569488525391
- O 0 0.008246847428381443
typed O 0 0.0023312666453421116
samples O 0 0.0004251952050253749
from O 0 0.00016828134539537132
non O 0 0.010059421882033348
- O 0 0.025314316153526306
Caucasian O 0 0.14146891236305237
populations O 0 0.001036828733049333
, O 0 0.0002481345145497471
comprising O 0 0.0009332956396974623
Australian O 0 0.012792333029210567
Aboriginal O 0 0.021861301735043526
, O 0 0.00040767359314486384
Chinese O 0 0.0006108926027081907
, O 0 0.00037691896432079375
and O 0 0.00038476771442219615
Pacific O 0 0.014024961739778519
Islanders O 0 0.017255712300539017
. O 0 0.000641362858004868

Results O 0 0.0028576017357409
showed O 0 0.0009842690778896213
that O 0 3.1653500627726316e-05
the O 0 0.00030329186120070517
845 O 1 0.9688303470611572
G O 1 0.9222400784492493
- O 0 0.034008774906396866
- O 0 0.014089025557041168
> O 0 0.012408980168402195
A O 0 0.006281591951847076
mutation O 0 0.005696041043847799
was O 0 0.0013821817701682448
present O 0 0.00022139989596325904
in O 0 0.00013695000961888582
these O 0 4.3750053009716794e-05
populations O 0 0.0008155260002240539
( O 0 0.0006607052637264132
allele O 0 0.0035789860412478447
frequency O 0 0.0006549271638505161
0 O 0 0.00240088882856071
. O 0 0.0002313658915227279
32 O 0 0.0013143784599378705
% O 0 0.00015457445988431573
) O 0 0.0005541021237149835
, O 0 0.0004157177754677832
and O 0 0.00030256438185460865
, O 0 0.0005331945139914751
furthermore O 0 0.003813037183135748
, O 0 0.0003313742927275598
it O 0 0.00025117816403508186
was O 0 0.001607032842002809
always O 0 0.0008528559119440615
seen O 0 0.0010484892409294844
in O 0 0.00015668803825974464
conjunction O 0 0.007569056004285812
with O 0 0.0012189628323540092
HLA O 1 0.9999592304229736
haplotypes O 0 0.04338562488555908
common O 0 0.0030986021738499403
in O 0 0.0009127297671511769
Caucasians O 1 0.9884393215179443
, O 0 0.000352938543073833
suggesting O 0 0.003406988922506571
that O 0 0.00022483272186946124
845 O 1 0.9565455317497253
G O 1 0.9489718079566956
- O 0 0.030036896467208862
- O 0 0.017838340252637863
> O 0 0.020185429602861404
A O 0 0.008696991950273514
may O 0 0.0025396235287189484
have O 0 0.00015811897173989564
been O 0 0.0003342476557008922
introduced O 0 0.00024016908719204366
into O 0 5.5588126997463405e-05
these O 0 2.202739051426761e-05
populations O 0 0.0003840542340185493
by O 0 0.00017741392366588116
Caucasian O 1 0.9695325493812561
admixture O 0 0.3027705252170563
. O 0 0.0018630967242643237

187 O 0 0.04480057954788208
C O 1 0.6605554819107056
- O 0 0.028183387592434883
- O 0 0.02049131505191326
> O 0 0.033821262419223785
G O 0 0.09996909648180008
was O 0 0.0017185858450829983
present O 0 0.00023681603488512337
at O 0 0.000541896210052073
an O 0 0.00020154996309429407
allele O 0 0.0025919750332832336
frequency O 0 0.0001955297775566578
of O 0 3.9622867916477844e-05
2 O 0 0.0031159028876572847
. O 0 0.0006511365645565093

68 O 0 0.020669488236308098
% O 0 9.76050432655029e-05
in O 0 0.0001221342827193439
the O 0 0.00012233851884957403
two O 0 5.703134593204595e-05
populations O 0 0.0006516133435070515
analyzed O 0 0.006112850736826658
( O 0 0.0012102131731808186
Australian O 0 0.010350332595407963
Aboriginal O 0 0.016211988404393196
and O 0 0.0002355392643949017
Chinese O 0 0.0010629522148519754
) O 0 0.0005583950551226735
. O 0 0.0005532492650672793

In O 0 0.0005072710919193923
the O 0 0.0003574197762645781
Australian O 0 0.006450222805142403
Aboriginal O 0 0.006672833114862442
samples O 0 0.0006480843876488507
, O 0 0.0003652764717116952
187 O 0 0.018819745630025864
C O 1 0.6515617966651917
- O 0 0.023607579991221428
- O 0 0.01779126189649105
> O 0 0.030870886519551277
G O 0 0.12835970520973206
was O 0 0.002123960293829441
found O 0 0.00023908498405944556
to O 0 4.3279189412714913e-05
be O 0 8.976618119049817e-05
associated O 0 0.00047462215297855437
with O 0 0.0005595559487119317
HLA O 1 0.9999735355377197
haplotypes O 0 0.046542614698410034
common O 0 0.0035945381969213486
in O 0 0.0011006082640960813
Caucasians O 1 0.9950242638587952
, O 0 0.000784927629865706
suggesting O 0 0.005251300986856222
that O 0 9.847054025158286e-05
it O 0 0.00016157951904460788
was O 0 0.0009966565994545817
introduced O 0 0.0002557117259129882
by O 0 5.351122672436759e-05
recent O 0 0.0020557146053761244
admixture O 0 0.0694444328546524
. O 0 0.001219109632074833

In O 0 0.0004247356264386326
the O 0 9.870727080851793e-05
Chinese O 0 0.0002157004055334255
samples O 0 0.0003809521731454879
analyzed O 0 0.0016817115247249603
, O 0 0.000339869613526389
187 O 0 0.01821129582822323
C O 0 0.24983447790145874
- O 0 0.020244160667061806
- O 0 0.014829837717115879
> O 0 0.029667213559150696
G O 0 0.06832875311374664
was O 0 0.0017191985389217734
present O 0 0.0003457345883361995
in O 0 0.0004498202761169523
association O 0 0.009156106039881706
with O 0 7.981390808708966e-05
a O 0 0.0005967739853076637
wide O 0 0.0008906513685360551
variety O 0 0.0006468785577453673
of O 0 0.000297955353744328
HLA O 1 0.9999977350234985
haplotypes O 0 0.06683824211359024
, O 0 0.0003863417950924486
showing O 0 0.0012369314208626747
this O 0 7.961301162140444e-05
mutation O 0 0.001473521813750267
to O 0 8.697167504578829e-05
be O 0 0.00013926031533628702
widespread O 0 0.001451679039746523
and O 0 0.00043154240120202303
likely O 0 0.002346138237044215
to O 0 0.00020699205924756825
predate O 0 0.0229985099285841
the O 0 9.140259498963133e-05
more O 0 5.6962202506838366e-05
genetically O 0 0.0011056219227612019
restricted O 0 0.0030931259971112013
845 O 1 0.9303818345069885
G O 1 0.928244411945343
- O 0 0.025420431047677994
- O 0 0.013423025608062744
> O 0 0.010475429706275463
A O 0 0.004298765677958727
mutation O 0 0.004449888132512569
. O 0 0.0005520498962141573

Genotype O 1 0.9820252656936646
- O 0 0.03462489694356918
phenotype O 0 0.03947407379746437
correlations O 0 0.0038113677874207497
in O 0 0.0010205918224528432
attenuated B-Disease 1 0.9999357461929321
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999974966049194
. O 0 0.0021164282225072384

Germ O 1 0.9998581409454346
- O 0 0.020264199003577232
line O 0 0.0016646110452711582
mutations O 0 0.00036700634518638253
of O 0 1.2422746294760145e-05
the O 0 0.0010589512530714273
tumor B-Disease 1 0.9999988079071045
suppressor O 1 0.9840821027755737
APC O 1 0.9964308738708496
are O 0 9.63092825259082e-05
implicated O 1 0.7799435257911682
in O 0 0.0008473800262436271
attenuated B-Disease 1 0.9999781847000122
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999998807907104
( O 0 0.026401493698358536
AAPC B-Disease 1 0.999998927116394
) O 0 0.0007756921695545316
, O 0 0.00010814666165970266
a O 0 0.0004885195521637797
variant O 0 0.014283115044236183
of O 0 0.0003794668591581285
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 0.06837313622236252
FAP B-Disease 1 0.999985933303833
) O 0 0.0016172879841178656
. O 0 0.0005894759087823331

AAPC B-Disease 1 0.9999853372573853
is O 0 0.0022343795280903578
recognized O 0 0.0016933645820245147
by O 0 3.342240597703494e-05
the O 0 0.00015317719953600317
occurrence O 0 0.007262134458869696
of O 0 7.835835276637226e-05
< O 0 0.0916031002998352
100 O 0 0.003587255021557212
colonic B-Disease 1 0.9999583959579468
adenomas I-Disease 1 0.999788224697113
and O 0 0.00017113317153416574
a O 0 0.00044057308696210384
later O 0 0.0009446541080251336
onset O 1 0.9999716281890869
of O 0 0.002315348479896784
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.002365577034652233
age O 0 0.002847574418410659
> O 0 0.01935701072216034
40 O 0 0.001368934172205627
years O 0 0.0014508359599858522
) O 0 0.00041529457666911185
. O 0 0.00036720893695019186

The O 0 0.0006787778693251312
aim O 0 0.003506224602460861
of O 0 2.5948271286324598e-05
this O 0 9.244686225429177e-05
study O 0 0.0014905034331604838
was O 0 0.0007783578475937247
to O 0 0.0001562667021062225
assess O 0 0.04713068902492523
genotype O 0 0.41223466396331787
- O 0 0.025113800540566444
phenotype O 0 0.07388470321893692
correlations O 0 0.010141261853277683
in O 0 0.0027866195887327194
AAPC B-Disease 1 0.999998927116394
families O 0 0.002385238651186228
. O 0 0.0008088120957836509

By O 0 0.0001455682941013947
protein O 0 0.001599271665327251
- O 0 0.007522355765104294
truncation O 0 0.03612278774380684
test O 0 0.009714964777231216
( O 0 0.001785330125130713
PTT O 1 0.9123030304908752
) O 0 0.0007391681428998709
assay O 0 0.007306415122002363
, O 0 0.00023091236653272063
the O 0 0.00023437166237272322
entire O 0 0.005264684092253447
coding O 0 0.01271642092615366
region O 0 0.0009765713475644588
of O 0 2.64544396486599e-05
the O 0 0.0010159362573176622
APC B-Disease 1 0.9992456436157227
gene O 0 0.007677003741264343
was O 0 0.0025402228347957134
screened O 0 0.004785475786775351
in O 0 0.0002687102241907269
affected O 0 0.004158756695687771
individuals O 0 0.000315263430820778
from O 0 0.0005305507802404463
11 O 0 0.024980394169688225
AAPC B-Disease 1 0.9999961853027344
kindreds O 1 0.9545801877975464
, O 0 0.0007747292402200401
and O 0 0.00012799561955034733
their O 0 9.740867972141132e-05
phenotypic O 0 0.02046830765902996
differences O 0 0.002287438604980707
were O 0 0.000233499362366274
examined O 0 0.14206163585186005
. O 0 0.0004986790008842945

Five O 0 0.0011728983372449875
novel O 0 0.007289981469511986
germ O 1 0.9998325109481812
- O 0 0.07805708795785904
line O 0 0.011848552152514458
APC B-Disease 1 0.9962961077690125
mutations O 0 0.0032217735424637794
were O 0 6.926832429599017e-05
identified O 0 0.0010132321622222662
in O 0 0.00015091006935108453
seven O 0 0.0007741861045360565
kindreds O 1 0.5871515870094299
. O 0 0.0008305267547257245

Mutations O 0 0.010875103995203972
were O 0 0.00013098270574118942
located O 0 0.0019239363027736545
in O 0 0.00014785102393943816
three O 0 3.610583007684909e-05
different O 0 8.103344043774996e-06
regions O 0 0.00011387127597117797
of O 0 1.6703972505638376e-05
the O 0 0.0012433299561962485
APC B-Disease 1 0.9990828037261963
gene O 0 0.01065349206328392
( O 0 0.0013596946373581886
1 O 0 0.00424989266321063
) O 0 0.0003638463094830513
at O 0 0.0007288875640369952
the O 0 0.00031702694832347333
5 O 0 0.0015054531395435333
end O 0 0.001857451512478292
spanning O 0 0.005754533689469099
exons O 0 0.01280650869011879
4 O 0 0.0021629021503031254
and O 0 0.0003374062362127006
5 O 0 0.002198216039687395
, O 0 0.0006284392438828945
( O 0 0.0011331549612805247
2 O 0 0.0018408255418762565
) O 0 0.00020133043290115893
within O 0 0.00022981700021773577
exon O 0 0.056780364364385605
9 O 0 0.004213932901620865
, O 0 0.0003504385822452605
and O 0 0.0004175017820671201
( O 0 0.001606268691830337
3 O 0 0.0028335086535662413
) O 0 0.0003191755968146026
at O 0 0.0007352045504376292
the O 0 0.00047967818682082
3 O 0 0.004184631630778313
distal O 1 0.9951186180114746
end O 0 0.001907814759761095
of O 0 2.244530332973227e-05
the O 0 0.0004069478891324252
gene O 0 0.006346773821860552
. O 0 0.0006188490660861135

Variability O 0 0.011059323325753212
in O 0 0.00011175810504937544
the O 0 6.4246472902596e-05
number O 0 4.397991506266408e-05
of O 0 0.0006042107124812901
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999997615814209
was O 0 0.005885569844394922
most O 0 0.0004902470973320305
apparent O 0 0.00943659245967865
in O 0 0.00020143584697507322
individuals O 0 0.0001747958012856543
with O 0 0.00017326981469523162
mutations O 0 0.0034719128161668777
in O 0 0.00030075106769800186
region O 0 0.002894591772928834
1 O 0 0.0016690260963514447
, O 0 0.00024033445515669882
and O 0 0.0006101123872213066
upper O 1 0.9998741149902344
- O 1 0.9998160004615784
gastrointestinal O 1 0.9999996423721313
manifestations O 1 0.994918167591095
were O 0 0.000105502680526115
more O 0 0.00043213312164880335
severe O 1 0.9999566078186035
in O 0 0.0002686863881535828
them O 0 0.00010091943840961903
. O 0 0.0005689648096449673

In O 0 0.0007225291919894516
individuals O 0 0.0002479568647686392
with O 0 0.00014964380534365773
mutations O 0 0.0037545450031757355
in O 0 0.00024610423133708537
either O 0 0.0009266334236599505
region O 0 0.0036199293099343777
2 O 0 0.002404123079031706
or O 0 0.0006448414060287178
region O 0 0.0039238110184669495
3 O 0 0.00173765211366117
, O 0 0.00016919490008149296
the O 0 0.00016941835929173976
average O 0 0.0009222939843311906
number O 0 3.280822420492768e-05
of O 0 0.00011395763431210071
adenomas B-Disease 1 0.9999527931213379
tended O 0 0.009805399924516678
to O 0 0.0001979235967155546
be O 0 0.00020736994338221848
lower O 0 0.00313282641582191
than O 0 0.00010196950461249799
those O 0 6.757226219633594e-05
in O 0 0.00015028627240099013
individuals O 0 0.00018869739142246544
with O 0 0.0001672515063546598
mutations O 0 0.003841168014332652
in O 0 0.00040021943277679384
region O 0 0.0033923275768756866
1 O 0 0.0024567877408117056
, O 0 0.00028885281062684953
although O 0 0.0005508859176188707
age O 0 0.0019672811031341553
at O 0 0.008808660320937634
diagnosis O 1 0.9999997615814209
was O 0 0.002634504111483693
similar O 0 0.0005589477950707078
. O 0 0.0006155803566798568

In O 0 0.0009425877942703664
all O 0 0.0008733484428375959
AAPC B-Disease 1 0.9999884366989136
kindreds O 1 0.5287075042724609
, O 0 0.0002522954309824854
a O 0 0.0003285673737991601
predominance O 0 0.008767493069171906
of O 0 6.978587043704465e-05
right O 0 0.23854464292526245
- O 1 0.9986584186553955
sided O 1 0.9999922513961792
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999998807907104
and O 0 0.006014954764395952
rectal B-Disease 1 1.0
polyp I-Disease 1 0.9999983310699463
sparing O 1 0.9683208465576172
was O 0 0.0022058715112507343
observed O 0 0.0011706409277394414
. O 0 0.0003576464660000056

No O 0 0.0054694353602826595
desmoid B-Disease 1 0.9998389482498169
tumors I-Disease 1 0.9999998807907104
were O 0 0.0001098926950362511
found O 0 0.0002456234360579401
in O 0 0.0001013179644360207
these O 0 8.748314576223493e-05
kindreds O 0 0.3400798738002777
. O 0 0.0008923081331886351

Our O 0 0.0009290078305639327
data O 0 0.00021788381855003536
suggest O 0 0.0009886490879580379
that O 0 9.20949169085361e-05
, O 0 0.00044515557237900794
in O 0 0.002138121984899044
AAPC B-Disease 1 0.9999974966049194
families O 0 0.0017867089482024312
, O 0 0.00021022575674578547
the O 0 0.00011948185419896618
location O 0 0.00029983665444888175
of O 0 2.1715573893743567e-05
the O 0 0.0011325328378006816
APC B-Disease 1 0.9998661279678345
mutation O 0 0.020607851445674896
may O 0 0.004022703506052494
partially O 0 0.020401298999786377
predict O 0 0.002327863359823823
specific O 0 0.0002954039955511689
phenotypic O 0 0.015730619430541992
expression O 0 0.002814321080222726
. O 0 0.0008004431147128344

This O 0 0.0005223328480497003
should O 0 0.0006675065378658473
help O 0 0.0010915965540334582
in O 0 9.995928121497855e-05
the O 0 0.00011050027387682348
design O 0 0.001352669671177864
of O 0 9.211053838953376e-05
tailored O 1 0.9987157583236694
clinical O 1 0.9999995231628418
- O 1 0.857194185256958
management O 1 0.7205373644828796
protocols O 0 0.027217809110879898
in O 0 8.767689723754302e-05
this O 0 2.8227075745235197e-05
subset O 0 0.001853969763033092
of O 0 0.00031755719101056457
FAP B-Disease 1 0.9999996423721313
patients O 1 0.9999983310699463
. O 0 0.000472360901767388
. O 0 0.00047413582797162235

Wilms B-Disease 1 0.9999994039535522
' I-Disease 1 0.9686030745506287
tumor I-Disease 1 0.9999542236328125
1 O 0 0.0020362138748168945
and O 0 0.0004688446060754359
Dax O 1 0.9979159235954285
- O 0 0.009773662313818932
1 O 0 0.00134936417452991
modulate O 0 0.018269581720232964
the O 0 0.00046123284846544266
orphan O 1 0.7352830171585083
nuclear O 0 0.010793392546474934
receptor O 0 0.04965047538280487
SF O 1 0.9998981952667236
- O 0 0.009913846850395203
1 O 0 0.0010719697456806898
in O 0 0.00018487796478439122
sex O 0 0.0029207279440015554
- O 0 0.004434232134371996
specific O 0 0.0003559202596079558
gene O 0 0.0027858165558427572
expression O 0 0.001814412884414196
. O 0 0.0007753570098429918

Products O 0 0.0020687594078481197
of O 0 6.282691902015358e-05
steroidogenic O 1 0.995766282081604
factor O 0 0.004402028862386942
1 O 0 0.0038238822016865015
( O 0 0.0026028710417449474
SF O 1 0.9999692440032959
- O 0 0.009942874312400818
1 O 0 0.0014581421855837107
) O 0 0.0001968129217857495
and O 0 0.0008792567532509565
Wilms B-Disease 1 1.0
tumor I-Disease 1 0.9999959468841553
1 O 0 0.005622264463454485
( O 0 0.003276688512414694
WT1 O 1 0.999841570854187
) O 0 0.00044409665861167014
genes O 0 0.00016077437612693757
are O 0 1.7699938325677067e-05
essential O 0 0.00210172007791698
for O 0 0.0003597535833250731
mammalian O 0 0.02351970039308071
gonadogenesis O 1 0.934114933013916
prior O 0 0.0012910622172057629
to O 0 0.00012886745389550924
sexual O 0 0.002740403637290001
differentiation O 0 0.013513244688510895
. O 0 0.0008947465103119612

In O 0 0.0012856426183134317
males O 0 0.003549652174115181
, O 0 0.0027160714380443096
SF O 1 0.9999831914901733
- O 0 0.01925535500049591
1 O 0 0.002723242621868849
participates O 0 0.015018485486507416
in O 0 0.00033233925933018327
sexual O 0 0.0035457115154713392
development O 0 0.0022532169241458178
by O 0 5.0578306399984285e-05
regulating O 0 0.004788324236869812
expression O 0 0.0002340686332900077
of O 0 7.42598876968259e-06
the O 0 0.00017414303147234023
polypeptide O 0 0.018274471163749695
hormone O 1 0.9877119660377502
Mullerian O 1 0.9990130662918091
inhibiting O 0 0.11234515905380249
substance O 1 0.9978426694869995
( O 0 0.00657607289031148
MIS O 1 0.9999599456787109
) O 0 0.0011353174922987819
. O 0 0.0005077428068034351

Here O 0 0.0019897539168596268
, O 0 0.00022991452715359628
we O 0 0.00014549876505043358
show O 0 0.00044992510811425745
that O 0 0.0004079658829141408
WT1 O 1 0.9998780488967896
- O 0 0.044653769582509995
KTS O 1 0.9821017980575562
isoforms O 0 0.0030282754451036453
associate O 0 0.010821254923939705
and O 0 0.00041465373942628503
synergize O 1 0.9922466278076172
with O 0 0.0014006970450282097
SF O 1 0.9999850988388062
- O 0 0.011865632608532906
1 O 0 0.0008028869051486254
to O 0 7.647612073924392e-05
promote O 0 0.003601537086069584
MIS O 1 0.9987844824790955
expression O 0 0.002965545514598489
. O 0 0.0006105623324401677

In O 0 0.0009381151176057756
contrast O 0 0.005168145056813955
, O 0 0.002327627269551158
WT1 O 1 0.9998646974563599
missense O 0 0.08152442425489426
mutations O 0 0.005945658776909113
, O 0 0.00036043397267349064
associated O 0 0.0004780905437655747
with O 0 0.00014875037595629692
male B-Disease 0 0.006166674196720123
pseudohermaphroditism I-Disease 1 0.9999477863311768
in O 0 0.0019615129567682743
Denys B-Disease 1 0.9999840259552002
- I-Disease 1 0.9993626475334167
Drash I-Disease 1 0.9999836683273315
syndrome I-Disease 1 1.0
, O 0 0.0014422469539567828
fail O 0 0.041662491858005524
to O 0 0.0002625139895826578
synergize O 1 0.986732542514801
with O 0 0.0012229502899572253
SF O 1 0.9999908208847046
- O 0 0.019467629492282867
1 O 0 0.002442444209009409
. O 0 0.00035451914300210774

Additionally O 0 0.006310832221060991
, O 0 0.00022695701045449823
the O 0 0.0006326846778392792
X O 1 0.8161888718605042
- O 0 0.0190548337996006
linked O 0 0.010325239039957523
, O 0 0.0002587059570942074
candidate O 0 0.00455917464569211
dosage O 1 0.9975213408470154
- O 0 0.013334435410797596
sensitive O 0 0.014516645111143589
sex O 0 0.0037660468369722366
- O 0 0.009695864282548428
reversal O 0 0.021722648292779922
gene O 0 0.0047721280716359615
, O 0 0.0009380570845678449
Dax O 1 0.9991030693054199
- O 0 0.011670547537505627
1 O 0 0.0015246396651491523
, O 0 0.0003856861439999193
antagonizes O 1 0.5090758204460144
synergy O 0 0.02741863764822483
between O 0 0.001994526479393244
SF O 1 0.9999675750732422
- O 0 0.014573919586837292
1 O 0 0.002250432502478361
and O 0 0.0010097461054101586
WT1 O 1 0.999942421913147
, O 0 0.0008112055365927517
most O 0 0.000394431030144915
likely O 0 0.0008265867363661528
through O 0 7.608535088365898e-05
a O 0 0.00011327152606099844
direct O 0 0.00012762524420395494
interaction O 0 0.0006329483003355563
with O 0 0.0010255001252517104
SF O 1 0.9999912977218628
- O 0 0.019405914470553398
1 O 0 0.0024307577405124903
. O 0 0.00040848308708518744

We O 0 0.0009443270391784608
propose O 0 0.0060501969419419765
that O 0 0.0004525141848716885
WT1 O 1 0.9997376799583435
and O 0 0.0018099405569955707
Dax O 1 0.9995393753051758
- O 0 0.026719819754362106
1 O 0 0.003706890158355236
functionally O 0 0.0356893315911293
oppose O 0 0.0011861252132803202
each O 0 2.2624617486144416e-05
other O 0 3.66884887625929e-05
in O 0 0.00036578206345438957
testis O 1 0.9962645173072815
development O 0 0.0017989006591960788
by O 0 0.00021422696590889245
modulating O 1 0.9878845810890198
SF O 1 0.9999644756317139
- O 0 0.019369708374142647
1 O 0 0.0038042194209992886
- O 0 0.011168633587658405
mediated O 0 0.05330399423837662
transactivation O 1 0.7983096837997437
. O 0 0.0005423625116236508
. O 0 0.0005237574805505574

A O 0 0.007415821310132742
mouse O 0 0.008463883772492409
model O 0 0.0012627056566998363
for O 0 0.0017244901973754168
Prader B-Disease 1 1.0
- I-Disease 1 0.9999929666519165
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9976219534873962
- O 1 0.5516954660415649
centre O 0 0.01708441972732544
mutations O 0 0.004490170627832413
. O 0 0.00048354847240261734

Imprinting O 0 0.09058702737092972
in O 0 0.0003337381931487471
the O 0 0.0006262857932597399
15q11 O 1 0.7323523163795471
- O 0 0.02199399471282959
q13 O 0 0.042340923100709915
region O 0 0.0015205525560304523
involves O 0 0.001401719287969172
an O 0 0.0005153133533895016
imprinting O 1 0.5521717071533203
centre O 0 0.06169082596898079
( O 0 0.00419981824234128
IC O 1 0.999707043170929
) O 0 0.0009622657089494169
, O 0 0.0002704763028305024
mapping O 0 0.005923025775700808
in O 0 0.00024040437710937113
part O 0 0.000926690234337002
to O 0 0.00013310054782778025
the O 0 0.0004716318508144468
promoter O 0 0.045887310057878494
and O 0 0.0001703107700450346
first O 0 0.00030817053630016744
exon O 0 0.016476765275001526
of O 0 0.00011560870188986883
SNRPN O 1 0.9995049238204956
. O 0 0.0011413519969210029

Deletion O 0 0.011896195821464062
of O 0 3.3949945645872504e-05
this O 0 0.0004138353397138417
IC O 1 0.9982287287712097
abolishes O 0 0.16319334506988525
local O 0 0.00046885403571650386
paternally O 0 0.028914596885442734
derived O 0 0.0005563009763136506
gene O 0 0.0015405318699777126
expression O 0 0.00047046979307197034
and O 0 0.00011117658868897706
results O 0 0.0007152713369578123
in O 0 0.0011758410837501287
Prader B-Disease 1 1.0
- I-Disease 1 0.9999947547912598
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.06900327652692795
PWS B-Disease 1 1.0
) O 0 0.0026347546372562647
. O 0 0.0006403941661119461

We O 0 0.0008001312962733209
have O 0 7.251914212247357e-05
created O 0 0.0002039392857113853
two O 0 6.09101407462731e-05
deletion O 0 0.009956940077245235
mutations O 0 0.002187153557315469
in O 0 0.0004040502244606614
mice O 0 0.028004247695207596
to O 0 0.0004194967041257769
understand O 0 0.33271536231040955
PWS B-Disease 1 0.9999996423721313
and O 0 0.00026474500191397965
the O 0 0.00010084584937430918
mechanism O 0 0.0006060997257009149
of O 0 2.341288018214982e-05
this O 0 0.0004046187677886337
IC O 1 0.9993402361869812
. O 0 0.0011583478190004826

Mice O 0 0.20545655488967896
harbouring O 1 0.9483011960983276
an O 0 0.0012031809892505407
intragenic O 1 0.9805606603622437
deletion O 0 0.0182945616543293
in O 0 0.0006747925071977079
Snrpn O 1 0.9764919877052307
are O 0 0.00019802892347797751
phenotypically O 0 0.4120865762233734
normal O 0 0.006994373630732298
, O 0 0.0003412836231291294
suggesting O 0 0.0031805553007870913
that O 0 9.37919394345954e-05
mutations O 0 0.0012610723497346044
of O 0 7.368480873992667e-05
SNRPN O 1 0.9997026324272156
are O 0 3.902965909219347e-05
not O 0 5.902076736674644e-05
sufficient O 0 0.0006551329279318452
to O 0 0.00032231968361884356
induce O 1 0.9919952154159546
PWS B-Disease 1 0.9999998807907104
. O 0 0.0019297492690384388

Mice O 0 0.030959445983171463
with O 0 6.278870569076389e-05
a O 0 0.0004694128001574427
larger O 0 0.0006504899938590825
deletion O 0 0.011282827705144882
involving O 0 0.0013136669294908643
both O 0 0.000541680317837745
Snrpn O 1 0.985480010509491
and O 0 0.00020588723418768495
the O 0 0.0006829602643847466
putative O 1 0.9936282634735107
PWS O 1 0.9999998807907104
- O 1 0.9688974022865295
IC O 1 0.9974395036697388
lack O 0 0.0038298757281154394
expression O 0 0.0003093509585596621
of O 0 1.665834497543983e-05
the O 0 0.00038253251113928854
imprinted O 0 0.11310329288244247
genes O 0 0.0016547603299841285
Zfp127 O 1 0.9794504046440125
( O 0 0.0013411069521680474
mouse O 0 0.01281257439404726
homologue O 0 0.03634162247180939
of O 0 0.0001986492279684171
ZNF127 O 1 0.9993454813957214
) O 0 0.001235030242241919
, O 0 0.0013699985574930906
Ndn O 1 0.9994848966598511
and O 0 0.001512056915089488
Ipw O 1 0.9923270344734192
, O 0 0.0007238744874484837
and O 0 0.00029932367033325136
manifest O 0 0.013663657009601593
several O 0 0.00019411930406931788
phenotypes O 0 0.02031683549284935
common O 0 0.00485188839957118
to O 0 0.0033261324279010296
PWS B-Disease 1 1.0
infants O 1 0.9999561309814453
. O 0 0.0012978393351659179

These O 0 0.00010720430873334408
data O 0 0.0002611196250654757
demonstrate O 0 0.0036500843707472086
that O 0 6.0186837799847126e-05
both O 0 6.981609476497397e-05
the O 0 0.00014871987514197826
position O 0 0.0010029934346675873
of O 0 2.718527684919536e-05
the O 0 0.0010396814905107021
IC O 1 0.9981245398521423
and O 0 0.00033208620152436197
its O 0 0.0004139621742069721
role O 0 0.004123923368752003
in O 0 0.0001869755215011537
the O 0 0.00016022771887946874
coordinate O 0 0.005079328548163176
expression O 0 0.00043530514813028276
of O 0 1.7613707314012572e-05
genes O 0 0.00031146747642196715
is O 0 0.00015152258856687695
conserved O 0 0.00029144142172299325
between O 0 0.00039492297219112515
mouse O 0 0.016875311732292175
and O 0 0.00042746984399855137
human O 0 0.0031831508968025446
, O 0 0.0005154331447556615
and O 0 0.0002506504242774099
indicate O 0 0.0013615997740998864
that O 0 6.108535308158025e-05
the O 0 0.00032085052225738764
mouse O 0 0.010485666804015636
is O 0 0.00027698586927726865
a O 0 0.0006208745180629194
suitable O 0 0.006879257038235664
model O 0 0.002265837276354432
system O 0 0.0031474826391786337
in O 0 0.00022444290516432375
which O 0 8.236180292442441e-05
to O 0 0.00015998909657355398
investigate O 0 0.007880358956754208
the O 0 0.00022218468075152487
molecular O 0 0.002997663104906678
mechanisms O 0 0.000984534970484674
of O 0 6.300475070020184e-05
imprinting O 0 0.14872600138187408
in O 0 0.0002942137070931494
this O 0 7.03723490005359e-05
region O 0 0.0008017821237444878
of O 0 1.398212043568492e-05
the O 0 0.00035234002280049026
genome O 0 0.007987570948898792
. O 0 0.0003022584714926779
. O 0 0.0004788204387295991

Mutations O 0 0.0028461203910410404
of O 0 1.3853956261300482e-05
the O 0 0.0003007889026775956
ATM O 0 0.052203405648469925
gene O 0 0.00343908229842782
detected O 0 0.00511005287989974
in O 0 0.00018058365094475448
Japanese O 0 0.016943037509918213
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999904632568359
telangiectasia I-Disease 1 1.0
patients O 1 0.9999998807907104
: O 0 0.0006915883277542889
possible O 0 0.0007473111618310213
preponderance O 0 0.01203963067382574
of O 0 1.6426194633822888e-05
the O 0 0.00014546186139341444
two O 0 0.00015193461149465293
founder O 0 0.03601910546422005
mutations O 0 0.00542091578245163
4612del165 O 0 0.0642852857708931
and O 0 0.0004926917026750743
7883del5 O 0 0.2692091763019562
. O 0 0.0007420357433147728

The O 0 0.0009435387910343707
ATM O 0 0.036508578807115555
( O 0 0.0020550095941871405
A O 1 0.9989707469940186
- O 1 0.9990707635879517
T O 1 0.9999910593032837
, O 0 0.0007451869314536452
mutated O 0 0.016589784994721413
) O 0 0.00037889843224547803
gene O 0 0.0017489315941929817
on O 0 0.0002300425840076059
human O 0 0.0020257574506103992
chromosome O 0 0.009565305896103382
11q22 O 0 0.12081103026866913
. O 0 0.0007231002673506737

3 O 0 0.004584948066622019
has O 0 0.0021013631485402584
recently O 0 0.006951555609703064
been O 0 0.0004901047213934362
identified O 0 0.0008491218322888017
as O 0 0.00010444881627336144
the O 0 0.00016381515888497233
gene O 0 0.002244694624096155
responsible O 0 0.0019169769948348403
for O 0 9.773376223165542e-05
the O 0 0.0002706223167479038
human O 0 0.14904558658599854
recessive B-Disease 1 0.999998927116394
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9998999834060669
telangiectasia I-Disease 1 0.999998927116394
( O 0 0.004716506693512201
A B-Disease 1 0.9998980760574341
- I-Disease 1 0.9994254112243652
T I-Disease 1 0.9999912977218628
) O 0 0.0007630952168256044
. O 0 0.00045401937677524984

In O 0 0.0005520735867321491
order O 0 0.00010074550664285198
to O 0 5.768354458268732e-05
define O 0 0.0012348642339929938
the O 0 9.491643868386745e-05
types O 0 0.0010501997312530875
of O 0 0.0004060623759869486
disease O 1 1.0
- O 1 0.6885906457901001
causing O 0 0.05487372353672981
ATM O 0 0.025515276938676834
mutations O 0 0.0014292702544480562
in O 0 0.00013720619608648121
Japanese O 0 0.0031668308656662703
A B-Disease 1 0.9996843338012695
- I-Disease 1 0.9999479055404663
T I-Disease 1 0.9999998807907104
patients O 1 0.9999953508377075
as O 0 0.00040616613114252687
well O 0 0.00025271603954024613
as O 0 0.00024195192963816226
to O 0 0.00015035306569188833
look O 0 0.0015800001565366983
for O 0 0.00019170111045241356
possible O 0 0.001689799828454852
mutational O 1 0.9037144184112549
hotspots O 0 0.06094098463654518
, O 0 0.000570876058191061
reverse O 0 0.012833470478653908
- O 0 0.00540510518476367
transcribed O 0 0.001304546371102333
RNA O 0 0.0008747010142542422
derived O 0 0.00016233175119850785
from O 0 0.00014362520596478134
ten O 0 0.0018142476910725236
patients O 1 0.9999425411224365
belonging O 0 0.0009871027432382107
to O 0 7.621730037499219e-05
eight O 0 0.00025768927298486233
unrelated O 0 0.004976080730557442
Japanese O 0 0.004627127666026354
A B-Disease 1 0.9997257590293884
- I-Disease 1 0.999704897403717
T I-Disease 1 0.9999971389770508
families O 0 0.0009512559627182782
was O 0 0.0016308048507198691
analyzed O 0 0.002030304865911603
for O 0 0.00020463975670281798
mutations O 0 0.0007823216146789491
by O 0 1.6766914995969273e-05
the O 0 0.00011530682240845636
restriction O 0 0.0015115472488105297
endonuclease O 0 0.18215082585811615
fingerprinting O 0 0.013614916242659092
method O 0 0.0009024617029353976
. O 0 0.0005343430675566196

As O 0 0.001823592814616859
has O 0 0.0014559054980054498
been O 0 0.0010349680669605732
reported O 0 0.002925667678937316
by O 0 6.0894111811649054e-05
others O 0 0.0008239249000325799
, O 0 0.0003308906452730298
mutations O 0 0.0014240897726267576
that O 0 3.921036477549933e-05
lead O 0 0.0003257968637626618
to O 0 0.00012292330211494118
exon O 0 0.05893972888588905
skipping O 0 0.046574804931879044
or O 0 0.0011960235424339771
premature O 1 0.6718800663948059
protein O 0 0.0016737665282562375
truncation O 0 0.030708668753504753
were O 0 8.761371282162145e-05
also O 0 0.00020856245828326792
predominant O 0 0.0025019203312695026
in O 0 0.0002054342330666259
our O 0 0.0014622121816501021
mutants O 0 0.027771318331360817
. O 0 0.0005739606567658484

Six O 0 0.0008518374525010586
different O 0 5.532687282538973e-05
mutations O 0 0.0023984676226973534
were O 0 9.618794865673408e-05
identified O 0 0.00141994864679873
on O 0 0.00019931649148929864
12 O 0 0.000322949344990775
of O 0 1.2110939678677823e-05
the O 0 0.0003530000103637576
16 O 0 0.002969146240502596
alleles O 0 0.011102976277470589
examined O 0 0.09212279319763184
. O 0 0.0007295554969459772

Four O 0 0.00046000542351976037
were O 0 7.193993224063888e-05
deletions O 0 0.0028784149326384068
involving O 0 0.001114658429287374
a O 0 0.0010705970926210284
loss O 0 0.0044416519813239574
of O 0 1.2768476153723896e-05
a O 0 0.00048024230636656284
single O 0 0.0006816344102844596
exon O 0 0.04626370221376419
exon O 0 0.04460575431585312
7 O 0 0.0024816582445055246
, O 0 0.00038948687142692506
exon O 0 0.038834165781736374
16 O 0 0.001907522208057344
, O 0 0.00036203672061674297
exon O 0 0.03902466222643852
33 O 0 0.004515447653830051
or O 0 0.0007233400829136372
exon O 0 0.04330550506711006
35 O 0 0.003544001840054989
. O 0 0.0005847098072990775

The O 0 0.0009587205131538212
others O 0 0.00045710717677138746
were O 0 3.522345650708303e-05
minute O 0 0.00032738508889451623
deletions O 0 0.003914226777851582
, O 0 0.0005507748574018478
4649delA O 0 0.10587974637746811
in O 0 0.0005422778194770217
exon O 0 0.04457223415374756
33 O 0 0.004374807700514793
and O 0 0.0002793248859234154
7883del5 O 0 0.048145946115255356
in O 0 0.0004370126698631793
exon O 0 0.04958821088075638
55 O 0 0.006888358388096094
. O 0 0.0005763842491433024

The O 0 0.0012377116363495588
mutations O 0 0.008845532312989235
4612del165 O 0 0.10297554731369019
and O 0 0.0006740398239344358
7883del5 O 0 0.08351112902164459
were O 0 9.048275387613103e-05
found O 0 0.00024798192316666245
in O 0 6.697379285469651e-05
more O 0 4.488097329158336e-05
than O 0 0.00011759569315472618
two O 0 0.00011286181688774377
unrelated O 0 0.009840833954513073
families O 0 0.0009036577539518476
; O 0 0.0004105104599148035
44 O 0 0.002144021214917302
% O 0 0.0002541563881095499
( O 0 0.001268845866434276
7 O 0 0.0017900961684063077
of O 0 5.474306453834288e-05
16 O 0 0.0028583002276718616
) O 0 0.00012512067041825503
of O 0 1.3177252185414545e-05
the O 0 0.0004670271882787347
mutant O 0 0.0167060736566782
alleles O 0 0.006867113057523966
had O 0 0.0007554743788205087
one O 0 4.807480581803247e-05
of O 0 7.295899195014499e-06
the O 0 0.00014319471665658057
two O 0 0.00010559668589849025
mutations O 0 0.004744317382574081
. O 0 0.0006175278103910387

The O 0 0.0022148096468299627
4612del165 O 0 0.12797515094280243
mutations O 0 0.003857753938063979
in O 0 0.00018263162928633392
three O 0 7.238399848574772e-05
different O 0 2.9233544410089962e-05
families O 0 0.00021049071801826358
were O 0 3.782369094551541e-05
all O 0 3.68063738278579e-05
ascribed O 0 0.0040900795720517635
to O 0 5.3486888646148145e-05
the O 0 0.00017959611432161182
same O 0 0.0014836897607892752
T O 1 0.999683141708374
- O 0 0.024659449234604836
- O 0 0.010059707798063755
> O 0 0.008547295816242695
A O 0 0.0016567545244470239
substitution O 0 0.0005716155283153057
at O 0 0.0006282568210735917
the O 0 0.00028930010739713907
splice O 0 0.0388043113052845
donor O 0 0.013090015389025211
site O 0 0.002780889393761754
in O 0 0.00040488579543307424
intron O 1 0.9687311053276062
33 O 0 0.011061648838222027
. O 0 0.0005648551159538329

Microsatellite O 0 0.20954570174217224
genotyping O 0 0.0673276036977768
around O 0 0.00032962061231955886
the O 0 0.0004148648586124182
ATM O 0 0.05401100590825081
locus O 0 0.031032826751470566
also O 0 0.0007822142797522247
indicated O 0 0.003564642509445548
that O 0 5.233400224824436e-05
a O 0 0.0007004186627455056
common O 0 0.005426408257335424
haplotype O 1 0.9748342037200928
was O 0 0.002202665666118264
shared O 0 0.0003831505891866982
by O 0 3.9179158193292096e-05
the O 0 0.0003313313645776361
mutant O 0 0.008017301559448242
alleles O 0 0.002962093334645033
in O 0 0.00018090831872541457
both O 0 0.0003209701972082257
mutations O 0 0.005828391294926405
. O 0 0.0007401062757708132

This O 0 0.0005235712742432952
suggests O 0 0.001729518873617053
that O 0 3.8474739994853735e-05
these O 0 2.3364544176729396e-05
two O 0 0.00015696619811933488
founder O 0 0.08352246135473251
mutations O 0 0.008820009417831898
may O 0 0.0017495752545073628
be O 0 0.00010862435738090426
predominant O 0 0.0022194962948560715
among O 0 0.00015074870316311717
Japanese O 0 0.0021845814771950245
ATM O 0 0.038763582706451416
mutant O 0 0.010744981467723846
alleles O 0 0.0058905575424432755
. O 0 0.0007100397488102317

W474C O 0 0.046402283012866974
amino O 0 0.0008208491490222514
acid O 0 0.009349939413368702
substitution O 0 0.002402723766863346
affects O 0 0.10885956138372421
early O 0 0.0004611321783158928
processing O 0 0.0003474960394669324
of O 0 1.4252314031182323e-05
the O 0 0.0002558873384259641
alpha O 0 0.0034360785502940416
- O 0 0.0010815231362357736
subunit O 0 0.00028631853638216853
of O 0 2.5076329620787874e-05
beta O 0 0.028639204800128937
- O 0 0.015142193995416164
hexosaminidase O 0 0.18241997063159943
A O 0 0.0028030029498040676
and O 0 0.00013612897600978613
is O 0 0.00044596701627597213
associated O 0 0.0006725485436618328
with O 0 0.0009666547412052751
subacute O 1 1.0
G B-Disease 1 0.9952223896980286
( I-Disease 0 0.005810062866657972
M2 I-Disease 1 0.9997643828392029
) I-Disease 0 0.0017692373367026448
gangliosidosis I-Disease 1 0.9296010136604309
. O 0 0.0008341100183315575

Mutations O 0 0.006221539806574583
in O 0 0.0002105539315380156
the O 0 0.001237626071088016
HEXA O 1 0.9996334314346313
gene O 0 0.0038899125065654516
, O 0 0.00011340814671711996
encoding O 0 0.0002603298635222018
the O 0 0.00013230691547505558
alpha O 0 0.0029050176963210106
- O 0 0.0008469005697406828
subunit O 0 0.00022948221885599196
of O 0 2.6403860829304904e-05
beta O 0 0.016584528610110283
- O 0 0.0090232128277421
hexosaminidase O 0 0.1409129798412323
A O 0 0.005975569598376751
( O 0 0.0010767400963231921
Hex O 0 0.05181577801704407
A O 0 0.008634351193904877
) O 0 0.00034740756382234395
, O 0 0.00012280626106075943
that O 0 6.631406722590327e-05
abolish O 0 0.006867441348731518
Hex O 0 0.010210219770669937
A O 0 0.000958014337811619
enzyme O 0 0.0015664338134229183
activity O 0 0.0019035580335184932
cause O 1 0.999788224697113
Tay B-Disease 1 1.0
- I-Disease 1 0.9998929500579834
Sachs I-Disease 1 0.9999994039535522
disease I-Disease 1 1.0
( O 0 0.0058339061215519905
TSD B-Disease 1 0.9999964237213135
) O 0 0.0006651942967437208
, O 0 0.00024215962912421674
the O 0 0.0012563248164951801
fatal O 1 0.9999947547912598
infantile B-Disease 1 0.9999792575836182
form I-Disease 0 0.0007501430809497833
of I-Disease 0 0.00011405623808968812
G I-Disease 1 0.9931974411010742
( I-Disease 0 0.004317565355449915
M2 I-Disease 1 0.9997197985649109
) I-Disease 0 0.0014772436115890741
gangliosidosis I-Disease 1 0.9478302001953125
, I-Disease 0 0.0005837017670273781
Type I-Disease 0 0.020216763019561768
1 I-Disease 0 0.0036441320553421974
. O 0 0.000555026694200933

Less O 0 0.006987742614001036
severe O 1 0.9999831914901733
, O 0 0.0036665541119873524
subacute O 1 0.9999998807907104
( O 0 0.007822299376130104
juvenile O 1 0.9999744892120361
- O 1 0.9930536150932312
onset O 1 0.9999881982803345
) O 0 0.001002039178274572
and O 0 0.0019005897920578718
chronic O 1 1.0
( O 0 0.002935445634648204
adult O 0 0.0954224094748497
- O 1 0.9956079125404358
onset O 1 0.9999750852584839
) O 0 0.0007974206819199026
variants O 0 0.0016761849401518703
are O 0 6.437206320697442e-05
characterized O 0 0.017590904608368874
by O 0 8.068561146501452e-05
a O 0 0.0008191324304789305
broad O 0 0.011456916108727455
spectrum O 0 0.0074212499894201756
of O 0 0.0002122683363268152
clinical O 1 0.9999994039535522
manifestations O 1 0.9988634586334229
and O 0 0.000271060795057565
are O 0 5.280674668028951e-05
associated O 0 0.0003397471737116575
with O 0 8.64317044033669e-05
residual O 0 0.01628742180764675
levels O 0 0.0017672509420663118
of O 0 2.326162939425558e-05
Hex O 0 0.023368604481220245
A O 0 0.0021899084094911814
enzyme O 0 0.0028450556565076113
activity O 0 0.000992821529507637
. O 0 0.0004997866926714778

We O 0 0.0006793943466618657
identified O 0 0.000993945519439876
a O 0 0.0016850902466103435
1422 O 1 0.9983591437339783
G O 1 0.9259684085845947
- O 0 0.03140517696738243
- O 0 0.018822137266397476
> O 0 0.02938186377286911
C O 0 0.05072983354330063
( O 0 0.0003697668435052037
amino O 0 0.0006515419809147716
acid O 0 0.026451613754034042
W474C O 0 0.09353223443031311
) O 0 0.00022167936549521983
substitution O 0 0.00043398840352892876
in O 0 0.00012349533790256828
the O 0 0.00013494258746504784
first O 0 0.00023938719823490828
position O 0 0.0010064929956570268
of O 0 4.492267908062786e-05
exon O 0 0.06187479570508003
13 O 0 0.0013748614583164454
of O 0 7.118810754036531e-05
HEXA O 1 0.9943451881408691
of O 0 5.564948878600262e-05
a O 0 0.0013418172020465136
non O 0 0.009168630465865135
- O 0 0.013387859798967838
Jewish O 0 0.004205291625112295
proband O 1 0.6894927620887756
who O 0 0.001788536785170436
manifested O 0 0.05001133680343628
a O 0 0.0035938757937401533
subacute O 1 0.9999970197677612
variant O 0 0.038102224469184875
of O 0 0.0001694761886028573
G B-Disease 1 0.9863980412483215
( I-Disease 0 0.0041623725555837154
M2 I-Disease 1 0.9994232654571533
) I-Disease 0 0.0017842937959358096
gangliosidosis I-Disease 1 0.981988787651062
. O 0 0.0006917593418620527

On O 0 0.000639530539046973
the O 0 0.00020258923177607358
second O 0 0.0013930299319326878
maternally O 0 0.22400031983852386
inherited O 1 0.9947028756141663
allele O 0 0.014767026528716087
, O 0 0.00032606066088192165
we O 0 0.0001740421139402315
identified O 0 0.0004356727295089513
the O 0 0.00014718496822752059
common O 0 0.18114687502384186
infantile O 1 1.0
disease O 1 1.0
- O 0 0.2008114606142044
causing O 0 0.05232218652963638
4 O 0 0.003604978322982788
- O 0 0.009557981975376606
bp O 0 0.0676327645778656
insertion O 0 0.018791591748595238
, O 0 0.0013475598534569144
+ O 0 0.3449907898902893
TATC O 1 0.9991901516914368
1278 O 1 0.9956592321395874
, O 0 0.0004650057526305318
in O 0 0.00032058177748695016
exon O 0 0.058749970048666
11 O 0 0.004290635231882334
. O 0 0.0005821282975375652

Pulse O 0 0.1289026290178299
- O 0 0.01772252842783928
chase O 0 0.009228254668414593
analysis O 0 0.00023329284158535302
using O 0 0.0004526747507043183
proband O 1 0.9850393533706665
fibroblasts O 1 0.5358759760856628
revealed O 0 0.006879739463329315
that O 0 4.695749157690443e-05
the O 0 0.00028440836467780173
W474C O 0 0.07201589643955231
- O 0 0.002429288811981678
containing O 0 0.00017049261077772826
alpha O 0 0.0031429152004420757
- O 0 0.002521313726902008
subunit O 0 0.0016934678424149752
precursor O 0 0.014417925849556923
was O 0 0.0017366299871355295
normally O 0 0.0011264042695984244
synthesized O 0 0.0019828255753964186
, O 0 0.0002072009810945019
but O 0 0.00016147419228218496
not O 0 0.0001832089328672737
phosphorylated O 0 0.018758589401841164
or O 0 0.0006116360309533775
secreted O 0 0.007856103591620922
, O 0 0.0002479615795891732
and O 0 0.00010702381405280903
the O 0 0.0003001919249072671
mature O 0 0.06597527861595154
lysosomal O 1 0.993556797504425
alpha O 0 0.008056528866291046
- O 0 0.0035624783486127853
subunit O 0 0.0013536129845306277
was O 0 0.0013033131835982203
not O 0 0.00025307119358330965
detected O 0 0.011206020601093769
. O 0 0.0003675473271869123

When O 0 0.0012181480415165424
the O 0 0.00037648805300705135
W474C O 0 0.06382256746292114
- O 0 0.0022217626683413982
containing O 0 0.0002167231432395056
alpha O 0 0.0025452561676502228
- O 0 0.002230098471045494
subunit O 0 0.001657233340665698
was O 0 0.004007625859230757
transiently O 0 0.3134988844394684
co O 0 0.038068316876888275
- O 0 0.0048069460317492485
expressed O 0 0.00030506838811561465
with O 0 4.7134213673416525e-05
the O 0 0.0002413296460872516
beta O 0 0.011333238333463669
- O 0 0.0015021315775811672
subunit O 0 0.00037587995757348835
to O 0 3.686346099129878e-05
produce O 0 0.0002908582391683012
Hex O 0 0.02793900854885578
A O 0 0.006477906834334135
( O 0 0.0016249740729108453
alphabeta O 1 0.9666383862495422
) O 0 0.000573646102566272
in O 0 0.0011535859666764736
COS O 1 0.9998250603675842
- O 0 0.019263388589024544
7 O 0 0.0021214461885392666
cells O 0 0.002546148607507348
, O 0 9.715958731248975e-05
the O 0 0.00020157919789198786
mature O 0 0.017250925302505493
alpha O 0 0.004910510033369064
- O 0 0.0033487516921013594
subunit O 0 0.0016311140498146415
was O 0 0.0016124316025525331
present O 0 0.0003051763342227787
, O 0 0.00022894938592799008
but O 0 0.00013512824079953134
its O 0 0.00023321031767409295
level O 0 0.004519032780081034
was O 0 0.0015239777276292443
much O 0 0.0005934280925430357
lower O 0 0.003781020175665617
than O 0 8.296039595734328e-05
that O 0 3.354838554514572e-05
from O 0 5.536645767278969e-05
normal O 0 0.0029473043978214264
alpha O 0 0.004659544210880995
- O 0 0.004612852819263935
subunit O 0 0.005253201816231012
transfections O 1 0.8990808725357056
, O 0 0.0004570548771880567
although O 0 0.0003557218296919018
higher O 0 0.00047016938333399594
than O 0 9.707151912152767e-05
in O 0 0.000168056387337856
those O 0 0.00018700334476307034
cells O 0 0.008455084636807442
transfected O 0 0.053515538573265076
with O 0 3.777661549975164e-05
an O 0 0.00018339770031161606
alpha O 0 0.004226884339004755
- O 0 0.002777124522253871
subunit O 0 0.001265744329430163
associated O 0 0.0007364969351328909
with O 0 0.000995222362689674
infantile O 1 0.9999996423721313
TSD B-Disease 1 0.9999948740005493
. O 0 0.0022470548283308744

Furthermore O 0 0.010606175288558006
, O 0 0.00024971537641249597
the O 0 0.00022700395493302494
precursor O 0 0.014797638170421124
level O 0 0.0012324905255809426
of O 0 1.5206317584670614e-05
the O 0 0.0003126277297269553
W474C O 0 0.06599893420934677
alpha O 0 0.003992075100541115
- O 0 0.0032525472342967987
subunit O 0 0.0019836861174553633
was O 0 0.0016030892729759216
found O 0 0.00032705755438655615
to O 0 0.00013996241614222527
accumulate O 0 0.015734709799289703
in O 0 0.0001898511400213465
comparison O 0 0.0008510974585078657
to O 0 5.0980172090930864e-05
the O 0 0.0001161040854640305
normal O 0 0.0029628414195030928
alpha O 0 0.003513801610097289
- O 0 0.0022076312452554703
subunit O 0 0.001371819875203073
precursor O 0 0.016052493825554848
levels O 0 0.007150693330913782
. O 0 0.0005260499310679734

We O 0 0.0008551999926567078
conclude O 0 0.003312376793473959
that O 0 3.315369031042792e-05
the O 0 0.0003826685715466738
1422 O 1 0.9993472695350647
G O 1 0.9362581372261047
- O 0 0.033964853733778
- O 0 0.024248113855719566
> O 0 0.030856769531965256
C O 0 0.06970424205064774
mutation O 0 0.002333331387490034
is O 0 0.00020817822951357812
the O 0 0.0001285586622543633
cause O 0 0.003493993543088436
of O 0 2.9937336876173504e-05
Hex B-Disease 0 0.06618967652320862
A I-Disease 0 0.024529822170734406
enzyme I-Disease 1 0.9994205236434937
deficiency I-Disease 1 1.0
in O 0 0.0005253895069472492
the O 0 0.0008273026323877275
proband O 1 0.9917491674423218
. O 0 0.0008265331853181124

The O 0 0.0006264851544983685
resulting O 0 0.0031879611779004335
W474C O 0 0.041442565619945526
substitution O 0 0.0014337410684674978
clearly O 0 0.004637435078620911
interferes O 0 0.0710807517170906
with O 0 0.00013862673949915916
alpha O 0 0.004904312081634998
- O 0 0.0028426432982087135
subunit O 0 0.0010422116611152887
processing O 0 0.0016473672585561872
, O 0 0.00044016671017743647
but O 0 0.0002778862835839391
because O 0 0.0002961394202429801
the O 0 0.0001430906995665282
base O 0 0.003457917831838131
substitution O 0 0.0033463588915765285
falls O 0 0.07391456514596939
at O 0 0.0008580134017392993
the O 0 0.0001583582634339109
first O 0 0.00018451499636285007
position O 0 0.0008439713274128735
of O 0 4.884925874648616e-05
exon O 0 0.06695809215307236
13 O 0 0.002607535570859909
, O 0 0.0003509082889650017
aberrant O 0 0.0667186826467514
splicing O 0 0.007274018134921789
may O 0 0.0020619749557226896
also O 0 0.00016015805886127055
contribute O 0 0.0023874815087765455
to O 0 0.00016010631225071847
Hex B-Disease 0 0.05791139230132103
A I-Disease 0 0.09496176242828369
deficiency I-Disease 1 0.9999997615814209
in O 0 0.000272581004537642
this O 0 0.0002149338397430256
proband O 1 0.9893787503242493
. O 0 0.0003340316761750728
. O 0 0.0004892082652077079

Two O 0 0.00022300392447505146
frequent O 0 0.007806823588907719
missense O 0 0.029450934380292892
mutations O 0 0.005479014944285154
in O 0 0.0020731992553919554
Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
. O 0 0.0020561101846396923

Pendred B-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
is O 0 0.0015942072495818138
an O 0 0.004588823299854994
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9994644522666931
by O 0 0.0003230324655305594
early O 0 0.014054400846362114
childhood O 1 0.9999979734420776
deafness B-Disease 1 1.0
and O 0 0.023638339713215828
goiter B-Disease 1 1.0
. O 0 0.0020312354899942875

A O 0 0.006503453478217125
century O 0 0.0007274962263181806
after O 0 0.0011649876832962036
its O 0 0.0001577867369633168
recognition O 0 0.0017459024675190449
as O 0 0.0006507076323032379
a O 0 0.010139155201613903
syndrome O 1 1.0
by O 0 0.00044205322046764195
Vaughan O 1 0.9983589053153992
Pendred O 1 0.9981458187103271
, O 0 0.0003237773780710995
the O 0 0.001369086909107864
disease O 1 1.0
gene O 0 0.015110312029719353
( O 0 0.003284730715677142
PDS O 1 0.9999904632568359
) O 0 0.0007605209248140454
was O 0 0.001120849745348096
mapped O 0 0.0029511782340705395
to O 0 0.00012136458099121228
chromosome O 0 0.005207246169447899
7q22 O 0 0.3146651089191437
- O 0 0.023241860792040825
q31 O 0 0.08576438575983047
. O 0 0.0006547021912410855

1 O 0 0.004797877743840218
and O 0 0.0004114307230338454
, O 0 0.0010310461511835456
recently O 0 0.01068674772977829
, O 0 0.00024442034191451967
found O 0 0.00011733795690815896
to O 0 1.881863863673061e-05
encode O 0 0.00014885877317283303
a O 0 0.0005808861460536718
putative O 0 0.06581101566553116
sulfate O 1 0.9998080134391785
transporter O 1 0.9983611702919006
. O 0 0.001031451509334147

We O 0 0.0010806836653500795
performed O 0 0.001656212960369885
mutation O 0 0.0006516879075206816
analysis O 0 9.915405098581687e-05
of O 0 1.49819798025419e-05
the O 0 0.001267221407033503
PDS B-Disease 1 0.9999861717224121
gene O 0 0.007822825573384762
in O 0 0.0010634500067681074
patients O 1 0.9999760389328003
from O 0 0.00038770335959270597
14 O 0 0.004226294811815023
Pendred B-Disease 1 0.9827141165733337
families O 0 0.0005850724992342293
originating O 0 0.0012082469183951616
from O 0 0.00013130220759194344
seven O 0 0.0002370448928559199
countries O 0 7.033196015981957e-05
and O 0 0.00019149281433783472
identified O 0 0.0012223462108522654
all O 0 5.6238459364976734e-05
mutations O 0 0.004369622562080622
. O 0 0.0005655645509250462

The O 0 0.0014082693960517645
mutations O 0 0.002713746391236782
include O 0 0.00018933664250653237
three O 0 7.475806341972202e-05
single O 0 0.00040544700459577143
base O 0 0.003982292953878641
deletions O 0 0.004410504829138517
, O 0 0.000191644809092395
one O 0 0.0002678758173715323
splice O 0 0.03753460571169853
site O 0 0.004139686468988657
mutation O 0 0.0018616697052493691
and O 0 0.0001483586966060102
10 O 0 0.0010527180274948478
missense O 0 0.0261812936514616
mutations O 0 0.005286280997097492
. O 0 0.0005477190716192126

One O 0 0.0008405828848481178
missense O 0 0.026640329509973526
mutation O 0 0.007502375170588493
( O 0 0.0017785490490496159
L236P O 0 0.3850661814212799
) O 0 0.0007697531254962087
was O 0 0.00166165956761688
found O 0 0.0003155779850203544
in O 0 0.00010690927592804655
a O 0 0.0008762271027080715
homozygous O 0 0.005952372681349516
state O 0 0.00018584598728921264
in O 0 0.00016347730706911534
two O 0 0.00019091089779976755
consanguineous O 1 0.8547655344009399
families O 0 0.0010351263917982578
and O 0 0.00021019650739617646
in O 0 0.000183973039384
a O 0 0.0010747857159003615
heterozygous O 0 0.00385611061938107
state O 0 0.00011144120071548969
in O 0 6.456449045799673e-05
five O 0 7.701843424001709e-05
additional O 0 0.00036215613363310695
non O 0 0.00954343006014824
- O 0 0.0345468632876873
consanguineous O 1 0.5281981229782104
families O 0 0.0009840652346611023
. O 0 0.000595691439229995

Another O 0 0.0034768888726830482
missense O 0 0.03351844847202301
mutation O 0 0.0077735562808811665
( O 0 0.002027014037594199
T416P O 0 0.49011167883872986
) O 0 0.0007117707282304764
was O 0 0.0016716181999072433
found O 0 0.00026113702915608883
in O 0 9.790091280592605e-05
a O 0 0.0007689917110837996
homozygous O 0 0.005458827130496502
state O 0 0.00019461874035187066
in O 0 0.00019459109171293676
one O 0 0.00039198106969706714
family O 0 0.0008726580999791622
and O 0 0.00020164338639006019
in O 0 0.000207610908546485
a O 0 0.0010974135948345065
heterozygous O 0 0.0054024760611355305
state O 0 0.00023537897504866123
in O 0 0.00016926202806644142
four O 0 0.00016705527377780527
families O 0 0.00047360185999423265
. O 0 0.0005431260797195137

Pendred B-Disease 1 0.9995885491371155
patients O 1 0.9999771118164062
in O 0 0.00019039571634493768
three O 0 0.00016163161490112543
non O 0 0.011435375548899174
- O 0 0.06291623413562775
consanguineous O 1 0.8395031094551086
families O 0 0.0005525882006622851
were O 0 6.934326665941626e-05
shown O 0 0.0006464148755185306
to O 0 8.65063993842341e-05
be O 0 0.00023550378682557493
compound O 0 0.0190877802670002
heterozygotes O 0 0.13639123737812042
for O 0 0.000703232130035758
L236P O 0 0.15778745710849762
and O 0 0.0005315672024153173
T416P O 0 0.24684177339076996
. O 0 0.0007225456647574902

In O 0 0.0006209295243024826
total O 0 0.00029427852132357657
, O 0 0.0004067992849741131
one O 0 0.0003147574025206268
or O 0 0.0003327546000946313
both O 0 6.109251262387261e-05
of O 0 1.7209404177265242e-05
these O 0 9.696780034573749e-05
mutations O 0 0.0029949136078357697
were O 0 0.0001016128808259964
found O 0 0.0003542302583809942
in O 0 0.00010570589802227914
nine O 0 0.00013781907910015434
of O 0 1.5099944903340656e-05
the O 0 0.0004216681409161538
14 O 0 0.001755941892042756
families O 0 0.0003634420863818377
analyzed O 0 0.0050252703949809074
. O 0 0.0005230749375186861

The O 0 0.00046215462498366833
identification O 0 0.0002910005277954042
of O 0 1.5712294043623842e-05
two O 0 0.0002314099983777851
frequent O 0 0.26890915632247925
PDS B-Disease 1 0.9999740123748779
mutations O 0 0.004163645673543215
will O 0 8.944626461016014e-05
facilitate O 0 0.0007329435902647674
the O 0 0.0002208066580351442
molecular O 1 0.6323379278182983
diagnosis O 1 0.9999998807907104
of O 0 0.0004907030379399657
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0018422743305563927

Insertional O 1 0.6234365105628967
mutation O 0 0.002729266183450818
by O 0 0.00011220028682146221
transposable O 0 0.09127090871334076
element O 0 0.005610398016870022
, O 0 0.0015884451568126678
L1 O 1 0.9962903261184692
, O 0 0.0003352024359628558
in O 0 0.00022742056171409786
the O 0 0.0019550754223018885
DMD B-Disease 1 0.9999997615814209
gene O 0 0.0040946523658931255
results O 0 0.0005282587953843176
in O 0 0.0003532245464157313
X B-Disease 1 0.991897702217102
- I-Disease 1 0.9120244979858398
linked I-Disease 1 0.9965747594833374
dilated I-Disease 1 0.9999977350234985
cardiomyopathy I-Disease 1 1.0
. O 0 0.0026955544017255306

X B-Disease 1 0.9677113890647888
- I-Disease 1 0.8638970255851746
linked I-Disease 1 0.9944849610328674
dilated I-Disease 1 0.9999994039535522
cardiomyopathy I-Disease 1 1.0
( O 0 0.013655858114361763
XLDCM B-Disease 1 0.9999136924743652
) O 0 0.0006836188840679824
is O 0 0.00042043026769533753
a O 0 0.0019188318401575089
clinical O 1 0.9999057054519653
phenotype O 0 0.06421121209859848
of O 0 9.992774721467867e-05
dystrophinopathy B-Disease 1 0.9953428506851196
which O 0 0.00013795014820061624
is O 0 0.0005064705619588494
characterized O 0 0.03179476410150528
by O 0 0.00021164871577639133
preferential O 1 0.8480087518692017
myocardial B-Disease 1 1.0
involvement I-Disease 0 0.24642100930213928
without O 0 0.00025772149092517793
any O 0 0.00015267106937244534
overt O 0 0.14493733644485474
clinical O 1 0.9999960660934448
signs O 0 0.00959064718335867
of O 0 0.00030670646810904145
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 0.0034838279243558645

To O 0 0.0006441283621825278
date O 0 0.0003888556675519794
, O 0 8.963838627096266e-05
several O 0 4.58144313597586e-05
mutations O 0 0.0009706064593046904
in O 0 0.00012325956777203828
the O 0 0.001694413716904819
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.7939477562904358
, O 0 0.005877133458852768
DMD O 1 1.0
, O 0 0.0007723350427113473
have O 0 0.00011420402734074742
been O 0 0.00031409398070536554
identified O 0 0.0010699802078306675
in O 0 0.0005553006776608527
patients O 1 0.9999949932098389
with O 0 0.0006101007456891239
XLDCM B-Disease 1 0.9999024868011475
, O 0 0.0004395084688439965
but O 0 0.0001880396594060585
a O 0 0.000643985578790307
pathogenic O 0 0.013092231936752796
correlation O 0 0.0008160134893842041
of O 0 1.1788689334935043e-05
these O 0 7.677819667151198e-05
cardiospecific O 1 0.9863410592079163
mutations O 0 0.004559496883302927
in O 0 0.001552484929561615
DMD O 1 1.0
with O 0 0.00028534187003970146
the O 0 0.0011903465492650867
XLDCM B-Disease 1 0.9998852014541626
phenotype O 1 0.902592122554779
has O 0 0.00121444056276232
remained O 0 0.0024327195715159178
to O 0 7.420795009238645e-05
be O 0 0.00020442855020519346
elucidated O 0 0.3332042396068573
. O 0 0.0005022768164053559

We O 0 0.0024430041667073965
report O 0 0.0014925316208973527
here O 0 0.00018220477795694023
the O 0 9.162416972685605e-05
identification O 0 0.0001518580102128908
of O 0 8.074970537563786e-06
a O 0 0.00048122197040356696
unique O 0 0.0014634269755333662
de O 0 0.009370481595396996
novo O 0 0.05629980191588402
L1 O 1 0.7483892440795898
insertion O 0 0.010618221946060658
in O 0 0.00016641919501125813
the O 0 0.0005256697768345475
muscle O 1 0.994475781917572
exon O 0 0.06252783536911011
1 O 0 0.0029751553665846586
in O 0 0.001492905430495739
DMD O 1 0.9999998807907104
in O 0 0.0006969658425077796
three O 0 0.0010362195316702127
XLDCM B-Disease 1 0.9999730587005615
patients O 1 0.9999798536300659
from O 0 0.0001372289698338136
two O 0 9.675000910647213e-05
unrelated O 0 0.007622641045600176
Japanese O 0 0.002119737211614847
families O 0 0.0007120238151401281
. O 0 0.0006327040609903634

The O 0 0.000646840373519808
insertion O 0 0.016655517742037773
was O 0 0.0018737930804491043
a O 0 0.0011199862929061055
5 O 0 0.0029951557517051697
- O 0 0.009924331679940224
truncated O 0 0.0352088138461113
form O 0 0.00026930245803669095
of O 0 4.333601827966049e-05
human O 0 0.00576000614091754
L1 O 1 0.955242395401001
inversely O 0 0.004622724372893572
integrated O 0 0.012678270228207111
in O 0 0.00025873829144984484
the O 0 0.000552656885702163
5 O 0 0.004665484186261892
- O 0 0.014512660913169384
untranslated O 0 0.06322889775037766
region O 0 0.001484484993852675
in O 0 0.0001357793516945094
the O 0 0.0006819076370447874
muscle O 1 0.9990791082382202
exon O 0 0.13677546381950378
1 O 0 0.0038082331884652376
, O 0 0.0003293027402833104
which O 0 0.00012265201075933874
affected O 0 0.0035348914097994566
the O 0 0.00017787805700208992
transcription O 0 0.0025357359554618597
or O 0 0.00039669545367360115
the O 0 0.0001575021888129413
stability O 0 0.0022025681100785732
of O 0 2.4074835891951807e-05
the O 0 0.0006027216440998018
muscle O 1 0.9990573525428772
form O 0 0.0005681249895133078
of O 0 0.0001282443554373458
dystrophin O 1 0.9999197721481323
transcripts O 0 0.0067740739323198795
but O 0 0.00020888008293695748
not O 0 3.688547440106049e-05
that O 0 1.0014677172875963e-05
of O 0 9.254606993636116e-06
the O 0 0.0009247519192285836
brain O 1 0.9999977350234985
or O 0 0.0023623628076165915
Purkinje O 1 0.9998088479042053
cell O 0 0.006367410067468882
form O 0 0.0010922488290816545
, O 0 0.0007012258865870535
probably O 0 0.004099047277122736
due O 0 0.0012896009720861912
to O 0 6.514391134260222e-05
its O 0 0.0001403331261826679
unique O 0 0.0006370427436195314
site O 0 0.0012773112393915653
of O 0 2.0762605345225893e-05
integration O 0 0.00509778643026948
. O 0 0.0007811390096321702

We O 0 0.0022703625727444887
speculate O 0 0.006554218474775553
that O 0 2.8681444746325724e-05
this O 0 2.546020914451219e-05
insertion O 0 0.0032401939388364553
of O 0 2.2721766072208993e-05
an O 0 0.0006968078087083995
L1 O 1 0.9871039986610413
sequence O 0 0.00046284706331789494
in O 0 0.0027134830597788095
DMD O 1 1.0
is O 0 0.0026912507601082325
responsible O 0 0.00669803936034441
for O 0 0.0001747811766108498
some O 0 2.541824142099358e-05
of O 0 1.0660144653229509e-05
the O 0 9.04766347957775e-05
population O 0 3.517645745887421e-05
of O 0 2.963055158033967e-05
Japanese O 0 0.014943224377930164
patients O 1 0.9999970197677612
with O 0 0.000821796478703618
XLDCM B-Disease 1 0.9999136924743652
. O 0 0.0005581566947512329
. O 0 0.00047438242472708225

Severe O 1 0.9999744892120361
early O 0 0.005586379673331976
- O 1 0.9974400997161865
onset O 1 0.9999995231628418
obesity B-Disease 1 1.0
, O 0 0.006040466483682394
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 0.0023191177751868963
red O 1 0.9990864992141724
hair O 1 0.9999912977218628
pigmentation O 1 0.9999971389770508
caused O 1 0.6734123826026917
by O 0 0.0007358402945101261
POMC O 1 0.9999457597732544
mutations O 0 0.004959387704730034
in O 0 0.0002465112484060228
humans O 0 0.003570432774722576
. O 0 0.0005099650006741285

Sequential O 0 0.0076261842623353004
cleavage O 0 0.016980167478322983
of O 0 1.0924622074526269e-05
the O 0 9.1363130195532e-05
precursor O 0 0.007172248791903257
protein O 0 0.0010405672946944833
pre O 0 0.014095676131546497
- O 0 0.01038188487291336
pro O 0 0.01997065171599388
- O 0 0.01856319233775139
opiomelanocortin O 1 0.9380567073822021
( O 0 0.00417808024212718
POMC O 1 0.9996210336685181
) O 0 0.00029853254090994596
generates O 0 0.0006769825704395771
the O 0 0.00038309433148242533
melanocortin O 1 0.9954002499580383
peptides O 0 0.009458797052502632
adrenocorticotrophin O 1 0.9733664393424988
( O 0 0.0036106796469539404
ACTH O 1 0.9998559951782227
) O 0 0.0005282482015900314
, O 0 0.0005104534793645144
melanocyte O 1 0.9991680383682251
- O 0 0.01400028821080923
stimulating O 0 0.3232342600822449
hormones O 0 0.04606672748923302
( O 0 0.0038462583906948566
MSH O 1 0.9999765157699585
) O 0 0.000675820279866457
alpha O 0 0.0032266543712466955
, O 0 0.0002815646876115352
beta O 0 0.007806383538991213
and O 0 0.00015750144666526467
gamma O 0 0.006660688202828169
as O 0 0.0001706337498035282
well O 0 9.676949412096292e-05
as O 0 9.227318514604121e-05
the O 0 0.0001971054880414158
opioid O 1 0.9761878848075867
- O 0 0.0038283350877463818
receptor O 0 0.0026568258181214333
ligand O 0 0.009265465661883354
beta O 0 0.017887013033032417
- O 0 0.024363568052649498
endorphin O 1 0.9949603080749512
. O 0 0.0007910904823802412

While O 0 0.0009039608994498849
a O 0 0.0005570989451371133
few O 0 0.00028784447931684554
cases O 0 0.00063489587046206
of O 0 6.825355376349762e-05
isolated O 1 0.9980077147483826
ACTH B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
have O 0 0.0003375643282197416
been O 0 0.0008308604592457414
reported O 0 0.008493523113429546
( O 0 0.004269339144229889
OMIM O 1 0.9999849796295166
201400 O 1 0.9921601414680481
) O 0 0.0005050575127825141
, O 0 0.00020766833040397614
an O 0 0.0012877942062914371
inherited O 1 0.9999877214431763
POMC O 1 0.9999994039535522
defect O 1 0.9999608993530273
has O 0 0.0015852992655709386
not O 0 0.00019399254233576357
been O 0 0.0004304852045606822
described O 0 0.0031449326779693365
so O 0 0.0004094372852705419
far O 0 0.000848246447276324
. O 0 0.0004385801439639181

Recent O 0 0.004055747762322426
studies O 0 0.0011954414658248425
in O 0 0.0002808202407322824
animal O 0 0.005867357831448317
models O 0 0.001991451717913151
elucidated O 0 0.05787956342101097
a O 0 0.0004975517513230443
central O 0 0.0004837104643229395
role O 0 0.001009544124826789
of O 0 5.0192189519293606e-05
alpha O 0 0.020911673083901405
- O 0 0.41469910740852356
MSH O 1 0.9999793767929077
in O 0 0.0002466605219524354
the O 0 0.00012309302110224962
regulation O 0 0.0005767761031165719
of O 0 1.9764922399190255e-05
food O 0 0.0018837291281670332
intake O 0 0.010249732993543148
by O 0 2.8936785383848473e-05
activation O 0 0.0008308604592457414
of O 0 1.246256670128787e-05
the O 0 0.0008856951608322561
brain O 1 0.9999850988388062
melanocortin O 1 0.9994733929634094
- O 0 0.009927481412887573
4 O 0 0.0015781170222908258
- O 0 0.004248865880072117
receptor O 0 0.009683254174888134
( O 0 0.0026550714392215014
MC4 O 1 0.9999812841415405
- O 0 0.05186258256435394
R O 0 0.21177254617214203
; O 0 0.0006312970072031021
refs O 0 0.11794409155845642
3 O 0 0.004725324921309948
- O 0 0.008535165339708328
5 O 0 0.00155668577644974
) O 0 0.00019223410345148295
and O 0 6.755808863090351e-05
the O 0 0.00015567893569823354
linkage O 0 0.012264665216207504
of O 0 7.566230488009751e-05
human O 0 0.03270751237869263
obesity B-Disease 1 0.9999997615814209
to O 0 0.0004769757797475904
chromosome O 0 0.00392969511449337
2 O 0 0.0010037518804892898
in O 0 0.0001420333719579503
close O 0 0.0014458891237154603
proximity O 0 0.001694203820079565
to O 0 0.0001589038729434833
the O 0 0.0014495177892968059
POMC O 1 0.9999635219573975
locus O 0 0.06391207128763199
, O 0 0.0008049257448874414
led O 0 0.0007527195266447961
to O 0 0.00010400563769508153
the O 0 0.0001548669970361516
proposal O 0 0.000992476474493742
of O 0 1.1969777006015647e-05
an O 0 0.0004624618450179696
association O 0 0.013045343570411205
of O 0 0.0002266436640638858
POMC O 1 0.9999827146530151
with O 0 0.000550566241145134
human O 0 0.08341145515441895
obesity B-Disease 1 0.9999998807907104
. O 0 0.0014338126638904214

The O 0 0.0005903569981455803
dual O 0 0.0026903729885816574
role O 0 0.0013188216835260391
of O 0 5.864632476004772e-05
alpha O 0 0.01910461112856865
- O 0 0.10799748450517654
MSH O 1 0.9998763799667358
in O 0 0.0002454787609167397
regulating O 0 0.008132582530379295
food O 0 0.002230329904705286
intake O 0 0.017992349341511726
and O 0 0.0004428122192621231
influencing O 0 0.1146254912018776
hair O 1 0.999976634979248
pigmentation O 1 0.9999912977218628
predicts O 0 0.09868992865085602
that O 0 0.00011056983203161508
the O 0 0.00039539497811347246
phenotype O 0 0.29209020733833313
associated O 0 0.0005973444785922766
with O 0 9.957589645637199e-05
a O 0 0.0031317363027483225
defect O 1 0.999767005443573
in O 0 0.00146329659037292
POMC O 1 0.9999055862426758
function O 0 0.002083014464005828
would O 0 0.00048224072088487446
include O 0 0.0017541134729981422
obesity B-Disease 1 1.0
, O 0 0.0005686211516149342
alteration O 0 0.12535801529884338
in O 0 0.0009878521086648107
pigmentation O 1 0.9999960660934448
and O 0 0.006702653598040342
ACTH B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
. O 0 0.0014251221437007189

The O 0 0.0007135494379326701
observation O 0 0.010945475660264492
of O 0 3.3871976484078914e-05
these O 0 0.00035988635499961674
symptoms O 1 0.9999983310699463
in O 0 0.00033054762752726674
two O 0 0.00024818727979436517
probands O 1 0.9891672134399414
prompted O 0 0.009496798738837242
us O 0 0.0016275271773338318
to O 0 7.100673974491656e-05
search O 0 0.0005153422825969756
for O 0 0.00019578405772335827
mutations O 0 0.0012048169737681746
within O 0 0.00011065739090554416
their O 0 0.0003747938317246735
POMC O 1 0.999845027923584
genes O 0 0.0014493735507130623
. O 0 0.0005701746558770537

Patient O 1 0.9999451637268066
1 O 0 0.005467262584716082
was O 0 0.001968313241377473
found O 0 0.00025615852791815996
to O 0 5.281299308990128e-05
be O 0 6.363489956129342e-05
a O 0 0.0006265754345804453
compound O 0 0.02040899731218815
heterozygote O 0 0.0536637045443058
for O 0 0.00015763213741593063
two O 0 5.327050166670233e-05
mutations O 0 0.0014170914655551314
in O 0 0.00033546073245815933
exon O 0 0.05872642248868942
3 O 0 0.0030995174311101437
( O 0 0.0016578891081735492
G7013T O 0 0.35158124566078186
, O 0 0.001575333415530622
C7133delta O 1 0.9960422515869141
) O 0 0.0004137022187933326
which O 0 7.841111801099032e-05
interfere O 0 0.00414019962772727
with O 0 2.7835669243359007e-05
appropriate O 0 0.0005411916063167155
synthesis O 0 0.0008750210399739444
of O 0 8.812887244857848e-05
ACTH O 1 0.9999203681945801
and O 0 0.0004019342304673046
alpha O 0 0.01687029004096985
- O 0 0.32280802726745605
MSH O 1 0.999968409538269
. O 0 0.0013858876191079617

Patient O 1 0.999783456325531
2 O 0 0.003063105046749115
was O 0 0.0016298687551170588
homozygous O 0 0.00200191349722445
for O 0 8.244242053478956e-05
a O 0 0.00046323169954121113
mutation O 0 0.0017275121062994003
in O 0 0.0003834509407170117
exon O 0 0.05712650716304779
2 O 0 0.003538405289873481
( O 0 0.0015777593944221735
C3804A O 0 0.10766453295946121
) O 0 0.00041626961319707334
which O 0 0.0002323770895600319
abolishes O 1 0.9502584338188171
POMC O 1 0.9992766976356506
translation O 0 0.0026988121680915356
. O 0 0.0006890124059282243

These O 0 0.00027336020139046013
findings O 0 0.002583164954558015
represent O 0 0.00023461067758034915
the O 0 0.0001076515472959727
first O 0 0.00011454758350737393
examples O 0 0.00013169166049920022
of O 0 2.184026743634604e-05
a O 0 0.003295044181868434
genetic B-Disease 1 0.9964454770088196
defect I-Disease 1 0.9999711513519287
within O 0 0.0003882163146045059
the O 0 0.001799301360733807
POMC O 1 0.9999587535858154
gene O 0 0.003902073949575424
and O 0 0.00010288997873431072
define O 0 0.0021024933084845543
a O 0 0.0008972623618319631
new O 0 0.0032360029872506857
monogenic B-Disease 1 0.9999995231628418
endocrine I-Disease 1 0.9999998807907104
disorder I-Disease 1 0.9999997615814209
resulting O 0 0.0030305280815809965
in O 0 0.0003004722238983959
early O 0 0.002628200687468052
- O 1 0.997148334980011
onset O 1 0.9999988079071045
obesity B-Disease 1 1.0
, O 0 0.006167609244585037
adrenal B-Disease 1 0.9999998807907104
insufficiency I-Disease 1 0.9999998807907104
and O 0 0.0026135933585464954
red O 1 0.9983661770820618
hair O 1 0.9999861717224121
pigmentation O 1 0.9999971389770508
. O 0 0.000725232413969934
. O 0 0.000588473048992455

A O 0 0.007149737793952227
European O 0 0.0023787154350429773
multicenter O 1 0.6279720067977905
study O 0 0.0007567244465462863
of O 0 9.990573744289577e-05
phenylalanine B-Disease 1 0.9999953508377075
hydroxylase I-Disease 1 0.9999943971633911
deficiency I-Disease 1 1.0
: O 0 0.0014870555605739355
classification O 0 0.01265464536845684
of O 0 5.307543324306607e-05
105 O 0 0.012401235289871693
mutations O 0 0.002786418190225959
and O 0 0.00012545300705824047
a O 0 0.0007364997291006148
general O 0 0.0018770768074318767
system O 0 0.0024614776484668255
for O 0 0.0008166602929122746
genotype O 1 0.6563639044761658
- O 0 0.006749853026121855
based O 0 0.00019122807134408504
prediction O 0 0.004919531289488077
of O 0 7.99459230620414e-05
metabolic O 1 0.9996812343597412
phenotype O 1 0.9528872966766357
. O 0 0.0010374478297308087

Phenylketonuria B-Disease 1 0.9999960660934448
( O 0 0.02128433622419834
PKU B-Disease 1 0.9999997615814209
) O 0 0.0010133447358384728
and O 0 0.0007431304547935724
mild B-Disease 1 0.999994158744812
hyperphenylalaninemia I-Disease 1 0.9999958276748657
( O 0 0.013146585784852505
MHP B-Disease 1 0.9999998807907104
) O 0 0.0009446518961340189
are O 0 0.00021591810218524188
allelic B-Disease 1 0.9994914531707764
disorders I-Disease 1 1.0
caused O 1 0.812140166759491
by O 0 0.00019837706349790096
mutations O 0 0.0019095431780442595
in O 0 6.453396781580523e-05
the O 0 8.544959564460441e-05
gene O 0 0.0010322508169338107
encoding O 0 0.0010657812235876918
phenylalanine O 1 0.7484984993934631
hydroxylase O 1 0.9876313805580139
( O 0 0.008227626793086529
PAH O 1 0.9999998807907104
) O 0 0.0011508677853271365
. O 0 0.0004998739459551871

Previous O 0 0.004751099273562431
studies O 0 0.0019551683217287064
have O 0 0.00013721261348109692
suggested O 0 0.0008611955563537776
that O 0 2.4883225705707446e-05
the O 0 6.62967431708239e-05
highly O 0 0.0027783934492617846
variable O 0 0.0046628424897789955
metabolic O 1 0.9977225661277771
phenotypes O 0 0.03619768097996712
of O 0 0.0007362134638242424
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 0 0.10334685444831848
with O 0 0.001709522563032806
PAH O 1 1.0
genotypes O 1 0.9807064533233643
. O 0 0.0009441853617317975

We O 0 0.0009955111891031265
identified O 0 0.0010309970239177346
both O 0 0.00023355121084023267
causative O 1 0.8384661078453064
mutations O 0 0.005566075444221497
in O 0 0.0014241982717067003
686 O 1 0.999762237071991
patients O 1 0.9999873638153076
from O 0 0.0001508446002844721
seven O 0 0.000308869406580925
European O 0 0.0012055998668074608
centers O 0 0.005093063227832317
. O 0 0.0006281777750700712

On O 0 0.0008804883109405637
the O 0 8.26768737169914e-05
basis O 0 5.235940989223309e-05
of O 0 1.3068862244836055e-05
the O 0 0.00023516184592153877
phenotypic O 0 0.011370314285159111
characteristics O 0 0.000788377074059099
of O 0 8.209253428503871e-05
297 O 1 0.9424929022789001
functionally O 1 0.9914671182632446
hemizygous O 1 0.999772846698761
patients O 1 0.9999912977218628
, O 0 0.00042787729762494564
105 O 0 0.0027192519046366215
of O 0 1.8849928892450407e-05
the O 0 0.0004720446595456451
mutations O 0 0.00339595228433609
were O 0 8.196284034056589e-05
assigned O 0 0.002691917819902301
to O 0 5.4801348596811295e-05
one O 0 3.5510944144334644e-05
of O 0 8.468870873912238e-06
four O 0 0.00010021859634434804
arbitrary O 0 0.0010854117572307587
phenotype O 1 0.6674849390983582
categories O 0 0.004241760354489088
. O 0 0.0008720641490072012

We O 0 0.0013639797689393163
proposed O 0 0.0016727548791095614
and O 0 0.00030379771487787366
tested O 0 0.012279433198273182
a O 0 0.0003437185368966311
simple O 0 0.0006492825341410935
model O 0 0.0009082460310310125
for O 0 0.00023707086802460253
correlation O 0 0.0029976717196404934
between O 0 0.0007832167902961373
genotype O 0 0.1130799949169159
and O 0 0.0003929787199012935
phenotypic O 0 0.021409019827842712
outcome O 0 0.005217095371335745
. O 0 0.0007422301569022238

The O 0 0.0008394774631597102
observed O 0 0.0025904052890837193
phenotype O 0 0.05707704275846481
matched O 0 0.0023334568832069635
the O 0 0.00029456563061103225
predicted O 0 0.01133052445948124
phenotype O 0 0.0775984525680542
in O 0 0.0005379204521887004
79 O 0 0.012511048465967178
% O 0 3.634138556662947e-05
of O 0 2.1155936337891035e-05
the O 0 0.0008058102102950215
cases O 0 0.008644521236419678
, O 0 0.0004635172663256526
and O 0 0.00016437155136372894
in O 0 0.0001472717267461121
only O 0 7.440011540893465e-05
5 O 0 0.0004047179245389998
of O 0 4.8591024096822366e-05
184 O 1 0.7088067531585693
patients O 1 0.9999986886978149
was O 0 0.0011233214754611254
the O 0 0.00019255145161878318
observed O 0 0.0017357092583552003
phenotype O 0 0.02816406637430191
more O 0 7.296314288396388e-05
than O 0 0.00011056139919674024
one O 0 0.00021691063011530787
category O 0 0.0017454535700380802
away O 0 0.00042319874046370387
from O 0 6.837798719061539e-05
that O 0 8.636751590529457e-05
expected O 0 0.001085289171896875
. O 0 0.00037832435918971896

Among O 0 0.0004705148166976869
the O 0 0.0002421630924800411
seven O 0 0.0006501259049400687
contributing O 0 0.009888306260108948
centers O 0 0.0041920775547623634
, O 0 0.00014574230590369552
the O 0 0.00012937028077431023
proportion O 0 0.0007226999150589108
of O 0 0.0002223656774731353
patients O 1 0.9999963045120239
for O 0 0.0006482051685452461
whom O 0 0.0018273035530000925
the O 0 0.00021265829855110496
observed O 0 0.002727068029344082
phenotype O 1 0.6019503474235535
did O 0 0.0009741519461385906
not O 0 9.121940820477903e-05
match O 0 0.0003496553690638393
the O 0 0.00016310380306094885
predicted O 0 0.0065713487565517426
phenotype O 0 0.06900694966316223
was O 0 0.0022015904542058706
4 O 0 0.0015407929895445704
% O 0 0.0002268520911457017
- O 0 0.008229120634496212
23 O 0 0.0028157075867056847
% O 0 0.00018396636005491018
( O 0 0.0028545204550027847
P O 1 0.9830001592636108
< O 0 0.20963311195373535
. O 0 0.0013394353445619345
0001 O 1 0.9691686034202576
) O 0 0.0011437147622928023
, O 0 0.00045450610923580825
suggesting O 0 0.004893832374364138
that O 0 8.224297926062718e-05
differences O 0 0.0009519753511995077
in O 0 0.00010193313210038468
methods O 0 0.0003965358773712069
used O 0 0.00016357572167180479
for O 0 0.0003124153008684516
mutation O 0 0.005872608162462711
detection O 0 0.03947006165981293
or O 0 0.003602375742048025
phenotype O 1 0.9953296184539795
classification O 1 0.9841071367263794
may O 0 0.0024677421897649765
account O 0 0.00015382499259430915
for O 0 8.84842302184552e-05
a O 0 0.00018549298692960292
considerable O 0 0.0002720630436670035
proportion O 0 0.00027499633142724633
of O 0 8.073671779129654e-05
genotype O 1 0.9908362627029419
- O 1 0.7052395343780518
phenotype O 1 0.8497041463851929
inconsistencies O 0 0.01864778995513916
. O 0 0.0008123856387101114

Our O 0 0.0008427025168202817
data O 0 0.00012098650040570647
indicate O 0 0.0005001699319109321
that O 0 6.00742241658736e-05
the O 0 0.0014037229120731354
PAH O 1 0.9999998807907104
- O 0 0.023129621520638466
mutation O 0 0.0042067416943609715
genotype O 0 0.03648441657423973
is O 0 0.0002367862471146509
the O 0 9.711706661619246e-05
main O 0 0.0009431931539438665
determinant O 0 0.01528469379991293
of O 0 0.00011313076538499445
metabolic O 1 0.9998096823692322
phenotype O 1 0.705311119556427
in O 0 0.00024212661082856357
most O 0 0.0010360843734815717
patients O 1 0.9999991655349731
with O 0 0.003386195981875062
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0012660499196499586

In O 0 0.0006629791459999979
the O 0 0.00024361185205634683
present O 0 0.0004673865914810449
study O 0 0.002088759560137987
, O 0 0.00014734940486960113
the O 0 0.00017454949556849897
classification O 0 0.009961218573153019
of O 0 8.291791891679168e-05
105 O 1 0.5775761008262634
PAH O 1 1.0
mutations O 0 0.013980048708617687
may O 0 0.001184362219646573
allow O 0 0.00014179143181536347
the O 0 0.00015076193085405976
prediction O 0 0.005320127587765455
of O 0 1.311834785155952e-05
the O 0 0.00036535030812956393
biochemical O 0 0.08334803581237793
phenotype O 0 0.15952061116695404
in O 0 0.0008234225097112358
> O 0 0.02523910440504551
10 O 0 0.0010303804883733392
, O 0 0.0004890313721261919
000 O 0 0.016876529902219772
genotypes O 0 0.39596986770629883
, O 0 0.0006913389079272747
which O 0 0.0002124460879713297
may O 0 0.0011736712185665965
be O 0 5.4514366638613865e-05
useful O 0 0.0008099240949377418
for O 0 0.00015834136866033077
the O 0 0.0003437234554439783
management O 0 0.2321517914533615
of O 0 0.00015901829465292394
hyperphenylalaninemia B-Disease 1 0.9999802112579346
in O 0 0.0013324780156835914
newborns O 1 0.9991952776908875
. O 0 0.0006623102817684412

Somatic O 0 0.04118059203028679
instability O 0 0.005955934524536133
of O 0 3.6111439840169623e-05
the O 0 0.001344545278698206
CTG O 1 0.9987009763717651
repeat O 0 0.024074941873550415
in O 0 0.0003796950331889093
mice O 0 0.009314697235822678
transgenic O 0 0.002195132663473487
for O 0 0.00022965621610637754
the O 0 0.0029015305917710066
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 0.033702801913022995
is O 0 0.0013663507997989655
age O 0 0.0015117086004465818
dependent O 0 0.003757069818675518
but O 0 0.00028952915454283357
not O 0 0.00016393234545830637
correlated O 0 0.0044693793170154095
to O 0 5.6783013860695064e-05
the O 0 9.160512126982212e-05
relative O 0 0.0006863038870505989
intertissue O 0 0.07860953360795975
transcription O 0 0.0024967349600046873
levels O 0 0.006902567110955715
and O 0 0.0007186527363955975
proliferative O 1 0.9999873638153076
capacities O 0 0.08735449612140656
. O 0 0.0012802088167518377

A O 0 0.020828906446695328
( O 0 0.00508422264829278
CTG O 1 0.9980899691581726
) O 0 0.0016237429808825254
nexpansion O 0 0.11614561825990677
in O 0 0.0001648903707973659
the O 0 0.00036941893631592393
3 O 0 0.0038574000354856253
- O 0 0.015214133076369762
untranslated O 0 0.12559767067432404
region O 0 0.007803558837622404
( O 0 0.0015802643029019237
UTR O 0 0.46557852625846863
) O 0 0.00011203061876585707
of O 0 1.252580295840744e-05
the O 0 0.001125285867601633
DM O 1 0.9999996423721313
protein O 0 0.002643710235133767
kinase O 0 0.024880696088075638
gene O 0 0.005692326929420233
( O 0 0.001963571645319462
DMPK O 1 0.9997343420982361
) O 0 0.00026698113651946187
is O 0 0.000192716033780016
responsible O 0 0.002518078312277794
for O 0 0.0005405711126513779
causing O 1 0.9998586177825928
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9262082576751709
DM B-Disease 1 1.0
) O 0 0.002159718656912446
. O 0 0.0006571267149411142

Major O 0 0.02662031352519989
instability O 0 0.031307317316532135
, O 0 0.00038084181142039597
with O 0 9.11763563635759e-05
very O 0 0.0006812723586335778
large O 0 0.00038123849662952125
expansions O 0 0.009968209080398083
between O 0 0.0002936087257694453
generations O 0 0.0012018815614283085
and O 0 0.00020261123427189887
high O 0 0.003775239223614335
levels O 0 0.0021487593185156584
of O 0 5.6478216720279306e-05
somatic O 1 0.5112526416778564
mosaicism O 1 0.999504566192627
, O 0 0.00043310743058100343
is O 0 0.0003324004355818033
observed O 0 0.0009647893020883203
in O 0 0.0013166418066248298
patients O 1 0.9999970197677612
. O 0 0.0008353728335350752

There O 0 0.0005198100116103888
is O 0 0.00027647006209008396
a O 0 0.00042300153290852904
good O 0 0.0021173954010009766
correlation O 0 0.0024318911600857973
between O 0 0.0003810827911365777
repeat O 0 0.01971007138490677
size O 0 0.0013113191816955805
( O 0 0.0008682978223077953
at O 0 0.00100430054590106
least O 0 0.0003296036156825721
in O 0 0.00044289324432611465
leucocytes O 1 0.9892817735671997
) O 0 0.0007347275386564434
, O 0 0.001272252993658185
clinical O 1 0.9999967813491821
severity O 1 0.9998248219490051
and O 0 0.0003030005609616637
age O 0 0.0008713781135156751
of O 0 0.00015109163359738886
onset O 1 0.9999842643737793
. O 0 0.0016726449830457568

The O 0 0.003829955356195569
trinucleotide O 1 0.9698372483253479
repeat O 0 0.029838785529136658
instability O 0 0.009822850115597248
mechanisms O 0 0.002623161766678095
involved O 0 0.002607431262731552
in O 0 0.002465075347572565
DM B-Disease 1 1.0
and O 0 0.00038095470517873764
other O 0 0.0001676536921877414
human O 0 0.22738614678382874
genetic B-Disease 1 0.9999133348464966
diseases I-Disease 1 1.0
are O 0 0.00016327184857800603
unknown O 0 0.0013177646324038506
. O 0 0.0005464379792101681

We O 0 0.0010960072977468371
studied O 0 0.0018639126792550087
somatic O 0 0.01213026698678732
instability O 0 0.005798203404992819
by O 0 4.896810060017742e-05
measuring O 0 0.010944020003080368
the O 0 0.0024308410938829184
CTG O 1 0.9985528588294983
repeat O 0 0.03387393802404404
length O 0 0.0016677490202710032
at O 0 0.0013313820818439126
several O 0 0.00019801875168923289
ages O 0 0.0018179232720285654
in O 0 0.00011540472769411281
various O 0 9.649230923969299e-05
tissues O 0 0.023089254274964333
of O 0 5.078971298644319e-05
transgenic O 0 0.014211566187441349
mice O 0 0.006809820421040058
carrying O 0 0.0006542095215991139
a O 0 0.0015000076964497566
( O 0 0.003066601697355509
CTG O 1 0.9989401698112488
) O 0 0.0021000446286052465
55expansion O 1 0.6350263357162476
surrounded O 0 0.006260574795305729
by O 0 8.385294495383278e-05
45 O 0 0.0008223553304560483
kb O 0 0.009092943742871284
of O 0 2.9000244467169978e-05
the O 0 0.0008488714229315519
human O 0 0.07412317395210266
DM B-Disease 1 1.0
region O 0 0.007538006640970707
, O 0 0.0001317100104643032
using O 0 0.00010985235712723807
small O 0 0.0005956919630989432
- O 0 0.010572313331067562
pool O 0 0.00999230146408081
PCR O 0 0.025080813094973564
. O 0 0.0007519502541981637

These O 0 0.0005335784517228603
mice O 0 0.016146522015333176
have O 0 0.00015118315059226006
been O 0 0.0003058783186133951
shown O 0 0.0004488122067414224
to O 0 8.723481005290523e-05
reproduce O 0 0.0015160359907895327
the O 0 0.0003996233572252095
intergenerational O 0 0.14433473348617554
and O 0 0.0004323498869780451
somatic O 0 0.018483776599168777
instability O 0 0.004670681431889534
of O 0 2.3309705284191296e-05
the O 0 0.0006638586055487394
55 O 0 0.024851802736520767
CTG O 1 0.9993869066238403
repeat O 0 0.05645054951310158
suggesting O 0 0.008095824159681797
that O 0 0.00013341772137209773
surrounding O 0 0.0013540745712816715
sequences O 0 0.00010609782475512475
and O 0 0.00011548079055501148
the O 0 0.00028509742696769536
chromatin O 0 0.01429364550858736
environment O 0 0.004292510449886322
are O 0 5.4904710850678384e-05
involved O 0 0.0011004767147824168
in O 0 0.0003364624863024801
instability O 0 0.016163136810064316
mechanisms O 0 0.005613002926111221
. O 0 0.0008684368804097176

As O 0 0.0013398336013779044
observed O 0 0.0006125359795987606
in O 0 5.462353874463588e-05
some O 0 9.40734116738895e-06
of O 0 7.392403858830221e-06
the O 0 0.00028894562274217606
tissues O 1 0.966179370880127
of O 0 0.0012708778958767653
DM B-Disease 1 1.0
patients O 1 0.9999997615814209
, O 0 0.0004135838826186955
there O 0 0.00011233978148084134
is O 0 0.00023039290681481361
a O 0 0.0005180016742087901
tendency O 0 0.007091839797794819
for O 0 0.0005397586501203477
repeat O 0 0.015997711569070816
length O 0 0.0009996206499636173
and O 0 0.00043042044853791595
somatic O 0 0.08766069263219833
mosaicism O 1 0.9942291975021362
to O 0 0.00016514005255885422
increase O 0 0.0002883514971472323
with O 0 6.84085171087645e-05
the O 0 0.0002988025080412626
age O 0 0.0005160865257494152
of O 0 2.349877468077466e-05
the O 0 0.0007647330639883876
mouse O 0 0.029273126274347305
. O 0 0.0008347060065716505

Furthermore O 0 0.015639668330550194
, O 0 0.00032090130844153464
we O 0 0.0001979152875719592
observed O 0 0.00043916545109823346
no O 0 0.00013523678353521973
correlation O 0 0.0009280010126531124
between O 0 9.438211418455467e-05
the O 0 0.00022166900453157723
somatic O 0 0.020730646327137947
mutation O 0 0.0029133083298802376
rate O 0 0.00035246461629867554
and O 0 0.0005764419911429286
tissue O 1 0.9994814991950989
proliferation O 0 0.1214311346411705
capacity O 0 0.006000733468681574
. O 0 0.0006936414283700287

The O 0 0.0009495408739894629
somatic O 0 0.02312820963561535
mutation O 0 0.004141541197896004
rates O 0 0.0007137059001252055
in O 0 0.00010659676627255976
different O 0 6.660870712948963e-05
tissues O 1 0.6975516676902771
were O 0 0.00011117648682557046
also O 0 0.00024946359917521477
not O 0 0.00011224447371205315
correlated O 0 0.002966600237414241
to O 0 3.52639181073755e-05
the O 0 9.89951440715231e-05
relative O 0 0.0014544824371114373
inter O 0 0.08148626983165741
- O 0 0.0359644889831543
tissue O 1 0.6517165899276733
difference O 0 0.0013223219430074096
in O 0 0.00013118807692080736
transcriptional O 0 0.004004724323749542
levels O 0 0.001588669023476541
of O 0 1.015200268739136e-05
the O 0 0.00010436816228320822
three O 0 8.447244908893481e-05
genes O 0 0.0006491296808235347
( O 0 0.0019734136294573545
DMAHP O 1 0.9994950294494629
, O 0 0.002023010980337858
DMPK O 1 0.9991850256919861
and O 0 0.0007338615250773728
59 O 0 0.018393702805042267
) O 0 0.00043041343451477587
surrounding O 0 0.0017980976263061166
the O 0 0.0004137020150665194
repeat O 0 0.03402804210782051
. O 0 0.0003399273264221847
. O 0 0.000477104214951396

A O 0 0.007068241480737925
novel O 0 0.0038115927018225193
missense O 0 0.02916540764272213
mutation O 0 0.004618906415998936
in O 0 0.0008869225857779384
patients O 1 0.9999887943267822
from O 0 0.0002137733536073938
a O 0 0.0040845125913619995
retinoblastoma B-Disease 1 0.999990701675415
pedigree O 1 0.5942090749740601
showing O 0 0.0032407715916633606
only O 0 0.0003150062693748623
mild O 1 0.9955982565879822
expression O 0 0.00036104334867559373
of O 0 1.9700562916113995e-05
the O 0 0.001491894363425672
tumor B-Disease 1 0.9999998807907104
phenotype O 1 0.98838871717453
. O 0 0.0008075301302596927

We O 0 0.00086435821140185
have O 0 5.145109025761485e-05
used O 0 9.420732385478914e-05
single O 0 0.0003132566635031253
strand O 0 0.006488462910056114
conformation O 0 0.00521861994639039
polymorphism O 0 0.0025828429497778416
analysis O 0 0.00039271131390705705
to O 0 0.00014677435683552176
study O 0 0.0009193806909024715
the O 0 0.00023279956076294184
27 O 0 0.002348515670746565
exons O 0 0.002230496145784855
of O 0 3.569122054614127e-05
the O 0 0.0024689878337085247
RB1 O 1 0.9999866485595703
gene O 0 0.0056257364340126514
in O 0 0.0001796091382857412
individuals O 0 0.00019768443598877639
from O 0 0.00013493988080881536
a O 0 0.0010333837708458304
family O 0 0.0016368211945518851
showing O 0 0.007531128358095884
mild O 1 0.9963322281837463
expression O 0 0.0005688911769539118
of O 0 3.78053737222217e-05
the O 0 0.002077794400975108
retinoblastoma B-Disease 1 0.9999982118606567
phenotype O 1 0.9865723848342896
. O 0 0.001063529634848237

In O 0 0.000581282249186188
this O 0 9.952272375812754e-05
family O 0 0.0010312000522390008
affected O 0 0.007163303904235363
individuals O 0 0.0006884295726194978
developed O 0 0.25291571021080017
unilateral B-Disease 1 0.9996722936630249
tumors I-Disease 1 1.0
and O 0 0.0005192920216359198
, O 0 0.0002853252808563411
as O 0 0.00023269372468348593
a O 0 0.00042377487989142537
result O 0 0.0002750674029812217
of O 0 2.7536058041732758e-05
linkage O 0 0.03559570014476776
analysis O 0 0.001098851440474391
, O 0 0.0008599188295193017
unaffected O 1 0.9713941216468811
mutation O 0 0.010442167520523071
carriers O 0 0.01430087722837925
were O 0 0.00010839290189323947
also O 0 0.00028108753031119704
identified O 0 0.0006307109724730253
within O 0 5.414284532889724e-05
the O 0 0.00030938340933062136
pedigree O 0 0.38611236214637756
. O 0 0.0008976694662123919

A O 0 0.004402643069624901
single O 0 0.0005825231783092022
band O 0 0.0012344644637778401
shift O 0 0.0015625591622665524
using O 0 0.0006355518125928938
SSCP O 1 0.9982640147209167
was O 0 0.003255050629377365
identified O 0 0.001252859947271645
in O 0 0.00032745624775998294
exon O 0 0.04877810180187225
21 O 0 0.002525661140680313
which O 0 7.579553493997082e-05
resulted O 0 0.001076580141671002
in O 0 0.00010541368828853592
a O 0 0.0006831565406173468
missense O 0 0.010777244344353676
mutation O 0 0.0009804645087569952
converting O 0 0.0008377594058401883
a O 0 0.003229497466236353
cys O 1 0.9995033740997314
- O 0 0.07559814304113388
- O 0 0.026959344744682312
> O 0 0.03708276525139809
arg O 0 0.14790810644626617
at O 0 0.000690012879204005
nucleotide O 0 0.0004306401824578643
position O 0 0.0033453479409217834
28 O 0 0.002230828395113349
in O 0 0.0001367703080177307
the O 0 0.0004789008235093206
exon O 0 0.07769463956356049
. O 0 0.0007135263294912875

The O 0 0.0010073857847601175
mutation O 0 0.004097416531294584
destroyed O 0 0.0057993256486952305
an O 0 0.00028096107416786253
NdeI O 0 0.2983282506465912
restriction O 0 0.0010643216082826257
enzyme O 0 0.005398851353675127
site O 0 0.004341083578765392
. O 0 0.00044992254697717726

Analysis O 0 0.0007272286457009614
of O 0 2.746729296632111e-05
all O 0 8.698229066794738e-05
family O 0 0.0008956061792559922
members O 0 0.00016267388127744198
demonstrated O 0 0.0029890278819948435
that O 0 3.792742427322082e-05
the O 0 0.0001789784582797438
missense O 0 0.026251081377267838
mutation O 0 0.00889962911605835
co O 0 0.05533146113157272
- O 0 0.011509863659739494
segregated O 0 0.017420293763279915
with O 0 0.0007864198996685445
patients O 1 0.9999990463256836
with O 0 0.0017496971413493156
tumors B-Disease 1 1.0
or O 0 0.00287041999399662
who O 0 0.0017988750478252769
, O 0 0.00021300389198586345
as O 0 0.00020047246653120965
a O 0 0.0004426547675393522
result O 0 0.0003373767831362784
of O 0 2.7460742785478942e-05
linkage O 0 0.04007306694984436
analysis O 0 0.0012088306248188019
had O 0 0.0013153301551938057
been O 0 0.0004656207747757435
predicted O 0 0.0012140508042648435
to O 0 3.64816005458124e-05
carry O 0 0.0001814139395719394
the O 0 0.000249603035626933
predisposing O 1 0.6979050636291504
mutation O 0 0.00598890520632267
. O 0 0.0007010514382272959

These O 0 0.00014506364823319018
observations O 0 0.0013371187960729003
point O 0 0.0006093850824981928
to O 0 8.548171172151342e-05
another O 0 0.0003205676912330091
region O 0 0.000605451816227287
of O 0 2.3681670427322388e-05
the O 0 0.0025306441821157932
RB1 O 1 0.9999898672103882
gene O 0 0.007089578080922365
where O 0 0.0003787700261455029
mutations O 0 0.0014351316494867206
only O 0 8.640285523142666e-05
modify O 0 0.005450952332466841
the O 0 8.708378300070763e-05
function O 0 0.00035053532337769866
of O 0 1.5964275007718243e-05
the O 0 0.000543394242413342
gene O 0 0.004134686663746834
and O 0 0.0001556590577820316
raise O 0 0.0010728758061304688
important O 0 0.000461329153040424
questions O 0 0.0008718722383491695
for O 0 0.0005252973642200232
genetic O 0 0.014670491218566895
counseling O 1 0.9972037076950073
in O 0 0.00030545430490747094
families O 0 0.0001986298884730786
with O 0 7.10740132490173e-05
these O 0 8.91818999662064e-05
distinctive O 0 0.04453957453370094
phenotypes O 0 0.1341804563999176
. O 0 0.0005292284185998142
. O 0 0.0005486392183229327

Maternal B-Disease 1 0.9147821664810181
disomy I-Disease 1 0.994599461555481
and O 0 0.002714259782806039
Prader B-Disease 1 1.0
- I-Disease 1 0.9999926090240479
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.013521503657102585
with O 0 0.0003120435285381973
gamete O 1 0.938243567943573
complementation O 1 0.9992642998695374
in O 0 0.0003033034154213965
a O 0 0.000555058941245079
case O 0 0.0009267609566450119
of O 0 6.086450594011694e-05
familial O 1 0.9998403787612915
translocation O 0 0.47038009762763977
( O 0 0.0020147033501416445
3 O 0 0.0027845147997140884
; O 0 0.0003183529479429126
15 O 0 0.0020972397178411484
) O 0 0.0005294880829751492
( O 0 0.0019393538823351264
p25 O 1 0.9787418842315674
; O 0 0.0008779151830822229
q11 O 0 0.08919475227594376
. O 0 0.00039088568883016706
2 O 0 0.0019667164888232946
) O 0 0.0004351983079686761
. O 0 0.00039383399416692555

Maternal B-Disease 1 0.9938021898269653
uniparental I-Disease 1 0.9999785423278809
disomy I-Disease 1 0.9983305335044861
( I-Disease 0 0.010052653029561043
UPD I-Disease 1 0.9999922513961792
) I-Disease 0 0.0008727636886760592
for I-Disease 0 0.0004204044525977224
chromosome I-Disease 0 0.0046728807501494884
15 I-Disease 0 0.0011907806620001793
is O 0 0.0004548774741124362
responsible O 0 0.003965576179325581
for O 0 0.00022181932581588626
an O 0 0.00037616118788719177
estimated O 0 0.0014415535842999816
30 O 0 0.0007358347065746784
% O 0 1.8255062968819402e-05
of O 0 1.3703866898140404e-05
cases O 0 0.001540139433927834
of O 0 0.00031893467530608177
Prader B-Disease 1 1.0
- I-Disease 1 0.9999982118606567
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.08079617470502853
PWS B-Disease 1 1.0
) O 0 0.0021671042777597904
. O 0 0.0007075866451486945

We O 0 0.0014491326874122024
report O 0 0.0007712369551882148
on O 0 0.00013387342914938927
an O 0 0.00019378031720407307
unusual O 0 0.001718688989058137
case O 0 0.0017693014815449715
of O 0 6.610217678826302e-05
maternal B-Disease 1 0.6136295199394226
disomy I-Disease 1 0.9917470216751099
15 I-Disease 0 0.003447158494964242
in O 0 0.0015792256454005837
PWS B-Disease 1 0.9999998807907104
that O 0 0.0002888216695282608
is O 0 0.00021693215239793062
most O 0 0.00012560145114548504
consistent O 0 0.0033679164480417967
with O 0 0.00016167355352081358
adjacent O 0 0.009342076256871223
- O 0 0.00889170914888382
1 O 0 0.00163508509285748
segregation O 0 0.005199519917368889
of O 0 1.7338454199489206e-05
a O 0 0.002229670761153102
paternal O 0 0.40997689962387085
t O 1 0.9961938858032227
( O 0 0.0017204675823450089
3 O 0 0.002583156106993556
; O 0 0.0003626173420343548
15 O 0 0.0019247907912358642
) O 0 0.0006067961803637445
( O 0 0.001983510795980692
p25 O 1 0.9318464994430542
; O 0 0.0011405282421037555
q11 O 0 0.13020741939544678
. O 0 0.0003777333186008036
2 O 0 0.0012880468275398016
) O 0 9.960361785488203e-05
with O 0 3.8336042052833363e-05
simultaneous O 0 0.0014485373394563794
maternal O 0 0.31453046202659607
meiotic O 1 0.9980092644691467
nondisjunction O 1 0.9451696872711182
for O 0 0.0005844557308591902
chromosome O 0 0.005131595768034458
15 O 0 0.0017879094230011106
. O 0 0.0005222417530603707

The O 0 0.002623089589178562
patient O 1 0.9999468326568604
( O 0 0.005696700420230627
J O 1 0.9999717473983765
. O 0 0.0009540569153614342
B O 1 0.9293825626373291
. O 0 0.00025135738542303443
) O 0 0.00017425449914298952
, O 0 0.00010734545503510162
a O 0 0.0008669535163789988
17 O 0 0.004861602559685707
- O 0 0.007474252954125404
year O 0 0.0025189754087477922
- O 0 0.01833249442279339
old O 0 0.008633759804069996
white O 0 0.02629077434539795
male O 0 0.003751212963834405
with O 0 0.0022499070037156343
PWS B-Disease 1 1.0
, O 0 0.002065282315015793
was O 0 0.003052231390029192
found O 0 0.00038925654371269047
to O 0 8.472098124912009e-05
have O 0 7.52385167288594e-05
47 O 0 0.001288923085667193
chromosomes O 0 0.00018078088760375977
with O 0 4.554374027065933e-05
a O 0 0.00183335121255368
supernumerary O 1 0.9950422048568726
, O 0 0.001295139896683395
paternal O 1 0.6981766223907471
der O 1 0.9998949766159058
( O 0 0.002048737369477749
15 O 0 0.0018635188462212682
) O 0 9.299062367063016e-05
consisting O 0 4.299702777643688e-05
of O 0 1.3870269867766183e-05
the O 0 0.0004814768908545375
short O 0 0.009201315231621265
arm O 1 0.9925979375839233
and O 0 0.00036606675712391734
the O 0 0.0011226466158404946
proximal O 1 0.9998007416725159
long O 0 0.02366338111460209
arm O 1 0.5291352868080139
of O 0 9.634530579205602e-05
chromosome O 0 0.0066924202255904675
15 O 0 0.0012166659580543637
, O 0 0.00022944020747672766
and O 0 0.00042143501923419535
distal O 1 0.9995087385177612
chromosome O 0 0.03827380761504173
arm O 1 0.9990641474723816
3p O 1 0.998534083366394
. O 0 0.0016212642658501863

The O 0 0.005778490100055933
t O 1 0.9789703488349915
( O 0 0.0019433321431279182
3 O 0 0.0030435449443757534
; O 0 0.00037501699989661574
15 O 0 0.0024400847032666206
) O 0 0.00047137020737864077
was O 0 0.001361711765639484
present O 0 0.00022699162946082652
in O 0 0.0001240427081938833
the O 0 0.00014012237079441547
balanced O 0 0.0032089301384985447
state O 0 0.00015915694530121982
in O 0 0.00018207088578492403
the O 0 0.00156367605086416
patients O 1 0.9999986886978149
father O 0 0.004667091183364391
and O 0 0.00024212244898080826
a O 0 0.0022660624235868454
sister O 0 0.009620648808777332
. O 0 0.00079263502266258

Fluorescent O 0 0.05823083221912384
in O 0 0.0005386061384342611
situ O 0 0.05317225307226181
hybridization O 0 0.0007515419274568558
analysis O 0 0.00036310942959971726
demonstrated O 0 0.003914842382073402
that O 0 0.00013899100304115564
the O 0 0.002035917714238167
PWS B-Disease 1 0.9999994039535522
critical O 0 0.06043967232108116
region O 0 0.009845100343227386
resided O 0 0.012867151759564877
on O 0 0.00020229777146596462
the O 0 0.00027381876134313643
derivative O 0 0.01699443720281124
chromosome O 0 0.0075029791332781315
3 O 0 0.00167052261531353
and O 0 0.00012689725554082543
that O 0 8.308730321004987e-05
there O 0 0.00011418715439504012
was O 0 0.0011770306155085564
no O 0 0.00024148661759682
deletion O 0 0.003344540484249592
of O 0 4.135081326239742e-05
the O 0 0.0032521174289286137
PWS B-Disease 1 0.9999997615814209
region O 0 0.00725576700642705
on O 0 0.0002892653865274042
the O 0 0.00022296266979537904
normal O 0 0.003086159937083721
pair O 0 0.00043167651165276766
of O 0 4.8911206249613315e-05
15s O 1 0.8326981067657471
present O 0 0.0008065339643508196
in O 0 0.0016108081908896565
J O 1 0.9999575614929199
. O 0 0.0012335528153926134

B O 1 0.9611337184906006
. O 0 0.0010658549144864082

Methylation O 0 0.004426421131938696
analysis O 0 0.0007411515689454973
at O 0 0.001508248271420598
exon O 0 0.02051774226129055
alpha O 0 0.00077187514398247
of O 0 6.511267201858573e-06
the O 0 0.0001007801984087564
small O 0 0.0003974026476498693
nuclear O 0 0.018640363588929176
ribonucleoprotein O 1 0.997677743434906
- O 0 0.011756062507629395
associated O 0 0.000833847385365516
polypeptide O 0 0.017569508403539658
N O 0 0.04799334332346916
( O 0 0.0034153242595493793
SNRPN O 1 0.9993010759353638
) O 0 0.0008518561953678727
gene O 0 0.0032131026964634657
showed O 0 0.0015311430906876922
a O 0 0.0007239835103973746
pattern O 0 0.003953367006033659
characteristic O 0 0.0024474533274769783
of O 0 2.2106076357886195e-05
only O 0 9.19150625122711e-05
the O 0 0.0003185129025951028
maternal O 0 0.04109032452106476
chromosome O 0 0.005512922536581755
15 O 0 0.0014806616818532348
in O 0 0.0010226998711004853
J O 1 0.9998937845230103
. O 0 0.0011198448482900858

B O 1 0.9664997458457947
. O 0 0.001049652579240501

Maternal B-Disease 1 0.9757091999053955
disomy I-Disease 1 0.9917421340942383
was O 0 0.003976866137236357
confirmed O 0 0.0018560216994956136
by O 0 3.9158243453130126e-05
polymerase O 0 0.005572247784584761
chain O 0 0.005348816979676485
reaction O 0 0.0008032121695578098
analysis O 0 0.00029561223345808685
of O 0 6.823710282333195e-05
microsatellite O 0 0.12614570558071136
repeats O 0 0.009496121667325497
at O 0 0.0005717994645237923
the O 0 0.00018721546803135425
gamma O 0 0.015070844441652298
- O 0 0.00701384712010622
aminobutyric O 0 0.05259818211197853
acid O 0 0.007416105363518
receptor O 0 0.0067465039901435375
beta3 O 0 0.06739950180053711
subunit O 0 0.005176583305001259
( O 0 0.002796440850943327
GABRB3 O 1 0.9991536140441895
) O 0 0.0008712357375770807
locus O 0 0.02376064658164978
. O 0 0.0007830693502910435

A O 0 0.025773951783776283
niece O 1 0.9815951585769653
( O 0 0.0037521878257393837
B O 1 0.9977729916572571
. O 0 0.0011909089516848326
B O 1 0.9861955642700195
. O 0 0.0003860218566842377
) O 0 0.00020039945957250893
with O 0 9.395836241310462e-05
45 O 0 0.0008355255704373121
chromosomes O 0 0.00046595706953667104
and O 0 0.0001192546624224633
the O 0 0.00026800381601788104
derivative O 0 0.014803889207541943
3 O 0 0.0015844829613342881
but O 0 0.000166861223988235
without O 0 0.00023446802515536547
the O 0 0.0008922291453927755
der O 1 0.9997159838676453
( O 0 0.0015287051210179925
15 O 0 0.0015884451568126678
) O 0 0.00024178771127481014
demonstrated O 0 0.003319252049550414
a O 0 0.0013625166611745954
phenotype O 0 0.07355391979217529
consistent O 0 0.00609790300950408
with O 0 0.00011883125262102112
that O 0 0.00017998904513660818
reported O 0 0.002576552564278245
for O 0 0.0002699708566069603
haploinsufficiency O 0 0.2842341661453247
of O 0 0.0001002568460535258
distal O 1 0.9989686012268066
3 O 0 0.010849600657820702
p O 0 0.04131408408284187
. O 0 0.0007399056921713054

Uniparental B-Disease 1 0.9999992847442627
disomy I-Disease 1 0.9995146989822388
associated O 0 0.0015344349667429924
with O 0 0.00019200822862330824
unbalanced O 1 0.8833812475204468
segregation O 0 0.017132731154561043
of O 0 4.999322845833376e-05
non O 0 0.011913018301129341
- O 0 0.0644167885184288
Robertsonian O 1 0.9939650893211365
translocations O 0 0.04681282117962837
has O 0 0.001603218144737184
been O 0 0.0009674412431195378
reported O 0 0.005088184494525194
previously O 0 0.0019271316705271602
but O 0 0.0003881725133396685
has O 0 0.0008057821542024612
not O 0 0.0001925197138916701
, O 0 0.00014035239291843027
to O 0 9.309442975791171e-05
our O 0 0.0005579513381235301
knowledge O 0 0.004416490439325571
, O 0 0.00038458366179838777
been O 0 0.00037562940269708633
observed O 0 0.00033874259679578245
in O 0 9.368325117975473e-05
a O 0 0.0005789498100057244
case O 0 0.0023048927541822195
of O 0 0.0003362296847626567
PWS B-Disease 1 1.0
. O 0 0.002494830871000886

Furthermore O 0 0.01671559549868107
, O 0 0.0004694743547588587
our O 0 0.0010974962497130036
findings O 0 0.0032845386303961277
are O 0 2.079530167975463e-05
best O 0 0.0003603305958677083
interpreted O 0 0.0003108306264039129
as O 0 0.0001574671914568171
true O 0 0.0018324892735108733
gamete O 0 0.12253416329622269
complementation O 1 0.9894673228263855
resulting O 0 0.002499451395124197
in O 0 0.0005968084442429245
maternal B-Disease 1 0.9970818161964417
UPD I-Disease 1 0.9999973773956299
15 I-Disease 0 0.006458197720348835
and O 0 0.0026223063468933105
PWS B-Disease 1 0.9999996423721313

Schwartz B-Disease 1 0.9987043142318726
- I-Disease 1 0.9949778914451599
Jampel I-Disease 1 0.9999203681945801
syndrome I-Disease 1 1.0
type I-Disease 0 0.021201498806476593
2 I-Disease 0 0.0016648235032334924
and O 0 0.0004162995610386133
Stuve B-Disease 1 0.999906063079834
- I-Disease 1 0.9991723299026489
Wiedemann I-Disease 1 0.9999936819076538
syndrome I-Disease 1 1.0
: O 0 0.000735742156393826
a O 0 0.0008224681951105595
case O 0 0.0019816558342427015
for O 0 0.00033885694574564695
" O 0 0.001244840444996953
lumping O 0 0.08935808390378952
" O 0 0.002224596217274666
. O 0 0.0005413167527876794

Recent O 0 0.005773012991994619
studies O 0 0.0020919523667544127
demonstrated O 0 0.004006839822977781
the O 0 0.0001794256386347115
existence O 0 0.0009802815038710833
of O 0 2.0894814952043816e-05
a O 0 0.0009092699619941413
genetically O 0 0.0017627646448090672
distinct O 0 0.0009306382853537798
, O 0 0.0004445593513082713
usually O 0 0.0005060094990767539
lethal O 0 0.012775025330483913
form O 0 0.00011069103493355215
of O 0 1.0621653018461075e-05
the O 0 0.0007672320352867246
Schwartz B-Disease 1 0.9998798370361328
- I-Disease 1 0.9980176687240601
Jampel I-Disease 1 0.9999837875366211
syndrome I-Disease 1 1.0
( O 0 0.01448182575404644
SJS B-Disease 1 0.9999982118606567
) O 0 0.0005000998498871922
of O 0 0.00017283800116274506
myotonia B-Disease 1 0.9999984502792358
and O 0 0.003699293825775385
skeletal B-Disease 1 0.9999996423721313
dysplasia I-Disease 1 1.0
, O 0 0.000752068473957479
which O 0 8.850987796904519e-05
we O 0 0.00045859412057325244
called O 0 0.00978801678866148
SJS B-Disease 1 0.9999912977218628
type I-Disease 0 0.025563538074493408
2 I-Disease 0 0.003029176965355873
. O 0 0.0005224216729402542

This O 0 0.0023680550511926413
disorder O 1 0.9999984502792358
is O 0 0.0007718689157627523
reminiscent O 0 0.002565110335126519
of O 0 2.9282926334417425e-05
another O 0 0.0019009996904060245
rare O 0 0.13056068122386932
condition O 1 0.9998156428337097
, O 0 0.00019172867177985609
the O 0 0.0005001432145945728
Stuve B-Disease 1 0.9998751878738403
- I-Disease 1 0.9996044039726257
Wiedemann I-Disease 1 0.9999982118606567
syndrome I-Disease 1 1.0
( O 0 0.012759199365973473
SWS B-Disease 1 0.9999921321868896
) O 0 0.0009838148253038526
, O 0 0.0001955961633939296
which O 0 9.006180334836245e-05
comprises O 0 0.002139039570465684
campomelia B-Disease 1 0.9347280859947205
at O 0 0.001231578877195716
birth O 0 0.001844262471422553
with O 0 0.0007487960974685848
skeletal B-Disease 1 0.9999998807907104
dysplasia I-Disease 1 1.0
, O 0 0.00728693138808012
contractures B-Disease 1 0.9999966621398926
, O 0 0.0006600572960451245
and O 0 0.00026066118152812123
early B-Disease 0 0.0019504025112837553
death I-Disease 0 0.0055651175789535046
. O 0 0.0004760128795169294

To O 0 0.00044141258695162833
test O 0 0.0019211152102798223
for O 0 0.0002071365888696164
possible O 0 0.0020098313689231873
nosologic O 1 0.9746300578117371
identity O 0 0.0009466921910643578
between O 0 0.0003764966386370361
these O 0 0.0006445407634600997
disorders O 1 1.0
, O 0 0.0009761406690813601
we O 0 0.00044270436046645045
reviewed O 0 0.0026277941651642323
the O 0 0.00010538041533436626
literature O 0 0.00020215121912769973
and O 0 0.00012422192958183587
obtained O 0 0.00040752533823251724
a O 0 0.0008550654747523367
follow O 0 0.0014931982150301337
- O 0 0.003326314501464367
up O 0 6.604068767046556e-05
of O 0 6.770929303456796e-06
the O 0 7.854626892367378e-05
only O 0 5.491360934684053e-05
two O 0 0.00013105654215905815
surviving O 0 0.258536696434021
patients O 1 0.9999972581863403
, O 0 0.00021091279631946236
one O 0 0.00021025964815635234
with O 0 0.000978049822151661
SJS B-Disease 1 0.9999992847442627
type I-Disease 0 0.034882012754678726
2 I-Disease 0 0.0031729901675134897
at O 0 0.0019073787843808532
age O 0 0.0015119999879971147
10 O 0 0.0007844872889108956
years O 0 0.0005090315244160593
and O 0 0.00010464281513122842
another O 0 0.0006932957912795246
with O 0 0.0006999919423833489
SWS B-Disease 1 0.9999850988388062
at O 0 0.004622176289558411
age O 0 0.0029132056515663862
7 O 0 0.0029739958699792624
years O 0 0.001339416834525764
. O 0 0.0004897474427707493

Patients O 1 0.9999988079071045
reported O 0 0.0042964862659573555
as O 0 0.0002353565359953791
having O 0 0.0024413932114839554
either O 0 0.007604685146361589
neonatal O 1 1.0
SJS B-Disease 1 0.9999996423721313
or O 0 0.011584224179387093
SWS B-Disease 1 0.9998612403869629
presented O 0 0.0016626627184450626
a O 0 0.00040747111779637635
combination O 0 0.0014845753321424127
of O 0 1.612859523447696e-05
a O 0 0.0021881661377847195
severe O 1 0.9999957084655762
, O 0 0.0014655747218057513
prenatal O 1 0.9999996423721313
- O 1 0.9999289512634277
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 0.0038536495994776487
with O 0 0.004793467465788126
congenital B-Disease 1 1.0
joint I-Disease 1 0.99998939037323
contractures I-Disease 1 1.0
, O 0 0.1502837985754013
respiratory O 1 1.0
and O 0 0.001042437506839633
feeding O 0 0.43000686168670654
difficulties O 1 0.7017920017242432
, O 0 0.0006112161790952086
tendency O 0 0.012738487683236599
to O 0 0.0008720695623196661
hyperthermia B-Disease 1 0.9999904632568359
, O 0 0.0005528320907615125
and O 0 0.0002683234342839569
frequent O 0 0.018268579617142677
death O 0 0.008289017714560032
in O 0 0.0007450598641298711
infancy O 1 0.9916724562644958
) O 0 0.00017264150665141642
with O 0 3.0035535019123927e-05
a O 0 0.00042489776387810707
distinct O 0 0.001992579083889723
campomelic B-Disease 1 0.9991499185562134
- I-Disease 1 0.986451268196106
metaphyseal I-Disease 1 0.9998891353607178
skeletal I-Disease 1 0.9999992847442627
dysplasia I-Disease 1 1.0
. O 0 0.002577849430963397

The O 0 0.00043548416579142213
similarity O 0 0.0005361043731682003
of O 0 2.225195203209296e-05
the O 0 0.0008822145173326135
clinical O 1 0.999992847442627
and O 0 0.0009836241370067
radiographic O 1 0.9999662637710571
findings O 0 0.010920456610620022
is O 0 0.00045794170000590384
so O 0 0.00028722957358695567
extensive O 0 0.003618587739765644
that O 0 0.00016814982518553734
these O 0 0.0003570846456568688
disorders O 1 0.9999998807907104
appear O 0 0.002970363013446331
to O 0 8.609599899500608e-05
be O 0 4.8065045120893046e-05
a O 0 0.00021287555864546448
single O 0 0.00042681428021751344
entity O 0 0.00993738416582346
. O 0 0.0008343816152773798

The O 0 0.0013722340809181333
follow O 0 0.001844846992753446
- O 0 0.005804524291306734
up O 0 0.0002687663654796779
observation O 0 0.007384459488093853
of O 0 1.734113357088063e-05
an O 0 0.00031428481452167034
identical O 0 0.0009339092648588121
and O 0 0.0001125230046454817
unique O 0 0.000574759382288903
pattern O 0 0.0025129453279078007
of O 0 0.00011508131865411997
progressive O 1 0.9999880790710449
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.00034645007690414786
the O 0 0.00027578059234656394
two O 0 0.0005598099087364972
patients O 1 0.9999988079071045
( O 0 0.0006280305096879601
one O 0 0.00027664596564136446
with O 0 0.0011974815279245377
SJS B-Disease 1 0.999998927116394
type I-Disease 0 0.04122231900691986
2 I-Disease 0 0.0022370005026459694
, O 0 0.00017532077617943287
one O 0 0.00017799428314901888
with O 0 0.00064476253464818
SWS B-Disease 1 0.9999686479568481
) O 0 0.001280420459806919
surviving O 0 0.011524803005158901
beyond O 0 0.01105253491550684
infancy O 1 0.9795037508010864
adds O 0 0.005916877184063196
to O 0 8.23015216155909e-05
the O 0 0.000181979761691764
evidence O 0 0.000443304015789181
in O 0 0.00010406605724710971
favor O 0 0.00015684604295529425
of O 0 3.2174040825339034e-05
identity O 0 0.0018266268307343125
. O 0 0.0007487650727853179

The O 0 0.0005541460122913122
hypothesis O 0 0.004615717567503452
that O 0 0.0005227444926276803
SWS B-Disease 1 0.9999606609344482
and O 0 0.004260497633367777
SJS B-Disease 1 0.9999985694885254
type I-Disease 0 0.03007655404508114
2 I-Disease 0 0.001141315558925271
are O 0 1.6720387066015974e-05
the O 0 0.000262322835624218
same O 0 0.0019114435417577624
disorder O 1 0.9999994039535522
should O 0 0.0007789262454025447
be O 0 7.950967119541019e-05
testable O 0 0.002443905221298337
by O 0 5.149497155798599e-05
molecular O 0 0.002759339287877083
methods O 0 0.0010976509656757116
. O 0 0.00028448106604628265
. O 0 0.0004663052677642554

A O 0 0.00918016117066145
mouse O 0 0.008836991153657436
model O 0 0.0005942238494753838
of O 0 0.00013572564057540148
severe O 1 0.9999998807907104
von B-Disease 1 0.9999998807907104
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.010101620107889175
defects O 1 0.9999871253967285
in O 0 0.0012309601297602057
hemostasis O 1 0.9999994039535522
and O 0 0.006403363309800625
thrombosis B-Disease 1 1.0
. O 0 0.0014204488834366202

von B-Disease 1 0.978175938129425
Willebrand I-Disease 1 0.999961256980896
factor I-Disease 0 0.009707150980830193
( I-Disease 0 0.0024269658606499434
vWf I-Disease 1 0.999576985836029
) I-Disease 0 0.008518218994140625
deficiency I-Disease 1 1.0
causes O 1 0.9999871253967285
severe O 1 1.0
von B-Disease 1 0.9999998807907104
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 0.001006672391667962
humans O 0 0.004340574610978365
. O 0 0.0004771306412294507

We O 0 0.0003195595054421574
generated O 0 0.00010359961743233725
a O 0 0.0007837550365366042
mouse O 0 0.009545738808810711
model O 0 0.0009189628763124347
for O 0 0.00037800351856276393
this O 0 0.0007118975627236068
disease O 1 0.9999991655349731
by O 0 6.17950499872677e-05
using O 0 0.00023809475533198565
gene O 0 0.002711842069402337
targeting O 0 0.0028190596494823694
. O 0 0.0006390981725417078

vWf B-Disease 1 0.9950817823410034
- I-Disease 1 0.9353039264678955
deficient I-Disease 1 0.9999390840530396
mice O 0 0.036626722663640976
appeared O 0 0.003064777236431837
normal O 0 0.004958620760589838
at O 0 0.002662800019606948
birth O 0 0.005937809124588966
; O 0 0.00021773988555651158
they O 0 6.783931166864932e-05
were O 0 6.651546573266387e-05
viable O 0 0.009207219816744328
and O 0 0.00042491417843848467
fertile O 0 0.06683509796857834
. O 0 0.001091808662749827

Neither O 0 0.04058629646897316
vWf O 1 0.9679314494132996
nor O 0 0.03112122230231762
vWf O 1 0.9875511527061462
propolypeptide O 1 0.9936901330947876
( O 0 0.0027142337057739496
von B-Disease 1 0.9980643391609192
Willebrand I-Disease 1 0.9999974966049194
antigen O 1 0.9999489784240723
II O 1 0.9997285008430481
) O 0 0.0003521351609379053
were O 0 3.4178283385699615e-05
detectable O 0 0.007113348226994276
in O 0 0.00016359348956029862
plasma O 0 0.02475224994122982
, O 0 0.000987724051810801
platelets O 1 0.9989394545555115
, O 0 0.0006402562139555812
or O 0 0.0013511247234418988
endothelial O 1 0.9912590384483337
cells O 0 0.0010092532029375434
of O 0 6.944073902559467e-06
the O 0 0.0002684091159608215
homozygous O 0 0.012183856219053268
mutant O 0 0.015030870214104652
mice O 0 0.025092219933867455
. O 0 0.0006140563054941595

The O 0 0.0010532424785196781
mutant O 0 0.025302734225988388
mice O 0 0.07709140330553055
exhibited O 1 0.5041196942329407
defects O 1 0.9999635219573975
in O 0 0.0011950633488595486
hemostasis O 1 0.9999616146087646
with O 0 0.00013315642718225718
a O 0 0.0010640601394698024
highly O 0 0.024206360802054405
prolonged O 1 0.9999619722366333
bleeding O 1 1.0
time O 0 0.0004321642336435616
and O 0 0.00034866869100369513
spontaneous O 0 0.08576568216085434
bleeding O 1 0.9999997615814209
events O 0 0.0006793783977627754
in O 0 0.00021628630929626524
approximately O 0 0.000772618455812335
10 O 0 0.0003603130462579429
% O 0 3.2873806048883125e-05
of O 0 7.745178299956024e-05
neonates O 1 0.9998334646224976
. O 0 0.0014820490032434464

As O 0 0.0006320296670310199
in O 0 0.00013848934031557292
the O 0 0.0004949387512169778
human O 0 0.47059741616249084
disease O 1 0.9999998807907104
, O 0 0.00024104607291519642
the O 0 0.0002828044234775007
factor O 0 0.008846446871757507
VIII O 1 0.9993845224380493
level O 0 0.004158322699368
in O 0 0.00016334599058609456
these O 0 9.068271901924163e-05
mice O 0 0.019726883620023727
was O 0 0.0017003597458824515
reduced O 0 0.0030746362172067165
strongly O 0 0.0014542649732902646
as O 0 0.0002730153501033783
a O 0 0.0005135010578669608
result O 0 0.00042416524956934154
of O 0 2.0741941625601612e-05
the O 0 0.0002943233703263104
lack O 0 0.0031516803428530693
of O 0 6.254476465983316e-05
protection O 0 0.015979381278157234
provided O 0 0.0010198199888691306
by O 0 0.00023808202240616083
vWf O 1 0.9741318821907043
. O 0 0.001043061027303338

Defective O 1 0.9999680519104004
thrombosis B-Disease 1 0.9999998807907104
in O 0 0.0011520376428961754
mutant O 0 0.022181643173098564
mice O 0 0.030827205628156662
was O 0 0.002040175022557378
also O 0 0.00032779230969026685
evident O 0 0.004166721366345882
in O 0 0.00010668441973393783
an O 0 0.00015758074005134404
in O 0 0.0002460911055095494
vivo O 0 0.00852223951369524
model O 0 0.0008334554731845856
of O 0 0.0004056259640492499
vascular B-Disease 1 1.0
injury I-Disease 1 0.9999997615814209
. O 0 0.0012524704216048121

In O 0 0.0005113858496770263
this O 0 7.097837806213647e-05
model O 0 0.0010391862597316504
, O 0 0.00021028089395258576
the O 0 0.0005423923139460385
exteriorized O 1 0.9725897312164307
mesentery O 1 0.9875582456588745
was O 0 0.005119513254612684
superfused O 0 0.12472514063119888
with O 0 0.0006436800467781723
ferric O 1 0.9999445676803589
chloride O 0 0.4587448835372925
and O 0 0.00015380654076579958
the O 0 0.0001395500876242295
accumulation O 0 0.00574186397716403
of O 0 7.381427712971345e-05
fluorescently O 1 0.992355465888977
labeled O 0 0.45307913422584534
platelets O 1 0.9980814456939697
was O 0 0.0015790534671396017
observed O 0 0.0005231851828284562
by O 0 0.00014130378258414567
intravital O 1 0.5221899747848511
microscopy O 0 0.05207324028015137
. O 0 0.000996229937300086

We O 0 0.0014197254786267877
conclude O 0 0.005636905319988728
that O 0 3.9667400415055454e-05
these O 0 3.4999513445654884e-05
mice O 0 0.009315489791333675
very O 0 0.0005522448918782175
closely O 0 0.0018669918645173311
mimic O 1 0.9991918206214905
severe O 1 0.9999984502792358
human O 1 0.9876634478569031
von B-Disease 1 0.9999990463256836
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.0007925383397378027
will O 0 0.00025316316168755293
be O 0 6.459140422521159e-05
very O 0 0.00025642954278737307
useful O 0 0.0015238667838275433
for O 0 0.0003539546742103994
investigating O 0 0.007915795780718327
the O 0 0.00021243882656563073
role O 0 0.001947865355759859
of O 0 8.835715561872348e-05
vWf O 1 0.9628509879112244
in O 0 0.0005287328385747969
normal O 0 0.011144465766847134
physiology O 1 0.998999297618866
and O 0 0.0005764930392615497
in O 0 0.0030861045233905315
disease O 1 1.0
models O 0 0.0027945840265601873
. O 0 0.00033823115518316627
. O 0 0.0004637384554371238

Oral O 1 0.9988018274307251
contraceptives O 1 0.9975652694702148
and O 0 0.00016834108100738376
the O 0 0.00022837991127744317
risk O 0 0.3732351064682007
of O 0 0.0003474489494692534
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0014594036620110273

Hereditary B-Disease 1 0.9999996423721313
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9999995231628418
Study O 0 0.00882868841290474
Group O 0 0.0011621896410360932
. O 0 0.00035881545045413077

BACKGROUND O 0 0.027170835062861443
Women O 0 0.002954244613647461
with O 0 0.000178898437297903
mutations O 0 0.002086714841425419
in O 0 0.000134169909870252
either O 0 0.0004494171298574656
the O 0 0.0009716320200823247
BRCA1 O 1 0.9999585151672363
or O 0 0.0011034581111744046
the O 0 0.0014712188858538866
BRCA2 O 1 0.9997789263725281
gene O 0 0.0022590302396565676
have O 0 3.736280996236019e-05
a O 0 0.0003080859314650297
high O 0 0.004769451450556517
lifetime O 1 0.9866665005683899
risk O 1 0.9591587781906128
of O 0 0.0011091638589277864
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0012156559387221932

Oral O 1 0.9987156391143799
contraceptives O 1 0.9997758269309998
protect O 0 0.36002761125564575
against O 0 0.4484030604362488
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0006072323303669691
general O 0 0.0024475359823554754
, O 0 0.00041519643855281174
but O 0 0.0002623293548822403
it O 0 0.0001413268328178674
is O 0 0.0002793851017486304
not O 0 0.0001874959416454658
known O 0 0.0008213741239160299
whether O 0 0.00042662027408368886
they O 0 4.1950366721721366e-05
also O 0 0.00020418640633579344
protect O 0 0.004871655255556107
against O 0 0.0005419454537332058
hereditary B-Disease 1 0.9969571828842163
forms I-Disease 0 0.0023482865653932095
of I-Disease 0 0.0019060838967561722
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0014309481484815478

METHODS O 0 0.00913249608129263
We O 0 0.0014213407412171364
enrolled O 0 0.031633343547582626
207 O 0 0.028701452538371086
women O 0 0.0013048258842900395
with O 0 0.00124206836335361
hereditary B-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.000976981595158577
161 O 0 0.008702198974788189
of O 0 2.1396963347797282e-05
their O 0 0.00011876498319907114
sisters O 0 0.003633470507338643
as O 0 0.0002500744303688407
controls O 0 0.0010153837502002716
in O 0 0.00018886190082412213
a O 0 0.0013148216530680656
case O 0 0.008791915141046047
- O 0 0.010142042301595211
control O 0 0.002169853774830699
study O 0 0.002583645284175873
. O 0 0.0004439774784259498

All O 0 0.000209804653422907
the O 0 0.0010114030446857214
patients O 1 0.9999587535858154
carried O 0 0.0003164625377394259
a O 0 0.0005790590075775981
pathogenic O 0 0.022082911804318428
mutation O 0 0.002372788731008768
in O 0 0.000245065544731915
either O 0 0.0023688513319939375
BRCA1 O 1 0.9999428987503052
( O 0 0.002281380817294121
179 O 0 0.0629398375749588
women O 0 0.004126593470573425
) O 0 0.00101148197427392
or O 0 0.0032815197482705116
BRCA2 O 1 0.9998489618301392
( O 0 0.0033594125416129827
28 O 0 0.009648585692048073
women O 0 0.0029081408865749836
) O 0 0.0007647221209481359
. O 0 0.0006674849428236485

The O 0 0.0014358527259901166
control O 0 0.006606085691601038
women O 0 0.002410987624898553
were O 0 0.00020332109124865383
enrolled O 0 0.022795813158154488
regardless O 0 0.000855413090903312
of O 0 3.515771095408127e-05
whether O 0 0.0015594325959682465
or O 0 0.0005698869936168194
not O 0 0.00018810995970852673
they O 0 6.024955291650258e-05
had O 0 0.00047876982716843486
either O 0 0.0004002247878815979
mutation O 0 0.003304768120869994
. O 0 0.0004907502443529665

Lifetime O 0 0.1024397760629654
histories O 0 0.003632955951616168
of O 0 0.000105372178950347
oral O 1 0.99957674741745
- O 0 0.10399846732616425
contraceptive O 1 0.9939299821853638
use O 0 0.00023178230912890285
were O 0 5.1136910769855604e-05
obtained O 0 0.00035429903073236346
by O 0 0.00015820222324691713
interview O 0 0.021023808047175407
or O 0 0.00047043320955708623
by O 0 6.04102315264754e-05
written O 0 0.0001610871113371104
questionnaire O 0 0.007162157911807299
and O 0 0.00013121285883244127
were O 0 5.0820919568650424e-05
compared O 0 0.0017250895034521818
between O 0 0.0016080421628430486
patients O 1 0.999996542930603
and O 0 0.00041947432328015566
control O 0 0.006026843097060919
women O 0 0.0037261173129081726
, O 0 0.0005599897704087198
after O 0 0.002243954688310623
adjustment O 0 0.006243113894015551
for O 0 0.00029154345975257456
year O 0 0.0004848766257055104
of O 0 2.0196090190438554e-05
birth O 0 0.0027045318856835365
and O 0 0.0002698040916584432
parity O 0 0.0447104349732399
. O 0 0.000894906756002456

RESULTS O 0 0.006391705945134163
The O 0 0.0003677991626318544
adjusted O 0 0.005597266368567944
odds O 0 0.013084927573800087
ratio O 0 0.00394065398722887
for O 0 0.05940040573477745
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 0.0014373117592185736
with O 0 5.265819709165953e-05
any O 0 7.401551556540653e-05
past O 0 0.00016222157864831388
use O 0 5.7667486544232816e-05
of O 0 4.350774179329164e-05
oral O 1 0.9967742562294006
contraceptives O 1 0.9986926913261414
was O 0 0.0030765191186219454
0 O 0 0.0025886683724820614
. O 0 0.00042412951006554067

5 O 0 0.005242239683866501
( O 0 0.0008647420909255743
95 O 0 0.003915589768439531
percent O 0 0.0008029147866182029
confidence O 0 0.0030699626076966524
interval O 0 0.002913939766585827
, O 0 0.00036242057103663683
0 O 0 0.0019591129384934902
. O 0 0.00010953291348414496
3 O 0 0.0005778899067081511
to O 0 0.00013155711349099874
0 O 0 0.001685675117187202
. O 0 0.00022569418069906533
8 O 0 0.0021111448295414448
) O 0 0.0004566613642964512
. O 0 0.0004541905364021659

The O 0 0.002944293199107051
risk O 1 0.8223398327827454
decreased O 0 0.01547771506011486
with O 0 7.95838568592444e-05
increasing O 0 0.0005935389781370759
duration O 0 0.003347071586176753
of O 0 2.544319795561023e-05
use O 0 0.0008210517116822302
( O 0 0.0020281195174902678
P O 0 0.4485449492931366
for O 0 0.0003451544907875359
trend O 0 0.004335011821240187
, O 0 0.0005910195759497583
< O 0 0.0484800711274147
0 O 0 0.0036105008330196142
. O 0 0.0005042914999648929
001 O 1 0.8034297823905945
) O 0 0.0006670925067737699
; O 0 0.00011621019802987576
use O 0 0.00014799600467085838
for O 0 0.0002656734432093799
six O 0 0.0004747761704493314
or O 0 0.00032644171733409166
more O 0 0.0001647768949624151
years O 0 0.001603281474672258
was O 0 0.001999188680201769
associated O 0 0.00032476417254656553
with O 0 6.070238305255771e-05
a O 0 0.0007785183843225241
60 O 0 0.0015095737762749195
percent O 0 0.001025306642986834
reduction O 0 0.006978501100093126
in O 0 0.0006014923565089703
risk O 1 0.9861160516738892
. O 0 0.000704413338098675

Oral O 1 0.9950620532035828
- O 0 0.024459151551127434
contraceptive O 1 0.9956173896789551
use O 0 0.0003067418874707073
protected O 0 0.039645954966545105
against O 0 0.1336551457643509
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 0.0002610083611216396
for O 0 0.0002464815916027874
carriers O 0 0.0030107770580798388
of O 0 1.5630559573764913e-05
the O 0 0.001044648583047092
BRCA1 O 1 0.9999171495437622
mutation O 0 0.009253191761672497
( O 0 0.0011528382310643792
odds O 0 0.023024704307317734
ratio O 0 0.0032045994885265827
, O 0 0.0005172655801288784
0 O 0 0.0026896127965301275
. O 0 0.00023584419977851212
5 O 0 0.001330542378127575
; O 0 0.00019053681171499193
95 O 0 0.003126405877992511
percent O 0 0.0007519577629864216
confidence O 0 0.0032951163593679667
interval O 0 0.0027737668715417385
, O 0 0.00041168948519043624
0 O 0 0.0019275106023997068
. O 0 0.00010708150512073189
3 O 0 0.0006102150655351579
to O 0 0.00013898940233048052
0 O 0 0.002217487897723913
. O 0 0.00030277649057097733
9 O 0 0.004199050832539797
) O 0 0.0003468785434961319
and O 0 0.0001092359671019949
for O 0 0.00028087294776923954
carriers O 0 0.004414730239659548
of O 0 2.316014069947414e-05
the O 0 0.0013243076391518116
BRCA2 O 1 0.9999265670776367
mutation O 0 0.011094419285655022
( O 0 0.0010567507706582546
odds O 0 0.021353961899876595
ratio O 0 0.0035619165282696486
, O 0 0.0005296503659337759
0 O 0 0.0027879183180630207
. O 0 0.00025865642237477005
4 O 0 0.0016351987142115831
; O 0 0.00019242135749664158
95 O 0 0.003129615681245923
percent O 0 0.0008061922853812575
confidence O 0 0.003310709958896041
interval O 0 0.003103698370978236
, O 0 0.0003632573352660984
0 O 0 0.002207618672400713
. O 0 0.000152587381307967
2 O 0 0.0007114452891983092
to O 0 0.00011512268974911422
1 O 0 0.001514349365606904
. O 0 0.0001936905609909445
1 O 0 0.002432429464533925
) O 0 0.0004913751618005335
. O 0 0.00043293472845107317

CONCLUSIONS O 0 0.03980917111039162
Oral O 1 0.9987970590591431
- O 0 0.22552736103534698
contraceptive O 1 0.9988518953323364
use O 0 0.0004887594259344041
may O 0 0.0011460530804470181
reduce O 0 0.002646041102707386
the O 0 0.00028941105119884014
risk O 1 0.9926506876945496
of O 0 0.0010254355147480965
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0005942646530456841
women O 0 0.0009630453423596919
with O 0 0.00013734863023273647
pathogenic O 0 0.06752823293209076
mutations O 0 0.0021259544882923365
in O 0 0.00011834647011710331
the O 0 0.0008931864285841584
BRCA1 O 1 0.9999927282333374
or O 0 0.006187305320054293
BRCA2 O 1 0.9997921586036682
gene O 0 0.017164863646030426

A O 0 0.007503489498049021
Japanese O 0 0.0027585469651967287
family O 0 0.00163183081895113
with O 0 0.0011075937654823065
adrenoleukodystrophy B-Disease 1 0.9999995231628418
with O 0 0.00023110704205464572
a O 0 0.0015042107552289963
codon O 0 0.0138523755595088
291 O 0 0.061486583203077316
deletion O 0 0.015405373647809029
: O 0 0.0005861684330739081
a O 0 0.0019578346982598305
clinical O 1 0.9999715089797974
, O 0 0.0007272075163200498
biochemical O 0 0.06827594339847565
, O 0 0.0013377562863752246
pathological O 1 0.9998745918273926
, O 0 0.0005579742137342691
and O 0 0.00031388417119160295
genetic O 0 0.006402298342436552
report O 0 0.002393547212705016
. O 0 0.0005682234768755734

We O 0 0.0011127169709652662
report O 0 0.0006608686526305974
a O 0 0.00036365591222420335
Japanese O 0 0.0012907744385302067
family O 0 0.001335409004241228
with O 0 0.0019473711727187037
adrenoleukodystrophy B-Disease 1 1.0
( O 0 0.11205390840768814
ALD B-Disease 1 1.0
) O 0 0.000839363900013268
with O 0 7.029179687378928e-05
a O 0 0.0005325048696249723
three O 0 9.244007378583774e-05
base O 0 0.003152998862788081
pair O 0 0.0017880882369354367
deletion O 0 0.02396048605442047
( O 0 0.0023906819988042116
delGAG O 1 0.9621344804763794
291 O 0 0.11516079306602478
) O 0 0.0003320137329865247
in O 0 0.00021966792701277882
the O 0 0.0025237302761524916
ALD B-Disease 1 1.0
gene O 0 0.015509217977523804
. O 0 0.0008101147832348943

A O 0 0.006087129935622215
variety O 0 0.0006727364379912615
of O 0 9.40172394621186e-05
phenotypes O 0 0.024562882259488106
were O 0 6.835935346316546e-05
observed O 0 0.0003693921898957342
within O 0 8.305570372613147e-05
this O 0 9.529043745715171e-05
family O 0 0.0013996874913573265
. O 0 0.0006710701854899526

While O 0 0.0008959421538747847
the O 0 0.0007023279322311282
proband O 1 0.9948523640632629
( O 0 0.0033602809999138117
patient O 1 0.999901533126831
1 O 0 0.0042832717299461365
) O 0 0.00039639734313823283
was O 0 0.0021367445588111877
classified O 0 0.014457158744335175
as O 0 0.0003130933619104326
having O 0 0.0012729286681860685
a O 0 0.0007733581005595624
rare O 0 0.00821223296225071
intermediate O 0 0.061892058700323105
type O 0 0.002959104022011161
of O 0 4.70948034489993e-05
adult O 0 0.39587855339050293
cerebral O 1 0.9999998807907104
and O 0 0.0013965320540592074
cerebello O 1 0.9998830556869507
- O 1 0.9949759244918823
brain O 1 0.9999393224716187
stem O 0 0.020436933264136314
forms O 0 0.0010992775205522776
, O 0 0.0003548207168933004
his O 0 0.00249504204839468
younger O 0 0.01322444062680006
brother O 0 0.013058229349553585
( O 0 0.0025213835760951042
patient O 1 0.9999376535415649
2 O 0 0.002669679932296276
) O 0 0.00031224318081513047
and O 0 0.00037454452831298113
nephew O 1 0.9671155214309692
( O 0 0.0033774080220609903
patient O 1 0.9999750852584839
3 O 0 0.002277976367622614
) O 0 0.00025516378809697926
had O 0 0.0006379641126841307
a O 0 0.002785559743642807
childhood O 1 0.9999915361404419
ALD B-Disease 1 1.0
type O 1 0.9749175906181335
. O 0 0.001229354296810925

Another O 0 0.008553906343877316
nephew O 1 0.632533073425293
( O 0 0.004297575913369656
patient O 1 0.9998635053634644
4 O 0 0.0029641306027770042
) O 0 0.000161381671205163
of O 0 7.081949297571555e-05
patient O 1 0.9999862909317017
1 O 0 0.0034897015430033207
was O 0 0.002170129446312785
classified O 0 0.018102699890732765
as O 0 0.00023202286683954298
having O 0 0.0011296565644443035
an O 0 0.0006519445450976491
adolescent O 1 0.9994331002235413
form O 0 0.0023112017661333084
. O 0 0.0008657895959913731

The O 0 0.0013521467335522175
tau O 0 0.049837395548820496
level O 0 0.0018027449259534478
in O 0 0.00010584286792436615
the O 0 0.0006218860507942736
cerebrospinal O 1 0.9999207258224487
fluid O 1 0.9959598183631897
( O 0 0.0077947513200342655
CSF O 1 0.999995231628418
) O 0 0.0008612452656961977
in O 0 0.0006408704211935401
patient O 1 0.9998661279678345
1 O 0 0.0023259359877556562
was O 0 0.001316755311563611
as O 0 0.00029023500974290073
high O 0 0.0018758701626211405
as O 0 0.00010108664719155058
that O 0 2.1169777028262615e-05
of O 0 6.271689926506951e-05
patients O 1 0.9999996423721313
with O 0 0.004178004339337349
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.0032535921782255173
AD B-Disease 0 0.3532438278198242
) O 0 0.0006788237951695919
. O 0 0.00042163801845163107

His O 0 0.0056870849803090096
brain O 1 0.999705970287323
magnetic O 0 0.0019922235514968634
resonance O 0 0.012730483897030354
image O 0 0.04905165359377861
( O 0 0.004823922645300627
MRI O 1 0.9999959468841553
) O 0 0.0009002116275951266
showed O 0 0.007201549597084522
abnormalities B-Disease 1 0.9993993043899536
in I-Disease 0 0.00014058451051823795
the I-Disease 0 0.0002491988125257194
bilateral I-Disease 0 0.2816678583621979
cerebellar I-Disease 1 0.9999960660934448
hemispheres I-Disease 1 0.9952731728553772
and O 0 0.002060792176052928
brain O 1 0.9999988079071045
stem O 0 0.44762465357780457
, O 0 0.00034752432839013636
but O 0 0.00015610452101100236
not O 0 6.971629045438021e-05
in O 0 0.00013134027540218085
the O 0 0.001646647579036653
cerebral O 1 0.9999998807907104
white O 1 0.7431303262710571
matter O 0 0.004428472835570574
, O 0 0.00036716784234158695
where O 0 0.00025746875326149166
marked O 0 0.001273944042623043
reductions O 0 0.004198660142719746
of O 0 1.827145206334535e-05
the O 0 0.0012416602112352848
cerebral O 1 0.9999998807907104
blood O 1 0.9482630491256714
flow O 0 0.0026366624515503645
and O 0 0.0002529103076085448
oxygen O 0 0.08821448683738708
metabolism O 0 0.17051619291305542
were O 0 9.324048005510122e-05
clearly O 0 0.0014451508177444339
demonstrated O 0 0.0021637361496686935
by O 0 6.552678678417578e-05
positron O 0 0.2676672041416168
emission O 0 0.013226543553173542
tomography O 1 0.5121735334396362
( O 0 0.003661890048533678
PET O 1 0.9989921450614929
) O 0 0.0011102145072072744
. O 0 0.0005238523590378463

In O 0 0.004187408834695816
patients O 1 0.9999829530715942
2 O 0 0.0019877043087035418
and O 0 0.00020590252825058997
3 O 0 0.001065738033503294
, O 0 0.00014657601423095912
the O 0 0.0004133064649067819
autopsy O 1 0.9829400777816772
findings O 0 0.003963252995163202
showed O 0 0.0024233018048107624
massive O 0 0.03554395213723183
demyelination B-Disease 1 0.9999984502792358
of I-Disease 0 9.87234670901671e-05
the I-Disease 0 0.0027850524056702852
cerebral I-Disease 1 1.0
white I-Disease 0 0.13391752541065216
matter I-Disease 0 0.0014621933223679662
with O 0 9.244562534149736e-05
sparing O 0 0.025948278605937958
of O 0 2.522981958463788e-05
the O 0 0.0009574078721925616
U O 1 0.9966678023338318
- O 0 0.13143271207809448
fibers O 1 0.9952433705329895
, O 0 0.0002645511704031378
compatible O 0 0.001521687489002943
with O 0 3.821638892986812e-05
the O 0 0.00019802121096290648
findings O 0 0.0024176985025405884
of O 0 0.00018264452228322625
childhood O 1 0.9999946355819702
ALD B-Disease 1 1.0
. O 0 0.0031487562227994204

Oleic O 0 0.4223697781562805
and O 0 0.0010112287709489465
erucic O 1 0.9694277048110962
acids O 0 0.00550161674618721
( O 0 0.002316058147698641
Lorenzos O 1 0.9261895418167114
Oil O 0 0.0078092943876981735
) O 0 0.0002419286174699664
were O 0 6.161381315905601e-05
administered O 0 0.02166936732828617
to O 0 0.0006412442889995873
patients O 1 0.9999709129333496
1 O 0 0.0021231258288025856
and O 0 0.00025199566152878106
4 O 0 0.001775443903170526
, O 0 0.00017097040836233646
but O 0 0.0001570380263729021
sufficient O 0 0.0023208605125546455
effectiveness O 1 0.9505897760391235
was O 0 0.0014664360787719488
not O 0 0.0001439898187527433
obtained O 0 0.0005446393042802811
. O 0 0.00042231823317706585

The O 0 0.0013231016928330064
findings O 0 0.003962578717619181
in O 0 0.00017830001888796687
this O 0 8.645000343676656e-05
family O 0 0.0009658686467446387
suggest O 0 0.002043480286374688
that O 0 0.00026381772477179766
delGAG291 O 1 0.7149305939674377
is O 0 0.0003441395238041878
part O 0 0.00032823579385876656
of O 0 1.2335762221482582e-05
the O 0 0.0003274025802966207
cause O 0 0.012495753355324268
of O 0 7.826126966392621e-05
Japanese O 0 0.09695124626159668
ALD B-Disease 1 1.0
with O 0 0.0004974687471985817
phenotypic O 0 0.021540464833378792
variations O 0 0.0010201814584434032
. O 0 0.0007625397411175072

Moreover O 0 0.024438217282295227
, O 0 0.0005501602427102625
although O 0 0.0002668816305231303
the O 0 8.669999078847468e-05
scale O 0 0.0005986678879708052
of O 0 1.8722173990681767e-05
the O 0 0.0003530195099301636
study O 0 0.002116559073328972
is O 0 0.0004968072171323001
limited O 0 0.0020325465593487024
, O 0 0.0002383332175668329
there O 0 0.00010432965791551396
is O 0 0.00022502723732031882
a O 0 0.0004222049319650978
possibility O 0 0.002461132127791643
that O 0 0.00023262891045305878
PET O 1 0.9950241446495056
can O 0 0.0002728493418544531
detect O 0 0.011576293036341667
an O 0 0.0008812265004962683
insidious B-Disease 1 0.9999644756317139
lesion I-Disease 1 0.9999991655349731
which O 0 0.00017974310321733356
is O 0 0.00046651888987980783
undetectable O 1 0.7176148891448975
by O 0 6.496631249319762e-05
computed O 0 0.007511775940656662
tomogram O 1 0.979434072971344
( O 0 0.006102615036070347
CT O 1 0.9999971389770508
) O 0 0.0011086720041930676
or O 0 0.0021336397621780634
MRI O 1 0.9999682903289795
analysis O 0 0.00103328179102391
, O 0 0.0003106898511759937
and O 0 0.0001146498616435565
that O 0 4.578704101732001e-05
the O 0 0.00011214155529160053
higher O 0 0.000801808899268508
level O 0 0.0019274996593594551
of O 0 6.024168396834284e-05
tau O 0 0.07221513241529465
reflects O 0 0.0011213190155103803
the O 0 5.2926883654436097e-05
process O 0 9.897834388539195e-05
of O 0 4.338030703365803e-05
neuronal B-Disease 1 0.9960964322090149
degeneration I-Disease 1 1.0
in O 0 0.010613379068672657
ALD B-Disease 1 1.0
. O 0 0.002537666354328394

Lorenzos O 1 0.7676548361778259
Oil O 0 0.008548516780138016
should O 0 0.0005760497879236937
be O 0 6.613559526158497e-05
given O 0 0.00010212430788669735
in O 0 7.964733231347054e-05
the O 0 0.00021251357975415885
early O 0 0.001628468162380159
stage O 0 0.007729358039796352
. O 0 0.00035585532896220684
. O 0 0.0005550943315029144

Nonsense O 0 0.0579218789935112
mutation O 0 0.004433079157024622
in O 0 0.0003740203392226249
exon O 0 0.02940160222351551
4 O 0 0.0005825742846354842
of O 0 1.7671536625130102e-05
human O 0 0.002600288251414895
complement O 0 0.029819685965776443
C9 O 1 0.9999555349349976
gene O 0 0.004048471339046955
is O 0 0.00022075300512369722
the O 0 0.00014802240184508264
major O 0 0.002860306529328227
cause O 0 0.0038394094444811344
of O 0 1.378760498482734e-05
Japanese O 0 0.002103265840560198
complement B-Disease 1 0.775688111782074
C9 I-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
. O 0 0.001312878797762096

Deficiency B-Disease 1 0.9999994039535522
of I-Disease 0 6.084489359636791e-05
the I-Disease 0 0.00035635216045193374
ninth I-Disease 0 0.014185029082000256
component I-Disease 0 0.002972366288304329
of I-Disease 0 1.6744304957683198e-05
human I-Disease 0 0.00188056705519557
complement I-Disease 0 0.011703330092132092
( O 0 0.0047715031541883945
C9 O 1 0.9999589920043945
) O 0 0.0007042841170914471
is O 0 0.00015286653069779277
the O 0 7.984475087141618e-05
most O 0 0.00027255009626969695
common O 0 0.007301797159016132
complement B-Disease 1 0.9997159838676453
deficiency I-Disease 1 1.0
in O 0 0.0006303393165580928
Japan O 0 0.0024206454399973154
but O 0 0.0004847790114581585
is O 0 0.0007200166000984609
rare O 0 0.0060237557627260685
in O 0 0.00017508539895061404
other O 0 5.1764098316198215e-05
countries O 0 0.00013469575787894428
. O 0 0.0007093413732945919

We O 0 0.000871234864462167
studied O 0 0.0005690036341547966
the O 0 6.542232586070895e-05
molecular O 0 0.0010220109252259135
basis O 0 9.077884169528261e-05
of O 0 0.00021636945893988013
C9 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999998807907104
in O 0 0.00019971806614194065
four O 0 0.00010403222404420376
Japanese O 0 0.006148645654320717
C9 B-Disease 1 0.9999994039535522
- I-Disease 1 0.9997853636741638
deficient I-Disease 1 0.9999996423721313
patients O 1 0.9999994039535522
who O 0 0.001407223055139184
had O 0 0.0023928077425807714
suffered O 1 0.9999979734420776
from O 0 0.0037424503825604916
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.0014845767291262746

Direct O 0 0.00036612540134228766
sequencing O 0 0.00026938310475088656
of O 0 2.2024198187864386e-05
amplified O 0 0.013108501210808754
C9 O 1 0.9993333220481873
cDNA O 0 0.004813865292817354
and O 0 0.00018803410057444125
DNA O 0 0.001805315027013421
revealed O 0 0.0032434866297990084
a O 0 0.0003940130991395563
nonsense O 0 0.00703557301312685
substitution O 0 0.0013455969747155905
( O 0 0.0011616991832852364
CGA O 1 0.8496279716491699
- O 0 0.025016114115715027
- O 0 0.021558932960033417
> O 0 0.04832376539707184
TGA O 1 0.9971537590026855
) O 0 0.0005321501521393657
at O 0 0.0010533415479585528
codon O 0 0.00433745700865984
95 O 0 0.0029626991599798203
in O 0 0.0002921299892477691
exon O 0 0.02772090584039688
4 O 0 0.000730715284589678
in O 0 6.681068771285936e-05
the O 0 0.00014955390361137688
four O 0 0.0011151662329211831
C9 B-Disease 1 0.9999973773956299
- I-Disease 1 0.9906936287879944
deficient I-Disease 1 0.9999308586120605
individuals O 0 0.0007063765660859644
. O 0 0.000614135293290019

An O 0 0.0013747828779742122
allele O 0 0.01416860893368721
- O 0 0.004416174720972776
specific O 0 0.000245627888944
polymerase O 0 0.007233188487589359
chain O 0 0.009405869990587234
reaction O 0 0.003426159964874387
system O 0 0.005239423364400864
designed O 0 0.002592352218925953
to O 0 0.000209371792152524
detect O 0 0.013081220909953117
exclusively O 0 0.0005341294454410672
only O 0 6.061641397536732e-05
one O 0 3.939199086744338e-05
of O 0 9.168245924229268e-06
the O 0 0.0002689093817025423
normal O 0 0.005300864111632109
and O 0 0.00033724153763614595
mutant O 0 0.0124356085434556
alleles O 0 0.007479890249669552
indicated O 0 0.004237361717969179
that O 0 3.457689308561385e-05
all O 0 1.5505964256590232e-05
the O 0 0.00022508086112793535
four O 0 0.0008826004341244698
patients O 1 0.9999549388885498
were O 0 7.061226642690599e-05
homozygous O 0 0.002724240068346262
for O 0 0.00010304795432602987
the O 0 0.0002049859904218465
mutation O 0 0.0027604284696280956
in O 0 0.00039951782673597336
exon O 0 0.062219295650720596
4 O 0 0.0025882795453071594
and O 0 0.00013467083044815809
that O 0 6.046521957614459e-05
the O 0 0.0001842653437051922
parents O 0 0.0005264697829261422
of O 0 0.00011416613415349275
patient O 1 0.9999780654907227
2 O 0 0.0013944063102826476
were O 0 8.551497012376785e-05
heterozygous O 0 0.004917589481920004
. O 0 0.0006021761801093817

The O 0 0.0010418319143354893
common O 0 0.0033429607283324003
mutation O 0 0.00412388052791357
at O 0 0.0012290815357118845
codon O 0 0.005220266990363598
95 O 0 0.0035263439640402794
in O 0 0.0004101601953152567
exon O 0 0.04965115338563919
4 O 0 0.0021321591921150684
might O 0 0.0007341700838878751
be O 0 5.6643912103027105e-05
responsible O 0 0.0015958301955834031
for O 0 0.00011166234617121518
most O 0 0.0003279242664575577
Japanese O 0 0.02271709032356739
C9 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 1.0
. O 0 0.0008115217206068337
. O 0 0.0005640416056849062

BRCA1 O 1 0.9975399971008301
required O 0 0.0007856771699152887
for O 0 0.0001591335894772783
transcription O 0 0.003762784879654646
- O 0 0.012083331122994423
coupled O 0 0.007684577722102404
repair O 1 0.9975106716156006
of O 0 6.3855986809358e-05
oxidative O 1 0.7050936818122864
DNA O 0 0.009342796169221401
damage O 1 0.9905071258544922
. O 0 0.0005716283340007067

The O 0 0.004419639240950346
breast B-Disease 1 1.0
and I-Disease 1 0.6761756539344788
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9957311749458313
gene O 0 0.006983416620641947
BRCA1 O 1 0.9966673254966736
encodes O 0 0.0017042639665305614
a O 0 0.0012396029196679592
zinc O 1 0.9577909708023071
finger O 0 0.06016743555665016
protein O 0 0.0003762228589039296
of O 0 2.1869196643820032e-05
unknown O 0 0.0009314362541772425
function O 0 0.0021595272701233625
. O 0 0.0007155398488976061

Association O 0 0.012002107687294483
of O 0 2.6713230909081176e-05
the O 0 0.0007245992310345173
BRCA1 O 1 0.9982678890228271
protein O 0 0.0003870770160574466
with O 0 3.2070929592009634e-05
the O 0 0.00022816922864876688
DNA O 0 0.006013580597937107
repair O 1 0.9995474219322205
protein O 0 0.0073605068027973175
Rad51 O 1 0.9995404481887817
and O 0 0.000360524223651737
changes O 0 0.0004193511849734932
in O 0 8.988610352389514e-05
the O 0 0.00012413666991051286
phosphorylation O 0 0.00045673063141293824
and O 0 0.00013994985783938318
cellular O 0 0.004329910036176443
localization O 0 0.0027056746184825897
of O 0 8.938945939007681e-06
the O 0 0.00013158297224435955
protein O 0 0.0014260350726544857
after O 0 0.002525557763874531
exposure O 0 0.1898943930864334
to O 0 0.0002485140576027334
DNA O 0 0.0059636374935507774
- O 0 0.021086832508444786
damaging O 1 0.7840602397918701
agents O 0 0.004204988479614258
are O 0 3.6638142773881555e-05
consistent O 0 0.0025861139874905348
with O 0 5.609507570625283e-05
a O 0 0.00048429222078993917
role O 0 0.0026650282088667154
for O 0 0.0010097292251884937
BRCA1 O 1 0.9999445676803589
in O 0 0.0006106956279836595
DNA O 0 0.01052136905491352
repair O 1 0.9998119473457336
. O 0 0.0011547848116606474

Here O 0 0.002026078524067998
, O 0 0.00026625950704328716
it O 0 0.0001444341178284958
is O 0 0.00026707813958637416
shown O 0 0.0004504654207266867
that O 0 9.721119567984715e-05
mouse O 0 0.011293631047010422
embryonic O 0 0.032764557749032974
stem O 0 0.04212086275219917
cells O 0 0.026641663163900375
deficient B-Disease 1 0.9999679327011108
in I-Disease 0 0.001269463449716568
BRCA1 I-Disease 1 0.999969482421875
are O 0 0.00027279576170258224
defective O 1 0.9985896944999695
in O 0 0.0002746062236838043
the O 0 0.0002378601348027587
ability O 0 0.002679505618289113
to O 0 6.288079748628661e-05
carry O 0 0.00017693566041998565
out O 0 6.920717714820057e-05
transcription O 0 0.002581957494840026
- O 0 0.009634612128138542
coupled O 0 0.009025276638567448
repair O 1 0.9988632202148438
of O 0 7.295153045561165e-05
oxidative O 1 0.9497449398040771
DNA O 0 0.025892699137330055
damage O 1 0.9985835552215576
, O 0 0.00033766988781280816
and O 0 0.00012993454583920538
are O 0 7.518616621382535e-05
hypersensitive O 1 0.994426965713501
to O 0 0.0003921774623449892
ionizing O 1 0.9818363189697266
radiation O 1 0.8578108549118042
and O 0 8.062354754656553e-05
hydrogen O 0 0.0032102344557642937
peroxide O 1 0.7954542636871338
. O 0 0.0008200192241929471

These O 0 0.00014142415602691472
results O 0 0.0007348851067945361
suggest O 0 0.00108217797242105
that O 0 0.0003912110987585038
BRCA1 O 1 0.9998992681503296
participates O 0 0.06675185263156891
, O 0 0.00037534013972617686
directly O 0 0.0008449048036709428
or O 0 0.0005988525226712227
indirectly O 0 0.009423520416021347
, O 0 0.00014771024871151894
in O 0 9.801506530493498e-05
transcription O 0 0.003983724862337112
- O 0 0.011729799211025238
coupled O 0 0.00886482559144497
repair O 1 0.998225748538971
of O 0 7.441487832693383e-05
oxidative O 1 0.7649348378181458
DNA O 0 0.013506379909813404
damage O 1 0.9971606731414795
. O 0 0.0003706274728756398
. O 0 0.0004169916792307049

Truncation O 0 0.1396123468875885
mutations O 0 0.00461387587711215
in O 0 0.00020190427312627435
the O 0 0.00041500426596030593
transactivation O 1 0.598693311214447
region O 0 0.0030012207571417093
of O 0 0.0002222010080004111
PAX6 O 1 0.9999105930328369
result O 0 0.0017101751873269677
in O 0 0.00034273802884854376
dominant O 0 0.017512714490294456
- O 0 0.013531372882425785
negative O 0 0.002585574984550476
mutants O 0 0.02120191417634487
. O 0 0.0006583450012840331

PAX6 O 1 0.9995071887969971
is O 0 0.00066560780396685
a O 0 0.00023431581212207675
transcription O 0 0.0009413518710061908
factor O 0 0.0009147582459263504
with O 0 5.352832158678211e-05
two O 0 7.762118184473366e-05
DNA O 0 0.0033074798993766308
- O 0 0.0034850866068154573
binding O 0 0.0008401384111493826
domains O 0 0.004615137353539467
( O 0 0.0013084696838632226
paired O 0 0.011049607768654823
box O 0 0.0061781518161296844
and O 0 0.0006743010599166155
homeobox O 1 0.9847645163536072
) O 0 0.0002829611476045102
and O 0 8.219390292651951e-05
a O 0 0.0008447945001535118
proline O 0 0.11053915321826935
- O 0 0.009155293926596642
serine O 0 0.019340798258781433
- O 0 0.011218411847949028
threonine O 0 0.12318747490644455
( O 0 0.004715351387858391
PST O 1 0.9984777569770813
) O 0 0.0014560441486537457
- O 0 0.008257352747023106
rich O 0 0.003105305368080735
transactivation O 0 0.16614322364330292
domain O 0 0.0025732044596225023
. O 0 0.0007297856500372291

PAX6 O 1 0.9999082088470459
regulates O 1 0.9818572998046875
eye O 1 0.9998874664306641
development O 0 0.004105534870177507
in O 0 0.000351564260199666
animals O 0 0.0009525837958790362
ranging O 0 0.0016649644821882248
from O 0 0.0002403223334113136
jellyfish O 0 0.006434082984924316
to O 0 8.598055865149945e-05
Drosophila O 0 0.002153413137421012
to O 0 0.0001301490410696715
humans O 0 0.0023763752542436123
. O 0 0.00046791398199275136

Heterozygous O 0 0.0203842855989933
mutations O 0 0.0019650000613182783
in O 0 0.00012341364345047623
the O 0 0.0003619763010647148
human O 0 0.013499394059181213
PAX6 O 1 0.9999821186065674
gene O 0 0.006889432203024626
result O 0 0.0006895858678035438
in O 0 0.00012081726163160056
various O 0 0.00010594122431939468
phenotypes O 0 0.039786968380212784
, O 0 0.00039186616777442396
including O 0 0.000576547987293452
aniridia B-Disease 1 0.9999873638153076
, O 0 0.002697403309866786
Peters B-Disease 1 0.9999868869781494
anomaly I-Disease 1 0.9997764229774475
, O 0 0.0014148595510050654
autosomal B-Disease 1 0.9990409016609192
dominant I-Disease 1 0.9969367980957031
keratitis I-Disease 1 0.9999986886978149
, O 0 0.0010064039379358292
and O 0 0.0009074852569028735
familial B-Disease 1 0.9999970197677612
foveal I-Disease 1 0.9999830722808838
dysplasia I-Disease 1 1.0
. O 0 0.002752248663455248

It O 0 0.0010123227257281542
is O 0 0.000563400040846318
believed O 0 0.001343580661341548
that O 0 2.5760638891370036e-05
the O 0 0.00013387075159698725
mutated O 0 0.00783652625977993
allele O 0 0.003491099691018462
of O 0 0.0001398527529090643
PAX6 O 1 0.9999183416366577
produces O 0 0.0031812116503715515
an O 0 0.0003519718593452126
inactive O 0 0.04364386573433876
protein O 0 0.0009840591810643673
and O 0 0.0006150892004370689
aniridia B-Disease 1 0.9999849796295166
is O 0 0.0014535312075167894
caused O 0 0.020913848653435707
due O 0 0.0016408718656748533
to O 0 0.00021927324996795505
genetic O 0 0.007752293720841408
haploinsufficiency O 1 0.9950962662696838
. O 0 0.0006955797434784472

However O 0 0.0017515468643978238
, O 0 0.00021859609114471823
several O 0 0.0001833996211644262
truncation O 0 0.06341081857681274
mutations O 0 0.004640865605324507
have O 0 0.00014653772814199328
been O 0 0.0003182015207130462
found O 0 0.00017108814790844917
to O 0 5.8876070397673175e-05
occur O 0 0.0003258825745433569
in O 0 0.00010290430509485304
the O 0 0.0008104491862468421
C O 1 0.9941826462745667
- O 0 0.021783532574772835
terminal O 0 0.1128215342760086
half O 0 0.00013188846060074866
of O 0 0.0001087347263819538
PAX6 O 1 0.9999791383743286
in O 0 0.0027733449824154377
patients O 1 0.9999942779541016
with O 0 0.0005948511534370482
Aniridia B-Disease 1 0.9999101161956787
resulting O 0 0.0019379263976588845
in O 0 0.0001981618843274191
mutant O 0 0.002480054274201393
proteins O 0 6.899657455505803e-05
that O 0 5.220330785959959e-05
retain O 0 0.0029422559309750795
the O 0 0.00026509101735427976
DNA O 0 0.003632992273196578
- O 0 0.004530551843345165
binding O 0 0.000794597843196243
domains O 0 0.003798580262809992
but O 0 0.0004326902562752366
have O 0 0.00016310301725752652
lost O 0 0.0019753207452595234
most O 0 4.940530561725609e-05
of O 0 1.2966381291334983e-05
the O 0 0.00041766700451262295
transactivation O 0 0.3468383848667145
domain O 0 0.0027722902595996857
. O 0 0.0007401062757708132

It O 0 0.0009130046237260103
is O 0 0.0004765379417221993
not O 0 0.0001598767121322453
clear O 0 0.0009397012181580067
whether O 0 0.00029614960658364
such O 0 5.667439108947292e-05
mutants O 0 0.01917162910103798
really O 0 0.0060377358458936214
behave O 0 0.01544047798961401
as O 0 0.0006010878132656217
loss O 0 0.019109318032860756
- O 0 0.0031415976118296385
of O 0 4.28804851253517e-05
- O 0 0.007407682482153177
function O 0 0.0018591779517009854
mutants O 0 0.011676697991788387
as O 0 0.0003188039700035006
predicted O 0 0.0029690824449062347
by O 0 0.0001677450054557994
haploinsufficiency O 1 0.9789880514144897
. O 0 0.0008425820851698518

Contrary O 0 0.00457038776949048
to O 0 8.689316746313125e-05
this O 0 4.838613676838577e-05
theory O 0 0.0004998796503059566
, O 0 0.00014867067511659116
our O 0 0.0003687581338454038
data O 0 0.0001930798462126404
showed O 0 0.0010824755299836397
that O 0 4.343705950304866e-05
these O 0 3.9863840356701985e-05
mutants O 0 0.008078434504568577
are O 0 4.79054288007319e-05
dominant O 0 0.01245073787868023
- O 0 0.006522301584482193
negative O 0 0.0010186635190621018
in O 0 0.00038284313632175326
transient O 0 0.49577367305755615
transfection O 1 0.9620636105537415
assays O 0 0.0047906022518873215
when O 0 0.0005245065549388528
they O 0 3.9631937397643924e-05
are O 0 3.2685431506251916e-05
coexpressed O 0 0.05699744075536728
with O 0 0.00012018001871183515
wild O 0 0.0017156889662146568
- O 0 0.030838681384921074
type O 0 0.21723529696464539
PAX6 O 1 0.9999812841415405
. O 0 0.0015049922512844205

We O 0 0.0009380748961120844
found O 0 0.00022386672208085656
that O 0 3.483864202280529e-05
the O 0 0.00020775747543666512
dominant O 0 0.019466282799839973
- O 0 0.013036897405982018
negative O 0 0.0023998888209462166
effects O 0 0.008260914124548435
result O 0 0.0008524619042873383
from O 0 8.227750367950648e-05
the O 0 0.0002131172368535772
enhanced O 0 0.01798672415316105
DNA O 0 0.00143900653347373
binding O 0 0.00044927853741683066
ability O 0 0.0012327254517003894
of O 0 1.7604335880605504e-05
these O 0 0.00010257433314109221
mutants O 0 0.023381303995847702
. O 0 0.0006989390822127461

Kinetic O 0 0.002881459193304181
studies O 0 0.0003629971470218152
of O 0 1.3148658581485506e-05
binding O 0 0.0009810138726606965
and O 0 0.0003936354478355497
dissociation O 0 0.23727858066558838
revealed O 0 0.008961486630141735
that O 0 3.099000241491012e-05
various O 0 5.758193219662644e-05
truncation O 0 0.061257533729076385
mutants O 0 0.013874917291104794
have O 0 0.0002054267970379442
3 O 0 0.0021976639982312918
- O 0 0.007513706106692553
5 O 0 0.0018376173684373498
- O 0 0.004980719182640314
fold O 0 0.002910522511228919
higher O 0 0.0006073623080737889
affinity O 0 0.0015718955546617508
to O 0 5.001778117730282e-05
various O 0 5.483224231284112e-05
DNA O 0 0.0041879271157085896
- O 0 0.003689918899908662
binding O 0 0.0005016625509597361
sites O 0 0.0004753743705805391
when O 0 0.00028227511211298406
compared O 0 0.0004429696418810636
with O 0 4.168016312178224e-05
the O 0 0.00022017538140062243
wild O 0 0.0017648594221100211
- O 0 0.03452713042497635
type O 0 0.18022888898849487
PAX6 O 1 0.9999687671661377
. O 0 0.0015837724786251783

These O 0 0.00016079323540907353
results O 0 0.0006806972669437528
provide O 0 0.0008843973628245294
a O 0 0.0008129559573717415
new O 0 0.000629626854788512
insight O 0 0.015814991667866707
into O 0 0.00012592668645083904
the O 0 0.00011452999751782045
role O 0 0.0013173718471080065
of O 0 6.256254710024223e-05
mutant O 0 0.044105470180511475
PAX6 O 1 0.9998959302902222
in O 0 0.0017756172455847263
causing O 1 0.9859164357185364
aniridia B-Disease 1 0.9996769428253174
. O 0 0.0005431048921309412
. O 0 0.0004953172756358981

Reversal O 0 0.03282328322529793
of O 0 0.0003813686198554933
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 0.0015232755104079843
excellent O 1 0.8203184604644775
neuropsychologic O 1 0.8769126534461975
outcome O 0 0.0011687506921589375
in O 0 0.00013771110388915986
very B-Disease 0 0.0016487733228132129
- I-Disease 0 0.010308134369552135
long I-Disease 0 0.004577586892992258
- I-Disease 0 0.006076107732951641
chain I-Disease 0 0.005028368439525366
acyl I-Disease 0 0.02887503243982792
- I-Disease 0 0.01001698337495327
coenzyme I-Disease 0 0.03770003840327263
A I-Disease 0 0.08481202274560928
dehydrogenase I-Disease 1 0.9999018907546997
deficiency I-Disease 1 0.9999998807907104
. O 0 0.001675151870585978

Very B-Disease 0 0.007106857839971781
- I-Disease 0 0.013217695988714695
long I-Disease 0 0.005133455619215965
- I-Disease 0 0.00622910400852561
chain I-Disease 0 0.0058658914640545845
acyl I-Disease 0 0.02771066688001156
- I-Disease 0 0.007207204587757587
coenzyme I-Disease 0 0.02077062427997589
A I-Disease 0 0.010330443270504475
dehydrogenase I-Disease 1 0.9875801205635071
( I-Disease 0 0.0037533645518124104
VLCAD I-Disease 1 0.9999775886535645
) I-Disease 0 0.005056611727923155
deficiency I-Disease 1 1.0
is O 0 0.0007671499042771757
a O 0 0.002155482769012451
disorder O 1 0.9999895095825195
of O 0 7.061489304760471e-05
fatty O 1 0.6126622557640076
acid O 0 0.02381483092904091
beta O 0 0.009950472973287106
oxidation O 0 0.0021819856483489275
that O 0 0.000239336775848642
reportedly O 0 0.01368771307170391
has O 0 0.000631533213891089
high O 0 0.00177281245123595
rates O 0 0.0003752628981601447
of O 0 6.354818469844759e-05
morbidity O 1 0.999690055847168
and O 0 0.001092011108994484
mortality O 1 0.998244047164917
. O 0 0.0008766984683461487

We O 0 0.0010517275659367442
describe O 0 0.0012768169399350882
the O 0 8.232835534727201e-05
outcome O 0 0.0003127034578938037
of O 0 8.547779543732759e-06
a O 0 0.0007208774331957102
5 O 0 0.0019936279859393835
- O 0 0.005354598630219698
year O 0 0.0015751461032778025
- O 0 0.009516016580164433
old O 0 0.005301047582179308
girl O 0 0.02731473557651043
with O 0 0.001628234051167965
VLCAD B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
who O 0 0.003337985137477517
was O 0 0.001453230855986476
first O 0 0.0003221624356228858
seen O 0 0.0025638053193688393
at O 0 0.0012053524842485785
5 O 0 0.0009171749697998166
months O 0 0.0005398715729825199
of O 0 1.3008554560656194e-05
age O 0 0.000927607121411711
with O 0 0.0008156434050761163
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 0 0.22589825093746185
hepatomegaly B-Disease 1 1.0
, O 0 0.3142445683479309
encephalopathy B-Disease 1 1.0
, O 0 0.0014441634994000196
and O 0 0.0012594301952049136
hypotonia B-Disease 1 0.9999732971191406
. O 0 0.0015394393121823668

Biochemical O 0 0.047156162559986115
studies O 0 0.006098209880292416
indicated O 1 0.9557467103004456
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 0.03250877931714058
by O 0 6.11130817560479e-05
a O 0 0.0008611130178906024
stable O 0 0.02564610168337822
yet O 0 0.0014932332560420036
inactive O 0 0.13694338500499725
enzyme O 0 0.00783341471105814
. O 0 0.0006256173946894705

Molecular O 0 0.012574080377817154
genetic O 0 0.0014930590987205505
analysis O 0 0.00018487444322090596
of O 0 4.218879257678054e-05
her O 0 0.006901612505316734
VLCAD O 1 0.9999198913574219
gene O 0 0.006623415742069483
revealed O 0 0.007633795030415058
a O 0 0.0016158480430021882
T1372C O 0 0.42907682061195374
( O 0 0.0018366849981248379
F458L O 0 0.17173047363758087
) O 0 0.000712763168849051
missense O 0 0.018527645617723465
mutation O 0 0.0027632745914161205
and O 0 0.0002187011414207518
a O 0 0.004075630567967892
1668 O 1 0.9988502264022827
ACAG O 1 0.9996017813682556
1669 O 1 0.9636458158493042
splice O 0 0.05714118108153343
site O 0 0.005703051574528217
mutation O 0 0.0037414850667119026
. O 0 0.00047346510109491646

After O 0 0.006627493537962437
initial O 0 0.006849321536719799
treatment O 1 0.9985344409942627
with O 0 0.000246460665948689
intravenous O 1 0.9980194568634033
glucose O 0 0.051009926944971085
and O 0 0.0008935359073802829
carnitine O 1 0.9998569488525391
, O 0 0.0005029945750720799
the O 0 0.0007238255930133164
patient O 1 0.9998782873153687
has O 0 0.0012254483299329877
thrived O 0 0.01669331081211567
on O 0 0.00015260717191267759
a O 0 0.0005677173030562699
low O 0 0.007518347818404436
- O 0 0.010335953906178474
fat O 0 0.015172623097896576
diet O 0 0.010561928153038025
supplemented O 0 0.0021973398979753256
with O 0 8.081142732407898e-05
medium O 0 0.006825925782322884
- O 0 0.012121876701712608
chain O 0 0.007749191019684076
triglyceride O 0 0.11711166799068451
oil O 0 0.0037798797711730003
and O 0 0.0006933228578418493
carnitine O 1 0.9997506737709045
and O 0 0.0004587734001688659
avoidance O 1 0.7652687430381775
of O 0 0.0001020111158140935
fasting O 0 0.06266593188047409
. O 0 0.0007698432891629636

Her O 0 0.02084464579820633
ventricular O 1 0.9999909400939941
hypertrophy O 1 0.9999806880950928
resolved O 0 0.032381460070610046
significantly O 0 0.007797000929713249
over O 0 0.00030195547151379287
1 O 0 0.0022540458012372255
year O 0 0.0011338465847074986
, O 0 0.0002981283760163933
and O 0 0.0006651068106293678
cognitively O 1 0.9994913339614868
, O 0 0.0011005549458786845
she O 0 0.0017140008276328444
is O 0 0.00027493288507685065
in O 0 0.000123643345432356
the O 0 0.0002910066395998001
superior O 0 0.03273361548781395
range O 0 0.0020088283345103264
for O 0 0.0006174178561195731
age O 0 0.002717206720262766
. O 0 0.0007318987627513707

Clinical O 1 0.9997962117195129
recognition O 0 0.003218221478164196
of O 0 0.0004952009185217321
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.0011201121378690004
important O 0 0.0011036599753424525
because O 0 0.0008136366959661245
it O 0 0.00013436772860586643
is O 0 0.0001570039166836068
one O 0 3.501380342640914e-05
of O 0 7.348438430199167e-06
the O 0 0.0001635504449950531
few O 0 0.0005221561877988279
directly O 0 0.005415918305516243
treatable O 1 1.0
causes O 1 0.9028451442718506
of O 0 0.00042780168587341905
cardiomyopathy B-Disease 1 1.0
in O 0 0.0020279092714190483
children O 0 0.003982037305831909
. O 0 0.00030608399538323283
. O 0 0.000607136869803071

Cloning O 0 0.009689277037978172
of O 0 3.102575647062622e-05
a O 0 0.0009265970438718796
novel O 0 0.001763093750923872
member O 0 0.0002422247634967789
of O 0 9.248156857211143e-06
the O 0 0.00020756974117830396
low O 0 0.006046197842806578
- O 0 0.00620734877884388
density O 0 0.0014552229549735785
lipoprotein O 1 0.999977707862854
receptor O 0 0.03196585178375244
family O 0 0.0021952164825052023
. O 0 0.0007064752280712128

A O 0 0.005614347755908966
gene O 0 0.0010739215649664402
encoding O 0 0.00027545556076802313
a O 0 0.00045423494884744287
novel O 0 0.0015012508956715465
transmembrane O 0 0.010851355269551277
protein O 0 0.0021430007182061672
was O 0 0.0020372411236166954
identified O 0 0.0007586983265355229
by O 0 2.5395851480425335e-05
DNA O 0 0.0004741310840472579
sequence O 0 2.2427460862672888e-05
analysis O 0 7.02171673765406e-05
within O 0 3.169778938172385e-05
the O 0 0.00023611508368048817
insulin B-Disease 1 0.9966049194335938
- I-Disease 0 0.3964175581932068
dependent I-Disease 1 0.9550267457962036
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 0.012643852271139622
IDDM B-Disease 1 0.9997907280921936
) O 0 0.0013911513378843665
locus O 0 0.043278977274894714
IDDM4 O 1 0.9960827827453613
on O 0 0.0007692940998822451
chromosome O 0 0.005358144640922546
11q13 O 0 0.08147014677524567
. O 0 0.0007442501955665648

Based O 0 0.0007425435469485819
on O 0 0.00023973120551090688
its O 0 0.00048328901175409555
chromosomal O 0 0.034300532191991806
position O 0 0.003932550083845854
, O 0 0.00021759171795565635
this O 0 8.906028961064294e-05
gene O 0 0.00230643292888999
is O 0 0.0002365696127526462
a O 0 0.000490092090331018
candidate O 0 0.000996786286123097
for O 0 0.00025320221902802587
conferring O 0 0.06215205043554306
susceptibility O 1 0.990257978439331
to O 0 0.0024253211449831724
diabetes B-Disease 1 1.0
. O 0 0.001364243682473898

The O 0 0.0010219519026577473
gene O 0 0.002937403041869402
, O 0 0.0002787369885481894
termed O 0 0.029824858531355858
low O 0 0.005398361943662167
- O 0 0.004304402507841587
density O 0 0.0009496879647485912
lipoprotein O 1 0.9994596838951111
receptor O 0 0.008003804832696915
related O 0 0.0012338231317698956
protein O 0 0.0017098848475143313
5 O 0 0.003151822602376342
( O 0 0.002987357322126627
LRP5 O 1 0.9991937279701233
) O 0 0.0004703365848399699
, O 0 9.95880545815453e-05
encodes O 0 0.0005594944232143462
a O 0 0.00022510126291308552
protein O 0 0.0003547111409716308
of O 0 5.355584653443657e-05
1615 O 0 0.0914405956864357
amino O 0 0.0003692086029332131
acids O 0 0.0004656784876715392
that O 0 3.523171471897513e-05
contains O 0 7.326741615543142e-05
conserved O 0 0.0003886399499606341
modules O 0 0.0016482553910464048
which O 0 4.2138890421483666e-05
are O 0 1.3945817954663653e-05
characteristic O 0 0.0008567614713683724
of O 0 1.3819186278851703e-05
the O 0 0.00017575461242813617
low O 0 0.004475024063140154
- O 0 0.005093125626444817
density O 0 0.001502709579654038
lipoprotein O 1 0.999984622001648
( O 0 0.007985998876392841
LDL O 1 0.9999997615814209
) O 0 0.00129484455101192
receptor O 0 0.012902582064270973
family O 0 0.0016269307816401124
. O 0 0.0006510472157970071

These O 0 0.00014524163270834833
modules O 0 0.0022184362169355154
include O 0 0.0002486339653842151
a O 0 0.0007513414020650089
putative O 0 0.014180343598127365
signal O 0 0.0020048352889716625
peptide O 0 0.0022462469059973955
for O 0 8.145871106535196e-05
protein O 0 0.0003819064877461642
export O 0 0.0004989723092876375
, O 0 0.00016172426694538444
four O 0 0.00021542496688198298
epidermal O 1 0.9980347752571106
growth O 0 0.0025415897835046053
factor O 0 0.004546556621789932
( O 0 0.002691227477043867
EGF O 1 0.9975639581680298
) O 0 0.0009016760159283876
repeats O 0 0.00539435213431716
with O 0 9.743543341755867e-05
associated O 0 0.0008867329452186823
spacer O 0 0.02762439288198948
domains O 0 0.0023041144013404846
, O 0 0.00024388796009588987
three O 0 0.00043001744779758155
LDL O 1 0.9999991655349731
- O 0 0.019090505316853523
receptor O 0 0.01720866560935974
( O 0 0.002561533357948065
LDLR O 1 0.999622106552124
) O 0 0.0008778453920967877
repeats O 0 0.007928923703730106
, O 0 0.0001662070135353133
a O 0 0.0003492905816528946
single O 0 0.0004222956486046314
transmembrane O 0 0.015384211204946041
spanning O 0 0.007493071258068085
domain O 0 0.00188320386223495
, O 0 0.0003409238124731928
and O 0 0.0001408622629242018
a O 0 0.0009043881436809897
cytoplasmic O 0 0.00881427526473999
domain O 0 0.0026375488378107548
. O 0 0.0006969604874029756

The O 0 0.0002058985992334783
encoded O 0 9.1415764472913e-05
protein O 0 0.0005996355321258307
has O 0 0.0003300623793620616
a O 0 0.0002233034756500274
unique O 0 0.00043215969344601035
organization O 0 0.0015740920789539814
of O 0 0.00011371177242835984
EGF O 1 0.9993256330490112
and O 0 0.0014346896205097437
LDLR O 1 0.99918133020401
repeats O 0 0.020437775179743767
; O 0 0.0003154745209030807
therefore O 0 0.0007552897441200912
, O 0 0.0009721867390908301
LRP5 O 1 0.9981778860092163
likely O 0 0.0025115576572716236
represents O 0 0.0014652800746262074
a O 0 0.0005571809597313404
new O 0 0.0002671463880687952
category O 0 0.0006394734955392778
of O 0 2.4491690055583604e-05
the O 0 0.0011727745877578855
LDLR O 1 0.9998088479042053
family O 0 0.002734532579779625
. O 0 0.0008205362828448415

Both O 0 0.0008241698960773647
human O 0 0.0022303147707134485
and O 0 0.0007899063057266176
mouse O 0 0.1255827099084854
LRP5 O 1 0.9994669556617737
cDNAs O 1 0.8552489876747131
have O 0 0.00035640376154333353
been O 0 0.0007427350501529872
isolated O 0 0.007565062493085861
and O 0 7.195826037786901e-05
the O 0 7.751925295451656e-05
encoded O 0 0.00018577314040157944
mature O 0 0.006069318391382694
proteins O 0 0.00011694922432070598
are O 0 4.3597203330136836e-05
95 O 0 0.0027557292487472296
% O 0 7.079504575813189e-05
identical O 0 0.000833267520647496
, O 0 0.0003644211683422327
indicating O 0 0.0037926065269857645
a O 0 0.0012800137046724558
high O 0 0.005220331251621246
degree O 0 0.0016674797516316175
of O 0 2.1576315702986903e-05
evolutionary O 0 0.003918670583516359
conservation O 0 0.016481690108776093
. O 0 0.00029031469603069127
. O 0 0.0004559599910862744

The O 0 0.0029208543710410595
APC B-Disease 1 0.9952664375305176
variants O 0 0.0060599371790885925
I1307K O 0 0.07159116864204407
and O 0 0.0002991727669723332
E1317Q O 0 0.02698568068444729
are O 0 3.439388092374429e-05
associated O 0 0.0007907719118520617
with O 0 0.004686290863901377
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.000996102811768651
but O 0 0.0003342183481436223
not O 0 0.00011872727918671444
always O 0 0.0002969115157611668
with O 0 5.018347656005062e-05
a O 0 0.0007898438489064574
family O 0 0.0009499254520051181
history O 0 0.001366800395771861
. O 0 0.0006218878552317619

Classical O 0 0.020889783278107643
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 0.03774336352944374
FAP B-Disease 1 0.999994158744812
) O 0 0.00047541881212964654
is O 0 0.00017238077998626977
a O 0 0.000519760767929256
high O 0 0.010335911065340042
- O 1 0.8421408534049988
penetrance O 1 0.9997246861457825
autosomal B-Disease 1 0.9999563694000244
dominant I-Disease 1 0.9997591376304626
disease I-Disease 1 1.0
that O 0 0.0007223308784887195
predisposes O 1 0.9992383718490601
to O 0 0.00014142361760605127
hundreds O 0 0.00033682529465295374
or O 0 0.0002018161176238209
thousands O 0 0.0005135551909916103
of O 0 0.0007803968037478626
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.17852509021759033
carcinoma I-Disease 1 1.0
and O 0 0.0004369785310700536
that O 0 0.0001164131608675234
results O 0 0.00048736348981037736
from O 0 0.00014666827337350696
truncating O 0 0.47318026423454285
mutations O 0 0.0019467450911179185
in O 0 0.00011218252620892599
the O 0 0.0006937617436051369
APC B-Disease 1 0.9995960593223572
gene O 0 0.008707021363079548
. O 0 0.0006844840245321393

A O 0 0.006890877615660429
variant O 0 0.014103736728429794
of O 0 0.00017458210641052574
FAP B-Disease 1 0.9999959468841553
is O 0 0.005973678082227707
attenuated B-Disease 1 0.9999005794525146
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999972581863403
, O 0 0.0005752065917477012
which O 0 5.315049202181399e-05
results O 0 0.00048555529792793095
from O 0 0.0003833910159301013
germ O 1 0.9999245405197144
- O 0 0.013510847464203835
line O 0 0.003087627701461315
mutations O 0 0.0014728022506460547
in O 0 0.00014020150410942733
the O 0 0.0003458262071944773
5 O 0 0.0019939932972192764
and O 0 0.00020559610857162625
3 O 0 0.0007568871951662004
regions O 0 0.00014484761049970984
of O 0 1.7587623005965725e-05
the O 0 0.00113105948548764
APC B-Disease 1 0.999640703201294
gene O 0 0.00886777974665165
. O 0 0.000553126388695091

Attenuated B-Disease 1 0.9999611377716064
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.9999978542327881
have O 0 0.00015253559104166925
" O 0 0.0005033499910496175
multiple O 0 0.005272748880088329
" O 0 0.21755008399486542
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999997615814209
( O 0 0.0020955405198037624
typically O 0 0.0005704581271857023
fewer O 0 0.0006713686161674559
than O 0 0.00017835359903983772
100 O 0 0.0008641884778626263
) O 0 0.00018977333093062043
without O 0 0.0001900967617984861
the O 0 0.00039243948413059115
florid O 1 0.9753872156143188
phenotype O 0 0.046187225729227066
of O 0 4.687489854404703e-05
classical O 0 0.008098064921796322
FAP B-Disease 1 0.999987006187439
. O 0 0.0016056264284998178

Another O 0 0.0022310034837573767
group O 0 0.0005015739588998258
of O 0 0.0001361489703413099
patients O 1 0.9999971389770508
with O 0 0.00029917535721324384
multiple O 0 0.031444281339645386
adenomas B-Disease 1 0.999964714050293
has O 0 0.001358609995804727
no O 0 0.00026999684632755816
mutations O 0 0.001119239255785942
in O 0 0.00013958947965875268
the O 0 0.0008225865894928575
APC B-Disease 1 0.9996678829193115
gene O 0 0.007663074880838394
, O 0 0.0003648676793090999
and O 0 0.00014219546574167907
their O 0 0.0003004744939971715
phenotype O 1 0.9739173054695129
probably O 0 0.0030321853701025248
results O 0 0.000501162139698863
from O 0 4.1789051465457305e-05
variation O 0 0.00029730977257713675
at O 0 0.0009041262092068791
a O 0 0.0011371065629646182
locus O 0 0.027226660400629044
, O 0 0.0008957683457992971
or O 0 0.0016499148914590478
loci O 0 0.025866832584142685
, O 0 0.0004809594538528472
elsewhere O 0 0.0007971540908329189
in O 0 0.00011143333540530875
the O 0 0.00028918759198859334
genome O 0 0.007938496768474579
. O 0 0.0005748911062255502

Recently O 0 0.04184141010046005
, O 0 0.0004265190218575299
however O 0 0.00030046477331779897
, O 0 0.00014610715152230114
a O 0 0.0007417740416713059
missense O 0 0.020785467699170113
variant O 0 0.015300087630748749
of O 0 0.00022417814761865884
APC B-Disease 1 0.9997859597206116
( O 0 0.003758040489628911
I1307K O 1 0.8889949321746826
) O 0 0.00060610834043473
was O 0 0.0013928409898653626
described O 0 0.002270903205499053
that O 0 8.292353595606983e-05
confers O 0 0.013783497735857964
an O 0 0.0001261727011296898
increased O 0 0.0011716216104105115
risk O 1 0.9857521653175354
of O 0 0.002046919660642743
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.0005728135001845658
including O 0 0.0002207883371738717
multiple O 0 0.025122232735157013
adenomas B-Disease 1 0.9999798536300659
, O 0 0.0006210521096363664
in O 0 0.0007596227806061506
Ashkenazim O 1 0.9871680736541748
. O 0 0.001305558835156262

We O 0 0.0011070510372519493
have O 0 0.00010805120837176219
studied O 0 0.0004329157236497849
a O 0 0.00012554779823403805
set O 0 2.821353882609401e-05
of O 0 3.004407335538417e-05
164 O 1 0.7673980593681335
patients O 1 0.9999932050704956
with O 0 0.0003787436871789396
multiple O 1 0.9997113347053528
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.00844099186360836
/ I-Disease 1 0.9997819066047668
or I-Disease 0 0.01170443743467331
carcinoma I-Disease 1 1.0
and O 0 0.000420956639572978
analyzed O 0 0.005491776391863823
codons O 0 0.015683144330978394
1263 O 1 0.9715534448623657
- O 0 0.03246307000517845
1377 O 1 0.9765092730522156
( O 0 0.001805393141694367
exon O 0 0.09073131531476974
15G O 0 0.15705402195453644
) O 0 0.00012610331759788096
of O 0 1.0869046491279732e-05
the O 0 0.0005505727604031563
APC B-Disease 1 0.9963680505752563
gene O 0 0.003326470497995615
for O 0 0.0009390684426762164
germ O 1 0.9998121857643127
- O 0 0.016131147742271423
line O 0 0.0034396282862871885
variants O 0 0.0022467065136879683
. O 0 0.0005528323817998171

Three O 0 0.003433641279116273
patients O 1 0.9999544620513916
with O 0 0.00010345202463213354
the O 0 0.0005634790286421776
I1307K O 0 0.3280905485153198
allele O 0 0.008622662164270878
were O 0 0.0001771441602613777
detected O 0 0.008960614912211895
, O 0 8.891033940017223e-05
each O 0 2.3293972844840027e-05
of O 0 6.917009886819869e-05
Ashkenazi O 1 0.9862529635429382
descent O 0 0.007631137501448393
. O 0 0.0009942036122083664

Four O 0 0.0025391806848347187
patients O 1 0.9999039173126221
had O 0 0.0007926200050860643
a O 0 0.001732292235828936
germ O 1 0.999962329864502
- O 0 0.016121910884976387
line O 0 0.004359290935099125
E1317Q O 0 0.08142886310815811
missense O 0 0.026601580902934074
variant O 0 0.012796975672245026
of O 0 0.00014372178702615201
APC O 1 0.9992222785949707
that O 0 0.00036267927498556674
was O 0 0.0016613322077319026
not O 0 0.000129685242427513
present O 0 0.00017583390581421554
in O 0 0.00033805883140303195
controls O 0 0.004312676843255758
; O 0 0.00027553015388548374
one O 0 9.295036579715088e-05
of O 0 1.6168358342838474e-05
these O 0 5.148254786035977e-05
individuals O 0 0.00045404117554426193
had O 0 0.001069325371645391
an O 0 0.0003453063254710287
unusually O 0 0.010837468318641186
large O 0 0.00012291087477933615
number O 0 2.3102673367247917e-05
of O 0 6.285317067522556e-05
metaplastic B-Disease 1 0.9992660880088806
polyps I-Disease 1 0.9909203052520752
of I-Disease 0 2.623378713906277e-05
the I-Disease 0 0.0006491674575954676
colorectum I-Disease 1 0.9910297393798828
. O 0 0.0008725204970687628

There O 0 0.0004462634678930044
is O 0 0.00024693956947885454
increasing O 0 0.0004526233533397317
evidence O 0 0.0003645679971668869
that O 0 5.6077642511809245e-05
there O 0 0.00012888429046142846
exist O 0 0.0020453892648220062
germ O 1 0.9998568296432495
- O 0 0.012447127141058445
line O 0 0.0013226583832874894
variants O 0 0.00031542606302537024
of O 0 1.4444069165620022e-05
the O 0 0.0009737024083733559
APC B-Disease 1 0.9992167949676514
gene O 0 0.005904096178710461
that O 0 0.00022228936722967774
predispose O 0 0.15754221379756927
to O 0 4.742569581139833e-05
the O 0 4.897393228020519e-05
development O 0 0.0005959117552265525
of O 0 6.0791822761530057e-05
multiple O 1 0.9998385906219482
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.41095027327537537
carcinoma I-Disease 1 1.0
, O 0 0.0011510234326124191
but O 0 0.000218180037336424
without O 0 0.00017934625793714076
the O 0 0.000357158191036433
florid O 1 0.9825281500816345
phenotype O 0 0.045313019305467606
of O 0 6.110672984505072e-05
classical O 0 0.008302583359181881
FAP B-Disease 1 0.9999969005584717
, O 0 0.0008931545307859778
and O 0 0.00018924243340734392
possibly O 0 0.0009563404018990695
with O 0 3.1161172955762595e-05
importance O 0 0.0037352265790104866
for O 1 0.7873103022575378
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9982157945632935
in O 0 0.00020605137979146093
the O 0 0.00023754830181133002
general O 0 0.0015895103570073843
population O 0 0.00013953809684608132
. O 0 0.0002761858340818435
. O 0 0.0005304524092935026

Genomic O 0 0.004649377893656492
structure O 0 0.00044677549158222973
of O 0 8.805985999060795e-06
the O 0 0.0003437729028519243
human O 1 0.992546021938324
congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999992847442627
diarrhea I-Disease 1 1.0
( O 0 0.06199277937412262
CLD B-Disease 1 0.9999995231628418
) O 0 0.0017656080890446901
gene O 0 0.004901399370282888
. O 0 0.0005116562242619693

Congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999983310699463
diarrhea I-Disease 1 1.0
( O 1 0.5043556094169617
CLD B-Disease 1 0.9999997615814209
) O 0 0.0015731652965769172
is O 0 0.0008288121316581964
caused O 0 0.0063365548849105835
by O 0 8.831942250253633e-05
mutations O 0 0.0020550459157675505
in O 0 0.00011519055988173932
a O 0 0.00048498428077436984
gene O 0 0.0009756260551512241
which O 0 2.538212538638618e-05
encodes O 0 0.0009117345907725394
an O 0 0.0012876071268692613
intestinal O 1 0.9999997615814209
anion O 1 0.9992848038673401
transporter O 1 0.9983500242233276
. O 0 0.0012141723418608308

We O 0 0.0020485566928982735
report O 0 0.0010377403814345598
here O 0 0.00013267403119243681
the O 0 0.00010381182801211253
complete O 0 0.0010169409215450287
genomic O 0 0.0025867093354463577
organization O 0 0.0008702745544724166
of O 0 1.7294725694227964e-05
the O 0 0.0005081274430267513
human O 0 0.01767144352197647
CLD B-Disease 1 0.9999731779098511
gene O 0 0.004378852900117636
which O 0 0.00012032531230943277
spans O 0 0.011691075749695301
approximately O 0 0.0019398320000618696
39kb O 1 0.7317879796028137
, O 0 0.00041196373058483005
and O 0 0.00016727637557778507
comprises O 0 0.0020245045889168978
21 O 0 0.0033479563426226377
exons O 0 0.013414830900728703
. O 0 0.000689127657096833

All O 0 0.0006401183782145381
exon O 0 0.2538328766822815
/ O 0 0.07557844370603561
intron O 0 0.14880572259426117
boundaries O 0 0.0003421040310058743
conform O 0 0.0024149685632437468
to O 0 0.00013139977818354964
the O 0 0.001279696123674512
GT O 1 0.9996920824050903
/ O 1 0.9981476068496704
AG O 1 0.9999537467956543
rule O 0 0.0018438155530020595
. O 0 0.000508196244481951

An O 0 0.00047787706716917455
analysis O 0 0.00024657067842781544
of O 0 2.1699011995224282e-05
the O 0 0.0005695114959962666
putative O 0 0.0563223622739315
promoter O 0 0.045473888516426086
region O 0 0.0012733828043565154
sequence O 0 6.964214844629169e-05
shows O 0 0.00019481460913084447
a O 0 0.0012783196289092302
putative O 1 0.8476634621620178
TATA O 1 0.9999852180480957
box O 0 0.012527075596153736
and O 0 0.00034673785557970405
predicts O 0 0.01497301273047924
multiple O 0 0.000547281582839787
transcription O 0 0.0007251044735312462
factor O 0 0.0010253594955429435
binding O 0 0.0006553877028636634
sites O 0 0.000721852935384959
. O 0 0.00039179594023153186

The O 0 0.0005884312558919191
genomic O 0 0.004479566588997841
structure O 0 0.004377317149192095
was O 0 0.0018509861547499895
determined O 0 0.0012801040429621935
using O 0 0.0001511378795839846
DNA O 0 0.0012659546919167042
from O 0 5.19467648700811e-05
several O 0 4.8852100007934496e-05
sources O 0 0.00018351926701143384
including O 0 6.944212509552017e-05
multiple O 0 0.0018747582798823714
large O 0 0.0009451425285078585
- O 0 0.023197943344712257
insert O 0 0.08906815201044083
libaries O 0 0.27785181999206543
and O 0 0.0001247427862836048
genomic O 0 0.0022943224757909775
DNA O 0 0.0011454548221081495
from O 0 0.00025183617253787816
Finnish O 1 0.9921368360519409
CLD B-Disease 1 0.9999998807907104
patients O 1 0.9999948740005493
and O 0 0.0003431043296586722
controls O 0 0.004111053887754679
. O 0 0.0006702201790176332

Exon O 0 0.15168936550617218
- O 0 0.007956761866807938
specific O 0 0.0005468871095217764
primers O 0 0.035516463220119476
developed O 0 0.00434900913387537
in O 0 0.0001359015004709363
this O 0 5.968074401607737e-05
study O 0 0.0006769570172764361
will O 0 7.575760537292808e-05
facilitate O 0 0.0019952459260821342
mutation O 0 0.0029443546663969755
screening O 0 0.004280498251318932
studies O 0 0.00045127925113774836
of O 0 7.991208985913545e-05
patients O 1 0.9999985694885254
with O 0 0.00015016910037957132
the O 0 0.002749459585174918
disease O 1 1.0
. O 0 0.0009534186101518571

Genomic O 0 0.0025401986204087734
sequencing O 0 0.00026979329413734376
of O 0 2.8555276003316976e-05
a O 0 0.0037971080746501684
BAC O 1 0.9991151690483093
clone O 1 0.9846757054328918
H O 1 0.9999241828918457
_ O 0 0.006091248244047165
RG364P16 O 0 0.1505334973335266
revealed O 0 0.007213607896119356
the O 0 0.00010844654752872884
presence O 0 0.00029171694768592715
of O 0 2.2469333998742513e-05
another O 0 0.0009452217491343617
, O 0 0.0002530342899262905
highly O 0 0.004606920760124922
homologous O 0 0.007854568772017956
gene O 0 0.0023286871146410704
3 O 0 0.00037562294164672494
of O 0 2.561561450420413e-05
the O 0 0.0025475756265223026
CLD B-Disease 1 0.9999982118606567
gene O 0 0.010439454577863216
, O 0 0.00018958738655783236
with O 0 4.6000659494893625e-05
a O 0 0.0003432135854382068
similar O 0 0.00022945486125536263
genomic O 0 0.004047800786793232
structure O 0 0.005267778877168894
, O 0 0.0005755969905294478
recently O 0 0.005251577589660883
identified O 0 0.0005761489155702293
as O 0 0.00012170158152002841
the O 0 0.0010666599264368415
Pendred B-Disease 1 0.9999995231628418
syndrome I-Disease 1 1.0
gene O 0 0.025625556707382202
( O 0 0.004445943515747786
PDS B-Disease 1 0.9999946355819702
) O 0 0.001291054766625166
. O 0 0.00028324127197265625
. O 0 0.0004378278972581029

The O 0 0.0022541475482285023
APCI1307K O 1 0.9991911053657532
allele O 0 0.031954340636730194
and O 0 0.004918387625366449
cancer B-Disease 1 1.0
risk O 1 0.574623167514801
in O 0 0.00021472180378623307
a O 0 0.000989333144389093
community O 0 0.002508798846974969
- O 0 0.005323973949998617
based O 0 0.0001706339098745957
study O 0 0.0006659783539362252
of O 0 6.104377098381519e-05
Ashkenazi O 1 0.9907323122024536
Jews O 0 0.0029336765874177217
. O 0 0.000756027817260474

Mutations O 0 0.011262749321758747
in O 0 0.0009107820806093514
APC O 1 0.9994298815727234
are O 0 0.000206067314138636
classically O 1 0.9957953691482544
associated O 0 0.0009747791336849332
with O 0 0.0010976671474054456
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 0.09488315135240555
FAP B-Disease 1 0.9999926090240479
) O 0 0.0006300032255239785
, O 0 0.00011901041580131277
a O 0 0.0006763575947843492
highly O 1 0.5646036863327026
penetrant O 1 0.9999973773956299
autosomal B-Disease 1 0.9999995231628418
dominant I-Disease 1 0.9999667406082153
disorder I-Disease 1 1.0
characterized O 1 0.9993165731430054
by O 0 0.0004636220110114664
multiple O 1 0.9990732669830322
intestinal O 1 1.0
polyps B-Disease 1 0.9999817609786987
and O 0 0.0005009686574339867
, O 0 0.0004608033050317317
without O 0 0.001792768482118845
surgical O 1 0.9999985694885254
intervention O 0 0.015308037400245667
, O 0 9.936615970218554e-05
the O 0 7.443099457304925e-05
development O 0 0.0016387818614020944
of O 0 0.0007481822976842523
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.0054113371297717094
CRC B-Disease 1 0.9998548030853271
) O 0 0.0008590500219725072
. O 0 0.0005141206784173846

APC B-Disease 1 0.9805405735969543
is O 0 0.0009919466683641076
a O 0 0.004324864596128464
tumour O 1 1.0
- O 0 0.061527591198682785
suppressor O 0 0.07055120915174484
gene O 0 0.0027469974011182785
, O 0 0.0001662312279222533
and O 0 0.00021353826741687953
somatic O 0 0.02998368814587593
loss O 0 0.028613679111003876
occurs O 0 0.002556547988206148
in O 0 0.0019153374014422297
tumours B-Disease 1 0.9999998807907104
. O 0 0.0011893687769770622

The O 0 0.0039532361552119255
germline O 1 0.9918671250343323
T O 1 0.9988285899162292
- O 0 0.006749677937477827
to O 0 0.00023045309353619814
- O 0 0.005172888748347759
A O 0 0.005574635695666075
transversion O 1 0.5602152943611145
responsible O 0 0.004500114358961582
for O 0 0.00021695531904697418
the O 0 0.0008126302855089307
APC O 1 0.995288610458374
I1307K O 0 0.07387883961200714
allele O 0 0.0038218284025788307
converts O 0 0.00044562388211488724
the O 0 0.00023292477999348193
wild O 0 0.0017266628565266728
- O 0 0.007255750708281994
type O 0 0.001750905066728592
sequence O 0 5.187503484194167e-05
to O 0 6.89664448145777e-05
a O 0 0.001851979293860495
homopolymer O 1 0.9994113445281982
tract O 1 0.9999897480010986
( O 0 0.009066716767847538
A8 O 1 0.9999938011169434
) O 0 0.000577032333239913
that O 0 9.651936852606013e-05
is O 0 0.0006099978927522898
genetically O 0 0.00488616619259119
unstable O 1 0.9987494945526123
and O 0 0.0009613228030502796
prone O 1 0.9545202851295471
to O 0 0.0003403873124625534
somatic O 0 0.026340307667851448
mutation O 0 0.005937383510172367
. O 0 0.0006113898125477135

The O 0 0.0014132341602817178
I1307K O 0 0.07836752384901047
allele O 0 0.011580521240830421
was O 0 0.002622138010337949
found O 0 0.00043975067092105746
in O 0 0.00022911667474545538
6 O 0 0.0036219535395503044
. O 0 0.0005277147865854204

1 O 0 0.0022758347913622856
% O 0 5.147818228579126e-05
of O 0 7.534966425737366e-05
unselected O 1 0.988361656665802
Ashkenazi O 1 0.9856643676757812
Jews O 0 0.0023838637862354517
and O 0 0.0002282954374095425
higher O 0 0.0010477419709786773
proportions O 0 0.005956883076578379
of O 0 0.00012496649287641048
Ashkenazim O 1 0.99436354637146
with O 0 0.00039253770955838263
family O 0 0.0017812600126489997
or O 0 0.0006000197608955204
personal O 0 0.001981127541512251
histories O 0 0.006147940643131733
of O 0 0.00028310250490903854
CRC B-Disease 1 0.9999212026596069
( O 0 0.004606934264302254
ref O 1 0.9517676830291748
. O 0 0.00039425675640814006
2 O 0 0.002049559261649847
) O 0 0.0004480938077904284
. O 0 0.0004650219634640962

To O 0 0.0006535413558594882
evaluate O 0 0.012532499618828297
the O 0 0.00012102169421268627
role O 0 0.001159493112936616
of O 0 6.105517968535423e-05
I1307K O 1 0.9541200399398804
in O 0 0.0030998955480754375
cancer B-Disease 1 1.0
, O 0 0.00033627983066253364
we O 0 0.0005874685011804104
genotyped O 1 0.5881015658378601
5 O 0 0.0018833329668268561
, O 0 0.0013207675656303763
081 O 1 0.9964967370033264
Ashkenazi O 1 0.9730637073516846
volunteers O 0 0.009359566494822502
in O 0 0.0001292923407163471
a O 0 0.0005692951963283122
community O 0 0.0013461014023050666
survey O 0 0.0027730772271752357
. O 0 0.0005962628056295216

Risk O 0 0.04930289089679718
of O 0 0.00013613287592306733
developing O 1 0.9990345239639282
colorectal B-Disease 1 1.0
, I-Disease 0 0.012173760682344437
breast I-Disease 1 1.0
and I-Disease 0 0.0005838802899233997
other I-Disease 0 0.0005240021273493767
cancers I-Disease 1 0.9999942779541016
were O 0 9.874803072307259e-05
compared O 0 0.0011264258064329624
between O 0 0.00078807701356709
genotyped O 1 0.9937813878059387
I1307K O 0 0.36990341544151306
carriers O 0 0.012783044017851353
and O 0 0.000335185817675665
non O 0 0.009606030769646168
- O 0 0.014942578040063381
carriers O 0 0.008682542480528355
and O 0 8.200741285691038e-05
their O 0 4.871458077104762e-05
first O 0 0.0007537286728620529
- O 0 0.013779881410300732
degree O 0 0.004762738477438688
relatives O 0 0.0027179254684597254
. O 0 0.0005385664408095181

Sperm O 0 0.0036811449099332094
DNA O 0 0.0009617643663659692
analysis O 0 0.00022224316489882767
in O 0 0.00018915729015134275
a O 0 0.005118911620229483
Friedreich B-Disease 1 0.9999657869338989
ataxia I-Disease 1 0.9999953508377075
premutation O 1 0.9996083378791809
carrier O 1 0.7054350972175598
suggests O 0 0.0035513138864189386
both O 0 0.0002976004616357386
meiotic O 1 0.619540810585022
and O 0 0.00029295781860128045
mitotic O 0 0.02160404995083809
expansion O 0 0.0023909620940685272
in O 0 0.00017906876746565104
the O 0 0.0007493460434488952
FRDA B-Disease 1 0.9992425441741943
gene O 0 0.007220762316137552
. O 0 0.0006304503767751157

Friedreich B-Disease 1 0.9999575614929199
ataxia I-Disease 1 0.9999914169311523
is O 0 0.004902231972664595
usually O 0 0.001249535009264946
caused O 0 0.007559573277831078
by O 0 3.8504800613736734e-05
an O 0 0.00013330379442777485
expansion O 0 0.0009069925872609019
of O 0 2.244433926534839e-05
a O 0 0.0026411465369164944
GAA O 1 0.8338940143585205
trinucleotide O 1 0.9713714122772217
repeat O 0 0.015336251817643642
in O 0 0.0004165232239756733
intron O 0 0.3036838173866272
1 O 0 0.0006793563952669501
of O 0 1.7363805454806425e-05
the O 0 0.000771178980357945
FRDA B-Disease 1 0.9996312856674194
gene O 0 0.007099623791873455
. O 0 0.000624054460786283

Occasionally O 0 0.013413064181804657
, O 0 0.0003753049240913242
a O 0 0.000747544749174267
fully O 0 0.007576745934784412
expanded O 0 0.0022158795036375523
allele O 0 0.007692850660532713
has O 0 0.0011840102961286902
been O 0 0.0005876062787137926
found O 0 0.00034755427623167634
to O 0 0.00012363957648631185
arise O 0 0.00410074507817626
from O 0 0.00011386258847778663
a O 0 0.0010971241863444448
premutation O 0 0.09685914218425751
of O 0 2.8324120648903772e-05
100 O 0 0.000540460052434355
or O 0 0.00033745879773050547
less O 0 0.0012490965891629457
triplet O 1 0.8976019620895386
repeats O 0 0.02814129926264286
. O 0 0.0009705597185529768

We O 0 0.0011513425270095468
have O 0 0.00019905573572032154
examined O 0 0.008483746089041233
the O 0 9.671026782598346e-05
sperm O 0 0.0005222781328484416
DNA O 0 0.0003328986931592226
of O 0 1.2027024240524042e-05
a O 0 0.002153152832761407
premutation O 1 0.9947044253349304
carrier O 0 0.21961750090122223
. O 0 0.0010958632919937372

This O 0 0.00039090841892175376
mans O 0 0.029923953115940094
leucocyte O 1 0.5528923273086548
DNA O 0 0.0032522082328796387
showed O 0 0.001499922014772892
one O 0 0.00024735197075642645
normal O 0 0.004937383346259594
allele O 0 0.007106736768037081
and O 0 0.00019397240248508751
one O 0 0.0001730725052766502
allele O 0 0.0016596191562712193
of O 0 2.154777575924527e-05
approximately O 0 0.0006696726777590811
100 O 0 0.001086142030544579
repeats O 0 0.014306597411632538
. O 0 0.0006181304925121367

His O 0 0.0027318501379340887
sperm O 0 0.0016106647672131658
showed O 0 0.0010975500335916877
an O 0 0.00019305627210997045
expanded O 0 0.0023799093905836344
allele O 0 0.005412210710346699
in O 0 0.00024460055283270776
a O 0 0.0008940076804719865
tight O 0 0.0050970870070159435
range O 0 0.0017702652839943767
centering O 0 0.010369781404733658
on O 0 0.00020452232274692506
a O 0 0.00021958710567560047
size O 0 0.00013094523455947638
of O 0 2.0160623535048217e-05
approximately O 0 0.0018585409270599484
320 O 0 0.08584674447774887
trinucleotide O 1 0.9880207180976868
repeats O 0 0.018251055851578712
. O 0 0.0006477775168605149

His O 0 0.007315513677895069
affected O 0 0.05824529379606247
son O 0 0.03287266939878464
has O 0 0.0011601997539401054
repeat O 0 0.007955459877848625
sizes O 0 0.00037658351357094944
of O 0 0.00010855683649424464
1040 O 1 0.9950383305549622
and O 0 0.0009678698843345046
540 O 0 0.11055224388837814
. O 0 0.0008834287873469293

These O 0 8.610642544226721e-05
data O 0 0.00016934856830630451
suggest O 0 0.0007713046506978571
that O 0 7.37190421205014e-05
expansion O 0 0.0032040346413850784
occurs O 0 0.0013302091974765062
in O 0 0.00016564660472795367
two O 0 0.00010124225809704512
stages O 0 0.006902504246681929
, O 0 0.00017759772890713066
the O 0 0.00012559474271256477
first O 0 0.0003334348148200661
during O 0 0.002158976625651121
meiosis O 0 0.026016615331172943
followed O 0 0.0003893994726240635
by O 0 2.8121778086642735e-05
a O 0 0.0004122964746784419
second O 0 0.0006207020487636328
mitotic O 0 0.02577061951160431
expansion O 0 0.005542336963117123
. O 0 0.000665197498165071

We O 0 0.0015684328973293304
also O 0 0.00041268637869507074
show O 0 0.0004243523289915174
that O 0 3.991020275861956e-05
in O 0 6.334078352665529e-05
all O 0 4.191269908915274e-05
informative O 0 0.017408814281225204
carrier O 0 0.29969924688339233
father O 0 0.005066371522843838
to O 0 0.00033676845487207174
affected O 0 0.021212266758084297
child O 0 0.022730452939867973
transmissions O 0 0.015049214474856853
, O 0 0.0002993339439854026
with O 0 9.900571603793651e-05
the O 0 0.00031705445144325495
notable O 0 0.0007300185970962048
exception O 0 0.0014762944774702191
of O 0 2.6104613425559364e-05
the O 0 0.0009108775993809104
premutation O 1 0.9946072697639465
carrier O 0 0.0808974876999855
, O 0 0.0002428627631161362
the O 0 0.00011403839744161814
expansion O 0 0.0018196945311501622
size O 0 0.0006669621798209846
decreases O 0 0.008077526465058327
. O 0 0.0002604483161121607
. O 0 0.00046319153625518084

The O 0 0.0010791831882670522
R496H O 0 0.0495574064552784
mutation O 0 0.001300504431128502
of O 0 4.291878212825395e-05
arylsulfatase O 1 0.9940863847732544
A O 0 0.004968800116330385
does O 0 0.000998708768747747
not O 0 0.0002843376132659614
cause O 1 0.9939690828323364
metachromatic B-Disease 1 0.9999957084655762
leukodystrophy I-Disease 1 0.9999996423721313
. O 0 0.001909220707602799

Deficiency B-Disease 1 0.9999985694885254
of I-Disease 0 0.00019811847596429288
arylsulfatase I-Disease 1 0.9944942593574524
A I-Disease 0 0.012544064782559872
( O 0 0.0032718763686716557
ARSA O 1 0.9998264908790588
) O 0 0.0004447621467988938
enzyme O 0 0.0023530651815235615
activity O 0 0.001788545399904251
causes O 1 0.9964601397514343
metachromatic B-Disease 1 0.9999939203262329
leukodystrophy I-Disease 1 0.9999998807907104
( O 0 0.0226118303835392
MLD B-Disease 1 0.9999984502792358
) O 0 0.0016927053220570087
. O 0 0.0006080072489567101

A O 0 0.001992535311728716
number O 0 3.0313738534459844e-05
of O 0 0.00010281229333486408
ARSA O 1 0.9999676942825317
gene O 0 0.006328823044896126
mutations O 0 0.0022624603006988764
responsible O 0 0.006933395750820637
for O 0 0.0027379340026527643
MLD B-Disease 1 0.9999994039535522
have O 0 0.00039211747935041785
been O 0 0.0006403193692676723
identified O 0 0.0018781895050778985
. O 0 0.00029971374897286296

Recently O 0 0.02499830722808838
, O 0 0.00022353226086124778
the O 0 0.0002759691560640931
R496H O 0 0.055193886160850525
mutation O 0 0.001933532184921205
of O 0 0.0001831490226322785
ARSA O 1 0.9999527931213379
was O 0 0.005103691015392542
proposed O 0 0.0009309943998232484
to O 0 5.936775414738804e-05
be O 0 4.152179462835193e-05
a O 0 0.0003584581718314439
cause O 0 0.006365922745317221
of O 0 0.00024268454581033438
MLD B-Disease 1 0.9999992847442627
( O 0 0.006166399456560612
Draghia O 1 0.9977495074272156
et O 0 0.1344945728778839
al O 0 0.03715275600552559
. O 0 0.0003040808078367263
, O 0 0.0006330481264740229
1997 O 0 0.02140052244067192
) O 0 0.0005369348800741136
. O 0 0.000502458366099745

We O 0 0.0009674968896433711
have O 0 0.00018521920719649643
investigated O 0 0.008061617612838745
the O 0 0.0003158603503834456
R496H O 0 0.0975085198879242
mutation O 0 0.003228291403502226
and O 0 0.00017674175614956766
found O 0 0.00025607453426346183
this O 0 6.626633694395423e-05
mutation O 0 0.002422889694571495
at O 0 0.0007178816013038158
a O 0 0.0006338740349747241
relatively O 0 0.001943149953149259
high O 0 0.0024291120935231447
frequency O 0 0.00034689658787101507
in O 0 0.00020256140851415694
an O 0 0.0004247426404617727
African O 0 0.0026889608707278967
American O 0 0.0011166156036779284
population O 0 0.0002596330887172371
( O 0 0.0015859182458370924
f O 0 0.021648509427905083
= O 0 0.009386678226292133
0 O 0 0.0024323537945747375
. O 0 0.00035777027369476855
09 O 0 0.33595937490463257
, O 0 0.0006179069168865681
n O 0 0.009321979247033596
= O 0 0.012009777128696442
61 O 0 0.01618438959121704
subjects O 0 0.007458535488694906
) O 0 0.0006691740709356964
. O 0 0.0005001415265724063

The O 0 0.0024253432638943195
ARSA O 1 0.9989456534385681
enzyme O 0 0.007782163564115763
activity O 0 0.0009590814006514847
in O 0 0.0003148639516439289
subjects O 0 0.002971354406327009
with O 0 0.00011494346836116165
and O 0 0.00018701564113143831
without O 0 0.00029732706025242805
the O 0 0.0003205514803994447
R496H O 0 0.1323375403881073
mutation O 0 0.004908348433673382
was O 0 0.0019294396042823792
determined O 0 0.003129087621346116
and O 0 0.00016538146883249283
found O 0 0.00027017889078706503
to O 0 6.254696927499026e-05
be O 0 0.00012199622869957238
normal O 0 0.003195695811882615
. O 0 0.00046542909694835544

It O 0 0.0008599758148193359
is O 0 0.00039442424895241857
therefore O 0 0.0008022644324228168
concluded O 0 0.009721880778670311
that O 0 4.238594920025207e-05
the O 0 0.00022246195294428617
R496H O 0 0.0489354133605957
mutation O 0 0.002147655002772808
of O 0 0.00020667118951678276
ARSA O 1 0.9999643564224243
does O 0 0.0034797480329871178
not O 0 0.00020485017739702016
negatively O 0 0.0032725997734814882
influence O 0 0.00014153616211842746
the O 0 0.00010911884601227939
activity O 0 0.0005228561349213123
of O 0 0.0001785117929102853
ARSA O 1 0.999982476234436
and O 0 0.0004978895885869861
is O 0 0.0003462044114712626
not O 0 8.446640276815742e-05
a O 0 0.00044162722770124674
cause O 0 0.010708170011639595
of O 0 0.00036103063030168414
MLD B-Disease 1 0.9999982118606567

Down O 0 0.01813715510070324
- O 0 0.00288247293792665
regulation O 0 0.00023105900618247688
of O 0 1.6994739780784585e-05
transmembrane O 0 0.04371858388185501
carbonic O 1 0.9983776807785034
anhydrases O 1 0.9975941777229309
in O 0 0.004213202744722366
renal B-Disease 1 1.0
cell I-Disease 1 0.9999161958694458
carcinoma I-Disease 1 1.0
cell O 0 0.009766723960638046
lines O 0 0.0007248892798088491
by O 0 5.2886120101902634e-05
wild O 0 0.0012374063953757286
- O 0 0.015483652241528034
type O 0 0.021814880892634392
von B-Disease 1 0.995644211769104
Hippel I-Disease 1 0.9999638795852661
- I-Disease 1 0.9488375186920166
Lindau I-Disease 1 0.9996188879013062
transgenes O 1 0.7149724364280701
. O 0 0.0009696493507362902

To O 0 0.0008240246097557247
discover O 0 0.005684934090822935
genes O 0 0.00030274270102381706
involved O 0 0.0007916238973848522
in O 0 0.0004735046240966767
von B-Disease 1 0.9878435134887695
Hippel I-Disease 1 0.9999550580978394
- I-Disease 1 0.9216527938842773
Lindau I-Disease 1 0.9999394416809082
( O 0 0.005275354720652103
VHL B-Disease 1 0.9999738931655884
) O 0 0.0018255806062370539
- O 0 0.02150397188961506
mediated O 0 0.15068331360816956
carcinogenesis O 1 0.9999011754989624
, O 0 0.000221287424210459
we O 0 0.00022368789359461516
used O 0 0.0035258850548416376
renal B-Disease 1 1.0
cell I-Disease 1 0.9997586607933044
carcinoma I-Disease 1 1.0
cell O 0 0.014304103329777718
lines O 0 0.0023087668232619762
stably O 0 0.06880777329206467
transfected O 0 0.06214240938425064
with O 0 0.0001237638934981078
wild O 0 0.0013587200082838535
- O 0 0.028659038245677948
type O 1 0.6710519790649414
VHL O 1 0.9999884366989136
- O 0 0.03474349528551102
expressing O 0 0.011086715385317802
transgenes O 1 0.6187512278556824
. O 0 0.0008372024167329073

Large O 0 0.0012700591469183564
- O 0 0.0038232537917792797
scale O 0 0.0010225021978840232
RNA O 0 0.002440202049911022
differential O 0 0.007442424073815346
display O 0 0.001654793624766171
technology O 0 0.007728269323706627
applied O 0 0.0018972974503412843
to O 0 9.805095760384575e-05
these O 0 5.67104943911545e-05
cell O 0 0.0063706208020448685
lines O 0 0.0019507589749991894
identified O 0 0.0011340663768351078
several O 0 9.214076271746308e-05
differentially O 0 0.024362055584788322
expressed O 0 0.0006820415728725493
genes O 0 0.00028101413045078516
, O 0 7.924150122562423e-05
including O 0 3.230809670640156e-05
an O 0 0.00018937619461212307
alpha O 0 0.007842972874641418
carbonic O 1 0.9687029123306274
anhydrase O 1 0.9949153661727905
gene O 0 0.004661133978515863
, O 0 0.0005551409558393061
termed O 1 0.7919918894767761
CA12 O 1 0.9989983439445496
. O 0 0.001020982745103538

The O 0 0.0003689998993650079
deduced O 0 0.001922884490340948
protein O 0 0.0003906366473529488
sequence O 0 0.00013216253137215972
was O 0 0.0015390467597171664
classified O 0 0.00915679894387722
as O 0 0.0001592750777490437
a O 0 0.00042477482929825783
one O 0 0.0003907001519110054
- O 0 0.006953161675482988
pass O 0 0.0022105996031314135
transmembrane O 0 0.052794117480516434
CA O 1 0.7241547107696533
possessing O 0 0.003089374862611294
an O 0 0.0005302353529259562
apparently O 0 0.0066681187599897385
intact O 0 0.009017313830554485
catalytic O 0 0.005603331606835127
domain O 0 0.000591553864069283
in O 0 0.00012742144463118166
the O 0 0.00029112905031070113
extracellular O 0 0.02872673235833645
CA O 1 0.96720951795578
module O 0 0.032829686999320984
. O 0 0.0007009225082583725

Reintroduced O 0 0.04060930758714676
wild O 0 0.00275365705601871
- O 0 0.029002055525779724
type O 0 0.04909014701843262
VHL B-Disease 1 0.999914288520813
strongly O 0 0.008609387092292309
inhibited O 0 0.02740688994526863
the O 0 0.0002928896283265203
overexpression O 0 0.00839313492178917
of O 0 2.2688745957566425e-05
the O 0 0.00081506377318874
CA12 O 1 0.9998319149017334
gene O 0 0.0017612333176657557
in O 0 6.412583024939522e-05
the O 0 0.00039728565025143325
parental O 1 0.9987146854400635
renal B-Disease 1 1.0
cell I-Disease 1 0.9999655485153198
carcinoma I-Disease 1 1.0
cell O 0 0.030836328864097595
lines O 0 0.002404040889814496
. O 0 0.000535609491635114

Similar O 0 0.0014751659473404288
results O 0 0.0007887704996392131
were O 0 3.835919051198289e-05
obtained O 0 0.0004681591526605189
with O 0 0.0006781597039662302
CA9 O 1 0.9999847412109375
, O 0 0.0003281606768723577
encoding O 0 0.0006629017298109829
another O 0 0.0013144039548933506
transmembrane O 0 0.05717546120285988
CA O 0 0.25506922602653503
with O 0 4.2636973375920206e-05
an O 0 0.00022926241217646748
intact O 0 0.012247064150869846
catalytic O 0 0.01154341734945774
domain O 0 0.002040846971794963
. O 0 0.0006996744778007269

Although O 0 0.0014258490409702063
both O 0 0.0001076413900591433
domains O 0 0.0007484336383640766
of O 0 2.8355041649774648e-05
the O 0 0.001186845707707107
VHL B-Disease 1 0.9998922348022461
protein O 0 0.001496921177022159
contribute O 0 0.0036007806193083525
to O 0 6.179398769745603e-05
regulation O 0 0.0006052441895008087
of O 0 9.52953560044989e-05
CA12 O 1 0.999594509601593
expression O 0 0.002084073144942522
, O 0 0.00030232302378863096
the O 0 0.00046758606913499534
elongin O 0 0.44584986567497253
binding O 0 0.0008091736235655844
domain O 0 0.0010808500228449702
alone O 0 0.0020904098637402058
could O 0 0.0002987882762681693
effectively O 0 0.005135904066264629
regulate O 0 0.031885839998722076
CA9 O 1 0.9998784065246582
expression O 0 0.0046456484124064445
. O 0 0.001077263499610126

We O 0 0.0017566701862961054
mapped O 0 0.0191455390304327
CA12 O 1 0.9958773851394653
and O 0 0.0023286505602300167
CA9 O 1 0.999954342842102
loci O 0 0.017077824100852013
to O 0 0.00015471350343432277
chromosome O 0 0.002198427449911833
bands O 0 0.001539845485240221
15q22 O 0 0.07807692885398865
and O 0 0.0005844148108735681
17q21 O 0 0.14497706294059753
. O 0 0.0007472767028957605

2 O 0 0.004641079343855381
respectively O 0 0.0015280413208529353
, O 0 0.00038431663415394723
regions O 0 0.0019089654088020325
prone O 0 0.16658392548561096
to O 0 0.00011198373249499127
amplification O 0 0.002635692246258259
in O 0 8.42183580971323e-05
some O 0 9.559441241435707e-05
human O 0 0.015187222510576248
cancers B-Disease 1 0.9999977350234985
. O 0 0.0010962329106405377

Additional O 0 0.0014473266201093793
experiments O 0 0.001518041011877358
are O 0 3.4391585359117016e-05
needed O 0 0.0013937923358753324
to O 0 6.181743810884655e-05
define O 0 0.0012375826481729746
the O 0 0.00012261435040272772
role O 0 0.0026220506988465786
of O 0 0.00022856004943605512
CA O 1 0.9992669224739075
IX O 1 0.9999122619628906
and O 0 0.00206894357688725
CA O 1 0.9986300468444824
XII O 1 0.9996979236602783
enzymes O 0 0.0007593641057610512
in O 0 0.00010435940203024074
the O 0 0.00011641626770142466
regulation O 0 0.0006045692716725171
of O 0 5.912374399485998e-05
pH O 1 0.6781364679336548
in O 0 0.0002115678071277216
the O 0 0.0002557866391725838
extracellular O 0 0.014102960005402565
microenvironment O 1 0.909281849861145
and O 0 0.00013835127174388617
its O 0 0.0001445130619686097
potential O 0 0.0014778050826862454
impact O 0 0.004286766517907381
on O 0 0.0033792532049119473
cancer B-Disease 1 1.0
cell O 0 0.007325944025069475
growth O 0 0.002070278860628605
. O 0 0.0004374753625597805

A O 0 0.004993264097720385
gene O 0 0.0009435445535928011
encoding O 0 0.0001984860427910462
a O 0 0.00022993578750174493
transmembrane O 0 0.005200131330639124
protein O 0 0.0009777807863429189
is O 0 0.0004300748696550727
mutated O 0 0.00908482726663351
in O 0 0.0007036890601739287
patients O 1 0.9999997615814209
with O 0 0.00591037655249238
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 0.03470318391919136
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 0 0.19090767204761505
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 0.0017314562574028969
. O 0 0.0006925209308974445

Wolfram B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
( O 0 0.03163759410381317
WFS B-Disease 1 0.9999992847442627
; O 0 0.0067850323393940926
OMIM O 1 0.9999864101409912
222300 O 1 0.9938130378723145
) O 0 0.0003540155594237149
is O 0 0.00021811599435750395
an O 0 0.0008997078402899206
autosomal B-Disease 1 0.9999938011169434
recessive I-Disease 1 0.9999997615814209
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 0.0044198911637067795
by O 0 0.000293192220851779
young O 0 0.030729027464985847
- O 0 0.10199256241321564
onset O 1 0.9998657703399658
non O 0 0.014715720899403095
- O 0 0.16150765120983124
immune O 1 0.9999203681945801
insulin B-Disease 1 0.998611330986023
- I-Disease 1 0.6571773290634155
dependent I-Disease 1 0.9545459747314453
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 0.0028192191384732723
progressive O 1 0.9999827146530151
optic B-Disease 1 1.0
atrophy I-Disease 1 0.9999991655349731
. O 0 0.0015754812629893422

Linkage O 0 0.04710259661078453
to O 0 0.0002175687113776803
markers O 0 0.00502020213752985
on O 0 0.0005748426192440093
chromosome O 0 0.014542212709784508
4p O 1 0.9992855191230774
was O 0 0.00613241083920002
confirmed O 0 0.004408218432217836
in O 0 0.00012259425420779735
five O 0 0.00016374206461478025
families O 0 0.00044438333134166896
. O 0 0.0006417811964638531

On O 0 0.0004632524505723268
the O 0 6.451673107221723e-05
basis O 0 4.3130203266628087e-05
of O 0 3.636409746832214e-05
meiotic O 1 0.9989041090011597
recombinants O 1 0.999394416809082
and O 0 0.006055331788957119
disease O 1 1.0
- O 0 0.1525058150291443
associated O 0 0.0014188089407980442
haplotypes O 0 0.015578154474496841
, O 0 0.00029379804618656635
the O 0 0.0012352619087323546
WFS B-Disease 1 0.9999908208847046
gene O 0 0.004732693545520306
was O 0 0.000984728685580194
localized O 0 0.006122090853750706
to O 0 0.00015956921561155468
a O 0 0.005037040449678898
BAC O 1 0.9999126195907593
/ O 1 0.9737204909324646
P1 O 1 0.9959338307380676
contig O 0 0.059238336980342865
of O 0 1.598139715497382e-05
less O 0 0.00031042666523717344
than O 0 0.0001841069315560162
250 O 0 0.0037733460776507854
kb O 0 0.04569778963923454
. O 0 0.0008044744608923793

Mutations O 0 0.005398895125836134
in O 0 0.0001371925900457427
a O 0 0.0007373080006800592
novel O 0 0.004548429977148771
gene O 0 0.009798643179237843
( O 0 0.0027832796331495047
WFS1 O 1 0.998173713684082
) O 0 0.00021336915961001068
encoding O 0 0.00035801215562969446
a O 0 0.0005706824595108628
putative O 0 0.013951976783573627
transmembrane O 0 0.00958415400236845
protein O 0 0.0010139347286894917
were O 0 5.586818588199094e-05
found O 0 0.00028197921346873045
in O 0 9.274929470848292e-05
all O 0 6.085864151827991e-05
affected O 0 0.005535973235964775
individuals O 0 0.0003158410545438528
in O 0 0.0005343351513147354
six O 0 0.0050565931014716625
WFS B-Disease 1 0.9999949932098389
families O 0 0.0023992564529180527
, O 0 0.00039295401074923575
and O 0 0.00014762123464606702
these O 0 5.299829717841931e-05
mutations O 0 0.0020476740319281816
were O 0 4.7556131903547794e-05
associated O 0 0.00035154380020685494
with O 0 0.0001346194912912324
the O 0 0.00360410800203681
disease O 1 1.0
phenotype O 1 0.9917402267456055
. O 0 0.0011109302286058664

WFS1 O 1 0.9984267950057983
appears O 0 0.008958574384450912
to O 0 7.025916420388967e-05
function O 0 0.0006100539467297494
in O 0 0.00021517886489164084
survival O 0 0.030649837106466293
of O 0 5.63489411433693e-05
islet O 0 0.13690811395645142
beta O 0 0.04063625633716583
- O 0 0.011095460504293442
cells O 0 0.0025731970090419054
and O 0 0.00026754988357424736
neurons O 0 0.03547075018286705
. O 0 0.0002260081673739478
. O 0 0.0004757030983455479

Stable O 0 0.047003038227558136
interaction O 0 0.0007623683195561171
between O 0 0.00019321427680552006
the O 0 0.00016921813949011266
products O 0 0.0008696921868249774
of O 0 2.4138518710969947e-05
the O 0 0.0012495052069425583
BRCA1 O 1 0.9999836683273315
and O 0 0.003262168727815151
BRCA2 O 1 0.999996542930603
tumor B-Disease 1 0.9999842643737793
suppressor O 0 0.022296389564871788
genes O 0 0.00020027224672958255
in O 0 0.0001515499025117606
mitotic O 0 0.027311628684401512
and O 0 0.0005456829676404595
meiotic O 1 0.9962282180786133
cells O 0 0.011958089657127857
. O 0 0.00050619977992028

BRCA1 O 1 0.9998719692230225
and O 0 0.003252004273235798
BRCA2 O 1 0.9994577765464783
account O 0 0.0003942845796700567
for O 0 0.0001810420653782785
most O 0 0.00021077350538689643
cases O 0 0.0007973298779688776
of O 0 4.394960342324339e-05
familial O 1 0.9999511241912842
, O 0 0.0006026849150657654
early O 0 0.0045127589255571365
onset O 1 0.9999997615814209
breast B-Disease 1 1.0
and I-Disease 0 0.004955710843205452
/ I-Disease 1 0.9999701976776123
or I-Disease 1 0.9837716221809387
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.00029169104527682066
encode O 0 0.000634406809695065
products O 0 0.0014590166974812746
that O 0 3.2004754757508636e-05
each O 0 2.367516754020471e-05
interact O 0 0.0015895238611847162
with O 0 0.00020833629241678864
hRAD51 O 1 0.9183756113052368
. O 0 0.0009321500547230244

Results O 0 0.00329995877109468
presented O 0 0.0011180104920640588
here O 0 0.00020705524366348982
show O 0 0.0005933204083703458
that O 0 0.0005613685352727771
BRCA1 O 1 0.9999016523361206
and O 0 0.0019683600403368473
BRCA2 O 1 0.9997790455818176
coexist O 0 0.006501548923552036
in O 0 0.00014706404181197286
a O 0 0.0007681677816435695
biochemical O 0 0.01798032969236374
complex O 0 0.007629006635397673
and O 0 0.0007193231722339988
colocalize O 1 0.9782145023345947
in O 0 0.0007606767467223108
subnuclear O 1 0.9728164672851562
foci O 0 0.06000097095966339
in O 0 0.0004745002370327711
somatic O 0 0.03633283078670502
cells O 0 0.004477709997445345
and O 0 0.00011030887981178239
on O 0 0.00017260397726204246
the O 0 0.00017095069051720202
axial O 0 0.010070130228996277
elements O 0 9.806143498281017e-05
of O 0 4.0220722439698875e-05
developing O 0 0.03376635164022446
synaptonemal O 1 0.9906266927719116
complexes O 0 0.0351393036544323
. O 0 0.0006937115103937685

Like O 0 0.006777607370167971
BRCA1 O 1 0.9998255372047424
and O 0 0.0020306692458689213
RAD51 O 1 0.9999735355377197
, O 0 0.004221288487315178
BRCA2 O 1 0.9994783997535706
relocates O 0 0.11397631466388702
to O 0 0.0011077241506427526
PCNA O 1 0.9997796416282654
+ O 0 0.046805497258901596
replication O 0 0.0027351074386388063
sites O 0 0.00045336782932281494
following O 0 0.0005814628093503416
exposure O 0 0.047847528010606766
of O 0 0.00011012914910679683
S O 1 0.9932259917259216
phase O 0 0.013943000696599483
cells O 0 0.0018567681545391679
to O 0 0.0001925762480823323
hydroxyurea O 1 0.9994550347328186
or O 0 0.001913542510010302
UV O 1 0.9998279809951782
irradiation O 0 0.0867929607629776
. O 0 0.0007518438505940139

Thus O 0 0.0024322476238012314
, O 0 0.0015457599656656384
BRCA1 O 1 0.9999688863754272
and O 0 0.00227230042219162
BRCA2 O 1 0.9998726844787598
participate O 0 0.002258400432765484
, O 0 0.00019468706159386784
together O 0 8.081004489213228e-05
, O 0 0.00015077315038070083
in O 0 0.000129641848616302
a O 0 0.0014112715143710375
pathway O 0 0.06649403274059296
( O 0 0.003803581465035677
s O 1 0.6263721585273743
) O 0 0.0006299563683569431
associated O 0 0.0004720739379990846
with O 0 3.24157444993034e-05
the O 0 9.275336924474686e-05
activation O 0 0.0015094815753400326
of O 0 2.681225487322081e-05
double O 0 0.005246568005532026
- O 0 0.009800044819712639
strand O 0 0.009515471756458282
break O 0 0.006656326819211245
repair O 1 0.9998750686645508
and O 0 0.0020460160449147224
/ O 1 0.5276978611946106
or O 0 0.0006857158150523901
homologous O 0 0.009371579624712467
recombination O 0 0.006683379411697388
. O 0 0.0007528644055128098

Dysfunction O 1 0.9999011754989624
of O 0 5.561601210501976e-05
this O 0 0.00022652570623904467
pathway O 0 0.0166983213275671
may O 0 0.0011391020379960537
be O 0 7.687622564844787e-05
a O 0 0.00046015408588573337
general O 0 0.0019499646732583642
phenomenon O 0 0.004528665915131569
in O 0 0.00014364602975547314
the O 0 0.00011066244769608602
majority O 0 0.00010560585360508412
of O 0 1.671322934271302e-05
cases O 0 0.00108677230309695
of O 0 0.00012413998774718493
hereditary B-Disease 1 0.9999982118606567
breast I-Disease 1 1.0
and I-Disease 0 0.00483217928558588
/ I-Disease 1 0.9999678134918213
or I-Disease 1 0.9963858127593994
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0005469456664286554
. O 0 0.0004330060910433531

A O 0 0.011948571540415287
novel O 0 0.006993088871240616
Arg362Ser O 1 0.8800605535507202
mutation O 0 0.0016349232755601406
in O 0 7.474458834622055e-05
the O 0 0.0002652543189469725
sterol O 1 0.8646799921989441
27 O 0 0.010728956200182438
- O 0 0.017461257055401802
hydroxylase O 1 0.8449771404266357
gene O 0 0.008000016212463379
( O 0 0.0024055358953773975
CYP27 O 1 0.9995891451835632
) O 0 0.0008054355857893825
: O 0 0.0002003344998229295
its O 0 0.00019048650574404746
effects O 0 0.004810681566596031
on O 0 0.0003440312575548887
pre O 0 0.00791086908429861
- O 0 0.0013833583798259497
mRNA O 0 0.0001992116158362478
splicing O 0 0.0006897752173244953
and O 0 0.00011341904610162601
enzyme O 0 0.002737860893830657
activity O 0 0.0013104529352858663
. O 0 0.0005850264569744468

A O 0 0.014041732996702194
novel O 0 0.009143760427832603
C O 0 0.10299404710531235
to O 0 0.00012534420238807797
A O 0 0.0027320096269249916
mutation O 0 0.0010362574830651283
in O 0 8.59276915434748e-05
the O 0 0.00034505705116316676
sterol O 1 0.919593870639801
27 O 0 0.012972133234143257
- O 0 0.019333025440573692
hydroxylase O 1 0.9036056995391846
gene O 0 0.007281318306922913
( O 0 0.0023337500169873238
CYP27 O 1 0.9994334578514099
) O 0 0.000953355454839766
was O 0 0.0016418274026364088
identified O 0 0.0004506827681325376
by O 0 1.607420745131094e-05
sequencing O 0 0.0007920725620351732
amplified O 0 0.008809276856482029
CYP27 O 1 0.9964242577552795
gene O 0 0.0031050443649291992
products O 0 0.0008965215529315174
from O 0 8.415245247306302e-05
a O 0 0.001485716551542282
patient O 1 0.9998787641525269
with O 0 0.0005464571295306087
cerebrotendinous B-Disease 1 0.9999852180480957
xanthomatosis I-Disease 1 0.9999195337295532
( O 0 0.010408048518002033
CTX B-Disease 1 0.9999970197677612
) O 0 0.0018528115469962358
. O 0 0.000587755290325731

The O 0 0.001170588075183332
mutation O 0 0.00484301894903183
changed O 0 0.002209979109466076
the O 0 0.00038283911999315023
adrenodoxin O 1 0.6152986884117126
cofactor O 0 0.055674079805612564
binding O 0 0.002099781995639205
residue O 0 0.032073505222797394
362Arg O 0 0.11495350301265717
to O 0 0.0005495600635185838
362Ser O 1 0.711297333240509
( O 0 0.0019911618437618017
CGT O 1 0.9911545515060425
362Arg O 1 0.6693892478942871
to O 0 0.0019291717326268554
AGT O 1 0.9999979734420776
362Ser O 1 0.9863303899765015
) O 0 0.000635025673545897
, O 0 0.00016787333879619837
and O 0 0.0001209188048960641
was O 0 0.001597119146026671
responsible O 0 0.007425633724778891
for O 0 0.0018064109608530998
deficiency O 1 0.9999997615814209
in O 0 0.0002577354898676276
the O 0 0.00045328549458645284
sterol O 1 0.9651353359222412
27 O 0 0.014408957213163376
- O 0 0.01841091737151146
hydroxylase O 0 0.35777565836906433
activity O 0 0.0010745213367044926
, O 0 0.00035273205139674246
as O 0 0.0005836460622958839
confirmed O 0 0.002394330920651555
by O 0 1.7811373254517093e-05
expression O 0 0.0001738639548420906
of O 0 1.9347682609804906e-05
mutant O 0 0.003819675650447607
cDNA O 0 0.0032306076027452946
into O 0 0.0007417931919917464
COS O 1 0.9981263279914856
- O 0 0.012934763915836811
1 O 0 0.0023341921623796225
cells O 0 0.004618581850081682
. O 0 0.00039196707075461745

Quantitative O 0 0.008278598077595234
analysis O 0 0.0009000374702736735
showed O 0 0.0015933348331600428
that O 0 3.816187381744385e-05
the O 0 6.790286715840921e-05
expression O 0 0.0004616707155946642
of O 0 8.95794146344997e-05
CYP27 O 1 0.9982837438583374
gene O 0 0.0011534633813425899
mRNA O 0 0.0002536468382459134
in O 0 0.00011246100621065125
the O 0 0.0005098787369206548
patient O 1 0.9982213377952576
represented O 0 0.0013202117988839746
52 O 0 0.012106828391551971
. O 0 0.0007700279238633811

5 O 0 0.001802818151190877
% O 0 2.611733907542657e-05
of O 0 9.745916941028554e-06
the O 0 0.0003090205427724868
normal O 0 0.006894905585795641
level O 0 0.0072333491407334805
. O 0 0.0006765361758880317

As O 0 0.0008178735733963549
the O 0 0.0004368008812889457
mutation O 0 0.005227440968155861
occurred O 0 0.003022710792720318
at O 0 0.0005798236234113574
the O 0 0.00021651637507602572
penultimate O 0 0.02357116900384426
nucleotide O 0 0.00016730348579585552
of O 0 3.651219594758004e-05
exon O 0 0.06182750687003136
6 O 0 0.008829683996737003
( O 0 0.0017737147863954306
- O 0 0.006132279522716999
2 O 0 0.000564343819860369
position O 0 0.0005214560660533607
of O 0 3.394136729184538e-05
exon O 0 0.071548230946064
6 O 0 0.00576905207708478
- O 0 0.012624652124941349
intron O 1 0.8235620856285095
6 O 0 0.00535464147105813
splice O 0 0.037968169897794724
site O 0 0.004352245479822159
) O 0 8.866412827046588e-05
of O 0 1.3470442354446277e-05
the O 0 0.0004781890020240098
gene O 0 0.005632777698338032
, O 0 0.00030392466578632593
we O 0 0.0002883742854464799
hypothesized O 0 0.009568220935761929
that O 0 4.575617640512064e-05
the O 0 0.00024246297834906727
mutation O 0 0.007718317676335573
may O 0 0.003501604311168194
partially O 0 0.024761319160461426
affect O 0 0.001618861802853644
the O 0 0.00010541248047957197
normal O 0 0.001575130270794034
splicing O 0 0.001207831664942205
efficiency O 0 0.00316800968721509
in O 0 0.0004597671504598111
exon O 0 0.050783317536115646
6 O 0 0.0034437726717442274
and O 0 0.00030941469594836235
cause O 0 0.011111629195511341
alternative O 0 0.0017921149265021086
splicing O 0 0.005087091121822596
elsewhere O 0 0.002212970284745097
, O 0 0.0002329814014956355
which O 0 6.155021401355043e-05
resulted O 0 0.0015780134126543999
in O 0 0.0003811036585830152
decreased O 0 0.04072947055101395
transcript O 0 0.008627424016594887
in O 0 0.00016918232722673565
the O 0 0.0009037730633281171
patient O 1 0.9999699592590332
. O 0 0.0009276624768972397

Transfection O 0 0.2912936508655548
of O 0 0.00014426840061787516
constructed O 0 0.017589636147022247
minigenes O 1 0.993416428565979
, O 0 0.0003580623015295714
with O 0 9.962754847947508e-05
or O 0 0.0004280525608919561
without O 0 0.0002228483062935993
the O 0 0.00019159619114361703
mutation O 0 0.0025835223495960236
, O 0 0.0002848466392606497
into O 0 0.0011225048219785094
COS O 1 0.9993566870689392
- O 0 0.014941835775971413
1 O 0 0.0021306287962943316
cells O 0 0.0038083456456661224
confirmed O 0 0.0018743834225460887
that O 0 3.3544863981660455e-05
the O 0 0.00022114442253950983
mutant O 0 0.01878359541296959
minigene O 1 0.9276391863822937
was O 0 0.003105565207079053
responsible O 0 0.0030188877135515213
for O 0 0.00012336763029452413
a O 0 0.00030774512561038136
mRNA O 0 0.0006059628212824464
species O 0 0.00016765481268521398
alternatively O 0 0.0037535587325692177
spliced O 0 0.0035105037968605757
at O 0 0.0005740594351664186
an O 0 0.00065060198539868
activated O 1 0.5939815640449524
cryptic O 0 0.05482072755694389
5 O 0 0.0018392289057374
splice O 0 0.029422705993056297
site O 0 0.0061650057323277
88 O 0 0.013326652348041534
bp O 0 0.08425949513912201
upstream O 0 0.005863798316568136
from O 0 9.191558638121933e-05
the O 0 0.00023609372146893293
3 O 0 0.0010992116294801235
end O 0 0.0009043838363140821
of O 0 4.5926542952656746e-05
exon O 0 0.0714295357465744
6 O 0 0.004235515370965004
. O 0 0.0004920429782941937

Our O 0 0.0008805932593531907
data O 0 0.00017756319721229374
suggest O 0 0.0006656147888861597
that O 0 5.845492341904901e-05
the O 0 0.000424097350332886
C O 0 0.06339500099420547
to O 0 0.00014809299318585545
A O 0 0.0043266285210847855
mutation O 0 0.0026304502971470356
at O 0 0.0007116489578038454
the O 0 0.000282500492176041
penultimate O 0 0.03275624290108681
nucleotide O 0 0.00020435056649148464
of O 0 4.015319427708164e-05
exon O 0 0.045882053673267365
6 O 0 0.0010643135756254196
of O 0 1.713907295197714e-05
the O 0 0.000710837310180068
CYP27 O 1 0.999340832233429
gene O 0 0.002244780072942376
not O 0 7.583602564409375e-05
only O 0 9.099725139094517e-05
causes O 0 0.279168963432312
the O 0 0.002008209004998207
deficiency B-Disease 1 0.9999998807907104
in I-Disease 0 0.00024187029339373112
the I-Disease 0 0.0004553035250864923
sterol I-Disease 1 0.9674811363220215
27 I-Disease 0 0.012323365546762943
- I-Disease 0 0.01686209812760353
hydroxylase I-Disease 0 0.21667088568210602
activity I-Disease 0 0.000975379254668951
, O 0 0.00026856581098400056
but O 0 0.0003490349045023322
also O 0 0.0006452850066125393
partially O 0 0.025469893589615822
leads O 0 0.0016148671275004745
to O 0 8.031437755562365e-05
alternative O 0 0.001540156314149499
pre O 0 0.008225074969232082
- O 0 0.0012254109606146812
mRNA O 0 0.00014077391824685037
splicing O 0 0.00025078002363443375
of O 0 9.751577636052389e-06
the O 0 0.0002887421287596226
gene O 0 0.0052913157269358635
. O 0 0.0005460021202452481

To O 0 0.00042369848233647645
our O 0 0.000653569120913744
knowledge O 0 0.003736507846042514
, O 0 0.0002407546271570027
this O 0 7.72022467572242e-05
is O 0 0.0002691043191589415
the O 0 0.00015591722331009805
first O 0 0.0004273427475709468
report O 0 0.0010438392637297511
regarding O 0 0.001006717560812831
effects O 0 0.007424285169690847
on O 0 0.0005221802275627851
pre O 0 0.009608772583305836
- O 0 0.0014268922386690974
mRNA O 0 0.00013191450852900743
splicing O 0 0.0002824075345415622
of O 0 1.1905261089850683e-05
a O 0 0.0008242173353210092
mutation O 0 0.0034645195119082928
at O 0 0.0012826637830585241
the O 0 0.0008150005014613271
- O 0 0.009385772049427032
2 O 0 0.0007009285618551075
position O 0 0.0005214188131503761
of O 0 1.3795996892440598e-05
a O 0 0.0007912012515589595
5 O 0 0.001688607269898057
splice O 0 0.04547008126974106
site O 0 0.0060707079246640205
. O 0 0.0004983375547453761

ATM O 0 0.10593787580728531
germline O 1 0.9209185838699341
mutations O 0 0.002053580479696393
in O 0 0.000193096770090051
classical O 0 0.006017406936734915
ataxia B-Disease 1 1.0
- I-Disease 1 0.999991774559021
telangiectasia I-Disease 1 0.9999998807907104
patients O 1 0.9999983310699463
in O 0 0.0003257791686337441
the O 0 0.00026132308994419873
Dutch O 0 0.0026689739897847176
population O 0 0.0001341747702099383
. O 0 0.0004893528530374169

Germline O 1 0.9819960594177246
mutations O 0 0.003395383944734931
in O 0 0.00013464361836668104
the O 0 0.00035538573865778744
ATM O 0 0.06916193664073944
gene O 0 0.0014384263195097446
are O 0 1.498592428106349e-05
responsible O 0 0.0016443399945273995
for O 0 0.00017523087444715202
the O 0 0.0018514619441702962
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999854564666748
telangiectasia I-Disease 1 0.9999990463256836
( O 0 0.006270915735512972
A B-Disease 1 0.9996775388717651
- I-Disease 1 0.9994010925292969
T I-Disease 1 0.9999923706054688
) O 0 0.0009003899758681655
. O 0 0.0005306084640324116

In O 0 0.0008822149247862399
our O 0 0.0013180577661842108
study O 0 0.0026564958970993757
, O 0 0.000271808443358168
we O 0 0.00018452416406944394
have O 0 5.9745034377556294e-05
determined O 0 0.000598725862801075
the O 0 0.0001594178902450949
ATM O 0 0.019610822200775146
mutation O 0 0.0019721759017556906
spectrum O 0 0.00288883107714355
in O 0 0.00015788304153829813
19 O 0 0.0009948370279744267
classical O 0 0.0010064911330118775
A B-Disease 1 0.999727189540863
- I-Disease 1 0.9999697208404541
T I-Disease 1 0.9999998807907104
patients O 1 0.9999991655349731
, O 0 0.00024248052795883268
including O 0 6.520327588077635e-05
some O 0 7.465177623089403e-05
immigrant O 0 0.0010186053114011884
populations O 0 0.0009365727892145514
, O 0 0.000315753131872043
as O 0 0.00034405163023620844
well O 0 0.0003135052102152258
as O 0 0.00040332251228392124
12 O 0 0.0005515710799954832
of O 0 2.25472504098434e-05
Dutch O 0 0.0018477627309039235
ethnic O 0 9.169847908196971e-05
origin O 0 0.00022405589697882533
. O 0 0.0006716300267726183

Both O 0 0.00014217539865057915
the O 0 6.304003181867301e-05
protein O 0 0.0011014568153768778
truncation O 0 0.0453764945268631
test O 0 0.012567066587507725
( O 0 0.0023848891723901033
PTT O 1 0.9651985168457031
) O 0 0.00035582476994022727
and O 0 4.36086775152944e-05
the O 0 9.660556679591537e-05
restriction O 0 0.0013855095021426678
endonuclease O 1 0.5743317604064941
fingerprinting O 0 0.1408940851688385
( O 0 0.004160639364272356
REF O 1 0.9957815408706665
) O 0 0.00029621314024552703
method O 0 0.00032810313859954476
were O 0 4.791031824424863e-05
used O 0 0.00023008862626738846
and O 0 0.00013659799878951162
compared O 0 0.0009791762568056583
for O 0 0.00010411807306809351
their O 0 6.0010497691109776e-05
detection O 0 0.010248539038002491
efficiency O 0 0.005995803512632847
, O 0 0.0006325268186628819
identifying O 0 0.025222649797797203
76 O 0 0.02986038662493229
% O 0 0.00015881874423939735
and O 0 0.00022075512970332056
60 O 0 0.0010143062099814415
% O 0 2.4834936994011514e-05
of O 0 1.1535403245943598e-05
the O 0 0.0005446393042802811
mutations O 0 0.006623676512390375
, O 0 0.0004683371807914227
respectively O 0 0.0020055652130395174
. O 0 0.0006054050754755735

Most O 0 0.007521013729274273
patients O 1 0.9999924898147583
were O 0 8.610625809524208e-05
found O 0 0.00020441295055206865
to O 0 4.530117075773887e-05
be O 0 0.00013046701496932656
compound O 0 0.015449941158294678
heterozygote O 0 0.10680026561021805
. O 0 0.000805782969109714

Seventeen O 0 0.019592082127928734
mutations O 0 0.0034615511540323496
were O 0 6.378484977176413e-05
distinct O 0 0.0005955258966423571
, O 0 0.00016968153067864478
of O 0 2.2698919565300457e-05
which O 0 0.00011399339564377442
10 O 0 0.0004189476021565497
were O 0 5.0655198720050976e-05
not O 0 0.000244452734477818
reported O 0 0.005137994885444641
previously O 0 0.0022639313247054815
. O 0 0.0005557581898756325

Mutations O 0 0.007413357496261597
are O 0 4.1653267544461414e-05
small O 0 0.000273543264484033
deletions O 0 0.005068342201411724
or O 0 0.0005791244329884648
point O 0 0.0013634279603138566
mutations O 0 0.003282677149400115
frequently O 0 0.0017488017911091447
affecting O 0 0.020676640793681145
splice O 0 0.04600387066602707
sites O 0 0.0015777226071804762
. O 0 0.0005721300840377808

Moreover O 0 0.01480819471180439
, O 0 0.0003480958112049848
a O 0 0.0012135796714574099
16 O 0 0.0025027869269251823
. O 0 0.0005305338418111205

7 O 0 0.009640037082135677
- O 0 0.012295803986489773
kb O 0 0.022596467286348343
genomic O 0 0.0044478499330580235
deletion O 0 0.003967686090618372
of O 0 2.9148744943086058e-05
the O 0 0.00037505224463529885
3 O 0 0.0018352363258600235
end O 0 0.0008598369313403964
of O 0 1.749137845763471e-05
the O 0 0.000440747186075896
gene O 0 0.004627512767910957
, O 0 0.00026073100161738694
most O 0 0.0002657208242453635
likely O 0 0.0010801294120028615
a O 0 0.00028324045706540346
result O 0 0.0002665322972461581
of O 0 1.7062360711861402e-05
recombination O 0 0.002320807194337249
between O 0 0.00022102321963757277
two O 0 0.0001318146678386256
LINE O 0 0.010975223034620285
elements O 0 0.00036667953827418387
, O 0 0.0005115849780850112
was O 0 0.0033450713381171227
identified O 0 0.0032239595893770456
. O 0 0.00041708152275532484

The O 0 0.0005835537449456751
most O 0 0.00030107988277450204
frequently O 0 0.0019064904190599918
found O 0 0.0007554322364740074
mutation O 0 0.0032665468752384186
, O 0 0.000291504809865728
identified O 0 0.0010282068978995085
in O 0 7.446832751156762e-05
three O 0 6.747561565134674e-05
unrelated O 0 0.0052938987500965595
Turkish O 0 0.008566787466406822
A B-Disease 1 0.9992424249649048
- I-Disease 1 0.999508261680603
T I-Disease 1 0.9999947547912598
individuals O 0 0.000887218106072396
, O 0 0.0006290687597356737
was O 0 0.0032682614400982857
previously O 0 0.002018741797655821
described O 0 0.001356990891508758
to O 0 4.6052722609601915e-05
be O 0 3.371918137418106e-05
a O 0 0.00025991047732532024
Turkish O 0 0.004426770377904177
A B-Disease 1 0.9952269792556763
- I-Disease 1 0.9984273910522461
T I-Disease 1 0.9999935626983643
founder O 0 0.048874422907829285
mutation O 0 0.004797941539436579
. O 0 0.0005049339961260557

The O 0 0.0004964304389432073
presence O 0 0.0004102139500901103
of O 0 3.241648664698005e-05
a O 0 0.0022428659722208977
founder O 0 0.0553780123591423
mutation O 0 0.0039649964310228825
among O 0 0.0001565894635859877
relatively O 0 0.0013181405374780297
small O 0 0.0002043994900304824
ethnic O 0 0.0001093224564101547
population O 0 7.089402060955763e-05
groups O 0 8.247364166891202e-05
in O 0 0.00039705069502815604
Western O 0 0.0032205688767135143
Europe O 0 0.004037134349346161
could O 0 0.0005058922688476741
indicate O 0 0.0007319956202991307
a O 0 0.0008339118212461472
high O 0 0.006472225300967693
carrier O 0 0.026895014569163322
frequency O 0 0.0003490911622066051
in O 0 9.864515595836565e-05
such O 0 6.585955270566046e-05
communities O 0 0.00109576724935323
. O 0 0.0007830372196622193

In O 0 0.004243357572704554
patients O 1 0.9999340772628784
of O 0 6.293005571933463e-05
Dutch O 0 0.002318966668099165
ethnic O 0 0.00014108918549027294
origin O 0 0.000197131434106268
, O 0 0.0003866798069793731
however O 0 0.000523718015756458
, O 0 0.00021893357916269451
no O 0 0.00019638551748357713
significant O 0 0.0013734225649386644
founder O 0 0.019650476053357124
effect O 0 0.001502473489381373
could O 0 0.000395732291508466
be O 0 0.000173510707099922
identified O 0 0.0014396439073607326
. O 0 0.0002867310249712318

The O 0 0.0007974799955263734
observed O 0 0.0013365027261897922
genetic O 0 0.003658353118225932
heterogeneity O 0 0.016820434480905533
including O 0 9.817754471441731e-05
the O 0 0.00014871888561174273
relative O 0 0.0007623298442922533
high O 0 0.002020612359046936
percentage O 0 0.0003139820182695985
of O 0 3.861434379359707e-05
splice O 0 0.33574989438056946
- O 0 0.033380597829818726
site O 0 0.004573816433548927
mutations O 0 0.0026070557069033384
had O 0 0.0005519757396541536
no O 0 0.00016682335990481079
reflection O 0 0.0047265090979635715
on O 0 0.00029307734803296626
the O 0 0.000594796787481755
phenotype O 1 0.7140541672706604
. O 0 0.000732647895347327

All O 0 0.0008302032365463674
patients O 1 0.9998251795768738
manifested O 0 0.03670670837163925
classical O 0 0.0019428115338087082
A B-Disease 1 0.9984305500984192
- I-Disease 1 0.9989830851554871
T I-Disease 1 0.9999724626541138
and O 0 0.0002067098394036293
increased O 0 0.0007936584297567606
cellular O 0 0.009246522560715675
radioresistant O 0 0.1922847479581833
DNA O 0 0.001364871277473867
synthesis O 0 0.0022253107745200396
. O 0 0.0005631563253700733

Determination O 0 0.00864320807158947
of O 0 2.371482696617022e-05
the O 0 0.00018034377717413008
genomic O 0 0.002656839555129409
structure O 0 0.000979413278400898
of O 0 2.9707485737162642e-05
the O 0 0.0011903101112693548
COL4A4 O 1 0.9999706745147705
gene O 0 0.002311406657099724
and O 0 3.4472133847884834e-05
of O 0 1.7674958144198172e-05
novel O 0 0.0039131189696490765
mutations O 0 0.012224233709275723
causing O 1 0.9989469647407532
autosomal B-Disease 1 0.9999978542327881
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0031038830056786537

Autosomal B-Disease 1 0.9999935626983643
recessive I-Disease 1 0.9999992847442627
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.0012285992270335555
a O 0 0.0014221050078049302
progressive O 1 0.9982112646102905
hematuric B-Disease 1 0.9999079704284668
glomerulonephritis I-Disease 1 0.9999998807907104
characterized O 1 0.9535456299781799
by O 0 0.0005317491013556719
glomerular B-Disease 1 0.9999921321868896
basement I-Disease 1 0.9989343285560608
membrane I-Disease 1 0.6922634243965149
abnormalities I-Disease 1 0.9999202489852905
and O 0 0.0003873655223287642
associated O 0 0.0006557276356033981
with O 0 0.00011970582272624597
mutations O 0 0.0022570141591131687
in O 0 0.00013024761574342847
either O 0 0.00040115645970217884
the O 0 0.000659249082673341
COL4A3 O 1 0.9994838237762451
or O 0 0.0008116489625535905
the O 0 0.0010528493439778686
COL4A4 O 1 0.9993526339530945
gene O 0 0.0047127678990364075
, O 0 0.00013411697000265121
which O 0 2.194595435867086e-05
encode O 0 0.00017385435057803988
the O 0 0.0002915423538070172
alpha3 O 1 0.5156408548355103
and O 0 0.0004862869391217828
alpha4 O 1 0.9858636260032654
type O 1 0.8651304244995117
IV O 1 0.9999934434890747
collagen O 1 0.9999879598617554
chains O 0 0.01555964257568121
, O 0 0.0006641047657467425
respectively O 0 0.0016344385221600533
. O 0 0.0005647781072184443

To O 0 0.0004677897959481925
date O 0 0.0005271092522889376
, O 0 0.00030279322527348995
mutation O 0 0.004130911082029343
screening O 0 0.006526000332087278
in O 0 0.000115618844574783
the O 0 0.00011744542280212045
two O 0 5.178241553949192e-05
genes O 0 0.0005152097437530756
has O 0 0.0012278342619538307
been O 0 0.0013630487956106663
hampered O 1 0.9965348243713379
by O 0 7.17760922270827e-05
the O 0 0.00018052115046884865
lack O 0 0.0016781833255663514
of O 0 3.334444045322016e-05
genomic O 0 0.0052485717460513115
structure O 0 0.003462492022663355
information O 0 0.0007947675185278058
. O 0 0.0006158966571092606

We O 0 0.0016819422598928213
report O 0 0.001299830386415124
here O 0 0.00019925092055927962
the O 0 0.00015376239025499672
complete O 0 0.0017769885016605258
characterization O 0 0.014914866536855698
of O 0 3.199669663445093e-05
the O 0 0.0004243905423209071
48 O 0 0.0030493654776364565
exons O 0 0.0027112693060189486
of O 0 2.83430636045523e-05
the O 0 0.0009643734083510935
COL4A4 O 1 0.9989637136459351
gene O 0 0.004388434812426567
, O 0 0.0001569910382386297
a O 0 0.0007926792604848742
comprehensive O 0 0.0529993511736393
gene O 0 0.005885988008230925
screen O 0 0.004214051179587841
, O 0 0.00033965372131206095
and O 0 0.00010595880303299055
the O 0 0.00018219261255580932
subsequent O 0 0.0011811614967882633
detection O 0 0.004389128647744656
of O 0 2.6097617592313327e-05
10 O 0 0.000608178146649152
novel O 0 0.0012791795888915658
mutations O 0 0.0013806826900690794
in O 0 0.00021573867707047611
eight O 0 0.00379350408911705
patients O 1 1.0
diagnosed O 1 1.0
with O 0 0.0012875377433374524
autosomal B-Disease 1 0.9999990463256836
recessive I-Disease 1 0.9999998807907104
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0032131606712937355

Furthermore O 0 0.013859267346560955
, O 0 0.00043871771777048707
we O 0 0.0002849297598004341
identified O 0 0.0006737842340953648
a O 0 0.00038220244459807873
glycine O 0 0.007794564124196768
to O 0 0.00014518250827677548
alanine O 0 0.015941988676786423
substitution O 0 0.0005542508442886174
in O 0 0.00018610346887726337
the O 0 0.0007120115333236754
collagenous O 1 0.9989732503890991
domain O 0 0.0021374260541051626
that O 0 0.00019283624715171754
is O 0 0.0010707254987210035
apparently O 0 0.008323654532432556
silent O 0 0.01049274392426014
in O 0 0.00017402767844032496
the O 0 0.000359773519448936
heterozygous O 0 0.009483329951763153
carriers O 0 0.016795186325907707
, O 0 0.0003547965607140213
in O 0 0.00035193009534850717
11 O 0 0.003141902619972825
. O 0 0.0005060664261691272

5 O 0 0.0021066877525299788
% O 0 3.591390486690216e-05
of O 0 1.3562348613049835e-05
all O 0 7.182538683991879e-05
control O 0 0.0035596699453890324
individuals O 0 0.0007452615536749363
, O 0 0.0005782711086794734
and O 0 0.00023891111777629703
in O 0 0.00023215120017994195
one O 0 0.00020628355559892952
control O 0 0.0011974289081990719
individual O 0 0.0003255605697631836
homozygous O 0 0.0032170559279620647
for O 0 8.526108285877854e-05
this O 0 6.515777204185724e-05
glycine O 0 0.008607194758951664
substitution O 0 0.00152123486623168
. O 0 0.0005609433283098042

There O 0 0.00102427217643708
has O 0 0.0012256240006536245
been O 0 0.0003790763730648905
no O 0 0.0001493199379183352
previous O 0 0.00029794624424539506
finding O 0 0.00043407484190538526
of O 0 1.0584220035525504e-05
a O 0 0.0005668100784532726
glycine O 0 0.01110372506082058
substitution O 0 0.0008132851799018681
that O 0 0.000121390497952234
is O 0 0.0004479016934055835
not O 0 0.00020464521367102861
associated O 0 0.00032031015143729746
with O 0 5.574057649937458e-05
any O 0 0.0002683346683625132
obvious O 0 0.022635042667388916
phenotype O 0 0.3403572142124176
in O 0 0.0006053567049093544
homozygous O 0 0.01060374453663826
individuals O 0 0.0005005700513720512
. O 0 0.0007479116902686656

Founder O 1 0.9706750512123108
BRCA1 O 1 0.9998362064361572
and O 0 0.002021803054958582
BRCA2 O 1 0.9986268281936646
mutations O 0 0.0017918761586770415
in O 0 0.0001828100357670337
French O 0 0.003074472304433584
Canadian O 1 0.8673171401023865
breast B-Disease 1 1.0
and I-Disease 1 0.9393119215965271
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.001618740032427013
. O 0 0.0005919943796470761

We O 0 0.0010776235722005367
have O 0 0.00014984224981162697
identified O 0 0.0008693764684721828
four O 0 9.58806267590262e-05
mutations O 0 0.0007486800896003842
in O 0 2.6664005417842418e-05
each O 0 5.826405413245084e-06
of O 0 1.3463700270222034e-05
the O 0 0.0051896292716264725
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 0 0.09738464653491974
susceptibility O 0 0.14824075996875763
genes O 0 0.0005508497124537826
, O 0 0.0008111699717119336
BRCA1 O 1 0.9999852180480957
and O 0 0.001702191773802042
BRCA2 O 1 0.9998639822006226
, O 0 0.00021443786681629717
in O 0 0.00013253976067062467
French O 0 0.0037891166284680367
Canadian O 1 0.9820340871810913
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.21911440789699554
breast B-Disease 1 1.0
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0010297769913449883
from O 0 0.00028943861252628267
Quebec O 0 0.03069799765944481
. O 0 0.0008118826081044972

To O 0 0.0006333562778308988
identify O 0 0.005623576231300831
founder O 0 0.049845267087221146
effects O 0 0.014814128167927265
, O 0 0.0003679896180983633
we O 0 0.00034855655394494534
examined O 0 0.009197582490742207
independently O 0 0.00038963748374953866
ascertained O 0 0.02222634106874466
French O 0 0.006861499510705471
Canadian O 1 0.8225710988044739
cancer B-Disease 1 1.0
families O 0 0.0005562964943237603
for O 0 0.00018412325880490243
the O 0 8.04253650130704e-05
distribution O 0 9.341705299448222e-05
of O 0 1.1134852684335783e-05
these O 0 2.4770670279394835e-05
eight O 0 0.0005272195558063686
mutations O 0 0.003614575369283557
. O 0 0.00047788230585865676

Mutations O 0 0.009980388917028904
were O 0 8.600557339377701e-05
found O 0 0.0002741092466749251
in O 0 0.00017932163609657437
41 O 0 0.002108766231685877
of O 0 4.877677929471247e-05
97 O 0 0.02389841340482235
families O 0 0.0008747092797420919
. O 0 0.0006884788163006306

Six O 0 0.0005514498334378004
of O 0 2.576668339315802e-05
eight O 0 0.0005301266792230308
mutations O 0 0.0016597345238551497
were O 0 3.864278914988972e-05
observed O 0 0.000512113852892071
at O 0 0.0007301803561858833
least O 0 0.0004712444497272372
twice O 0 0.003945361822843552
. O 0 0.00047776364954188466

The O 0 0.0033090536016970873
BRCA1 O 1 0.9996747970581055
C4446T O 1 0.7697455883026123
mutation O 0 0.005052873399108648
was O 0 0.0008788224076852202
the O 0 0.00013196318468544632
most O 0 0.0002677489537745714
common O 0 0.0033915075473487377
mutation O 0 0.005961260758340359
found O 0 0.0006249877042137086
, O 0 0.0001804161729523912
followed O 0 0.0002714448201004416
by O 0 5.418173168436624e-05
the O 0 0.0011428947327658534
BRCA2 O 1 0.9999504089355469
8765delAG O 1 0.9766701459884644
mutation O 0 0.006442178972065449
. O 0 0.0006335899233818054

Together O 0 0.0006013932288624346
, O 0 0.0002811223967000842
these O 0 6.910891534062102e-05
mutations O 0 0.0024160558823496103
were O 0 6.651184958172962e-05
found O 0 0.0004167585866525769
in O 0 0.00024574127746745944
28 O 0 0.001836838899180293
of O 0 5.4626772907795385e-05
41 O 0 0.007848013192415237
families O 0 0.0007773241377435625
identified O 0 0.001439411542378366
to O 0 5.9049532865174115e-05
have O 0 4.888956755166873e-05
a O 0 0.0004921284271404147
mutation O 0 0.00401711743324995
. O 0 0.0004928945563733578

The O 0 0.0013727889163419604
odds O 0 0.011503431014716625
of O 0 4.731286026071757e-05
detection O 0 0.005533421877771616
of O 0 1.1200746484973934e-05
any O 0 2.6957368390867487e-05
of O 0 8.511078704032116e-06
the O 0 0.0002037966187344864
four O 0 0.000764509430155158
BRCA1 O 1 0.9998158812522888
mutations O 0 0.006124412175267935
was O 0 0.0026758983731269836
18 O 0 0.0011855033226311207
. O 0 0.00042459266842342913

7x O 1 0.9952985644340515
greater O 0 0.0016194414347410202
if O 0 0.0006863026064820588
one O 0 9.702117677079514e-05
or O 0 0.0001288793864659965
more O 0 6.189678242662922e-05
cases O 0 0.0019395927665755153
of O 0 0.0010114724282175303
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.00016345130279660225
also O 0 0.00017067590670194477
present O 0 0.000133402063511312
in O 0 0.0001349617523374036
the O 0 0.0003348249301780015
family O 0 0.001655645202845335
. O 0 0.0007496271282434464

The O 0 0.0015069827204570174
odds O 0 0.009798726066946983
of O 0 4.1136656363960356e-05
detection O 0 0.00467042438685894
of O 0 1.0030898010882083e-05
any O 0 3.157743776682764e-05
of O 0 9.75197872321587e-06
the O 0 0.00027286651311442256
four O 0 0.0009495870326645672
BRCA2 O 1 0.9996169805526733
mutations O 0 0.005878504365682602
was O 0 0.0025590003933757544
5 O 0 0.0016707382164895535
. O 0 0.00036073478986509144

3x O 1 0.928817093372345
greater O 0 0.0021987399086356163
if O 0 0.0008711369009688497
there O 0 7.509072020184249e-05
were O 0 3.892045424436219e-05
at O 0 0.0003779307007789612
least O 0 0.0001234352821484208
five O 0 0.00011133689258713275
cases O 0 0.0011678672162815928
of O 0 0.00045500759733840823
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0003313802881166339
the O 0 0.0003714704071171582
family O 0 0.0015371990157291293
. O 0 0.0006831198115833104

Interestingly O 0 0.0636940598487854
, O 0 0.00016547422274015844
the O 0 3.936596476705745e-05
presence O 0 0.00014604712487198412
of O 0 2.5300199922639877e-05
a O 0 0.04621335491538048
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
case O 0 0.01329719740897417
< O 0 0.08861693739891052
36 O 0 0.0024582992773503065
years O 0 0.00026076260837726295
of O 0 2.5007764634210616e-05
age O 0 0.0018248386913910508
was O 0 0.0015799873508512974
strongly O 0 0.0019695295486599207
predictive O 0 0.010873082093894482
of O 0 2.4541957827750593e-05
the O 0 0.00019908684771507978
presence O 0 0.00041584757855162024
of O 0 1.0465071682119742e-05
any O 0 3.41107152053155e-05
of O 0 1.0133420801139437e-05
the O 0 0.0002039180981228128
eight O 0 0.0006602985667996109
mutations O 0 0.003915037494152784
screened O 0 0.00854079332202673
. O 0 0.00048290975973941386

Carriers O 0 0.01463103387504816
of O 0 2.7555026463232934e-05
the O 0 0.00023004808463156223
same O 0 0.0005178205319680274
mutation O 0 0.004793237894773483
, O 0 0.000263145484495908
from O 0 6.920850137248635e-05
different O 0 3.436588667682372e-05
families O 0 0.0004462755750864744
, O 0 0.00031045949435792863
shared O 0 0.0011404217220842838
similar O 0 0.0012299083173274994
haplotypes O 0 0.04906827211380005
, O 0 0.00046189199201762676
indicating O 0 0.0034762131981551647
that O 0 7.347669452428818e-05
the O 0 0.00026452093152329326
mutant O 0 0.01090400293469429
alleles O 0 0.0048133437521755695
were O 0 0.00013687272439710796
likely O 0 0.0012094214325770736
to O 0 9.037384734256193e-05
be O 0 8.226942009059712e-05
identical O 0 0.00030435086227953434
by O 0 5.149624848854728e-05
descent O 0 0.0009053240064531565
for O 0 0.00020078540546819568
a O 0 0.0009555616998113692
mutation O 0 0.002830896293744445
in O 0 0.0001827218511607498
the O 0 0.0005287156091071665
founder O 0 0.020008618012070656
population O 0 0.00019139534560963511
. O 0 0.0005716697778552771

The O 0 0.0003559596370905638
identification O 0 0.00028878371813334525
of O 0 4.12340959883295e-05
common O 0 0.030747542157769203
BRCA1 O 1 0.9999896287918091
and O 0 0.0026532220654189587
BRCA2 O 1 0.9998263716697693
mutations O 0 0.002903056563809514
will O 0 0.00010641496191965416
facilitate O 0 0.0017918796511366963
carrier O 0 0.024469509720802307
detection O 0 0.0040133376605808735
in O 0 0.000124239333672449
French O 0 0.003007400780916214
Canadian O 1 0.967768669128418
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.09569226205348969
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0012919134460389614
. O 0 0.0005739404004998505

Are O 0 0.00038876355392858386
Dp71 O 1 0.9069142937660217
and O 0 0.0007251704810187221
Dp140 O 1 0.990420937538147
brain O 1 0.999984622001648
dystrophin O 1 0.9971628785133362
isoforms O 0 0.0018277168273925781
related O 0 0.0009601401397958398
to O 0 0.0001685276802163571
cognitive B-Disease 1 0.9996604919433594
impairment I-Disease 1 0.9999969005584717
in O 0 0.004034929443150759
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9394460916519165

Molecular O 0 0.01777247153222561
study O 0 0.002671572146937251
and O 0 0.00037897159927524626
neuropsychological O 1 0.9863677620887756
analysis O 0 0.0004627788730431348
were O 0 4.424958024173975e-05
performed O 0 0.0008079503895714879
concurrently O 0 0.0013728032354265451
on O 0 0.00030813764897175133
49 O 0 0.015979796648025513
patients O 1 0.9999946355819702
with O 0 0.0014063328271731734
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9455982446670532
DMD B-Disease 1 1.0
) O 0 0.0012652338482439518
in O 0 0.0001703167799860239
order O 0 0.0001094479302992113
to O 0 9.035255789058283e-05
find O 0 0.000501603411976248
a O 0 0.0004572613979689777
molecular O 0 0.0031193841714411974
explanation O 0 0.0016265190206468105
for O 0 0.00012708932626992464
the O 0 0.00047401737538166344
cognitive B-Disease 1 0.9997697472572327
impairment I-Disease 1 0.9999912977218628
observed O 0 0.0010026900563389063
in O 0 0.00028191605815663934
most O 0 0.005412500351667404
DMD B-Disease 1 1.0
patients O 1 0.9999995231628418
. O 0 0.0009831818751990795

Complete O 0 0.001896149362437427
analysis O 0 0.00014211522648110986
of O 0 1.534889634058345e-05
the O 0 0.0007811897085048258
dystrophin O 1 0.999842643737793
gene O 0 0.010649365372955799
was O 0 0.0025403411127626896
performed O 0 0.001707596704363823
to O 0 8.008380245883018e-05
define O 0 0.0017998506082221866
the O 0 0.00019241217523813248
localization O 0 0.007738876156508923
of O 0 5.702841008314863e-05
deletions O 0 0.006486794911324978
and O 0 0.00047972414176911116
duplications O 0 0.02390698343515396
in O 0 0.00028222508262842894
relation O 0 0.0011026001302525401
to O 0 7.670231570955366e-05
the O 0 0.00019624286505859345
different O 0 0.0006168807158246636
DMD B-Disease 1 1.0
promoters O 0 0.16877460479736328
. O 0 0.0009980994509533048

Qualitative O 0 0.006764664314687252
analysis O 0 0.0002474538632668555
of O 0 2.138311174348928e-05
the O 0 0.0009526072535663843
Dp71 O 1 0.9990859031677246
transcript O 0 0.016789203509688377
and O 0 0.0001856599992606789
testing O 0 0.0047955745831131935
for O 0 9.889843204291537e-05
the O 0 8.92468960955739e-05
specific O 0 0.00020776616293005645
first O 0 0.00031882617622613907
exon O 0 0.018500985577702522
of O 0 8.797697955742478e-05
Dp140 O 0 0.08356451988220215
were O 0 8.02181675680913e-05
also O 0 0.00018790648027788848
carried O 0 0.00031947880052030087
out O 0 0.00021255369938444346
. O 0 0.00047114831977523863

Neuropsychological O 1 0.9719005823135376
analysis O 0 0.001229223795235157
assessed O 0 0.019767791032791138
verbal O 0 0.022119497880339622
and O 0 0.0008941736887209117
visuospatial O 1 0.999757707118988
intelligence O 0 0.03825579583644867
, O 0 0.0009684223332442343
verbal O 0 0.09661128371953964
memory O 1 0.5341370701789856
, O 0 0.0004939679056406021
and O 0 0.000275083672022447
reading O 0 0.0072776940651237965
skills O 0 0.03724539279937744
. O 0 0.000807988632004708

Comparison O 0 0.0019529472338035703
of O 0 3.348292739246972e-05
molecular O 0 0.0070653436705470085
and O 0 0.0005848048604093492
psychometric O 1 0.9967141151428223
findings O 0 0.008909804746508598
demonstrated O 0 0.0046440474689006805
that O 0 0.000119002019346226
deletions O 0 0.0027489694766700268
and O 0 0.0002488348400220275
duplications O 0 0.016250452026724815
that O 0 9.823954314924777e-05
were O 0 5.444547423394397e-05
localized O 0 0.011723251082003117
in O 0 0.00023177101684268564
the O 0 0.0006449622451327741
distal O 1 0.9966592788696289
part O 0 0.0011870921589434147
of O 0 2.898525599448476e-05
the O 0 0.0005120785208418965
gene O 0 0.005366550292819738
seemed O 0 0.004363249987363815
to O 0 6.018132989993319e-05
be O 0 9.737384243635461e-05
preferentially O 0 0.004452420864254236
associated O 0 0.0003947966906707734
with O 0 0.0003038608410861343
cognitive B-Disease 1 0.9998279809951782
impairment I-Disease 1 0.9999982118606567
. O 0 0.001245049643330276

Two O 0 0.0005613893736153841
altered O 0 0.011953228153288364
Dp71 O 1 0.6758822798728943
transcripts O 0 0.002904907101765275
and O 0 8.64979883772321e-05
two O 0 7.353402907028794e-05
deleted O 0 0.007569259963929653
Dp140 O 0 0.03954886645078659
DNA O 0 0.0007419600151479244
sequences O 0 4.042498403578065e-05
were O 0 2.2762042135582305e-05
found O 0 0.000159349205205217
in O 0 0.00010286505857948214
four O 0 0.0005826326087117195
patients O 1 0.9999988079071045
with O 0 0.0009920151205733418
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 0.9999998807907104
. O 0 0.0023313399869948626

These O 0 0.00030849920585751534
findings O 0 0.005393367726355791
suggest O 0 0.0008551172795705497
that O 0 2.8812104574171826e-05
some O 0 2.447291808493901e-05
sequences O 0 8.682872430654243e-05
located O 0 0.0015922185266390443
in O 0 0.00020288924861233681
the O 0 0.0006682811654172838
distal O 1 0.9942063093185425
part O 0 0.001404820242896676
of O 0 3.664820542326197e-05
the O 0 0.0005711967241950333
gene O 0 0.004545520059764385
and O 0 0.00027122674509882927
, O 0 0.000237913234741427
in O 0 0.00015337055083364248
particular O 0 0.000490376609377563
, O 0 0.00039395864587277174
some O 0 0.0006285874987952411
DMD B-Disease 1 0.9999996423721313
isoforms O 0 0.001633689273148775
expressed O 0 0.00042215618304908276
in O 0 0.00022018271556589752
the O 0 0.0016003927448764443
brain O 1 0.9999992847442627
may O 0 0.0025123837403953075
be O 0 9.51577749219723e-05
related O 0 0.000523576803971082
to O 0 4.459929186850786e-05
the O 0 0.00032081353128887713
cognitive B-Disease 1 0.9998377561569214
impairment I-Disease 1 0.9999988079071045
associated O 0 0.0025227053556591272
with O 0 0.0018333782209083438
DMD B-Disease 1 1.0
. O 0 0.0009386399760842323
. O 0 0.0006410646601580083

I1307K O 1 0.9408937692642212
APC O 1 0.9973692893981934
and O 0 0.001047323690727353
hMLH1 O 0 0.2350149005651474
mutations O 0 0.001969440607354045
in O 0 0.00011255509161856025
a O 0 0.0008888807496987283
non O 0 0.007239919155836105
- O 0 0.00964224524796009
Jewish O 0 0.001028948463499546
family O 0 0.000398283707909286
with O 0 0.00020140166452620178
hereditary B-Disease 1 0.9998250603675842
non I-Disease 1 0.9986286163330078
- I-Disease 1 0.9999979734420776
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0017862411914393306

We O 0 0.0006560435285791755
describe O 0 0.0010851987171918154
a O 0 0.0004578903899528086
French O 0 0.0021315680351108313
Canadian O 0 0.005295561160892248
hereditary B-Disease 1 0.9994049072265625
non I-Disease 1 0.9989480376243591
- I-Disease 1 0.9999986886978149
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.032353777438402176
HNPCC B-Disease 1 0.9999998807907104
) O 0 0.0026206914335489273
kindred O 1 0.9938581585884094
which O 0 8.565583266317844e-05
carries O 0 0.0010132123716175556
a O 0 0.0006018130225129426
novel O 0 0.003564603393897414
truncating O 1 0.8935282826423645
mutation O 0 0.004496339242905378
in O 0 0.0006169289699755609
hMLH1 O 1 0.9853445887565613
. O 0 0.0008962319698184729

Interestingly O 0 0.06343113631010056
, O 0 0.0004406169755384326
the O 0 0.0006106391083449125
I1307K O 1 0.921592652797699
APC O 1 0.997183084487915
polymorphism O 0 0.009026125073432922
, O 0 0.0004251408390700817
associated O 0 0.00025951085262931883
with O 0 2.1884152374695987e-05
an O 0 0.00013054815644863993
increased O 0 0.0010191353503614664
risk O 1 0.9905243515968323
of O 0 0.0016856990987434983
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0008719141478650272
is O 0 0.0005033494671806693
also O 0 0.00014392983575817198
present O 0 0.00010345922783017159
in O 0 9.727648284751922e-05
this O 0 9.477480489294976e-05
family O 0 0.001384575036354363
. O 0 0.000763341027777642

The O 0 0.0012343862326815724
I1307K O 0 0.05827629566192627
polymorphism O 0 0.004683384671807289
has O 0 0.001039639813825488
previously O 0 0.0010308120399713516
only O 0 8.337383042089641e-05
been O 0 0.0004669913905672729
identified O 0 0.0006589925615116954
in O 0 6.117098382674158e-05
individuals O 0 6.776623922633007e-05
of O 0 4.590670869220048e-05
self O 0 0.22483383119106293
- O 1 0.5214375257492065
reported O 0 0.013377716764807701
Ashkenazi O 1 0.7872818112373352
Jewish O 0 0.003972162492573261
origins O 0 0.00441980455070734
. O 0 0.0009356666705571115

In O 0 0.000879337138030678
addition O 0 0.0007505989633500576
, O 0 0.00027512587257660925
in O 0 0.00016789381334092468
this O 0 0.00013480675988830626
family O 0 0.0011918473755940795
, O 0 0.0003814225783571601
there O 0 0.000321945030009374
appears O 0 0.005094426218420267
to O 0 0.000101350640761666
be O 0 0.000133491528686136
no O 0 0.00027824309654533863
relationship O 0 0.003889280604198575
between O 0 0.0002087841130560264
the O 0 0.00048319599591195583
I1307K O 0 0.0874565839767456
polymorphism O 0 0.003168524708598852
and O 0 0.00011146393808303401
the O 0 0.000180626186192967
presence O 0 0.0011912493500858545
or O 0 0.0005622692406177521
absence O 0 0.005930962506681681
of O 0 0.0004842502239625901
cancer B-Disease 1 1.0
. O 0 0.00047676736721768975
. O 0 0.0005221982137300074

Identification O 0 0.0008969696355052292
of O 0 2.2000980607117526e-05
a O 0 0.0007677130051888525
novel O 0 0.0019510254496708512
mutation O 0 0.0007783307810314
of O 0 1.933772182383109e-05
the O 0 0.0006524249329231679
CPO O 0 0.2878343462944031
gene O 0 0.0019162247190251946
in O 0 9.773310739547014e-05
a O 0 0.0007802381296642125
Japanese O 0 0.0066107469610869884
hereditary B-Disease 1 0.9998514652252197
coproporphyria I-Disease 1 0.9994316697120667
family O 0 0.0033987611532211304
. O 0 0.0009162526112049818

Hereditary B-Disease 1 0.9996647834777832
coproporphyria I-Disease 1 0.9990887641906738
( O 0 0.007030425127595663
HCP B-Disease 1 0.9999810457229614
) O 0 0.0005724696675315499
is O 0 0.0003233476891182363
an O 0 0.0008540025446563959
autosomal B-Disease 1 0.9999798536300659
dominant I-Disease 1 0.9999446868896484
disease I-Disease 1 1.0
characterized O 1 0.874160885810852
by O 0 0.00012896173575427383
a O 0 0.004531478509306908
deficiency B-Disease 1 0.9999991655349731
of I-Disease 0 0.00012983348278794438
coproporphyrinogen I-Disease 1 0.9969966411590576
oxidase I-Disease 0 0.32934150099754333
( O 0 0.002794064348563552
CPO O 1 0.957994818687439
) O 0 0.000841285684145987
caused O 0 0.004685561638325453
by O 0 3.744863352039829e-05
a O 0 0.000625015702098608
mutation O 0 0.001434455974958837
in O 0 0.00013336811389308423
the O 0 0.0005058164242655039
CPO O 1 0.7366377115249634
gene O 0 0.005605696700513363
. O 0 0.0005004117265343666

Only O 0 0.0006437150295823812
11 O 0 0.0017518243985250592
mutations O 0 0.0006719546508975327
of O 0 1.2282268471608404e-05
the O 0 0.00027371279429644346
gene O 0 0.002558627165853977
have O 0 9.004034654935822e-05
been O 0 0.00043238408397883177
reported O 0 0.00326553825289011
in O 0 0.0013964297249913216
HCP B-Disease 1 0.9999992847442627
patients O 1 0.9999983310699463
. O 0 0.0009695209446363151

We O 0 0.0012086884817108512
report O 0 0.0008430503075942397
another O 0 0.000601981591898948
mutation O 0 0.0017189899226650596
in O 0 0.0001295227266382426
a O 0 0.000676449213642627
Japanese O 0 0.0031389137730002403
family O 0 0.002044973662123084
. O 0 0.0008505153236910701

Polymerase O 0 0.017797352746129036
chain O 0 0.008885486982762814
reaction O 0 0.003893537214025855
- O 0 0.006646947003901005
single O 0 0.0005690903635695577
strand O 0 0.010357411578297615
conformational O 0 0.005520194303244352
polymorphism O 0 0.0031616417691111565
and O 0 8.167034684447572e-05
direct O 0 0.0001612121850484982
sequence O 0 9.275681804865599e-05
analyses O 0 0.0011935151414945722
demonstrated O 0 0.0038317935541272163
a O 0 0.0018113141413778067
C O 0 0.14104484021663666
to O 0 0.0006265048868954182
T O 1 0.927447497844696
substitution O 0 0.0006414325325749815
in O 0 0.000294800236588344
exon O 0 0.02826514281332493
1 O 0 0.0006611109129153192
of O 0 1.672861799306702e-05
the O 0 0.0005648302612826228
CPO O 0 0.13318952918052673
gene O 0 0.00241305329836905
at O 0 0.0004933307645842433
nucleotide O 0 0.0004304142785258591
position O 0 0.004002404399216175
85 O 0 0.010384633205831051
, O 0 0.00038839143235236406
which O 0 0.0001679456909187138
lies O 0 0.005217415280640125
in O 0 0.00015096116112545133
the O 0 0.0004358779115136713
putative O 0 0.05511124059557915
presequence O 1 0.5626856088638306
for O 0 0.00025859451852738857
targeting O 0 0.0013520462671294808
to O 0 0.0001587639271747321
mitochondria O 0 0.00412755785509944
. O 0 0.0004758590366691351

This O 0 0.000415885093389079
mutation O 0 0.0018737715436145663
changes O 0 0.00022762858134228736
the O 0 0.00016355029947590083
codon O 0 0.0036609454546123743
for O 0 0.0002951610367745161
glutamine O 0 0.009811664931476116
to O 0 8.575637184549123e-05
a O 0 0.000888736336492002
termination O 0 0.05492342635989189
codon O 0 0.003764306427910924
at O 0 0.0003764668363146484
amino O 0 0.00037089132820256054
acid O 0 0.011602386832237244
position O 0 0.005792909301817417
29 O 0 0.008586199954152107
. O 0 0.0005902160773985088

MaeI O 1 0.6121090650558472
restriction O 0 0.0012901597656309605
analysis O 0 0.0006823308649472892
showed O 0 0.0015864982269704342
two O 0 5.466845686896704e-05
other O 0 7.862818165449426e-05
carriers O 0 0.010488674975931644
in O 0 0.00022067238751333207
the O 0 0.0003976194129791111
family O 0 0.0020122267305850983
. O 0 0.0008379151113331318

The O 0 0.004082348197698593
C O 1 0.9901691675186157
- O 1 0.8583577275276184
T O 1 0.9972149133682251
mutation O 0 0.0034380494616925716
is O 0 0.0004609305178746581
located O 0 0.0011715195141732693
within O 0 0.00013942518853582442
a O 0 0.0012338842498138547
recently O 0 0.006827898323535919
proposed O 0 0.0012512559769675136
putative O 0 0.006588554475456476
alternative O 0 0.0005769144045189023
translation O 0 0.00042273709550499916
initiation O 0 0.005108390469104052
codon O 0 0.011593765579164028
( O 0 0.003760674735531211
TIC O 1 0.9999592304229736
- O 0 0.01826673187315464
1 O 0 0.0027323903050273657
) O 0 0.00023718414013274014
, O 0 0.00014465255662798882
supporting O 0 0.0026496094651520252
that O 0 0.0008076445665210485
TIC O 1 0.9999395608901978
- O 0 0.010476221330463886
1 O 0 0.0008853391627781093
is O 0 0.00016024788783397526
the O 0 0.00018112684483639896
real O 0 0.005961497779935598
TIC O 1 0.9997101426124573
rather O 0 0.0009487170609645545
than O 0 0.0012808437459170818
TIC O 1 0.9999624490737915
- O 0 0.020135700702667236
2 O 0 0.0019064395455643535
. O 0 0.00022521504433825612
. O 0 0.0004451173881534487

Human B-Disease 0 0.0018312104512006044
complement I-Disease 0 0.003968869801610708
factor I-Disease 0 0.2017415314912796
H I-Disease 1 0.9999995231628418
deficiency I-Disease 1 1.0
associated O 0 0.003875880502164364
with O 0 0.006408608052879572
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0027089084032922983

This O 0 0.00032806495437398553
study O 0 0.0014478147495537996
reports O 0 0.0004927851259708405
on O 0 0.00019025309302378446
six O 0 0.0003592513094190508
cases O 0 0.001953558996319771
of O 0 0.0003403981972951442
deficiency B-Disease 1 1.0
in I-Disease 0 0.00033311708830296993
the I-Disease 0 0.00014828714483883232
human I-Disease 0 0.0006526544457301497
complement I-Disease 0 0.001436966354958713
regulatory I-Disease 0 0.0032434710301458836
protein I-Disease 0 0.0015729472506791353
Factor I-Disease 0 0.02120773307979107
H I-Disease 1 0.9999361038208008
( O 0 0.007630289066582918
FH O 1 0.9999804496765137
) O 0 0.0004999806988053024
in O 0 7.489677955163643e-05
the O 0 4.47690581495408e-05
context O 0 0.00015699418145231903
of O 0 3.306629150756635e-05
an O 0 0.017797434702515602
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.002647681161761284

Five O 0 0.0003835690440610051
of O 0 2.378941462666262e-05
the O 0 0.00043804282904602587
cases O 0 0.002148789819329977
were O 0 4.342227475717664e-05
observed O 0 0.00042630149982869625
in O 0 0.00015640861238352954
children O 0 0.00085649942047894
presenting O 0 0.014346683397889137
with O 0 0.007057680748403072
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.7346208691596985
HUS B-Disease 1 1.0
) O 0 0.002316276542842388
. O 0 0.0006775053916499019

Two O 0 6.668821879429743e-05
of O 0 1.6838992451084778e-05
the O 0 0.00037385441828519106
children O 0 0.002124510006979108
exhibited O 0 0.01906231790781021
a O 0 0.004002830013632774
homozygous O 1 0.9668067693710327
deficiency O 1 1.0
characterized O 0 0.2970987558364868
by O 0 0.0001047097030095756
the O 0 0.00028688719612546265
absence O 0 0.0026767165400087833
of O 0 1.6928435798035935e-05
the O 0 0.0004434244765434414
150 O 0 0.0063768476247787476
- O 0 0.01976402848958969
kD O 0 0.16267363727092743
form O 0 0.0001914201711770147
of O 0 3.647888661362231e-05
Factor O 0 0.03711174055933952
H O 1 0.9995881915092468
and O 0 0.0001942950184457004
the O 0 0.0002467536542098969
presence O 0 0.0014273584820330143
, O 0 0.0003786449378821999
upon O 0 0.0015080408193171024
immunoblotting O 1 0.7968136072158813
, O 0 9.675120963947847e-05
of O 0 1.1119465852971189e-05
the O 0 0.0003570829576347023
42 O 0 0.010964042507112026
- O 0 0.014670517295598984
kD O 1 0.8536012172698975
Factor O 0 0.013381663709878922
H O 1 0.998789370059967
- O 0 0.0026209685020148754
like O 0 0.00011792662553489208
protein O 0 0.00059296446852386
1 O 0 0.0027532840613275766
( O 0 0.0026780853513628244
FHL O 1 0.9999109506607056
- O 0 0.01575900800526142
1 O 0 0.0021887272596359253
) O 0 0.00018175797595176846
and O 0 0.00011421208910178393
other O 0 0.0004846215306315571
FH O 1 0.9999674558639526
- O 0 0.009057510644197464
related O 0 0.0014793933369219303
protein O 0 0.0024538773577660322
( O 0 0.002531156875193119
FHR O 1 0.9990119934082031
) O 0 0.0007417327142320573
bands O 0 0.0012437553377822042
. O 0 0.000575779180508107

Southern O 0 0.01952359825372696
blot O 1 0.9901366233825684
and O 0 0.0004137043724767864
PCR O 0 0.008603452704846859
analysis O 0 0.0001478535559726879
of O 0 1.3445428521663416e-05
DNA O 0 0.00048270775005221367
of O 0 1.3865403161616996e-05
one O 0 0.0004736470291391015
patient O 1 0.9997736811637878
with O 0 0.000557568040676415
homozygous O 1 0.9651570916175842
deficiency O 1 1.0
ruled O 0 0.00877273827791214
out O 0 0.00011604541214182973
the O 0 9.49008681345731e-05
presence O 0 0.00025563471717759967
of O 0 1.2240418982401025e-05
a O 0 0.0004085676046088338
large O 0 0.0002344780950807035
deletion O 0 0.004336985759437084
of O 0 3.652138912002556e-05
the O 0 0.0022673499770462513
FH O 1 0.9999918937683105
gene O 0 0.003331335261464119
as O 0 0.0002027689479291439
the O 0 0.00033957374398596585
underlying O 1 0.9938308000564575
defect O 1 0.9997504353523254
for O 0 0.0005426303832791746
the O 0 0.0031849348451942205
deficiency O 1 1.0
. O 0 0.0013567995047196746

The O 0 0.000591539777815342
other O 0 7.243453001137823e-05
four O 0 0.00020006150589324534
children O 0 0.0008698521414771676
presented O 0 0.0009206600370816886
with O 0 0.00038227715413086116
heterozygous O 1 0.7057733535766602
deficiency O 1 0.9999998807907104
and O 0 0.000631313247140497
exhibited O 0 0.027462461963295937
a O 0 0.0019059476908296347
normal O 0 0.014198758639395237
immunoblotting O 1 0.5802205801010132
pattern O 0 0.001713050645776093
of O 0 6.825824129919056e-06
proteins O 0 5.089137994218618e-05
of O 0 2.8688833481282927e-05
the O 0 0.002837082836776972
FH O 1 0.9999960660934448
family O 0 0.003848990425467491
. O 0 0.0008618864230811596

Factor B-Disease 0 0.3382498025894165
H I-Disease 1 0.9999847412109375
deficiency I-Disease 1 0.9999996423721313
is O 0 0.0003901655145455152
the O 0 0.00010539860522840172
only O 0 0.0002605612971819937
complement B-Disease 1 0.9993470311164856
deficiency I-Disease 1 1.0
associated O 0 0.003174800658598542
with O 0 0.001705856528133154
HUS B-Disease 1 1.0
. O 0 0.0018648133845999837

These O 0 7.229142647702247e-05
observations O 0 0.0007861924823373556
suggest O 0 0.0006388458423316479
a O 0 0.0003600663039833307
role O 0 0.0035223437007516623
for O 0 0.0023394611198455095
FH O 1 0.9999971389770508
and O 0 0.0025253475178033113
/ O 1 0.9931841492652893
or O 0 0.0038762858603149652
FH O 1 0.9998835325241089
receptors O 0 0.004861397668719292
in O 0 0.00010654177458491176
the O 0 0.0004665482265409082
pathogenesis O 1 0.9999938011169434
of O 0 0.0012026105541735888
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 0.0015140719478949904
. O 0 0.0007663797005079687

Further O 0 0.0009036779520101845
evidence O 0 0.0001956685446202755
for O 0 8.216412243200466e-05
a O 0 0.00029310642275959253
major O 0 0.0013880723854526877
ancient O 0 0.0009296887437812984
mutation O 0 0.013842788524925709
underlying O 1 0.9998877048492432
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 0.0026321508921682835
linkage O 1 0.5802859663963318
disequilibrium O 1 0.9942836165428162
studies O 0 0.0019524318631738424
in O 0 0.00015526413335464895
the O 0 0.00019028934184461832
Japanese O 0 0.0013855438446626067
population O 0 0.00011768240801757202
. O 0 0.0004716464609373361

The O 0 0.009078926406800747
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.574679970741272
DM B-Disease 1 1.0
) O 0 0.0012094560079276562
mutation O 0 0.0016382704488933086
is O 0 0.00025516669848002493
an O 0 0.0008142536971718073
unstable O 1 0.9995699524879456
( O 0 0.006891645025461912
CTG O 1 0.9988208413124084
) O 0 0.0016191409667953849
n O 0 0.009033898822963238
repeat O 0 0.026869310066103935
, O 0 0.0003872262896038592
present O 0 0.00034129631239920855
at O 0 0.0008790046558715403
a O 0 0.0005376551998779178
copy O 0 0.0006871369550935924
number O 0 1.4405730325961486e-05
of O 0 2.989673703268636e-05
5 O 0 0.003829566529020667
- O 0 0.010503439232707024
37 O 0 0.004386670421808958
repeats O 0 0.005896109156310558
on O 0 0.0003101589099969715
normal O 0 0.002226515905931592
chromosomes O 0 0.00038489687722176313
but O 0 9.717747161630541e-05
amplified O 0 0.0014936464140191674
to O 0 0.00013868253154214472
50 O 0 0.0014043942792341113
- O 0 0.00889931432902813
3000 O 0 0.03735232353210449
copies O 0 0.0005547156906686723
on O 0 0.0028861004393547773
DM B-Disease 1 0.9999995231628418
chromosomes O 0 0.002517960499972105
. O 0 0.0004933307645842433

Previous O 0 0.004843524657189846
findings O 0 0.006320130079984665
in O 0 0.0004991560126654804
Caucasian O 0 0.06339714676141739
populations O 0 0.00036835161154158413
of O 0 5.2879313443554565e-05
a O 0 0.017729537561535835
DM B-Disease 1 1.0
founder O 1 0.5474486351013184
chromosome O 0 0.004893558565527201
raise O 0 0.0015678126364946365
a O 0 0.0005981717258691788
question O 0 0.0008752333233132958
about O 0 0.0001792137773009017
the O 0 0.0002003455738304183
molecular O 0 0.004103916697204113
events O 0 0.0003730656171683222
involved O 0 0.0010926489485427737
in O 0 9.633979061618447e-05
the O 0 0.0001752820098772645
expansion O 0 0.005120893474668264
mutation O 0 0.004419103730469942
. O 0 0.0005416067433543503

To O 0 0.0006379024125635624
investigate O 0 0.00911665614694357
whether O 0 0.0006467676721513271
a O 0 0.0009210719726979733
founder O 0 0.016241157427430153
chromosome O 0 0.0018260158831253648
for O 0 0.00031744761508889496
the O 0 0.002557827392593026
DM B-Disease 1 1.0
mutation O 0 0.009988727979362011
exists O 0 0.0017433187458664179
in O 0 0.000142557400977239
the O 0 0.0002050063048955053
Japanese O 0 0.0019234344363212585
population O 0 0.00016456851153634489
, O 0 0.0004318895225878805
we O 0 0.0006896000122651458
genotyped O 0 0.12332777678966522
families O 0 0.00020560943812597543
using O 0 0.00023080249957274646
polymorphic O 0 0.04673485457897186
markers O 0 0.013139739632606506
near O 0 0.0040915790013968945
the O 0 0.0006526015349663794
( O 0 0.003165933769196272
CTG O 1 0.998910665512085
) O 0 0.001239582197740674
n O 0 0.006641218904405832
repeat O 0 0.01741158217191696
region O 0 0.0032216329127550125
and O 0 0.00023174956731963903
constructed O 0 0.008139554411172867
haplotypes O 0 0.03044295683503151
. O 0 0.000669176341034472

Six O 0 0.0006832066574133933
different O 0 5.43885980732739e-05
haplotypes O 0 0.012364065274596214
were O 0 0.0001034681117744185
found O 0 0.0009483442408964038
and O 0 0.0019655779469758272
DM B-Disease 1 0.9999998807907104
alleles O 0 0.008809501305222511
were O 0 0.00010259429109282792
always O 0 0.0014319889014586806
haplotype O 0 0.12325572967529297
A O 0 0.007040105760097504
. O 0 0.0007805002969689667

To O 0 0.0004971125745214522
find O 0 0.0004755799600388855
an O 0 7.131067104637623e-05
origin O 0 1.8165368601330556e-05
of O 0 1.4939407265046611e-05
the O 0 0.0007853250135667622
( O 0 0.00548328272998333
CTG O 1 0.9993483424186707
) O 0 0.0014653416583314538
n O 0 0.006991423200815916
repeat O 0 0.021266885101795197
mutation O 0 0.004306440241634846
and O 0 0.00021138248848728836
to O 0 0.00026630214415490627
investigate O 0 0.008099853992462158
the O 0 0.0001262862206203863
mechanism O 0 0.0007224592845886946
of O 0 1.8296021153219044e-05
the O 0 0.0002506762684788555
expansion O 0 0.005380888935178518
mutation O 0 0.0019455852452665567
in O 0 0.0001500411453889683
the O 0 0.0002266065130243078
Japanese O 0 0.0014551287749782205
population O 0 8.137369150063023e-05
we O 0 0.00015889281348790973
have O 0 7.454805745510384e-05
studied O 0 0.0012307127472013235
90 O 0 0.0025143176317214966
Japanese O 0 0.01359481830149889
DM B-Disease 1 0.9999996423721313
families O 0 0.0009526799549348652
comprising O 0 0.0008711493574082851
190 O 0 0.017382176592946053
affected O 0 0.010331301018595695
and O 0 0.00037617102498188615
130 O 0 0.008380591869354248
unaffected O 0 0.18889863789081573
members O 0 0.00042727874824777246
. O 0 0.0005677273729816079

The O 0 0.0010973189491778612
results O 0 0.0014458134537562728
suggest O 0 0.0009428606717847288
that O 0 5.830338704981841e-05
a O 0 0.00043035083217546344
few O 0 0.00034294684883207083
common O 0 0.0024371789768338203
ancestral O 0 0.012529294937849045
mutations O 0 0.004522502887994051
in O 0 0.0002980607678182423
both O 0 0.0008140624850057065
Caucasian O 1 0.9932048320770264
and O 0 0.0006115821888670325
Japanese O 0 0.0032353666611015797
populations O 0 0.0009328661253675818
have O 0 0.00012834870722144842
originated O 0 0.0004846808733418584
by O 0 2.4781444153632037e-05
expansion O 0 0.0008170089568011463
of O 0 1.8054524844046682e-05
an O 0 0.00043932642438448966
ancestral O 0 0.014271102845668793
n O 0 0.01096757035702467
= O 0 0.009604379534721375
5 O 0 0.0012087407521903515
repeat O 0 0.006407096050679684
to O 0 0.00021388630557339638
n O 0 0.006480546668171883
= O 0 0.010522078722715378
19 O 0 0.004859596025198698
- O 0 0.006360746454447508
37 O 0 0.0020822652149945498
copies O 0 0.00046500645112246275
. O 0 0.00047192678903229535

These O 0 7.316303526749834e-05
data O 0 0.0001308839418925345
support O 0 0.00082709378330037
multistep O 0 0.0437939390540123
models O 0 0.0008382489322684705
of O 0 8.946110028773546e-05
triplet O 1 0.9860588908195496
repeat O 0 0.03259536623954773
expansion O 0 0.0034750751219689846
that O 0 9.06402783584781e-05
have O 0 6.796492380090058e-05
been O 0 0.0001636455999687314
proposed O 0 0.00040496952715329826
for O 0 0.00022454350255429745
both O 0 0.0018777408404275775
DM B-Disease 1 1.0
and O 0 0.0016868958482518792
Friedreichs B-Disease 1 0.9998944997787476
ataxia I-Disease 1 0.9999732971191406
. O 0 0.0008088393369689584
. O 0 0.000647270237095654

The O 0 0.00035518064396455884
molecular O 0 0.0011630234075710177
basis O 0 0.00010550700972089544
of O 0 0.0003463039465714246
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0005471342010423541
the O 0 0.0004453625006135553
western O 0 0.005108734592795372
Cape O 0 0.06486745923757553
, O 0 0.0006555002182722092
South O 0 0.0037831219378858805
Africa O 0 0.0037572085857391357
. O 0 0.000504082883708179

Deficiency B-Disease 1 0.9999985694885254
of I-Disease 0 5.671011967933737e-05
the I-Disease 0 0.00033571719541214406
sixth I-Disease 0 0.005532527808099985
component I-Disease 0 0.00280228303745389
of I-Disease 0 2.2976204490987584e-05
human I-Disease 0 0.0015747410943731666
complement I-Disease 0 0.011186371557414532
( O 0 0.004947612527757883
C6 O 1 0.9999892711639404
) O 0 0.001470634713768959
has O 0 0.0012616363819688559
been O 0 0.0009347243467345834
reported O 0 0.003293015295639634
in O 0 0.00011511566117405891
a O 0 0.00023672395036555827
number O 0 1.8211399947176687e-05
of O 0 2.1468194972840138e-05
families O 0 0.00037080381298437715
from O 0 0.00015102638280950487
the O 0 0.0004691587237175554
western O 0 0.0048577007837593555
Cape O 0 0.05565495416522026
, O 0 0.000824297487270087
South O 0 0.003717333311215043
Africa O 0 0.00382159068249166
. O 0 0.0005624699406325817

Meningococcal B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
is O 0 0.003098101355135441
endemic O 0 0.05291662737727165
in O 0 0.0003592772118281573
the O 0 0.0008675145800225437
Cape O 0 0.04012826085090637
and O 0 0.0001372930855723098
almost O 0 0.00021678120538126677
all O 0 2.3765178411849774e-05
pedigrees O 0 0.0021254525054246187
of O 0 2.1002495486754924e-05
total O 0 0.002129410393536091
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 0.009518910199403763
C6Q0 O 1 0.9998975992202759
) O 0 0.00047992446343414485
have O 0 7.352435204666108e-05
been O 0 0.00028832978568971157
ascertained O 0 0.00995019543915987
because O 0 0.00023464580590371042
of O 0 0.00012557437003124505
recurrent O 1 0.9999998807907104
disease O 1 1.0
. O 0 0.001478769932873547

We O 0 0.0010423273779451847
have O 0 8.765365782892331e-05
sequenced O 0 0.0012011141516268253
the O 0 9.508529183221981e-05
expressed O 0 0.0003215242177248001
exons O 0 0.0019808937795460224
of O 0 2.798282730509527e-05
the O 0 0.001413943711668253
C6 O 1 0.9999747276306152
gene O 0 0.005371979437768459
from O 0 0.00017549740732647479
selected O 0 0.0008690394461154938
cases O 0 0.002102470491081476
and O 0 0.0001346387289231643
have O 0 9.730377496453002e-05
found O 0 0.00020804347877856344
three O 0 0.00011809822171926498
molecular O 0 0.04922126606106758
defects O 1 0.999971866607666
leading O 0 0.0021297766361385584
to O 0 0.00015794509090483189
total O 0 0.0018753213807940483
deficiency O 1 1.0
879delG O 1 0.9958981871604919
, O 0 0.00043416916741989553
which O 0 6.654350727330893e-05
is O 0 0.00029864016687497497
the O 0 0.0003074069682043046
common O 0 0.009326291270554066
defect O 1 0.9993047714233398
in O 0 0.0003755226789508015
the O 0 0.0008352020522579551
Cape O 0 0.040516894310712814
and O 0 0.000409632280934602
hitherto O 0 0.04328547418117523
unreported O 0 0.040941059589385986
, O 0 0.0004873007710557431
and O 0 0.0005705647054128349
1195delC O 1 0.9682756662368774
and O 0 0.0008438700460828841
1936delG O 1 0.976934552192688
, O 0 0.00040147319668903947
which O 0 8.692416304256767e-05
have O 0 8.758564217714593e-05
been O 0 0.0004226970486342907
previously O 0 0.0017796988831833005
reported O 0 0.0032641321886330843
in O 0 0.0003025018086191267
African O 0 0.005646535195410252
- O 0 0.015216026455163956
Americans O 0 0.0027518244460225105
. O 0 0.0005671256803907454

We O 0 0.0011430945014581084
also O 0 0.00021129948436282575
show O 0 0.0002545868919696659
that O 0 3.5916371416533366e-05
the O 0 0.00024961543385870755
879delG O 1 0.9794114232063293
and O 0 0.0008941414416767657
1195delC O 1 0.9995064735412598
defects O 1 0.9999454021453857
are O 0 4.347149297245778e-05
associated O 0 0.0003106208750978112
with O 0 0.0001547556894365698
characteristic O 1 0.9820979237556458
C6 O 1 0.9999998807907104
/ O 1 0.999703586101532
C7 O 1 0.9999091625213623
region O 0 0.010324868373572826
DNA O 0 0.006248293444514275
marker O 0 0.03742029517889023
haplotypes O 0 0.030866380780935287
, O 0 0.0003810976922977716
although O 0 0.000296740880003199
small O 0 0.0001354838314000517
variations O 0 0.00019689436885528266
were O 0 5.75582635065075e-05
observed O 0 0.0010759395081549883
. O 0 0.0005111311911605299

The O 0 0.0034610016737133265
1936delG O 1 0.9956769347190857
defect O 1 0.9991562366485596
was O 0 0.001812795177102089
observed O 0 0.0006095262360759079
only O 0 0.00010117816418642178
once O 0 0.0015356233343482018
in O 0 0.00017210125224664807
the O 0 0.0007890260894782841
Cape O 0 0.0507211796939373
, O 0 0.00039163182373158634
but O 0 0.000162072668899782
its O 0 0.00034540248452685773
associated O 0 0.0018638587789610028
haplotype O 0 0.10552705079317093
could O 0 0.0003092536353506148
be O 0 9.603681974112988e-05
deduced O 0 0.004355922807008028
. O 0 0.00034249384771101177

The O 0 0.00042391885654069483
data O 0 0.00019908344256691635
from O 0 9.334607602795586e-05
the O 0 0.00041861008503474295
haplotypes O 0 0.023136571049690247
indicate O 0 0.0011173487873747945
that O 0 3.066755016334355e-05
these O 0 1.4632039892603643e-05
three O 0 0.00018726152484305203
molecular O 0 0.05181938782334328
defects O 1 0.999774158000946
account O 0 0.0002509385521989316
for O 0 0.00036447448655962944
the O 0 0.0014902097173035145
defects O 1 0.9999773502349854
in O 0 0.00015140994219109416
all O 0 3.266626663389616e-05
the O 0 0.00040254625491797924
38 O 0 0.010157933458685875
unrelated O 0 0.06904862076044083
C6Q0 O 1 0.9996035695075989
individuals O 0 0.0006813729414716363
we O 0 0.00034402962774038315
have O 0 0.00011336186435073614
studied O 0 0.0009216426406055689
from O 0 9.620612399885431e-05
the O 0 0.0005590458167716861
Cape O 0 0.04430650174617767
. O 0 0.0007043248042464256

We O 0 0.0009807214373722672
have O 0 8.443387196166441e-05
also O 0 0.00011301486665615812
observed O 0 0.0003334847278892994
the O 0 0.0004911742871627212
879delG O 1 0.9882633090019226
defect O 1 0.9778195023536682
in O 0 0.00013833463890478015
two O 0 0.00012159567268099636
Dutch O 0 0.039708565920591354
C6 B-Disease 1 0.9999998807907104
- I-Disease 1 0.999487042427063
deficient I-Disease 1 0.9999994039535522
kindreds O 1 0.9333860278129578
, O 0 0.0004012704303022474
but O 0 0.0002192872780142352
the O 0 0.0005799634382128716
879delG O 1 0.9938123226165771
defect O 1 0.995441198348999
in O 0 0.0003291690081823617
the O 0 0.0007295631221495569
Cape O 0 0.08765996992588043
probably O 0 0.004716595634818077
did O 0 0.0008066461887210608
not O 0 0.00010332356032449752
come O 0 0.00013311604561749846
from O 0 5.9558675275184214e-05
The O 0 0.00046524606295861304
Netherlands O 0 0.003677037777379155
. O 0 0.00028342523728497326
. O 0 0.0005425649578683078

Complement B-Disease 1 0.9862028360366821
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.0010952178854495287
seven O 0 0.0002040186373051256
further O 0 0.0007077839109115303
molecular O 1 0.6006667613983154
defects O 1 0.9999916553497314
and O 0 0.00016042645438574255
their O 0 8.363285451196134e-05
associated O 0 0.0015802981797605753
marker O 0 0.05002538114786148
haplotypes O 0 0.029020769521594048
. O 0 0.0006950314273126423

Seven O 0 0.0005742533830925822
further O 0 0.00019863367197103798
molecular O 0 0.0012626064708456397
bases O 0 0.000465331511804834
of O 0 0.00037844988401047885
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.00024849484907463193
described O 0 0.0067236898466944695
. O 0 0.0006192334112711251

All O 0 8.570354839321226e-05
these O 0 3.356415982125327e-05
new O 0 0.0008164715836755931
molecular O 0 0.045010920614004135
defects O 1 0.9998654127120972
involve O 0 0.00309046171605587
single O 0 0.0010510710999369621
- O 0 0.0036198655143380165
nucleotide O 0 0.0003632398147601634
events O 0 0.0003530222165863961
, O 0 0.00043876294512301683
deletions O 0 0.004604934249073267
and O 0 0.00021990576351527125
substitutions O 0 0.0020841634832322598
, O 0 0.00012845927267335355
some O 0 2.1817410015501082e-05
of O 0 1.955637344508432e-05
which O 0 0.0001783189072739333
alter O 0 0.03305918723344803
splice O 0 0.03813475742936134
sites O 0 0.0012760302051901817
, O 0 0.0002720933989621699
and O 0 0.00021474230743478984
others O 0 0.0009221630170941353
codons O 0 0.00990660022944212
. O 0 0.0005558710545301437

They O 0 0.00018087624630425125
are O 0 1.7872762327897362e-05
distributed O 0 0.0002016757061937824
along O 0 0.0002576573460828513
the O 0 0.0008974347147159278
C7 O 1 0.9999908208847046
gene O 0 0.008430734276771545
, O 0 0.0003092563129030168
but O 0 0.00014641760208178312
predominantly O 0 0.0003671449376270175
towards O 0 0.0007575509953312576
the O 0 0.00043441756861284375
3 O 0 0.0029432771261781454
end O 0 0.004639890044927597
. O 0 0.0007129587465897202

All O 0 0.00017964013386517763
were O 0 6.157327879918739e-05
found O 0 0.00027064731693826616
in O 0 0.00024458166444674134
compound O 0 0.02332315221428871
heterozygous O 0 0.006864911876618862
individuals O 0 0.0004494728927966207
. O 0 0.000735633191652596

The O 0 0.006518282927572727
C6 O 1 0.9999988079071045
/ O 1 0.999014139175415
C7 O 1 0.999970555305481
marker O 0 0.06908463686704636
haplotypes O 0 0.021538080647587776
associated O 0 0.0005193504621274769
with O 0 0.00013203341222833842
most O 0 0.0035350879188627005
C7 B-Disease 1 0.9999995231628418
defects I-Disease 1 0.9999642372131348
are O 0 0.00013034787843935192
tabulated O 0 0.004543363582342863
. O 0 0.0002979888813570142
. O 0 0.00044099302613176405

A O 0 0.011478878557682037
genome O 0 0.011738060042262077
- O 0 0.005402995739132166
wide O 0 0.0006994614377617836
search O 0 0.0005592840607278049
for O 0 0.00035211333306506276
chromosomal O 0 0.06588856130838394
loci O 0 0.03262946754693985
linked O 0 0.029572566971182823
to O 0 0.001023993594571948
mental O 1 0.9999998807907104
health O 1 0.9999946355819702
wellness O 1 0.9999663829803467
in O 0 0.0004115501942578703
relatives O 0 0.00125863344874233
at O 0 0.0009268403518944979
high O 0 0.0062360684387385845
risk O 1 0.9871988892555237
for O 0 0.004848992917686701
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
among O 0 0.0004415552248246968
the O 0 0.000434809917351231
Old O 0 0.006747910287231207
Order O 0 0.0005688309902325273
Amish O 0 0.022059878334403038
. O 0 0.0006428426131606102

Bipolar B-Disease 1 1.0
affective I-Disease 1 0.9999997615814209
disorder I-Disease 1 1.0
( O 0 0.019522037357091904
BPAD B-Disease 1 0.9999997615814209
; O 0 0.0046203359961509705
manic B-Disease 1 1.0
- I-Disease 1 0.9999949932098389
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 0.0009588246466591954
is O 0 0.000749387894757092
characterized O 0 0.02192593179643154
by O 0 6.822968134656549e-05
episodes O 0 0.0010870125843212008
of O 0 0.00016707838221918792
mania B-Disease 1 0.9999856948852539
and O 0 0.0027087139897048473
/ O 1 0.997116208076477
or O 0 0.00457390770316124
hypomania B-Disease 1 0.9999691247940063
interspersed O 0 0.005050517152994871
with O 0 8.34033198771067e-05
periods O 0 0.0011159504065290093
of O 0 0.0002094109368044883
depression B-Disease 1 0.9999994039535522
. O 0 0.0011945160804316401

Compelling O 0 0.010314022190868855
evidence O 0 0.0008127196924760938
supports O 0 0.0039323302917182446
a O 0 0.00035733068943955004
significant O 0 0.0007736742263659835
genetic O 0 0.002129589207470417
component O 0 0.006657023914158344
in O 0 0.00016278217663057148
the O 0 0.00032899269717745483
susceptibility O 1 0.7752084136009216
to O 0 0.0005790145951323211
develop O 1 0.9917606115341187
BPAD B-Disease 1 0.9999932050704956
. O 0 0.0009958427399396896

To O 0 0.0006801668205298483
date O 0 0.0006727557047270238
, O 0 0.00027539909933693707
however O 0 0.0005944249569438398
, O 0 0.00047938316129148006
linkage O 0 0.04231970012187958
studies O 0 0.0013216319493949413
have O 0 8.507152961101383e-05
attempted O 0 0.0009023507591336966
only O 0 3.961304173571989e-05
to O 0 9.654570021666586e-05
identify O 0 0.0029918060172349215
chromosomal O 0 0.042620699852705
loci O 0 0.017127281054854393
that O 0 0.00036258139880374074
cause O 0 0.0561540387570858
or O 0 0.000363740895409137
increase O 0 0.00042355895857326686
the O 0 0.0002852134930435568
risk O 0 0.03281654044985771
of O 0 7.246639142977074e-05
developing O 1 0.9820132851600647
BPAD B-Disease 1 0.999996542930603
. O 0 0.0013961703516542912

To O 0 0.00042974884854629636
determine O 0 0.000820618646685034
whether O 0 0.0004222565912641585
there O 0 7.43801865610294e-05
could O 0 0.0002571991353761405
be O 0 0.00022791702940594405
protective O 1 0.9933688044548035
alleles O 0 0.004971518646925688
that O 0 0.00019205383432563394
prevent O 0 0.010150542482733727
or O 0 0.0007810135721229017
reduce O 0 0.0073417071253061295
the O 0 0.00031461758771911263
risk O 0 0.05997517704963684
of O 0 9.80090771918185e-05
developing O 1 0.995975911617279
BPAD B-Disease 1 0.9999984502792358
, O 0 0.0005085349548608065
similar O 0 0.00024099578149616718
to O 0 9.87022795015946e-05
what O 0 0.00028802506858482957
is O 0 0.00019603998225647956
observed O 0 0.00036129611544311047
in O 0 0.00012157120363553986
other O 0 0.00029998362879268825
genetic B-Disease 1 0.9999713897705078
disorders I-Disease 1 1.0
, O 0 0.0005934569635428488
we O 0 0.0003405849856790155
used O 0 0.0017030054004862905
mental O 1 0.9999998807907104
health O 1 0.9999963045120239
wellness O 1 0.9999898672103882
( O 0 0.0007098952773958445
absence O 0 0.0017599082784727216
of O 0 2.845575363608077e-05
any O 0 0.0026356782764196396
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 0.0008134026429615915
as O 0 0.0002863682166207582
the O 0 0.00042655516881495714
phenotype O 0 0.06999645382165909
in O 0 0.00018500970327295363
our O 0 0.000920563586987555
genome O 0 0.009284271858632565
- O 0 0.008038550615310669
wide O 0 0.003132724901661277
linkage O 0 0.07955105602741241
scan O 0 0.05866072326898575
of O 0 1.757870450092014e-05
several O 0 6.536882574437186e-05
large O 0 0.0007908146362751722
multigeneration O 1 0.9889379739761353
Old O 0 0.007787644397467375
Order O 0 0.0005169075448065996
Amish O 0 0.01990908570587635
pedigrees O 0 0.016664493829011917
exhibiting O 0 0.014665128663182259
an O 0 0.00044371135300025344
extremely O 0 0.03743850812315941
high O 0 0.02186085842549801
incidence O 1 0.9993663430213928
of O 0 0.00039164471672847867
BPAD B-Disease 1 0.9999971389770508
. O 0 0.0014018673682585359

We O 0 0.0011972648790106177
have O 0 0.00011455873027443886
found O 0 0.0001669696212047711
strong O 0 0.00022251668269746006
evidence O 0 0.00023586196766700596
for O 0 0.00012596786837093532
a O 0 0.0006997184245847166
locus O 0 0.013863537460565567
on O 0 0.0007590443128719926
chromosome O 0 0.013758882880210876
4p O 1 0.9916394352912903
at O 0 0.003251030808314681
D4S2949 O 0 0.06943292170763016
( O 0 0.0005450999597087502
maximum O 0 0.0019219776149839163
GENEHUNTER O 1 0.9985491633415222
- O 0 0.010548468679189682
PLUS O 0 0.008757068775594234
nonparametric O 0 0.0457356758415699
linkage O 0 0.012860617600381374
score O 0 0.00047667621402069926
= O 0 0.005574720911681652
4 O 0 0.0014539022231474519
. O 0 0.0003284843696746975
05 O 1 0.9553006887435913
, O 0 0.00121533521451056
P O 1 0.7355000972747803
= O 0 0.009696641936898232
5 O 0 0.001106001203879714
. O 0 0.00013593184121418744
22 O 0 0.002075021853670478
x O 0 0.005175640340894461
10 O 0 0.0011905459687113762
( O 0 0.0014378532068803906
- O 0 0.010883348993957043
4 O 0 0.002253833459690213
) O 0 0.0004478700866457075
; O 0 0.0005034380592405796
SIBPAL O 1 0.9946531057357788
Pempirical O 0 0.20043106377124786
value O 0 0.0008190988446585834
< O 0 0.035866010934114456
3 O 0 0.001895563560537994
x O 0 0.005121959839016199
10 O 0 0.001122727757319808
( O 0 0.0012074371334165335
- O 0 0.011889422312378883
5 O 0 0.002349043032154441
) O 0 0.00047760840971022844
) O 0 0.0003291464236099273
and O 0 0.00026214358513243496
suggestive O 0 0.044285308569669724
evidence O 0 0.0004568257718347013
for O 0 0.00011552649812074378
a O 0 0.0006723124533891678
locus O 0 0.015714671462774277
on O 0 0.000879291445016861
chromosome O 0 0.01769743114709854
4q O 1 0.9998061060905457
at O 0 0.003001507604494691
D4S397 O 0 0.06340312212705612
( O 0 0.0004871535347774625
maximum O 0 0.0023497759830206633
GENEHUNTER O 1 0.9986825585365295
- O 0 0.011102483607828617
PLUS O 0 0.009076489135622978
nonparametric O 0 0.04362843930721283
linkage O 0 0.016579918563365936
score O 0 0.0006510184612125158
= O 0 0.006365335080772638
3 O 0 0.0012989251408725977
. O 0 0.00022240509861148894
29 O 0 0.00532571179792285
, O 0 0.0011594898533076048
P O 0 0.45156073570251465
= O 0 0.010460522957146168
2 O 0 0.001511902897618711
. O 0 0.00019256319501437247
57 O 0 0.00795003492385149
x O 0 0.006696059834212065
10 O 0 0.0012381208362057805
( O 0 0.001292768749408424
- O 0 0.010985723696649075
3 O 0 0.0021132754627615213
) O 0 0.00041492359014227986
; O 0 0.0005776426405645907
SIBPAL O 1 0.9962294697761536
Pempirical O 0 0.22936128079891205
value O 0 0.0007801986648701131
< O 0 0.03407031670212746
1 O 0 0.0026213712990283966
x O 0 0.005187557078897953
10 O 0 0.001363323419354856
( O 0 0.0015339814126491547
- O 0 0.012185280211269855
3 O 0 0.002641132799908519
) O 0 0.00044237927068024874
) O 0 0.0001422589411959052
that O 0 3.558142270776443e-05
are O 0 3.505362838041037e-05
linked O 0 0.016550684347748756
to O 0 0.0007402614573948085
mental O 1 1.0
health O 1 0.9999985694885254
wellness O 1 0.9999864101409912
. O 0 0.0009506561909802258

These O 0 0.000282761815469712
findings O 0 0.004306836519390345
are O 0 3.2706699130358174e-05
consistent O 0 0.0032569405157119036
with O 0 6.237561319721863e-05
the O 0 0.00025934758014045656
hypothesis O 0 0.0025431057438254356
that O 0 4.6502773329848424e-05
certain O 0 0.0001665865129325539
alleles O 0 0.004585667513310909
could O 0 0.0008270851103588939
prevent O 0 0.007484723813831806
or O 0 0.0006499886512756348
modify O 0 0.012474553659558296
the O 0 0.0009993554558604956
clinical O 1 0.9999841451644897
manifestations O 1 0.9783758521080017
of O 0 0.0002485504955984652
BPAD B-Disease 1 0.9999995231628418
and O 0 0.00024892023066058755
perhaps O 0 0.0011436853092163801
other O 0 0.00010900994675466791
related O 0 0.12498103082180023
affective B-Disease 1 0.9999997615814209
disorders I-Disease 1 1.0
. O 0 0.0020793206058442593

Segregation O 0 0.12397236377000809
distortion O 0 0.042674433439970016
in O 0 0.004920726642012596
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.004578906111419201

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.8099109530448914
DM B-Disease 1 1.0
) O 0 0.0008725271327421069
is O 0 0.0003032091772183776
an O 0 0.0007824554340913892
autosomal B-Disease 1 0.9999277591705322
dominant I-Disease 1 0.9996695518493652
disease I-Disease 1 1.0
which O 0 0.00034614166361279786
, O 0 0.0002213173866039142
in O 0 0.000147762504639104
the O 0 0.00032808436662890017
typical O 0 0.010177877731621265
pedigree O 0 0.06937184184789658
, O 0 0.00035732710966840386
shows O 0 0.0002138296258635819
a O 0 0.000330485898302868
three O 0 8.777176844887435e-05
generation O 0 0.0030365444254130125
anticipation O 0 0.007219354156404734
cascade O 0 0.3682801127433777
. O 0 0.0007078712806105614

This O 0 0.00021121164900250733
results O 0 0.0007997184875421226
in O 0 0.0008505417499691248
infertility B-Disease 1 0.9999997615814209
and O 0 0.06494012475013733
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.08377879112958908
CDM B-Disease 1 0.999961256980896
) O 0 0.00042480844422243536
with O 0 4.795566565007903e-05
the O 0 0.0003018872521352023
disappearance O 0 0.011045198887586594
of O 0 0.0004362684558145702
DM B-Disease 1 1.0
in O 0 0.0006169636035338044
that O 0 0.0002488786994945258
pedigree O 0 0.05419906973838806
. O 0 0.0007510915747843683

The O 0 0.0004360077728051692
concept O 0 0.0005547103937715292
of O 0 6.932607357157394e-05
segregation O 0 0.18202710151672363
distortion O 0 0.04434318095445633
, O 0 0.0006505224737338722
where O 0 0.00031252048211172223
there O 0 0.00012104580673621967
is O 0 0.0004907764378003776
preferential O 0 0.00976281426846981
transmission O 0 0.0049547189846634865
of O 0 1.8639369955053553e-05
the O 0 0.00016761277220211923
larger O 0 0.000603373977355659
allele O 0 0.008120736107230186
at O 0 0.002374424831941724
the O 0 0.004210280254483223
DM B-Disease 1 1.0
locus O 0 0.06828231364488602
, O 0 0.0006396938697434962
has O 0 0.0007045744569040835
been O 0 0.00026875099865719676
put O 0 0.00045379417133517563
forward O 0 0.000364598206942901
to O 0 8.608951611677185e-05
explain O 0 0.0036215889267623425
partially O 0 0.016681019216775894
the O 0 0.0004039310442749411
maintenance O 1 0.9958480596542358
of O 0 0.000738746311981231
DM B-Disease 1 1.0
in O 0 0.00034232655889354646
the O 0 0.00017576434765942395
population O 0 0.00012850631901528686
. O 0 0.0005560541758313775

In O 0 0.0004416373267304152
a O 0 0.0005273751448839903
survey O 0 0.0014912969199940562
of O 0 0.00035140544059686363
DM B-Disease 1 1.0
in O 0 0.0012161179911345243
Northern O 0 0.006279366556555033
Ireland O 0 0.0037504606880247593
, O 0 0.0007930233841761947
59 O 0 0.01731634885072708
pedigrees O 0 0.015602127648890018
were O 0 0.00018875334353651851
ascertained O 0 0.03459326922893524
. O 0 0.0005969366757199168

Sibships O 1 0.9549446105957031
where O 0 0.000671534042339772
the O 0 0.00018810063193086535
status O 0 0.0008980047423392534
of O 0 1.0636158549459651e-05
all O 0 2.924985710706096e-05
the O 0 0.00022772584634367377
members O 0 0.00027522927848622203
had O 0 0.0014456578064709902
been O 0 0.0007436971645802259
identified O 0 0.0012781673576682806
were O 0 7.907988037914038e-05
examined O 0 0.01395413652062416
to O 0 7.410704711219296e-05
determine O 0 0.0003739117819350213
the O 0 0.00010909439879469573
transmission O 0 0.0038916345220059156
of O 0 4.735475158668123e-05
the O 0 0.003365651238709688
DM B-Disease 1 1.0
expansion O 0 0.011695378459990025
from O 0 0.0004144806298427284
affected O 0 0.00852472148835659
parents O 0 0.0005556102260015905
to O 0 7.384610216831788e-05
their O 0 6.045023110345937e-05
offspring O 0 0.0030264765955507755
. O 0 0.0005256900913082063

Where O 0 0.0008396703051403165
the O 0 0.0003828982880804688
transmitting O 0 0.26982277631759644
parent O 0 0.09908062219619751
was O 0 0.003994641359895468
male O 0 0.002398359589278698
, O 0 0.0006430705543607473
58 O 0 0.013448952697217464
. O 0 0.0005947065656073391

3 O 0 0.002171335043385625
% O 0 3.7107318348716944e-05
of O 0 1.744531800795812e-05
the O 0 0.0004595434875227511
offspring O 0 0.0030621676705777645
were O 0 0.00018057123816106468
affected O 0 0.012808534316718578
, O 0 0.00048137386329472065
and O 0 0.0001728010829538107
in O 0 0.00018989460659213364
the O 0 0.00021997389558237046
case O 0 0.0009010543581098318
of O 0 1.6014304492273368e-05
a O 0 0.0010155453346669674
female O 0 0.004764944780617952
transmitting O 1 0.944324254989624
parent O 0 0.08420009166002274
, O 0 0.0010656294180080295
68 O 0 0.013958333991467953
. O 0 0.0006445873877964914

7 O 0 0.003594989189878106
% O 0 9.599067561794072e-05
were O 0 0.00010526581900194287
affected O 0 0.010302736423909664
. O 0 0.000780885573476553

Studies O 0 0.0022562954109162092
on O 0 0.0005479198298417032
meiotic O 1 0.9535990953445435
drive O 0 0.007019016891717911
in O 0 0.0026993926148861647
DM B-Disease 1 1.0
have O 0 0.0003493771073408425
shown O 0 0.0007693417137488723
increased O 0 0.0006384041626006365
transmission O 0 0.002897783648222685
of O 0 1.2744339073833544e-05
the O 0 0.00012140913895564154
larger O 0 0.0005450916360132396
allele O 0 0.005518033634871244
at O 0 0.0015680694486945868
the O 0 0.0028131892904639244
DM B-Disease 1 0.9999996423721313
locus O 0 0.02106812410056591
in O 0 0.0005116985994391143
non O 0 0.019347352907061577
- O 1 0.9957731366157532
DM O 1 0.9999998807907104
heterozygotes O 1 0.9622260928153992
for O 0 0.0011749441036954522
CTGn O 1 0.983816385269165
. O 0 0.001014547306112945

This O 0 0.0003267695428803563
study O 0 0.0010642244014889002
provides O 0 0.0013045998057350516
further O 0 0.00019678233365993947
evidence O 0 0.00018812234338838607
that O 0 7.152049511205405e-05
the O 0 0.001368829282000661
DM B-Disease 1 1.0
expansion O 0 0.008412388153374195
tends O 0 0.0046279518865048885
to O 0 8.769529085839167e-05
be O 0 0.00017651540110819042
transmitted O 0 0.00668573472648859
preferentially O 0 0.01417448464781046
. O 0 0.0005335534806363285

Diagnosis O 1 0.9999984502792358
of O 0 0.0011983190197497606
hemochromatosis B-Disease 1 1.0
. O 0 0.002845077309757471

If O 0 0.013209948316216469
untreated O 1 0.9999963045120239
, O 0 0.004193732049316168
hemochromatosis B-Disease 1 1.0
can O 0 0.001967719290405512
cause O 1 0.9994031190872192
serious O 1 0.999993085861206
illness O 1 0.9999997615814209
and O 0 0.0004521871742326766
early B-Disease 0 0.0018513933755457401
death I-Disease 0 0.005186156835407019
, O 0 0.0002340143983019516
but O 0 0.00031010215752758086
the O 0 0.0013780854642391205
disease O 1 1.0
is O 0 0.0004997705691494048
still O 0 0.0007562338723801076
substantially O 0 0.01868894137442112
under O 0 0.0026093306951224804
- O 1 0.9996860027313232
diagnosed O 1 1.0
. O 0 0.0009173951693810523

The O 0 0.0010284431045874953
cornerstone O 0 0.17133107781410217
of O 0 7.750018266960979e-05
screening O 0 0.01476126816123724
and O 0 0.00033459323458373547
case O 0 0.003864426165819168
detection O 0 0.010245428420603275
is O 0 0.0001657259272178635
the O 0 6.616549217142165e-05
measurement O 0 0.0016784613253548741
of O 0 9.805301669985056e-05
serum O 1 0.9972584247589111
transferrin O 1 0.9718099236488342
saturation O 0 0.036023154854774475
and O 0 0.0001303033932344988
the O 0 0.00037968397373333573
serum O 1 0.9933304190635681
ferritin O 1 0.9794395565986633
level O 0 0.009266292676329613
. O 0 0.0006177220493555069

Once O 0 0.007589252199977636
the O 0 0.0015120806638151407
diagnosis O 1 0.9999996423721313
is O 0 0.0020130707416683435
suspected O 0 0.024006037041544914
, O 0 0.0006286432035267353
physicians O 1 0.9940328001976013
must O 0 0.00020433306053746492
use O 0 0.0002864632406271994
serum O 1 0.9927499294281006
ferritin O 1 0.9842793345451355
levels O 0 0.006277819164097309
and O 0 0.0007880165358074009
hepatic O 1 0.9999997615814209
iron O 1 0.9989125728607178
stores O 0 0.0017612818628549576
on O 0 0.0021480924915522337
liver O 1 1.0
biopsy O 1 0.9999980926513672
specimens O 0 0.006470018066465855
to O 0 0.00037622268428094685
assess O 1 0.9906808733940125
patients O 1 0.9999877214431763
for O 0 7.986401033122092e-05
the O 0 6.61642334307544e-05
presence O 0 0.00030516847618855536
of O 0 6.887679774081334e-05
iron B-Disease 1 0.9999065399169922
overload I-Disease 1 0.9997515082359314
. O 0 0.0009870020439848304

Liver O 1 0.9999998807907104
biopsy O 1 0.999992847442627
is O 0 0.001519227516837418
also O 0 0.00022054222063161433
used O 0 0.00013341162411961704
to O 0 5.8758734667208046e-05
establish O 0 0.0008571313810534775
the O 0 0.00014641956659033895
presence O 0 0.0012798496754840016
or O 0 0.0005873318878002465
absence O 0 0.005372125189751387
of O 0 0.0002548073825892061
cirrhosis B-Disease 1 1.0
, O 0 0.0006188510451465845
which O 0 0.00010693822696339339
can O 0 0.0004046778194606304
affect O 0 0.07072065025568008
prognosis O 1 0.9999998807907104
and O 0 0.0009732373291626573
management O 1 0.9953241944313049
. O 0 0.0009006624459289014

A O 0 0.008721553720533848
DNA O 0 0.005176438484340906
- O 0 0.004417214076966047
based O 0 0.0002056645171251148
test O 0 0.0013029284309595823
for O 0 0.0001541733363410458
the O 0 0.000945583451539278
HFE O 1 0.9998621940612793
gene O 0 0.004627411253750324
is O 0 0.0003329214814584702
commercially O 0 0.002871789038181305
available O 0 0.0003955186402890831
, O 0 0.00017314744764007628
but O 0 0.00011035031639039516
its O 0 9.858723933575675e-05
place O 0 0.0001450182608095929
in O 0 0.0001266972831217572
the O 0 0.0008673129486851394
diagnosis O 1 0.9999995231628418
of O 0 0.0006048104842193425
hemochromatosis B-Disease 1 1.0
is O 0 0.002588171511888504
still O 0 0.0013958517229184508
being O 0 0.0012267902493476868
evaluated O 0 0.040846314281225204
. O 0 0.00042715700692497194

Currently O 0 0.004449380561709404
, O 0 0.0001998519874177873
the O 0 0.0001124047048506327
most O 0 0.0001693332160357386
useful O 0 0.0023226840421557426
role O 0 0.0018492680974304676
for O 0 0.00018159080354962498
this O 0 9.552679694024846e-05
test O 0 0.0031473208218812943
is O 0 0.00021935587574262172
in O 0 6.113581184763461e-05
the O 0 0.00016386013885494322
detection O 0 0.013802994973957539
of O 0 0.0004020979395136237
hemochromatosis B-Disease 1 1.0
in O 0 0.0007155603379942477
the O 0 0.00040603725938126445
family O 0 0.0008102032006718218
members O 0 0.00012435633107088506
of O 0 0.00015248992713168263
patients O 1 0.9999960660934448
with O 0 0.00010678822582121938
a O 0 0.0011753562139347196
proven O 1 0.8528896570205688
case O 0 0.0007820450700819492
of O 0 2.228478479082696e-05
the O 0 0.0028716472443193197
disease O 1 1.0
. O 0 0.0011937193339690566

It O 0 0.00036718661431223154
is O 0 0.0001441212953068316
crucial O 0 0.0025631822645664215
to O 0 0.0013102949596941471
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 0 0.15413787961006165
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.999778687953949
because O 0 0.006724836304783821
phlebotomy O 1 0.9999872446060181
therapy O 1 0.9999793767929077
can O 0 0.0006836746470071375
avert O 1 0.9985156655311584
serious O 1 0.9999985694885254
chronic O 1 1.0
disease O 1 1.0
and O 0 0.00046689348528161645
can O 0 0.00024092226522043347
even O 0 0.00020070291066076607
lead O 0 0.000262382352957502
to O 0 9.488585055805743e-05
normal O 0 0.004718987736850977
life O 0 0.0041912575252354145
expectancy O 1 0.6667616963386536
. O 0 0.00032379868207499385
. O 0 0.00045943225268274546

Prevalence O 1 0.5749828219413757
of O 0 3.0192251870175824e-05
the O 0 0.0006545331561937928
I1307K O 1 0.9822455644607544
APC B-Disease 1 0.9988558292388916
gene O 0 0.011964039877057076
variant O 0 0.028325136750936508
in O 0 0.0005625479388982058
Israeli O 0 0.006111460272222757
Jews O 0 0.00040420916047878563
of O 0 1.305494788539363e-05
differing O 0 0.00023184795281849802
ethnic O 0 7.4106763349846e-05
origin O 0 7.871071284171194e-05
and O 0 0.00029046478448435664
risk O 1 0.999864935874939
for O 1 0.5796810388565063
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0016876268200576305

BACKGROUND O 0 0.09407270699739456
& O 1 0.9158074855804443
AIMS O 0 0.16080226004123688
Israeli O 0 0.0055060298182070255
Jews O 0 0.0003043778706341982
of O 0 1.9619566955952905e-05
European O 0 0.0017660047160461545
birth O 0 0.00667869858443737
, O 0 0.0007473481819033623
i O 0 0.005916624329984188
. O 0 0.00033728574635460973
e O 0 0.004450534004718065
. O 0 0.00026481214445084333
, O 0 0.0007377603906206787
Ashkenazim O 1 0.9691357016563416
, O 0 0.00020831760775763541
have O 0 4.5033339119981974e-05
the O 0 0.0003804305160883814
highest O 1 0.99982088804245
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9996951818466187
of O 0 3.719365849974565e-05
any O 0 0.00022936344612389803
Israeli O 0 0.003765830770134926
ethnic O 0 0.00019537399930413812
group O 0 0.00122260011266917
. O 0 0.0005988530465401709

The O 0 0.0015660342760384083
I1307K O 1 0.5972936153411865
APC B-Disease 1 0.9943958520889282
gene O 0 0.008515710942447186
variant O 0 0.032362859696149826
was O 0 0.002309272065758705
found O 0 0.0004485273966565728
in O 0 0.00026617117691785097
6 O 0 0.0034982184879481792
. O 0 0.0006461644661612809

1 O 0 0.0029744100756943226
% O 0 4.810658356291242e-05
of O 0 2.600269544927869e-05
American O 0 0.0014760814374312758
Jews O 0 0.0017092573689296842
, O 0 0.0004931793664582074
28 O 0 0.001168839749880135
% O 0 1.2723246982204728e-05
of O 0 1.2563223208417185e-05
their O 0 0.0009830647613853216
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 0.08594227582216263
, O 0 0.0003184731467626989
but O 0 0.00016691884957253933
not O 0 7.930212450446561e-05
in O 0 0.00014722470950800925
non O 0 0.005753439385443926
- O 0 0.010580407455563545
Jews O 0 0.0013639084063470364
. O 0 0.0006155293085612357

We O 0 0.0009699247311800718
assessed O 0 0.01040111668407917
the O 0 0.0006469254731200635
I1307K O 1 0.9678298234939575
prevalence O 1 0.9964073300361633
in O 0 0.0006157523603178561
Israeli O 0 0.005883974488824606
Jews O 0 0.0004230100312270224
of O 0 1.332346710114507e-05
differing O 0 0.00019273000361863524
ethnic O 0 6.773724453523755e-05
origin O 0 7.624580030096695e-05
and O 0 0.000253134174272418
risk O 1 0.9996980428695679
for O 1 0.83406001329422
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0012637886684387922

METHODS O 0 0.007545094471424818
DNA O 0 0.002335031284019351
samples O 0 0.0007258964469656348
from O 0 0.00022882979828864336
500 O 0 0.005148654337972403
unrelated O 0 0.006648943293839693
Jews O 0 0.00039674178697168827
of O 0 2.992725967487786e-05
European O 0 0.0017239836743101478
or O 0 0.0015688197454437613
non O 0 0.010276664048433304
- O 0 0.009007364511489868
European O 0 0.0007295873365364969
origin O 0 0.00011139763228129596
, O 0 0.00023143825819715858
with O 0 0.00010307419870514423
or O 0 0.0005081213894300163
without O 0 0.0002917789970524609
a O 0 0.0007366243517026305
personal O 0 0.0044738538563251495
and O 0 0.0019589243456721306
/ O 1 0.9956694841384888
or O 0 0.0008220400777645409
family O 0 0.0006485230405814946
history O 0 0.0005489734467118979
of O 0 0.0001918929337989539
neoplasia B-Disease 1 0.9999960660934448
, O 0 0.0007880229386501014
were O 0 0.00013618404045701027
examined O 0 0.018338361755013466
for O 0 0.00016130214498843998
the O 0 0.000542886380571872
I1307K O 0 0.2468874454498291
variant O 0 0.012317952699959278
by O 0 5.274790964904241e-05
the O 0 0.0002927321766037494
allele O 0 0.01106192171573639
- O 0 0.00497811334207654
specific O 0 0.0006874006357975304
oligonucleotide O 0 0.2959984838962555
( O 0 0.005564957391470671
ASO O 1 0.9999556541442871
) O 0 0.0005658617010340095
method O 0 0.0008412287570536137
. O 0 0.00051514757797122

RESULTS O 0 0.010129053145647049
In O 0 0.00036493485094979405
persons O 0 0.0009474470862187445
at O 0 0.0007059607305563986
average O 0 0.0028200100641697645
risk O 1 0.994257926940918
for O 0 0.19249549508094788
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0011426926357671618
I1307K O 0 0.4833524227142334
was O 0 0.0019312576623633504
found O 0 0.00032184802694246173
in O 0 0.0002037402882706374
5 O 0 0.001584229408763349
. O 0 0.000470915314508602

0 O 0 0.0025144300889223814
% O 0 3.454996840446256e-05
of O 0 1.9879076717188582e-05
120 O 0 0.0016675068764016032
European O 0 0.001166212954558432
and O 0 0.0004578059888444841
1 O 0 0.003970944322645664
. O 0 0.0005802050582133234

6 O 0 0.003143944777548313
% O 0 3.946004289900884e-05
of O 0 3.0443672585533932e-05
188 O 0 0.026864899322390556
non O 0 0.008560191839933395
- O 0 0.0065909577533602715
European O 0 0.0011524355504661798
Jews O 0 0.0026951569598168135
( O 0 0.0033591536339372396
P O 1 0.8899272084236145
= O 0 0.012230549938976765
0 O 0 0.0030679814517498016
. O 0 0.0005676533910445869
08 O 0 0.1243336945772171
) O 0 0.0006674047908745706
. O 0 0.0005108830519020557

It O 0 0.0009913406101986766
occurred O 0 0.0018853130750358105
in O 0 0.0002470712352078408
15 O 0 0.0013162919785827398
. O 0 0.0004848766257055104

4 O 0 0.0017387791303917766
% O 0 3.452368400758132e-05
of O 0 3.320013274787925e-05
52 O 0 0.016705753281712532
Ashkenazi O 1 0.9885627031326294
Israelis O 0 0.010032989084720612
with O 0 0.0008529375772923231
familial O 1 0.9999995231628418
cancer B-Disease 1 1.0
( O 0 0.005717202089726925
P O 1 0.9926443099975586
= O 0 0.014170574024319649
0 O 0 0.003919210284948349
. O 0 0.0007269161869771779
02 O 1 0.9958360195159912
) O 0 0.0005306132370606065
and O 0 0.00017364477389492095
was O 0 0.0014426747802644968
not O 0 0.000195131593500264
detected O 0 0.005030282307416201
in O 0 0.0002316970203537494
51 O 0 0.008289567194879055
non O 0 0.006739879958331585
- O 0 0.006337395869195461
European O 0 0.0006342197302728891
Jews O 0 0.0007903989753685892
at O 0 0.0015886101173236966
increased O 0 0.028841977939009666
cancer B-Disease 1 1.0
risk O 1 0.9951543807983398
. O 0 0.0007251293864101171

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999969005584717
occurred O 0 0.03397578373551369
personally O 1 0.8355607390403748
or O 0 0.0007903610821813345
in O 0 0.00019152423192281276
the O 0 0.00017254997510463
families O 0 0.00014810993161518127
of O 0 2.3629831048310734e-05
13 O 0 0.0012558437883853912
of O 0 4.554260885925032e-05
20 O 0 0.00436990475282073
Ashkenazi O 1 0.9900463223457336
I1307K O 1 0.8849281072616577
carriers O 0 0.029613852500915527
, O 0 0.0005010983441025019
8 O 0 0.0007955319597385824
of O 0 4.1749899537535384e-05
whom O 0 0.003680200781673193
also O 0 0.00041281149606220424
had O 0 0.0007165313581936061
a O 0 0.0005912314518354833
personal O 0 0.002703523961827159
or O 0 0.0009130634134635329
family O 0 0.0005727839889004827
history O 0 0.00039469829061999917
of O 0 0.00011195331171620637
noncolonic O 1 0.9997268319129944
neoplasia B-Disease 1 0.9999841451644897
. O 0 0.0015435897512361407

CONCLUSIONS O 0 0.012840444222092628
The O 0 0.0012478692224249244
I1307K O 1 0.9702209830284119
APC O 1 0.9996775388717651
variant O 0 0.1386563777923584
may O 0 0.0008604335598647594
represent O 0 0.0001132394463638775
a O 0 0.0007421014015562832
susceptibility O 1 0.9581042528152466
gene O 0 0.005010104272514582
for O 0 0.003107313998043537
colorectal B-Disease 1 1.0
, I-Disease 0 0.0007623697747476399
or I-Disease 0 0.00044322223402559757
other I-Disease 0 0.00011350507702445611
, I-Disease 0 0.0016146287089213729
cancers I-Disease 1 0.9999984502792358
in O 0 0.0009915947448462248
Ashkenazi O 1 0.9972150325775146
Jews O 0 0.002252912614494562
, O 0 0.0004517626075539738
and O 0 0.00041191361378878355
partially O 0 0.07154466211795807
explains O 0 0.0024627139791846275
the O 0 0.00011113473010482267
higher O 0 0.0018103334587067366
incidence O 1 0.9999167919158936
of O 0 0.0028326453175395727
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.000513327366206795
European O 0 0.0017668138025328517
Israelis O 0 0.01759895496070385
. O 0 0.0005878107040189207

Systematic O 0 0.006915739271789789
analysis O 0 0.0002335167082492262
of O 0 4.865441587753594e-05
coproporphyrinogen O 1 0.9984343647956848
oxidase O 1 0.9395851492881775
gene O 0 0.023514948785305023
defects O 1 0.9999383687973022
in O 0 0.0008950611227191985
hereditary B-Disease 1 0.9998767375946045
coproporphyria I-Disease 1 0.9990634322166443
and O 0 0.0005506615270860493
mutation O 0 0.00828180555254221
update O 0 0.026658233255147934
. O 0 0.0006169059779495001

Hereditary B-Disease 1 0.998865008354187
coproporphyria I-Disease 1 0.9994970560073853
( O 0 0.008557404391467571
HC B-Disease 1 0.9999998807907104
) O 0 0.0009737497894093394
is O 0 0.00046597307664342225
an O 0 0.0021899761632084846
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 0.002063976600766182
autosomal O 1 0.999440610408783
dominant O 1 0.7148998975753784
inheritance O 0 0.26539936661720276
caused O 0 0.148899644613266
by O 0 0.0003200979845132679
deficient B-Disease 1 0.999893069267273
activity I-Disease 0 0.0003701135574374348
of I-Disease 0 5.714850703952834e-05
coproporphyrinogen I-Disease 1 0.9978991746902466
III I-Disease 1 0.9983055591583252
oxidase I-Disease 0 0.09829605370759964
( O 0 0.0024960569571703672
CPO O 1 0.8003816604614258
) O 0 0.0008245842182077467
. O 0 0.0005041167605668306

Clinical O 1 0.9999611377716064
manifestations O 0 0.19266033172607422
of O 0 7.988001016201451e-05
the O 0 0.00373437674716115
disease O 1 1.0
are O 0 0.00011689626262523234
characterized O 0 0.42344582080841064
by O 0 0.00043755373917520046
acute O 1 0.9999992847442627
attacks O 0 0.008167019113898277
of O 0 0.00045798884821124375
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 0.0027802635449916124
precipitated O 1 0.9938316345214844
by O 0 0.00022060528863221407
drugs O 0 0.15788471698760986
, O 0 0.00040613909368403256
fasting O 0 0.03559902310371399
, O 0 0.0005069062463007867
cyclical O 1 0.9981288313865662
hormonal O 1 0.9968453049659729
changes O 0 0.0012423730222508311
, O 0 0.0006875994149595499
or O 0 0.013021433725953102
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 0 0.0014572273939847946

Skin O 1 1.0
photosensitivity O 1 0.9999966621398926
may O 0 0.008762343786656857
also O 0 0.00023666910419706255
be O 0 8.51942750159651e-05
present O 0 0.000205775533686392
. O 0 0.000379979785066098

The O 0 0.000696495408192277
seven O 0 0.000526083807926625
exons O 0 0.006475175730884075
, O 0 0.0002359982900088653
the O 0 0.0007362794131040573
exon O 1 0.6477690935134888
/ O 0 0.10225227475166321
intron O 0 0.24473674595355988
boundaries O 0 0.0005154017708264291
and O 0 0.00017840886721387506
part O 0 0.0007909969426691532
of O 0 4.205298682791181e-05
3 O 0 0.0017141494899988174
noncoding O 0 0.016947375610470772
sequence O 0 5.100089038023725e-05
of O 0 1.7425514670321718e-05
the O 0 0.0007289883214980364
CPO O 0 0.43333521485328674
gene O 0 0.002819007495418191
were O 0 6.293888145592064e-05
systematically O 0 0.007218152284622192
analyzed O 0 0.0009350231848657131
by O 0 2.369427602388896e-05
an O 0 0.0003742100961972028
exon O 0 0.05570245161652565
- O 0 0.004114098381251097
by O 0 0.00012181536294519901
- O 0 0.009119965136051178
exon O 0 0.04244733974337578
denaturing O 1 0.510837197303772
gradient O 0 0.045116521418094635
gel O 1 0.9974777102470398
electrophoresis O 1 0.8320346474647522
( O 0 0.006463088560849428
DGGE O 1 0.9994931221008301
) O 0 0.0010602726833894849
strategy O 0 0.007893914356827736
followed O 0 0.00023803053773008287
by O 0 1.5501056623179466e-05
direct O 0 0.00012737017823383212
sequencing O 0 0.0004141602839808911
in O 0 9.80354452622123e-05
seven O 0 0.00039881651173345745
unrelated O 0 0.014888301491737366
heterozygous O 0 0.09590502083301544
HC B-Disease 1 0.9999998807907104
patients O 1 0.9999971389770508
from O 0 0.0005891310283914208
France O 0 0.008053438737988472
, O 0 0.0012365698348730803
Holland O 0 0.15037745237350464
, O 0 0.00040265428833663464
and O 0 0.00034073583083227277
Czech O 0 0.011322115547955036
Republic O 0 0.002035878598690033
. O 0 0.0007431558333337307

Seven O 0 0.002036748919636011
novel O 0 0.0038844302762299776
mutations O 0 0.0027245378587394953
and O 0 0.00010576045315247029
two O 0 5.0570251914905384e-05
new O 0 0.00033734444878064096
polymorphisms O 0 0.005058332812041044
were O 0 0.00014834411558695138
detected O 0 0.014805760234594345
. O 0 0.0005269181565381587

Among O 0 0.0003760871186386794
these O 0 4.532943421509117e-05
mutations O 0 0.0011485677678138018
two O 0 3.508178997435607e-05
are O 0 4.992466710973531e-05
missense O 0 0.03076280653476715
( O 0 0.0017011596355587244
G197W O 0 0.3988076448440552
, O 0 0.0014682015171274543
W427R O 1 0.5017984509468079
) O 0 0.0005935397930443287
, O 0 0.00014187340275384486
two O 0 3.878647476085462e-05
are O 0 6.65468760416843e-05
nonsense O 0 0.03553338348865509
( O 0 0.0023347516544163227
Q306X O 1 0.8004904985427856
, O 0 0.001357948873192072
Q385X O 0 0.4659249484539032
) O 0 0.0005738440668210387
, O 0 0.0001464142551412806
two O 0 2.757568654487841e-05
are O 0 1.7330470654997043e-05
small O 0 0.0003364055301062763
deletions O 0 0.009194676764309406
( O 0 0.002036984311416745
662de14bp O 1 0.6145071983337402
; O 0 0.0005766061949543655
1168del3bp O 0 0.2818230092525482
removing O 0 0.01145921554416418
a O 0 0.0010278142290189862
glycine O 0 0.0161266066133976
at O 0 0.0019074630690738559
position O 0 0.007509819697588682
390 O 0 0.0983840674161911
) O 0 0.0007949876016937196
, O 0 0.00027370391762815416
and O 0 9.699952352093533e-05
one O 0 0.0001005475060082972
is O 0 0.0001160424217232503
a O 0 0.00019468856044113636
splicing O 0 0.002608640817925334
mutation O 0 0.004579972941428423
( O 0 0.001691603334620595
IVS1 O 1 0.9983128309249878
- O 0 0.027217518538236618
15c O 1 0.9171454906463623
- O 0 0.02448960766196251
- O 0 0.015909399837255478
> O 0 0.024823622778058052
g O 0 0.012185169383883476
) O 0 0.00020976744417566806
which O 0 4.051096402690746e-05
creates O 0 0.0014558793045580387
a O 0 0.0005859815864823759
new O 0 0.0009269777219742537
acceptor O 1 0.8316187858581543
splice O 0 0.09960255026817322
site O 0 0.009307531639933586
. O 0 0.0006361271953210235

The O 0 0.002162383636459708
pathological O 1 0.9702050089836121
significance O 0 0.000832876714412123
of O 0 1.676494866842404e-05
the O 0 0.00018301546515431255
point O 0 0.0014260356547310948
mutations O 0 0.005832963157445192
G197W O 0 0.14494551718235016
, O 0 0.0010095940669998527
W427R O 0 0.09920446574687958
, O 0 0.00030204385984688997
and O 0 9.330487955594435e-05
the O 0 0.0002000584645429626
in O 0 0.0005348626291379333
- O 0 0.013001935556530952
frame O 0 0.012077570892870426
deletion O 0 0.03619271516799927
390delGly O 0 0.33167505264282227
were O 0 0.00017523556016385555
assessed O 0 0.013690263032913208
by O 0 4.1021248762262985e-05
their O 0 3.904417098965496e-05
respective O 0 0.0005039332900196314
expression O 0 0.0008604274480603635
in O 0 0.0001564709673402831
a O 0 0.0006830927450209856
prokaryotic O 0 0.006392068695276976
system O 0 0.0019736294634640217
using O 0 0.0003683110699057579
site O 0 0.006841661408543587
- O 0 0.0071156322956085205
directed O 0 0.0004881510976701975
mutagenesis O 0 0.021849878132343292
. O 0 0.0006365065346471965

These O 0 0.00024029779888223857
mutations O 0 0.002971029607579112
resulted O 0 0.0021067566704005003
in O 0 0.00017145216406788677
the O 0 0.0003989903489127755
absence O 0 0.00959320180118084
or O 0 0.0004238572728354484
a O 0 0.0006546367076225579
dramatic O 0 0.005427195690572262
decrease O 0 0.0034873890690505505
of O 0 7.528071728302166e-05
CPO O 1 0.6007845401763916
activity O 0 0.0017899564700201154
. O 0 0.0005481410771608353

The O 0 0.0004775038978550583
two O 0 8.265434007626027e-05
polymorphisms O 0 0.004238280933350325
were O 0 0.00010613546328386292
localized O 0 0.02205805666744709
in O 0 0.0004921405925415456
noncoding O 0 0.035962481051683426
part O 0 0.0005400805384851992
of O 0 1.4006864148541354e-05
the O 0 0.00027961962041445076
gene O 0 0.0024690867867320776
1 O 0 0.001525492174550891
) O 0 0.00022605685808230191
a O 0 0.0023153838701546192
C O 1 0.9881161451339722
/ O 1 0.5624762773513794
G O 0 0.05811196193099022
polymorphism O 0 0.0026154164224863052
in O 0 0.0002512957726139575
the O 0 0.0008665480418130755
promotor O 1 0.9781315922737122
region O 0 0.007195913698524237
, O 0 0.0006334503996185958
142 O 0 0.02493925392627716
bp O 0 0.08557633310556412
upstream O 0 0.0031561944633722305
from O 0 2.775858411041554e-05
the O 0 5.0863673095591366e-05
transcriptional O 0 0.00329417223110795
initiation O 0 0.00746242655441165
site O 0 0.005223405081778765
( O 0 0.001577162416651845
- O 0 0.03738786280155182
142C O 1 0.9450372457504272
/ O 1 0.7325006127357483
G O 0 0.19300909340381622
) O 0 0.0006718065124005079
, O 0 0.0003381700371392071
and O 0 0.00026485606213100255
2 O 0 0.0019703111611306667
) O 0 0.0001997542567551136
a O 0 0.0009247749694623053
6 O 0 0.004770155996084213
bp O 0 0.08959553390741348
deletion O 0 0.00810487475246191
polymorphism O 0 0.0019421810284256935
in O 0 0.00017694341659080237
the O 0 0.00033524652826599777
3 O 0 0.002026224974542856
noncoding O 0 0.02623562514781952
part O 0 0.0005365125834941864
of O 0 2.3322267225012183e-05
the O 0 0.000809292308986187
CPO O 1 0.5390546321868896
gene O 0 0.005661902483552694
, O 0 0.0009212321601808071
574 O 1 0.6570005416870117
bp O 0 0.11678049713373184
downstream O 0 0.003100423375144601
of O 0 2.5437131625949405e-05
the O 0 0.00031006609788164496
last O 0 0.0014004969270899892
base O 0 0.0008052622433751822
of O 0 9.280847734771669e-06
the O 0 0.00016175572818610817
normal O 0 0.005915753077715635
termination O 0 0.3563317358493805
codon O 0 0.015382463112473488
( O 0 0.00250465190038085
+ O 0 0.16862201690673828
574 O 1 0.9734150767326355
delATTCTT O 1 0.9450387358665466
) O 0 0.0008787140250205994
. O 0 0.0005071452469564974

Five O 0 0.002519174013286829
intragenic O 1 0.8046737313270569
dimorphisms O 1 0.6275820136070251
are O 0 0.00011005756095983088
now O 0 0.0009973399573937058
well O 0 0.0004573034821078181
characterized O 0 0.02981983684003353
and O 0 0.00018673980957828462
the O 0 0.00031020803726278245
high O 0 0.004755263216793537
degree O 0 0.0014657602878287435
of O 0 4.133046604692936e-05
allelic O 0 0.3108837306499481
heterogeneity O 0 0.061590276658535004
in O 0 0.002993334084749222
HC B-Disease 1 0.9999998807907104
is O 0 0.0030866884626448154
demonstrated O 0 0.0063506788574159145
with O 0 0.00011804970563389361
seven O 0 0.00036978645948693156
new O 0 0.00019496197637636214
different O 0 3.513776391628198e-05
mutations O 0 0.0013029346009716392
making O 0 0.0002831314050126821
a O 0 0.00014272116823121905
total O 0 3.915570050594397e-05
of O 0 2.5601546440157108e-05
nineteen O 0 0.017857691273093224
CPO O 1 0.9885128736495972
gene B-Disease 0 0.14968404173851013
defects I-Disease 1 0.99998939037323
reported O 0 0.010076388716697693
so O 0 0.0006020745495334268
far O 0 0.0008596128900535405
. O 0 0.0002054213109659031
. O 0 0.00042389932787045836

Coincidence O 0 0.0064168935641646385
of O 0 2.5701107006170787e-05
two O 0 0.00010250364721287042
novel O 0 0.004309156443923712
arylsulfatase O 1 0.6769341826438904
A O 0 0.0037911762483417988
alleles O 0 0.002777330344542861
and O 0 0.0002715786686167121
mutation O 0 0.009552602656185627
459 O 1 0.9758511781692505
+ O 0 0.39430075883865356
1G O 1 0.9884898066520691
> O 0 0.025069862604141235
A O 0 0.0021338551305234432
within O 0 0.00013455520092975348
a O 0 0.0007581402314826846
family O 0 0.001202996470965445
with O 0 0.0011562459403648973
metachromatic B-Disease 1 0.9999982118606567
leukodystrophy I-Disease 1 0.9999998807907104
: O 0 0.001399098546244204
molecular O 0 0.001096224063076079
basis O 0 5.0578495574882254e-05
of O 0 2.2237782104639336e-05
phenotypic O 0 0.039442725479602814
heterogeneity O 0 0.07559714466333389
. O 0 0.0010771183297038078

In O 0 0.0008171849185600877
a O 0 0.0009558457531966269
family O 0 0.0008528429316356778
with O 0 0.00016288371989503503
three O 0 0.0004664494772441685
siblings O 0 0.00834299810230732
, O 0 0.0002110401401296258
one O 0 0.00014780493802390993
developed O 0 0.002108828630298376
classical O 0 0.001043281052261591
late O 0 0.011024353094398975
infantile O 1 0.9999995231628418
metachromatic B-Disease 1 0.999996542930603
leukodystrophy I-Disease 1 0.9999998807907104
( O 0 0.019488748162984848
MLD B-Disease 1 0.9999990463256836
) O 0 0.002049459610134363
, O 0 0.0015378014650195837
fatal O 1 0.9999885559082031
at O 0 0.00271912501193583
age O 0 0.0022081807255744934
5 O 0 0.0014271968975663185
years O 0 0.0007518327329307795
, O 0 0.0001881506759673357
with O 0 0.0005476464866660535
deficient O 1 0.999990701675415
arylsulfatase O 1 0.9914986491203308
A O 0 0.015870170667767525
( O 0 0.004534476436674595
ARSA O 1 0.9997963309288025
) O 0 0.0005302764475345612
activity O 0 0.0003648271376732737
and O 0 0.00010994888725690544
increased O 0 0.0019975604955106974
galactosylsulfatide O 1 0.9949873685836792
( O 0 0.005067912396043539
GS O 1 0.999993085861206
) O 0 0.0014744115760549903
excretion O 0 0.04085078090429306
. O 0 0.0006746478611603379

The O 0 0.0005590154323726892
two O 0 7.559588266303763e-05
other O 0 0.0001285064354306087
siblings O 0 0.0066573102958500385
, O 0 0.0005718217580579221
apparently O 0 0.006661354564130306
healthy O 0 0.05822975933551788
at O 0 0.0016922550275921822
12 O 0 0.002276727231219411
( O 0 0.0012721683597192168
1 O 0 0.008968519978225231
/ O 0 0.06685696542263031
2 O 0 0.002728765131905675
) O 0 0.00034665127168409526
and O 0 0.00024929645587690175
15 O 0 0.002190344501286745
years O 0 0.0013992758467793465
, O 0 0.0004669913905672729
respectively O 0 0.0017425341065973043
, O 0 0.00035350784310139716
and O 0 0.00016210885951295495
their O 0 0.00017070113972295076
father O 0 0.005993008613586426
, O 0 0.0007445935043506324
apparently O 0 0.00923934020102024
healthy O 0 0.09184466302394867
as O 0 0.0002839620865415782
well O 0 0.0003400511050131172
, O 0 0.0005788509733974934
presented O 0 0.0095219099894166
ARSA O 1 0.9999183416366577
and O 0 0.003227892331779003
GS O 1 0.9999096393585205
values O 0 0.00017072977789212018
within O 0 4.9059101002058014e-05
the O 0 8.634644473204389e-05
range O 0 0.001020513940602541
of O 0 0.0004399676981847733
MLD B-Disease 1 1.0
patients O 1 0.9999985694885254
. O 0 0.0008597677806392312

Mutation O 0 0.020830119028687477
screening O 0 0.008237929083406925
and O 0 9.692094317870215e-05
sequence O 0 0.00011313454160699621
analysis O 0 0.001203914755024016
disclosed O 0 0.04828369617462158
the O 0 0.0002522307331673801
involvement O 0 0.007841370068490505
of O 0 2.0193818272673525e-05
three O 0 0.0001103753675124608
different O 0 0.00026771269040182233
ARSA O 1 0.9998949766159058
mutations O 0 0.008704922161996365
being O 0 0.0005100531852804124
the O 0 0.0001370129466522485
molecular O 0 0.001189720118418336
basis O 0 6.333305645966902e-05
of O 0 4.3993801227770746e-05
intrafamilial O 1 0.982376217842102
phenotypic O 0 0.04739053174853325
heterogeneity O 0 0.0530589334666729
. O 0 0.0009985617361962795

The O 0 0.001351127284578979
late O 0 0.017734680324792862
infantile O 1 0.9999998807907104
patient O 1 0.9999990463256836
inherited O 1 0.999395489692688
from O 0 0.000332462863298133
his O 0 0.0021220773924142122
mother O 0 0.0038960236124694347
the O 0 0.00017211667727679014
frequent O 0 0.00663132406771183
0 O 0 0.003508056281134486
- O 0 0.006961365230381489
type O 0 0.006869120057672262
mutation O 0 0.008430973626673222
459 O 1 0.9694972634315491
+ O 0 0.1503693163394928
1G O 1 0.9861207604408264
> O 0 0.04097473621368408
A O 0 0.006915846839547157
, O 0 0.00042241523624397814
and O 0 0.000186933291843161
from O 0 0.00018282310338690877
his O 0 0.002456613816320896
father O 0 0.004338116385042667
a O 0 0.0011871271999552846
novel O 0 0.002619899343699217
, O 0 0.0002692179987207055
single O 0 0.0012796339578926563
basepair O 1 0.9526968002319336
microdeletion O 0 0.06999099999666214
of O 0 3.196339457645081e-05
guanine O 0 0.004744177218526602
at O 0 0.0006295491475611925
nucleotide O 0 0.0004329066432546824
7 O 0 0.0009247705456800759
in O 0 0.00025231443578377366
exon O 0 0.049831416457891464
1 O 0 0.005034659057855606
( O 0 0.002053815871477127
7delG O 1 0.953826904296875
) O 0 0.0008958123507909477
. O 0 0.0005208668881095946

The O 0 0.0006411168724298477
two O 0 0.0004444318183232099
clinically O 1 0.9999704360961914
unaffected O 1 0.9891854524612427
siblings O 0 0.004191641695797443
carried O 0 0.0002448819577693939
the O 0 0.00019381505262572318
maternal O 0 0.030766086652874947
mutation O 0 0.01251448318362236
459 O 1 0.9823236465454102
+ O 0 0.37119582295417786
1G O 1 0.9929129481315613
> O 0 0.04452270641922951
A O 0 0.006189026404172182
and O 0 0.00032934005139395595
, O 0 0.00023773498833179474
on O 0 0.00018975124112330377
their O 0 9.224520908901468e-05
paternal O 0 0.013474802486598492
allele O 0 0.013551417738199234
, O 0 0.0003471490053925663
a O 0 0.0008740249322727323
novel O 0 0.0028310457710176706
cytosine O 0 0.010791783221065998
to O 0 0.0002516314561944455
thymidine O 0 0.04885808750987053
transition O 0 0.004752772394567728
at O 0 0.000836295890621841
nucleotide O 0 0.0019220649264752865
2435 O 1 0.8856692314147949
in O 0 0.0008403902174904943
exon O 0 0.06291436403989792
8 O 0 0.003079237649217248
, O 0 0.0002605965710245073
resulting O 0 0.0009026215993799269
in O 0 7.452430872945115e-05
substitution O 0 0.0003087351506110281
of O 0 4.785374767379835e-05
alanine O 0 0.20135529339313507
464 O 1 0.6823723316192627
by O 0 0.0005101081915199757
valine O 1 0.9740694165229797
( O 0 0.004077439196407795
A464V O 0 0.3546976149082184
) O 0 0.00103439437225461
. O 0 0.00050351646495983

The O 0 0.0008948052418418229
fathers O 0 0.0039097098633646965
genotype O 0 0.03463000804185867
thus O 0 0.0009261866216547787
was O 0 0.005495700053870678
7delG O 1 0.9943503737449646
/ O 1 0.9283551573753357
A464V O 0 0.17116029560565948
. O 0 0.0006376256351359189

Mutation O 0 0.02267375774681568
A464V O 0 0.09150443971157074
was O 0 0.0018143807537853718
not O 0 0.00012842474097851664
found O 0 0.00018013840599451214
in O 0 0.00016807384963613003
18 O 0 0.00245546642690897
unrelated O 1 0.972891628742218
MLD B-Disease 1 1.0
patients O 1 0.9999970197677612
and O 0 0.000354522344423458
50 O 0 0.0010721790604293346
controls O 0 0.0028539220802485943
. O 0 0.0005684678326360881

A464V O 0 0.2357306182384491
, O 0 0.00039029939216561615
although O 0 0.00042353817843832076
clearly O 0 0.0034333609510213137
modifying O 0 0.11175879836082458
ARSA O 1 0.9999344348907471
and O 0 0.0045056757517158985
GS O 1 0.9999978542327881
levels O 0 0.02001206763088703
, O 0 0.0007544250693172216
apparently O 0 0.005649572238326073
bears O 0 0.005931305233389139
little O 0 0.00045714370207861066
significance O 0 0.0010420052567496896
for O 0 0.0007204170105978847
clinical O 1 0.9999823570251465
manifestation O 1 0.9890416264533997
of O 0 0.0004599050444085151
MLD B-Disease 1 0.9999998807907104
, O 0 0.0011924157151952386
mimicking O 0 0.06135321035981178
the O 0 0.0005774570745415986
frequent O 0 0.05521629750728607
ARSA O 1 0.9998190999031067
pseudodeficiency O 1 0.9393979907035828
allele O 0 0.02136407047510147
. O 0 0.0011233467375859618

Our O 0 0.002617067424580455
results O 0 0.0013788299402222037
demonstrate O 0 0.0021212920546531677
that O 0 3.8533784390892833e-05
in O 0 5.732065255870111e-05
certain O 0 0.00019452004926279187
genetic O 0 0.008670306764543056
conditions O 1 0.9855064153671265
MLD B-Disease 1 0.9999998807907104
- O 0 0.3430387079715729
like O 0 0.0033027923200279474
ARSA O 1 0.9999325275421143
and O 0 0.0026820735074579716
GS O 1 0.999943733215332
values O 0 0.0004633284406736493
need O 0 0.000700596661772579
not O 0 6.441702134907246e-05
be O 0 5.664623677148484e-05
paralleled O 0 0.006860300432890654
by O 0 0.00043110206024721265
clinical O 1 1.0
disease O 1 1.0
, O 0 0.00021583620400633663
a O 0 0.0004434436559677124
finding O 0 0.0013506208779290318
with O 0 0.00026746498770080507
serious O 1 0.999923825263977
diagnostic O 1 0.9999649524688721
and O 0 0.0008296709274873137
prognostic O 1 0.9996941089630127
implications O 0 0.25529804825782776
. O 0 0.000698220741469413

Moreover O 0 0.01216596458107233
, O 0 0.00046765265869908035
further O 0 0.002652100520208478
ARSA O 1 0.9995922446250916
alleles O 0 0.01918204315006733
functionally O 0 0.053099703043699265
similar O 0 0.0006132730632089078
to O 0 0.0003951357211917639
A464V O 0 0.3347315192222595
might O 0 0.0015091224340721965
exist O 0 0.00026664105826057494
which O 0 4.7395991714438424e-05
, O 0 6.927294452907518e-05
together O 0 3.377949906280264e-05
with O 0 0.00011043476115446538
0 O 0 0.005193839780986309
- O 0 0.011794413439929485
type O 0 0.008561932481825352
mutations O 0 0.0035243574529886246
, O 0 0.0004155547940172255
may O 0 0.004250326193869114
cause O 1 0.9927287101745605
pathological O 1 0.9999853372573853
ARSA O 1 0.9999904632568359
and O 0 0.004827805794775486
GS O 1 0.9999986886978149
levels O 0 0.012474047020077705
, O 0 0.0003098305605817586
but O 0 0.00023728479573037475
not O 0 0.0005219752201810479
clinical O 1 0.9999889135360718
outbreak O 1 0.9936390519142151
of O 0 4.551707752398215e-05
the O 0 0.003575848415493965
disease O 1 1.0
. O 0 0.000514549610670656
. O 0 0.0005324215744622052

Human O 1 0.751264750957489
MLH1 O 1 0.9999995231628418
deficiency O 1 1.0
predisposes O 1 0.9999420642852783
to O 0 0.001950831268914044
hematological B-Disease 1 0.9999978542327881
malignancy I-Disease 1 0.9999997615814209
and O 0 0.0034392359666526318
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9403383731842041
1 I-Disease 0 0.005563320592045784
. O 0 0.0005564863095059991

Heterozygous O 0 0.06489468365907669
germ O 1 0.9994370341300964
- O 0 0.020618543028831482
line O 0 0.002616377780213952
mutations O 0 0.0010126139968633652
in O 0 8.07304895715788e-05
the O 0 0.00022638581867795438
DNA O 0 0.00839369185268879
mismatch O 1 0.9993558526039124
repair O 1 0.9993250370025635
genes O 0 0.00033951792283914983
lead O 0 0.000310733710648492
to O 0 0.0002892229240387678
hereditary B-Disease 1 0.999993085861206
nonpolyposis I-Disease 1 0.9999996423721313
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0013728825142607093

The O 0 0.009814005345106125
disease O 1 0.9999998807907104
susceptibility O 1 0.6433287262916565
of O 0 4.231014827382751e-05
individuals O 0 0.0006063007167540491
who O 0 0.0018884704913944006
constitutionally O 0 0.02541991136968136
lack O 0 0.003570824395865202
both O 0 0.0002973894588649273
wild O 0 0.0018919683061540127
- O 0 0.01535207312554121
type O 0 0.009015429764986038
alleles O 0 0.004692947492003441
is O 0 0.0007648497121408582
unknown O 0 0.0015654675662517548
. O 0 0.0005790455034002662

We O 0 0.0011574869276955724
have O 0 0.00014990841737017035
identified O 0 0.0006695676711387932
three O 0 4.2609379306668416e-05
offspring O 0 0.00037335383240133524
in O 0 8.425531268585473e-05
a O 0 0.002110934117808938
hereditary B-Disease 1 0.9999948740005493
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.004625887610018253
who O 0 0.0019001368200406432
developed O 1 0.8087388277053833
hematological B-Disease 1 0.9999979734420776
malignancy I-Disease 1 0.9999982118606567
at O 0 0.0015513069229200482
a O 0 0.0007004149374552071
very O 0 0.0012851378414779902
early O 0 0.0018677028128877282
age O 0 0.002404083963483572
, O 0 0.000509012897964567
and O 0 0.0003747077425941825
at O 0 0.0012963357148692012
least O 0 0.00021695531904697418
two O 0 1.4660101442132145e-05
of O 0 7.348641702265013e-06
them O 0 3.565421138773672e-05
displayed O 0 0.0016560852527618408
signs O 0 0.004093954339623451
of O 0 0.00017472983745392412
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.5402448773384094
1 I-Disease 0 0.009440498426556587
( O 0 0.00450114393606782
NF1 B-Disease 1 0.9999302625656128
) O 0 0.0011381014483049512
. O 0 0.0005358979688026011

DNA O 0 0.0015362720005214214
sequence O 0 7.499140338040888e-05
analysis O 0 0.000357526121661067
and O 0 0.00034272854099981487
allele O 0 0.01714065857231617
- O 0 0.0048075891099870205
specific O 0 0.00021292752353474498
amplification O 0 0.004110192414373159
in O 0 0.00015573283599223942
two O 0 0.00012058408174198121
siblings O 0 0.005636625457555056
revealed O 0 0.005715410690754652
a O 0 0.0010784703772515059
homozygous O 0 0.021555835381150246
MLH1 O 1 0.9993731379508972
mutation O 0 0.009598227217793465
( O 0 0.0015682065859436989
C676T O 1 0.7637460231781006
- O 0 0.030855562537908554
- O 0 0.01840093545615673
> O 0 0.031354404985904694
Arg226Stop O 1 0.9635964035987854
) O 0 0.0006139418692328036
. O 0 0.00043400307185947895

Thus O 0 0.0009268655558116734
, O 0 0.0001260316785192117
a O 0 0.0008248891681432724
homozygous O 0 0.018038611859083176
germ O 1 0.9995261430740356
- O 0 0.02738349698483944
line O 0 0.007649851031601429
MLH1 O 1 0.9996108412742615
mutation O 0 0.0038870195858180523
and O 0 0.000263679918134585
consequent O 1 0.9994914531707764
mismatch O 1 0.9999985694885254
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.0011447803117334843
in O 0 0.00012229557614773512
a O 0 0.0020061135292053223
mutator O 1 0.9998874664306641
phenotype O 1 0.9905637502670288
characterized O 1 0.8450754880905151
by O 0 0.001200907165184617
leukemia B-Disease 1 1.0
and O 0 0.0032311417162418365
/ O 1 0.9999198913574219
or O 0 0.4212270677089691
lymphoma B-Disease 1 1.0
associated O 0 0.0026371588464826345
with O 0 0.0008150090579874814
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9255480170249939
1 I-Disease 0 0.0042998529970645905
. O 0 0.000281853717751801
. O 0 0.00046302773989737034

Missense O 0 0.11586649715900421
mutations O 0 0.004785916768014431
in O 0 0.0001725618349155411
the O 0 0.0001252775255125016
most O 0 0.00011901598190888762
ancient O 0 0.0003016539558302611
residues O 0 0.0008474449277855456
of O 0 2.515628148103133e-05
the O 0 0.0014069402823224664
PAX6 O 1 0.9999803304672241
paired O 0 0.012830650433897972
domain O 0 0.001609630766324699
underlie O 0 0.10654021054506302
a O 0 0.00031514745205640793
spectrum O 0 0.001630584360100329
of O 0 6.808311445638537e-05
human O 1 0.999504804611206
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 0.9999995231628418
. O 0 0.0018395730294287205

Mutations O 0 0.0022211982868611813
of O 0 1.1737480235751718e-05
the O 0 0.00021201468189246953
human O 0 0.009631723165512085
PAX6 O 1 0.9999936819076538
gene O 0 0.025922728702425957
underlie O 1 0.9998377561569214
aniridia B-Disease 1 0.9999971389770508
( O 0 0.017511608079075813
congenital B-Disease 1 1.0
absence I-Disease 0 0.008697682991623878
of I-Disease 0 5.2390772907529026e-05
the I-Disease 0 0.0019519691122695804
iris I-Disease 1 0.999954104423523
) O 0 0.0005878673400729895
, O 0 0.0001810279063647613
a O 0 0.0008420852245762944
rare O 0 0.015035361051559448
dominant O 0 0.10778067260980606
malformation B-Disease 1 0.9999696016311646
of I-Disease 0 7.948950224090368e-05
the I-Disease 0 0.0020869611762464046
eye I-Disease 1 0.9999773502349854
. O 0 0.0013117172056809068

The O 0 0.0004441379278432578
spectrum O 0 0.0036408528685569763
of O 0 0.00021353746706154197
PAX6 O 1 0.9999778270721436
mutations O 0 0.008388176560401917
in O 0 0.001550970133394003
aniridia B-Disease 1 0.9999977350234985
patients O 1 0.9999946355819702
is O 0 0.0007946263067424297
highly O 0 0.006774208974093199
biased O 0 0.020609015598893166
, O 0 0.0004660148697439581
with O 0 0.00020997454703319818
92 O 0 0.014386256225407124
% O 0 2.9922977773821913e-05
of O 0 1.1603446182562038e-05
all O 0 0.00010215986549155787
reported O 0 0.006837625056505203
mutations O 0 0.002774266991764307
leading O 0 0.002819535555317998
to O 0 0.0003636420296970755
premature O 1 0.9813960194587708
truncation O 0 0.012296829372644424
of O 0 1.835402326832991e-05
the O 0 0.00021222907525952905
protein O 0 0.002380287740379572
( O 0 0.0014396259794011712
nonsense O 0 0.025570083409547806
, O 0 0.00038646606844849885
splicing O 0 0.0028903200291097164
, O 0 0.0004627894959412515
insertions O 0 0.00922004971653223
and O 0 0.0004241980204824358
deletions O 0 0.010492248460650444
) O 0 0.0004907818511128426
and O 0 0.00027390860486775637
just O 0 0.0018344257259741426
2 O 0 0.0014496303629130125
% O 0 7.872985588619485e-05
leading O 0 0.0015086763305589557
to O 0 6.212783046066761e-05
substitution O 0 0.0001514348987257108
of O 0 6.465188562287949e-06
one O 0 7.244206062750891e-05
amino O 0 0.00029867602279409766
acid O 0 0.005282040219753981
by O 0 6.135008879937232e-05
another O 0 0.0015866727335378528
( O 0 0.0018856287933886051
missense O 0 0.0579109787940979
) O 0 0.0008089912007562816
. O 0 0.0006424288731068373

The O 0 0.0006571703124791384
extraordinary O 0 0.0036566744092851877
conservation O 0 0.004140573553740978
of O 0 2.455391950206831e-05
the O 0 0.0008416569326072931
PAX6 O 1 0.998364269733429
protein O 0 0.0010886489180848002
at O 0 0.0003437729028519243
the O 0 6.539924652315676e-05
amino O 0 0.0004493319138418883
acid O 0 0.010478910990059376
level O 0 0.003251457354053855
amongst O 0 0.0018146710935980082
vertebrates O 0 0.009702661074697971
predicts O 0 0.022458350285887718
that O 0 0.00030850977054797113
pathological O 1 0.9989203214645386
missense O 0 0.053693197667598724
mutations O 0 0.004785521421581507
should O 0 0.00047825873480178416
in O 0 0.00016648934979457408
fact O 0 0.0007770145894028246
be O 0 0.00022119208006188273
common O 0 0.0021880671847611666
even O 0 0.0008743914659135044
though O 0 0.0006188292754814029
they O 0 4.4134067138656974e-05
are O 0 3.274608025094494e-05
hardly O 0 0.005114607512950897
ever O 0 0.0009448158089071512
seen O 0 0.0019522096263244748
in O 0 0.0011356101604178548
aniridia B-Disease 1 0.9999915361404419
patients O 1 0.9999910593032837
. O 0 0.0008675464196130633

This O 0 0.0003974712162744254
indicates O 0 0.002284569665789604
that O 0 5.115939711686224e-05
there O 0 5.636495552607812e-05
is O 0 0.0001951591402757913
a O 0 0.0007722220616415143
heavy O 0 0.031119264662265778
ascertainment O 1 0.9994056224822998
bias O 0 0.011679472401738167
in O 0 0.0001558409712743014
the O 0 9.474046237301081e-05
selection O 0 0.0004014140577055514
of O 0 0.00012482523743528873
patients O 1 0.9999991655349731
for O 0 0.0016585371922701597
PAX6 O 1 0.9999808073043823
mutation O 0 0.0036048409529030323
analysis O 0 0.00028880438185296953
and O 0 8.06418465799652e-05
that O 0 4.169797830400057e-05
the O 0 0.00028524993103928864
missing O 0 0.029231982305645943
PAX6 O 1 0.999875545501709
missense O 0 0.10223796963691711
mutations O 0 0.007963309995830059
frequently O 0 0.00477400328963995
may O 0 0.0051003554835915565
underlie O 1 0.9947605729103088
phenotypes O 0 0.021394331008195877
distinct O 0 0.0008200981537811458
from O 0 0.000332119467202574
textbook O 1 0.9989448189735413
aniridia B-Disease 1 0.9999418258666992
. O 0 0.001202195300720632

Here O 0 0.00109617761336267
we O 0 0.0001259589771507308
present O 0 0.0001120773158618249
four O 0 0.00019627244910225272
novel O 0 0.008412476629018784
PAX6 O 1 0.9999233484268188
missense O 0 0.1013917326927185
mutations O 0 0.004953616764396429
, O 0 0.00018667412223294377
two O 0 5.021363540436141e-05
in O 0 0.00029682432068511844
association O 0 0.018679838627576828
with O 0 0.000533738115336746
atypical O 1 0.9999243021011353
phenotypes O 1 0.9484119415283203
ectopia B-Disease 1 0.9978600144386292
pupillae I-Disease 1 0.9946341514587402
( O 0 0.001659172005020082
displaced B-Disease 0 0.021738436073064804
pupils I-Disease 0 0.022059481590986252
) O 0 0.0007786972564645112
and O 0 0.002619316102936864
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999966621398926
( O 0 0.0038778288289904594
searching B-Disease 0 0.018433894962072372
gaze I-Disease 1 0.7269232273101807
) O 0 0.0008886869181878865
, O 0 0.00031352974474430084
and O 0 0.00011487201845739037
two O 0 5.807548586744815e-05
in O 0 0.00030889594927430153
association O 0 0.007222950924187899
with O 0 8.152600639732555e-05
more O 0 0.00031115347519516945
recognizable O 1 0.5538385510444641
aniridia B-Disease 1 0.9998750686645508
phenotypes O 0 0.06384448707103729
. O 0 0.000871345226187259

Strikingly O 0 0.09575818479061127
, O 0 0.0004288235795684159
all O 0 4.735086258733645e-05
four O 0 0.00021697103511542082
mutations O 0 0.0015577570302411914
are O 0 3.54769617842976e-05
located O 0 0.0009917826391756535
within O 0 0.000136527291033417
the O 0 0.0010064778616651893
PAX6 O 1 0.9999682903289795
paired O 0 0.014162182807922363
domain O 0 0.0007548496942035854
and O 0 0.00014173061936162412
affect O 0 0.0023351137060672045
amino O 0 0.00037222259561531246
acids O 0 0.0006515143322758377
which O 0 4.664987500291318e-05
are O 0 1.548740328871645e-05
highly O 0 0.0013788469368591905
conserved O 0 0.0003122470516245812
in O 0 0.00011811376316472888
all O 0 4.6793968067504466e-05
known O 0 0.0015123231569305062
paired O 0 0.003384021110832691
domain O 0 0.0005204996559768915
proteins O 0 0.0002671804977580905
. O 0 0.0005951512139290571

Our O 0 0.00201019668020308
results O 0 0.000659344659652561
support O 0 0.00034706262522377074
the O 0 0.00022417321451939642
hypothesis O 0 0.0027540733572095633
that O 0 5.064384458819404e-05
the O 0 0.0001875560119515285
under O 0 0.0007919476483948529
- O 0 0.00197943695820868
representation O 0 7.776951679261401e-05
of O 0 4.909569543087855e-05
missense O 0 0.06401281803846359
mutations O 0 0.004580564796924591
is O 0 0.000877775892149657
caused O 0 0.011503875255584717
by O 0 0.00037142648943699896
ascertainment O 1 0.9996603727340698
bias O 0 0.027496768161654472
and O 0 0.0003044167533516884
suggest O 0 0.0008049329626373947
that O 0 3.482156898826361e-05
a O 0 0.00019472713756840676
substantial O 0 0.0013938653282821178
burden O 0 0.025920888409018517
of O 0 0.0002615097910165787
PAX6 B-Disease 1 0.9999995231628418
- I-Disease 1 0.999556839466095
related I-Disease 1 0.9885918498039246
disease I-Disease 1 1.0
remains O 0 0.005590089131146669
to O 0 8.183897443814203e-05
be O 0 0.00019798286666627973
uncovered O 0 0.011298635974526405
. O 0 0.00021317943173926324
. O 0 0.0004200723487883806

The O 0 0.0016561670927330852
chromosomal O 0 0.018082352355122566
order O 0 0.00010030589328380302
of O 0 1.6377925931010395e-05
genes O 0 0.0004336525744292885
controlling O 0 0.008215779438614845
the O 0 0.0006378520047292113
major O 0 0.028560444712638855
histocompatibility O 1 0.999991774559021
complex O 0 0.015259773470461369
, O 0 0.000840271299239248
properdin O 1 0.9387029409408569
factor O 0 0.008402545936405659
B O 1 0.9852373003959656
, O 0 0.0006692732567898929
and O 0 0.0013555365148931742
deficiency B-Disease 1 0.9999986886978149
of I-Disease 0 3.892706081387587e-05
the I-Disease 0 0.00022803351748734713
second I-Disease 0 0.00046309700701385736
component I-Disease 0 0.0027479224372655153
of I-Disease 0 2.21880036406219e-05
complement I-Disease 0 0.006673358380794525
. O 0 0.0006785929435864091

The O 0 0.0011536101810634136
relationship O 0 0.0029011196456849575
of O 0 1.541099845780991e-05
the O 0 0.0001744691253406927
genes O 0 0.000670009758323431
coding O 0 0.01873433031141758
for O 0 0.0020399263594299555
HLA O 1 0.9993029832839966
to O 0 0.00015398100367747247
those O 0 7.620799442520365e-05
coding O 0 0.009245797991752625
for O 0 0.0006248495192267001
properdin O 1 0.9374487996101379
Factor O 0 0.014713467098772526
B O 1 0.9671589732170105
allotypes O 1 0.6660436391830444
and O 0 0.00040888244984671474
for O 0 0.0023432038724422455
deficiency B-Disease 1 0.9999988079071045
of I-Disease 0 2.4718427084735595e-05
the I-Disease 0 0.0001437784085283056
second I-Disease 0 0.0002755669120233506
component I-Disease 0 0.002639475278556347
of I-Disease 0 3.016876507899724e-05
complement I-Disease 0 0.0143429609015584
( O 0 0.005967219825834036
C2 O 1 0.9999985694885254
) O 0 0.0015071334782987833
was O 0 0.0019742439035326242
studied O 0 0.0008869374287314713
in O 0 8.135197276715189e-05
families O 0 0.00011720108886947855
of O 0 9.074535773834214e-05
patients O 1 0.9999995231628418
with O 0 0.0009091374231502414
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 0.002131884219124913

Patients O 1 0.999993085861206
were O 0 0.00018875532259698957
selected O 0 0.000655969197396189
because O 0 0.0004426285740919411
they O 0 2.5428764274693094e-05
were O 0 2.532810867705848e-05
heterozygous O 0 0.002166061894968152
or O 0 0.000371386791812256
homozygous O 0 0.00845019705593586
for O 0 0.005265755113214254
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0023529944010078907

12 O 0 0.0024472996592521667
families O 0 0.00019832391990348697
with O 0 9.219851199304685e-05
15 O 0 0.001405836665071547
matings O 0 0.08041281998157501
informative O 0 0.018054883927106857
for O 0 0.009538505226373672
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.00031243226840160787
found O 0 0.0007453893776983023
. O 0 0.00038610261981375515

Of O 0 0.00020098539243917912
57 O 0 0.013656752184033394
informative O 0 0.029412543401122093
meioses O 1 0.745648205280304
, O 0 0.0003538986493367702
two O 0 6.373376527335495e-05
crossovers O 0 0.0025889850221574306
were O 0 4.0567949326941743e-05
noted O 0 0.0004929077113047242
between O 0 0.0002532249200157821
the O 0 0.004827581811696291
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.005124944262206554
and O 0 0.0001661255519138649
the O 0 0.0013688519829884171
HLA O 1 0.999995231628418
- O 0 0.4525505006313324
B O 1 0.9719844460487366
gene O 0 0.003147000912576914
, O 0 0.00011114066728623584
with O 0 3.392680446268059e-05
a O 0 0.00035769978421740234
recombinant O 0 0.003250364912673831
fraction O 0 0.0005484541761688888
of O 0 4.2471569031476974e-05
0 O 0 0.003376214299350977
. O 0 0.000498226610943675

035 O 1 0.9758307337760925
. O 0 0.0017241404857486486

A O 0 0.019887877628207207
lod O 1 0.6283228993415833
score O 0 0.00017546795425005257
of O 0 3.195391400367953e-05
13 O 0 0.001740012550726533
was O 0 0.00047449185512959957
calculated O 0 0.00027804344426840544
for O 0 0.00017716830188874155
linkage O 0 0.044748593121767044
between O 0 0.005877779331058264
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.005205289460718632
HLA O 1 0.9999960660934448
- O 1 0.5301428437232971
B O 1 0.6141740679740906
at O 0 0.0006434040260501206
a O 0 0.00027041288558393717
maximum O 0 0.0005167436902411282
likelihood O 0 0.0019119568169116974
value O 0 4.266434916644357e-05
of O 0 8.020778295758646e-06
the O 0 0.00012265001714695245
recombinant O 0 0.0033161351457238197
fraction O 0 0.0005970271304249763
of O 0 4.0688446460990235e-05
0 O 0 0.003355181310325861
. O 0 0.0005137004191055894

04 O 1 0.9955515265464783
. O 0 0.0012036224361509085

18 O 0 0.002340318402275443
families O 0 0.0002915267541538924
with O 0 0.00013907278480473906
21 O 0 0.0027183496858924627
informative O 0 0.012996827252209187
matings O 0 0.06708714365959167
for O 0 0.00019915748271159828
both O 0 0.00026771012926474214
properdin O 1 0.8185909986495972
Factor O 0 0.011841057799756527
B O 1 0.9348466396331787
allotype O 1 0.9431369304656982
and O 0 0.0015550762182101607
HLA O 1 0.9999768733978271
- O 0 0.16644781827926636
B O 0 0.1220650002360344
were O 0 8.870929741533473e-05
found O 0 0.0005096648819744587
. O 0 0.00035593280335888267

Of O 0 0.00016697727551218122
72 O 0 0.013847189955413342
informative O 0 0.020348886027932167
meioses O 1 0.9422556161880493
, O 0 0.0004167941224295646
three O 0 0.00024979872978292406
recombinants O 1 0.6706671714782715
were O 0 0.00010166210267925635
found O 0 0.0004161327378824353
, O 0 0.00010890064004343003
giving O 0 0.000533171696588397
a O 0 0.00037290246109478176
recombinant O 0 0.0027890163473784924
fraction O 0 0.0006906387861818075
of O 0 3.684107286971994e-05
0 O 0 0.003650106955319643
. O 0 0.0005680284812115133

042 O 1 0.8227266073226929
. O 0 0.0014684427296742797

A O 0 0.01732816733419895
lod O 0 0.1634446233510971
score O 0 0.00010098519851453602
of O 0 1.7162545191240497e-05
16 O 0 0.001387555617839098
between O 0 0.0015716127818450332
HLA O 1 0.999971866607666
- O 0 0.05716577172279358
B O 0 0.47689881920814514
and O 0 0.00031384764588437974
Factor O 0 0.01405917014926672
B O 1 0.9840819835662842
allotypes O 1 0.9080359935760498
was O 0 0.0017637936398386955
calculated O 0 0.0009012577938847244
at O 0 0.0005556324031203985
a O 0 0.0002721842029131949
maximum O 0 0.0005412190803326666
likelihood O 0 0.0019222008995711803
value O 0 5.390261867432855e-05
of O 0 8.040306965995114e-06
the O 0 0.00012549776874948293
recombinant O 0 0.0031713182106614113
fraction O 0 0.0006757632945664227
of O 0 4.426726445672102e-05
0 O 0 0.003344928380101919
. O 0 0.0005434437771327794

04 O 1 0.9923014640808105
. O 0 0.0011393222957849503

A O 0 0.0066589247435331345
crossover O 0 0.005104707553982735
was O 0 0.0022894549183547497
shown O 0 0.0009355306974612176
to O 0 0.00010369785013608634
have O 0 0.00010539489449001849
occurred O 0 0.0008006285061128438
between O 0 5.187835267861374e-05
genes O 0 0.0001208222092827782
for O 0 0.00015428217011503875
Factor O 0 0.007090413942933083
B O 1 0.9427714943885803
and O 0 0.0012576777953654528
HLA O 1 0.9999818801879883
- O 0 0.21028414368629456
D O 1 0.9926003813743591
, O 0 0.00016319434507749975
in O 0 0.00012572581181302667
which O 0 0.0003659547364804894
HLA O 1 0.9999527931213379
- O 0 0.1436522752046585
D O 1 0.9942507743835449
segregared O 0 0.3140432834625244
with O 0 0.0009960861643776298
HLA O 1 0.9998812675476074
- O 0 0.010683935135602951
A O 0 0.004991719964891672
and O 0 0.0007357693975791335
B O 1 0.9902430176734924
. O 0 0.0006901127635501325

These O 0 0.00022292228823062032
studies O 0 0.0012510194210335612
suggest O 0 0.0006497650756500661
that O 0 2.080022204609122e-05
the O 0 3.6321252991911024e-05
genes O 0 7.621657277923077e-05
for O 0 0.00013011480041313916
Factor O 0 0.011598434299230576
B O 1 0.9990578293800354
and O 0 0.005856419913470745
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.00013275313540361822
located O 0 0.0014745242660865188
outside O 0 0.00027500762371346354
those O 0 0.00012799915566574782
for O 0 0.0017703527119010687
HLA O 1 0.9999805688858032
, O 0 0.00037951223202981055
that O 0 4.1350336687173694e-05
the O 0 5.218424121267162e-05
order O 0 4.126536805415526e-05
of O 0 2.8008325898554176e-05
genese O 1 0.9743150472640991
is O 0 0.002652685856446624
HLA O 1 0.9997720122337341
- O 0 0.0070666116662323475
A O 0 0.003560096025466919
, O 0 0.0006693832692690194
- O 0 0.017055977135896683
B O 0 0.4286555349826813
, O 0 0.0009876441909000278
- O 0 0.02979293279349804
D O 1 0.9866644144058228
, O 0 0.00026554736541584134
Factor O 0 0.007204679772257805
B O 1 0.9853179454803467
allotype O 1 0.9958658218383789
, O 0 0.010638057254254818
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.0004652671341318637
that O 0 2.5026351067936048e-05
the O 0 4.6682362153660506e-05
genes O 0 0.00026295086718164384
coding O 0 0.014071906916797161
for O 0 0.0055684857070446014
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.0009204894304275513
Factor O 0 0.014890925958752632
B O 1 0.9202937483787537
allotypes O 0 0.069302998483181
are O 0 3.1370247597806156e-05
approximately O 0 0.000489968981128186
3 O 0 0.002425560960546136
- O 0 0.008511277846992016
- O 0 0.0049892570823431015
5 O 0 0.0009579663164913654
centimorgans O 0 0.04656634107232094
from O 0 0.00010678802209440619
the O 0 0.0008799767820164561
HLA O 1 0.9999152421951294
- O 0 0.007295885123312473
A O 0 0.003381557995453477
and O 0 0.0013060306664556265
HLA O 1 0.9999922513961792
- O 0 0.4904545843601227
B O 1 0.9736607074737549
loci O 0 0.020823370665311813
, O 0 0.00035789288813248277
and O 0 0.0001365263742627576
that O 0 8.577271364629269e-05
the O 0 0.0003097857115790248
apparent O 0 0.01571839116513729
lack O 0 0.0029471053276211023
of O 0 7.938875933177769e-05
recombinants O 1 0.6444382667541504
between O 0 0.00011687965161399916
the O 0 0.00018124727648682892
Factor O 0 0.008535509929060936
B O 1 0.9858621954917908
gene O 0 0.00668283412232995
and O 0 0.0034197517670691013
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.014441010542213917
suggests O 0 0.0021799576934427023
that O 0 3.9509974158136174e-05
these O 0 1.186883764603408e-05
two O 0 5.079649781691842e-05
genes O 0 0.0006924301269464195
lie O 0 0.006706698797643185
in O 0 0.00021921681764069945
close O 0 0.001791317481547594
proximity O 0 0.0017907259752973914
to O 0 8.653347322251648e-05
one O 0 0.00014029887097422034
another O 0 0.0008536982350051403
. O 0 0.0005229124799370766

Distribution O 0 0.0004890127456746995
of O 0 8.651935786474496e-05
emerin O 1 0.9668553471565247
and O 0 0.0008806565310806036
lamins O 1 0.9966832995414734
in O 0 0.00039323806413449347
the O 0 0.0008386379340663552
heart O 1 0.9999723434448242
and O 0 0.0001566533901495859
implications O 0 0.01236596331000328
for O 0 0.0007354711415246129
Emery B-Disease 1 0.9999301433563232
- I-Disease 1 0.9991521835327148
Dreifuss I-Disease 1 0.9999998807907104
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0029516401700675488

Emerin O 1 0.8329228162765503
is O 0 0.00047665307647548616
a O 0 0.0003923670738004148
nuclear O 0 0.0021674518939107656
membrane O 0 0.0015341121470555663
protein O 0 0.00043733359780162573
which O 0 6.462375313276425e-05
is O 0 0.0003894698456861079
missing O 0 0.00314255035482347
or O 0 0.0006090570823289454
defective O 1 0.9980286955833435
in O 0 0.0008821947267279029
Emery B-Disease 1 0.9999480247497559
- I-Disease 1 0.999103307723999
Dreifuss I-Disease 1 0.9999998807907104
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.03877357393503189
EDMD B-Disease 1 0.9999971389770508
) O 0 0.0016041718190535903
. O 0 0.0005708676180802286

It O 0 0.0008857597131282091
is O 0 0.0003751931362785399
one O 0 0.00014429425937123597
member O 0 0.00034081513877026737
of O 0 2.021235013671685e-05
a O 0 0.0007836213335394859
family O 0 0.0007283189333975315
of O 0 0.0002019327657762915
lamina O 1 0.9999905824661255
- O 0 0.017096029594540596
associated O 0 0.00029514305060729384
proteins O 0 6.215211760718375e-05
which O 0 7.304480095626786e-05
includes O 0 0.0009817394893616438
LAP1 O 1 0.9995089769363403
, O 0 0.0011279323371127248
LAP2 O 1 0.9985610842704773
and O 0 0.0007974476902745664
lamin O 1 0.9991348385810852
B O 1 0.9679262042045593
receptor O 0 0.03563947603106499
( O 0 0.0050188349559903145
LBR O 1 0.999983549118042
) O 0 0.0013688260223716497
. O 0 0.0005072639323771

A O 0 0.006553828250616789
panel O 0 0.0022025934886187315
of O 0 3.116904917987995e-05
16 O 0 0.0023244780022650957
monoclonal O 0 0.09124089777469635
antibodies O 0 0.05601383000612259
( O 0 0.004572676494717598
mAbs O 1 0.9981796741485596
) O 0 0.000997544382698834
has O 0 0.0009994644206017256
been O 0 0.0005357688060030341
mapped O 0 0.003586847335100174
to O 0 8.798100316198543e-05
six O 0 0.0001443636283511296
specific O 0 0.00014598474081140012
sites O 0 0.00023139565018936992
throughout O 0 0.00012439153215382248
the O 0 0.00018682460358832031
emerin O 0 0.09275533258914948
molecule O 0 0.0015055843396112323
using O 0 0.00029168801847845316
phage O 1 0.9770594239234924
- O 0 0.006537288427352905
displayed O 0 0.0015536574646830559
peptide O 0 0.0062449038960039616
libraries O 0 0.0016227258602157235
and O 0 0.0002231000253232196
has O 0 0.0006585517548955977
been O 0 0.0001787362853065133
used O 0 9.867112385109067e-05
to O 0 0.00013390126696322113
localize O 0 0.29734328389167786
emerin O 0 0.25161904096603394
in O 0 0.00030299596255645156
human O 0 0.002086956985294819
and O 0 0.0011994884116575122
rabbit O 1 0.9992753863334656
heart O 1 0.9999831914901733
. O 0 0.001184041379019618

Several O 0 0.001363938208669424
mAbs O 1 0.8284081816673279
against O 0 0.0003279739757999778
different O 0 0.0001120671586249955
emerin O 1 0.9811177849769592
epitopes O 0 0.19180874526500702
did O 0 0.0013171002501621842
not O 0 0.00020845868857577443
recognize O 0 0.009932572953402996
intercalated O 1 0.6345224976539612
discs O 0 0.005051715299487114
in O 0 0.0002557283150963485
the O 0 0.0014411240117624402
heart O 1 0.999998927116394
, O 0 0.0007166328141465783
though O 0 0.0006273437757045031
they O 0 9.100584429688752e-05
recognized O 0 0.0037533449940383434
cardiomyocyte O 0 0.1483592987060547
nuclei O 0 0.0033327327109873295
strongly O 0 0.0026130424812436104
, O 0 0.0002762851072475314
both O 0 0.0001795930293155834
at O 0 0.001131395110860467
the O 0 0.0005767045659013093
rim O 0 0.05229279771447182
and O 0 0.0002662300248630345
in O 0 0.0006168519612401724
intranuclear O 1 0.9847197532653809
spots O 0 0.013768558390438557
or O 0 0.0005483966087922454
channels O 0 0.0010707194451242685
. O 0 0.000504998373799026

A O 0 0.015949098393321037
polyclonal O 1 0.8879161477088928
rabbit O 1 0.8882336020469666
antiserum O 1 0.9535247087478638
against O 0 0.002860408741980791
emerin O 1 0.9911357164382935
did O 0 0.0025567112024873495
recognize O 0 0.004714192822575569
both O 0 0.0001358153676846996
nuclear O 0 0.0039438814856112
membrane O 0 0.004046816378831863
and O 0 0.00037759580300189555
intercalated O 1 0.9949359893798828
discs O 0 0.0101504847407341
but O 0 0.00035765976645052433
, O 0 0.00020009167201351374
after O 0 0.0007964365649968386
affinity O 0 0.0022539030760526657
purification O 0 0.010534821078181267
against O 0 0.00017775784363038838
a O 0 0.0006917718565091491
pure O 0 0.007130581419914961
- O 0 0.0270230770111084
emerin O 0 0.49534931778907776
band O 0 0.0014128132024779916
on O 0 0.00017960707191377878
a O 0 0.0007617953815497458
western O 0 0.003220267128199339
blot O 1 0.9974888563156128
, O 0 0.000727969512809068
it O 0 0.0005606840713880956
stained O 1 0.9940316081047058
only O 0 7.442189962603152e-05
the O 0 0.00018525488849263638
nuclear O 0 0.007051832042634487
membrane O 0 0.00706600584089756
. O 0 0.0005438600783236325

These O 0 0.00023531256010755897
results O 0 0.001096869120374322
would O 0 0.000218826302443631
not O 0 9.289711306337267e-05
be O 0 7.004776125540957e-05
expected O 0 0.0005888756131753325
if O 0 0.000742527365218848
immunostaining O 1 0.7108765840530396
at O 0 0.002478498499840498
intercalated O 1 0.881131112575531
discs O 0 0.008483830839395523
were O 0 7.970119622768834e-05
due O 0 0.0009911309462040663
to O 0 6.555165600730106e-05
a O 0 0.0002503063005860895
product O 0 0.0004780614108312875
of O 0 1.9450355466688052e-05
the O 0 0.0007181974360719323
emerin O 1 0.9841773509979248
gene O 0 0.005172352306544781
and O 0 0.00027990658418275416
, O 0 0.00045897215022705495
therefore O 0 0.0008297034073621035
, O 0 0.00023177522234618664
cast O 0 0.0002310762065462768
some O 0 5.1815259212162346e-05
doubt O 0 0.0017171824583783746
upon O 0 0.00017440343799535185
the O 0 0.00010601145913824439
hypothesis O 0 0.0038330694660544395
that O 0 0.0007984323310665786
cardiac B-Disease 1 1.0
defects I-Disease 1 0.9999969005584717
in O 0 0.002229040954262018
EDMD B-Disease 1 0.9999992847442627
are O 0 0.00017054185445886105
caused O 0 0.007043058983981609
by O 0 7.909480336820707e-05
absence O 0 0.0030759514775127172
of O 0 5.963188232271932e-05
emerin O 1 0.9497690200805664
from O 0 0.0004008315154351294
intercalated O 1 0.9574863910675049
discs O 0 0.014482174068689346
. O 0 0.0007351863314397633

Although O 0 0.0049020638689398766
emerin O 1 0.7114247679710388
was O 0 0.0015663130907341838
abundant O 0 0.0007378302398137748
in O 0 0.00010884967923630029
the O 0 0.00022938114125281572
membranes O 0 0.014368187636137009
of O 0 7.506043039029464e-05
cardiomyocyte O 1 0.9605147838592529
nuclei O 0 0.0044260029681026936
, O 0 0.00025763572193682194
it O 0 0.00022263509163167328
was O 0 0.0018378306413069367
absent O 0 0.0061471955850720406
from O 0 4.9068083171732724e-05
many O 0 8.397713099839166e-05
non O 0 0.009380348026752472
- O 0 0.04669572412967682
myocyte O 1 0.9964693784713745
cells O 0 0.003543031867593527
in O 0 0.0001681685826042667
the O 0 0.0009457384003326297
heart O 1 0.9999792575836182
. O 0 0.0009595599258318543

This O 0 0.00011035422357963398
distribution O 0 0.00014889484737068415
of O 0 9.795442747417837e-05
emerin O 1 0.995410144329071
was O 0 0.002195885870605707
similar O 0 0.00018881491268984973
to O 0 4.877845276496373e-05
that O 0 3.075438871746883e-05
of O 0 6.98539151926525e-05
lamin O 1 0.9998834133148193
A O 0 0.009158758446574211
, O 0 0.00032376687158830464
a O 0 0.0008629924268461764
candidate O 0 0.0021940115839242935
gene O 0 0.0011791414581239223
for O 0 0.00011993331281701103
an O 0 0.0005094152875244617
autosomal O 1 0.9336435198783875
form O 0 0.0012415442615747452
of O 0 0.0003679523942992091
EDMD B-Disease 1 0.9999992847442627
. O 0 0.0014257887378335

In O 0 0.0008197344141080976
contrast O 0 0.004489938262850046
, O 0 0.0023327399976551533
lamin O 1 0.9999550580978394
B1 O 1 0.9999970197677612
was O 0 0.0067748986184597015
absent O 0 0.011384076438844204
from O 0 0.00023761873308103532
cardiomyocyte O 0 0.20421122014522552
nuclei O 0 0.003072533290833235
, O 0 0.00026478435029275715
showing O 0 0.002340318402275443
that O 0 0.0008116516401059926
lamin O 1 0.9999464750289917
B1 O 1 0.9999972581863403
is O 0 0.001031063380651176
not O 0 0.00012381133274175227
essential O 0 0.00176363589707762
for O 0 0.00018344001728110015
localization O 0 0.006433446425944567
of O 0 6.62782767903991e-05
emerin O 1 0.6596823334693909
to O 0 9.422304719919339e-05
the O 0 0.00028812119853682816
nuclear O 0 0.0286699328571558
lamina O 1 0.9999499320983887
. O 0 0.001097452244721353

Lamin O 1 0.9999014139175415
B1 O 1 0.9999896287918091
is O 0 0.0011408301070332527
also O 0 0.00018835728405974805
almost O 0 0.0004759432340506464
completely O 0 0.008851337246596813
absent O 0 0.00996420904994011
from O 0 0.0006112174014560878
skeletal O 1 0.9999853372573853
muscle O 1 0.9995740056037903
nuclei O 0 0.011483418755233288
. O 0 0.000840498018078506

In O 0 0.007027606479823589
EDMD B-Disease 1 0.9999635219573975
, O 0 0.0003078936133533716
the O 0 7.671708590351045e-05
additional O 0 0.00022721249843016267
absence O 0 0.002704278565943241
of O 0 0.0001293473324039951
lamin O 1 0.9999856948852539
B1 O 1 0.9999991655349731
from O 0 0.001418506377376616
heart O 1 0.9999979734420776
and O 0 0.0010840926552191377
skeletal O 1 0.999998927116394
muscle O 1 0.9999352693557739
nuclei O 0 0.004861039575189352
which O 0 0.00017853429017122835
already O 0 0.00231146696023643
lack O 0 0.010118149220943451
emerin O 1 0.9967498779296875
may O 0 0.002501658396795392
offer O 0 0.0007107455749064684
an O 0 0.0001516876509413123
alternative O 0 0.0014515705406665802
explanation O 0 0.0014770845882594585
of O 0 3.0964118195697665e-05
why O 0 0.0029165952000766993
these O 0 7.554622425232083e-05
tissues O 1 0.5020601153373718
are O 0 6.860731809865683e-05
particularly O 0 0.004265484865754843
affected O 0 0.015900801867246628
. O 0 0.0003348159370943904
. O 0 0.0005093414802104235

Genetic O 0 0.0030270982533693314
mapping O 0 0.0020201874431222677
of O 0 1.9807073840638623e-05
the O 0 0.0005241740727797151
copper B-Disease 1 0.9903938174247742
toxicosis I-Disease 1 0.9999277591705322
locus O 0 0.032418813556432724
in O 0 0.0012577369343489408
Bedlington O 1 0.9992497563362122
terriers O 0 0.4745188057422638
to O 0 0.0006612898432649672
dog O 0 0.08522412925958633
chromosome O 0 0.005224696360528469
10 O 0 0.0007279234123416245
, O 0 0.00016941092326305807
in O 0 0.00013821189349982888
a O 0 0.0011015806812793016
region O 0 0.005408746190369129
syntenic O 1 0.7931369543075562
to O 0 0.00011540274863364175
human O 0 0.001207620371133089
chromosome O 0 0.003202478401362896
region O 0 0.00498681515455246
2p13 O 1 0.8022225499153137
- O 0 0.027052806690335274
p16 O 0 0.3257848024368286
. O 0 0.0006556044681929052

Abnormal O 1 0.9994768500328064
hepatic B-Disease 1 0.9999991655349731
copper I-Disease 1 0.9524754881858826
accumulation I-Disease 0 0.04272482171654701
is O 0 0.0006320687825791538
recognized O 0 0.0013974580215290189
as O 0 0.00034023725311271846
an O 0 0.0021917475387454033
inherited B-Disease 1 0.9999998807907104
disorder I-Disease 1 1.0
in O 0 0.0017226611962541938
man O 0 0.049363698810338974
, O 0 0.0007710495847277343
mouse O 0 0.022325847297906876
, O 0 0.0013307679910212755
rat O 1 0.9819913506507874
and O 0 0.0008025304414331913
dog O 0 0.1672874391078949
. O 0 0.0010486200917512178

The O 0 0.0006289185839705169
major O 0 0.003322187578305602
cause O 0 0.007392295636236668
of O 0 0.0001706744369585067
hepatic B-Disease 1 0.9999998807907104
copper I-Disease 1 0.9932502508163452
accumulation I-Disease 0 0.07147715240716934
in O 0 0.0003960870672017336
man O 0 0.004422665107995272
is O 0 0.00027038194821216166
a O 0 0.0013528538402169943
dysfunctional O 1 0.9977872371673584
ATP7B O 1 0.9995585083961487
gene O 0 0.005828237161040306
, O 0 0.0006509790546260774
causing O 1 0.998372495174408
Wilson B-Disease 1 0.9999793767929077
disease I-Disease 1 1.0
( O 0 0.009385303594172001
WD B-Disease 1 0.9999841451644897
) O 0 0.001151268370449543
. O 0 0.0005640023737214506

Mutations O 0 0.008793219923973083
in O 0 0.00023964342835824937
the O 0 0.0007019118056632578
ATP7B O 1 0.9984525442123413
genes O 0 0.0003850286011584103
have O 0 8.317466563312337e-05
also O 0 0.00017943826969712973
been O 0 0.00033916576649062335
demonstrated O 0 0.002886230358853936
in O 0 0.0003315614303573966
mouse O 0 0.016239861026406288
and O 0 0.0007918366463854909
rat O 1 0.98267662525177
. O 0 0.0008426716085523367

The O 0 0.0027967016212642193
ATP7B O 1 0.9991413354873657
gene O 0 0.0061884308233857155
has O 0 0.0010192091576755047
been O 0 0.0004825955256819725
excluded O 0 0.0023069395683705807
in O 0 5.0730752263916656e-05
the O 0 6.819787085987628e-05
much O 0 0.0006293292390182614
rarer O 1 0.786831796169281
human O 0 0.004714049398899078
copper B-Disease 1 0.9997560381889343
overload I-Disease 1 0.9999973773956299
disease O 1 1.0
non B-Disease 0 0.023708060383796692
- I-Disease 0 0.09417977184057236
Indian I-Disease 0 0.006025009322911501
childhood I-Disease 1 0.9999760389328003
cirrhosis I-Disease 1 0.9999998807907104
, O 0 0.0008649814408272505
indicating O 0 0.005804755259305239
genetic O 0 0.004757100250571966
heterogeneity O 0 0.036677516996860504
. O 0 0.0010083895176649094

By O 0 0.00032748153898864985
investigating O 0 0.006627517752349377
the O 0 0.0003122905036434531
common O 0 0.007065140176564455
autosomal O 1 0.9998441934585571
recessive O 1 0.9999157190322876
copper B-Disease 1 0.9998787641525269
toxicosis I-Disease 1 0.9999974966049194
( O 0 0.0203243438154459
CT B-Disease 1 0.9999991655349731
) O 0 0.0008305992232635617
in O 0 0.0009388832258991897
Bedlington O 1 0.9998063445091248
terriers O 1 0.9679135680198669
, O 0 0.0004845429502893239
we O 0 0.0002337949408683926
have O 0 7.976636698003858e-05
identified O 0 0.0005293611320666969
a O 0 0.000269632349954918
new O 0 0.00027851754566654563
locus O 0 0.01275433599948883
involved O 0 0.0010935424361377954
in O 0 0.0007586917490698397
progressive O 1 0.9999967813491821
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.0022221284452825785

We O 0 0.0012636898318305612
examined O 0 0.012850843369960785
whether O 0 0.00048018095549196005
the O 0 0.0006895986734889448
WD B-Disease 1 0.9998717308044434
gene O 0 0.013697037473320961
ATP7B O 1 0.9972303509712219
was O 0 0.0020927446894347668
also O 0 0.00043693644693121314
causative O 1 0.9527660012245178
for O 0 0.0030115817207843065
CT B-Disease 1 0.999988317489624
by O 0 0.0001585813151905313
investigating O 0 0.009273404255509377
the O 0 0.0007618882809765637
chromosomal O 0 0.1819881647825241
co O 0 0.060916390269994736
- O 0 0.006961563602089882
localization O 0 0.005719447508454323
of O 0 0.00011118304973933846
ATP7B O 1 0.9996719360351562
and O 0 0.0007746134069748223
C04107 O 0 0.057385239750146866
, O 0 0.00012250986765138805
using O 0 9.922802564688027e-05
fluorescence O 0 0.014587887562811375
in O 0 0.0003373603685759008
situ O 0 0.0908358171582222
hybridization O 0 0.0029450433794409037
( O 0 0.0010049715638160706
FISH O 0 0.008456435054540634
) O 0 0.0005525110755115747
. O 0 0.00043949251994490623

C04107 O 0 0.08913120627403259
is O 0 0.0003712261386681348
an O 0 0.00021490802464541048
anonymous O 0 0.005412800703197718
microsatellite O 0 0.07135657966136932
marker O 0 0.01515353936702013
closely O 0 0.0012210062704980373
linked O 0 0.012934795580804348
to O 0 0.001048393314704299
CT B-Disease 1 0.999998927116394
. O 0 0.0009210412972606719

However O 0 0.0029166233725845814
, O 0 0.0018408894538879395
BAC O 1 0.9961697459220886
clones O 0 0.012778831645846367
containing O 0 0.0012229239800944924
ATP7B O 1 0.9976697564125061
and O 0 0.0005022663390263915
C04107 O 0 0.06126251816749573
mapped O 0 0.003822325961664319
to O 0 7.88528413977474e-05
the O 0 0.000422505458118394
canine O 1 0.9964603781700134
chromosome O 0 0.006421476136893034
regions O 0 0.002324611647054553
CFA22q11 O 1 0.9969314336776733
and O 0 0.0010177583899348974
CFA10q26 O 1 0.9984456896781921
, O 0 0.0005096131353639066
respectively O 0 0.0008802593220025301
, O 0 0.00025646400172263384
demonstrating O 0 0.007146773394197226
that O 0 0.0007631577318534255
WD B-Disease 1 0.9999152421951294
cannot O 0 0.0010050395503640175
be O 0 6.673809548374265e-05
homologous O 0 0.0037277955561876297
to O 0 0.0009354882640764117
CT B-Disease 1 0.9999978542327881
. O 0 0.0007918208139017224

The O 0 0.0012803056742995977
copper O 0 0.034848541021347046
transport O 0 0.015021061524748802
genes O 0 0.002621919848024845
CTR1 O 1 0.998262345790863
and O 0 0.0010881127091124654
CTR2 O 1 0.9977598190307617
were O 0 0.00013005960499867797
also O 0 0.00037227178108878434
excluded O 0 0.003607638878747821
as O 0 0.00020845192193519324
candidate O 0 0.0010356530547142029
genes O 0 0.00042706538806669414
for O 0 0.0022821775637567043
CT B-Disease 1 0.9999996423721313
since O 0 0.0020815825555473566
they O 0 5.49880278413184e-05
both O 0 0.00010755172115750611
mapped O 0 0.004684156272560358
to O 0 0.00029594582156278193
canine O 1 0.9883241653442383
chromosome O 0 0.00782578345388174
region O 0 0.0081082908436656
CFA11q22 O 1 0.9836106300354004
. O 0 0.0008569745696149766

2 O 0 0.009266835637390614
- O 0 0.012247365899384022
22 O 0 0.002685836050659418
. O 0 0.0004474676970858127

5 O 0 0.004317741375416517
. O 0 0.0006079736049287021

A O 0 0.005374489817768335
transcribed O 0 0.0016769103240221739
sequence O 0 0.00015791677287779748
identified O 0 0.0007280732388608158
from O 0 5.1817874918924645e-05
the O 0 0.00035236484836786985
C04107 O 0 0.21953490376472473
- O 0 0.009303447790443897
containing O 0 0.001608680933713913
BAC O 1 0.999562680721283
was O 0 0.0022090233396738768
found O 0 0.00024399423273280263
to O 0 4.924528184346855e-05
be O 0 6.595585000468418e-05
homologous O 0 0.0015318181831389666
to O 0 5.9612550103338435e-05
a O 0 0.0005795705365017056
gene O 0 0.0015671498840674758
expressed O 0 0.00031530612614005804
from O 0 9.174465230898932e-05
human O 0 0.002163059776648879
chromosome O 0 0.009883283637464046
2p13 O 1 0.5717115998268127
- O 0 0.03294287994503975
p16 O 0 0.22584764659404755
, O 0 0.00041174248326569796
a O 0 0.0007179349777288735
region O 0 0.0021708307322114706
devoid O 0 0.0046606105752289295
of O 0 1.314695236942498e-05
any O 0 9.038599091582e-05
positional O 0 0.010286232456564903
candidate O 0 0.0022232811897993088
genes O 0 0.000621796294581145
. O 0 0.000532312027644366

Molecular O 0 0.006204023025929928
analysis O 0 0.00020666290947701782
of O 0 2.2946645913179964e-05
the O 0 0.0010680787963792682
APC B-Disease 1 0.9961502552032471
gene O 0 0.0038735875859856606
in O 0 0.0003806300228461623
205 O 0 0.02105681039392948
families O 0 0.0005122051225043833
: O 0 0.0004443155776243657
extended O 0 0.003985738381743431
genotype O 1 0.5194994211196899
- O 0 0.024739744141697884
phenotype O 0 0.06095028296113014
correlations O 0 0.008641652762889862
in O 0 0.0015965582570061088
FAP B-Disease 1 0.9999885559082031
and O 0 0.0003612034779507667
evidence O 0 0.0004143129335716367
for O 0 0.00012899187277071178
the O 0 0.00012570424587465823
role O 0 0.0013086418621242046
of O 0 4.023019937449135e-05
APC B-Disease 1 0.9391641020774841
amino O 0 0.00044285881449468434
acid O 0 0.006630155257880688
changes O 0 0.0010515633039176464
in O 0 0.0380467064678669
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9999901056289673
. O 0 0.001135884434916079

BACKGROUND O 0 0.1520853340625763
/ O 1 0.6055862307548523
AIMS O 0 0.019960016012191772
The O 0 0.00021889264462515712
development O 0 0.0025015503633767366
of O 0 0.0014101461274549365
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.00025709884357638657
a O 0 0.0003928202495444566
variable O 0 0.0009174878359772265
range O 0 0.0004158777301199734
of O 0 4.467301914701238e-05
extracolonic O 1 0.9985467791557312
manifestations O 1 0.9968305230140686
in O 0 0.002347923582419753
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 0.06191125512123108
FAP B-Disease 1 0.9999982118606567
) O 0 0.0011626003542914987
is O 0 0.00028960921918042004
the O 0 0.00012655238970182836
result O 0 0.00025975541211664677
of O 0 9.662624506745487e-06
the O 0 0.0001989856973523274
dominant O 0 0.007405098993331194
inheritance O 0 0.00421709381043911
of O 0 0.0008901084656827152
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999996423721313
( O 0 0.007346991449594498
APC B-Disease 1 0.999716579914093
) O 0 0.0009226165129803121
gene O 0 0.0039354912005364895
mutations O 0 0.003376529086381197
. O 0 0.00043292850023135543

In O 0 0.0005815133336000144
this O 0 0.00012162199709564447
study O 0 0.0014057973166927695
, O 0 0.00011121614079456776
direct O 0 0.00028893849230371416
mutation O 0 0.0008862887043505907
analysis O 0 9.794461220735684e-05
of O 0 1.6468828107463196e-05
the O 0 0.0009708460420370102
APC B-Disease 1 0.9994303584098816
gene O 0 0.0073563167825341225
was O 0 0.0015756799839437008
performed O 0 0.0010837295558303595
to O 0 9.924807818606496e-05
determine O 0 0.0025767215993255377
genotype O 1 0.870046854019165
- O 0 0.026021353900432587
phenotype O 0 0.033284205943346024
correlations O 0 0.002821960486471653
for O 0 0.00031104256049729884
nine O 0 0.001527669606730342
extracolonic O 1 0.9972171783447266
manifestations O 1 0.9879924058914185
and O 0 0.00021358105004765093
to O 0 0.00019056571181863546
investigate O 0 0.007399819325655699
the O 0 0.00041282587335444987
incidence O 1 0.9860724210739136
of O 0 9.749156015459448e-05
APC B-Disease 1 0.9978764057159424
mutations O 0 0.0017687649233266711
in O 0 0.00022416359570343047
non O 0 0.08659124374389648
- O 1 0.9999648332595825
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.001853535883128643

METHODS O 0 0.006995631847530603
The O 0 0.001974232727661729
APC B-Disease 1 0.9949519634246826
gene O 0 0.005377592984586954
was O 0 0.0010533480672165751
analysed O 0 0.0026969059836119413
in O 0 0.0002424782287562266
190 O 0 0.014584297314286232
unrelated O 0 0.05392100661993027
FAP B-Disease 1 0.9999194145202637
and O 0 0.00022308577899821103
15 O 0 0.0011781646171584725
non O 0 0.19892342388629913
- O 1 0.9999897480010986
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999923706054688
using O 0 0.0004900885978713632
denaturing O 1 0.9714173078536987
gradient O 0 0.05521216616034508
gel O 1 0.998227059841156
electrophoresis O 0 0.05504831671714783
, O 0 0.00012520517338998616
the O 0 8.966745372163132e-05
protein O 0 0.0014071011682972312
truncation O 0 0.08142397552728653
test O 0 0.00629656994715333
, O 0 0.0002132756053470075
and O 0 6.450935325119644e-05
direct O 0 0.0003001564182341099
sequencing O 0 0.0017570867203176022
. O 0 0.000551352568436414

RESULTS O 0 0.022281350567936897
Chain O 0 0.028500773012638092
terminating O 0 0.2174461930990219
signals O 0 0.0017354037845507264
were O 0 4.662168430513702e-05
only O 0 9.060466982191429e-05
identified O 0 0.00181393523234874
in O 0 0.0007112245657481253
patients O 1 0.9999769926071167
belonging O 0 0.00107955327257514
to O 0 0.0001221107813762501
the O 0 0.0008681794861331582
FAP B-Disease 1 0.9999786615371704
group O 0 0.0025440857280045748
( O 0 0.001550141954794526
105 O 0 0.04449963569641113
patients O 1 0.9999840259552002
) O 0 0.0007496532052755356
. O 0 0.0005104379379190505

Amino O 0 0.0017379466444253922
acid O 0 0.011262425221502781
changes O 0 0.00043137482134625316
were O 0 5.238358426140621e-05
identified O 0 0.001057113753631711
in O 0 0.00023028001305647194
four O 0 0.0011368925916031003
patients O 1 0.9999970197677612
, O 0 0.00025595640181563795
three O 0 6.640772335231304e-05
of O 0 4.3053325498476624e-05
whom O 0 0.003954723943024874
belonged O 0 0.0022401667665690184
to O 0 4.629132308764383e-05
the O 0 0.00018408166943117976
non O 0 0.010210568085312843
- O 0 0.46360263228416443
FAP O 1 0.9999204874038696
group O 0 0.001422907691448927
of O 0 0.0014558840775862336
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999995231628418
. O 0 0.0008019892266020179

Genotype O 1 0.9791847467422485
- O 0 0.06738670915365219
phenotype O 0 0.07946181297302246
correlations O 0 0.008774437941610813
identified O 0 0.001636304659768939
significant O 0 0.0007801856263540685
differences O 0 0.001723123830743134
in O 0 0.00019695858645718545
the O 0 0.00020989749464206398
nature O 0 0.0011320431949570775
of O 0 1.4968327377573587e-05
certain O 0 0.0005784346139989793
extracolonic O 1 0.9990830421447754
manifestations O 1 0.9930672645568848
in O 0 0.004094382282346487
FAP B-Disease 1 0.9999997615814209
patients O 1 0.9999951124191284
belonging O 0 0.0014073161873966455
to O 0 6.8050911067985e-05
three O 0 9.34842464630492e-05
mutation O 0 0.0022759216371923685
subgroups O 0 0.003485912922769785
. O 0 0.0005978767876513302

CONCLUSIONS O 0 0.02323276177048683
Extended O 0 0.010686143301427364
genotype O 1 0.5475811958312988
- O 0 0.033237844705581665
phenotype O 0 0.04675240442156792
correlations O 0 0.005095479544252157
made O 0 0.00041567086009308696
in O 0 0.00018180720508098602
this O 0 0.00014361506327986717
study O 0 0.0040183039382100105
may O 0 0.0014438466168940067
have O 0 5.2705578127643093e-05
the O 0 0.0001241383288288489
potential O 0 0.0013447931269183755
to O 0 8.778473420534283e-05
determine O 0 0.0004411257104948163
the O 0 8.612621604697779e-05
most O 0 0.00013594840129371732
appropriate O 0 0.0017622344894334674
surveillance O 0 0.009327651932835579
and O 0 0.0007228963077068329
prophylactic O 1 0.9999960660934448
treatment O 1 0.9999985694885254
regimens O 1 0.9997822642326355
for O 0 0.000408879917813465
those O 0 0.0005618128343485296
patients O 1 0.9999988079071045
with O 0 0.00020474045595619828
mutations O 0 0.0053077577613294125
associated O 0 0.0005039615789428353
with O 0 0.00021073853713460267
life O 0 0.016456540673971176
threatening O 1 0.9964285492897034
conditions O 0 0.08582866936922073
. O 0 0.0009810541523620486

This O 0 0.000382304860977456
study O 0 0.0014438829384744167
also O 0 0.00020172934455331415
provided O 0 0.0005761834909208119
evidence O 0 0.0003105687501374632
for O 0 0.0002025266585405916
the O 0 0.0006622036453336477
pathological O 1 0.9986538887023926
nature O 0 0.0013770335353910923
of O 0 1.7107931853388436e-05
amino O 0 0.0006218611379154027
acid O 0 0.010573879815638065
changes O 0 0.000531625933945179
in O 0 0.0006814191001467407
APC O 1 0.9990668892860413
associated O 0 0.000640475598629564
with O 0 6.732874317094684e-05
both O 0 0.000693963491357863
FAP B-Disease 1 0.9999591112136841
and O 0 0.0003818426630459726
non O 1 0.5589683055877686
- O 1 0.9999915361404419
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999998807907104
. O 0 0.00037574832094833255
. O 0 0.00036536407424136996

Inherited B-Disease 1 0.9999996423721313
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.5375871062278748
cancer B-Disease 1 1.0
risk O 0 0.05663048475980759
of O 0 2.1288658899720758e-05
the O 0 0.0006136300507932901
APC O 1 0.999099612236023
I1307K O 0 0.09178020805120468
polymorphism O 0 0.00546460784971714
. O 0 0.0005111740902066231

Germ O 1 0.999884843826294
- O 0 0.02535606175661087
line O 0 0.002454963279888034
and O 0 0.000285703397821635
somatic O 0 0.029845673590898514
truncating O 0 0.39545419812202454
mutations O 0 0.0011444101110100746
of O 0 2.06718614208512e-05
the O 0 0.0009336184011772275
APC B-Disease 1 0.9996509552001953
gene O 0 0.0025995306205004454
are O 0 1.9385208361200057e-05
thought O 0 0.0005108007462695241
to O 0 0.00014110545453149825
initiate O 1 0.9976069927215576
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9999995231628418
formation O 0 0.21979409456253052
in O 0 0.002277277410030365
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.002219599671661854
sporadic O 1 0.9992175102233887
colorectal O 1 1.0
carcinogenesis O 1 0.9999974966049194
, O 0 0.0012480178847908974
respectively O 0 0.001439729705452919
. O 0 0.0005240461323410273

Recently O 0 0.01606079563498497
, O 0 0.00017819125787355006
an O 0 0.0005990666104480624
isoleucine O 1 0.996049702167511
- O 0 0.031397610902786255
- O 0 0.01206519827246666
> O 0 0.012507314793765545
lysine O 0 0.01604386605322361
polymorphism O 0 0.002611490897834301
at O 0 0.0016789446817710996
codon O 0 0.020433209836483
1307 O 1 0.9229859709739685
( O 0 0.0029306402429938316
I1307K O 0 0.08677131682634354
) O 0 0.00014588230988010764
of O 0 1.4967699826229364e-05
the O 0 0.0008238325826823711
APC B-Disease 1 0.9993829727172852
gene O 0 0.0052315532229840755
has O 0 0.0007453467696905136
been O 0 0.00047904669190756977
identified O 0 0.0009749908931553364
in O 0 0.0002405921695753932
6 O 0 0.0028601260855793953
% O 0 0.0002597494749352336
- O 0 0.009382923133671284
7 O 0 0.001037425477989018
% O 0 2.0725887225125916e-05
of O 0 1.601966687303502e-05
the O 0 0.000859501538798213
Ashkenazi O 1 0.9950413107872009
Jewish O 0 0.0030268593691289425
population O 0 0.00025195241323672235
. O 0 0.0005928025930188596

To O 0 0.0007128528086468577
assess O 0 0.02419833093881607
the O 0 0.00035934470361098647
risk O 0 0.011831424199044704
of O 0 1.4772726899536792e-05
this O 0 9.899552242131904e-05
common O 0 0.006495583336800337
APC B-Disease 1 0.9995193481445312
allelic O 1 0.7531983256340027
variant O 1 0.7950747609138489
in O 0 0.007083363831043243
colorectal O 1 1.0
carcinogenesis O 1 0.9999951124191284
, O 0 0.0010157639626413584
we O 0 0.00023357260215561837
have O 0 6.253999163163826e-05
analyzed O 0 0.0008043101406656206
a O 0 0.0001842354831751436
large O 0 0.00018358175293542445
cohort O 0 0.004686151165515184
of O 0 5.392822276917286e-05
unselected O 1 0.996297299861908
Ashkenazi O 1 0.9947112798690796
Jewish O 0 0.003185160690918565
subjects O 0 0.005156209226697683
with O 0 0.0018481092993170023
adenomatous B-Disease 1 0.9999998807907104
polyps I-Disease 1 0.9999827146530151
and O 0 0.00041123959817923605
. O 0 0.0004939768114127219
or O 1 0.7731034755706787
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.0003700405650306493
for O 0 0.0001880841446109116
the O 0 0.0006480398587882519
APC O 1 0.9986525177955627
I1307K O 0 0.08586902171373367
polymorphism O 0 0.005810536444187164
. O 0 0.0006305201095528901

The O 0 0.0029291165992617607
APC O 1 0.9911412000656128
I1307K O 0 0.13001443445682526
allele O 0 0.014740853570401669
was O 0 0.0030887171160429716
identified O 0 0.0015154241118580103
in O 0 0.0003149383992422372
48 O 0 0.005726626142859459
( O 0 0.0010805231286212802
10 O 0 0.0009917373536154628
. O 0 0.00016774694086052477
1 O 0 0.001214692834764719
% O 0 6.184320227475837e-05
) O 0 0.00015182787319645286
of O 0 0.00010822506010299549
476 O 1 0.999250590801239
patients O 1 0.999998927116394
. O 0 0.0009948053630068898

Compared O 0 0.004547799471765757
with O 0 8.854136103764176e-05
the O 0 0.00020473614858929068
frequency O 0 0.0004216112429276109
in O 0 0.0001742890599416569
two O 0 4.7823683416936547e-05
separate O 0 0.00021158333402127028
population O 0 8.816786430543289e-05
control O 0 0.001429678639397025
groups O 0 6.325181311694905e-05
, O 0 0.0002516839886084199
the O 0 0.0011853385949507356
APC O 1 0.9992990493774414
I1307K O 0 0.2363305240869522
allele O 0 0.014982525259256363
is O 0 0.0008915046928450465
associated O 0 0.0003846424806397408
with O 0 3.83595543098636e-05
an O 0 0.0002508244360797107
estimated O 0 0.0011518077226355672
relative O 0 0.0011053974740207195
risk O 0 0.022817112505435944
of O 0 5.818269346491434e-05
1 O 0 0.004532549995929003
. O 0 0.0006265126285143197

5 O 0 0.007218752056360245
- O 0 0.00848623737692833
1 O 0 0.0020398146007210016
. O 0 0.00038912042509764433

7 O 0 0.004543708637356758
for O 0 0.0037693744525313377
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999871253967285
( O 0 0.0021010420750826597
both O 0 0.0013013452989980578
P O 1 0.9920054078102112
= O 0 0.018099313601851463
. O 0 0.0008377079502679408
01 O 1 0.9987674951553345
) O 0 0.0008079484687186778
. O 0 0.0005774422315880656

Furthermore O 0 0.010689315386116505
, O 0 0.00036844928399659693
compared O 0 0.0010777376592159271
with O 0 0.0002832170284818858
noncarriers O 1 0.9947276711463928
, O 0 0.002151122083887458
APC O 1 0.9995465874671936
I1307K O 1 0.7742957472801208
carriers O 0 0.014732218347489834
had O 0 0.0004174856294412166
increased O 0 0.00011464451381471008
numbers O 0 2.172180757042952e-05
of O 0 5.116457032272592e-05
adenomas B-Disease 1 0.9999973773956299
and O 0 0.007108896970748901
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999982118606567
per O 0 0.0013832595432177186
patient O 1 0.9999830722808838
( O 0 0.003250176552683115
P O 1 0.9909837245941162
= O 0 0.02133486606180668
. O 0 0.0010188731830567122
03 O 1 0.997285008430481
) O 0 0.0006401903228834271
, O 0 0.00020358007168397307
as O 0 0.0001942235103342682
well O 0 0.00013646208390127867
as O 0 0.00019702527788467705
a O 0 0.0010740779107436538
younger O 0 0.007532564923167229
age O 0 0.003258976386860013
at O 0 0.01116217765957117
diagnosis O 1 0.9999997615814209
. O 0 0.0012054919498041272

We O 0 0.0011572317453101277
conclude O 0 0.004331178963184357
that O 0 4.8364963731728494e-05
the O 0 0.0005046199075877666
APC O 1 0.998384952545166
I1307K O 0 0.36401498317718506
variant O 0 0.036703675985336304
leads O 0 0.002190524712204933
to O 0 0.00014778997865505517
increased O 0 0.00480771716684103
adenoma B-Disease 1 0.9999998807907104
formation O 0 0.06789838522672653
and O 0 0.00022331839136313647
directly O 0 0.000915932294446975
contributes O 0 0.021987009793519974
to O 0 0.00021425654995255172
3 O 0 0.001183545682579279
% O 0 0.00019299516861792654
- O 0 0.00560509879142046
4 O 0 0.0005021969554945827
% O 0 1.0317427950212732e-05
of O 0 7.13636472937651e-06
all O 0 0.00014559508417733014
Ashkenazi O 1 0.9998505115509033
Jewish O 1 0.9992559552192688
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0017219759756699204

The O 0 0.0005892001208849251
estimated O 0 0.0009914444526657462
relative O 0 0.0015811929479241371
risk O 0 0.3924250900745392
for O 0 0.0007760851876810193
carriers O 0 0.050546444952487946
may O 0 0.0025124948006123304
justify O 0 0.009739627130329609
specific O 0 0.0015135370194911957
clinical O 1 0.9999371767044067
screening O 0 0.006885638926178217
for O 0 0.00018892946536652744
the O 0 0.00039235304575413465
360 O 0 0.022064419463276863
, O 0 0.0006192408036440611
000 O 0 0.00842443760484457
Americans O 0 0.001232585753314197
expected O 0 0.0005813980242237449
to O 0 0.0001252236688742414
harbor O 0 0.018152089789509773
this O 0 0.00010218987881671637
allele O 0 0.008188579231500626
, O 0 0.0004863415961153805
and O 0 0.00032701139571145177
genetic O 0 0.005160083528608084
testing O 0 0.009210806339979172
in O 0 0.0001352485123788938
the O 0 9.117653098655865e-05
setting O 0 0.00045121769653633237
of O 0 5.3634143114322796e-05
long O 0 0.014039712958037853
- O 0 0.015858156606554985
term O 0 0.007912331260740757
- O 0 0.0051543316803872585
outcome O 0 0.0013264593435451388
studies O 0 0.0006612680153921247
may O 0 0.0006007058545947075
impact O 0 0.0018030967330560088
significantly O 0 0.026178613305091858
on O 0 0.07010212540626526
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.9999772310256958
in O 0 0.00015598353638779372
this O 0 4.3126790842507035e-05
population O 0 9.023322490975261e-05
. O 0 0.0005126488395035267

Localization O 0 0.012948459014296532
of O 0 9.490367665421218e-05
human O 0 0.009418193250894547
BRCA1 O 1 0.9991917014122009
and O 0 0.00024635353474877775
its O 0 0.00031611876329407096
loss O 0 0.0072695533744990826
in O 0 0.0003064051561523229
high O 0 0.010809705592691898
- O 0 0.015942662954330444
grade O 0 0.053104352205991745
, O 0 0.00033214129507541656
non B-Disease 0 0.013236435130238533
- I-Disease 1 0.998957633972168
inherited I-Disease 1 0.9999967813491821
breast I-Disease 1 1.0
carcinomas I-Disease 1 0.9999995231628418
. O 0 0.001765892026014626

Although O 0 0.0010993340983986855
the O 0 0.00020132178906351328
link O 0 0.0039667971432209015
between O 0 0.00013435761502478272
the O 0 0.0012709032744169235
BRCA1 O 1 0.9999996423721313
tumour B-Disease 1 1.0
- O 0 0.08985884487628937
suppressor O 0 0.04401862621307373
gene O 0 0.0020330939441919327
and O 0 0.0005090014892630279
hereditary B-Disease 1 0.9999970197677612
breast I-Disease 1 1.0
and I-Disease 1 0.9942552447319031
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 0.0011965385638177395
established O 0 0.0008475641370750964
, O 0 0.00014396839833352715
the O 0 0.00024696829495951533
role O 0 0.005977167282253504
, O 0 0.0003987009695265442
if O 0 0.00031901069451123476
any O 0 5.595745096798055e-05
, O 0 9.307578147854656e-05
of O 0 6.936231511645019e-05
BRCA1 O 1 0.9998981952667236
in O 0 0.0005457602092064917
non B-Disease 0 0.05342688411474228
- I-Disease 1 0.9981829524040222
familial I-Disease 1 0.9999970197677612
cancers I-Disease 1 0.9999996423721313
is O 0 0.0015929914079606533
unclear O 0 0.0034602812957018614
. O 0 0.0004652613715734333

BRCA1 O 1 0.9998038411140442
mutations O 0 0.00413612462580204
are O 0 4.181257099844515e-05
rare O 0 0.0034910528920590878
in O 0 0.00046235122135840356
sporadic B-Disease 1 0.7272587418556213
cancers I-Disease 1 0.9999994039535522
, O 0 0.0005513723008334637
but O 0 0.0002950876369141042
loss O 0 0.006093921605497599
of O 0 0.0001254678500117734
BRCA1 O 1 0.9999736547470093
resulting O 0 0.0026763181667774916
from O 0 0.00015684141544625163
reduced O 0 0.0036795870400965214
expression O 0 0.0011617568088695407
or O 0 0.0005211892421357334
incorrect O 0 0.008093909360468388
subcellular O 0 0.026954295113682747
localization O 0 0.01862148940563202
is O 0 0.0008220612071454525
postulated O 0 0.008679800666868687
to O 0 4.928164344164543e-05
be O 0 2.3779573893989436e-05
important O 0 0.00010259722330374643
in O 0 0.0001306836784351617
non B-Disease 0 0.014711090363562107
- I-Disease 1 0.9979977011680603
familial I-Disease 1 0.9999986886978149
breast I-Disease 1 1.0
and I-Disease 1 0.9230197072029114
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.0017203408060595393

Epigenetic O 0 0.048099335283041
loss O 0 0.03873676434159279
, O 0 0.0005960068665444851
however O 0 0.0006487777573056519
, O 0 0.00039916494279168546
has O 0 0.0007105105905793607
not O 0 0.00020191716612316668
received O 0 0.001859711715951562
general O 0 0.002651090733706951
acceptance O 0 0.017054779455065727
due O 0 0.0025736894458532333
to O 0 0.0001644792646402493
controversy O 0 0.0015905866166576743
regarding O 0 0.0004421217308845371
the O 0 0.00013421739276964217
subcellular O 0 0.010336772538721561
localization O 0 0.00726702157407999
of O 0 0.00015902497398201376
BRCA1 O 1 0.9983915686607361
proteins O 0 0.0005177455605007708
, O 0 0.0003807572356890887
reports O 0 0.0005104131414555013
of O 0 2.6537671146797948e-05
which O 0 9.845082240644842e-05
have O 0 0.00015288563736248761
ranged O 0 0.004890313372015953
from O 0 0.00012565079669002444
exclusively O 0 0.001078990986570716
nuclear O 0 0.00655199633911252
, O 0 0.0002594489778857678
to O 0 0.00026018000789918005
conditionally O 0 0.07099062949419022
nuclear O 0 0.003635922446846962
, O 0 0.00011375852045603096
to O 0 9.495834819972515e-05
the O 0 0.001306856982409954
ER O 1 0.9999934434890747
/ O 1 0.9478509426116943
golgi O 1 0.943112850189209
, O 0 0.0004017940373159945
to O 0 0.0001574777124915272
cytoplasmic O 0 0.011777769774198532
invaginations O 0 0.1082737147808075
into O 0 0.00012667577539104968
the O 0 0.000182580784894526
nucleus O 0 0.012673009186983109
. O 0 0.0006645853281952441

In O 0 0.0006587153184227645
an O 0 0.0002810489968396723
attempt O 0 0.0019034603610634804
to O 0 0.00023298720770981163
resolve O 0 0.02095724456012249
this O 0 0.00015375857765320688
issue O 0 0.0020702998153865337
, O 0 0.000215502645005472
we O 0 0.0001906636607600376
have O 0 0.0001143537592724897
comprehensively O 0 0.07246343046426773
characterized O 0 0.021314747631549835
19 O 0 0.0040961699560284615
anti O 0 0.02370052970945835
- O 0 0.45687490701675415
BRCA1 O 1 0.9996048808097839
antibodies O 0 0.02746398001909256
. O 0 0.0006263458635658026

These O 0 0.0001640336704440415
reagents O 0 0.023571576923131943
detect O 0 0.014094417914748192
a O 0 0.0012557373847812414
220 O 0 0.009873542003333569
- O 0 0.01716768555343151
kD O 0 0.14988861978054047
protein O 0 0.0008618157007731497
localized O 0 0.008625246584415436
in O 0 0.00011840731895063072
discrete O 0 0.0029487633146345615
nuclear O 0 0.011600871570408344
foci O 0 0.03734245523810387
in O 0 0.00017169803322758526
all O 0 0.0001600054238224402
epithelial O 1 0.9995469450950623
cell O 0 0.013379409909248352
lines O 0 0.0018549389205873013
, O 0 0.00019796323613263667
including O 0 5.2529750973917544e-05
those O 0 4.693027221946977e-05
derived O 0 0.0003350797633174807
from O 0 0.0008999689016491175
breast B-Disease 1 1.0
malignancies I-Disease 1 0.9999462366104126
. O 0 0.0014858631184324622

Immunohistochemical O 1 0.9985565543174744
staining O 1 0.6038904786109924
of O 0 9.883064922178164e-05
human O 0 0.26796168088912964
breast O 1 1.0
specimens O 0 0.007287497632205486
also O 0 0.0005774559685960412
revealed O 0 0.06846322864294052
BRCA1 O 1 0.999687671661377
nuclear O 0 0.009449665434658527
foci O 0 0.057984158396720886
in O 0 0.0008401353261433542
benign O 1 0.9999995231628418
breast O 1 1.0
, O 0 0.0035289658699184656
invasive B-Disease 1 0.9999996423721313
lobular I-Disease 1 1.0
cancers I-Disease 1 0.9999991655349731
and O 0 0.00030935657559894025
low B-Disease 0 0.01894109696149826
- I-Disease 1 0.9733570218086243
grade I-Disease 1 0.9996084570884705
ductal I-Disease 1 1.0
carcinomas I-Disease 1 0.9999991655349731
. O 0 0.001518928213045001

Conversely O 0 0.057770729064941406
, O 0 0.0016828584484755993
BRCA1 O 1 0.9989259839057922
expression O 0 0.002012575278058648
was O 0 0.002196903806179762
reduced O 0 0.006228265818208456
or O 0 0.001756323967128992
undetectable O 1 0.994534969329834
in O 0 0.00015414759400300682
the O 0 8.143463492160663e-05
majority O 0 9.026798943523318e-05
of O 0 3.6208133678883314e-05
high O 0 0.032255128026008606
- O 0 0.1760808527469635
grade O 1 0.9917094111442566
, O 0 0.0035678467247635126
ductal B-Disease 1 1.0
carcinomas I-Disease 1 0.9999997615814209
, O 0 0.0010281639406457543
suggesting O 0 0.0034386722836643457
that O 0 8.116436947602779e-05
absence O 0 0.002742012031376362
of O 0 0.00013631473120767623
BRCA1 O 1 0.9999922513961792
may O 0 0.003378774505108595
contribute O 0 0.0050123571418225765
to O 0 0.00014509477477986366
the O 0 0.0005797111662104726
pathogenesis O 1 0.999870777130127
of O 0 1.9579718355089426e-05
a O 0 0.0002463806013111025
significant O 0 0.00029063207330182195
percentage O 0 0.0002459581010043621
of O 0 5.3650717745767906e-05
sporadic B-Disease 1 0.9965038299560547
breast I-Disease 1 1.0
cancers I-Disease 1 0.9999997615814209
. O 0 0.0006172918947413564
. O 0 0.0005524633452296257

